


  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dichloro-4-fluoro-5-nitrobenzene
C6H2Cl2FNO2
2339-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 Cl 5.3901 5.3349 0.0 0
M  V30 6 Cl 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dichloro-N-methyl-2-nitrobenzenamine
C7H6Cl2N2O2
107342-18-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 Cl 5.3901 6.6687 0.0 0
M  V30 7 Cl 6.9302 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2339-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 107342-18-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis and Evaluation of New 1H-benzo[d]imidazole based PqsR
Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soukarieh, Fadi; Mashabi, Alaa; Richardson, William; Oton, Eduard Vico;
Romero, Manuel; Dubern, Jean-Frederic; Robertson, Shaun N.; Lucanto,
Simone; Markham-Lee, Zoe; Sou, Tomas; Kukavica-Ibrulj, Irena; Levesque,
Roger C.; Bergstrom, Christel A. S.; Halliday, Nigel; Kellam, Barrie;
Emsley, Jonas; Heeb, Stephan; Williams, Paul; Stocks, Michael J.; Camara,
Miguel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1008-1023

$RFMT $RIREG SCHEME2 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-3-nitrobenzoate
C8H6FNO4
329-59-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 1.5400 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 C 9.3359 1.5400 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 F 1.3337 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
36242-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 6.1600 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0
M  V30 5 C 1.3336 0.0000 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 O 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 6.1600 0.0 0
M  V30 9 C 9.3358 4.6200 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 15 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-59-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36242-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12131664
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 88% yield over two steps from 4-fluoro-3-nitrobenzoic acid
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM When Inhibitors Do Not Inhibit: Critical Evaluation of Rational Drug
Design Targeting Chorismate Mutase from Mycobacterium tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Munack, Steffi; Leroux, Vincent; Roderer, Kathrin; Oekvist, Mats; van
Eerde, Andre; Gundersen, Lise-Lotte; Krengel, Ute; Kast, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry & Biodiversity (2012), 9(11), 2507-2527

$RFMT $RIREG SCHEME3 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzoic acid
C7H4FNO4
453-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 453-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1333845
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Aminonitrobenzoic acids (5a-z). 4-fluoro-3-nitrobenzoic acid (4), amine
(1.1 equiv.) and sodium bicarbonate (2.1 equiv) in H2O (3 mL) was heated
to 150°C for 20 minutes under microwave irradiation in a sealed heavy
walled Pyrex tube. The resulting orange mixture was cooled, poured into
1M HCl (40 mL) and extracted into EtOAc. Solvent was removed under
reduced pressure to give a yellow solid (>95% yield) which was used
without further purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Alkyl-benzotriazole-5-carboxylic Acids Are Highly Selective Agonists of
the Human Orphan G-Protein-Coupled Receptor GPR109b
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Semple, Graeme; Skinner, Philip J.; Cherrier, Martin C.; Webb, Peter J.;
Sage, Carleton R.; Tamura, Susan Y.; Chen, Ruoping; Richman, Jeremy G.;
Connolly, Daniel T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2006), 49(4), 1227-1230

$RFMT $RIREG SCHEME4 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)benzimidazole
C8H7ClN2
4857-04-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 3.9554 0.0 0
M  V30 2 Cl 7.4149 3.1854 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3100 2.6673 0.0 0
M  V30 5 N 4.5865 1.6538 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 N 3.3406 3.8119 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 4.7474 3.1854 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-benzimidazole-2-methanamine
C9H11N3
98997-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5772 1.5400 0.0 0
M  V30 2 N 7.3472 2.8737 0.0 0
M  V30 3 C 8.8872 2.8737 0.0 0
M  V30 4 C 2.6673 2.3101 0.0 0
M  V30 5 C 2.6673 0.7700 0.0 0
M  V30 6 N 4.1321 2.7859 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 N 4.1321 0.2941 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.0371 1.5400 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4857-04-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98997-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20029152
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cooperative Mn(I)-complex catalyzed transfer hydrogenation of ketones and
imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ganguli, Kasturi; Shee, Sujan; Panja, Dibyajyoti; Kundu, Sabuj
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2019), 48(21), 7358-7366

$RFMT $RIREG SCHEME5 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4-Nitrophenyl)methylene]methanamine
C8H8N2O2
877-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5 CFG=2
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 877-80-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31477786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 16898-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, green chemistry-solvent, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 4,4'-Trimethylenedipiperidine, a safe and greener alternative for
piperidine, catalyzed the synthesis of N-methyl imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gorjian, Hayedeh; Khaligh, Nader Ghaffari
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research on Chemical Intermediates (2022), 48(5), 2035-2045

$RFMT $RIREG SCHEME6 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzaldehyde
C7H5ClO
587-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Chlorophenyl)methylene]methanamine
C8H8ClN
90434-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 N 6.6686 2.3100 0.0 0
M  V30 3 C 8.0022 3.0800 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 587-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90434-25-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1636248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gamma-lactams-A novel scaffold for highly potent and selective α7
nicotinic acetylcholine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enz, Albert; Feuerbach, Dominik; Frederiksen, Mathias U.; Gentsch,
Conrad; Hurth, Konstanze; Muller, Werner; Nozulak, Joachim; Roy, Bernard
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1287-1291

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-chloro-2-(methylthio)-5-pyrimidinecarboxylate
C8H9ClN2O2S
5909-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6675 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 O 2.3100 1.3338 0.0 0
M  V30 4 C 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 4.6201 0.0000 0.0 0
M  V30 7 S 9.2401 2.6675 0.0 0
M  V30 8 C 10.0101 4.0011 0.0 0
M  V30 9 C 4.6201 2.6675 0.0 0
M  V30 10 C 5.3901 1.3338 0.0 0
M  V30 11 C 5.3901 4.0011 0.0 0
M  V30 12 N 6.9301 1.3338 0.0 0
M  V30 13 N 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 1 7 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Pyrimidinecarboxylic acid, 4-(methylamino)-2-(methylthio)-, ethyl ester
C9H13N3O2S
76360-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3338 0.0 0
M  V30 2 C 5.3901 0.0000 0.0 0
M  V30 3 C 3.0801 4.0012 0.0 0
M  V30 4 O 2.3101 5.3348 0.0 0
M  V30 5 O 2.3101 2.6675 0.0 0
M  V30 6 C 0.7700 5.3348 0.0 0
M  V30 7 C 0.0000 6.6687 0.0 0
M  V30 8 S 9.2402 4.0012 0.0 0
M  V30 9 C 10.0102 5.3348 0.0 0
M  V30 10 C 5.3901 2.6675 0.0 0
M  V30 11 C 4.6201 4.0012 0.0 0
M  V30 12 N 6.9302 2.6675 0.0 0
M  V30 13 C 5.3901 5.3348 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 N 6.9302 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5909-24-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76360-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2429937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one
as a potent selective inhibitor of Polo like kinase 2 (PLK2)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reddy, M. V. Ramana; Akula, Balireddy; Jatiani, Shashidhar; Vasquez-Del
Carpio, Rodrigo; Billa, Vinay K.; Mallireddigari, Muralidhar R.; Cosenza,
Stephen C.; Venkata Subbaiah, D. R. C.; Bharathi, E. Vijaya; Pallela,
Venkat R.; Ramkumar, Poornima; Jain, Rinku; Aggarwal, Aneel K.; Reddy, E.
Premkumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(4), 521-544

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzenemethanamine
C9H13NO
41789-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41789-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1487518
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enabling Synthesis of Triple Reuptake Inhibitor (+)-BMS-820836, a
Potential Therapeutic Agent for the Treatment of Depression
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lobben, Paul C.; Amin, Rasidul; Chen, Bang-Chi; Cui, Wenge; Hu, Min;
Isherwood, Matthew; Liu, Shuang; Nacro, Kassoum; Miles, Brandon; Mobele,
Bingidimi; Olson, Richard E.; Wang, Bei; Yang, Yuh-Lin; Zhao, Rulin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2016), 20(1), 44-50

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromopyridine
C5H3Br2N
624-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 Br 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyridinamine
C6H7BrN2
84539-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 N 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 624-28-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 84539-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13824388
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 16: N-methyl-5-(tributylstannyl)pyridin-2-amine [0360]
2,5-Dibromopyridine (6 g, 25 mmol) in 40 ml 33% CH3NH2 in ethanol (13
eq.) was heated at 80 °C. for 60 hours. After evaporation the solid
residue was suspended in CH2Cl2, extracted 3× with 1 N HCl. The combined
aqueous phase was neutralized with 2 N NaOH (pH-10-11), and then back
extracted 3× with CH2Cl2. The combined CH2Cl2 phase was washed with water
and dried over sodium sulfate. Concentration gave 4.457 g of
5-bromo-N-methylpyridin-2-amine as off-white solid. (yield: 95.3%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods of treating hepatitis c virus with oxoacetamide compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM MacDonald, James E.; Jeffrey, McKelvy F.; Wong-Staal, Flossie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110117055 A1 2011-05-19

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone
C16H12Cl2O
79560-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 Cl 9.2400 6.6685 0.0 0
M  V30 3 Cl 10.7800 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 3.8500 5.3347 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 8.4700 2.6674 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene]methanamine
C17H15Cl2N
79560-20-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3348 0.0 0
M  V30 3 Cl 10.0101 6.6686 0.0 0
M  V30 4 Cl 11.5501 4.0011 0.0 0
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 5.3901 4.0011 0.0 0
M  V30 7 C 3.0800 2.6675 0.0 0
M  V30 8 C 5.3901 1.3338 0.0 0
M  V30 9 C 4.6201 5.3348 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6201 0.0000 0.0 0
M  V30 13 C 3.0800 5.3348 0.0 0
M  V30 14 C 3.0800 0.0000 0.0 0
M  V30 15 C 6.9301 4.0011 0.0 0
M  V30 16 C 7.7001 5.3348 0.0 0
M  V30 17 C 7.7001 2.6675 0.0 0
M  V30 18 C 9.2401 5.3348 0.0 0
M  V30 19 C 9.2401 2.6675 0.0 0
M  V30 20 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 3 18
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 2 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79560-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 79560-20-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19889151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of [3]ferrocenophane-derived N/B frustrated Lewis pairs for
the metal-free catalytic hydrogenation of imines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pan, Zhentao; Wang, Hui; Ling, Fei; Xiao, Lian; Song, Dingguo; Zhong,
Weihui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2019), 49(4), 522-528

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19397985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable Fe(III) phenoxyimines as selective and robust CO2/epoxide coupling
catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fazekas, Eszter; Nichol, Gary S.; Shaver, Michael P.; Garden, Jennifer A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2018), 47(37), 13106-13112

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2987235
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of azomethines: The starting azomethines I were prepared as
follows. Equimolar amounts of salicylaldehyde and an appropriate amine
were refluxed in benzene on a water bath with a Dean-Stark trap until the
water released during the reaction was completely removed. Then the
reaction mixture was concentrated on a rotary evaporator. Azomethines,
yellow oil, yield 95%. Empirical formula: C8H9NO. Content
(found/calculated), % C 71.18/71.09 H 6.92/6.71 N 10.49/10.49. Tm =
228-229°C. IR (ν, cm-1) 3100-3400 (OH) 1634 (C=N) 1276 (Ph-O). 1H NMR
(CDCl3, δ, ppm) 0.86 (3H, t, CH3, 3J = 6.6 Hz), 6.80-7.30 (4H, m, CAr-H),
8.01 (1H, s, CH=N), 13.26 (1H, s, OH).
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark head used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tribochemically active chelate complexes of salicylideneimines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Garnovskii, A. D.; Burlov, A. S.; Lysenko, K. A.; Garnovskii, D. A.;
Borodkina, I. G.; Ponomarenko, A. G.; Chigarenko, G. G.; Nikolaevskii, S.
A.; Minkin, V. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Coordination Chemistry (2009), 35(2), 120-127

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7568850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal carbene catalysts used in olefin metathesis, atom/group transfer
radical polymerization, addition reaction and vinylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verpoort, Francis Walter Cornelius; De Clercq, Bob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003062253 A1 2003-07-31

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Salicylaldehyde
C7H6O2
90-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Methylimino)methyl]phenol
C8H9NO
3117-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 O 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3117-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5124903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal carbene complexes, methods and intermediates for making them and
their use in metathesis reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Verpoort, Francis Walter Cornelius; De Clercq, Bob
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP1329455 A1 2003-07-23

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitrobenzoic acid
C7H4ClNO4
96-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22408363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Computer-aid drug design, synthesis, and anticoagulant activity
evaluation of novel dabigatran derivatives as thrombin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Shanshan; Ren, Yujie; Peng, Xiuxiu; Qian, Pingping; Meng, Lingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Pharmaceutical Sciences (2019), 137104965

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-nitrobenzoic acid
C7H4ClNO4
96-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-nitrobenzoic acid
C8H8N2O4
41263-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 96-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41263-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9703869
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and structural exploration of novel fluorinated
dabigatran derivatives as direct thrombin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mei-Lin; Ren, Yu-Jie; Dong, Ming-Hui; Ren, Wei-Xin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2015), 96122-138

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19512652
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino methyl benzimidazol ethyl butanoate via iron powder
catalyzed reduction of dinitrochlorobenzene and methylamine.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mathiyazhagan, Kasinathan; Srinivas, Satti; Prasad, J. V. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Journal of Pharmacy and Pharmaceutical Sciences (2018), 7(5),
1446-1453

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2,4-dinitrobenzene
C6H3ClN2O4
97-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Cl 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4-dinitroaniline
C7H7N3O4
2044-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 97-00-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2044-88-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2685310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: Methylamine (40% w/w solution; 34 mL) was added to a solution of
1-chloro-2,4-dinitrobenzene (12.3 g, 61 mmol) in ethanol (120 mL), at
0°C. The mixture was stirred at room temperature for 15 h. The solvent
was evaporated under reduced pressure and the brown oil residue was
treated with hot water. The precipitate was filtered and dried to yield
over 95% yield of 1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroxamic acid derivatives as histone deacetylase inhibitors and their
preparation and use in the treatment of disease
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Yu; Chen, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010085377 A2 2010-07-29

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chloropyridine-2-carboxylate
C7H6ClNO2
24484-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24484-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11825932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and biological activities of thiourea containing
sorafenib analogs as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yao, Jianwen; Chen, Jing; He, Zuopeng; Sun, Wei; Xu, Wenfang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2012), 20(9), 2923-2929

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35576112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Degrader compounds and application
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veits, Gesine Kerstin; Fitzgerald, Mark E.; Hird, Alexander W.; Sweis,
Ramzi F.; Kort, Michael E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022271727 A1 2022-12-29

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31611313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM closed flask used, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1H-Benzo[d]imidazole derivatives as TLR9 inhibitors for the treatment of
fibrosis and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoon, David S.; Regueiro-Ren, Alicia; Mandler, Michael; Posy, Shoshana L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022040260 A1 2022-02-24

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31094344
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as BRAF degraders for treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolente, Cosimo; Duplessis, Martin; Fitzgerald, Mark E.; Garza, Victoria;
Good, Andrew Charles; Hewings, David Stephen; Hunziker, Daniel; Jackson,
Katrina L.; Kuhn, Bernd; Liang, Yanke; Moustakim, Moses; Nasveschuk,
Christopher G.; O'Shea, Morgan Welzel; Pettazzoni, Piergiorgio Francesco
Tommaso; Ricklin, Fabienne; Riemer, Claus; Veits, Gesine Kerstin;
Wichmann, Juergen; Yap, Jeremy L.; Yu, Robert T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021255212 A1 2021-12-23

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23972382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted naphthyl thiadiazolidinones as protein
tyrosine phosphatase degraders and methods of use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Veits, Gesine Kerstin; Fitzgerald, Mark E.; Hird, Alexander W.;
Henderson, James A.; Vora, Harit U.; Sweis, Ramzi F.; Nasveschuk,
Christopher G.; Duplessis, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021127586 A1 2021-06-24

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20091496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of protein targeting, ubiquitin ligase binding bifunctional
compounds as protein degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Zhang, Yi; Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019060742 A1 2019-03-28

$RFMT $RIREG SCHEME15 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluoro-1-nitrobenzene
C6H3BrFNO2
321-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Br 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-nitrobenzenamine
C7H7BrN2O2
302800-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 321-23-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 302800-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17091827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted quinoxaline derivatives as PFKFB3 inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fabritius, Charles-Henry Robert Yves; Nowak, Mateusz Oktawian; Wiklik,
Katarzyna Anna; Sabiniarz, Aleksandra Barbara; Bien, Marcin Dominik;
Buda, Anna Malgorzata; Guzik, Pawel Szczepan; Jakubiec, Krzysztof Roman;
Maciuszek, Monika; Kwiecinska, Katarzyna; Tomczyk, Mateusz Michal;
Galezowski, Michal Mikolaj; Gondela, Andrzej; Dudek, Lukasz Piotr
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016180536 A1 2016-11-17

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-1-fluoro-2-nitrobenzene
C6H3ClFNO2
345-18-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Cl 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
15950-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0 VAL=5
M  V30 2 O 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 345-18-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15950-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825110
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis and Evaluation of New 1H-benzo[d]imidazole based PqsR
Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soukarieh, Fadi; Mashabi, Alaa; Richardson, William; Oton, Eduard Vico;
Romero, Manuel; Dubern, Jean-Frederic; Robertson, Shaun N.; Lucanto,
Simone; Markham-Lee, Zoe; Sou, Tomas; Kukavica-Ibrulj, Irena; Levesque,
Roger C.; Bergstrom, Christel A. S.; Halliday, Nigel; Kellam, Barrie;
Emsley, Jonas; Heeb, Stephan; Williams, Paul; Stocks, Michael J.; Camara,
Miguel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1008-1023

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoronitrobenzene
C6H3F2NO2
446-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
120381-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 F 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120381-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41595483
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From methylene bridged diindole to carbonyl linked benzimidazoleindole:
Development of potent and metabolically stable PCSK9 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Haibo; Yang, Ka; Winston-McPherson, Gabrielle N.; Stapleton, Donnie
S.; Keller, Mark P.; Attie, Alan D.; Smith, Kerry A.; Tang, Weiping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 206112678

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Difluoronitrobenzene
C6H3F2NO2
446-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 F 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
120381-42-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 F 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 120381-42-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22326419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 7-aminopyrido[2,3-b]indole compounds and their
prodrugs for the treatment and prophylaxis of bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Xiao; Liu, Yongqiang; Shen, Hong; Shi, Houguang; Tan, Xuefei; Zhou,
Chengang; Zhou, Mingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020064661 A1 2020-04-02

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36799818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel bifunctional compounds as Tyk2 degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marx, Isaac; Yates, Christopher Michael; Zhu, Xiao; Pennington, Lewis
Dale; Comer, Eamon; Ford, Melissa
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023076161 A1 2023-05-04

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36504840
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctionalized compounds as MDM2 degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023049790 A2 2023-03-30

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36294496
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of the Bcl-xl degraders and their medical applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aversa, Robert; Yang, Bin; Dong, Huijun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023044046 A1 2023-03-23

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35810325
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mk2 degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yang, Bin; Weiss, Matthew M.; Zhu, Xiao; Dong, Huijun; Marx, Isaac
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023278759 A1 2023-01-05

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35166936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterobifunctional compounds as CDK2 degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Xiaozhang; Zhang, Yi; Aversa, Robert; Zhu, Xiao; Collier, Philip
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022236058 A1 2022-11-10

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33767960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022147465 A1 2022-07-07

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33369724
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused heterocyclic compounds as IRAK4 degraders and their preparation,
pharmaceutical compositions and use in the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022125790 A1 2022-06-16

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32244909
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of trifunctional compounds as IRAK4 degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022087216 A1 2022-04-28

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31729131
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapidly accelerating fibrosarcoma protein degrading compounds and
associated methods of use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hornberger, Keith R.; Snyder, Lawrence B.; Wang, Jing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022047145 A1 2022-03-03

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30644799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of deuterated heterobifunctional compounds as IRAK degraders
and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021247897 A1 2021-12-09

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27642919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Crystalline forms of IRAK degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zheng, Xiaozhang; Corson, Don
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021247899 A1 2021-12-09

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24567503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as MDM2 degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021188948 A1 2021-09-23

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24193210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel bifunctional compounds as IRAK degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021158634 A1 2021-08-12

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24033023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzothiazole derivatives as IRAK degraders and uses
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weiss, Matthew M.; Zheng, Xiaozhang; Zhu, Xiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021127283 A2 2021-06-24

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23739059
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020264499 A1 2020-12-30

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-23588789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocycles as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Weiss, Matthew M.; Zheng, Xiaozhang; Zhang, Yi;
Fleming, Paul R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020264490 A1 2020-12-30

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22610678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bifunctional compounds as IRAK degraders and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi;
Zheng, Xiaozhang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020113233 A1 2020-06-04

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20995281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptide conjugates as IRAK4 protein kinase degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20190192668 A1 2019-06-27

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Bromo-2-fluoro-3-nitrobenzene
C6H3BrFNO2
58534-94-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.0800 0.0 0 VAL=5
M  V30 2 O 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 4.6200 0.0 0
M  V30 4 F 2.6674 4.6200 0.0 0
M  V30 5 Br 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methyl-6-nitrobenzenamine
C7H7BrN2O2
1004618-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0 VAL=5
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 O 6.6686 2.3100 0.0 0
M  V30 6 Br 0.0000 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 2.3100 0.0 0
M  V30 10 C 4.0011 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58534-94-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1004618-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20132661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of functionalized pyrazoles and other nitrogen-containing
heterocycles as inhibitors of MCT4 for the treatment of MCT4-mediated
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Parnell, Kenneth Mark; McCall, John; Romero, Donna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20180162822 A1 2018-06-14

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzaldehyde
C8H8O2
591-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3-Methoxyphenyl)methylene]methanamine
C9H11NO
16928-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 591-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16928-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8636759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gamma-lactams-A novel scaffold for highly potent and selective α7
nicotinic acetylcholine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enz, Albert; Feuerbach, Dominik; Frederiksen, Mathias U.; Gentsch,
Conrad; Hurth, Konstanze; Muller, Werner; Nozulak, Joachim; Roy, Bernard
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1287-1291

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzoyl chloride
C7H4Cl2O
618-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methylbenzamide
C8H8ClNO
18370-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 618-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18370-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzoyl chloride
C7H4Cl2O
618-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methylbenzamide
C8H8ClNO
18370-10-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 618-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18370-10-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-19960050
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen Bond-Accelerated meta-Selective C-H Borylation of Aromatic
Compounds and Expression of Functional Group and Substrate Specificities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Xu; Yoshigoe, Yusuke; Ida, Haruka; Nishi, Mitsumi; Kanai, Motomu;
Kuninobu, Yoichiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2019), 9(3), 1705-1709

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitrobenzene
C6H4ClNO2
88-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19796975
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deciphering the Influence of Meridional versus Facial Isomers in Spin
Crossover Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lathion, Timothee; Guenee, Laure; Besnard, Celine; Bousseksou, Azzedine;
Piguet, Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2018), 24(63), 16873-16888

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitrobenzene
C6H4ClNO2
88-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenamine
C7H8N2O2
612-28-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 612-28-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9766086
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of 2-iminobenzimidazoles as potent hepatitis C virus inhibitors
with a novel mechanism of action
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Windisch, Marc Peter; Jo, Suyeon; Kim, Hee-Young; Kim, Soo-Hyun; Kim,
Keumhyun; Kong, Sunju; Jeong, Hyangsuk; Ahn, Sujin; No, Zaesung; Hwang,
Jong Yeon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 7835-42

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzoyl chloride
C8H4ClF3O
329-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 Cl 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-methyl-4-(trifluoromethyl)-
C9H8F3NO
65017-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 O 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65017-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292385
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzoyl chloride
C8H4ClF3O
329-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 Cl 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-methyl-4-(trifluoromethyl)-
C9H8F3NO
65017-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 O 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65017-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585786
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzoyl chloride
C8H4ClF3O
329-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.5400 0.0 0
M  V30 2 F 6.9300 3.0800 0.0 0
M  V30 3 F 8.4700 1.5400 0.0 0
M  V30 4 F 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 Cl 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, N-methyl-4-(trifluoromethyl)-
C9H8F3NO
65017-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 N 8.4700 2.8736 0.0 0
M  V30 7 O 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 329-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65017-76-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11975455
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. N-methyl-4-(trifluoromethyl) benzamide 1e. White
solid. Yield: (60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-4-nitrophenol
C6H4FNO3
394-41-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-4-nitrophenol
C7H8N2O3
14703-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 O 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-41-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14703-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14903068
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
N-[3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl]-2-(aryloxy)acetamide
as PRMT5 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duncan, Kenneth W.; Chesworth, Richard; Boriack-Sjodin, Paula Ann;
Munchhof, Michael John; Jin, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014100730 A1 2014-06-26

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzamide
C8H8FNO
701-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzamide
C8H8FNO
701-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-methylbenzamide
C8H8FNO
701-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 F 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-714743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 4-fluoro-N-methylbenzamide 1g. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzoyl chloride
C7H4BrClO
586-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzoyl chloride
C7H4BrClO
586-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585790
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzoyl chloride
C7H4BrClO
586-75-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Br 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methylbenzamide
C8H8BrNO
27466-83-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-75-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 27466-83-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-12268103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 4-bromo-N-methylbenzamide 1i. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-2314466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM methylamine also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Naphthalimides exhibit in vitro antiproliferative and antiangiogenic
activities by inhibiting both topoisomerase II (topo II) and receptor
tyrosine kinases (RTKs)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xin; Chen, Zhuo; Tong, Linjiang; Tan, Shaoying; Zhou, Wei; Peng,
Ting; Han, Kun; Ding, Jian; Xie, Hua; Xu, Yufang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 65477-486

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1,8-naphthalic anhydride
C12H5BrO3
81-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.0000 0.0 0
M  V30 2 O 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 6.6685 3.8500 0.0 0
M  V30 13 C 5.3347 6.1600 0.0 0
M  V30 14 O 1.3336 2.3100 0.0 0
M  V30 15 C 6.6685 2.3100 0.0 0
M  V30 16 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 14
M  V30 16 1 11 16
M  V30 17 2 12 15
M  V30 18 2 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81-86-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-2763759
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new PET fluorescent sensor for Zn2+
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Jiangli; Peng, Xiaojun; Wu, Yunkou; Lu, Erhu; Hou, Jun; Zhang,
Hongbing; Zhang, Rong; Fu, Xinmei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Luminescence (2005), 114(2), 125-130

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37016100
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leit, Silvana; Greenwood, Jeremy; Carriero, Samantha; Mondal, Sayan;
Abel, Robert; Ashwell, Mark; Blanchette, Heather; Boyles, Nicholas A.;
Cartwright, Mark; Collis, Alan; Feng, Shulu; Ghanakota, Phani; Harriman,
Geraldine C.; Hosagrahara, Vinayak; Kaila, Neelu; Kapeller, Rosanna;
Rafi, Salma B.; Romero, Donna L.; Tarantino, Paul M.; Timaniya, Jignesh;
Toms, Angela V.; Wester, Ronald T.; Westlin, William; Srivastava,
Bhaskar; Miao, Wenyan; Tummino, Peter; McElwee, Joshua J.; Edmondson,
Scott D.; Masse, Craig E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(15), 10495-10518

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5,7-dichloropyrazolo[1,5-a]pyrimidine-3-carboxylate
C9H7Cl2N3O2
940284-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6519 4.5602 0.0 0
M  V30 2 O 7.6823 5.7048 0.0 0
M  V30 3 O 7.1277 3.0957 0.0 0
M  V30 4 C 9.1887 5.3846 0.0 0
M  V30 5 C 10.2191 6.5290 0.0 0
M  V30 6 Cl 0.0000 4.6200 0.0 0
M  V30 7 Cl 2.6674 0.0000 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 N 2.6674 4.6200 0.0 0
M  V30 10 C 5.1454 4.8804 0.0 0
M  V30 11 N 4.0011 2.3100 0.0 0
M  V30 12 N 2.9876 6.1263 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 4.5191 6.2874 0.0 0
M  V30 15 C 2.6674 1.5400 0.0 0
M  V30 16 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-chloro-7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxylate
C10H11ClN4O2
2271470-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 4.6200 0.0 0
M  V30 2 C 0.0000 3.8500 0.0 0
M  V30 3 C 7.9856 4.5603 0.0 0
M  V30 4 O 9.0160 5.7048 0.0 0
M  V30 5 O 8.4614 3.0957 0.0 0
M  V30 6 C 10.5224 5.3846 0.0 0
M  V30 7 C 11.5529 6.5290 0.0 0
M  V30 8 Cl 4.0011 0.0000 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 N 4.3213 6.1263 0.0 0
M  V30 13 C 6.4791 4.8804 0.0 0
M  V30 14 N 5.3348 2.3100 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 5.8528 6.2874 0.0 0
M  V30 17 C 4.0011 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 2 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 940284-55-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2271470-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20912396
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazolopyrimidines as TYK2 inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Masse, Craig E.; Greenwood, Jeremy Robert; Mondal, Sayan; Cowen, Scott
D.; McLean, Thomas H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019023468 A1 2019-01-31

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzoyl chloride
C7H4ClFO
393-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methylbenzamide
C8H8FNO
52833-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 F 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 393-52-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52833-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292378
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzenemethanamine
C8H10N2O2
19499-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19499-60-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8320686
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development and in Vitro Evaluation of a Microbicide Gel Formulation for
a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the
N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tintori, Cristina; Brai, Annalaura; Dasso Lang, Maria Chiara; Deodato,
Davide; Greco, Antonia Michela; Bizzarri, Bruno Mattia; Cascone, Lorena;
Casian, Alexandru; Zamperini, Claudio; Dreassi, Elena; Crespan,
Emmanuele; Maga, Giovanni; Vanham, Guido; Ceresola, Elisa; Canducci,
Filippo; Arien, Kevin K.; Botta, Maurizio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2016), 59(6), 2747-2759

$RFMT $RIREG SCHEME30 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-fluoro-1-nitrobenzene
C6H3ClFNO2
700-37-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-N-methyl-2-nitrobenzenamine
C7H7ClN2O2
35966-84-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6674 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 Cl 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 700-37-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35966-84-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis and Evaluation of New 1H-benzo[d]imidazole based PqsR
Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soukarieh, Fadi; Mashabi, Alaa; Richardson, William; Oton, Eduard Vico;
Romero, Manuel; Dubern, Jean-Frederic; Robertson, Shaun N.; Lucanto,
Simone; Markham-Lee, Zoe; Sou, Tomas; Kukavica-Ibrulj, Irena; Levesque,
Roger C.; Bergstrom, Christel A. S.; Halliday, Nigel; Kellam, Barrie;
Emsley, Jonas; Heeb, Stephan; Williams, Paul; Stocks, Michael J.; Camara,
Miguel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1008-1023

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Difluoro-2-nitrobenzene
C6H3F2NO2
19064-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 F 2.3101 5.3350 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluoro-N-methyl-2-nitrobenzenamine
C7H7FN2O2
947255-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 4.0012 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 F 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19064-24-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 947255-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41595502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From methylene bridged diindole to carbonyl linked benzimidazoleindole:
Development of potent and metabolically stable PCSK9 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Haibo; Yang, Ka; Winston-McPherson, Gabrielle N.; Stapleton, Donnie
S.; Keller, Mark P.; Attie, Alan D.; Smith, Kerry A.; Tang, Weiping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 206112678

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (1S,3S)-1-(2,4-dichlorophenyl)-6,7-difluoro-2,3,4,9-tetrahydro-1H-pyrid...
C20H16Cl2F2N2O2
1918181-96-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 8.8071 0.0 0
M  V30 2 O 10.6696 8.0371 0.0 0
M  V30 3 O 9.3359 10.3471 0.0 0
M  V30 4 C 12.0033 8.8071 0.0 0
M  V30 5 C 13.3369 8.0371 0.0 0
M  V30 6 Cl 5.3348 11.1171 0.0 0
M  V30 7 F 7.5323 0.3220 0.0 0
M  V30 8 F 4.4692 0.0000 0.0 0
M  V30 9 Cl 0.0000 11.1171 0.0 0
M  V30 10 C 5.3348 6.4971 0.0 0
M  V30 11 C 6.6685 5.7270 0.0 0
M  V30 12 C 5.3348 8.0371 0.0 0 CFG=2
M  V30 13 N 4.1903 5.4666 0.0 0
M  V30 14 C 6.3483 4.2206 0.0 0
M  V30 15 C 8.0021 6.4971 0.0 0
M  V30 16 N 6.6685 8.8071 0.0 0
M  V30 17 C 4.8167 4.0597 0.0 0
M  V30 18 C 7.2535 2.9747 0.0 0
M  V30 19 C 8.0021 8.0371 0.0 0 CFG=1
M  V30 20 C 4.1903 2.6528 0.0 0
M  V30 21 C 6.6270 1.5679 0.0 0
M  V30 22 C 5.0955 1.4070 0.0 0
M  V30 23 C 4.0010 8.8071 0.0 0
M  V30 24 C 4.0010 10.3471 0.0 0
M  V30 25 C 2.6673 8.0371 0.0 0
M  V30 26 C 2.6673 11.1171 0.0 0
M  V30 27 C 1.3337 8.8071 0.0 0
M  V30 28 C 1.3337 10.3471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 19 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 24
M  V30 7 1 7 21
M  V30 8 1 8 22
M  V30 9 1 9 28
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 23 CFG=3
M  V30 17 1 13 17
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-1-(2,4-Dichlorophenyl)-6,7-difluoro-2,3,4,9-tetrahydro-N-methyl-1H-py...
C19H15Cl2F2N3O
1918182-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4464 2.3100 0.0 0
M  V30 2 N 5.1128 1.5400 0.0 0
M  V30 3 O 7.7802 1.5400 0.0 0
M  V30 4 C 5.1128 0.0000 0.0 0
M  V30 5 Cl 10.4475 4.6200 0.0 0
M  V30 6 F 0.0000 8.1144 0.0 0
M  V30 7 F 1.2528 10.9281 0.0 0
M  V30 8 Cl 13.1149 9.2400 0.0 0
M  V30 9 C 6.4464 6.9300 0.0 0
M  V30 10 C 5.1128 6.1600 0.0 0
M  V30 11 C 7.7802 6.1600 0.0 0 CFG=2
M  V30 12 N 6.1263 8.4364 0.0 0
M  V30 13 C 3.9684 7.1904 0.0 0
M  V30 14 C 5.1128 4.6200 0.0 0
M  V30 15 N 7.7802 4.6200 0.0 0
M  V30 16 C 4.5947 8.5974 0.0 0
M  V30 17 C 2.4367 7.0295 0.0 0
M  V30 18 C 6.4464 3.8500 0.0 0 CFG=1
M  V30 19 C 3.6895 9.8432 0.0 0
M  V30 20 C 1.5317 8.2753 0.0 0
M  V30 21 C 2.1580 9.6823 0.0 0
M  V30 22 C 9.1139 6.9300 0.0 0
M  V30 23 C 10.4475 6.1600 0.0 0
M  V30 24 C 9.1139 8.4700 0.0 0
M  V30 25 C 11.7812 6.9300 0.0 0
M  V30 26 C 10.4475 9.2400 0.0 0
M  V30 27 C 11.7812 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 18 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 23
M  V30 6 1 6 20
M  V30 7 1 7 21
M  V30 8 1 8 27
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 22 CFG=3
M  V30 16 1 12 16
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 17 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918181-96-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15830673
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-dichlorophenyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoq...
C19H19Cl2NO4
1918182-10-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 Cl 5.3348 10.0102 0.0 0
M  V30 4 C 9.3360 7.7002 0.0 0
M  V30 5 O 10.6697 6.9302 0.0 0
M  V30 6 O 9.3360 9.2402 0.0 0
M  V30 7 C 12.0033 7.7002 0.0 0
M  V30 8 O 5.3348 0.7700 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 Cl 0.0000 10.0102 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 N 6.6685 7.7002 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0 CFG=2
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 7.7002 0.0 0
M  V30 22 C 4.0012 9.2402 0.0 0
M  V30 23 C 2.6673 6.9302 0.0 0
M  V30 24 C 2.6673 10.0102 0.0 0
M  V30 25 C 1.3337 7.7002 0.0 0
M  V30 26 C 1.3337 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 22
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 21 CFG=3
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dichlorophenyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-N-methyl-3-is...
C19H20Cl2N2O3
1918182-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 2.3101 0.0 0
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 Cl 5.3348 10.0102 0.0 0
M  V30 4 C 9.3360 7.7002 0.0 0
M  V30 5 N 10.6697 6.9302 0.0 0
M  V30 6 O 9.3360 9.2402 0.0 0
M  V30 7 C 12.0033 7.7002 0.0 0
M  V30 8 O 5.3348 0.7700 0.0 0
M  V30 9 C 6.6685 0.0000 0.0 0
M  V30 10 Cl 0.0000 10.0102 0.0 0
M  V30 11 C 5.3348 5.3901 0.0 0
M  V30 12 C 5.3348 6.9302 0.0 0 CFG=2
M  V30 13 C 6.6685 4.6201 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 N 6.6685 7.7002 0.0 0
M  V30 16 C 8.0022 5.3901 0.0 0
M  V30 17 C 6.6685 3.0801 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 8.0022 6.9302 0.0 0 CFG=2
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 7.7002 0.0 0
M  V30 22 C 4.0012 9.2402 0.0 0
M  V30 23 C 2.6673 6.9302 0.0 0
M  V30 24 C 2.6673 10.0102 0.0 0
M  V30 25 C 1.3337 7.7002 0.0 0
M  V30 26 C 1.3337 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 3 22
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 19 4 CFG=3
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 20
M  V30 10 1 10 26
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 21 CFG=3
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 2 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-10-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15823784
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(4-bromo-2-chlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]...
C19H16BrClN2O2
1918182-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Br 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(4-Bromo-2-chlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-...
C19H17BrClN3O
1918182-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Br 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19106434
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biological Studies and Target Engagement of the 2-C-Methyl-D-Erythritol
4-Phosphate Cytidylyltransferase (IspD)-Targeting Antimalarial Agent
(1R,3S)-MMV008138 and Analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghavami, Maryam; Merino, Emilio F.; Yao, Zhong-Ke; Elahi, Rubayet;
Simpson, Morgan E.; Fernandez-Murga, Maria L.; Butler, Joshua H.;
Casasanta, Michael A.; Krai, Priscilla M.; Totrov, Maxim M.; Slade,
Daniel J.; Carlier, Paul R.; Cassera, Maria Belen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Infectious Diseases (2018), 4(4), 549-559

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(4-bromo-2-chlorophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]...
C19H16BrClN2O2
1918182-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 O 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Br 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(4-Bromo-2-chlorophenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-...
C19H17BrClN3O
1918182-28-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3359 7.4001 0.0 0
M  V30 2 N 10.6696 6.6301 0.0 0
M  V30 3 O 9.3359 8.9401 0.0 0
M  V30 4 C 12.0032 7.4001 0.0 0
M  V30 5 Cl 5.3348 9.7102 0.0 0
M  V30 6 Br 0.0000 9.7102 0.0 0
M  V30 7 C 5.3348 5.0901 0.0 0
M  V30 8 C 6.6685 4.3201 0.0 0
M  V30 9 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 10 N 4.1902 4.0597 0.0 0
M  V30 11 C 6.3483 2.8138 0.0 0
M  V30 12 C 8.0021 5.0901 0.0 0
M  V30 13 N 6.6685 7.4001 0.0 0
M  V30 14 C 4.8167 2.6527 0.0 0
M  V30 15 C 7.2535 1.5679 0.0 0
M  V30 16 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 17 C 4.1902 1.2459 0.0 0
M  V30 18 C 6.6270 0.1609 0.0 0
M  V30 19 C 5.0955 0.0000 0.0 0
M  V30 20 C 4.0011 7.4001 0.0 0
M  V30 21 C 4.0011 8.9401 0.0 0
M  V30 22 C 2.6673 6.6301 0.0 0
M  V30 23 C 2.6673 9.7102 0.0 0
M  V30 24 C 1.3337 7.4001 0.0 0
M  V30 25 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 21
M  V30 6 1 6 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=1
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-28-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15956941
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3S)-1-(2,4-dichlorophenyl)-2,3,4,9-tetrahydro-9-methyl-1H-pyrido[3...
C20H18Cl2N2O2
1918182-59-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6840 4.3798 0.0 0
M  V30 2 C 9.3359 7.4001 0.0 0
M  V30 3 O 10.6696 6.6301 0.0 0
M  V30 4 O 9.3359 8.9401 0.0 0
M  V30 5 C 12.0032 7.4001 0.0 0
M  V30 6 Cl 5.3348 9.7101 0.0 0
M  V30 7 Cl 0.0000 9.7101 0.0 0
M  V30 8 C 5.3348 5.0901 0.0 0
M  V30 9 C 6.6684 4.3201 0.0 0
M  V30 10 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 11 N 4.1902 4.0597 0.0 0
M  V30 12 C 6.3483 2.8138 0.0 0
M  V30 13 C 8.0021 5.0901 0.0 0
M  V30 14 N 6.6684 7.4001 0.0 0
M  V30 15 C 4.8167 2.6527 0.0 0
M  V30 16 C 7.2535 1.5679 0.0 0
M  V30 17 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 18 C 4.1902 1.2459 0.0 0
M  V30 19 C 6.6272 0.1609 0.0 0
M  V30 20 C 5.0955 0.0000 0.0 0
M  V30 21 C 4.0011 7.4001 0.0 0
M  V30 22 C 4.0011 8.9401 0.0 0
M  V30 23 C 2.6673 6.6301 0.0 0
M  V30 24 C 2.6673 9.7101 0.0 0
M  V30 25 C 1.3337 7.4001 0.0 0
M  V30 26 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 17 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 22
M  V30 7 1 7 26
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 21 CFG=1
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S)-1-(2,4-Dichlorophenyl)-2,3,4,9-tetrahydro-N,9-dimethyl-1H-pyrido[3,4-...
C20H19Cl2N3O
1918182-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6840 4.3798 0.0 0
M  V30 2 C 9.3359 7.4001 0.0 0
M  V30 3 N 10.6696 6.6301 0.0 0
M  V30 4 O 9.3359 8.9401 0.0 0
M  V30 5 C 12.0032 7.4001 0.0 0
M  V30 6 Cl 5.3348 9.7101 0.0 0
M  V30 7 Cl 0.0000 9.7101 0.0 0
M  V30 8 C 5.3348 5.0901 0.0 0
M  V30 9 C 6.6684 4.3201 0.0 0
M  V30 10 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 11 N 4.1902 4.0597 0.0 0
M  V30 12 C 6.3483 2.8138 0.0 0
M  V30 13 C 8.0021 5.0901 0.0 0
M  V30 14 N 6.6684 7.4001 0.0 0
M  V30 15 C 4.8167 2.6527 0.0 0
M  V30 16 C 7.2535 1.5679 0.0 0
M  V30 17 C 8.0021 6.6301 0.0 0 CFG=1
M  V30 18 C 4.1902 1.2459 0.0 0
M  V30 19 C 6.6272 0.1609 0.0 0
M  V30 20 C 5.0955 0.0000 0.0 0
M  V30 21 C 4.0011 7.4001 0.0 0
M  V30 22 C 4.0011 8.9401 0.0 0
M  V30 23 C 2.6673 6.6301 0.0 0
M  V30 24 C 2.6673 9.7101 0.0 0
M  V30 25 C 1.3337 7.4001 0.0 0
M  V30 26 C 1.3337 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 17 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 22
M  V30 7 1 7 26
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 10 21 CFG=1
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1918182-59-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1918182-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15883742
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and formulations of methylerthritol phosphate pathway
inhibitors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carlier, Paul R.; Cassera, Maria Belen; Merino, Emilio Fernando; Yao,
Zhong-Ke; Ghavami, Maryam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016069949 A1 2016-05-06

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridyl ketone
C11H8N2O
19437-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0
M  V30 6 C 6.6685 4.6200 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 N 1.3336 1.5400 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Lithium, chlorobis[N-[2-pyridinyl(2-pyridinyl-κN)methylene]methanamine-κN]-, ...
C24H22ClLiN6
868592-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.7797 7.7166 0.0 0 CHG=-1 VAL=1
M  V30 2 C 6.5066 8.7967 0.0 0
M  V30 3 C 4.0606 4.2982 0.0 0
M  V30 4 Li 5.3411 6.5809 0.0 0 CHG=1 VAL=5
M  V30 5 N 8.0136 6.5809 0.0 0 VAL=4
M  V30 6 N 2.6687 6.5809 0.0 0 VAL=4
M  V30 7 N 5.3411 8.1212 0.0 0 VAL=4
M  V30 8 N 5.3411 5.0368 0.0 0 VAL=4
M  V30 9 C 8.0136 5.0368 0.0 0
M  V30 10 C 9.3461 7.3529 0.0 0
M  V30 11 C 2.6687 8.1212 0.0 0
M  V30 12 C 1.3362 5.8088 0.0 0
M  V30 13 C 4.0086 8.8932 0.0 0
M  V30 14 C 6.6774 4.2685 0.0 0
M  V30 15 C 9.3461 4.2685 0.0 0
M  V30 16 C 10.6823 6.5809 0.0 0
M  V30 17 C 1.3362 8.8932 0.0 0
M  V30 18 C 0.0000 6.5809 0.0 0
M  V30 19 C 10.6823 5.0368 0.0 0
M  V30 20 C 0.0000 8.1212 0.0 0
M  V30 21 C 4.0086 10.2406 0.0 0
M  V30 22 C 5.2780 10.9681 0.0 0
M  V30 23 N 2.7467 10.9681 0.0 0
M  V30 24 C 5.2780 12.4305 0.0 0
M  V30 25 C 2.7467 12.4305 0.0 0
M  V30 26 C 4.0086 13.1617 0.0 0
M  V30 27 C 6.6774 2.9211 0.0 0
M  V30 28 C 7.9468 2.1899 0.0 0
M  V30 29 N 5.4154 2.1899 0.0 0
M  V30 30 C 7.9468 0.7275 0.0 0
M  V30 31 C 5.4154 0.7275 0.0 0
M  V30 32 C 6.6774 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 7
M  V30 3 1 3 8
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 2 6 12
M  V30 12 2 7 13
M  V30 13 2 8 14
M  V30 14 1 9 14
M  V30 15 2 9 15
M  V30 16 1 10 16
M  V30 17 1 11 13
M  V30 18 2 11 17
M  V30 19 1 12 18
M  V30 20 1 13 21
M  V30 21 1 14 27
M  V30 22 1 15 19
M  V30 23 2 16 19
M  V30 24 1 17 20
M  V30 25 2 18 20
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19437-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 868592-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9827948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7447-41-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of [Li(dpNmei)2Cl)]. Method A: A mixture of dpk (0.118 g, 0.641
mmol) in 5.0 mL of dry methanol and 30.0 mL of dry benzene was added to a
solution of methylamine 2.0 M (1.0 mL, 0.062 g, 2.00 mmol) and LiCl
(0.014 g, 0.330 mmol). The mixture was refluxed for 48 h using a
Dean-Stark trap. The excess of solvent and methylamine were evaporated to
dryness in vacuum to give an amber solid. The complex easily changes
color from amber to brown in the presence of traces of moisture and
satisfactory elemental analysis were not obtained. Yield: 95% (0.265 g).
mp: 119-121°C. 1H NMR: δ 8.72 (d, 1H, H-3, J= 4.80 Hz), 8.45 (d, 1H, H-8,
J= 4.80 Hz), 7.75 (td, 1H, H-5, J= 7.70, 1.46 Hz), 7.58 (td, 1H, H-10, J=
7.70, 1.46 Hz), 7.34 (d, 1H, H-11, J= 7.70 Hz), 7.28 (td, 1H, H-4, J=
6.20, 1.10 Hz), 7.20 (d, 1H, H-6, J= 8.10 Hz), 7.17 (td, 1H, H-9, J=
6.40, 1.28 Hz), 3.16 (s, Me-12); 13C 1H NMR: δ 167.6 (C-1), 155.0 (C-7),
154.0 (C-2), 150.3 (C-3), 149.5 (C-8), 137.1 (C-10), 136.7 (C-5), 124.8
(C-6), 123.7 (C-11, C-9 and C-4), 41.3 (Me-12); 7Li NMR δ 2.23; IR data
(CH2Cl2): ν (C═N) 1679 cm-1. Formula: C24H22ClLiN6, Crystal size (mm)
0.28 × 0.55 × 0.55, Crystal system: Orthorhombic, Space group Pbcn, a (Å)
10.0092(12), b (Å) 9.8201(12), c (Å) 23.669(3), α 90°, β 90°, γ 90°, Z:
4.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, characterization and crystal structures of
dipyridyl-N-methylimine and chloro-bis
(N,N'-2,2'-dipyridyl-N-methylimine)lithium complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flores-Chavez, Benito; Martinez-Ortega, Bernat Abeit; Alvarado-Rodriguez,
Jose Guadalupe; Andrade-Lopez, Noemi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Crystallography (2005), 35(6), 451-456

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-5-methoxypyrimidine
C5H4Cl2N2O
19646-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 Cl 2.3101 0.0000 0.0 0
M  V30 4 Cl 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 N 4.6201 1.3337 0.0 0
M  V30 9 N 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-methoxy-N-methyl-4-pyrimidinamine
C6H8ClN3O
1351762-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 4.0011 0.0 0
M  V30 2 C 0.0000 5.3349 0.0 0
M  V30 3 N 2.3100 1.3338 0.0 0
M  V30 4 C 3.0800 0.0000 0.0 0
M  V30 5 Cl 6.9300 4.0011 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 3.0800 5.3349 0.0 0
M  V30 9 N 4.6200 2.6674 0.0 0
M  V30 10 N 4.6200 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19646-07-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1351762-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16660415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate
dehydrogenase inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashwell, Susan; Campbell, Ann-Marie; Caravella, Justin Andrew; Diebold,
R. Bruce; Ericsson, Anna; Gustafson, Gary; Lancia, David R.; Lin, Jian;
Lu, Wei; Wang, Zhongguo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016171755 A1 2016-10-27

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-chloro-3,5-dinitro-, ethyl ester
C9H7ClN2O6
19649-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 5.3901 0.0 0
M  V30 2 O 8.0022 4.6201 0.0 0
M  V30 3 O 6.6684 6.9301 0.0 0
M  V30 4 C 9.3359 5.3901 0.0 0
M  V30 5 C 10.6695 4.6201 0.0 0
M  V30 6 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 7 O 5.3348 0.0000 0.0 0
M  V30 8 O 2.6673 0.0000 0.0 0
M  V30 9 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 10 O 0.0000 4.6201 0.0 0
M  V30 11 O 1.3337 6.9301 0.0 0
M  V30 12 Cl 1.3337 2.3100 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 5.3348 3.0800 0.0 0
M  V30 15 C 4.0011 5.3901 0.0 0
M  V30 16 C 4.0011 2.3100 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0
M  V30 18 C 2.6673 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(methylamino)-3,5-dinitrobenzoate
C10H11N3O6
6083-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 O 1.3337 6.9302 0.0 0
M  V30 9 C 6.6685 5.3901 0.0 0
M  V30 10 O 8.0023 4.6201 0.0 0
M  V30 11 O 6.6685 6.9302 0.0 0
M  V30 12 C 9.3360 5.3901 0.0 0
M  V30 13 C 10.6697 4.6201 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 4.0012 5.3901 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 19
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19649-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6083-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14631250
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Palladium on Carbon Catalyzed One-Pot Synthesis of Substituted
Benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Joardar, Soumen; Bhattacharyya, Anjan; Das, Saktipada
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2014), 46(22), 3121-3132

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(6-Bromohexyl)-3-methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-in...
C35H36BrNO2
1973474-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 7.8272 0.0 0
M  V30 2 C 10.2458 6.6827 0.0 0
M  V30 3 C 10.7216 5.2181 0.0 0
M  V30 4 C 9.6912 4.0736 0.0 0
M  V30 5 C 10.1671 2.6091 0.0 0
M  V30 6 C 9.1367 1.4645 0.0 0
M  V30 7 Br 9.6125 0.0000 0.0 0
M  V30 8 C 11.2762 13.2482 0.0 0
M  V30 9 O 5.3347 12.0776 0.0 0
M  V30 10 C 4.0011 11.3076 0.0 0
M  V30 11 O 17.8655 10.5376 0.0 0
M  V30 12 C 18.6355 11.8714 0.0 0
M  V30 13 N 10.8003 9.2917 0.0 0
M  V30 14 C 11.7055 10.5376 0.0 0
M  V30 15 C 9.3358 9.7676 0.0 0
M  V30 16 C 10.8003 11.7836 0.0 0
M  V30 17 C 9.3358 11.3076 0.0 0
M  V30 18 C 8.0020 8.9976 0.0 0
M  V30 19 C 8.0020 12.0776 0.0 0
M  V30 20 C 6.6684 9.7676 0.0 0
M  V30 21 C 6.6684 11.3076 0.0 0
M  V30 22 C 13.2455 10.5376 0.0 0
M  V30 23 C 14.0155 9.2040 0.0 0
M  V30 24 C 14.0155 11.8714 0.0 0
M  V30 25 C 15.5555 9.2040 0.0 0
M  V30 26 C 15.5555 11.8714 0.0 0
M  V30 27 C 16.3255 10.5376 0.0 0
M  V30 28 C 2.6673 12.0776 0.0 0
M  V30 29 C 1.3336 11.3076 0.0 0
M  V30 30 C 2.6673 13.6176 0.0 0
M  V30 31 C 0.0000 12.0776 0.0 0
M  V30 32 C 1.3336 14.3876 0.0 0
M  V30 33 C 0.0000 13.6176 0.0 0
M  V30 34 C 20.1755 11.8714 0.0 0
M  V30 35 C 20.9455 10.5376 0.0 0
M  V30 36 C 20.9455 13.2050 0.0 0
M  V30 37 C 22.4855 10.5376 0.0 0
M  V30 38 C 22.4855 13.2050 0.0 0
M  V30 39 C 23.2555 11.8714 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 28
M  V30 12 1 11 12
M  V30 13 1 11 27
M  V30 14 1 12 34
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 14 22
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 1 16 17
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole-1-hexana...
C36H40N2O2
1973474-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.2762 8.9716 0.0 0
M  V30 2 C 10.2458 7.8272 0.0 0
M  V30 3 C 10.7217 6.3625 0.0 0
M  V30 4 C 9.6913 5.2182 0.0 0
M  V30 5 C 10.1671 3.7535 0.0 0
M  V30 6 C 9.1367 2.6091 0.0 0
M  V30 7 N 9.6126 1.1444 0.0 0
M  V30 8 C 8.5822 0.0000 0.0 0
M  V30 9 C 11.2762 14.3928 0.0 0
M  V30 10 O 5.3347 13.2222 0.0 0
M  V30 11 C 4.0011 12.4522 0.0 0
M  V30 12 O 17.8656 11.6822 0.0 0
M  V30 13 C 18.6356 13.0158 0.0 0
M  V30 14 N 10.8004 10.4363 0.0 0
M  V30 15 C 11.7056 11.6822 0.0 0
M  V30 16 C 9.3358 10.9122 0.0 0
M  V30 17 C 10.8004 12.9281 0.0 0
M  V30 18 C 9.3358 12.4522 0.0 0
M  V30 19 C 8.0020 10.1422 0.0 0
M  V30 20 C 8.0020 13.2222 0.0 0
M  V30 21 C 6.6684 10.9122 0.0 0
M  V30 22 C 6.6684 12.4522 0.0 0
M  V30 23 C 13.2456 11.6822 0.0 0
M  V30 24 C 14.0156 10.3485 0.0 0
M  V30 25 C 14.0156 13.0158 0.0 0
M  V30 26 C 15.5556 10.3485 0.0 0
M  V30 27 C 15.5556 13.0158 0.0 0
M  V30 28 C 16.3256 11.6822 0.0 0
M  V30 29 C 2.6673 13.2222 0.0 0
M  V30 30 C 1.3336 12.4522 0.0 0
M  V30 31 C 2.6673 14.7622 0.0 0
M  V30 32 C 0.0000 13.2222 0.0 0
M  V30 33 C 1.3336 15.5322 0.0 0
M  V30 34 C 0.0000 14.7622 0.0 0
M  V30 35 C 20.1756 13.0158 0.0 0
M  V30 36 C 20.9456 11.6822 0.0 0
M  V30 37 C 20.9456 14.3496 0.0 0
M  V30 38 C 22.4857 11.6822 0.0 0
M  V30 39 C 22.4857 14.3496 0.0 0
M  V30 40 C 23.2557 13.0158 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 22
M  V30 12 1 11 29
M  V30 13 1 12 13
M  V30 14 1 12 28
M  V30 15 1 13 35
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 15 23
M  V30 20 1 16 18
M  V30 21 2 16 19
M  V30 22 1 17 18
M  V30 23 2 18 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1973474-25-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1973474-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15986113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antiproliferative and pro-apoptotic activity of
2-phenylindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelly, Patrick M.; Bright, Sandra A.; Fayne, Darren; Pollock, Jade K.;
Zisterer, Daniela M.; Williams, D. Clive; Meegan, Mary J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(18), 4075-4099

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-N-(2-chloroethyl)-4-quinolinamine
C11H10Cl2N2
199444-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 4.0011 0.0 0
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 C 9.2400 5.3349 0.0 0
M  V30 4 Cl 10.7800 5.3349 0.0 0
M  V30 5 Cl 0.0000 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 N 4.6200 0.0000 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 2.3100 4.0011 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 15 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1-(7-Chloro-4-quinolinyl)-N2-methyl-1,2-ethanediamine
C12H14ClN3
91494-89-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 3.0801 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 C 12.0033 3.0801 0.0 0
M  V30 6 Cl 0.0000 5.3901 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 N 2.6673 0.7700 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 199444-65-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 91494-89-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6304282
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro antitubercular activity of a series of quinoline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Souza, Marcus V. N.; Pais, Karla C.; Kaiser, Carlos R.; Peralta,
Monica A.; Ferreira, Marcelle de L.; Lourenco, Maria C. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(4), 1474-1480

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-Heptadecafluoro-11-iodoundecane
C11H6F17I
200112-75-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0
M  V30 2 C 6.1600 2.6673 0.0 0
M  V30 3 C 9.2400 2.6673 0.0 0
M  V30 4 F 7.7000 1.1273 0.0 0
M  V30 5 F 7.7000 4.2073 0.0 0
M  V30 6 C 4.6200 2.6673 0.0 0
M  V30 7 F 6.1600 1.1273 0.0 0
M  V30 8 F 6.1600 4.2073 0.0 0
M  V30 9 C 10.7800 2.6673 0.0 0
M  V30 10 F 9.2400 1.1273 0.0 0
M  V30 11 F 9.2400 4.2073 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 F 4.6200 1.1273 0.0 0
M  V30 14 F 4.6200 4.2073 0.0 0
M  V30 15 C 12.3200 2.6673 0.0 0
M  V30 16 F 10.7800 1.1273 0.0 0
M  V30 17 F 10.7800 4.2073 0.0 0
M  V30 18 C 1.5400 2.6673 0.0 0
M  V30 19 F 3.0800 1.1273 0.0 0
M  V30 20 F 3.0800 4.2073 0.0 0
M  V30 21 C 13.8600 2.6673 0.0 0
M  V30 22 F 12.3200 1.1273 0.0 0
M  V30 23 F 12.3200 4.2073 0.0 0
M  V30 24 F 0.0000 2.6673 0.0 0
M  V30 25 F 1.5400 1.1273 0.0 0
M  V30 26 F 1.5400 4.2073 0.0 0
M  V30 27 C 14.6300 1.3336 0.0 0
M  V30 28 C 16.1700 1.3336 0.0 0
M  V30 29 I 16.9400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 18 26
M  V30 26 1 21 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Heptadecafluoro-N-methyl-1-undecanamine
C12H10F17N
160641-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0
M  V30 2 C 6.1600 2.6673 0.0 0
M  V30 3 C 9.2400 2.6673 0.0 0
M  V30 4 F 7.7000 1.1273 0.0 0
M  V30 5 F 7.7000 4.2073 0.0 0
M  V30 6 C 4.6200 2.6673 0.0 0
M  V30 7 F 6.1600 1.1273 0.0 0
M  V30 8 F 6.1600 4.2073 0.0 0
M  V30 9 C 10.7800 2.6673 0.0 0
M  V30 10 F 9.2400 1.1273 0.0 0
M  V30 11 F 9.2400 4.2073 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 F 4.6200 1.1273 0.0 0
M  V30 14 F 4.6200 4.2073 0.0 0
M  V30 15 C 12.3200 2.6673 0.0 0
M  V30 16 F 10.7800 1.1273 0.0 0
M  V30 17 F 10.7800 4.2073 0.0 0
M  V30 18 C 1.5400 2.6673 0.0 0
M  V30 19 F 3.0800 1.1273 0.0 0
M  V30 20 F 3.0800 4.2073 0.0 0
M  V30 21 C 13.8600 2.6673 0.0 0
M  V30 22 F 12.3200 1.1273 0.0 0
M  V30 23 F 12.3200 4.2073 0.0 0
M  V30 24 F 0.0000 2.6673 0.0 0
M  V30 25 F 1.5400 1.1273 0.0 0
M  V30 26 F 1.5400 4.2073 0.0 0
M  V30 27 C 14.6300 1.3336 0.0 0
M  V30 28 C 16.1700 1.3336 0.0 0
M  V30 29 N 16.9400 0.0000 0.0 0
M  V30 30 C 18.4800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 24 1 18 25
M  V30 25 1 18 26
M  V30 26 1 21 27
M  V30 27 1 27 28
M  V30 28 1 28 29
M  V30 29 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 200112-75-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 160641-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9068919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient syntheses and characterization of fluorophilic
(perfluorooctyl)propyl amines and ab initio calculations of proton
affinities of related model compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Szlavik, Z.; Tarkanyi, G.; Gomory, A.; Tarczay, G.; Rabai, J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2001), 108(1), 7-14

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-2-(phenylmethoxy)benzaldehyde
C15H14O3
2011-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3336 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 C 2.3100 8.0021 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 2 3 4
M  V30 5 1 3 8
M  V30 6 1 5 6
M  V30 7 1 5 9
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methyl-2-(phenylmethoxy)benzenemethanamine
C16H19NO2
88741-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 N 9.2400 4.0011 0.0 0
M  V30 5 C 10.0100 2.6674 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 C 2.3100 8.0021 0.0 0
M  V30 8 C 5.3900 5.3347 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 C 4.6200 6.6685 0.0 0
M  V30 11 C 7.7000 6.6685 0.0 0
M  V30 12 C 5.3900 8.0021 0.0 0
M  V30 13 C 6.9300 8.0021 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 3.0800 1.3336 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 2.3100 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 3 9
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 10
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2011-06-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 88741-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-23704942
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationships of aristoyagonine
derivatives as Brd4 bromodomain inhibitors with X-ray co-crystal research
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoo, Minjin; Park, Tae Hyun; Yoo, Miyoun; Kim, Yeongrin; Lee, Joo-Youn;
Lee, Kyu Myung; Ryu, Seong Eon; Lee, Byung Il; Jung, Kwan-Young; Park,
Chi Hoon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2021), 26(6), 1686

$RFMT $RIREG SCHEME43 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,6-Dimethyl-1H-indole-3-carboxaldehyde
C11H11NO
202584-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6948 0.0 0
M  V30 2 O 8.7354 4.2188 0.0 0
M  V30 3 C 4.5602 0.0000 0.0 0
M  V30 4 C 0.0000 3.9844 0.0 0
M  V30 5 C 4.6200 3.9844 0.0 0
M  V30 6 C 3.8500 2.6508 0.0 0
M  V30 7 C 6.1264 3.6643 0.0 0
M  V30 8 C 3.8500 5.3182 0.0 0
M  V30 9 N 4.8805 1.5064 0.0 0
M  V30 10 C 2.3100 2.6508 0.0 0
M  V30 11 C 6.2873 2.1327 0.0 0
M  V30 12 C 2.3100 5.3182 0.0 0
M  V30 13 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1,6-Trimethyl-1H-indole-3-methanamine
C12H16N2
335032-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2706 4.6948 0.0 0
M  V30 2 N 8.7353 4.2188 0.0 0
M  V30 3 C 9.8797 5.2494 0.0 0
M  V30 4 C 4.5602 0.0000 0.0 0
M  V30 5 C 0.0000 3.9844 0.0 0
M  V30 6 C 4.6200 3.9844 0.0 0
M  V30 7 C 3.8500 2.6508 0.0 0
M  V30 8 C 6.1263 3.6643 0.0 0
M  V30 9 C 3.8500 5.3182 0.0 0
M  V30 10 N 4.8804 1.5064 0.0 0
M  V30 11 C 2.3100 2.6508 0.0 0
M  V30 12 C 6.2872 2.1327 0.0 0
M  V30 13 C 2.3100 5.3182 0.0 0
M  V30 14 C 1.5400 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 10
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 202584-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4016894
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 36. Preparation of
1-methyl-3-(methylaminomethyl)-1H-indole (Method B). To a solution of
1-methylindole-3-carboxaldehyde (10.0 g, 62.8 mmole) in MeOH (100 mL) was
added a solution of 2.0 M CH3NH2 in MeOH (126 mL, 252.0 mmole). The
reaction was stirred at RT for 2 hrs, then was concentrated to a light
yellow oil. This oil was dissolved in EtOH (300 mL), and NaBH4 (2.38 g,
62.8 mmole) was added. After 2 hrs the reaction was concentrated to a
slurry and dissolved in 1.0 N NaOH (75 mL). The aqueous solution was
extracted with Et2O (2 × 200 mL) and the combined organic fractions were
dried over Na2SO4 and concentrated. Flash chromatography on silica gel
(9:1 CHCl3/MeOH containing 5% NH4OH) and drying in high vacuum left the
title compound. 1,6-Dimethyl-3-(methylaminomethyl)-1H-indole. According
to the procedure of Preparation 36, except substituting
1,5-dimethyl-1H-indole-3-carboxaldehyde for
1,3-dimethyl-1H-indole-1-carboxaldehyde, the title compound (95%) was
prepared as an oil. MS (ES) m/e 189.2 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(5-Fluoro-2,3-dihydro-1H-inden-1-ylidene)-2-phenyl-5(4H)-oxazolone
C18H12FNO2
2036341-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.4372 7.9700 0.0 0
M  V30 2 F 12.0665 4.0971 0.0 0
M  V30 3 C 6.3388 6.2949 0.0 0
M  V30 4 C 7.6724 5.5249 0.0 0
M  V30 5 C 6.6590 7.8012 0.0 0
M  V30 6 C 8.8170 6.5553 0.0 0
M  V30 7 C 7.9926 4.0184 0.0 0
M  V30 8 C 8.1905 7.9621 0.0 0
M  V30 9 C 10.2816 6.0794 0.0 0
M  V30 10 C 9.4573 3.5425 0.0 0
M  V30 11 C 10.6017 4.5730 0.0 0
M  V30 12 C 4.9318 5.6684 0.0 0
M  V30 13 N 4.6116 4.1621 0.0 0
M  V30 14 C 3.5981 6.4384 0.0 0
M  V30 15 C 3.0801 4.0010 0.0 0
M  V30 16 O 2.4537 5.4080 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 0.7700 2.6673 0.0 0
M  V30 20 C 2.3101 0.0000 0.0 0
M  V30 21 C 0.0000 1.3337 0.0 0
M  V30 22 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-(5-Fluoro-2,3-dihydro-1H-inden-1-ylidene)-2-(methylamino)-2-oxoethy...
C19H17FN2O2
2036341-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 C 3.0800 5.3347 0.0 0
M  V30 5 N 5.3900 1.3336 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 O 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 F 11.2685 8.3384 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.8352 5.2469 0.0 0
M  V30 12 C 7.8352 2.7552 0.0 0
M  V30 13 C 9.2998 4.7711 0.0 0
M  V30 14 C 7.5151 6.7534 0.0 0
M  V30 15 C 9.2998 3.2311 0.0 0
M  V30 16 C 10.4443 5.8015 0.0 0
M  V30 17 C 8.6594 7.7838 0.0 0
M  V30 18 C 10.1241 7.3079 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 0.7700 6.6684 0.0 0
M  V30 21 C 3.0800 8.0022 0.0 0
M  V30 22 C 0.0000 8.0022 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 19
M  V30 9 1 5 8
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-11-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18012902
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazole derivatives as dual emission fluorescent compounds and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karuso, Peter; Chatterjee, Soumit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017147646 A1 2017-09-08

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(5-Fluoro-2,3-dihydro-1H-inden-1-ylidene)-2-phenyl-5(4H)-oxazolone
C18H12FNO2
2036341-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.4372 7.9700 0.0 0
M  V30 2 F 12.0665 4.0971 0.0 0
M  V30 3 C 6.3388 6.2949 0.0 0
M  V30 4 C 7.6724 5.5249 0.0 0
M  V30 5 C 6.6590 7.8012 0.0 0
M  V30 6 C 8.8170 6.5553 0.0 0
M  V30 7 C 7.9926 4.0184 0.0 0
M  V30 8 C 8.1905 7.9621 0.0 0
M  V30 9 C 10.2816 6.0794 0.0 0
M  V30 10 C 9.4573 3.5425 0.0 0
M  V30 11 C 10.6017 4.5730 0.0 0
M  V30 12 C 4.9318 5.6684 0.0 0
M  V30 13 N 4.6116 4.1621 0.0 0
M  V30 14 C 3.5981 6.4384 0.0 0
M  V30 15 C 3.0801 4.0010 0.0 0
M  V30 16 O 2.4537 5.4080 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 18 C 3.0801 1.3337 0.0 0
M  V30 19 C 0.7700 2.6673 0.0 0
M  V30 20 C 2.3101 0.0000 0.0 0
M  V30 21 C 0.0000 1.3337 0.0 0
M  V30 22 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 12
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1Z)-1-(5-Fluoro-2,3-dihydro-1H-inden-1-ylidene)-2-(methylamino)-2-oxoethy...
C19H17FN2O2
2036341-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0
M  V30 2 N 4.6200 5.3347 0.0 0
M  V30 3 C 4.6200 2.6674 0.0 0
M  V30 4 C 3.0800 5.3347 0.0 0
M  V30 5 N 5.3900 1.3336 0.0 0
M  V30 6 O 3.0800 2.6674 0.0 0
M  V30 7 O 2.3100 4.0011 0.0 0
M  V30 8 C 4.6200 0.0000 0.0 0
M  V30 9 F 11.2685 8.3384 0.0 0
M  V30 10 C 6.9300 4.0011 0.0 0
M  V30 11 C 7.8352 5.2469 0.0 0
M  V30 12 C 7.8352 2.7552 0.0 0
M  V30 13 C 9.2998 4.7711 0.0 0
M  V30 14 C 7.5151 6.7534 0.0 0
M  V30 15 C 9.2998 3.2311 0.0 0
M  V30 16 C 10.4443 5.8015 0.0 0
M  V30 17 C 8.6594 7.7838 0.0 0
M  V30 18 C 10.1241 7.3079 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 0.7700 6.6684 0.0 0
M  V30 21 C 3.0800 8.0022 0.0 0
M  V30 22 C 0.0000 8.0022 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 19
M  V30 9 1 5 8
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2036341-11-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2036341-18-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16404851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and concise method to synthesize locked GFP chromophore
analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chatterjee, Soumit; Karuso, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(47), 5197-5200

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-aminobenzenebutanoate
C11H15NO2
20637-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 10.6697 3.0801 0.0 0
M  V30 6 O 9.3360 0.7700 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 N 0.0000 0.0000 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-N-methylbenzenebutanamide
C11H16N2O
1267951-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 N 10.6697 3.0801 0.0 0
M  V30 6 O 9.3360 0.7700 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 N 0.0000 0.0000 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 2.6673 3.0801 0.0 0
M  V30 12 C 2.6673 0.0000 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 20637-09-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1267951-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12682809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 4-(4-aminophenyl)-N-methylbutanamide 30. [00205] A
solution of compound 27 (450 mg, 2.33 mmol) in CH3NH2/CH3OH (29, 50 mL)
was stirred at room temperature for overnight. The reaction mixture was
concentrated to dryness to give compound 30. The crude product was used
directly for the next step without purification. (450 mg, 95%) white
solid. 1H NMR (400 MHz, CDCl3) 56.95 (d, 2H, J=8.3 Hz), 6.61 (d, 2H,
J=8.3 Hz), 5.30(br s, 1H), 3.50(br s, 2H), 2.78(d, 3H, J=4.8 Hz), 2.54(t,
2H, J=7.4 Hz), 2.14(t, 2H, J=7.4 Hz), 1.85-1.95(m, 2H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thioimidazolidinones as androgen receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tong, Youzhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012119559 A1 2012-09-13

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R)-4-(6-chloro-4-pyrimidinyl)-2-morpholinecarboxylate
C10H12ClN3O3
2072804-03-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 O 10.6697 2.3101 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 C 12.0033 3.0801 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 N 5.3348 2.3101 0.0 0
M  V30 7 C 6.6685 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0 CFG=2
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 O 8.0022 0.7700 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 N 4.0012 4.6201 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 N 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2R)-4-(6-Chloro-4-pyrimidinyl)-N-methyl-2-morpholinecarboxamide
C10H13ClN4O2
2072804-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 3.0801 0.0 0
M  V30 2 N 10.6697 2.3101 0.0 0
M  V30 3 O 9.3360 4.6201 0.0 0
M  V30 4 C 12.0033 3.0801 0.0 0
M  V30 5 Cl 0.0000 2.3101 0.0 0
M  V30 6 N 5.3348 2.3101 0.0 0
M  V30 7 C 6.6685 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 8.0022 2.3101 0.0 0 CFG=2
M  V30 10 C 6.6685 0.0000 0.0 0
M  V30 11 O 8.0022 0.7700 0.0 0
M  V30 12 C 4.0012 3.0801 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 N 4.0012 4.6201 0.0 0
M  V30 15 C 1.3337 3.0801 0.0 0
M  V30 16 C 2.6673 5.3901 0.0 0
M  V30 17 N 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2072804-03-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2072804-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17449599
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds that inhibit LRRK2 kinase activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Xiao; Jin, Yun; Liu, Qian; Ren, Feng; Sang, Yingxia; Stasi, Luigi
Piero; Wan, Zehong; Wang, Hailong; Xing, Weiqiang; Zhan, Yang; Zhao,
Baowei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017012576 A1 2017-01-26

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-methoxy-4-(methylthio)-3-quinolinecarboxylate
C14H15NO3S
2075787-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 O 10.6697 3.0801 0.0 0
M  V30 5 O 9.3360 0.7700 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 N 6.6685 5.3901 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 2.6673 3.0801 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-methoxy-4-(methylamino)-3-quinolinecarboxylate
C14H16N2O3
1215735-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.7700 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 C 9.3360 2.3101 0.0 0
M  V30 4 O 10.6697 3.0801 0.0 0
M  V30 5 O 9.3360 0.7700 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 C 13.3370 3.0801 0.0 0
M  V30 8 O 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 3.0801 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 8.0022 3.0801 0.0 0
M  V30 15 N 6.6685 5.3901 0.0 0
M  V30 16 C 4.0010 5.3901 0.0 0
M  V30 17 C 2.6673 3.0801 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 2 16 19
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2075787-89-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215735-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-21311970
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel 3,4,6-trisubstituted quinolines enabled by a
Gould-Jacobs cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trah, Stephan; Lamberth, Clemens
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2017), 58(8), 794-796

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-5-[2-[3-(methoxycarbonyl)phen...
C15H14N2O6.C2H7NO
2088317-61-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 C 2.6673 3.0800 0.0 0
M  V30 4 O 4.0010 2.3100 0.0 0
M  V30 5 O 1.3337 2.3100 0.0 0
M  V30 6 O 5.3348 7.7001 0.0 0
M  V30 7 O 0.0000 7.7001 0.0 0
M  V30 8 C 12.0033 5.3901 0.0 0
M  V30 9 O 13.3370 4.6201 0.0 0
M  V30 10 O 12.0033 6.9301 0.0 0
M  V30 11 C 14.6707 5.3901 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 4.0010 6.9301 0.0 0
M  V30 15 N 1.3337 5.3901 0.0 0
M  V30 16 N 2.6673 7.7001 0.0 0
M  V30 17 C 1.3337 6.9301 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3358 5.3901 0.0 0
M  V30 20 C 8.0022 3.0800 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 9.3358 2.3100 0.0 0
M  V30 23 C 10.6697 3.0800 0.0 0
M  V30 24 C 6.6685 0.0000 0.0 0
M  V30 25 C 8.0022 0.7700 0.0 0
M  V30 26 N 5.3348 0.7700 0.0 0
M  V30 27 O 9.3358 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 2 6 14
M  V30 8 2 7 17
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-5-[2-[3-[(methylamino)carbony...
C15H15N3O5.C2H7NO
2088317-65-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0
M  V30 3 C 2.6673 3.0800 0.0 0
M  V30 4 O 1.3337 2.3100 0.0 0
M  V30 5 O 4.0010 2.3100 0.0 0
M  V30 6 O 5.3348 7.7001 0.0 0
M  V30 7 O 0.0000 7.7001 0.0 0
M  V30 8 C 12.0033 5.3901 0.0 0
M  V30 9 N 13.3370 4.6201 0.0 0
M  V30 10 O 12.0033 6.9301 0.0 0
M  V30 11 C 14.6707 5.3901 0.0 0
M  V30 12 C 4.0010 5.3901 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 4.0010 6.9301 0.0 0
M  V30 15 N 1.3337 5.3901 0.0 0
M  V30 16 N 2.6673 7.7001 0.0 0
M  V30 17 C 1.3337 6.9301 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 9.3358 5.3901 0.0 0
M  V30 20 C 8.0022 3.0800 0.0 0
M  V30 21 C 10.6697 4.6201 0.0 0
M  V30 22 C 9.3358 2.3100 0.0 0
M  V30 23 C 10.6697 3.0800 0.0 0
M  V30 24 C 6.6685 0.0000 0.0 0
M  V30 25 C 8.0022 0.7700 0.0 0
M  V30 26 N 5.3348 0.7700 0.0 0
M  V30 27 O 9.3358 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 2 6 14
M  V30 8 2 7 17
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 21
M  V30 12 1 9 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2088317-61-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2088317-65-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17039812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 141-43-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM AcOH buffered solution used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of potent substrate-based inhibitors of the
Trypanosoma cruzi dihydroorotate dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inaoka, Daniel Ken; Iida, Maiko; Hashimoto, Satoshi; Tabuchi, Toshiyuki;
Kuranaga, Takefumi; Balogun, Emmanuel Oluwadare; Honma, Teruki; Tanaka,
Akiko; Harada, Shigeharu; Nara, Takeshi; Kita, Kiyoshi; Inoue, Masayuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(4), 1465-1470

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-cyano-5-(dimethylamino)-2-oxazoleacetate
C9H11N3O3
2089258-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2078 5.4355 0.0 0
M  V30 2 C 7.5415 4.6655 0.0 0
M  V30 3 O 8.8752 5.4355 0.0 0
M  V30 4 O 7.5415 3.1255 0.0 0
M  V30 5 C 10.2088 4.6655 0.0 0
M  V30 6 N 0.9051 4.3084 0.0 0
M  V30 7 C 0.2787 5.7153 0.0 0
M  V30 8 C 0.0000 3.0625 0.0 0
M  V30 9 C 2.5803 1.4070 0.0 0
M  V30 10 N 1.9540 0.0000 0.0 0
M  V30 11 C 4.8740 4.6655 0.0 0
M  V30 12 O 3.4672 5.2920 0.0 0
M  V30 13 N 4.7131 3.1339 0.0 0
M  V30 14 C 2.4368 4.1474 0.0 0
M  V30 15 C 3.2068 2.8138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 14
M  V30 9 3 9 10
M  V30 10 1 9 15
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyano-5-(dimethylamino)-N-methyl-2-oxazoleacetamide
C9H12N4O2
2668278-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2079 5.4355 0.0 0
M  V30 2 C 7.5415 4.6655 0.0 0
M  V30 3 N 8.8752 5.4355 0.0 0
M  V30 4 O 7.5415 3.1255 0.0 0
M  V30 5 C 10.2089 4.6655 0.0 0
M  V30 6 N 0.9051 4.3084 0.0 0
M  V30 7 C 0.2787 5.7154 0.0 0
M  V30 8 C 0.0000 3.0625 0.0 0
M  V30 9 C 2.5803 1.4068 0.0 0
M  V30 10 N 1.9540 0.0000 0.0 0
M  V30 11 C 4.8741 4.6655 0.0 0
M  V30 12 O 3.4672 5.2920 0.0 0
M  V30 13 N 4.7131 3.1340 0.0 0
M  V30 14 C 2.4368 4.1475 0.0 0
M  V30 15 C 3.2068 2.8138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 14
M  V30 9 3 9 10
M  V30 10 1 9 15
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2089258-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2668278-87-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27641545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalized 5-Amino-4-cyanoxazoles, their Hetero- and Macrocyclic
Derivatives: Preparation and Synthetic Applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Merzhyievskyi, Danylo O.; Shablykin, Oleh V.; Shablykina, Olga V.;
Kozytskiy, Andriy V.; Rusanov, Eduard B.; Moskvina, Viktoriia S.;
Brovarets, Volodymyr S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(47), 6511-6523

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(S)-Methyl mandelate
C9H10O3
21210-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 O 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(αS)-α-Hydroxy-N-methylbenzeneacetamide
C9H11NO2
65645-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0 CFG=2
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 N 6.6685 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21210-43-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65645-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4099036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of (SJ-l-Hydroxy-N-methyl-l-phenylacetamide (37). Methyl (S)-
(+)-mandelate 36 (4.60 g, 27.7 mmol, 1.0 eq) was added to a 2M solution
of methylamine in methanol, (70 mL, 140 mmol, 5.05 eq) and the mixture
was stirred at rt for 24 h. The mixture was concentrated under reduced
pressure to a semi-solid. Residual methanol was co- evaporated with
toluene (2 x 50 mL) followed by 1 : 1 toluene/heptanes (50 mL) to give a
white crystalline solid. The solid was triturated with heptanes (50 mL),
filtered and dried to give 4.35 g (95%) of 37 as a white solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinoline derivatives as orexin receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Julie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009079637 A1 2009-06-25

$RFMT $RIREG SCHEME51 STEP1
$RXN



  2  1
$MOL
1,1,1-Trifluoro-N-(trans-4-phenylcyclohexyl)methanesulfinamide
C13H16F3NOS
2124261-79-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 2.6673 0.0 0
M  V30 2 S 10.0102 1.3337 0.0 0 CFG=3 VAL=4
M  V30 3 C 11.5503 1.3337 0.0 0
M  V30 4 O 9.2402 0.0000 0.0 0
M  V30 5 F 12.3203 0.0000 0.0 0
M  V30 6 F 13.0903 1.3337 0.0 0
M  V30 7 F 12.3203 2.6673 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0 CFG=2
M  V30 9 C 5.3901 4.0010 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 11 C 6.9302 4.0010 0.0 0
M  V30 12 C 6.9302 1.3337 0.0 0
M  V30 13 C 7.7002 2.6673 0.0 0 CFG=2
M  V30 14 C 3.0801 2.6673 0.0 0
M  V30 15 C 2.3101 1.3337 0.0 0
M  V30 16 C 2.3101 4.0010 0.0 0
M  V30 17 C 0.7700 1.3337 0.0 0
M  V30 18 C 0.7700 4.0010 0.0 0
M  V30 19 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14 CFG=1
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 8 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonimidamide, 1,1,1-trifluoro-N-methyl-N′-(trans-4-phenylcyclohexyl)-
C14H19F3N2OS
2124261-71-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 4.0011 0.0 0
M  V30 2 S 2.3100 2.6674 0.0 0 CFG=3 VAL=6
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 N 0.9764 3.4374 0.0 0
M  V30 5 O 3.6436 1.8974 0.0 0
M  V30 6 F 0.0000 1.3338 0.0 0
M  V30 7 F 0.7700 0.0000 0.0 0
M  V30 8 F 2.3100 0.0000 0.0 0
M  V30 9 C 0.9764 4.9774 0.0 0
M  V30 10 C 7.7000 4.0011 0.0 0 CFG=2
M  V30 11 C 6.9300 5.3349 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 5.3900 5.3349 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3349 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 11.5500 2.6674 0.0 0
M  V30 21 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 4 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2124261-79-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2124261-71-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29263876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 128-09-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 429-41-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Synthesis of Trifluoromethyl-sulfonimidamides from Sulfinamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Richards-Taylor, Charlotte S.; Martinez-Lamenca, Carolina; Leenaerts,
Joseph E.; Trabanco, Andres A.; Oehlrich, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2017), 82(18), 9898-9904

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl β-oxo-4-(trifluoromethyl)benzenepropanoate
C11H9F3O3
212755-76-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0
M  V30 2 C 8.4700 1.3336 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 10.0100 1.3336 0.0 0
M  V30 5 O 10.7800 0.0000 0.0 0
M  V30 6 O 10.7800 2.6673 0.0 0
M  V30 7 C 12.3200 0.0000 0.0 0
M  V30 8 C 1.5400 2.6673 0.0 0
M  V30 9 F 1.5400 1.1273 0.0 0
M  V30 10 F 0.0000 2.6673 0.0 0
M  V30 11 F 1.5400 4.2073 0.0 0
M  V30 12 C 6.1600 2.6673 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 5.3900 4.0011 0.0 0
M  V30 15 C 3.8500 1.3336 0.0 0
M  V30 16 C 3.8500 4.0011 0.0 0
M  V30 17 C 3.0800 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-3-[4-(trifluoromethyl)phenyl]-2-propenoate
C12H12F3NO2
2304416-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6674 0.0 0
M  V30 2 C 8.4700 4.0011 0.0 0
M  V30 3 N 8.4700 1.3338 0.0 0
M  V30 4 C 10.0100 4.0011 0.0 0
M  V30 5 C 7.7000 0.0000 0.0 0
M  V30 6 O 10.7800 5.3349 0.0 0
M  V30 7 O 10.7800 2.6674 0.0 0
M  V30 8 C 12.3200 5.3349 0.0 0
M  V30 9 C 1.5400 2.6674 0.0 0
M  V30 10 F 1.5400 4.2074 0.0 0
M  V30 11 F 0.0000 2.6674 0.0 0
M  V30 12 F 1.5400 1.1274 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 14 C 5.3900 1.3338 0.0 0
M  V30 15 C 5.3900 4.0011 0.0 0
M  V30 16 C 3.8500 1.3338 0.0 0
M  V30 17 C 3.8500 4.0011 0.0 0
M  V30 18 C 3.0800 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 212755-76-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-16-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methyl]-5-oxoproline methyl ester
C23H27NO7
213608-58-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8691 6.6685 0.0 0
M  V30 2 C 2.5369 7.0187 0.0 0
M  V30 3 O 1.0306 7.3389 0.0 0
M  V30 4 O 3.0128 5.5541 0.0 0
M  V30 5 C 0.0000 6.1945 0.0 0
M  V30 6 O 7.2317 9.7293 0.0 0
M  V30 7 O 10.4892 9.3360 0.0 0
M  V30 8 C 12.0292 9.3360 0.0 0
M  V30 9 O 10.4892 4.0012 0.0 0
M  V30 10 C 9.7192 2.6673 0.0 0
M  V30 11 O 12.0292 6.6685 0.0 0
M  V30 12 C 12.7992 5.3348 0.0 0
M  V30 13 O 2.7890 1.3337 0.0 0
M  V30 14 C 3.5590 0.0000 0.0 0
M  V30 15 N 5.0991 8.0022 0.0 0
M  V30 16 C 3.5673 8.1633 0.0 0
M  V30 17 C 5.7254 9.4091 0.0 0
M  V30 18 C 3.2472 9.6696 0.0 0
M  V30 19 C 4.5810 10.4396 0.0 0
M  V30 20 C 7.4091 6.6685 0.0 0
M  V30 21 C 8.1791 8.0022 0.0 0
M  V30 22 C 8.1791 5.3348 0.0 0
M  V30 23 C 9.7192 8.0022 0.0 0
M  V30 24 C 9.7192 5.3348 0.0 0
M  V30 25 C 10.4892 6.6685 0.0 0
M  V30 26 C 5.0991 5.3348 0.0 0
M  V30 27 C 5.8691 4.0012 0.0 0
M  V30 28 C 3.5590 5.3348 0.0 0
M  V30 29 C 5.0991 2.6673 0.0 0
M  V30 30 C 2.7890 4.0012 0.0 0
M  V30 31 C 3.5590 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 2 16
M  V30 7 1 3 5
M  V30 8 2 6 17
M  V30 9 1 7 8
M  V30 10 1 7 23
M  V30 11 1 9 10
M  V30 12 1 9 24
M  V30 13 1 11 12
M  V30 14 1 11 25
M  V30 15 1 13 14
M  V30 16 1 13 31
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)(3,4,5-trimethoxyphenyl)methyl]-N-methyl-5-oxo-2-pyrrolid...
C23H28N2O6
440643-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8691 6.6685 0.0 0
M  V30 2 C 2.5369 7.0187 0.0 0
M  V30 3 N 1.0306 7.3389 0.0 0
M  V30 4 O 3.0128 5.5541 0.0 0
M  V30 5 C 0.0000 6.1945 0.0 0
M  V30 6 O 7.2317 9.7293 0.0 0
M  V30 7 O 10.4892 9.3360 0.0 0
M  V30 8 C 12.0292 9.3360 0.0 0
M  V30 9 O 10.4892 4.0012 0.0 0
M  V30 10 C 9.7192 2.6673 0.0 0
M  V30 11 O 12.0292 6.6685 0.0 0
M  V30 12 C 12.7992 5.3348 0.0 0
M  V30 13 O 2.7890 1.3337 0.0 0
M  V30 14 C 3.5590 0.0000 0.0 0
M  V30 15 N 5.0991 8.0022 0.0 0
M  V30 16 C 3.5673 8.1633 0.0 0
M  V30 17 C 5.7254 9.4091 0.0 0
M  V30 18 C 3.2472 9.6696 0.0 0
M  V30 19 C 4.5810 10.4396 0.0 0
M  V30 20 C 7.4091 6.6685 0.0 0
M  V30 21 C 8.1791 8.0022 0.0 0
M  V30 22 C 8.1791 5.3348 0.0 0
M  V30 23 C 9.7192 8.0022 0.0 0
M  V30 24 C 9.7192 5.3348 0.0 0
M  V30 25 C 10.4892 6.6685 0.0 0
M  V30 26 C 5.0991 5.3348 0.0 0
M  V30 27 C 5.8691 4.0012 0.0 0
M  V30 28 C 3.5590 5.3348 0.0 0
M  V30 29 C 5.0991 2.6673 0.0 0
M  V30 30 C 2.7890 4.0012 0.0 0
M  V30 31 C 3.5590 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 2 16
M  V30 7 1 3 5
M  V30 8 2 6 17
M  V30 9 1 7 8
M  V30 10 1 7 23
M  V30 11 1 9 10
M  V30 12 1 9 24
M  V30 13 1 11 12
M  V30 14 1 11 25
M  V30 15 1 13 14
M  V30 16 1 13 31
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 213608-58-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 440643-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1931799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies on pyrrolidinones: some attempts to improve the anticancer
properties of methyl N-(3,4,4',5-tetramethoxybenzhydryl)pyroglutamate
(HEI 81)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bourry, Anne; Rigo, Benoit; Sanz, Gerard; Couturier, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2002), 39(1), 119-124

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
(2S,3S)-1-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,3-diphenylcyclopropanecarbo...
C21H23NO4
214557-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9883 5.4270 0.0 0
M  V30 2 C 8.1680 6.4170 0.0 0
M  V30 3 O 9.6151 5.8903 0.0 0
M  V30 4 O 7.9006 7.9336 0.0 0
M  V30 5 C 10.7950 6.8801 0.0 0
M  V30 6 C 11.7847 5.7004 0.0 0
M  V30 7 C 11.9746 7.8700 0.0 0
M  V30 8 C 9.8050 8.0599 0.0 0
M  V30 9 C 5.8085 7.4704 0.0 0
M  V30 10 O 7.2557 7.9970 0.0 0
M  V30 11 O 4.6289 8.4603 0.0 0
M  V30 12 C 5.5412 5.9537 0.0 0 CFG=1
M  V30 13 C 4.7712 4.6201 0.0 0 CFG=2
M  V30 14 C 4.0011 5.9537 0.0 0 CFG=2
M  V30 15 C 4.7712 3.0800 0.0 0
M  V30 16 C 3.4375 2.3100 0.0 0
M  V30 17 C 6.1048 2.3100 0.0 0
M  V30 18 C 3.4375 0.7700 0.0 0
M  V30 19 C 6.1048 0.7700 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 2.6675 6.7237 0.0 0
M  V30 22 C 2.6675 8.2638 0.0 0
M  V30 23 C 1.3337 5.9537 0.0 0
M  V30 24 C 1.3337 9.0338 0.0 0
M  V30 25 C 0.0000 6.7237 0.0 0
M  V30 26 C 0.0000 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 12 9 CFG=1
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 15 1 13 15 CFG=3
M  V30 16 1 14 21 CFG=1
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(2S,3S)-1-[(methylamino)carbonyl]-2,3-diphenylcyclopropyl]-, ...
C22H26N2O3
876625-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.9883 5.4270 0.0 0
M  V30 2 C 8.1680 6.4170 0.0 0
M  V30 3 O 9.6151 5.8903 0.0 0
M  V30 4 O 7.9006 7.9336 0.0 0
M  V30 5 C 10.7950 6.8801 0.0 0
M  V30 6 C 11.7847 5.7004 0.0 0
M  V30 7 C 11.9746 7.8700 0.0 0
M  V30 8 C 9.8050 8.0599 0.0 0
M  V30 9 C 5.8085 7.4704 0.0 0
M  V30 10 N 4.6289 8.4603 0.0 0
M  V30 11 O 7.2557 7.9970 0.0 0
M  V30 12 C 4.8962 9.9769 0.0 0
M  V30 13 C 5.5412 5.9537 0.0 0 CFG=2
M  V30 14 C 4.0011 5.9537 0.0 0 CFG=2
M  V30 15 C 4.7712 4.6201 0.0 0 CFG=2
M  V30 16 C 2.6675 6.7237 0.0 0
M  V30 17 C 2.6675 8.2638 0.0 0
M  V30 18 C 1.3337 5.9537 0.0 0
M  V30 19 C 1.3337 9.0338 0.0 0
M  V30 20 C 0.0000 6.7237 0.0 0
M  V30 21 C 0.0000 8.2638 0.0 0
M  V30 22 C 4.7712 3.0800 0.0 0
M  V30 23 C 6.1048 2.3100 0.0 0
M  V30 24 C 3.4375 2.3100 0.0 0
M  V30 25 C 6.1048 0.7700 0.0 0
M  V30 26 C 3.4375 0.7700 0.0 0
M  V30 27 C 4.7712 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 13 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 13 9 CFG=1
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=1
M  V30 17 1 15 22 CFG=3
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 214557-96-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 876625-48-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4290964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):NOTES
$DATUM no exptl. detail, reactant assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preferred 3D-structure of peptides rich in a severely conformationally
restricted cyclopropane analog of phenylalanine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crisma, Marco; De Borggraeve, Wim M.; Peggion, Cristina; Formaggio,
Fernando; Royo, Soledad; Jimenez, Ana I.; Cativiela, Carlos; Toniolo,
Claudio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2005), 12(1), 251-260

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
1,5-Dimethyl 3-[(6-carboxy-2-pyridinyl)methyl]-9-hydroxy-7-methyl-2,4-di-2-py...
C29H31N5O7
2151045-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.8515 5.8640 0.0 0
M  V30 2 O 13.1842 5.0923 0.0 0
M  V30 3 O 11.8535 7.4040 0.0 0
M  V30 4 C 14.5188 5.8605 0.0 0
M  V30 5 C 6.9979 7.1659 0.0 0
M  V30 6 O 8.3891 4.7563 0.0 0
M  V30 7 C 5.6988 2.3117 0.0 0
M  V30 8 O 5.7006 0.7717 0.0 0
M  V30 9 O 4.3641 3.0800 0.0 0
M  V30 10 C 4.3681 0.0000 0.0 0
M  V30 11 C 10.5502 1.0132 0.0 0
M  V30 12 C 2.3779 9.8332 0.0 0
M  V30 13 O 0.8379 9.8332 0.0 0
M  V30 14 O 3.1479 11.1668 0.0 0
M  V30 15 C 9.2965 6.0390 0.0 0
M  V30 16 C 10.5168 5.0957 0.0 0
M  V30 17 N 7.7679 5.8321 0.0 0
M  V30 18 C 9.1591 3.4227 0.0 0
M  V30 19 C 10.7184 3.5760 0.0 0
M  V30 20 C 6.8247 4.6118 0.0 0
M  V30 21 C 7.0315 3.0834 0.0 0
M  V30 22 N 9.7802 2.3468 0.0 0
M  V30 23 C 8.2465 2.1489 0.0 0
M  V30 24 C 9.6951 7.5264 0.0 0
M  V30 25 C 11.1826 7.9251 0.0 0
M  V30 26 N 8.6061 8.6154 0.0 0
M  V30 27 C 11.5813 9.4126 0.0 0
M  V30 28 C 9.0047 10.1030 0.0 0
M  V30 29 C 10.4922 10.5016 0.0 0
M  V30 30 C 3.0332 3.9433 0.0 0
M  V30 31 C 2.0433 5.1230 0.0 0
M  V30 32 N 2.5065 2.4962 0.0 0
M  V30 33 C 0.5267 4.8556 0.0 0
M  V30 34 C 0.9898 2.2287 0.0 0
M  V30 35 C 0.0000 3.4085 0.0 0
M  V30 36 C 5.4579 7.1659 0.0 0
M  V30 37 N 4.6879 8.4996 0.0 0
M  V30 38 C 4.6879 5.8321 0.0 0
M  V30 39 C 3.1479 8.4996 0.0 0
M  V30 40 C 3.1479 5.8321 0.0 0
M  V30 41 C 2.3779 7.1659 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 17
M  V30 6 1 5 36
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 8 10
M  V30 12 1 11 22
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 39
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 15 24
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 20 30
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 1 36 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,7-Diazabicyclo[3.3.1]nonane-1,5-dicarboxylic acid, 9-hydroxy-7-methyl-3-[[6...
C30H34N6O6
2907774-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8640 9.4895 0.0 0
M  V30 2 O 5.0923 10.8220 0.0 0
M  V30 3 O 7.4040 9.4913 0.0 0
M  V30 4 C 5.8606 12.1568 0.0 0
M  V30 5 O 4.7564 6.0271 0.0 0
M  V30 6 C 7.1659 4.6359 0.0 0
M  V30 7 C 2.3117 3.3366 0.0 0
M  V30 8 O 0.7717 3.3386 0.0 0
M  V30 9 O 3.0800 2.0020 0.0 0
M  V30 10 C 0.0000 2.0059 0.0 0
M  V30 11 C 1.0132 8.1882 0.0 0
M  V30 12 C 12.5006 4.6359 0.0 0
M  V30 13 N 13.8344 5.4059 0.0 0
M  V30 14 O 12.5006 3.0959 0.0 0
M  V30 15 C 15.1681 4.6359 0.0 0
M  V30 16 C 5.0957 8.1548 0.0 0
M  V30 17 C 6.0391 6.9345 0.0 0
M  V30 18 C 3.4228 6.7971 0.0 0
M  V30 19 C 3.5762 8.3563 0.0 0
M  V30 20 N 5.8323 5.4059 0.0 0
M  V30 21 C 3.0834 4.6693 0.0 0
M  V30 22 N 2.3468 7.4182 0.0 0
M  V30 23 C 4.6120 4.4626 0.0 0
M  V30 24 C 2.1491 5.8845 0.0 0
M  V30 25 C 8.9884 9.4091 0.0 0
M  V30 26 C 8.7209 10.9257 0.0 0
M  V30 27 N 10.4355 8.8824 0.0 0
M  V30 28 C 9.9007 11.9156 0.0 0
M  V30 29 C 11.6151 9.8723 0.0 0
M  V30 30 C 11.3478 11.3889 0.0 0
M  V30 31 C 5.0105 2.9750 0.0 0
M  V30 32 C 3.9216 1.8860 0.0 0
M  V30 33 N 6.4980 2.5764 0.0 0
M  V30 34 C 4.3202 0.3986 0.0 0
M  V30 35 C 6.8966 1.0889 0.0 0
M  V30 36 C 5.8076 0.0000 0.0 0
M  V30 37 C 8.4997 5.4059 0.0 0
M  V30 38 N 9.8334 4.6359 0.0 0
M  V30 39 C 8.4997 6.9459 0.0 0
M  V30 40 C 11.1670 5.4059 0.0 0
M  V30 41 C 9.8334 7.7159 0.0 0
M  V30 42 C 11.1670 6.9459 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 5 18
M  V30 6 1 6 20
M  V30 7 1 6 37
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 8 10
M  V30 12 1 11 22
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 40
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 17 25
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 20 23
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 1 22 24
M  V30 28 1 23 31
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 37 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2151045-80-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2907774-10-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36023326
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1075198-30-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactivities of iron(IV)-oxido compounds with pentadentate bispidine
ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bleher, Katharina; Comba, Peter; Kass, Dustin; Ray, Kallol; Wadepohl,
Hubert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Inorganic Biochemistry (2023), 241112123

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3S,6′R,12′R)-8′-chloro-1,2-dihydro-1-methyl-2-oxospiro[3H-indole-3,5′(...
C25H21ClN2O4
2161350-00-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.4627 10.3495 0.0 0
M  V30 2 C 1.5072 9.5512 0.0 0
M  V30 3 C 9.3582 7.2243 0.0 0
M  V30 4 O 10.5811 6.2884 0.0 0
M  V30 5 O 9.5572 8.7513 0.0 0
M  V30 6 C 12.0031 6.8796 0.0 0
M  V30 7 C 13.2261 5.9438 0.0 0
M  V30 8 Cl 4.5378 0.0000 0.0 0
M  V30 9 C 4.2126 6.6255 0.0 0 CFG=1
M  V30 10 C 4.2221 5.0831 0.0 0 CFG=2
M  V30 11 N 5.3067 7.7152 0.0 0
M  V30 12 C 2.9011 5.8181 0.0 0
M  V30 13 C 3.8499 8.1222 0.0 0
M  V30 14 C 5.3078 4.0010 0.0 0
M  V30 15 C 6.3756 5.1475 0.0 0
M  V30 16 C 6.8465 7.7246 0.0 0
M  V30 17 C 4.8218 9.1768 0.0 0
M  V30 18 C 1.7281 6.8159 0.0 0
M  V30 19 C 2.6236 4.3034 0.0 0
M  V30 20 N 2.3146 8.2399 0.0 0
M  V30 21 C 6.8541 4.0010 0.0 0
M  V30 22 C 4.5378 2.6674 0.0 0
M  V30 23 C 7.9362 6.6331 0.0 0 CFG=2
M  V30 24 C 7.3134 9.1922 0.0 0
M  V30 25 C 6.0619 10.0897 0.0 0
M  V30 26 C 0.2775 6.2989 0.0 0
M  V30 27 C 1.1731 3.7865 0.0 0
M  V30 28 O 7.9417 5.1002 0.0 0
M  V30 29 C 7.6177 2.6674 0.0 0
M  V30 30 C 5.3078 1.3338 0.0 0
M  V30 31 C 0.0000 4.7841 0.0 0
M  V30 32 C 6.8478 1.3338 0.0 0
M  V30 33 H 2.3950 3.6699 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 23
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 30
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 13 CFG=3
M  V30 13 1 10 14
M  V30 14 1 10 15 CFG=1
M  V30 15 1 10 33
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 12 18
M  V30 19 2 12 19
M  V30 20 1 13 20
M  V30 21 1 14 21
M  V30 22 2 14 22
M  V30 23 1 23 15 CFG=1
M  V30 24 1 16 23
M  V30 25 2 16 24
M  V30 26 2 17 25
M  V30 27 1 18 20
M  V30 28 2 18 26
M  V30 29 1 19 27
M  V30 30 1 21 28
M  V30 31 2 21 29
M  V30 32 1 22 30
M  V30 33 1 23 28
M  V30 34 1 24 25
M  V30 35 1 26 31
M  V30 36 2 27 31
M  V30 37 1 29 32
M  V30 38 2 30 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S,6′R,12′R)-8′-Chloro-1,2-dihydro-N,1-dimethyl-2-oxospiro[3H-indole-3,5′(6′...
C24H20ClN3O3
2161350-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.2585 9.6070 0.0 0
M  V30 2 C 1.5072 9.5512 0.0 0
M  V30 3 C 9.3582 7.2242 0.0 0
M  V30 4 N 10.5811 6.2883 0.0 0
M  V30 5 O 9.5571 8.7512 0.0 0
M  V30 6 C 12.0031 6.8797 0.0 0
M  V30 7 Cl 4.5377 0.0000 0.0 0
M  V30 8 C 4.2126 6.6254 0.0 0 CFG=1
M  V30 9 C 4.2221 5.0831 0.0 0 CFG=2
M  V30 10 N 5.3066 7.7151 0.0 0
M  V30 11 C 2.9012 5.8182 0.0 0
M  V30 12 C 3.8499 8.1221 0.0 0
M  V30 13 C 5.3077 4.0010 0.0 0
M  V30 14 C 6.3756 5.1474 0.0 0
M  V30 15 C 6.8466 7.7246 0.0 0
M  V30 16 C 4.8218 9.1767 0.0 0
M  V30 17 C 1.7282 6.8159 0.0 0
M  V30 18 C 2.6236 4.3033 0.0 0
M  V30 19 N 2.3144 8.2398 0.0 0
M  V30 20 C 6.8541 4.0010 0.0 0
M  V30 21 C 4.5377 2.6672 0.0 0
M  V30 22 C 7.9362 6.6330 0.0 0 CFG=2
M  V30 23 C 7.3135 9.1921 0.0 0
M  V30 24 C 6.0619 10.0896 0.0 0
M  V30 25 C 0.2775 6.2988 0.0 0
M  V30 26 C 1.1731 3.7863 0.0 0
M  V30 27 O 7.9418 5.1001 0.0 0
M  V30 28 C 7.6176 2.6672 0.0 0
M  V30 29 C 5.3077 1.3336 0.0 0
M  V30 30 C 0.0000 4.7841 0.0 0
M  V30 31 C 6.8476 1.3336 0.0 0
M  V30 32 H 3.1860 3.9437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 22
M  V30 6 1 4 6
M  V30 7 1 7 29
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12 CFG=3
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=1
M  V30 14 1 9 32
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 1 11 17
M  V30 18 2 11 18
M  V30 19 1 12 19
M  V30 20 1 13 20
M  V30 21 2 13 21
M  V30 22 1 22 14 CFG=1
M  V30 23 1 15 22
M  V30 24 2 15 23
M  V30 25 2 16 24
M  V30 26 1 17 19
M  V30 27 2 17 25
M  V30 28 1 18 26
M  V30 29 1 20 27
M  V30 30 2 20 28
M  V30 31 1 21 29
M  V30 32 1 22 27
M  V30 33 1 23 24
M  V30 34 1 25 30
M  V30 35 2 26 30
M  V30 36 1 28 31
M  V30 37 2 29 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 9 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2161350-00-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2161350-01-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17952798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organo-Catalyzed Asymmetric Michael-Hemiketalization-Oxa-Pictet-Spengler
Cyclization for Bridged and Spiro Heterocyclic Skeletons: Oxocarbenium
Ion as a Key Intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Wei-Tai; Li, Nai-Kai; Xu, Lumei; Qiao, Chunhua; Wang, Xing-Wang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(24), 6626-6629

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxybenzoyl chloride
C8H7ClO2
21615-34-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 1.3338 0.0 0
M  V30 2 C 6.1600 1.3338 0.0 0
M  V30 3 C 1.5400 1.3338 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methylbenzamide
C9H11NO2
3400-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 O 3.8500 5.3349 0.0 0
M  V30 4 C 6.9300 5.3349 0.0 0
M  V30 5 O 1.5400 4.0011 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 21615-34-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292361
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
4-[[(2R)-3-Oxo-3-(phenylamino)-2-[[(phenylmethoxy)carbonyl]amino]propyl]thio]...
C21H24N2O5S
2176461-58-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 6.6684 0.0 0 CFG=2
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 9.2400 6.6684 0.0 0
M  V30 4 C 6.9300 8.0020 0.0 0
M  V30 5 N 7.7000 4.0011 0.0 0
M  V30 6 O 5.3900 5.3347 0.0 0
M  V30 7 C 10.0100 8.0020 0.0 0
M  V30 8 S 5.3900 8.0020 0.0 0
M  V30 9 O 11.5500 8.0020 0.0 0
M  V30 10 O 9.2400 9.3358 0.0 0
M  V30 11 C 4.6200 9.3358 0.0 0
M  V30 12 C 12.3200 9.3358 0.0 0
M  V30 13 C 3.0800 9.3358 0.0 0
M  V30 14 C 2.3100 10.6694 0.0 0
M  V30 15 C 0.7700 10.6694 0.0 0
M  V30 16 O 0.0000 9.3358 0.0 0
M  V30 17 O 0.0000 12.0031 0.0 0
M  V30 18 C 6.9300 2.6673 0.0 0
M  V30 19 C 5.3900 2.6673 0.0 0
M  V30 20 C 7.7000 1.3336 0.0 0
M  V30 21 C 4.6200 1.3336 0.0 0
M  V30 22 C 6.9300 0.0000 0.0 0
M  V30 23 C 5.3900 0.0000 0.0 0
M  V30 24 C 13.8600 9.3358 0.0 0
M  V30 25 C 14.6300 10.6694 0.0 0
M  V30 26 C 14.6300 8.0020 0.0 0
M  V30 27 C 16.1700 10.6694 0.0 0
M  V30 28 C 16.1700 8.0020 0.0 0
M  V30 29 C 16.9400 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 18
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 24
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 2 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 28
M  V30 29 2 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1R)-1-[[[4-(methylamino)-4-oxobutyl]thio]methyl]-2-oxo-2-(ph...
C22H27N3O4S
2176461-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 6.6684 0.0 0 CFG=2
M  V30 2 C 8.4700 5.3347 0.0 0
M  V30 3 N 10.7800 6.6684 0.0 0
M  V30 4 C 8.4700 8.0020 0.0 0
M  V30 5 N 9.2400 4.0011 0.0 0
M  V30 6 O 6.9300 5.3347 0.0 0
M  V30 7 C 11.5500 8.0020 0.0 0
M  V30 8 S 6.9300 8.0020 0.0 0
M  V30 9 O 13.0900 8.0020 0.0 0
M  V30 10 O 10.7800 9.3358 0.0 0
M  V30 11 C 6.1600 9.3358 0.0 0
M  V30 12 C 13.8600 9.3358 0.0 0
M  V30 13 C 4.6200 9.3358 0.0 0
M  V30 14 C 3.8500 10.6694 0.0 0
M  V30 15 C 2.3100 10.6694 0.0 0
M  V30 16 N 1.5400 12.0031 0.0 0
M  V30 17 O 1.5400 9.3358 0.0 0
M  V30 18 C 0.0000 12.0031 0.0 0
M  V30 19 C 8.4700 2.6673 0.0 0
M  V30 20 C 6.9300 2.6673 0.0 0
M  V30 21 C 9.2400 1.3336 0.0 0
M  V30 22 C 6.1600 1.3336 0.0 0
M  V30 23 C 8.4700 0.0000 0.0 0
M  V30 24 C 6.9300 0.0000 0.0 0
M  V30 25 C 15.4000 9.3358 0.0 0
M  V30 26 C 16.1700 10.6694 0.0 0
M  V30 27 C 16.1700 8.0020 0.0 0
M  V30 28 C 17.7100 10.6694 0.0 0
M  V30 29 C 17.7100 8.0020 0.0 0
M  V30 30 C 18.4800 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 19
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 25
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2176461-58-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2176461-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19455350
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 543-27-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The mimics of Nε-acyl-lysine derived from cysteine as sirtuin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Chun; Wang, Fang; Chen, Xiaoxue; Zou, Yefang; Zhu, Hong; Zhao,
Qingjie; Shen, Jingshan; Li, Yan; Li, Yongjun; He, Bin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2018), 28(14), 2375-2378

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-α-(1-methylethyl)-2-(methylthio)-5-pyrimidinemethanol
C9H12Cl2N2OS
2195400-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 1.3337 3.8501 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 Cl 5.3348 0.0000 0.0 0
M  V30 7 Cl 2.6675 4.6201 0.0 0
M  V30 8 S 8.0023 4.6201 0.0 0
M  V30 9 C 9.3360 3.8501 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 4.0012 3.8501 0.0 0
M  V30 13 N 6.6685 2.3101 0.0 0
M  V30 14 N 5.3348 4.6201 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(methylamino)-α-(1-methylethyl)-2-(methylthio)-5-pyrimidinemethanol
C10H16ClN3OS
2246957-51-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 C 1.5400 5.3348 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 2.3100 6.6686 0.0 0
M  V30 5 C 0.0000 5.3348 0.0 0
M  V30 6 N 3.8500 1.3338 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 Cl 3.8500 6.6686 0.0 0
M  V30 9 S 8.4701 4.0011 0.0 0
M  V30 10 C 9.2401 5.3348 0.0 0
M  V30 11 C 3.8500 4.0011 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 N 6.1601 2.6675 0.0 0
M  V30 15 N 6.1601 5.3348 0.0 0
M  V30 16 C 6.9301 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 1 6 12
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2195400-92-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2246957-51-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19235310
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile synthesis of 1,4-dihydro-2H-pyrimido[4,5-d][1,3]oxazin-2-one
derivatives from 4,6-dichloro-2-(methylsulfanyl)pyrimidine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Kazuhiro; Tsunomori, Yuka; Nogi, Takashi; Hiyoshi, Hidetaka;
Umezu, Kazuto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2018), 96(4), 757-765

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, 2-[(dimethylamino)methylene]-N-(4-nitrophenyl)-3-oxo-
C13H15N3O4
2197964-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 C 0.0000 5.3349 0.0 0
M  V30 12 N 11.5500 4.0011 0.0 0 VAL=5
M  V30 13 O 12.3200 2.6674 0.0 0
M  V30 14 O 12.3200 5.3349 0.0 0
M  V30 15 C 6.9300 4.0011 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 7.7000 5.3349 0.0 0
M  V30 18 C 9.2400 2.6674 0.0 0
M  V30 19 C 9.2400 5.3349 0.0 0
M  V30 20 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 15
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, 2-[(methylamino)methylene]-N-(4-nitrophenyl)-3-oxo-
C12H13N3O4
2197964-23-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 2.6674 0.0 0
M  V30 2 C 4.6200 2.6674 0.0 0
M  V30 3 C 2.3100 4.0011 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 N 5.3900 4.0011 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 N 11.5500 4.0011 0.0 0 VAL=5
M  V30 12 O 12.3200 2.6674 0.0 0
M  V30 13 O 12.3200 5.3349 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 C 7.7000 5.3349 0.0 0
M  V30 17 C 9.2400 2.6674 0.0 0
M  V30 18 C 9.2400 5.3349 0.0 0
M  V30 19 C 10.0100 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 14
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 2 11 13
M  V30 13 1 11 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2197964-35-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-23-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenylacrylamide
C9H9NO
2210-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 3.0800 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 2.6674 0.7700 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 C 1.3336 0.0000 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-(Methylimino)bis[N-phenylpropanamide]
C19H23N3O2
50735-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 14.6705 1.5400 0.0 0
M  V30 2 C 13.3369 2.3100 0.0 0
M  V30 3 C 12.0032 1.5400 0.0 0
M  V30 4 O 13.3369 3.8500 0.0 0
M  V30 5 C 10.6694 2.3100 0.0 0
M  V30 6 N 9.3358 1.5400 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 9.3358 0.0000 0.0 0
M  V30 9 C 6.6684 1.5400 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 N 4.0011 1.5400 0.0 0
M  V30 12 O 5.3347 3.8500 0.0 0
M  V30 13 C 16.0041 2.3100 0.0 0
M  V30 14 C 16.0041 3.8500 0.0 0
M  V30 15 C 17.3379 1.5400 0.0 0
M  V30 16 C 17.3379 4.6200 0.0 0
M  V30 17 C 18.6716 2.3100 0.0 0
M  V30 18 C 18.6716 3.8500 0.0 0
M  V30 19 C 2.6674 2.3100 0.0 0
M  V30 20 C 1.3336 1.5400 0.0 0
M  V30 21 C 2.6674 3.8500 0.0 0
M  V30 22 C 0.0000 2.3100 0.0 0
M  V30 23 C 1.3336 4.6200 0.0 0
M  V30 24 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 19
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2210-24-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 50735-56-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-20448066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Potent Isoprenylcysteine Carboxylmethyltransferase (ICMT) Inhibitor
Improves Survival in Ras-Driven Acute Myeloid Leukemia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marin-Ramos, Nagore I.; Balabasquer, Moises; Ortega-Nogales, Francisco
J.; Torrecillas, Ivan R.; Gil-Ordonez, Ana; Marcos-Ramiro, Beatriz;
Aguilar-Garrido, Pedro; Cushman, Ian; Romero, Antonio; Medrano, Francisco
J.; Gajate, Consuelo; Mollinedo, Faustino; Philips, Mark R.; Campillo,
Mercedes; Gallardo, Miguel; Martin-Fontecha, Mar; Lopez-Rodriguez, Maria
L.; Ortega-Gutierrez, Silvia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(13), 6035-6046

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyridinemethanol, 2,6-dichloro-, 4-methanesulfonate
C7H7Cl2NO3S
221095-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 O 6.6685 3.8501 0.0 0
M  V30 3 S 8.0023 4.6201 0.0 0 VAL=6
M  V30 4 C 8.7723 3.2864 0.0 0
M  V30 5 O 9.3360 5.3901 0.0 0
M  V30 6 O 7.2323 5.9538 0.0 0
M  V30 7 Cl 2.6675 0.0000 0.0 0
M  V30 8 Cl 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 14 N 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 12
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-N-methyl-4-pyridinemethanamine
C7H8Cl2N2
873928-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 C 8.0021 4.6200 0.0 0
M  V30 4 Cl 2.6674 0.0000 0.0 0
M  V30 5 Cl 0.0000 4.6200 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 N 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221095-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 873928-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21499413
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phenylpyridinylmethylpiperidines,
phenylpyridinylmethylpiperazines and their analogs as furin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Axten, Jeffrey Michael; Cheung, Mui; Demartino, Michael P.; Guan, Huiping
Amy; Hu, Yan; Miller, Aaron Bayne; Qin, Donghui; Wu, Chengde; Zhang,
Zhiliu; Lin, Xiaojuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019215341 A1 2019-11-14

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloroquinoxaline
C8H4Cl2N2
2213-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9300 2.6674 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-quinoxalinamine
C9H8ClN3
90537-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2213-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90537-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37447162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of raloxifene-like quinoxaline derivatives by intramolecular
electrophilic cyclization with disulfides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Umezu, Yuhi; Horiyama, Eito; Nakai, Yuto; Ninomiya, Masayuki; Nishina,
Atsuyoshi; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2023), 93129415

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloroquinoxaline
C8H4Cl2N2
2213-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9300 2.6674 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-quinoxalinamine
C9H8ClN3
90537-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2213-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90537-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7273534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-Alkyl-3-chloroquinoxalin-2-amines 2a-f;
General Procedure A mixture of 2,3-dichloroquinoxaline (0.01 mmol) and
primary alkylamine (0.02 mmol) in EtOH (5 mL) was heated under reflux for
4 h. The solvent was evaporated under reduced pressure, and the resultant
solid was washed with H2O and dried. The crude product obtained was of
sufficient purity that further purification was not necessary (Table 1).
N-Benzyl-3-chloroquinoxalin-2-amine (2a)
3-Chloro-N-methylquinoxalin-2-amine (2f) Yield: 95%. Mp 89-90 °C. IR
(KBr): 3410 (NH), 1580, 1080, 750 cm-1. 1H NMR (500 MHz, DMSO-d 6): δ =
3.07 (d, J = 5.25 Hz, 3 H, CH3), 7.51-8.13 (m, 5 H, ArH, NH). Anal. Calcd
for C9H8N3Cl: C, 55.83; H, 4.16; N, 21.70. Found: C, 55.68; H, 4.31; N,
21.88.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of unexpected pyrrolo[2,3-b]quinoxaline-2-carbaldehydes via
Sonogashira coupling reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keivanloo, Ali; Bakherad, Mohammad; Rahimi, Amin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2010), (10), 1599-1602

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dichloroquinoxaline
C8H4Cl2N2
2213-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9300 2.6674 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 2.3100 2.6674 0.0 0
M  V30 5 N 4.6200 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 N 3.0800 1.3338 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 C 5.3900 2.6674 0.0 0
M  V30 10 C 0.7700 5.3349 0.0 0
M  V30 11 C 4.6200 1.3338 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methyl-2-quinoxalinamine
C9H8ClN3
90537-58-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9300 2.6674 0.0 0
M  V30 2 C 7.7000 4.0011 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2213-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90537-58-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-784492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis of 1,2-disubstituted pyrrolo[2,3-b]quinoxalines via
palladium-catalyzed heteroannulation in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Keivanloo, Ali; Bakherad, Mohammad; Rahimi, Amin; Taheri, Sayed Ali Naghi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2010), 51(18), 2409-2412

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Fluoro-3-methyl-5-nitro-1,2-benzisoxazole
C8H5FN2O3
221559-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.4294 0.3694 0.0 0
M  V30 2 N 6.3709 1.5400 0.0 0 VAL=5
M  V30 3 O 7.7047 2.3100 0.0 0
M  V30 4 O 6.3709 0.0000 0.0 0
M  V30 5 F 6.3709 4.6200 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 C 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 N 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-5-nitro-1,2-benzisoxazol-6-amine
C9H9N3O3
1983933-63-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0408 3.2907 0.0 0
M  V30 2 N 0.7700 4.0012 0.0 0
M  V30 3 C 0.0000 5.3348 0.0 0
M  V30 4 N 2.3101 1.3337 0.0 0 VAL=5
M  V30 5 O 0.7700 1.3337 0.0 0
M  V30 6 O 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 5.3348 0.0 0
M  V30 8 C 5.3901 4.0012 0.0 0
M  V30 9 C 3.0801 5.3348 0.0 0
M  V30 10 O 5.6505 6.4792 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.8964 4.3213 0.0 0
M  V30 13 C 2.3101 4.0012 0.0 0
M  V30 14 N 7.0574 5.8529 0.0 0
M  V30 15 C 3.0801 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221559-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1983933-63-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18939788
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Based Discovery and Optimization of Benzo[d]isoxazole
Derivatives as Potent and Selective BET Inhibitors for Potential
Treatment of Castration-Resistant Prostate Cancer (CRPC)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Maofeng; Zhang, Yan; Song, Ming; Xue, Xiaoqian; Wang, Junjian;
Wang, Chao; Zhang, Cheng; Li, Chenchang; Xiang, Qiuping; Zou, Lingjiao;
Wu, Xishan; Wu, Chun; Dong, Baijun; Xue, Wei; Zhou, Yulai; Chen, Hongwu;
Wu, Donghai; Ding, Ke; Xu, Yong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(7), 3037-3058

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-(Chloromethyl)-2,3-dihydro-3-(1-methylethyl)-5-(phenylmethoxy)-1H-pyrido[2,...
C18H20ClN3O3
2228933-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 6.6684 0.0 0
M  V30 2 C 7.7000 8.0021 0.0 0
M  V30 3 O 6.9300 4.0011 0.0 0
M  V30 4 C 0.7700 6.6684 0.0 0
M  V30 5 Cl 0.0000 8.0021 0.0 0
M  V30 6 O 5.3900 9.3358 0.0 0
M  V30 7 C 5.3900 1.3336 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 4.6200 0.0000 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 N 3.0800 5.3347 0.0 0
M  V30 12 C 5.3900 6.6684 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 2.3100 6.6684 0.0 0
M  V30 15 N 2.3100 4.0011 0.0 0
M  V30 16 C 4.6200 8.0021 0.0 0
M  V30 17 N 4.6200 2.6674 0.0 0
M  V30 18 C 3.0800 8.0021 0.0 0
M  V30 19 C 3.0800 2.6674 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 10.0100 9.3358 0.0 0
M  V30 22 C 10.0100 6.6684 0.0 0
M  V30 23 C 11.5500 9.3358 0.0 0
M  V30 24 C 11.5500 6.6684 0.0 0
M  V30 25 C 12.3200 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 20
M  V30 4 2 3 13
M  V30 5 1 4 5
M  V30 6 1 4 14
M  V30 7 2 6 16
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-8-[(methylamino)methyl]-3-(1-methylethyl)-5-(phenylmethoxy)-1H-py...
C19H24N4O3
2228933-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 O 5.3900 4.0011 0.0 0
M  V30 4 C 11.5500 6.6684 0.0 0
M  V30 5 N 12.3200 8.0021 0.0 0
M  V30 6 C 13.8600 8.0021 0.0 0
M  V30 7 O 6.9300 9.3358 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 5.3900 1.3336 0.0 0
M  V30 10 C 7.7000 0.0000 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 N 9.2400 5.3347 0.0 0
M  V30 13 C 6.9300 6.6684 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 10.0100 6.6684 0.0 0
M  V30 16 N 10.0100 4.0011 0.0 0
M  V30 17 C 7.7000 8.0021 0.0 0
M  V30 18 N 7.7000 2.6674 0.0 0
M  V30 19 C 9.2400 8.0021 0.0 0
M  V30 20 C 9.2400 2.6674 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 9.3358 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 24 C 0.7700 9.3358 0.0 0
M  V30 25 C 0.7700 6.6684 0.0 0
M  V30 26 C 0.0000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 21
M  V30 4 2 3 14
M  V30 5 1 4 5
M  V30 6 1 4 15
M  V30 7 1 5 6
M  V30 8 2 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 18
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2228933-34-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2228933-35-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20340620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic heterocycle compounds useful as HIV integrase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Graham, Thomas H.; Yu, Tao; Waddell, Sherman T.; McCauley, John A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018102634 A1 2018-06-07

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,4,5,6-tetrahydro-5-methyl-3-(4-methylphenyl)-4,6-dioxopyrrolo[3,4-c]p...
C17H16N2O4
2242709-27-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1942 2.4898 0.0 0
M  V30 2 C 9.3038 5.1590 0.0 0
M  V30 3 O 9.9301 6.5659 0.0 0
M  V30 4 O 10.2089 3.9131 0.0 0
M  V30 5 C 11.4617 6.7269 0.0 0
M  V30 6 C 12.0880 8.1338 0.0 0
M  V30 7 O 8.4968 1.3628 0.0 0
M  V30 8 C 5.4360 0.0000 0.0 0
M  V30 9 C 0.0000 8.5962 0.0 0
M  V30 10 C 5.4958 3.9845 0.0 0
M  V30 11 C 7.0021 3.6644 0.0 0
M  V30 12 C 5.3348 5.5161 0.0 0
M  V30 13 C 4.7257 2.6509 0.0 0
M  V30 14 C 7.7721 4.9980 0.0 0
M  V30 15 C 7.1632 2.1328 0.0 0
M  V30 16 N 6.7417 6.1426 0.0 0
M  V30 17 N 5.7562 1.5063 0.0 0
M  V30 18 C 4.0010 6.2861 0.0 0
M  V30 19 C 4.0010 7.8261 0.0 0
M  V30 20 C 2.6673 5.5161 0.0 0
M  V30 21 C 2.6673 8.5962 0.0 0
M  V30 22 C 1.3337 6.2861 0.0 0
M  V30 23 C 1.3337 7.8261 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 15
M  V30 8 1 8 17
M  V30 9 1 9 23
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 18
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N2,N3,N4-Trimethyl-5-(4-methylphenyl)-1H-pyrrole-2,3,4-tricarboxamide
C17H20N4O3
2242709-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 2.6091 0.0 0
M  V30 2 N 4.8087 1.4647 0.0 0
M  V30 3 O 7.3455 2.2889 0.0 0
M  V30 4 C 5.2845 0.0000 0.0 0
M  V30 5 C 2.6528 3.6444 0.0 0
M  V30 6 N 1.2459 4.2707 0.0 0
M  V30 7 O 2.8137 2.1129 0.0 0
M  V30 8 C 0.0000 3.3657 0.0 0
M  V30 9 C 2.6528 6.9949 0.0 0
M  V30 10 N 2.8137 8.5264 0.0 0
M  V30 11 O 1.2459 6.3684 0.0 0
M  V30 12 C 1.5679 9.4316 0.0 0
M  V30 13 C 12.4285 5.3196 0.0 0
M  V30 14 C 6.2684 5.3196 0.0 0
M  V30 15 C 5.3632 4.0738 0.0 0
M  V30 16 N 5.3632 6.5655 0.0 0
M  V30 17 C 3.8987 4.5496 0.0 0
M  V30 18 C 3.8987 6.0897 0.0 0
M  V30 19 C 7.8085 5.3196 0.0 0
M  V30 20 C 8.5785 6.6533 0.0 0
M  V30 21 C 8.5785 3.9860 0.0 0
M  V30 22 C 10.1185 6.6533 0.0 0
M  V30 23 C 10.1185 3.9860 0.0 0
M  V30 24 C 10.8885 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 18
M  V30 12 1 10 12
M  V30 13 1 13 24
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 19
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242709-27-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242709-38-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19137702
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile access to highly functionalized pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Meng; Zhao, Wenting; Zhao, Hongyi; Lin, Ziyun; Zhang, Dongfeng;
Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14884-890

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-ethyl-2,4,5,6-tetrahydro-4,6-dioxo-3-phenylpyrrolo[3,4-c]pyrrole-1-ca...
C17H16N2O4
2242709-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.8604 3.5204 0.0 0
M  V30 2 C 7.9700 6.1895 0.0 0
M  V30 3 O 8.5965 7.5965 0.0 0
M  V30 4 O 8.8752 4.9437 0.0 0
M  V30 5 C 10.1280 7.7575 0.0 0
M  V30 6 C 10.7544 9.1643 0.0 0
M  V30 7 O 7.1632 2.3932 0.0 0
M  V30 8 C 4.1023 1.0304 0.0 0
M  V30 9 C 5.2467 0.0000 0.0 0
M  V30 10 C 4.1621 5.0151 0.0 0
M  V30 11 C 5.6684 4.6949 0.0 0
M  V30 12 C 4.0010 6.5467 0.0 0
M  V30 13 C 3.3921 3.6813 0.0 0
M  V30 14 C 6.4384 6.0286 0.0 0
M  V30 15 C 5.8293 3.1632 0.0 0
M  V30 16 N 5.4080 7.1730 0.0 0
M  V30 17 N 4.4225 2.5369 0.0 0
M  V30 18 C 2.6673 7.3167 0.0 0
M  V30 19 C 1.3337 6.5467 0.0 0
M  V30 20 C 2.6673 8.8567 0.0 0
M  V30 21 C 0.0000 7.3167 0.0 0
M  V30 22 C 1.3337 9.6268 0.0 0
M  V30 23 C 0.0000 8.8567 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 15
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 12 18
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-Ethyl-N2,N3-dimethyl-5-phenyl-1H-pyrrole-2,3,4-tricarboxamide
C17H20N4O3
2242709-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8391 3.7536 0.0 0
M  V30 2 N 4.8087 2.6091 0.0 0
M  V30 3 O 7.3455 3.4334 0.0 0
M  V30 4 C 5.2845 1.1445 0.0 0
M  V30 5 C 4.2541 0.0000 0.0 0
M  V30 6 C 2.6528 4.7889 0.0 0
M  V30 7 N 1.2459 5.4153 0.0 0
M  V30 8 O 2.8137 3.2574 0.0 0
M  V30 9 C 0.0000 4.5100 0.0 0
M  V30 10 C 2.6528 8.1392 0.0 0
M  V30 11 N 2.8137 9.6709 0.0 0
M  V30 12 O 1.2459 7.5129 0.0 0
M  V30 13 C 1.5679 10.5761 0.0 0
M  V30 14 C 5.3632 5.2181 0.0 0
M  V30 15 C 3.8987 5.6941 0.0 0
M  V30 16 C 6.2684 6.4641 0.0 0
M  V30 17 C 3.8987 7.2341 0.0 0
M  V30 18 N 5.3632 7.7100 0.0 0
M  V30 19 C 7.8084 6.4641 0.0 0
M  V30 20 C 8.5784 5.1304 0.0 0
M  V30 21 C 8.5784 7.7978 0.0 0
M  V30 22 C 10.1184 5.1304 0.0 0
M  V30 23 C 10.1184 7.7978 0.0 0
M  V30 24 C 10.8884 6.4641 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 17
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2242709-32-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242709-44-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-19137708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and facile access to highly functionalized pyrrole
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gao, Meng; Zhao, Wenting; Zhao, Hongyi; Lin, Ziyun; Zhang, Dongfeng;
Huang, Haihong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Beilstein Journal of Organic Chemistry (2018), 14884-890

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-(4-chlorophenyl)-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indole-2-carboxy...
C19H17ClN2O2
2244200-70-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 4.0011 0.7700 0.0 0
M  V30 3 O 2.6673 3.0800 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 0.0000 7.7000 0.0 0
M  V30 6 C 6.6684 5.3900 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 8.0022 4.6200 0.0 0
M  V30 9 N 6.9886 6.8963 0.0 0
M  V30 10 N 5.3347 3.0800 0.0 0
M  V30 11 C 9.1466 5.6504 0.0 0
M  V30 12 C 8.0022 3.0800 0.0 0
M  V30 13 C 8.5202 7.0572 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 10.6781 5.4895 0.0 0
M  V30 16 C 9.4253 8.3031 0.0 0
M  V30 17 C 11.5833 6.7354 0.0 0
M  V30 18 C 10.9570 8.1422 0.0 0
M  V30 19 C 4.0011 5.3900 0.0 0
M  V30 20 C 4.0011 6.9300 0.0 0
M  V30 21 C 2.6673 4.6200 0.0 0
M  V30 22 C 2.6673 7.7000 0.0 0
M  V30 23 C 1.3336 5.3900 0.0 0
M  V30 24 C 1.3336 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 24
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 19
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 2 11 15
M  V30 17 1 12 14
M  V30 18 2 13 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H20ClN3O2
2294850-00-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.0810 0.0 0
M  V30 2 N 6.9300 7.4148 0.0 0
M  V30 3 C 8.4700 7.4148 0.0 0
M  V30 4 C 9.4921 5.7308 0.0 0
M  V30 5 C 10.9984 5.4106 0.0 0
M  V30 6 N 12.0289 6.5552 0.0 0
M  V30 7 C 13.5352 6.2350 0.0 0
M  V30 8 O 14.5656 7.3794 0.0 0
M  V30 9 O 14.0111 4.7703 0.0 0
M  V30 10 C 16.0721 7.0592 0.0 0
M  V30 11 Cl 0.0000 6.0810 0.0 0
M  V30 12 C 6.9300 4.7474 0.0 0
M  V30 13 C 8.4615 4.5864 0.0 0
M  V30 14 N 6.3037 3.3406 0.0 0
M  V30 15 C 8.7819 3.0800 0.0 0
M  V30 16 C 7.4481 2.3100 0.0 0
M  V30 17 C 10.1155 2.3100 0.0 0
M  V30 18 C 7.4481 0.7700 0.0 0
M  V30 19 C 10.1155 0.7700 0.0 0
M  V30 20 C 8.7819 0.0000 0.0 0
M  V30 21 C 4.6200 6.0810 0.0 0
M  V30 22 C 3.8500 4.7474 0.0 0
M  V30 23 C 3.8500 7.4148 0.0 0
M  V30 24 C 2.3100 4.7474 0.0 0
M  V30 25 C 2.3100 7.4148 0.0 0
M  V30 26 C 1.5400 6.0810 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 1 21
M  V30 4 1 2 3
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 11 26
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2244200-70-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2294850-00-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-123-CAS-19864203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7775-14-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7553-56-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indole based antimalarial compounds targeting the melatonin pathway:
their design, synthesis and biological evaluation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luthra, Tania; Nayak, Akshay Kumar; Bose, Sarpita; Chakrabarti, Saikat;
Gupta, Ashish; Sen, Subhabrata
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 16811-27

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (αE)-5-bromo-α-[(dimethylamino)methylene]-2-fluoro-β-oxo-3-pyridineprop...
C13H14BrFN2O3
2245359-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 4.0012 3.8501 0.0 0
M  V30 5 C 6.6685 3.8501 0.0 0
M  V30 6 O 4.0012 2.3101 0.0 0
M  V30 7 O 2.6675 4.6201 0.0 0
M  V30 8 N 8.0023 4.6201 0.0 0
M  V30 9 C 2.6675 1.5400 0.0 0
M  V30 10 C 9.3360 3.8501 0.0 0
M  V30 11 C 8.0023 6.1601 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 13 F 5.3348 9.2402 0.0 0
M  V30 14 Br 0.0000 6.1601 0.0 0
M  V30 15 C 4.0012 6.9302 0.0 0
M  V30 16 C 4.0012 8.4702 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 N 2.6675 9.2402 0.0 0
M  V30 19 C 1.3337 6.9302 0.0 0
M  V30 20 C 1.3337 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 13 16
M  V30 14 1 14 19
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-1,4-dihydro-1-methyl-4-oxo-1,8-naphthyridine-3-carboxylate
C12H11BrN2O3
2414237-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.1601 0.0 0
M  V30 2 C 5.3348 0.0000 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 O 9.3360 3.8501 0.0 0
M  V30 5 O 8.0022 6.1601 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 C 12.0033 3.8501 0.0 0
M  V30 8 Br 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 N 5.3348 1.5400 0.0 0
M  V30 14 N 2.6673 1.5400 0.0 0
M  V30 15 C 6.6685 3.8501 0.0 0
M  V30 16 C 1.3337 3.8501 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2245359-39-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2414237-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22326428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 7-aminopyrido[2,3-b]indole compounds and their
prodrugs for the treatment and prophylaxis of bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Xiao; Liu, Yongqiang; Shen, Hong; Shi, Houguang; Tan, Xuefei; Zhou,
Chengang; Zhou, Mingwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020064661 A1 2020-04-02

$RFMT $RIREG SCHEME70 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-methoxybenzenepropanal
C10H12O3
80638-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 1.5400 0.0 0
M  V30 4 O 9.3360 2.3101 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 0.0000 0.0000 0.0 0
M  V30 7 O 0.0000 4.6201 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 2.6675 1.5400 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenethyl isothiocyanate
C9H9NS
2257-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 N 6.6685 3.0801 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 S 9.3360 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 1.3337 3.0801 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-(4-Hydroxy-3-methoxyphenyl)propyl]-N-methyl-N′-(2-phenylethyl)thiourea
C20H26N2O2S
401908-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 2.3100 0.0 0
M  V30 2 C 6.6684 3.0800 0.0 0
M  V30 3 C 8.0022 2.3100 0.0 0
M  V30 4 N 9.3359 3.0800 0.0 0
M  V30 5 C 10.6695 2.3100 0.0 0
M  V30 6 C 9.3359 4.6201 0.0 0
M  V30 7 N 12.0034 3.0800 0.0 0
M  V30 8 S 10.6695 0.7700 0.0 0
M  V30 9 C 13.3370 2.3100 0.0 0
M  V30 10 C 14.6707 3.0800 0.0 0
M  V30 11 O 0.0000 2.3100 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 13 O 0.0000 5.3901 0.0 0
M  V30 14 C 4.0011 3.0800 0.0 0
M  V30 15 C 2.6675 2.3100 0.0 0
M  V30 16 C 4.0011 4.6201 0.0 0
M  V30 17 C 1.3337 3.0800 0.0 0
M  V30 18 C 2.6675 5.3901 0.0 0
M  V30 19 C 1.3337 4.6201 0.0 0
M  V30 20 C 16.0043 2.3100 0.0 0
M  V30 21 C 17.3381 3.0800 0.0 0
M  V30 22 C 16.0043 0.7700 0.0 0
M  V30 23 C 18.6718 2.3100 0.0 0
M  V30 24 C 17.3381 0.0000 0.0 0
M  V30 25 C 18.6718 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 20
M  V30 12 1 11 12
M  V30 13 1 11 17
M  V30 14 1 13 19
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 80638-48-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2257-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 401908-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1788334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N,N',N''-trisubstituted thiourea derivatives and their
antagonist effect on the vanilloid receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Park, Hyeung-geun; Park, Mi-kyung; Choi, Ji-yeon; Choi, Sea-hoon; Lee,
Jihye; Park, Boon-saeng; Kim, Myoung Goo; Suh, Young-ger; Cho, Hawon; Oh,
Uhtaek; Lee, Jeewoo; Kim, Hee-Doo; Park, Young-Ho; Koh, Hyun-Ju; Lim,
Kyung Min; Moh, Joo-Hyun; Jew, Sang-sup
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2003), 13(4), 601-604

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,9-Bis(2,5-dimethoxyphenyl)-6-(phenylmethyl)-1,7-dioxa-2,8-diazaspiro[4.4]no...
C29H28N2O8
2270183-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0981 3.8987 0.0 0
M  V30 2 C 8.0003 5.1180 0.0 0
M  V30 3 O 8.6021 3.7004 0.0 0
M  V30 4 O 8.9272 6.3478 0.0 0
M  V30 5 O 1.5400 6.9729 0.0 0
M  V30 6 C 0.0000 6.9729 0.0 0
M  V30 7 O 4.6201 12.3077 0.0 0
M  V30 8 C 3.8501 13.6415 0.0 0
M  V30 9 O 9.2614 10.9871 0.0 0
M  V30 10 C 9.7373 12.4518 0.0 0
M  V30 11 O 13.3833 6.4094 0.0 0
M  V30 12 C 14.8895 6.7296 0.0 0
M  V30 13 C 6.1516 6.8120 0.0 0
M  V30 14 C 6.4718 5.3057 0.0 0
M  V30 15 C 4.6201 6.9729 0.0 0
M  V30 16 C 7.6832 6.6510 0.0 0
M  V30 17 O 5.8314 8.3184 0.0 0
M  V30 18 O 5.1381 4.5357 0.0 0
M  V30 19 N 3.9936 5.5661 0.0 0
M  V30 20 C 8.3095 8.0579 0.0 0
M  V30 21 N 7.1651 9.0884 0.0 0
M  V30 22 C 3.8501 8.3067 0.0 0
M  V30 23 C 2.3100 8.3067 0.0 0
M  V30 24 C 4.6201 9.6404 0.0 0
M  V30 25 C 1.5400 9.6404 0.0 0
M  V30 26 C 3.8501 10.9740 0.0 0
M  V30 27 C 2.3100 10.9740 0.0 0
M  V30 28 C 6.1929 2.6528 0.0 0
M  V30 29 C 6.8194 1.2460 0.0 0
M  V30 30 C 4.6613 2.8138 0.0 0
M  V30 31 C 5.9141 0.0000 0.0 0
M  V30 32 C 3.7561 1.5679 0.0 0
M  V30 33 C 4.3826 0.1611 0.0 0
M  V30 34 C 9.8159 8.3780 0.0 0
M  V30 35 C 10.2918 9.8427 0.0 0
M  V30 36 C 10.8464 7.2336 0.0 0
M  V30 37 C 11.7983 10.1629 0.0 0
M  V30 38 C 12.3528 7.5538 0.0 0
M  V30 39 C 12.8287 9.0185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 5 6
M  V30 7 1 5 23
M  V30 8 1 7 8
M  V30 9 1 7 26
M  V30 10 1 9 10
M  V30 11 1 9 35
M  V30 12 1 11 12
M  V30 13 1 11 38
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 1 15 22
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 34
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,9-Bis(2,5-dimethoxyphenyl)-N-methyl-6-(phenylmethyl)-1,7-dioxa-2,8-diazaspi...
C30H31N3O7
2270183-30-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0981 3.8987 0.0 0
M  V30 2 C 8.0003 5.1180 0.0 0
M  V30 3 N 8.6021 3.7004 0.0 0
M  V30 4 O 8.9272 6.3478 0.0 0
M  V30 5 C 10.1306 3.5126 0.0 0
M  V30 6 O 1.5400 6.9729 0.0 0
M  V30 7 C 0.0000 6.9729 0.0 0
M  V30 8 O 4.6201 12.3077 0.0 0
M  V30 9 C 3.8501 13.6415 0.0 0
M  V30 10 O 9.2614 10.9871 0.0 0
M  V30 11 C 9.7373 12.4519 0.0 0
M  V30 12 O 13.3833 6.4094 0.0 0
M  V30 13 C 14.8896 6.7296 0.0 0
M  V30 14 C 6.1516 6.8120 0.0 0
M  V30 15 C 6.4718 5.3057 0.0 0
M  V30 16 C 4.6201 6.9729 0.0 0
M  V30 17 C 7.6832 6.6511 0.0 0
M  V30 18 O 5.8315 8.3184 0.0 0
M  V30 19 O 5.1381 4.5357 0.0 0
M  V30 20 N 3.9936 5.5661 0.0 0
M  V30 21 C 8.3095 8.0579 0.0 0
M  V30 22 N 7.1651 9.0884 0.0 0
M  V30 23 C 3.8501 8.3067 0.0 0
M  V30 24 C 2.3100 8.3067 0.0 0
M  V30 25 C 4.6201 9.6404 0.0 0
M  V30 26 C 1.5400 9.6404 0.0 0
M  V30 27 C 3.8501 10.9741 0.0 0
M  V30 28 C 2.3100 10.9741 0.0 0
M  V30 29 C 6.1929 2.6528 0.0 0
M  V30 30 C 4.6613 2.8138 0.0 0
M  V30 31 C 6.8194 1.2460 0.0 0
M  V30 32 C 3.7561 1.5679 0.0 0
M  V30 33 C 5.9142 0.0000 0.0 0
M  V30 34 C 4.3826 0.1611 0.0 0
M  V30 35 C 9.8160 8.3780 0.0 0
M  V30 36 C 10.2918 9.8427 0.0 0
M  V30 37 C 10.8464 7.2336 0.0 0
M  V30 38 C 11.7983 10.1629 0.0 0
M  V30 39 C 12.3528 7.5538 0.0 0
M  V30 40 C 12.8287 9.0185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 10 11
M  V30 12 1 10 36
M  V30 13 1 12 13
M  V30 14 1 12 39
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 16 23
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 35
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2270183-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2270183-30-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19652613
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of spirobiisoxazoline dibenzoquinone derivatives via
[3 + 2] double 1,3-dipolar cycloaddition reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Swapnaja, K. Jones M.; Yennam, Satyanarayana; Chavali, Murthy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2019), 60(6), 461-464

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4023407
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3. 4-(3-(N-Methylcarbamoly)-4-methoxyphenoxy)-1-nitrobenzene: To a
solution of 4-(3-carboxy-4-methoxyphenoxy)-1-nitrobenzene (0.50 g, 1.75
mmol) in CH2Cl2 (12 mL) was added SOCl2 (0.64 mL, 8.77 mmol) in portions.
The resulting solution was heated at the reflux temp. for 18 h, cooledto
room temp., and concentrated under reduced pressure. The resulting yellow
solids were dissolved in CH2Cl2 (3 mL) then the resulting solution was
treated with a methylamine solution (2.0 M in THF, 3.5 mL, 7.02 mmol) in
portions (CAUTION: gas evolution), and stirred at room temp. for 4 h. The
resulting mixture was treated with a 1NNaOH solution, then extracted with
CH2Cl2 (25 mL). The organic layer was dried (Na2SO4) and concentrated
under reduced pressure to give
4-(3-(N-methylcarbamoly)-4-methoxyphenoxy)-1-nitrobenzene as a yellow
solid (0.50 g, 95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM safety
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-Katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7235576 B1 2007-06-26

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14401620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of omega-carboxyaryl substituted diphenyl ureas as raf kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-Katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030207872 A1 2003-11-06

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10074038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, gas evolution
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of omega-carboxyaryl substituted diphenyl ureas as raf kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030181442 A1 2003-09-25

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7369036
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM safety
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diphenylureas as RAF kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030144278 A1 2003-07-31

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6507366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinolyl, isoquinolyl or pyridyl-ureas as inhibitors of
raf kinase for the treatment of tumors and/or cancerous cell growth
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumas, Jacques; Riedl, Bernd; Khire, Uday; Wood, Jill E.; Robert, Sibley
N.; Monahan, Mary-Katherine; Renick, Joel; Gunn, David E.; Lowinger,
Timothy B.; Scott, William J.; Smith, Roger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020165394 A1 2002-11-07

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6978299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3. 4-(3-(N-Methylcarbamoyl)-4-methoxyphenoxy)-1-nitrobenzene: To a
solution of 4-(3-carboxy-4-methoxyphenoxy)-1-nitrobenzene (0.50 g, 1.75
mmol) in CH2Cl2 (12 mL) was added SOCl2 (0.64 mL, 8.77 mmol) in portions.
The resulting solution was heated at the reflux temp. for 18 h, cooled to
room temp., and concentrated under reduced pressure. The resulting yellow
solids were dissolved in CH2Cl2 (3 mL) then the resulting solution was
treated with a methylamine solution (2.0 M in THF, 3.5 mL, 7.02 mmol) in
portions (CAUTION: gas evolution), and stirred at room temp. for 4 h. The
resulting mixture was treated with a 1N NaOH solution, then extracted
with CH2Cl2 (25 mL). The organic layer was dried (Na2SO4) and
concentrated under reduced pressure to give
4-(3-(N-methylcarbamoyl)-4-methoxyphenoxy)-1-nitrobenzene. Yellow solid,
yield (0.50 g, 95%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl-N'-[(acylphenoxy)phenyl]ureas as raf kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumas, Jacques; Riedl, Bernd; Khire, Uday; Wood, Jill E.; Sibley, Robert
N.; Monahan, Mary-Katherine; Renick, Joel; Gunn, David E.; Lowinger,
Timothy B.; Scott, William J.; Smith, Roger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002062763 A2 2002-08-15

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13163907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 3. 4-(3-(N-Methylcarbamoly)-4-methoxyphenoxy)-1-nitrobenzene: To a
solution of4-(3-carboxy-4-methoxyphenoxy)-1-nitrobenzene (0.50 g, 1.75
mmol) in CH2Cl2 (12 mL) was added SOCl2 (0.64 mL, 8.77 mmol) in portions.
The resulting solution was heated at the reflux temp. for 18 h, cooled to
room temp., and concentrated under reduced pressure. The resulting yellow
solids were dissolved in CH2Cl2 (3 mL) then the resulting solution was
treated with a methylamine solution (2.0 M in THF, 3.5 mL, 7.02 mmol) in
portions (CAUTION: gas evolution), and stirred at room temp. for 4 h. The
resulting mixture was treated with a 1H NaOH solution, then extracted
with CH2Cl2 (25 mL). The organic layer was dried (Na2SO4) and
concentrated under reduced pressure. Yield: (0.50 g, 95%). yellow solid.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dumas, Jacques; Riedl, Bernd; Khire, Uday; Sibley, Robert N.;
Hatoum-Mokdad, Holia; Monahan, Mary-katherine; Gunn, David E.; Lowinger,
Timotthy B.; Scott, William J.; Smith, Roger A.; Wood, Jill E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020065296 A1 2002-05-30

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
2-Methoxy-5-(4-nitrophenoxy)benzoic acid
C14H11NO6
228401-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 1.5400 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 1.3337 6.1601 0.0 0
M  V30 7 N 12.0032 4.6201 0.0 0 VAL=5
M  V30 8 O 13.3369 3.8500 0.0 0
M  V30 9 O 12.0032 6.1601 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0010 1.5400 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 17 C 8.0021 3.8500 0.0 0
M  V30 18 C 9.3359 1.5400 0.0 0
M  V30 19 C 9.3359 4.6201 0.0 0
M  V30 20 C 10.6695 2.3100 0.0 0
M  V30 21 C 10.6695 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-N-methyl-5-(4-nitrophenoxy)benzamide
C15H14N2O5
284462-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5500 4.0011 0.0 0
M  V30 2 N 12.3200 5.3347 0.0 0
M  V30 3 O 12.3200 2.6674 0.0 0
M  V30 4 C 13.8600 5.3347 0.0 0
M  V30 5 O 10.0100 1.3336 0.0 0
M  V30 6 C 9.2400 0.0000 0.0 0
M  V30 7 O 6.9300 6.6685 0.0 0
M  V30 8 N 0.7700 6.6685 0.0 0 VAL=5
M  V30 9 O 0.0000 8.0021 0.0 0
M  V30 10 O 0.0000 5.3347 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 9.2400 5.3347 0.0 0
M  V30 14 C 7.7000 2.6674 0.0 0
M  V30 15 C 7.7000 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 5.3900 6.6685 0.0 0
M  V30 18 C 4.6200 5.3347 0.0 0
M  V30 19 C 4.6200 8.0021 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 15
M  V30 8 1 7 17
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 228401-44-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284462-46-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17659809
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ω-carboxy(hetero)aryl substituted diphenyl ureas as raf
kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riedl, Bernd; Dumas, Jacques; Khire, Uday; Lowinger, Timothy B.; Scott,
William J.; Smith, Roger A.; Wood, Jill E.; Monahan, Mary-Katherine;
Natero, Reina; Renick, Joel; Sibley, Robert N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000042012 A1 2000-07-20

$RFMT $RIREG SCHEME73 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dichloro-4-fluoro-5-nitrobenzene
C6H2Cl2FNO2
2339-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0011 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 F 2.3100 0.0000 0.0 0
M  V30 5 Cl 5.3901 5.3349 0.0 0
M  V30 6 Cl 6.9301 2.6675 0.0 0
M  V30 7 C 2.3100 2.6675 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 4.6201 1.3338 0.0 0
M  V30 11 C 4.6201 4.0011 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 11
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoyl isothiocyanate
C8H5NOS
532-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 S 8.4702 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5,6-Dichloro-1-methyl-1H-benzimidazol-2-yl)benzamide
C15H11Cl2N3O
496838-00-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.9416 0.0000 0.0 0
M  V30 2 N 7.9110 2.7106 0.0 0
M  V30 3 C 8.6810 4.0442 0.0 0
M  V30 4 O 7.9110 5.3780 0.0 0
M  V30 5 Cl 0.0000 4.2506 0.0 0
M  V30 6 Cl 0.0000 1.1706 0.0 0
M  V30 7 C 4.0011 3.4806 0.0 0
M  V30 8 C 4.0011 1.9406 0.0 0
M  V30 9 N 5.4658 3.9564 0.0 0
M  V30 10 C 2.6674 4.2506 0.0 0
M  V30 11 N 5.4658 1.4647 0.0 0
M  V30 12 C 2.6674 1.1706 0.0 0
M  V30 13 C 6.3710 2.7106 0.0 0
M  V30 14 C 1.3338 3.4806 0.0 0
M  V30 15 C 1.3338 1.9406 0.0 0
M  V30 16 C 10.2210 4.0442 0.0 0
M  V30 17 C 10.9910 2.7106 0.0 0
M  V30 18 C 10.9910 5.3780 0.0 0
M  V30 19 C 12.5310 2.7106 0.0 0
M  V30 20 C 12.5310 5.3780 0.0 0
M  V30 21 C 13.3010 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 2 3 4
M  V30 5 1 3 16
M  V30 6 1 5 14
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2339-78-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496838-00-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-208438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney nickel used in stage 2, Trisamine resin used in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Azido-5-bromo-3,4-dihydro-3-pyridinecarboxaldehyde
C6H5BrN4O
2351937-44-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 4.0010 0.0 0
M  V30 2 N 6.1601 4.0010 0.0 0 CHG=1 VAL=4
M  V30 3 N 7.7001 4.0010 0.0 0 CHG=-1
M  V30 4 C 1.5400 4.0010 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 Br 6.1601 1.3337 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 N 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-2-methyl-2H-pyrazolo[4,3-c]pyridine
C7H6BrN3
1956310-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.3337 0.0000 0.0 0
M  V30 2 C 6.5771 3.0800 0.0 0
M  V30 3 C 2.6673 3.8500 0.0 0
M  V30 4 C 2.6673 2.3100 0.0 0
M  V30 5 C 4.1320 4.3259 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 N 4.1320 1.8342 0.0 0
M  V30 8 C 1.3337 1.5400 0.0 0
M  V30 9 N 5.0371 3.0800 0.0 0
M  V30 10 N 0.0000 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 9
M  V30 11 2 8 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2351937-44-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1956310-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-20544049
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2)
inhibitors demonstrating effective cell-based blockade of IL-13 signaling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zak, Mark; Hanan, Emily J.; Lupardus, Patrick; Brown, David G.; Robinson,
Colin; Siu, Michael; Lyssikatos, Joseph P.; Romero, F. Anthony; Zhao,
Guiling; Kellar, Terry; Mendonca, Rohan; Ray, Nicholas C.; Goodacre,
Simon C.; Crackett, Peter H.; McLean, Neville; Hurley, Christopher A.;
Yuen, Po-wai; Cheng, Yun-Xing; Liu, Xiongcai; Liimatta, Marya; Kohli,
Pawan Bir; Nonomiya, Jim; Salmon, Gary; Buckley, Gerry; Lloyd, Julia;
Gibbons, Paul; Ghilardi, Nico; Kenny, Jane R.; Johnson, Adam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2019), 29(12), 1522-1531

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[1-[(1,1-Dimethylethoxy)carbonyl]-4-piperidinyl]pyrazolo[1,5-a]pyridine-3-c...
C18H23N3O4
2370833-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 4.2506 0.0 0
M  V30 2 O 2.5369 5.3950 0.0 0
M  V30 3 O 0.0000 4.5708 0.0 0
M  V30 4 C 11.4491 5.3901 0.0 0
M  V30 5 O 12.7829 4.6201 0.0 0
M  V30 6 O 11.4491 6.9302 0.0 0
M  V30 7 C 14.1166 5.3901 0.0 0
M  V30 8 C 13.3465 6.7238 0.0 0
M  V30 9 C 15.4502 6.1601 0.0 0
M  V30 10 C 14.8866 4.0564 0.0 0
M  V30 11 C 3.4469 2.3101 0.0 0
M  V30 12 N 3.4469 0.7700 0.0 0
M  V30 13 C 1.9822 2.7859 0.0 0
M  V30 14 C 4.7806 3.0801 0.0 0
M  V30 15 C 4.7806 0.0000 0.0 0
M  V30 16 N 1.9822 0.2941 0.0 0
M  V30 17 C 1.0771 1.5400 0.0 0
M  V30 18 C 6.1142 2.3101 0.0 0
M  V30 19 C 6.1142 0.7700 0.0 0
M  V30 20 C 7.4481 3.0801 0.0 0
M  V30 21 C 7.4481 4.6201 0.0 0
M  V30 22 C 8.7817 2.3101 0.0 0
M  V30 23 C 8.7817 5.3901 0.0 0
M  V30 24 C 10.1154 3.0801 0.0 0
M  V30 25 N 10.1154 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 25
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-[(methylamino)carbonyl]pyrazolo[1,5-a]pyridin-5-yl]-1-...
C19H26N4O3
2370833-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.9822 4.2506 0.0 0
M  V30 2 N 0.4759 4.5708 0.0 0
M  V30 3 O 3.0128 5.3950 0.0 0
M  V30 4 C 0.0000 6.0354 0.0 0
M  V30 5 C 11.9251 5.3901 0.0 0
M  V30 6 O 13.2588 4.6201 0.0 0
M  V30 7 O 11.9251 6.9302 0.0 0
M  V30 8 C 14.5924 5.3901 0.0 0
M  V30 9 C 15.3625 4.0564 0.0 0
M  V30 10 C 15.9261 6.1601 0.0 0
M  V30 11 C 13.8224 6.7238 0.0 0
M  V30 12 C 3.9228 2.3101 0.0 0
M  V30 13 N 3.9228 0.7700 0.0 0
M  V30 14 C 2.4580 2.7859 0.0 0
M  V30 15 C 5.2564 3.0801 0.0 0
M  V30 16 N 2.4580 0.2941 0.0 0
M  V30 17 C 5.2564 0.0000 0.0 0
M  V30 18 C 1.5530 1.5400 0.0 0
M  V30 19 C 6.5903 2.3101 0.0 0
M  V30 20 C 6.5903 0.7700 0.0 0
M  V30 21 C 7.9239 3.0801 0.0 0
M  V30 22 C 9.2576 2.3101 0.0 0
M  V30 23 C 7.9239 4.6201 0.0 0
M  V30 24 C 10.5913 3.0801 0.0 0
M  V30 25 C 9.2576 5.3901 0.0 0
M  V30 26 N 10.5913 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 26
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 16 18
M  V30 20 2 17 20
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2370833-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2370833-17-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21582574
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazolopyridinecarboxamides as inhibitors of
the notch transcriptional activation complex kinase (NACK) and methods
for use of the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Capobianco, Anthony J.; Schurer, Stephan C.; Zhu, Xiaoxia; Kelley, Tanya
T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019157065 A1 2019-08-15

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(6-fluoro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-2-pyridinecarboxylate
C14H10FN3O3
2378817-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 F 0.5546 6.4379 0.0 0
M  V30 3 C 9.7544 5.6420 0.0 0
M  V30 4 O 11.0882 4.8720 0.0 0
M  V30 5 O 9.7544 7.1821 0.0 0
M  V30 6 C 12.4218 5.6420 0.0 0
M  V30 7 C 3.0127 3.1885 0.0 0
M  V30 8 N 4.4196 2.5620 0.0 0
M  V30 9 C 1.9823 2.0439 0.0 0
M  V30 10 C 2.5369 4.6530 0.0 0
M  V30 11 C 4.2586 1.0304 0.0 0
M  V30 12 N 2.7523 0.7103 0.0 0
M  V30 13 C 0.4759 2.3641 0.0 0
M  V30 14 C 1.0304 4.9732 0.0 0
M  V30 15 C 0.0000 3.8288 0.0 0
M  V30 16 C 5.7534 3.3320 0.0 0
M  V30 17 C 5.7534 4.8720 0.0 0
M  V30 18 C 7.0870 2.5620 0.0 0
M  V30 19 C 7.0870 5.6420 0.0 0
M  V30 20 N 8.4207 3.3320 0.0 0
M  V30 21 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(6-Fluoro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-N-methyl-2-pyridinecarbox...
C14H11FN4O2
2378817-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4032 0.0000 0.0 0
M  V30 2 F 0.5546 6.4379 0.0 0
M  V30 3 C 9.7544 5.6420 0.0 0
M  V30 4 N 11.0882 4.8720 0.0 0
M  V30 5 O 9.7544 7.1821 0.0 0
M  V30 6 C 12.4218 5.6420 0.0 0
M  V30 7 C 3.0127 3.1885 0.0 0
M  V30 8 N 4.4196 2.5620 0.0 0
M  V30 9 C 1.9823 2.0439 0.0 0
M  V30 10 C 2.5369 4.6530 0.0 0
M  V30 11 C 4.2586 1.0304 0.0 0
M  V30 12 N 2.7523 0.7103 0.0 0
M  V30 13 C 0.4759 2.3641 0.0 0
M  V30 14 C 1.0304 4.9732 0.0 0
M  V30 15 C 0.0000 3.8288 0.0 0
M  V30 16 C 5.7534 3.3320 0.0 0
M  V30 17 C 7.0870 2.5620 0.0 0
M  V30 18 C 5.7534 4.8720 0.0 0
M  V30 19 C 8.4207 3.3320 0.0 0
M  V30 20 N 7.0870 5.6420 0.0 0
M  V30 21 C 8.4207 4.8720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378817-90-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378817-87-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860286
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-4-methyl-2-pyridinecarboxylate
C15H13N3O3
2378817-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0849 6.4933 0.0 0
M  V30 2 C 5.0543 6.4501 0.0 0
M  V30 3 C 9.6743 3.7827 0.0 0
M  V30 4 O 10.4443 2.4491 0.0 0
M  V30 5 O 10.4443 5.1163 0.0 0
M  V30 6 C 11.9843 2.4491 0.0 0
M  V30 7 N 3.5143 3.7827 0.0 0
M  V30 8 C 2.6091 2.5368 0.0 0
M  V30 9 C 2.6091 5.0286 0.0 0
M  V30 10 C 1.1445 3.0127 0.0 0
M  V30 11 C 2.9292 1.0304 0.0 0
M  V30 12 N 1.1445 4.5527 0.0 0
M  V30 13 C 0.0000 1.9823 0.0 0
M  V30 14 C 1.7849 0.0000 0.0 0
M  V30 15 C 0.3202 0.4759 0.0 0
M  V30 16 C 5.0543 3.7827 0.0 0
M  V30 17 C 5.8243 5.1163 0.0 0
M  V30 18 C 5.8243 2.4491 0.0 0
M  V30 19 C 7.3643 5.1163 0.0 0
M  V30 20 N 7.3643 2.4491 0.0 0
M  V30 21 C 8.1343 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-N,4-dimethyl-2-pyridinecarboxamide
C15H14N4O2
2378817-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0849 6.4933 0.0 0
M  V30 2 C 5.0543 6.4501 0.0 0
M  V30 3 C 9.6743 3.7827 0.0 0
M  V30 4 N 10.4443 2.4491 0.0 0
M  V30 5 O 10.4443 5.1163 0.0 0
M  V30 6 C 11.9843 2.4491 0.0 0
M  V30 7 N 3.5143 3.7827 0.0 0
M  V30 8 C 2.6091 2.5368 0.0 0
M  V30 9 C 2.6091 5.0286 0.0 0
M  V30 10 C 1.1445 3.0127 0.0 0
M  V30 11 C 2.9292 1.0304 0.0 0
M  V30 12 N 1.1445 4.5527 0.0 0
M  V30 13 C 0.0000 1.9823 0.0 0
M  V30 14 C 1.7849 0.0000 0.0 0
M  V30 15 C 0.3202 0.4759 0.0 0
M  V30 16 C 5.0543 3.7827 0.0 0
M  V30 17 C 5.8243 5.1163 0.0 0
M  V30 18 C 5.8243 2.4491 0.0 0
M  V30 19 C 7.3643 5.1163 0.0 0
M  V30 20 N 7.3643 2.4491 0.0 0
M  V30 21 C 8.1343 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2378817-99-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378817-96-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20860293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused cyclic urea derivatives as CRHR2 antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ohmi, Masashi; Matsushita, Takeshi; Ando, Kazuo; Yamaguchi, Ryuichi;
Fukumoto, Yutaka; Magara, Ryohei; Yamagishi, Tatsuya; Takefuji, Mikito
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019198692 A1 2019-10-17

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-[[2-(3,5-Dichlorophenyl)-6-[[6-[4-[2-[(methylsulfonyl)oxy]ethyl]-1-pipe...
C32H40Cl2N6O5S
2387628-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6697 11.5503 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 Cl 1.3337 10.7802 0.0 0
M  V30 4 Cl 4.0010 15.4003 0.0 0
M  V30 5 C 2.6673 3.8501 0.0 0
M  V30 6 N 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 20.0055 6.1601 0.0 0
M  V30 11 C 21.3393 6.9302 0.0 0
M  V30 12 O 22.6730 6.1601 0.0 0
M  V30 13 S 24.0067 6.9302 0.0 0 VAL=6
M  V30 14 C 23.2366 8.2638 0.0 0
M  V30 15 O 25.3403 7.7002 0.0 0
M  V30 16 O 24.7767 5.5965 0.0 0
M  V30 17 C 6.6685 10.7802 0.0 0
M  V30 18 N 8.0022 11.5503 0.0 0
M  V30 19 C 6.6685 9.2402 0.0 0
M  V30 20 C 9.3358 10.7802 0.0 0
M  V30 21 C 8.0022 8.4702 0.0 0
M  V30 22 C 9.3358 9.2402 0.0 0
M  V30 23 C 5.3348 11.5503 0.0 0
M  V30 24 C 4.0010 10.7802 0.0 0
M  V30 25 C 5.3348 13.0903 0.0 0
M  V30 26 C 2.6673 11.5503 0.0 0
M  V30 27 C 4.0010 13.8603 0.0 0
M  V30 28 C 2.6673 13.0903 0.0 0
M  V30 29 C 12.0033 10.7802 0.0 0
M  V30 30 C 12.0033 9.2402 0.0 0
M  V30 31 C 13.3370 11.5503 0.0 0
M  V30 32 C 13.3370 8.4702 0.0 0
M  V30 33 N 14.6707 10.7802 0.0 0
M  V30 34 C 14.6707 9.2402 0.0 0
M  V30 35 N 6.6685 6.1601 0.0 0
M  V30 36 C 6.6685 4.6201 0.0 0
M  V30 37 C 5.3348 6.9302 0.0 0
M  V30 38 C 5.3348 3.8501 0.0 0
M  V30 39 C 4.0010 6.1601 0.0 0
M  V30 40 C 4.0010 4.6201 0.0 0
M  V30 41 N 16.0045 8.4702 0.0 0
M  V30 42 C 17.3382 9.2402 0.0 0
M  V30 43 C 16.0045 6.9302 0.0 0
M  V30 44 C 18.6718 8.4702 0.0 0
M  V30 45 C 17.3382 6.1601 0.0 0
M  V30 46 N 18.6718 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 29
M  V30 3 1 2 21
M  V30 4 1 2 35
M  V30 5 1 3 26
M  V30 6 1 4 27
M  V30 7 1 5 6
M  V30 8 1 5 40
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 10 11
M  V30 13 1 10 46
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 2 13 16
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 1 17 23
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 38 1 34 41
M  V30 39 1 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 40
M  V30 45 1 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-[[2-(3,5-Dichlorophenyl)-6-[[6-[4-[2-(methylamino)ethyl]-1-piperazinyl]...
C32H41Cl2N7O2
2387628-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.6697 11.5503 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 Cl 4.0010 15.4003 0.0 0
M  V30 4 Cl 1.3337 10.7802 0.0 0
M  V30 5 C 2.6673 3.8501 0.0 0
M  V30 6 N 2.6673 2.3101 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 20.0057 6.1601 0.0 0
M  V30 11 C 21.3393 6.9302 0.0 0
M  V30 12 N 22.6730 6.1601 0.0 0
M  V30 13 C 24.0067 6.9302 0.0 0
M  V30 14 C 6.6685 10.7802 0.0 0
M  V30 15 N 8.0022 11.5503 0.0 0
M  V30 16 C 6.6685 9.2402 0.0 0
M  V30 17 C 9.3358 10.7802 0.0 0
M  V30 18 C 8.0022 8.4702 0.0 0
M  V30 19 C 9.3358 9.2402 0.0 0
M  V30 20 C 5.3348 11.5503 0.0 0
M  V30 21 C 5.3348 13.0903 0.0 0
M  V30 22 C 4.0010 10.7802 0.0 0
M  V30 23 C 4.0010 13.8603 0.0 0
M  V30 24 C 2.6673 11.5503 0.0 0
M  V30 25 C 2.6673 13.0903 0.0 0
M  V30 26 C 12.0033 10.7802 0.0 0
M  V30 27 C 12.0033 9.2402 0.0 0
M  V30 28 C 13.3370 11.5503 0.0 0
M  V30 29 C 13.3370 8.4702 0.0 0
M  V30 30 N 14.6707 10.7802 0.0 0
M  V30 31 C 14.6707 9.2402 0.0 0
M  V30 32 N 6.6685 6.1601 0.0 0
M  V30 33 C 5.3348 6.9302 0.0 0
M  V30 34 C 6.6685 4.6201 0.0 0
M  V30 35 C 4.0010 6.1601 0.0 0
M  V30 36 C 5.3348 3.8501 0.0 0
M  V30 37 C 4.0010 4.6201 0.0 0
M  V30 38 N 16.0045 8.4702 0.0 0
M  V30 39 C 16.0045 6.9302 0.0 0
M  V30 40 C 17.3382 9.2402 0.0 0
M  V30 41 C 17.3382 6.1601 0.0 0
M  V30 42 C 18.6718 8.4702 0.0 0
M  V30 43 N 18.6718 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 26
M  V30 3 1 2 18
M  V30 4 1 2 32
M  V30 5 1 3 23
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 5 37
M  V30 9 1 6 7
M  V30 10 1 7 8
M  V30 11 2 7 9
M  V30 12 1 10 11
M  V30 13 1 10 43
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 1 14 20
M  V30 19 2 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 31 38
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2387628-70-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2387628-71-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21499246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted phenylpyridinylmethylpiperidines,
phenylpyridinylmethylpiperazines and their analogs as furin inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Axten, Jeffrey Michael; Cheung, Mui; Demartino, Michael P.; Guan, Huiping
Amy; Hu, Yan; Miller, Aaron Bayne; Qin, Donghui; Wu, Chengde; Zhang,
Zhiliu; Lin, Xiaojuan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019215341 A1 2019-11-14

$RFMT $RIREG SCHEME79 STEP1
$RXN



  1  1
$MOL
3H-1,2,3-Triazolo[4,5-c]pyridazin-7-amine, 6-chloro-, 1-oxide, compd. with hy...
C4H3ClN6O.H4N2
2411775-83-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7035 1.5400 0.0 0
M  V30 2 O 0.4294 1.9094 0.0 0
M  V30 3 Cl 6.3710 3.0800 0.0 0
M  V30 4 C 2.3699 3.8500 0.0 0
M  V30 5 C 2.3699 5.3900 0.0 0
M  V30 6 C 3.7035 3.0800 0.0 0
M  V30 7 N 0.9052 3.3741 0.0 0 VAL=5
M  V30 8 N 3.7035 6.1600 0.0 0
M  V30 9 N 0.9052 5.8659 0.0 0
M  V30 10 C 5.0372 3.8500 0.0 0
M  V30 11 N 0.0000 4.6200 0.0 0
M  V30 12 N 5.0372 5.3900 0.0 0
M  V30 13 N 2.4155 0.0000 0.0 0
M  V30 14 N 3.9555 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3H-1,2,3-Triazolo[4,5-c]pyridazin-7-amine, 6-chloro-, 1-oxide
C4H3ClN6O
2411775-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7035 0.0000 0.0 0
M  V30 2 O 0.4294 0.3694 0.0 0
M  V30 3 Cl 6.3710 1.5400 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 3.7035 1.5400 0.0 0
M  V30 7 N 0.9052 1.8341 0.0 0 VAL=5
M  V30 8 N 3.7035 4.6200 0.0 0
M  V30 9 N 0.9052 4.3259 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 11 N 0.0000 3.0800 0.0 0
M  V30 12 N 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 7
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2411775-83-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411775-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-21700144
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nitrogen-Rich Tetrazolo[1,5-b]pyridazine: Promising Building Block for
Advanced Energetic Materials
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Wei; Tang, Yongxing; Imler, Gregory H.; Parrish, Damon A.;
Shreeve, Jean'ne M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2020), 142(7), 3652-3657

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.2]octane-1-carboxylic acid, 4-(4-methoxy-3-methylphenyl)-
C17H22O3
2417143-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 0.0000 0.0 0
M  V30 2 C 0.7700 2.6674 0.0 0
M  V30 3 O 0.0000 1.3338 0.0 0
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 O 11.5500 2.6674 0.0 0
M  V30 6 C 12.3200 4.0011 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 4.6200 1.3327 0.0 0
M  V30 9 C 4.6200 4.0022 0.0 0
M  V30 10 C 4.4147 3.2322 0.0 0
M  V30 11 C 3.0800 1.3327 0.0 0
M  V30 12 C 3.0800 4.0022 0.0 0
M  V30 13 C 3.2853 3.2322 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 7.7000 1.3338 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 9.2400 1.3336 0.0 0
M  V30 19 C 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 6
M  V30 6 1 5 20
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 15
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bicyclo[2.2.2]octane-1-carboxamide, 4-(4-methoxy-3-methylphenyl)-N-methyl-
C18H25NO2
2417143-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 0.0000 0.0 0
M  V30 2 C 11.5500 2.6674 0.0 0
M  V30 3 N 12.3200 1.3338 0.0 0
M  V30 4 O 12.3200 4.0011 0.0 0
M  V30 5 C 13.8600 1.3336 0.0 0
M  V30 6 O 0.7700 2.6674 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 7.7000 1.3327 0.0 0
M  V30 10 C 7.7000 4.0022 0.0 0
M  V30 11 C 7.9053 3.2322 0.0 0
M  V30 12 C 9.2400 1.3327 0.0 0
M  V30 13 C 9.2400 4.0022 0.0 0
M  V30 14 C 9.0347 3.2322 0.0 0
M  V30 15 C 10.0100 2.6674 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 4.6200 1.3338 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.0800 1.3338 0.0 0
M  V30 20 C 3.0800 4.0011 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 21
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 16
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2417143-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417143-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22866813
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryloxymethylpropenamine derivatives as SSAO inhibitors and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, Nicholas D.; Hudson, Andrew R.; Chen, Mi; Nagasawa, Johnny Y.;
Botrous, Iriny
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020086747 A2 2020-04-30

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (5S,11S)-9-chloro-3,11-dihydro-1-(2-naphthalenyl)-3-phenyl-5,11-methano...
C31H23ClN2O4
2417431-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 13.1762 5.8441 0.0 0
M  V30 2 O 14.4458 6.7156 0.0 0
M  V30 3 O 13.2961 4.3089 0.0 0
M  V30 4 C 15.8355 6.0519 0.0 0
M  V30 5 C 17.1051 6.9232 0.0 0
M  V30 6 Cl 8.7470 13.3127 0.0 0
M  V30 7 C 8.0722 6.7076 0.0 0
M  V30 8 C 9.1046 5.5563 0.0 0
M  V30 9 C 8.1529 8.2384 0.0 0 CFG=1
M  V30 10 C 6.6684 6.0793 0.0 0
M  V30 11 N 8.3320 4.2242 0.0 0
M  V30 12 O 10.6491 5.4806 0.0 0
M  V30 13 C 9.2948 9.2753 0.0 0
M  V30 14 C 9.6387 6.6781 0.0 0
M  V30 15 N 6.8262 4.5473 0.0 0
M  V30 16 C 11.7865 6.5080 0.0 0 CFG=2
M  V30 17 C 10.8325 9.1903 0.0 0
M  V30 18 C 8.5997 10.6494 0.0 0
M  V30 19 O 11.8719 8.0482 0.0 0
M  V30 20 C 11.6750 10.4794 0.0 0
M  V30 21 C 9.4422 11.9385 0.0 0
M  V30 22 C 10.9799 11.8535 0.0 0
M  V30 23 C 5.3347 6.8493 0.0 0
M  V30 24 C 4.0009 6.0793 0.0 0
M  V30 25 C 5.3347 8.3893 0.0 0
M  V30 26 C 2.6673 6.8493 0.0 0
M  V30 27 C 4.0009 9.1593 0.0 0
M  V30 28 C 2.6673 8.3893 0.0 0
M  V30 29 C 1.3336 6.0793 0.0 0
M  V30 30 C 1.3336 9.1593 0.0 0
M  V30 31 C 0.0000 6.8493 0.0 0
M  V30 32 C 0.0000 8.3893 0.0 0
M  V30 33 C 8.9556 2.8162 0.0 0
M  V30 34 C 10.4868 2.6522 0.0 0
M  V30 35 C 8.0479 1.5720 0.0 0
M  V30 36 C 11.1105 1.2440 0.0 0
M  V30 37 C 8.6716 0.1640 0.0 0
M  V30 38 C 10.2028 0.0000 0.0 0
M  V30 39 H 6.7617 8.8987 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 21
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14 CFG=1
M  V30 14 1 9 39
M  V30 15 2 10 15
M  V30 16 1 10 23
M  V30 17 1 11 15
M  V30 18 1 11 33
M  V30 19 1 12 16
M  V30 20 1 13 17
M  V30 21 2 13 18
M  V30 22 1 16 14 CFG=1
M  V30 23 1 16 19
M  V30 24 1 17 19
M  V30 25 2 17 20
M  V30 26 1 18 21
M  V30 27 1 20 22
M  V30 28 2 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 26 29
M  V30 35 1 27 28
M  V30 36 1 28 30
M  V30 37 2 29 31
M  V30 38 2 30 32
M  V30 39 1 31 32
M  V30 40 2 33 34
M  V30 41 1 33 35
M  V30 42 1 34 36
M  V30 43 2 35 37
M  V30 44 2 36 38
M  V30 45 1 37 38
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5S,11S)-9-Chloro-3,11-dihydro-N-methyl-1-(2-naphthalenyl)-3-phenyl-5,11-meth...
C30H22ClN3O3
2417431-79-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6596 5.8286 0.0 0
M  V30 2 N 1.3885 6.6979 0.0 0
M  V30 3 O 2.5422 4.2930 0.0 0
M  V30 4 C 0.0000 6.0317 0.0 0
M  V30 5 Cl 7.0884 13.2994 0.0 0
M  V30 6 C 7.7660 6.7005 0.0 0
M  V30 7 C 6.7339 5.5543 0.0 0
M  V30 8 C 7.6744 8.2402 0.0 0 CFG=1
M  V30 9 C 9.1713 6.0724 0.0 0
M  V30 10 N 7.5039 4.2205 0.0 0
M  V30 11 O 5.1942 5.4625 0.0 0
M  V30 12 C 6.5327 9.2631 0.0 0
M  V30 13 C 5.5272 8.0613 0.0 0
M  V30 14 N 9.0104 4.5408 0.0 0
M  V30 15 C 4.0480 6.4946 0.0 0 CFG=2
M  V30 16 C 4.9948 9.1810 0.0 0
M  V30 17 C 7.2304 10.6358 0.0 0
M  V30 18 O 3.9609 8.0251 0.0 0
M  V30 19 C 4.1549 10.4718 0.0 0
M  V30 20 C 6.3905 11.9266 0.0 0
M  V30 21 C 4.8527 11.8446 0.0 0
M  V30 22 C 10.5055 6.8413 0.0 0
M  V30 23 C 11.8386 6.0703 0.0 0
M  V30 24 C 10.5066 8.3813 0.0 0
M  V30 25 C 13.1728 6.8393 0.0 0
M  V30 26 C 11.8409 9.1503 0.0 0
M  V30 27 C 13.1740 8.3793 0.0 0
M  V30 28 C 14.5060 6.0683 0.0 0
M  V30 29 C 14.5083 9.1483 0.0 0
M  V30 30 C 15.8402 6.8373 0.0 0
M  V30 31 C 15.8413 8.3773 0.0 0
M  V30 32 C 6.8776 2.8137 0.0 0
M  V30 33 C 5.3461 2.6528 0.0 0
M  V30 34 C 7.7828 1.5679 0.0 0
M  V30 35 C 4.7196 1.2459 0.0 0
M  V30 36 C 7.1564 0.1609 0.0 0
M  V30 37 C 5.6248 0.0000 0.0 0
M  V30 38 H 9.0612 8.9099 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13 CFG=3
M  V30 13 1 8 38
M  V30 14 2 9 14
M  V30 15 1 9 22
M  V30 16 1 10 14
M  V30 17 1 10 32
M  V30 18 1 11 15
M  V30 19 1 12 16
M  V30 20 2 12 17
M  V30 21 1 15 13 CFG=3
M  V30 22 1 15 18
M  V30 23 1 16 18
M  V30 24 2 16 19
M  V30 25 1 17 20
M  V30 26 1 19 21
M  V30 27 2 20 21
M  V30 28 2 22 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 25 28
M  V30 34 1 26 27
M  V30 35 1 27 29
M  V30 36 2 28 30
M  V30 37 2 29 31
M  V30 38 1 30 31
M  V30 39 2 32 33
M  V30 40 1 32 34
M  V30 41 1 33 35
M  V30 42 2 34 36
M  V30 43 2 35 37
M  V30 44 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 8 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2417431-63-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2417431-79-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-22007444
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee 94%, dr ratio = >20:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral Binaphthyl Box-Copper-Catalyzed Enantioselective Tandem
Michael-Ketalization Annulations for Optically Active Aryl and Heteroaryl
Fused bicyclic nonanes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fan, Wei-Tai; Yang, Xiao-Peng; Lv, Hao-Peng; Wang, Xing-Wang; Wang, Zheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2020), 22(10), 3936-3941

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dibromo-2,4-dinitrobenzene
C6H2Br2N2O4
24239-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 Br 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 Br 6.6685 4.6200 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N1,N3-Dimethyl-4,6-dinitro-1,3-benzenediamine
C8H10N4O4
2873-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0 VAL=5
M  V30 2 O 0.0000 3.0801 0.0 0
M  V30 3 O 1.3337 0.7700 0.0 0
M  V30 4 N 4.0012 0.7700 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 N 4.0012 6.9302 0.0 0 VAL=5
M  V30 7 O 5.3348 7.7002 0.0 0
M  V30 8 O 2.6675 7.7002 0.0 0
M  V30 9 N 6.6687 5.3901 0.0 0
M  V30 10 C 8.0023 4.6201 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 2.3101 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 4.0012 5.3901 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24239-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2873-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12081520
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1,5-Bis(methylamino)-2,5-dinitrobenzene (6). To 2.48 g (7.6 mmol) of
1,5-dibromo-2,4-dinitrobenzene was added 25 mL of dimethylformamide
followed by 15 mL of 17% methylamine in dimethylformamide. The reaction
was stirred at room temperature for 15 min and then 30 mL of ice water
was added to precipitate the product. The yellow product was filtered
off, washed with ice water, and dried under vacuum. Yield 1.62 g (95%).
mp 260 °C dec; TLC (CH2Cl2) Rf = 0.62; IR (KBr pellet) 3385, 1629, 1593,
1541, 1425, 1410, 1342, 1294, 1195, 1010, 800 cm-1; 1H NMR (dimethyl
sulfoxide-d6) δ 8.97 and 5.69 (2H, 2s, C(5) and C(2) protons), 8.5 (2H,
s, amine protons), 3.0 (6H, s, N-methyl's); MS (EI mode) m/z 226. Anal.
(C8H10N4O4) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of topoisomerase II based on the benzodiimidazole and
dipyrroloimidazobenzimidazole ring systems: controlling DT-diaphorase
reductive inactivation with steric bulk
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulz, William G.; Skibo, Edward B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2000), 43(4), 629-638

$RFMT $RIREG SCHEME83 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[7-[4-[4-[(1,1-Dimethylethoxy)carbonyl]-1-piperazinyl]phenyl]-6-methylimida...
C32H32N6O4
2445907-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.7336 0.5798 0.0 0
M  V30 2 C 1.1444 4.4404 0.0 0
M  V30 3 O 0.8242 5.9467 0.0 0
M  V30 4 O 0.0000 3.4100 0.0 0
M  V30 5 C 23.5136 3.2471 0.0 0
M  V30 6 O 24.2836 4.5809 0.0 0
M  V30 7 O 24.2836 1.9135 0.0 0
M  V30 8 C 25.8236 4.5809 0.0 0
M  V30 9 C 25.8236 6.1209 0.0 0
M  V30 10 C 27.3636 4.5809 0.0 0
M  V30 11 C 25.8236 3.0409 0.0 0
M  V30 12 C 8.1474 3.5673 0.0 0
M  V30 13 N 9.6536 3.2471 0.0 0
M  V30 14 C 7.9864 5.0989 0.0 0
M  V30 15 C 10.4236 4.5809 0.0 0
M  V30 16 N 10.4236 1.9135 0.0 0
M  V30 17 N 9.3932 5.7253 0.0 0
M  V30 18 C 11.9636 4.5809 0.0 0
M  V30 19 C 11.9636 1.9135 0.0 0
M  V30 20 C 12.7336 3.2471 0.0 0
M  V30 21 C 7.0028 2.5368 0.0 0
M  V30 22 C 5.5383 3.0127 0.0 0
M  V30 23 C 7.3232 1.0306 0.0 0
M  V30 24 C 4.3938 1.9823 0.0 0
M  V30 25 C 5.2181 4.5191 0.0 0
M  V30 26 C 6.1786 0.0000 0.0 0
M  V30 27 C 2.9292 2.4581 0.0 0
M  V30 28 N 4.7139 0.4760 0.0 0
M  V30 29 C 3.7534 4.9950 0.0 0
M  V30 30 C 2.6091 3.9646 0.0 0
M  V30 31 C 14.2736 3.2471 0.0 0
M  V30 32 C 15.0436 1.9135 0.0 0
M  V30 33 C 15.0436 4.5809 0.0 0
M  V30 34 C 16.5836 1.9135 0.0 0
M  V30 35 C 16.5836 4.5809 0.0 0
M  V30 36 C 17.3536 3.2471 0.0 0
M  V30 37 N 18.8936 3.2471 0.0 0
M  V30 38 C 19.6636 1.9135 0.0 0
M  V30 39 C 19.6636 4.5809 0.0 0
M  V30 40 C 21.2036 1.9135 0.0 0
M  V30 41 C 21.2036 4.5809 0.0 0
M  V30 42 N 21.9736 3.2471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 19
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 30
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 42
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 2 15 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 20 31
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 1 24 28
M  V30 31 2 25 29
M  V30 32 2 26 28
M  V30 33 2 27 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 41 1 36 37
M  V30 42 1 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[6-methyl-7-[4-(1-piperazinyl)phenyl]imidazo[1,2-b]pyridazin-3-yl]...
C28H27N7O
2445906-64-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 0.5797 0.0 0
M  V30 2 C 20.8294 4.4403 0.0 0
M  V30 3 N 21.9738 3.4099 0.0 0
M  V30 4 O 21.1496 5.9466 0.0 0
M  V30 5 C 23.4385 3.8857 0.0 0
M  V30 6 C 13.8264 3.5673 0.0 0
M  V30 7 N 12.3200 3.2471 0.0 0
M  V30 8 C 13.9874 5.0988 0.0 0
M  V30 9 C 11.5500 4.5807 0.0 0
M  V30 10 N 11.5500 1.9133 0.0 0
M  V30 11 N 12.5806 5.7251 0.0 0
M  V30 12 C 10.0100 4.5807 0.0 0
M  V30 13 C 10.0100 1.9133 0.0 0
M  V30 14 C 9.2400 3.2471 0.0 0
M  V30 15 C 14.9708 2.5367 0.0 0
M  V30 16 C 16.4355 3.0125 0.0 0
M  V30 17 C 14.6506 1.0304 0.0 0
M  V30 18 C 17.5799 1.9821 0.0 0
M  V30 19 C 16.7557 4.5190 0.0 0
M  V30 20 C 15.7952 0.0000 0.0 0
M  V30 21 C 19.0446 2.4580 0.0 0
M  V30 22 N 17.2597 0.4759 0.0 0
M  V30 23 C 18.2204 4.9948 0.0 0
M  V30 24 C 19.3647 3.9644 0.0 0
M  V30 25 C 7.7000 3.2471 0.0 0
M  V30 26 C 6.9300 4.5807 0.0 0
M  V30 27 C 6.9300 1.9133 0.0 0
M  V30 28 C 5.3900 4.5807 0.0 0
M  V30 29 C 5.3900 1.9133 0.0 0
M  V30 30 C 4.6200 3.2471 0.0 0
M  V30 31 N 3.0800 3.2471 0.0 0
M  V30 32 C 2.3100 1.9133 0.0 0
M  V30 33 C 2.3100 4.5807 0.0 0
M  V30 34 C 0.7700 1.9133 0.0 0
M  V30 35 C 0.7700 4.5807 0.0 0
M  V30 36 N 0.0000 3.2471 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 24
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 2 10 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 14 25
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 18 22
M  V30 25 2 19 23
M  V30 26 2 20 22
M  V30 27 2 21 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 30 31
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2445907-69-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2445906-64-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-22862230
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridazine and imidazopyridine compounds as
inhibitors of activin receptor-like kinase-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pan, Jun; Roach, Jeremy; Mei, Song; He, Chunhong; Wu, Liangxing; Yao,
Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020132197 A1 2020-06-25

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(1,1-Dimethylethoxy)carbonyl]amino]-5-hydroxybenzoic acid
C12H15NO5
244765-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3101 0.0 0
M  V30 2 C 6.6685 3.0801 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 4.6201 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 8.5660 4.4137 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 C 10.1060 1.7464 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 O 4.0012 0.0000 0.0 0
M  V30 11 O 1.3337 0.0000 0.0 0
M  V30 12 O 0.0000 5.3901 0.0 0
M  V30 13 C 4.0012 3.0801 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0012 4.6201 0.0 0
M  V30 16 C 1.3337 3.0801 0.0 0
M  V30 17 C 2.6673 5.3901 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 14
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-hydroxy-2-[(methylamino)carbonyl]phenyl]carbamate
C13H18N2O4
1416018-21-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 O 8.0023 3.8501 0.0 0
M  V30 4 O 6.6685 6.1601 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 8.5660 5.9538 0.0 0
M  V30 7 C 10.6697 5.3901 0.0 0
M  V30 8 C 10.1060 3.2864 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 N 1.3337 1.5400 0.0 0
M  V30 11 O 4.0012 1.5400 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 O 0.0000 6.9302 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 2.6673 6.9302 0.0 0
M  V30 19 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 244765-00-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1416018-21-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11745921
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2: A mixture of the above product (2.0 g, 7.9 mmol), methane amine
(2.6 g, 39.5 mmol), HATU (3.3 g, 8.7 mmol) and DIPEA (21.24 g, 17.4 mmol)
in THF (20 mL) was stirred at room temperature for 24 h. An aqueous
workup with EtOAc extraction was followed by column chromatography (PE :
EA = 50% : 50%) to give tert-butyl
(4-hydroxy-2-(methylcarbamoyl)phenyl)carbamate. White solid, yield (2.0
g, 95.1%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinolines and related compounds as S-nitrosoglutathione
reductase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Xicheng; Qiu, Jian; Stout, Adam
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012170371 A1 2012-12-13

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1H-pyrrolo[3,2-b]pyridine-3-acetate
C11H12N2O2
24509-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7532 1.6412 0.0 0
M  V30 2 C 7.0869 2.4112 0.0 0
M  V30 3 O 8.4205 1.6412 0.0 0
M  V30 4 O 7.0869 3.9511 0.0 0
M  V30 5 C 9.7543 2.4112 0.0 0
M  V30 6 C 11.0879 1.6412 0.0 0
M  V30 7 C 3.0127 1.7848 0.0 0
M  V30 8 C 4.4196 2.4112 0.0 0
M  V30 9 C 1.9823 2.9292 0.0 0
M  V30 10 N 2.5368 0.3202 0.0 0
M  V30 11 C 4.2585 3.9428 0.0 0
M  V30 12 N 2.7523 4.2630 0.0 0
M  V30 13 C 0.4759 2.6090 0.0 0
M  V30 14 C 1.0304 0.0000 0.0 0
M  V30 15 C 0.0000 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-pyrrolo[3,2-b]pyridine-3-acetamide
C10H11N3O
1206686-29-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 1.6412 0.0 0
M  V30 2 C 7.0869 2.4112 0.0 0
M  V30 3 N 8.4206 1.6412 0.0 0
M  V30 4 O 7.0869 3.9512 0.0 0
M  V30 5 C 9.7544 2.4112 0.0 0
M  V30 6 C 3.0127 1.7849 0.0 0
M  V30 7 C 4.4196 2.4112 0.0 0
M  V30 8 C 1.9823 2.9292 0.0 0
M  V30 9 N 2.5368 0.3202 0.0 0
M  V30 10 C 4.2586 3.9429 0.0 0
M  V30 11 N 2.7523 4.2630 0.0 0
M  V30 12 C 0.4759 2.6091 0.0 0
M  V30 13 C 1.0306 0.0000 0.0 0
M  V30 14 C 0.0000 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 24509-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1206686-29-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3729535
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3. Synthesis of N-methyl-2-(1H-pyrrolo[3,2-b]pyridin-3-yl)acetamide.
Triethylamine (2 mL) and 33% methylamine (68.1 mmol) were added to a
solution of ethyl 2-(1H-pyrrolo[3,2-b]pyridin-3-yl)acetate (11.3 mmol) in
tetrahydrofuran (30 mL) and methanol (30 mL) and the reaction mixture was
heated at 55 °C for 16 h. The reaction mixture was concentrated and the
residue was purified by Flash chromatography (100/1 to 40/1
dichloromethane/methanol) to provide
N-methyl-2-(1H-pyrrolo[3,2-b]pyridin-3-yl)acetamide in 95% yield as a
white solid. N-methyl-2-(1H-pyrrolo[3,2-b]pyridin-3-yl)acetamide, yield
95%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of acyclic compounds having 5-HT6 receptor affinity for
disease treatment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Conticello, Richard; Dunn, Robert; Tehim, Ashok; Xie, Wenge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010011546 A2 2010-01-28

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-4-methylbenzoic acid
C8H9NO2
2458-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 N 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Amino-N,4-dimethylbenzamide
C9H12N2O
54884-19-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 N 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2458-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54884-19-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7457602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-pyrazolopyrimidinyl anilines as p38 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Das, Jagabandhu; Liu, Chunjian; Moquin, Robert V.; Leftheris, Katerina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003099820 A1 2003-12-04

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dodecyl glycidyl ether
C15H30O2
2461-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.1037 0.0 0
M  V30 2 O 4.2075 1.3337 0.0 0
M  V30 3 C 5.5412 2.1037 0.0 0
M  V30 4 C 6.8749 1.3337 0.0 0
M  V30 5 C 8.2085 2.1037 0.0 0
M  V30 6 C 9.5424 1.3337 0.0 0
M  V30 7 C 10.8760 2.1037 0.0 0
M  V30 8 C 12.2097 1.3337 0.0 0
M  V30 9 C 13.5435 2.1037 0.0 0
M  V30 10 C 14.8772 1.3337 0.0 0
M  V30 11 C 16.2109 2.1037 0.0 0
M  V30 12 C 17.5445 1.3337 0.0 0
M  V30 13 C 18.8783 2.1037 0.0 0
M  V30 14 C 20.2120 1.3337 0.0 0
M  V30 15 C 1.5400 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(Methylimino)bis[3-(dodecyloxy)-2-propanol]
C31H65NO4
792931-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0057 2.3101 0.0 0
M  V30 2 N 21.3393 1.5400 0.0 0
M  V30 3 C 18.6718 1.5400 0.0 0
M  V30 4 C 22.6730 2.3101 0.0 0
M  V30 5 C 21.3393 0.0000 0.0 0
M  V30 6 C 17.3382 2.3101 0.0 0
M  V30 7 O 18.6718 0.0000 0.0 0
M  V30 8 C 24.0067 1.5400 0.0 0
M  V30 9 O 16.0045 1.5400 0.0 0
M  V30 10 C 25.3405 2.3101 0.0 0
M  V30 11 O 24.0067 0.0000 0.0 0
M  V30 12 C 14.6708 2.3101 0.0 0
M  V30 13 O 26.6742 1.5400 0.0 0
M  V30 14 C 13.3370 1.5400 0.0 0
M  V30 15 C 28.0078 2.3101 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 29.3415 1.5400 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 30.6753 2.3101 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 32.0090 1.5400 0.0 0
M  V30 22 C 8.0022 1.5400 0.0 0
M  V30 23 C 33.3427 2.3101 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 C 34.6765 1.5400 0.0 0
M  V30 26 C 5.3348 1.5400 0.0 0
M  V30 27 C 36.0101 2.3101 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 37.3438 1.5400 0.0 0
M  V30 30 C 2.6673 1.5400 0.0 0
M  V30 31 C 38.6775 2.3101 0.0 0
M  V30 32 C 1.3337 2.3101 0.0 0
M  V30 33 C 40.0113 1.5400 0.0 0
M  V30 34 C 0.0000 1.5400 0.0 0
M  V30 35 C 41.3450 2.3101 0.0 0
M  V30 36 C 42.6786 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2461-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792931-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-6460130
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and interfacial properties of ethoxylated cationic surfactants
derived from n-dodecyl glycidyl ether
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lim, J. C.; Kang, E. K.; Lee, Hayun; Lee, B. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Industrial and Engineering Chemistry (Amsterdam, Netherlands)
(2015), 2275-82

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dodecyl glycidyl ether
C15H30O2
2461-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.1037 0.0 0
M  V30 2 O 4.2075 1.3337 0.0 0
M  V30 3 C 5.5412 2.1037 0.0 0
M  V30 4 C 6.8749 1.3337 0.0 0
M  V30 5 C 8.2085 2.1037 0.0 0
M  V30 6 C 9.5424 1.3337 0.0 0
M  V30 7 C 10.8760 2.1037 0.0 0
M  V30 8 C 12.2097 1.3337 0.0 0
M  V30 9 C 13.5435 2.1037 0.0 0
M  V30 10 C 14.8772 1.3337 0.0 0
M  V30 11 C 16.2109 2.1037 0.0 0
M  V30 12 C 17.5445 1.3337 0.0 0
M  V30 13 C 18.8783 2.1037 0.0 0
M  V30 14 C 20.2120 1.3337 0.0 0
M  V30 15 C 1.5400 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 O 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(Methylimino)bis[3-(dodecyloxy)-2-propanol]
C31H65NO4
792931-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 20.0057 2.3101 0.0 0
M  V30 2 N 21.3393 1.5400 0.0 0
M  V30 3 C 18.6718 1.5400 0.0 0
M  V30 4 C 22.6730 2.3101 0.0 0
M  V30 5 C 21.3393 0.0000 0.0 0
M  V30 6 C 17.3382 2.3101 0.0 0
M  V30 7 O 18.6718 0.0000 0.0 0
M  V30 8 C 24.0067 1.5400 0.0 0
M  V30 9 O 16.0045 1.5400 0.0 0
M  V30 10 C 25.3405 2.3101 0.0 0
M  V30 11 O 24.0067 0.0000 0.0 0
M  V30 12 C 14.6708 2.3101 0.0 0
M  V30 13 O 26.6742 1.5400 0.0 0
M  V30 14 C 13.3370 1.5400 0.0 0
M  V30 15 C 28.0078 2.3101 0.0 0
M  V30 16 C 12.0033 2.3101 0.0 0
M  V30 17 C 29.3415 1.5400 0.0 0
M  V30 18 C 10.6697 1.5400 0.0 0
M  V30 19 C 30.6753 2.3101 0.0 0
M  V30 20 C 9.3360 2.3101 0.0 0
M  V30 21 C 32.0090 1.5400 0.0 0
M  V30 22 C 8.0022 1.5400 0.0 0
M  V30 23 C 33.3427 2.3101 0.0 0
M  V30 24 C 6.6685 2.3101 0.0 0
M  V30 25 C 34.6765 1.5400 0.0 0
M  V30 26 C 5.3348 1.5400 0.0 0
M  V30 27 C 36.0101 2.3101 0.0 0
M  V30 28 C 4.0012 2.3101 0.0 0
M  V30 29 C 37.3438 1.5400 0.0 0
M  V30 30 C 2.6673 1.5400 0.0 0
M  V30 31 C 38.6775 2.3101 0.0 0
M  V30 32 C 1.3337 2.3101 0.0 0
M  V30 33 C 40.0113 1.5400 0.0 0
M  V30 34 C 0.0000 1.5400 0.0 0
M  V30 35 C 41.3450 2.3101 0.0 0
M  V30 36 C 42.6786 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2461-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 792931-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-4974422
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Syntheses and surface active properties of cationic surfactants having
multi ammonium and hydroxyl groups
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lim, Jong Choo; Kang, Eun-kyung; Park, Jong-mok; Kang, Ho Cheol; Lee,
Byung Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Industrial and Engineering Chemistry (Amsterdam, Netherlands)
(2012), 18(4), 1406-1411

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
3-Methylbenzofuran-2-carboxylic acid
C10H8O3
24673-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0205 0.1773 0.0 0
M  V30 2 C 6.0811 1.5400 0.0 0
M  V30 3 O 7.4149 2.3100 0.0 0
M  V30 4 O 6.0811 0.0000 0.0 0
M  V30 5 C 2.3100 2.8281 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 C 3.3406 1.6836 0.0 0
M  V30 8 C 0.7700 2.8281 0.0 0
M  V30 9 O 4.5865 3.8416 0.0 0
M  V30 10 C 2.3100 5.4954 0.0 0
M  V30 11 C 4.7474 2.3100 0.0 0
M  V30 12 C 0.0000 4.1618 0.0 0
M  V30 13 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 1 10 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-2-benzofurancarboxamide
C11H11NO2
52819-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 0.0000 0.0 0
M  V30 2 C 6.5770 2.7104 0.0 0
M  V30 3 N 7.3470 4.0442 0.0 0
M  V30 4 O 7.3470 1.3768 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 2.6673 3.4804 0.0 0
M  V30 7 C 2.6673 1.9404 0.0 0
M  V30 8 O 4.1320 3.9564 0.0 0
M  V30 9 C 1.3336 4.2504 0.0 0
M  V30 10 C 4.1320 1.4645 0.0 0
M  V30 11 C 1.3336 1.1704 0.0 0
M  V30 12 C 5.0370 2.7104 0.0 0
M  V30 13 C 0.0000 3.4804 0.0 0
M  V30 14 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 24673-56-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 52819-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4428190
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 10
(E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
p-toluene sulfonate Monohydrate form: Large-Scale Process (Scheme II,
Vida Supra) A. N,3-dimethylbenzofuran-2-carboxamide A mixture of
3-methylbenzofuran-2-carboxylic acid (1.0 kg, 5.676 mol) in methylene
chloride (5.8 L) and DMF (5 mL) was chilled to ˜2 &#x00B0;C. A solution
of oxalyl chloride (864 g, 6.81 mol) was added to the reaction mixture
keeping the temperature below 10 &#x00B0;C, over a period of 2 hrs. A
vigorous evolution of a gas was observed. The reaction mixture was
stirred overnight under nitrogen at room temperature and then refluxed
for 3 hrs. All of the solids were dissolved to give a brown color
solution. HPLC analysis of an aliquot indicated that the reaction was
complete. The mixture was concentrated on a rotary evaporator and the
residual oxalyl chloride was chased with DCM (2 L). The solid product was
re-dissolved in DCM (6 L) in a round bottom flask (10 L) and chilled to
˜−5 &#x00B0;C. A solution of methyl amine (40% in water, 1.7 L, 3.5 eq,
19.86 mol) was carefully added to the acid chloride solution while
keeping the temperature below 8&#x00B0; C then stirred overnight at room
temperature. Analysis of an aliquot indicated that the reaction was
complete. Water (8.0 L) was added to the reaction mixture, the layers
were separated, the aqueous layer was back extracted with DCM (2×3 L),
the combined organic layer was washed with water (4 L) and dried over
Na2SO4. The organic layer was filtered, the filtrate was concentrated and
traces of DCM were co evaporated with heptanes (2 L). The heptanes slurry
was filtered and the cake was washed with heptanes (2×2 L). All the brown
color was removed in the heptane filtrate. The solid product was dried
under high vacuum overnight to a constant weight. Yield of the title
compound was 1.015 kg (94.5%). 1H NMR {CDCl3}: &#x03B4; (ppm) 8.45 (s,
1H), 7.61 (d, 1H), 7.41 (m, 2H), 7.30 (m, 1H), 3.03 (d, 2H), 2.63 (s,
3H). HPLC: 99.0 area % (RT=7.91 min)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of salts, prodrugs, and polymorphs of a 1,8-naphthyridine
based fab I inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pauls, Henry; Ramnauth, Jailall
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008098374 A1 2008-08-21

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-5-[4-(1,1-dimethylethoxy)phenyl]-2-(methylthio)-7-phenyl-4H-pyrano[2...
C27H25NO4S
2489549-69-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 10.0101 0.0 0
M  V30 2 C 4.0010 11.5501 0.0 0
M  V30 3 C 5.3348 12.3201 0.0 0
M  V30 4 O 2.6673 12.3201 0.0 0
M  V30 5 S 1.3337 10.0101 0.0 0
M  V30 6 C 0.0000 9.2401 0.0 0
M  V30 7 O 12.0032 10.0101 0.0 0
M  V30 8 C 13.3369 9.2401 0.0 0
M  V30 9 C 12.5668 7.9064 0.0 0
M  V30 10 C 14.6705 8.4701 0.0 0
M  V30 11 C 14.1069 10.5738 0.0 0
M  V30 12 C 6.6684 6.9301 0.0 0
M  V30 13 C 5.3348 7.7001 0.0 0
M  V30 14 C 6.6684 5.3901 0.0 0
M  V30 15 C 4.0010 6.9301 0.0 0
M  V30 16 C 5.3348 9.2401 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 N 4.0010 5.3901 0.0 0
M  V30 19 O 2.6673 7.7001 0.0 0
M  V30 20 C 4.0010 10.0101 0.0 0
M  V30 21 C 2.6673 9.2401 0.0 0
M  V30 22 C 8.0021 7.7001 0.0 0
M  V30 23 C 9.3357 6.9301 0.0 0
M  V30 24 C 8.0021 9.2401 0.0 0
M  V30 25 C 10.6695 7.7001 0.0 0
M  V30 26 C 9.3357 10.0101 0.0 0
M  V30 27 C 10.6695 9.2401 0.0 0
M  V30 28 C 5.3348 3.0800 0.0 0
M  V30 29 C 4.0010 2.3100 0.0 0
M  V30 30 C 6.6684 2.3100 0.0 0
M  V30 31 C 4.0010 0.7700 0.0 0
M  V30 32 C 6.6684 0.7700 0.0 0
M  V30 33 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 22
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 17 28
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Acetyl-5-[4-(1,1-dimethylethoxy)phenyl]-2-(methylamino)-7-phenyl-4H-pyrano[...
C27H26N2O4
2489549-90-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 10.0101 0.0 0
M  V30 2 C 4.0010 11.5501 0.0 0
M  V30 3 C 2.6673 12.3201 0.0 0
M  V30 4 O 5.3348 12.3201 0.0 0
M  V30 5 N 1.3337 10.0101 0.0 0
M  V30 6 C 0.0000 9.2401 0.0 0
M  V30 7 O 12.0032 10.0101 0.0 0
M  V30 8 C 13.3369 9.2401 0.0 0
M  V30 9 C 14.1069 10.5738 0.0 0
M  V30 10 C 14.6705 8.4701 0.0 0
M  V30 11 C 12.5668 7.9064 0.0 0
M  V30 12 C 6.6684 6.9301 0.0 0
M  V30 13 C 5.3348 7.7001 0.0 0
M  V30 14 C 6.6684 5.3901 0.0 0
M  V30 15 C 4.0010 6.9301 0.0 0
M  V30 16 C 5.3348 9.2401 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 N 4.0010 5.3901 0.0 0
M  V30 19 O 2.6673 7.7001 0.0 0
M  V30 20 C 4.0010 10.0101 0.0 0
M  V30 21 C 2.6673 9.2401 0.0 0
M  V30 22 C 8.0021 7.7001 0.0 0
M  V30 23 C 9.3357 6.9301 0.0 0
M  V30 24 C 8.0021 9.2401 0.0 0
M  V30 25 C 10.6695 7.7001 0.0 0
M  V30 26 C 9.3357 10.0101 0.0 0
M  V30 27 C 10.6695 9.2401 0.0 0
M  V30 28 C 5.3348 3.0800 0.0 0
M  V30 29 C 6.6684 2.3100 0.0 0
M  V30 30 C 4.0010 2.3100 0.0 0
M  V30 31 C 6.6684 0.7700 0.0 0
M  V30 32 C 4.0010 0.7700 0.0 0
M  V30 33 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 27
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 22
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 2 14 17
M  V30 18 2 15 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 1 17 28
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2489549-69-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2489549-90-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26534637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, toxic methanethiol release during reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-(Substituted amino)-8-azachromones from 4,6-Diaryl-2-pyridones: A
Synthetic Strategy toward Compounds of Broad Structural Diversity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saulnier, Steve; Ghoteimi, Rayane; Mathe, Christophe; Peyrottes, Suzanne;
Uttaro, Jean-Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2020), 85(18), 11778-11793

$RFMT $RIREG SCHEME90 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-[2-(Acetylamino)ethyl]-2-naphthalenesulfonyl chloride
C14H14ClNO3S
250133-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7238 4.0012 0.0 0
M  V30 2 C 8.2638 4.0012 0.0 0
M  V30 3 N 9.0338 5.3348 0.0 0
M  V30 4 C 10.5739 5.3348 0.0 0
M  V30 5 C 11.3439 6.6687 0.0 0
M  V30 6 O 11.3439 4.0012 0.0 0
M  V30 7 S 1.3337 5.3348 0.0 0 VAL=6
M  V30 8 Cl 0.5637 6.6687 0.0 0
M  V30 9 O 2.6673 6.1048 0.0 0
M  V30 10 O 0.0000 4.5648 0.0 0
M  V30 11 C 4.4137 2.6675 0.0 0
M  V30 12 C 3.6437 1.3338 0.0 0
M  V30 13 C 5.9538 2.6675 0.0 0
M  V30 14 C 3.6437 4.0012 0.0 0
M  V30 15 C 2.1037 1.3338 0.0 0
M  V30 16 C 4.4137 0.0000 0.0 0
M  V30 17 C 6.7238 1.3338 0.0 0
M  V30 18 C 2.1037 4.0012 0.0 0
M  V30 19 C 1.3337 2.6675 0.0 0
M  V30 20 C 5.9538 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 18
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 1 17 20
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[7-[(Methylamino)sulfonyl]-1-naphthalenyl]ethyl]acetamide
C15H18N2O3S
250133-08-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 4.0011 0.0 0
M  V30 2 C 9.2401 4.0011 0.0 0
M  V30 3 N 10.0101 5.3348 0.0 0
M  V30 4 C 11.5501 5.3348 0.0 0
M  V30 5 C 12.3201 6.6686 0.0 0
M  V30 6 O 12.3201 4.0011 0.0 0
M  V30 7 S 2.3100 5.3348 0.0 0 VAL=6
M  V30 8 N 1.5400 6.6686 0.0 0
M  V30 9 O 3.6437 6.1048 0.0 0
M  V30 10 O 0.9764 4.5648 0.0 0
M  V30 11 C 0.0000 6.6686 0.0 0
M  V30 12 C 5.3901 2.6675 0.0 0
M  V30 13 C 4.6201 1.3338 0.0 0
M  V30 14 C 6.9301 2.6675 0.0 0
M  V30 15 C 4.6201 4.0011 0.0 0
M  V30 16 C 3.0800 1.3338 0.0 0
M  V30 17 C 5.3901 0.0000 0.0 0
M  V30 18 C 7.7001 1.3338 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 2.3100 2.6675 0.0 0
M  V30 21 C 6.9301 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 7 10
M  V30 10 1 7 19
M  V30 11 1 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 1 18 21
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 250133-77-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 250133-08-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-8290545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of naphthalenic derivatives as new ligands at the
melatonin binding site MT3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leclerc, Veronique; Ettaoussi, Mohamed; Rami, Marouan; Farce, Amaury;
Boutin, Jean Albert; Delagrange, Philippe; Caignard, Daniel-Henri;
Renard, Pierre; Berthelot, Pascal; Yous, Said
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2011), 46(5), 1622-1629

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Diethoxy-3-butyn-2-one
C8H12O3
25234-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 3.0800 5.3347 0.0 0
M  V30 3 O 3.0800 2.6674 0.0 0
M  V30 4 O 5.3900 4.0011 0.0 0
M  V30 5 C 1.5400 5.3347 0.0 0
M  V30 6 O 3.8500 6.6685 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 5.3347 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 3 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-1,1-Diethoxy-4-(methylamino)-3-buten-2-one
C9H17NO3
1356477-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 O 2.6675 4.6201 0.0 0
M  V30 4 O 4.0012 2.3101 0.0 0
M  V30 5 C 5.3348 6.1601 0.0 0
M  V30 6 O 6.6685 3.8501 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 6.6685 6.9302 0.0 0
M  V30 10 C 0.0000 4.6201 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 N 8.0023 6.1601 0.0 0
M  V30 13 C 9.3360 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25234-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1356477-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7181257
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Compounds 4a–f by the Addition of Ammonia or
Primary or Secondary Amines to 1; General Procedure A round-bottom flask
was charged with a soln of 1 (0.156 g, 1.00 mmol) in EtOH (5 mL) and the
appropriate amine (1.00 mmol) was added. NH3 and MeNH2 were added as 25%
and 40% aq solns, respectively, whereas the other amines were added as
pure liquids. The reaction mixture was stirred at r.t. for 45 min; EtOH
was then removed by evaporation on a rotary evaporator, and the resulting
crude product was purified by flash chromatography (silica gel,
hexanes–EtOAc, 4:1). Compounds 4a–f were prepared according to this
procedure. (Z)-1,1-Diethoxy-4-(methylamino)but-3-en-2-one (4b) Yield:
0.178 g (95%); slightly yellow liquid IR (film): 3550–3100 (s), 3069 (m),
2975 (s), 2930 (s), 2883 (s), 1645 (s), 1565 (s), 1503 (s), 1429 (s),
1372 (s), 1293 (s), 1240 (m), 1094 (s), 1052 (s), 976 (w), 955 (w), 881
(m), 840 (w), 798 (m), 763(m) cm–1. 1H NMR (400 MHz, CDCl3): δ = 9.91 (br
s, 1 H), 6.85 (dd, J = 12.9Hz, 7.3 Hz, 1 H), 5.39 (d, J = 7.3 Hz, 1 H),
4.66 (s, 1 H), 3.74–3.52 (m, 4 H), 3.03 (d, J = 5.0 Hz, 3 H), 1.24 (t, J
= 7.0 Hz, 6 H). 13C NMR (100 MHz, CDCl3): δ = 193.6, 156.3, 102.2, 89.8,
62.5,35.6, 15.4. HRMS (DART): m/z [M + H]+ calcd for C9H18NO3: 188.1286;
found: 188.1297.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael addition of various nitrogen and oxygen nucleophiles to
1,1-diethoxybut-3-yn-2-one
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sengee, Myagmarsuren; Sydnes, Leiv K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2011), (23), 3899-3907

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Chloroethyl)-4-[4-[2-(phenylmethoxy)ethoxy]phenyl]piperazine
C21H27ClN2O2
2532104-60-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 C 6.6685 5.3901 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 4.0012 5.3901 0.0 0
M  V30 6 C 18.6720 0.0000 0.0 0
M  V30 7 C 20.0057 0.7700 0.0 0
M  V30 8 Cl 21.3393 0.0000 0.0 0
M  V30 9 C 13.3372 3.0801 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 13.3372 4.6201 0.0 0
M  V30 12 C 10.6697 3.0801 0.0 0
M  V30 13 C 12.0033 5.3901 0.0 0
M  V30 14 C 10.6697 4.6201 0.0 0
M  V30 15 N 14.6708 2.3101 0.0 0
M  V30 16 C 16.0045 3.0801 0.0 0
M  V30 17 C 14.6708 0.7700 0.0 0
M  V30 18 C 17.3382 2.3101 0.0 0
M  V30 19 C 16.0045 0.0000 0.0 0
M  V30 20 N 17.3382 0.7700 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 1.3337 5.3901 0.0 0
M  V30 23 C 2.6673 3.0801 0.0 0
M  V30 24 C 0.0000 4.6201 0.0 0
M  V30 25 C 1.3337 2.3101 0.0 0
M  V30 26 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 21
M  V30 7 1 6 7
M  V30 8 1 6 20
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[4-[2-(phenylmethoxy)ethoxy]phenyl]-1-piperazineethanamine
C22H31N3O2
2532104-49-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 5.3901 0.0 0
M  V30 2 C 8.0022 4.6201 0.0 0
M  V30 3 C 6.6685 5.3901 0.0 0
M  V30 4 O 5.3348 4.6201 0.0 0
M  V30 5 C 4.0012 5.3901 0.0 0
M  V30 6 C 18.6718 0.0000 0.0 0
M  V30 7 C 20.0057 0.7700 0.0 0
M  V30 8 N 21.3393 0.0000 0.0 0
M  V30 9 C 22.6730 0.7700 0.0 0
M  V30 10 C 13.3370 3.0801 0.0 0
M  V30 11 C 12.0033 2.3101 0.0 0
M  V30 12 C 13.3370 4.6201 0.0 0
M  V30 13 C 10.6697 3.0801 0.0 0
M  V30 14 C 12.0033 5.3901 0.0 0
M  V30 15 C 10.6697 4.6201 0.0 0
M  V30 16 N 14.6708 2.3101 0.0 0
M  V30 17 C 16.0045 3.0801 0.0 0
M  V30 18 C 14.6708 0.7700 0.0 0
M  V30 19 C 17.3382 2.3101 0.0 0
M  V30 20 C 16.0045 0.0000 0.0 0
M  V30 21 N 17.3382 0.7700 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 1.3337 5.3901 0.0 0
M  V30 24 C 2.6673 3.0801 0.0 0
M  V30 25 C 0.0000 4.6201 0.0 0
M  V30 26 C 1.3337 2.3101 0.0 0
M  V30 27 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2532104-60-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2532104-49-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23380366
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolopyrimidine diamine compounds and salts thereof as
selective adenosine A2 receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Anand, Neel K.; Aurrecoechea, Natalia; Brockway, Anthony James; Cai,
Haiying; Cheng, Lin; Deng, Bo-Liang; O'Mahony, Donogh John Roger; Ren,
Zhongxu; Zhang, Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020227156 A1 2020-11-12

$RFMT $RIREG SCHEME93 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Methyl-1,3-benzodioxole-5-acetic acid
C10H10O4
25476-44-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 O 7.7047 3.8500 0.0 0
M  V30 5 O 9.0383 1.5400 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 O 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-acetamide, N,α-dimethyl-
C11H13NO3
3047050-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 1.5400 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 6.3709 0.0000 0.0 0
M  V30 4 N 9.0383 1.5400 0.0 0
M  V30 5 O 7.7045 3.8500 0.0 0
M  V30 6 C 10.3720 2.3100 0.0 0
M  V30 7 C 2.3698 2.3100 0.0 0
M  V30 8 C 2.3698 3.8500 0.0 0
M  V30 9 C 3.7036 1.5400 0.0 0
M  V30 10 O 0.9052 1.8341 0.0 0
M  V30 11 C 3.7036 4.6200 0.0 0
M  V30 12 O 0.9052 4.3259 0.0 0
M  V30 13 C 5.0372 2.3100 0.0 0
M  V30 14 C 0.0000 3.0800 0.0 0
M  V30 15 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25476-44-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3047050-10-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41911193
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of substituted ethylamine fused heterocyclic mescaline
derivatives for pharmaceutical use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matinkhoo, Kaveh; Press, David James; Lee, Jessica Bik-Jing; Cai, Ye;
Hagel, Jillian M.; Facchini, Peter J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024124353 A1 2024-06-20

$RFMT $RIREG SCHEME94 STEP1
$RXN



  3  1
$MOL
Thiophosgene
CCl2S
463-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 S 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Amino-5-bromo-2,3-dihydro-7-methyl-1H-indol-1-yl)ethanone
C11H13BrN2O
2556943-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 1.9572 0.0 0
M  V30 2 C 8.7355 2.4330 0.0 0
M  V30 3 O 6.9506 0.4508 0.0 0
M  V30 4 C 4.6200 0.0000 0.0 0
M  V30 5 N 1.5400 5.3349 0.0 0
M  V30 6 Br 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 4.0011 0.0 0
M  V30 9 N 6.1264 2.9876 0.0 0
M  V30 10 C 3.8500 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 4.8806 5.1456 0.0 0
M  V30 13 C 6.2874 4.5191 0.0 0
M  V30 14 C 2.3100 1.3338 0.0 0
M  V30 15 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 10
M  V30 5 1 5 11
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Acetyl-5-bromo-2,3-dihydro-7-methyl-1H-indol-4-yl)-N′-methylthiourea
C13H16BrN3OS
2556942-03-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.6825 1.6672 0.0 0
M  V30 2 C 9.0161 2.4373 0.0 0
M  V30 3 N 10.3500 1.6672 0.0 0
M  V30 4 S 9.0161 3.9773 0.0 0
M  V30 5 C 11.6836 2.4373 0.0 0
M  V30 6 C 1.0304 1.7270 0.0 0
M  V30 7 C 0.5546 3.1917 0.0 0
M  V30 8 O 0.0000 0.5826 0.0 0
M  V30 9 C 2.3476 4.7473 0.0 0
M  V30 10 Br 7.6825 4.7473 0.0 0
M  V30 11 C 5.0151 1.6672 0.0 0
M  V30 12 C 3.6813 2.4373 0.0 0
M  V30 13 C 6.3488 2.4373 0.0 0
M  V30 14 C 4.6948 0.1609 0.0 0
M  V30 15 N 2.5369 1.4068 0.0 0
M  V30 16 C 3.6813 3.9773 0.0 0
M  V30 17 C 6.3488 3.9773 0.0 0
M  V30 18 C 3.1632 0.0000 0.0 0
M  V30 19 C 5.0151 4.7473 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 9 16
M  V30 10 1 10 17
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 463-71-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2556943-33-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2556942-03-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31072197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
4-((2S,4S)-4-Ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic
Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be
Applicable to Treating a Diverse Array of Complement Mediated Diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ehara, Takeru; Karki, Rajeshri G.; Anderson, Karen;
MacSweeney, Aengus; Liao, Sha-Mei; Argikar, Upendra A.; Jendza, Keith;
Zhang, Chun; Powers, James; Klosowski, Daniel W.; Crowley, Maura;
Kawanami, Toshio; Ding, Jian; April, Myriam; Forster, Cornelia;
Serrano-Wu, Michael; Capparelli, Michael; Ramqaj, Rrezarta; Solovay,
Catherine; Cumin, Frederic; Smith, Thomas M.; Ferrara, Luciana; Lee,
Wendy; Long, Debby; Prentiss, Melissa; De Erkenez, Andrea; Yang, Louis;
Liu, Fang; Sellner, Holger; Sirockin, Finton; Valeur, Eric; Erbel,
Paulus; Ostermeier, Daniela; Ramage, Paul; Gerhartz, Bernd; Schubart,
Anna; Flohr, Stefanie; Gradoux, Nathalie; Feifel, Roland; Vogg, Barbara;
Wiesmann, Christian; Maibaum, Jurgen; Eder, Jorg; Sedrani, Richard;
Harrison, Richard A.; Mogi, Muneto; Jaffee, Bruce D.; Adams, Christopher
M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(11), 5697-5722

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S,5R)-3,4-Dihydroxy-5-(3-methylbutyl)-2-(3-methyl-1-oxobutyl)-4-(4-methyl-1...
C21H34O5
26054-22-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0326 5.9716 0.0 0
M  V30 2 C 9.3663 6.7416 0.0 0
M  V30 3 O 8.0326 4.4316 0.0 0
M  V30 4 C 10.7000 5.9716 0.0 0
M  V30 5 C 12.0336 6.7416 0.0 0
M  V30 6 C 13.3674 5.9716 0.0 0
M  V30 7 C 12.0336 8.2817 0.0 0
M  V30 8 O 7.6040 7.9875 0.0 0
M  V30 9 C 6.8425 4.0010 0.0 0
M  V30 10 C 6.0725 2.6673 0.0 0
M  V30 11 C 6.8425 1.3337 0.0 0
M  V30 12 C 6.0725 0.0000 0.0 0
M  V30 13 C 8.3825 1.3337 0.0 0
M  V30 14 O 5.7154 9.3038 0.0 0
M  V30 15 O 3.5105 4.3512 0.0 0
M  V30 16 C 2.8138 7.6285 0.0 0
M  V30 17 C 2.6529 9.1601 0.0 0
M  V30 18 O 1.5679 6.7233 0.0 0
M  V30 19 C 1.2460 9.7864 0.0 0
M  V30 20 C 0.0000 8.8812 0.0 0
M  V30 21 C 1.0849 11.3180 0.0 0
M  V30 22 C 6.6988 6.7416 0.0 0 CFG=1
M  V30 23 C 6.0725 5.3348 0.0 0 CFG=1
M  V30 24 C 5.5544 7.7721 0.0 0
M  V30 25 C 4.5409 5.4957 0.0 0
M  V30 26 C 4.2208 7.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 22 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 22 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 23 9 CFG=1
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 14 24
M  V30 15 2 15 25
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 26
M  V30 19 1 17 19
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R,5R)-4-Hydroxy-5-(3-methylbutyl)-2-[3-methyl-1-(methylamino)butylidene]-4-...
C22H37NO4
1538546-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2481 3.3420 0.0 0
M  V30 2 C 5.0022 2.4369 0.0 0
M  V30 3 C 5.1632 0.9052 0.0 0
M  V30 4 C 6.5701 0.2789 0.0 0
M  V30 5 C 3.9173 0.0000 0.0 0
M  V30 6 C 8.5653 6.6741 0.0 0
M  V30 7 C 9.8990 5.9041 0.0 0
M  V30 8 O 8.5653 8.2141 0.0 0
M  V30 9 C 11.2326 6.6741 0.0 0
M  V30 10 C 12.5662 5.9041 0.0 0
M  V30 11 C 13.9000 6.6741 0.0 0
M  V30 12 C 12.5662 4.3641 0.0 0
M  V30 13 O 8.1367 4.6582 0.0 0
M  V30 14 O 3.3466 5.0172 0.0 0
M  V30 15 O 7.3752 8.6446 0.0 0
M  V30 16 C 4.0433 8.2944 0.0 0
M  V30 17 C 2.5368 7.9741 0.0 0
M  V30 18 N 4.5191 9.7590 0.0 0
M  V30 19 C 1.5064 9.1186 0.0 0
M  V30 20 C 3.4886 10.9035 0.0 0
M  V30 21 C 0.0000 8.7985 0.0 0
M  V30 22 C 1.9823 10.5832 0.0 0
M  V30 23 C 6.0872 4.8736 0.0 0 CFG=1
M  V30 24 C 7.2315 5.9041 0.0 0 CFG=1
M  V30 25 C 4.7535 5.6436 0.0 0
M  V30 26 C 6.6052 7.3108 0.0 0
M  V30 27 C 5.0737 7.1499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 24 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 24 13 CFG=1
M  V30 14 2 14 25
M  V30 15 2 15 26
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 2 16 27 CFG=2
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26054-22-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1538546-93-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28140082
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydro-isohumulone derivatives, methods of making and using
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konda, Veera; Urban, Jan; Desai, Anuradha; Dahlberg, Clinton J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014011680 A2 2014-01-16

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(5-Bromopentyl)oxy]-5-nitro-1-(phenylmethyl)-1H-indazole
C19H20BrN3O3
2611186-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.5188 8.2358 0.0 0
M  V30 2 C 9.0503 8.0749 0.0 0
M  V30 3 C 9.9555 9.3207 0.0 0
M  V30 4 C 11.4871 9.1598 0.0 0
M  V30 5 C 12.3923 10.4057 0.0 0
M  V30 6 C 13.9238 10.2446 0.0 0
M  V30 7 Br 14.8290 11.4906 0.0 0
M  V30 8 C 5.8436 3.0800 0.0 0
M  V30 9 N 1.5063 8.9587 0.0 0 VAL=5
M  V30 10 O 1.9821 10.4232 0.0 0
M  V30 11 O 0.0000 8.6384 0.0 0
M  V30 12 C 5.0736 6.9899 0.0 0
M  V30 13 C 4.5977 5.5252 0.0 0
M  V30 14 C 6.6136 6.9899 0.0 0
M  V30 15 C 4.0431 8.1343 0.0 0
M  V30 16 N 5.8436 4.6200 0.0 0
M  V30 17 C 3.0914 5.2051 0.0 0
M  V30 18 N 7.0894 5.5252 0.0 0
M  V30 19 C 2.5367 7.8142 0.0 0
M  V30 20 C 2.0608 6.3496 0.0 0
M  V30 21 C 7.1774 2.3100 0.0 0
M  V30 22 C 7.1774 0.7700 0.0 0
M  V30 23 C 8.5110 3.0800 0.0 0
M  V30 24 C 8.5110 0.0000 0.0 0
M  V30 25 C 9.8447 2.3100 0.0 0
M  V30 26 C 9.8447 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 16
M  V30 9 1 8 21
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 19
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-[[5-nitro-1-(phenylmethyl)-1H-indazol-3-yl]oxy]-1-pentanamine
C20H24N4O3
2611186-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.7052 7.9273 0.0 0
M  V30 2 C 8.0388 7.1573 0.0 0
M  V30 3 C 9.3725 7.9273 0.0 0
M  V30 4 C 10.7062 7.1573 0.0 0
M  V30 5 C 12.0400 7.9273 0.0 0
M  V30 6 C 13.3737 7.1573 0.0 0
M  V30 7 N 14.7073 7.9273 0.0 0
M  V30 8 C 16.0410 7.1573 0.0 0
M  V30 9 C 3.0776 3.8986 0.0 0
M  V30 10 N 1.5063 11.0333 0.0 0 VAL=5
M  V30 11 O 0.0000 11.3534 0.0 0
M  V30 12 O 2.5367 12.1777 0.0 0
M  V30 13 C 3.9645 7.7838 0.0 0
M  V30 14 C 2.9341 6.6392 0.0 0
M  V30 15 C 5.3713 7.1573 0.0 0
M  V30 16 C 3.4886 9.2484 0.0 0
M  V30 17 N 3.7041 5.3056 0.0 0
M  V30 18 C 1.4276 6.9594 0.0 0
M  V30 19 N 5.2104 5.6257 0.0 0
M  V30 20 C 1.9822 9.5685 0.0 0
M  V30 21 C 0.9517 8.4241 0.0 0
M  V30 22 C 3.9828 2.6527 0.0 0
M  V30 23 C 3.3565 1.2459 0.0 0
M  V30 24 C 5.5144 2.8138 0.0 0
M  V30 25 C 4.2617 0.0000 0.0 0
M  V30 26 C 6.4196 1.5678 0.0 0
M  V30 27 C 5.7933 0.1609 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 17
M  V30 10 1 9 22
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 20
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 20
M  V30 21 1 17 19
M  V30 22 1 18 21
M  V30 23 2 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2611186-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2611186-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23314479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Promising hit compounds against resistant trichomoniasis: Synthesis and
antiparasitic activity of 3-(ω-aminoalkoxy)-1-benzyl-5-nitroindazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ibanez-Escribano, Alexandra; Reviriego, Felipe; Vela, Nerea;
Fonseca-Berzal, Cristina; Nogal-Ruiz, Juan Jose; Aran, Vicente J.;
Escario, Jose Antonio; Gomez-Barrio, Alicia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 37127843

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(1,1-dimethylethyl) 2-(6-bromo-4-pyrimidinyl)imidodicarbonate
C14H20BrN3O4
2612275-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 C 6.1600 5.3347 0.0 0
M  V30 4 O 4.6200 2.6674 0.0 0
M  V30 5 O 2.3100 4.0011 0.0 0
M  V30 6 O 6.9300 6.6684 0.0 0
M  V30 7 O 6.9300 4.0011 0.0 0
M  V30 8 C 3.8500 1.3336 0.0 0
M  V30 9 C 8.4700 6.6684 0.0 0
M  V30 10 C 5.1836 0.5636 0.0 0
M  V30 11 C 3.0800 0.0000 0.0 0
M  V30 12 C 2.5164 2.1036 0.0 0
M  V30 13 C 8.4700 8.2084 0.0 0
M  V30 14 C 10.0100 6.6684 0.0 0
M  V30 15 C 8.4700 5.1284 0.0 0
M  V30 16 Br 0.0000 8.0021 0.0 0
M  V30 17 C 3.8500 6.6684 0.0 0
M  V30 18 C 2.3100 6.6684 0.0 0
M  V30 19 N 4.6200 8.0021 0.0 0
M  V30 20 C 1.5400 8.0021 0.0 0
M  V30 21 C 3.8500 9.3358 0.0 0
M  V30 22 N 2.3100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 16 20
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Bis(1,1-dimethylethyl) 2-[6-(methylamino)-4-pyrimidinyl]imidodicarbonate
C15H24N4O4
2762660-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3347 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 C 6.9300 5.3347 0.0 0
M  V30 4 O 5.3900 2.6674 0.0 0
M  V30 5 O 3.0800 4.0011 0.0 0
M  V30 6 O 7.7000 6.6684 0.0 0
M  V30 7 O 7.7000 4.0011 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 9.2400 6.6684 0.0 0
M  V30 10 C 3.2864 2.1036 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 5.9536 0.5636 0.0 0
M  V30 13 C 9.2400 5.1284 0.0 0
M  V30 14 C 10.7800 6.6684 0.0 0
M  V30 15 C 9.2400 8.2084 0.0 0
M  V30 16 N 0.7700 8.0021 0.0 0
M  V30 17 C 0.0000 9.3358 0.0 0
M  V30 18 C 4.6200 6.6684 0.0 0
M  V30 19 C 3.0800 6.6684 0.0 0
M  V30 20 N 5.3900 8.0021 0.0 0
M  V30 21 C 2.3100 8.0021 0.0 0
M  V30 22 C 4.6200 9.3358 0.0 0
M  V30 23 N 3.0800 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 16 17
M  V30 17 1 16 21
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2612275-29-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2762660-29-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31733590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spirocyclic compounds as MNK inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mo, Cheng; Xu, Xiaodong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022038563 A1 2022-02-24

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S,3S,4R)-3-Methoxy-8-[(4-methylphenyl)sulfonyl]-5-(methylsulfonyl)-2-oxa-5-...
C15H19NO6S2
2637392-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 5.5964 5.1470 0.0 0 VAL=6
M  V30 2 O 5.5964 6.6870 0.0 0
M  V30 3 O 5.5964 3.6070 0.0 0
M  V30 4 S 2.8604 1.4239 0.0 0 VAL=6
M  V30 5 C 3.4471 0.0000 0.0 0
M  V30 6 O 1.4365 0.8373 0.0 0
M  V30 7 O 4.2843 2.0106 0.0 0
M  V30 8 O 2.1663 7.1606 0.0 0
M  V30 9 C 1.4211 8.5082 0.0 0
M  V30 10 C 11.7564 5.1470 0.0 0
M  V30 11 C 2.7086 4.4628 0.0 0 CFG=1
M  V30 12 C 4.0564 5.1470 0.0 0
M  V30 13 N 2.2738 2.8478 0.0 0
M  V30 14 C 1.3720 5.8412 0.0 0 CFG=1
M  V30 15 C 2.7851 5.7924 0.0 0
M  V30 16 C 1.0649 3.5499 0.0 0
M  V30 17 O 0.2224 6.1759 0.0 0
M  V30 18 C 1.4696 5.1057 0.0 0 CFG=2
M  V30 19 C 7.1364 5.1470 0.0 0
M  V30 20 C 7.9064 6.4807 0.0 0
M  V30 21 C 7.9064 3.8134 0.0 0
M  V30 22 C 9.4464 6.4807 0.0 0
M  V30 23 C 9.4464 3.8134 0.0 0
M  V30 24 C 10.2164 5.1470 0.0 0
M  V30 25 H 3.9041 3.4921 0.0 0
M  V30 26 H 0.0000 4.6454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 1 19
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 13
M  V30 9 1 8 9
M  V30 10 1 14 8 CFG=3
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 25 CFG=1
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 18 26 CFG=3
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 14 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3S,4R,7R,8S)-3-Methoxy-N-methyl-8-[(4-methylphenyl)sulfonyl]-5-(methylsul...
C16H24N2O6S2
2637392-94-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 7.0985 5.3718 0.0 0 VAL=6
M  V30 2 O 7.0985 3.8318 0.0 0
M  V30 3 O 7.0985 6.9118 0.0 0
M  V30 4 S 4.6984 1.4239 0.0 0 VAL=6
M  V30 5 C 5.2850 0.0000 0.0 0
M  V30 6 O 6.1223 2.0105 0.0 0
M  V30 7 O 3.2745 0.8371 0.0 0
M  V30 8 O 1.5300 3.8281 0.0 0
M  V30 9 C 0.0000 4.0038 0.0 0
M  V30 10 N 4.4554 7.7621 0.0 0
M  V30 11 C 5.7922 8.5264 0.0 0
M  V30 12 C 13.2585 5.3718 0.0 0
M  V30 13 C 4.2308 4.3545 0.0 0 CFG=1
M  V30 14 C 5.5585 5.3718 0.0 0 CFG=1
M  V30 15 N 4.1116 2.8478 0.0 0
M  V30 16 C 2.4471 5.0654 0.0 0 CFG=1
M  V30 17 C 4.4488 6.2221 0.0 0 CFG=2
M  V30 18 C 3.0307 3.7773 0.0 0
M  V30 19 O 1.6999 6.0008 0.0 0
M  V30 20 C 3.1644 5.2553 0.0 0 CFG=2
M  V30 21 C 8.6385 5.3718 0.0 0
M  V30 22 C 9.4085 6.7055 0.0 0
M  V30 23 C 9.4085 4.0382 0.0 0
M  V30 24 C 10.9485 6.7055 0.0 0
M  V30 25 C 10.9485 4.0382 0.0 0
M  V30 26 C 11.7185 5.3718 0.0 0
M  V30 27 H 5.5839 3.6190 0.0 0
M  V30 28 H 3.0303 6.7894 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 1 21
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 15
M  V30 9 1 8 9
M  V30 10 1 16 8 CFG=1
M  V30 11 1 10 11
M  V30 12 1 17 10 CFG=1
M  V30 13 1 12 26
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 27 CFG=1
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 20 28 CFG=3
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 13 14 16 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2637392-91-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2637392-94-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-23640135
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael Acceptor, Masked Aldehyde and Leaving Group in a Single
Intermediate: Unorthodox Approach to Enantiopure Saturated
Aza-Heterocycles from a Multifunctional Glyco-Substrate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manna, Chinmoy; Pathak, Tanmaya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2017), 2(14), 4021-4027

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3R)-2,3-dihydro-3-(3-methyl-2-buten-1-yl)-2-oxo-1H-indole-3-acetate
C16H19NO3
2656377-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.5057 3.8987 0.0 0
M  V30 2 C 4.4109 2.6528 0.0 0
M  V30 3 O 3.7844 1.2459 0.0 0
M  V30 4 O 5.9424 2.8137 0.0 0
M  V30 5 C 4.6896 0.0000 0.0 0
M  V30 6 C 5.4656 4.5356 0.0 0
M  V30 7 C 6.7994 5.3056 0.0 0
M  V30 8 C 8.1331 4.5356 0.0 0
M  V30 9 C 8.1331 2.9956 0.0 0
M  V30 10 C 9.4667 5.3056 0.0 0
M  V30 11 O 6.5772 6.5515 0.0 0
M  V30 12 C 4.1320 5.3056 0.0 0 CFG=1
M  V30 13 C 2.6673 5.7815 0.0 0
M  V30 14 C 5.0372 6.5515 0.0 0
M  V30 15 C 2.6673 7.3215 0.0 0
M  V30 16 C 1.3336 5.0115 0.0 0
M  V30 17 N 4.1320 7.7974 0.0 0
M  V30 18 C 1.3336 8.0915 0.0 0
M  V30 19 C 0.0000 5.7815 0.0 0
M  V30 20 C 0.0000 7.3215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 12 6 CFG=1
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3R)-2,3-Dihydro-N-methyl-3-(3-methyl-2-buten-1-yl)-2-oxo-1H-indole-3-acetamide
C16H20N2O2
2656377-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.5057 3.8987 0.0 0
M  V30 2 C 4.4109 2.6528 0.0 0
M  V30 3 N 3.7844 1.2459 0.0 0
M  V30 4 O 5.9424 2.8137 0.0 0
M  V30 5 C 4.6896 0.0000 0.0 0
M  V30 6 C 5.4656 4.5356 0.0 0
M  V30 7 C 6.7994 5.3056 0.0 0
M  V30 8 C 8.1331 4.5356 0.0 0
M  V30 9 C 8.1331 2.9956 0.0 0
M  V30 10 C 9.4667 5.3056 0.0 0
M  V30 11 O 6.5772 6.5515 0.0 0
M  V30 12 C 4.1320 5.3056 0.0 0 CFG=1
M  V30 13 C 2.6673 5.7815 0.0 0
M  V30 14 C 5.0372 6.5515 0.0 0
M  V30 15 C 2.6673 7.3215 0.0 0
M  V30 16 C 1.3336 5.0115 0.0 0
M  V30 17 N 4.1320 7.7974 0.0 0
M  V30 18 C 1.3336 8.0915 0.0 0
M  V30 19 C 0.0000 5.7815 0.0 0
M  V30 20 C 0.0000 7.3215 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 12 6 CFG=1
M  V30 8 2 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 14
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2656377-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2656377-91-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-24010070
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphine-catalyzed enantioselective [4 + 1] annulation of oxindoles with
allenic ketones for the construction of spirocyclopentene oxindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Xiaodong; Ni, Huanzhen; Lu, Yixin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Chemistry Frontiers (2021), 8(16), 4485-4489

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C81H140N16O20
2678593-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  117 117 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 19.1951 5.7998 0.0 0
M  V30 2 N 20.5288 6.5698 0.0 0
M  V30 3 N 17.8615 6.5698 0.0 0
M  V30 4 C 20.5288 8.1098 0.0 0
M  V30 5 C 17.8615 8.1098 0.0 0
M  V30 6 C 21.8626 8.8798 0.0 0
M  V30 7 C 16.5278 8.8798 0.0 0
M  V30 8 N 21.8626 10.4199 0.0 0
M  V30 9 O 23.1963 8.1098 0.0 0
M  V30 10 N 16.5278 10.4199 0.0 0
M  V30 11 O 15.1940 8.1098 0.0 0
M  V30 12 C 23.1963 11.1899 0.0 0 CFG=1
M  V30 13 C 15.1940 11.1899 0.0 0 CFG=1
M  V30 14 C 23.1963 12.7299 0.0 0
M  V30 15 C 24.5300 10.4199 0.0 0
M  V30 16 C 15.1940 12.7299 0.0 0
M  V30 17 C 13.8603 10.4199 0.0 0
M  V30 18 N 24.5300 13.4999 0.0 0
M  V30 19 O 21.8626 13.4999 0.0 0
M  V30 20 C 25.8636 11.1899 0.0 0
M  V30 21 N 13.8603 13.4999 0.0 0
M  V30 22 O 16.5276 13.4999 0.0 0
M  V30 23 C 12.5266 11.1899 0.0 0
M  V30 24 C 24.5300 15.0400 0.0 0
M  V30 25 C 25.8636 12.7299 0.0 0
M  V30 26 C 27.1975 10.4199 0.0 0
M  V30 27 C 13.8603 15.0400 0.0 0
M  V30 28 C 12.5266 12.7299 0.0 0
M  V30 29 C 11.1930 10.4199 0.0 0
M  V30 30 C 26.0700 15.0400 0.0 0
M  V30 31 C 24.5300 16.5800 0.0 0
M  V30 32 C 22.9899 15.0400 0.0 0
M  V30 33 C 12.3203 15.0400 0.0 0
M  V30 34 C 13.8603 16.5800 0.0 0
M  V30 35 C 15.4003 15.0400 0.0 0
M  V30 36 N 26.8400 16.3738 0.0 0
M  V30 37 O 26.8400 13.7063 0.0 0
M  V30 38 N 11.5503 16.3738 0.0 0
M  V30 39 O 11.5503 13.7063 0.0 0
M  V30 40 C 28.3800 16.3738 0.0 0 CFG=1
M  V30 41 C 10.0102 16.3738 0.0 0 CFG=1
M  V30 42 C 29.1501 17.7075 0.0 0
M  V30 43 C 29.1501 15.0400 0.0 0
M  V30 44 C 9.2402 17.7075 0.0 0
M  V30 45 C 9.2402 15.0400 0.0 0
M  V30 46 N 30.6901 17.7075 0.0 0
M  V30 47 O 28.3800 19.0411 0.0 0
M  V30 48 C 30.6901 15.0400 0.0 0
M  V30 49 C 28.3800 13.7063 0.0 0
M  V30 50 N 7.7002 17.7075 0.0 0
M  V30 51 O 10.0102 19.0411 0.0 0
M  V30 52 C 7.7002 15.0400 0.0 0
M  V30 53 C 10.0102 13.7063 0.0 0
M  V30 54 C 31.4601 19.0411 0.0 0 CFG=1
M  V30 55 C 6.9302 19.0411 0.0 0 CFG=1
M  V30 56 C 33.0001 19.0411 0.0 0
M  V30 57 C 30.6901 20.3748 0.0 0
M  V30 58 C 5.3901 19.0411 0.0 0
M  V30 59 C 7.7002 20.3748 0.0 0
M  V30 60 N 33.7702 20.3748 0.0 0
M  V30 61 O 33.7702 17.7075 0.0 0
M  V30 62 N 4.6201 20.3748 0.0 0
M  V30 63 O 4.6201 17.7075 0.0 0
M  V30 64 C 35.3102 20.3748 0.0 0 CFG=1
M  V30 65 C 3.0801 20.3748 0.0 0 CFG=1
M  V30 66 C 36.0802 21.7086 0.0 0
M  V30 67 C 36.0802 19.0411 0.0 0
M  V30 68 C 2.3101 21.7086 0.0 0
M  V30 69 C 2.3101 19.0411 0.0 0
M  V30 70 N 35.3102 23.0423 0.0 0
M  V30 71 O 37.6202 21.7086 0.0 0
M  V30 72 C 37.6202 19.0411 0.0 0
M  V30 73 N 3.0801 23.0423 0.0 0
M  V30 74 O 0.7700 21.7086 0.0 0
M  V30 75 C 0.7700 19.0411 0.0 0
M  V30 76 C 36.0802 24.3760 0.0 0
M  V30 77 C 38.3903 17.7075 0.0 0
M  V30 78 C 38.3903 20.3748 0.0 0
M  V30 79 C 2.3101 24.3760 0.0 0
M  V30 80 C 0.0000 20.3748 0.0 0
M  V30 81 C 0.0000 17.7075 0.0 0
M  V30 82 C 34.7465 25.1460 0.0 0
M  V30 83 C 36.8502 25.7096 0.0 0
M  V30 84 C 37.4139 23.6059 0.0 0
M  V30 85 C 3.6437 25.1460 0.0 0
M  V30 86 C 1.5400 25.7096 0.0 0
M  V30 87 C 0.9764 23.6059 0.0 0
M  V30 88 N 34.7465 26.6860 0.0 0
M  V30 89 O 33.4127 24.3760 0.0 0
M  V30 90 N 3.6437 26.6860 0.0 0
M  V30 91 O 4.9774 24.3760 0.0 0
M  V30 92 C 33.4127 27.4560 0.0 0 CFG=1
M  V30 93 C 4.9774 27.4560 0.0 0 CFG=1
M  V30 94 C 32.0791 26.6860 0.0 0
M  V30 95 C 33.4127 28.9961 0.0 0
M  V30 96 C 4.9774 28.9961 0.0 0
M  V30 97 C 6.3112 26.6860 0.0 0
M  V30 98 O 30.7454 27.4560 0.0 0
M  V30 99 O 32.0791 25.1460 0.0 0
M  V30 100 C 34.7465 29.7661 0.0 0
M  V30 101 C 32.0791 29.7661 0.0 0
M  V30 102 O 3.6437 29.7661 0.0 0
M  V30 103 O 6.3112 29.7661 0.0 0
M  V30 104 C 6.3112 25.1460 0.0 0
M  V30 105 C 7.6449 27.4560 0.0 0
M  V30 106 C 29.4117 26.6860 0.0 0
M  V30 107 C 3.6437 31.3061 0.0 0
M  V30 108 O 21.8626 4.2597 0.0 0
M  V30 109 O 16.5278 4.2597 0.0 0
M  V30 110 C 18.2052 0.0000 0.0 0
M  V30 111 C 20.1851 0.0000 0.0 0
M  V30 112 C 19.1951 4.2597 0.0 0
M  V30 113 C 20.5288 3.4897 0.0 0
M  V30 114 C 17.8615 3.4897 0.0 0
M  V30 115 C 20.5288 1.9497 0.0 0
M  V30 116 C 17.8615 1.9497 0.0 0
M  V30 117 C 19.1951 1.1797 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 112
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=3
M  V30 16 1 13 16
M  V30 17 1 13 17 CFG=1
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 23
M  V30 24 1 18 24
M  V30 25 1 20 25
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 23 28
M  V30 29 1 23 29
M  V30 30 1 24 30
M  V30 31 1 24 31
M  V30 32 1 24 32
M  V30 33 1 27 33
M  V30 34 1 27 34
M  V30 35 1 27 35
M  V30 36 1 30 36
M  V30 37 2 30 37
M  V30 38 1 33 38
M  V30 39 2 33 39
M  V30 40 1 36 40
M  V30 41 1 38 41
M  V30 42 1 40 42
M  V30 43 1 40 43 CFG=3
M  V30 44 1 41 44
M  V30 45 1 41 45 CFG=1
M  V30 46 1 42 46
M  V30 47 2 42 47
M  V30 48 1 43 48
M  V30 49 1 43 49
M  V30 50 1 44 50
M  V30 51 2 44 51
M  V30 52 1 45 52
M  V30 53 1 45 53
M  V30 54 1 46 54
M  V30 55 1 50 55
M  V30 56 1 54 56
M  V30 57 1 54 57 CFG=1
M  V30 58 1 55 58
M  V30 59 1 55 59 CFG=3
M  V30 60 1 56 60
M  V30 61 2 56 61
M  V30 62 1 58 62
M  V30 63 2 58 63
M  V30 64 1 60 64
M  V30 65 1 62 65
M  V30 66 1 64 66
M  V30 67 1 64 67 CFG=3
M  V30 68 1 65 68
M  V30 69 1 65 69 CFG=1
M  V30 70 1 66 70
M  V30 71 2 66 71
M  V30 72 1 67 72
M  V30 73 1 68 73
M  V30 74 2 68 74
M  V30 75 1 69 75
M  V30 76 1 70 76
M  V30 77 1 72 77
M  V30 78 1 72 78
M  V30 79 1 73 79
M  V30 80 1 75 80
M  V30 81 1 75 81
M  V30 82 1 76 82
M  V30 83 1 76 83
M  V30 84 1 76 84
M  V30 85 1 79 85
M  V30 86 1 79 86
M  V30 87 1 79 87
M  V30 88 1 82 88
M  V30 89 2 82 89
M  V30 90 1 85 90
M  V30 91 2 85 91
M  V30 92 1 88 92
M  V30 93 1 90 93
M  V30 94 1 92 94
M  V30 95 1 92 95 CFG=3
M  V30 96 1 93 96
M  V30 97 1 93 97 CFG=3
M  V30 98 1 94 98
M  V30 99 2 94 99
M  V30 100 1 95 100
M  V30 101 1 95 101
M  V30 102 1 96 102
M  V30 103 2 96 103
M  V30 104 1 97 104
M  V30 105 1 97 105
M  V30 106 1 98 106
M  V30 107 1 102 107
M  V30 108 2 108 113
M  V30 109 2 109 114
M  V30 110 1 110 117
M  V30 111 1 111 117
M  V30 112 1 112 113
M  V30 113 1 112 114
M  V30 114 1 113 115
M  V30 115 1 114 116
M  V30 116 1 115 117
M  V30 117 1 116 117
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 12 13 40 41 54 55 64 65 92 93)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL

C81H142N18O18
2678593-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  117 117 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 19.1947 5.7998 0.0 0
M  V30 2 N 20.5284 6.5698 0.0 0
M  V30 3 N 17.8611 6.5698 0.0 0
M  V30 4 C 20.5284 8.1098 0.0 0
M  V30 5 C 17.8611 8.1098 0.0 0
M  V30 6 C 21.8621 8.8798 0.0 0
M  V30 7 C 16.5274 8.8798 0.0 0
M  V30 8 N 21.8621 10.4198 0.0 0
M  V30 9 O 23.1958 8.1098 0.0 0
M  V30 10 N 16.5274 10.4198 0.0 0
M  V30 11 O 15.1936 8.1098 0.0 0
M  V30 12 C 23.1958 11.1898 0.0 0 CFG=1
M  V30 13 C 15.1936 11.1898 0.0 0 CFG=1
M  V30 14 C 23.1958 12.7298 0.0 0
M  V30 15 C 24.5294 10.4198 0.0 0
M  V30 16 C 15.1936 12.7298 0.0 0
M  V30 17 C 13.8600 10.4198 0.0 0
M  V30 18 N 24.5294 13.4998 0.0 0
M  V30 19 O 21.8621 13.4998 0.0 0
M  V30 20 C 25.8631 11.1898 0.0 0
M  V30 21 N 13.8600 13.4998 0.0 0
M  V30 22 O 16.5274 13.4998 0.0 0
M  V30 23 C 12.5264 11.1898 0.0 0
M  V30 24 C 24.5294 15.0398 0.0 0
M  V30 25 C 25.8631 12.7298 0.0 0
M  V30 26 C 27.1969 10.4198 0.0 0
M  V30 27 C 13.8600 15.0398 0.0 0
M  V30 28 C 12.5264 12.7298 0.0 0
M  V30 29 C 11.1927 10.4198 0.0 0
M  V30 30 C 26.0694 15.0398 0.0 0
M  V30 31 C 22.9894 15.0398 0.0 0
M  V30 32 C 24.5294 16.5798 0.0 0
M  V30 33 C 12.3200 15.0398 0.0 0
M  V30 34 C 13.8600 16.5798 0.0 0
M  V30 35 C 15.4000 15.0398 0.0 0
M  V30 36 N 26.8394 16.3734 0.0 0
M  V30 37 O 26.8394 13.7062 0.0 0
M  V30 38 N 11.5500 16.3734 0.0 0
M  V30 39 O 11.5500 13.7062 0.0 0
M  V30 40 C 28.3794 16.3734 0.0 0 CFG=1
M  V30 41 C 10.0100 16.3734 0.0 0 CFG=1
M  V30 42 C 29.1494 15.0398 0.0 0
M  V30 43 C 29.1494 17.7071 0.0 0
M  V30 44 C 9.2400 15.0398 0.0 0
M  V30 45 C 9.2400 17.7071 0.0 0
M  V30 46 N 30.6894 15.0398 0.0 0
M  V30 47 O 28.3794 13.7062 0.0 0
M  V30 48 C 28.3794 19.0409 0.0 0
M  V30 49 C 30.6894 17.7071 0.0 0
M  V30 50 N 7.7000 15.0398 0.0 0
M  V30 51 O 10.0100 13.7062 0.0 0
M  V30 52 C 10.0100 19.0409 0.0 0
M  V30 53 C 7.7000 17.7071 0.0 0
M  V30 54 C 31.4594 13.7062 0.0 0 CFG=1
M  V30 55 C 6.9300 13.7062 0.0 0 CFG=1
M  V30 56 C 32.9994 13.7062 0.0 0
M  V30 57 C 30.6894 12.3724 0.0 0
M  V30 58 C 5.3900 13.7062 0.0 0
M  V30 59 C 7.7000 12.3724 0.0 0
M  V30 60 N 33.7694 12.3724 0.0 0
M  V30 61 O 33.7694 15.0398 0.0 0
M  V30 62 N 4.6200 12.3724 0.0 0
M  V30 63 O 4.6200 15.0398 0.0 0
M  V30 64 C 35.3094 12.3724 0.0 0 CFG=1
M  V30 65 C 3.0800 12.3724 0.0 0 CFG=1
M  V30 66 C 36.0794 11.0387 0.0 0
M  V30 67 C 36.0794 13.7062 0.0 0
M  V30 68 C 2.3100 11.0387 0.0 0
M  V30 69 C 2.3100 13.7062 0.0 0
M  V30 70 N 35.3094 9.7051 0.0 0
M  V30 71 O 37.6194 11.0387 0.0 0
M  V30 72 C 37.6194 13.7062 0.0 0
M  V30 73 N 3.0800 9.7051 0.0 0
M  V30 74 O 0.7700 11.0387 0.0 0
M  V30 75 C 0.7700 13.7062 0.0 0
M  V30 76 C 36.0794 8.3714 0.0 0
M  V30 77 C 38.3894 15.0398 0.0 0
M  V30 78 C 38.3894 12.3724 0.0 0
M  V30 79 C 2.3100 8.3714 0.0 0
M  V30 80 C 0.0000 12.3724 0.0 0
M  V30 81 C 0.0000 15.0398 0.0 0
M  V30 82 C 34.7458 7.6014 0.0 0
M  V30 83 C 36.8494 7.0376 0.0 0
M  V30 84 C 37.4131 9.1414 0.0 0
M  V30 85 C 3.6436 7.6014 0.0 0
M  V30 86 C 1.5400 7.0376 0.0 0
M  V30 87 C 0.9764 9.1414 0.0 0
M  V30 88 N 34.7458 6.0614 0.0 0
M  V30 89 O 33.4121 8.3714 0.0 0
M  V30 90 N 3.6436 6.0614 0.0 0
M  V30 91 O 4.9773 8.3714 0.0 0
M  V30 92 C 33.4121 5.2914 0.0 0 CFG=1
M  V30 93 C 4.9773 5.2914 0.0 0 CFG=1
M  V30 94 C 33.4121 3.7514 0.0 0
M  V30 95 C 32.0784 6.0614 0.0 0
M  V30 96 C 4.9773 3.7514 0.0 0
M  V30 97 C 6.3111 6.0614 0.0 0
M  V30 98 N 32.0784 2.9814 0.0 0
M  V30 99 O 34.7458 2.9814 0.0 0
M  V30 100 C 32.0784 7.6014 0.0 0
M  V30 101 C 30.7447 5.2914 0.0 0
M  V30 102 N 3.6436 2.9814 0.0 0
M  V30 103 O 6.3111 2.9814 0.0 0
M  V30 104 C 7.6447 5.2914 0.0 0
M  V30 105 C 6.3111 7.6014 0.0 0
M  V30 106 C 32.0784 1.4414 0.0 0
M  V30 107 C 3.6436 1.4414 0.0 0
M  V30 108 O 21.8621 4.2598 0.0 0
M  V30 109 O 16.5274 4.2598 0.0 0
M  V30 110 C 18.2048 0.0000 0.0 0
M  V30 111 C 20.1846 0.0000 0.0 0
M  V30 112 C 19.1947 4.2598 0.0 0
M  V30 113 C 20.5284 3.4898 0.0 0
M  V30 114 C 17.8611 3.4898 0.0 0
M  V30 115 C 20.5284 1.9498 0.0 0
M  V30 116 C 17.8611 1.9498 0.0 0
M  V30 117 C 19.1947 1.1798 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 112
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 12 15 CFG=3
M  V30 16 1 13 16
M  V30 17 1 13 17 CFG=1
M  V30 18 1 14 18
M  V30 19 2 14 19
M  V30 20 1 15 20
M  V30 21 1 16 21
M  V30 22 2 16 22
M  V30 23 1 17 23
M  V30 24 1 18 24
M  V30 25 1 20 25
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 23 28
M  V30 29 1 23 29
M  V30 30 1 24 30
M  V30 31 1 24 31
M  V30 32 1 24 32
M  V30 33 1 27 33
M  V30 34 1 27 34
M  V30 35 1 27 35
M  V30 36 1 30 36
M  V30 37 2 30 37
M  V30 38 1 33 38
M  V30 39 2 33 39
M  V30 40 1 36 40
M  V30 41 1 38 41
M  V30 42 1 40 42
M  V30 43 1 40 43 CFG=1
M  V30 44 1 41 44
M  V30 45 1 41 45 CFG=3
M  V30 46 1 42 46
M  V30 47 2 42 47
M  V30 48 1 43 48
M  V30 49 1 43 49
M  V30 50 1 44 50
M  V30 51 2 44 51
M  V30 52 1 45 52
M  V30 53 1 45 53
M  V30 54 1 46 54
M  V30 55 1 50 55
M  V30 56 1 54 56
M  V30 57 1 54 57 CFG=3
M  V30 58 1 55 58
M  V30 59 1 55 59 CFG=1
M  V30 60 1 56 60
M  V30 61 2 56 61
M  V30 62 1 58 62
M  V30 63 2 58 63
M  V30 64 1 60 64
M  V30 65 1 62 65
M  V30 66 1 64 66
M  V30 67 1 64 67 CFG=1
M  V30 68 1 65 68
M  V30 69 1 65 69 CFG=3
M  V30 70 1 66 70
M  V30 71 2 66 71
M  V30 72 1 67 72
M  V30 73 1 68 73
M  V30 74 2 68 74
M  V30 75 1 69 75
M  V30 76 1 70 76
M  V30 77 1 72 77
M  V30 78 1 72 78
M  V30 79 1 73 79
M  V30 80 1 75 80
M  V30 81 1 75 81
M  V30 82 1 76 82
M  V30 83 1 76 83
M  V30 84 1 76 84
M  V30 85 1 79 85
M  V30 86 1 79 86
M  V30 87 1 79 87
M  V30 88 1 82 88
M  V30 89 2 82 89
M  V30 90 1 85 90
M  V30 91 2 85 91
M  V30 92 1 88 92
M  V30 93 1 90 93
M  V30 94 1 92 94
M  V30 95 1 92 95 CFG=3
M  V30 96 1 93 96
M  V30 97 1 93 97 CFG=1
M  V30 98 1 94 98
M  V30 99 2 94 99
M  V30 100 1 95 100
M  V30 101 1 95 101
M  V30 102 1 96 102
M  V30 103 2 96 103
M  V30 104 1 97 104
M  V30 105 1 97 105
M  V30 106 1 98 106
M  V30 107 1 102 107
M  V30 108 2 108 113
M  V30 109 2 109 114
M  V30 110 1 110 117
M  V30 111 1 111 117
M  V30 112 1 112 113
M  V30 113 1 112 114
M  V30 114 1 113 115
M  V30 115 1 114 116
M  V30 116 1 115 117
M  V30 117 1 116 117
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(10 12 13 40 41 54 55 64 65 92 93)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2678593-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2678593-47-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-24170337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dimedone-Based Rigid Organic Scaffold for Organizing Symmetrical Helical
Peptide Chains.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Madica, Krishnaprasad; Lakshmi, Jerripothula K.; Madhu, Suresh;
Nadimpally, Krishna Chaitanya; Gonnade, Rajesh; Jagadeesh, Bharatam;
Sanjayan, Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2019), 4(39), 11518-11522

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H40FNO6Si
2713997-54-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 13.0903 2.6675 0.0 0
M  V30 2 C 16.0913 7.9567 0.0 0
M  V30 3 O 17.4250 7.1867 0.0 0
M  V30 4 Si 18.7588 7.9567 0.0 0
M  V30 5 C 20.0925 8.7268 0.0 0
M  V30 6 C 19.5289 6.6229 0.0 0
M  V30 7 C 17.9888 9.2904 0.0 0
M  V30 8 C 19.3225 10.0604 0.0 0
M  V30 9 C 21.4262 9.4968 0.0 0
M  V30 10 C 20.8625 7.3929 0.0 0
M  V30 11 O 8.4702 5.3348 0.0 0
M  V30 12 C 7.7002 4.0012 0.0 0
M  V30 13 C 6.1601 4.0012 0.0 0
M  V30 14 N 5.3901 5.3348 0.0 0
M  V30 15 C 5.3901 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 O 6.1601 1.3337 0.0 0
M  V30 18 O 3.8501 2.6675 0.0 0
M  V30 19 O 3.0801 6.6685 0.0 0
M  V30 20 O 3.0801 4.0012 0.0 0
M  V30 21 C 5.3901 0.0000 0.0 0
M  V30 22 C 1.5400 6.6685 0.0 0
M  V30 23 C 1.5400 8.2085 0.0 0
M  V30 24 C 0.0000 6.6685 0.0 0
M  V30 25 C 1.5400 5.1285 0.0 0
M  V30 26 C 13.0903 5.3348 0.0 0
M  V30 27 C 12.3203 6.6685 0.0 0
M  V30 28 C 14.5966 5.6550 0.0 0
M  V30 29 C 12.3203 4.0012 0.0 0
M  V30 30 C 13.3507 7.8131 0.0 0
M  V30 31 C 10.7802 6.6685 0.0 0
M  V30 32 C 14.7577 7.1867 0.0 0
M  V30 33 C 10.7802 4.0012 0.0 0
M  V30 34 C 10.0102 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 1 2 3
M  V30 3 1 2 32
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 1 11 34
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 19 22
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 2 27 31
M  V30 31 1 28 32
M  V30 32 1 29 33
M  V30 33 1 30 32
M  V30 34 1 31 34
M  V30 35 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C25H41FN2O5Si
2713997-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 13.0900 2.6674 0.0 0
M  V30 2 C 16.0910 7.9566 0.0 0
M  V30 3 O 17.4246 7.1866 0.0 0
M  V30 4 Si 18.7584 7.9566 0.0 0
M  V30 5 C 20.0921 8.7266 0.0 0
M  V30 6 C 17.9883 9.2902 0.0 0
M  V30 7 C 19.5283 6.6228 0.0 0
M  V30 8 C 19.3221 10.0602 0.0 0
M  V30 9 C 21.4257 9.4966 0.0 0
M  V30 10 C 20.8621 7.3928 0.0 0
M  V30 11 O 8.4700 5.3347 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 N 5.3900 5.3347 0.0 0
M  V30 15 C 5.3900 2.6674 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 N 6.1600 1.3336 0.0 0
M  V30 18 O 3.8500 2.6674 0.0 0
M  V30 19 O 3.0800 6.6684 0.0 0
M  V30 20 O 3.0800 4.0011 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 C 1.5400 6.6684 0.0 0
M  V30 23 C 1.5400 8.2084 0.0 0
M  V30 24 C 0.0000 6.6684 0.0 0
M  V30 25 C 1.5400 5.1284 0.0 0
M  V30 26 C 13.0900 5.3347 0.0 0
M  V30 27 C 12.3200 6.6684 0.0 0
M  V30 28 C 14.5963 5.6549 0.0 0
M  V30 29 C 12.3200 4.0011 0.0 0
M  V30 30 C 13.3504 7.8129 0.0 0
M  V30 31 C 10.7800 6.6684 0.0 0
M  V30 32 C 14.7574 7.1866 0.0 0
M  V30 33 C 10.7800 4.0011 0.0 0
M  V30 34 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 1 2 3
M  V30 3 1 2 32
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 11 12
M  V30 12 1 11 34
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 19 22
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 26 27
M  V30 27 1 26 28
M  V30 28 2 26 29
M  V30 29 1 27 30
M  V30 30 2 27 31
M  V30 31 1 28 32
M  V30 32 1 29 33
M  V30 33 1 30 32
M  V30 34 1 31 34
M  V30 35 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2713997-54-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2713997-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24583816
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and their use in the treatment of
bacterial infection
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cumming, John G.; Kramer, Christian; Kreis, Lukas; Kuehne, Holger;
Schnider, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021190727 A1 2021-09-30

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-butanone
C12H12O2
2755454-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 O 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 C 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Ethyl-N-methyl-5-benzofuranethanamine
C13H17NO
2855966-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 4.0011 0.0 0
M  V30 2 C 7.0573 2.6673 0.0 0
M  V30 3 C 6.2873 1.3337 0.0 0
M  V30 4 N 8.5973 2.6673 0.0 0
M  V30 5 C 7.0573 0.0000 0.0 0
M  V30 6 C 9.3673 4.0011 0.0 0
M  V30 7 C 1.6672 4.0011 0.0 0
M  V30 8 C 2.4372 5.3348 0.0 0
M  V30 9 C 2.4372 2.6673 0.0 0
M  V30 10 O 0.1609 4.3213 0.0 0
M  V30 11 C 3.9772 5.3348 0.0 0
M  V30 12 C 1.4068 6.4792 0.0 0
M  V30 13 C 3.9772 2.6673 0.0 0
M  V30 14 C 0.0000 5.8528 0.0 0
M  V30 15 C 4.7473 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2755454-40-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855966-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37063912
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM product also isolated as HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Specialized combinations for mental disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Dalziel, Sean
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107715 A1 2023-06-15

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-butanone
C12H12O2
2755454-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 O 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 C 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Ethyl-N-methyl-5-benzofuranethanamine
C13H17NO
2855966-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 4.0011 0.0 0
M  V30 2 C 7.0573 2.6673 0.0 0
M  V30 3 C 6.2873 1.3337 0.0 0
M  V30 4 N 8.5973 2.6673 0.0 0
M  V30 5 C 7.0573 0.0000 0.0 0
M  V30 6 C 9.3673 4.0011 0.0 0
M  V30 7 C 1.6672 4.0011 0.0 0
M  V30 8 C 2.4372 5.3348 0.0 0
M  V30 9 C 2.4372 2.6673 0.0 0
M  V30 10 O 0.1609 4.3213 0.0 0
M  V30 11 C 3.9772 5.3348 0.0 0
M  V30 12 C 1.4068 6.4792 0.0 0
M  V30 13 C 3.9772 2.6673 0.0 0
M  V30 14 C 0.0000 5.8528 0.0 0
M  V30 15 C 4.7473 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2755454-40-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855966-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37132006
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzofuran salt morphic forms and mixtures for the treatment of mental
disorders or mental enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew J.; Lofthus, Sean Jeffrey; De Leon, Xanthe Marie
Renomeron; Singh, Aniruddh; Hudgins, Connor James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023107653 A2 2023-06-15

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Benzofuranyl)-2-butanone
C12H12O2
2755454-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 C 9.0383 3.0800 0.0 0
M  V30 4 O 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 C 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Ethyl-N-methyl-5-benzofuranethanamine
C13H17NO
2855966-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2873 4.0011 0.0 0
M  V30 2 C 7.0573 2.6673 0.0 0
M  V30 3 C 6.2873 1.3337 0.0 0
M  V30 4 N 8.5973 2.6673 0.0 0
M  V30 5 C 7.0573 0.0000 0.0 0
M  V30 6 C 9.3673 4.0011 0.0 0
M  V30 7 C 1.6672 4.0011 0.0 0
M  V30 8 C 2.4372 5.3348 0.0 0
M  V30 9 C 2.4372 2.6673 0.0 0
M  V30 10 O 0.1609 4.3213 0.0 0
M  V30 11 C 3.9772 5.3348 0.0 0
M  V30 12 C 1.4068 6.4792 0.0 0
M  V30 13 C 3.9772 2.6673 0.0 0
M  V30 14 C 0.0000 5.8528 0.0 0
M  V30 15 C 4.7473 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2755454-40-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855966-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31073426
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Advantageous enantiomerically enriched mixtures of benzofurans and
compositions for mental disorders or enhancement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baggott, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021252538 A2 2021-12-16

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[2,3-dihydro-5-[(1E)-1-(methoxyimino)ethyl]-2,2-dimethyl-7-be...
C24H28N2O6
2795115-38-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2000 0.0 0
M  V30 4 C 1.0304 9.9849 0.0 0
M  V30 5 C 6.2537 4.0010 0.0 0
M  V30 6 N 5.4837 2.6673 0.0 0
M  V30 7 C 7.7938 4.0010 0.0 0
M  V30 8 O 6.2537 1.3337 0.0 0
M  V30 9 C 5.4837 0.0000 0.0 0
M  V30 10 C 10.8738 9.3360 0.0 0
M  V30 11 C 10.1038 8.0021 0.0 0
M  V30 12 N 12.4139 9.3360 0.0 0
M  V30 13 O 10.8738 6.6685 0.0 0
M  V30 14 O 8.5638 8.0021 0.0 0
M  V30 15 O 13.1839 10.6696 0.0 0
M  V30 16 C 12.4139 6.6685 0.0 0
M  V30 17 C 14.7239 10.6696 0.0 0
M  V30 18 C 3.9437 8.0021 0.0 0
M  V30 19 C 3.1737 6.6685 0.0 0
M  V30 20 C 5.4837 8.0021 0.0 0
M  V30 21 O 2.9133 9.1467 0.0 0
M  V30 22 C 3.9437 5.3348 0.0 0
M  V30 23 C 1.6674 6.9886 0.0 0
M  V30 24 C 6.2537 6.6685 0.0 0
M  V30 25 C 1.5063 8.5202 0.0 0
M  V30 26 C 5.4837 5.3348 0.0 0
M  V30 27 C 8.5638 10.6696 0.0 0
M  V30 28 C 10.1038 10.6696 0.0 0
M  V30 29 C 7.7938 12.0033 0.0 0
M  V30 30 C 10.8738 12.0033 0.0 0
M  V30 31 C 8.5638 13.3369 0.0 0
M  V30 32 C 10.1038 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 27
M  V30 4 1 3 25
M  V30 5 1 4 25
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[2,3-Dihydro-5-[(1E)-1-(methoxyimino)ethyl]-2,2-dimethyl-7-benzofura...
C24H29N3O5
2795115-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2000 0.0 0
M  V30 4 C 1.0304 9.9849 0.0 0
M  V30 5 C 6.2537 4.0010 0.0 0
M  V30 6 N 5.4837 2.6673 0.0 0
M  V30 7 C 7.7938 4.0010 0.0 0
M  V30 8 O 6.2537 1.3337 0.0 0
M  V30 9 C 5.4837 0.0000 0.0 0
M  V30 10 C 10.8738 9.3360 0.0 0
M  V30 11 C 10.1038 8.0021 0.0 0
M  V30 12 N 12.4139 9.3360 0.0 0
M  V30 13 N 10.8738 6.6685 0.0 0
M  V30 14 O 8.5638 8.0021 0.0 0
M  V30 15 O 13.1839 10.6696 0.0 0
M  V30 16 C 12.4139 6.6685 0.0 0
M  V30 17 C 14.7239 10.6696 0.0 0
M  V30 18 C 3.9437 8.0021 0.0 0
M  V30 19 C 3.1737 6.6685 0.0 0
M  V30 20 C 5.4837 8.0021 0.0 0
M  V30 21 O 2.9133 9.1467 0.0 0
M  V30 22 C 3.9437 5.3348 0.0 0
M  V30 23 C 1.6674 6.9886 0.0 0
M  V30 24 C 6.2537 6.6685 0.0 0
M  V30 25 C 1.5063 8.5202 0.0 0
M  V30 26 C 5.4837 5.3348 0.0 0
M  V30 27 C 8.5638 10.6696 0.0 0
M  V30 28 C 10.1038 10.6696 0.0 0
M  V30 29 C 7.7938 12.0033 0.0 0
M  V30 30 C 10.8738 12.0033 0.0 0
M  V30 31 C 8.5638 13.3369 0.0 0
M  V30 32 C 10.1038 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 27
M  V30 4 1 3 25
M  V30 5 1 4 25
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 15 17
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 18 21
M  V30 22 2 19 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2795115-38-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2795115-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471944
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[[2,3-dihydro-5-[(1E)-1-(methoxyimino)butyl]-2,2-dimethyl-7-be...
C26H32N2O6
2795115-50-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2000 0.0 0
M  V30 4 C 1.0304 9.9849 0.0 0
M  V30 5 C 6.2537 4.0010 0.0 0
M  V30 6 C 5.4837 2.6673 0.0 0
M  V30 7 N 7.7938 4.0010 0.0 0
M  V30 8 C 6.2537 1.3337 0.0 0
M  V30 9 O 8.5638 2.6673 0.0 0
M  V30 10 C 5.4837 0.0000 0.0 0
M  V30 11 C 10.1038 2.6673 0.0 0
M  V30 12 C 10.8738 9.3360 0.0 0
M  V30 13 C 10.1038 8.0021 0.0 0
M  V30 14 N 12.4139 9.3360 0.0 0
M  V30 15 O 10.8738 6.6685 0.0 0
M  V30 16 O 8.5638 8.0021 0.0 0
M  V30 17 O 13.1839 10.6696 0.0 0
M  V30 18 C 12.4139 6.6685 0.0 0
M  V30 19 C 14.7239 10.6696 0.0 0
M  V30 20 C 3.9437 8.0021 0.0 0
M  V30 21 C 3.1737 6.6685 0.0 0
M  V30 22 C 5.4837 8.0021 0.0 0
M  V30 23 O 2.9133 9.1467 0.0 0
M  V30 24 C 3.9437 5.3348 0.0 0
M  V30 25 C 1.6674 6.9886 0.0 0
M  V30 26 C 6.2537 6.6685 0.0 0
M  V30 27 C 1.5063 8.5202 0.0 0
M  V30 28 C 5.4837 5.3348 0.0 0
M  V30 29 C 8.5638 10.6696 0.0 0
M  V30 30 C 10.1038 10.6696 0.0 0
M  V30 31 C 7.7938 12.0033 0.0 0
M  V30 32 C 10.8738 12.0033 0.0 0
M  V30 33 C 8.5638 13.3369 0.0 0
M  V30 34 C 10.1038 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 29
M  V30 4 1 3 27
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 30
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[[2,3-Dihydro-5-[(1E)-1-(methoxyimino)butyl]-2,2-dimethyl-7-benzofura...
C26H33N3O5
2795115-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2537 9.3360 0.0 0
M  V30 2 C 7.7938 9.3360 0.0 0
M  V30 3 C 0.0000 8.2000 0.0 0
M  V30 4 C 1.0304 9.9849 0.0 0
M  V30 5 C 6.2537 4.0010 0.0 0
M  V30 6 C 5.4837 2.6673 0.0 0
M  V30 7 N 7.7938 4.0010 0.0 0
M  V30 8 C 6.2537 1.3337 0.0 0
M  V30 9 O 8.5638 2.6673 0.0 0
M  V30 10 C 5.4837 0.0000 0.0 0
M  V30 11 C 10.1038 2.6673 0.0 0
M  V30 12 C 10.8738 9.3360 0.0 0
M  V30 13 C 10.1038 8.0021 0.0 0
M  V30 14 N 12.4139 9.3360 0.0 0
M  V30 15 N 10.8738 6.6685 0.0 0
M  V30 16 O 8.5638 8.0021 0.0 0
M  V30 17 O 13.1839 10.6696 0.0 0
M  V30 18 C 12.4139 6.6685 0.0 0
M  V30 19 C 14.7239 10.6696 0.0 0
M  V30 20 C 3.9437 8.0021 0.0 0
M  V30 21 C 3.1737 6.6685 0.0 0
M  V30 22 C 5.4837 8.0021 0.0 0
M  V30 23 O 2.9133 9.1467 0.0 0
M  V30 24 C 3.9437 5.3348 0.0 0
M  V30 25 C 1.6674 6.9886 0.0 0
M  V30 26 C 6.2537 6.6685 0.0 0
M  V30 27 C 1.5063 8.5202 0.0 0
M  V30 28 C 5.4837 5.3348 0.0 0
M  V30 29 C 8.5638 10.6696 0.0 0
M  V30 30 C 10.1038 10.6696 0.0 0
M  V30 31 C 7.7938 12.0033 0.0 0
M  V30 32 C 10.8738 12.0033 0.0 0
M  V30 33 C 8.5638 13.3369 0.0 0
M  V30 34 C 10.1038 13.3369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 29
M  V30 4 1 3 27
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 30
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2795115-50-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2795115-51-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dichloro-9-[(3aR,3bR,4aS,5R,5aS)-hexahydro-2,2-dimethyl-3b-[(phenylmethox...
C22H22Cl2N4O3
281191-63-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.3222 5.3435 0.0 0
M  V30 2 O 11.0922 6.6771 0.0 0
M  V30 3 C 12.6323 6.6771 0.0 0
M  V30 4 C 9.6067 0.4284 0.0 0
M  V30 5 C 7.5908 0.0000 0.0 0
M  V30 6 Cl 0.0000 6.8242 0.0 0
M  V30 7 Cl 3.9645 10.3938 0.0 0
M  V30 8 C 8.7822 5.3435 0.0 0 CFG=2
M  V30 9 C 7.3754 5.9698 0.0 0 CFG=1
M  V30 10 C 8.6213 3.8119 0.0 0 CFG=1
M  V30 11 C 8.6213 6.8750 0.0 0
M  V30 12 C 6.3448 4.8254 0.0 0 CFG=1
M  V30 13 C 7.1148 3.4917 0.0 0 CFG=1
M  V30 14 O 9.3913 2.4782 0.0 0
M  V30 15 O 6.9539 1.9602 0.0 0
M  V30 16 C 8.3608 1.3337 0.0 0
M  V30 17 N 4.8132 4.9863 0.0 0
M  V30 18 C 4.0432 6.3201 0.0 0
M  V30 19 C 3.7828 3.8419 0.0 0
M  V30 20 C 2.5369 5.9998 0.0 0
M  V30 21 N 4.5191 7.7847 0.0 0
M  V30 22 N 2.3758 4.4683 0.0 0
M  V30 23 C 1.5063 7.1444 0.0 0
M  V30 24 C 3.4886 8.9293 0.0 0
M  V30 25 N 1.9823 8.6089 0.0 0
M  V30 26 C 13.4023 8.0109 0.0 0
M  V30 27 C 12.6323 9.3446 0.0 0
M  V30 28 C 14.9423 8.0109 0.0 0
M  V30 29 C 13.4023 10.6783 0.0 0
M  V30 30 C 15.7123 9.3446 0.0 0
M  V30 31 C 14.9423 10.6783 0.0 0
M  V30 32 H 6.3448 7.1143 0.0 0
M  V30 33 H 10.1276 4.1321 0.0 0
M  V30 34 H 5.6085 3.1715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 26
M  V30 5 1 4 16
M  V30 6 1 5 16
M  V30 7 1 6 23
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 32 CFG=3
M  V30 15 1 10 13
M  V30 16 1 10 14
M  V30 17 1 10 33 CFG=3
M  V30 18 1 12 13
M  V30 19 1 12 17 CFG=3
M  V30 20 1 13 15
M  V30 21 1 13 34 CFG=3
M  V30 22 1 14 16
M  V30 23 1 15 16
M  V30 24 1 17 18
M  V30 25 1 17 19
M  V30 26 1 18 20
M  V30 27 2 18 21
M  V30 28 2 19 22
M  V30 29 1 20 22
M  V30 30 2 20 23
M  V30 31 1 21 24
M  V30 32 1 23 25
M  V30 33 2 24 25
M  V30 34 2 26 27
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 2 28 30
M  V30 38 2 29 31
M  V30 39 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 10 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Chloro-9-[(3aR,3bR,4aS,5R,5aS)-hexahydro-2,2-dimethyl-3b-[(phenylmethoxy)me...
C23H26ClN5O3
436847-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3434 0.0 0
M  V30 2 O 4.6201 6.6771 0.0 0
M  V30 3 C 3.0800 6.6771 0.0 0
M  V30 4 C 6.1057 0.4284 0.0 0
M  V30 5 C 8.1216 0.0000 0.0 0
M  V30 6 N 15.7122 6.8242 0.0 0
M  V30 7 C 16.7428 7.9685 0.0 0
M  V30 8 Cl 11.7478 10.3938 0.0 0
M  V30 9 C 6.9301 5.3434 0.0 0 CFG=2
M  V30 10 C 8.3371 5.9697 0.0 0 CFG=1
M  V30 11 C 7.0912 3.8119 0.0 0 CFG=1
M  V30 12 C 7.0912 6.8750 0.0 0
M  V30 13 C 9.3675 4.8254 0.0 0 CFG=1
M  V30 14 C 8.5975 3.4917 0.0 0 CFG=1
M  V30 15 O 6.3212 2.4782 0.0 0
M  V30 16 O 8.7584 1.9601 0.0 0
M  V30 17 C 7.3516 1.3337 0.0 0
M  V30 18 N 10.8991 4.9863 0.0 0
M  V30 19 C 11.6691 6.3201 0.0 0
M  V30 20 C 11.9296 3.8419 0.0 0
M  V30 21 C 13.1755 5.9998 0.0 0
M  V30 22 N 11.1932 7.7847 0.0 0
M  V30 23 N 13.3364 4.4682 0.0 0
M  V30 24 C 14.2059 7.1443 0.0 0
M  V30 25 C 12.2236 8.9292 0.0 0
M  V30 26 N 13.7301 8.6089 0.0 0
M  V30 27 C 2.3100 8.0109 0.0 0
M  V30 28 C 0.7700 8.0109 0.0 0
M  V30 29 C 3.0800 9.3446 0.0 0
M  V30 30 C 0.0000 9.3446 0.0 0
M  V30 31 C 2.3100 10.6782 0.0 0
M  V30 32 C 0.7700 10.6782 0.0 0
M  V30 33 H 9.3675 7.1143 0.0 0
M  V30 34 H 5.5847 4.1320 0.0 0
M  V30 35 H 10.1038 3.1715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 9 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 27
M  V30 5 1 4 17
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 33 CFG=1
M  V30 16 1 11 14
M  V30 17 1 11 15
M  V30 18 1 11 34 CFG=1
M  V30 19 1 13 14
M  V30 20 1 13 18 CFG=1
M  V30 21 1 14 16
M  V30 22 1 14 35 CFG=1
M  V30 23 1 15 17
M  V30 24 1 16 17
M  V30 25 1 18 19
M  V30 26 1 18 20
M  V30 27 1 19 21
M  V30 28 2 19 22
M  V30 29 2 20 23
M  V30 30 1 21 23
M  V30 31 2 21 24
M  V30 32 1 22 25
M  V30 33 1 24 26
M  V30 34 2 25 26
M  V30 35 2 27 28
M  V30 36 1 27 29
M  V30 37 1 28 30
M  V30 38 2 29 31
M  V30 39 2 30 32
M  V30 40 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 9 10 11 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 281191-63-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 436847-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2071990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Phosphorylation Procedure: Synthesis
of (N)-Methanocarbaadenosine Derivatives (23-26). (1'S,2'
R,3'S,4'R,5'S)-4-(6-Amino-9H-purin-9-yl)-1-[(phenylmethoxy)
methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene) (23). To a solution of
21 (0.2 g, 0.47 mmol) in i-PrOH (3 mL) was added NH3 (2 M solution in
i-PrOH, 5 mL, 10 mmol), and the reaction mixture was heated at 90 °C in a
closed tube for 15 h for complete reaction. The resulting mixture was
concentrated under reduced pressure, and the residue obtained was
purified by flash chromatography using 9/1 CHCl3/MeOH. (1'S,2'
R,3'S,4'R,5'S)-4-(6-Methylamino-2-chloro-9H-purin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene)
(26). 1H NMR (CDCl3) δ 8.15 (s, 1H), 7.40-7.28 (m, 5H), 6.29 (bs, 1H),
5.32 (d, 1H, J = 7.1 Hz), 5.05 (s, 1H), 4.61 (qAB, 2H, J = 12.4, 17.6
Hz), 3.90 (d, 1H, J = 10.2 Hz), 3.42 (d, 1H, J = 10.2 Hz), 3.17 (bs, 3H),
1.60-1.56 (m, 1H), 1.54 (s, 3H), 1.30-1.26 (m, 1H), 1.24 (s, 3H),
0.96-0.92 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Adenine Nucleotide Analogues Locked in a Northern Methanocarba
Conformation: Enhanced Stability and Potency as P2Y1 Receptor Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ravi, R. Gnana; Kim, Hak Sung; Servos, Joerg; Zimmermann, Herbert; Lee,
Kyeong; Maddileti, Savitri; Boyer, Jose L.; Harden, T. Kendall; Jacobson,
Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(10), 2090-2100

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S)-2,3-Dihydro-3-[[(methylsulfonyl)oxy]methyl]-2-oxo-1H-indole-3-acetaldehyde
C12H13NO5S
2826262-01-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6892 3.6896 0.0 0
M  V30 2 O 2.2823 3.0631 0.0 0
M  V30 3 S 2.1212 1.5316 0.0 0 VAL=6
M  V30 4 C 0.5897 1.6925 0.0 0
M  V30 5 O 1.9603 0.0000 0.0 0
M  V30 6 O 3.6528 1.3706 0.0 0
M  V30 7 C 2.3101 5.2212 0.0 0
M  V30 8 C 1.5400 6.5548 0.0 0
M  V30 9 O 0.0000 6.5548 0.0 0
M  V30 10 O 2.3555 7.5228 0.0 0
M  V30 11 C 3.8501 5.2212 0.0 0 CFG=1
M  V30 12 C 5.3565 4.9010 0.0 0
M  V30 13 C 3.6892 6.7527 0.0 0
M  V30 14 C 6.1266 6.2347 0.0 0
M  V30 15 C 6.1266 3.5673 0.0 0
M  V30 16 N 5.0960 7.3791 0.0 0
M  V30 17 C 7.6666 6.2347 0.0 0
M  V30 18 C 7.6666 3.5673 0.0 0
M  V30 19 C 8.4366 4.9010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 11 7 CFG=3
M  V30 9 2 8 9
M  V30 10 2 10 13
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3S)-1′-Methylspiro[3H-indole-3,3′-pyrrolidin]-2(1H)-one
C12H14N2O
1662684-45-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.0810 0.0000 0.0 0
M  V30 2 C 8.3942 3.4761 0.0 0
M  V30 3 C 4.5863 2.3015 0.0 0 CFG=1
M  V30 4 C 3.0800 2.6217 0.0 0
M  V30 5 C 4.7474 0.7700 0.0 0
M  V30 6 C 6.0927 1.9814 0.0 0
M  V30 7 C 4.4253 3.8332 0.0 0
M  V30 8 C 2.3100 1.2881 0.0 0
M  V30 9 C 2.3100 3.9555 0.0 0
M  V30 10 N 3.3404 0.1437 0.0 0
M  V30 11 N 6.8627 3.3150 0.0 0
M  V30 12 C 5.8323 4.4595 0.0 0
M  V30 13 C 0.7700 1.2881 0.0 0
M  V30 14 C 0.7700 3.9555 0.0 0
M  V30 15 C 0.0000 2.6217 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5 CFG=3
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 10
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2826262-01-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1662684-45-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33898021
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 546-68-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An approach for preparing 3,3-disubstituted oxindole from acyclic
tetrasubstituted aldehyde: Total synthesis of (-)-coerulescine &
(-)-coixspirolactam A
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shahnawaz Ali, M.; Rahaman, Mizzanoor; Belayet, Jawad Bin; Asad, Sharif
A.; Hossain, M. Mahmun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Results in Chemistry (2022), 4100389

$RFMT $RIREG SCHEME107 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(3-fluorophenyl)-4-oxo-1-piperidinecarboxylate
C16H20FNO3
2842297-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6436 5.3347 0.0 0
M  V30 2 O 2.1036 5.3347 0.0 0
M  V30 3 O 4.4136 6.6685 0.0 0
M  V30 4 C 1.3336 6.6685 0.0 0
M  V30 5 C 2.6673 7.4385 0.0 0
M  V30 6 C 0.5636 8.0021 0.0 0
M  V30 7 C 0.0000 5.8985 0.0 0
M  V30 8 O 6.7236 0.0000 0.0 0
M  V30 9 F 10.5736 6.6685 0.0 0
M  V30 10 C 5.9536 4.0011 0.0 0 CFG=2
M  V30 11 N 4.4136 4.0011 0.0 0
M  V30 12 C 6.7236 2.6674 0.0 0
M  V30 13 C 3.6436 2.6674 0.0 0
M  V30 14 C 5.9536 1.3336 0.0 0
M  V30 15 C 4.4136 1.3336 0.0 0
M  V30 16 C 6.7236 5.3347 0.0 0
M  V30 17 C 8.2636 5.3347 0.0 0
M  V30 18 C 5.9536 6.6685 0.0 0
M  V30 19 C 9.0336 6.6685 0.0 0
M  V30 20 C 6.7236 8.0021 0.0 0
M  V30 21 C 8.2636 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16 CFG=3
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(3-fluorophenyl)-4-(methylamino)-1-piperidinecarboxy...
C17H25FN2O2
2842297-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 6.6685 0.0 0
M  V30 2 O 3.0800 8.0021 0.0 0
M  V30 3 O 3.0800 5.3347 0.0 0
M  V30 4 C 1.5400 8.0021 0.0 0
M  V30 5 C 1.5400 9.5421 0.0 0
M  V30 6 C 0.0000 8.0021 0.0 0
M  V30 7 C 1.5400 6.4621 0.0 0
M  V30 8 N 10.0100 6.6685 0.0 0
M  V30 9 C 10.7800 8.0021 0.0 0
M  V30 10 F 6.1600 0.0000 0.0 0
M  V30 11 C 6.1600 5.3347 0.0 0 CFG=2
M  V30 12 N 5.3900 6.6685 0.0 0
M  V30 13 C 7.7000 5.3347 0.0 0
M  V30 14 C 6.1600 8.0021 0.0 0
M  V30 15 C 8.4700 6.6685 0.0 0 CFG=3
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 5.3900 4.0011 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 3.8500 4.0011 0.0 0
M  V30 20 C 5.3900 1.3336 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 3.8500 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 15
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17 CFG=1
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2842297-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2842297-44-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34674140
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Ubiquitin specific protease 19 inhibitors treating muscular
atrophy, obesity, insulin resistance or type 2 diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rountree, James Samuel Shane; Whitehead, Steven Kristopher; Shepherd,
Steven David; Helm, Matthew Duncan; Burkamp, Frank; O'Dowd, Colin;
Harrison, Timothy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022200523 A1 2022-09-29

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Methyl 3-(phenylmethyl) (4aR)-1,2,4a,5-tetrahydropyrazino[1,2-d]pyrido[2,3-...
C20H21N3O5
2855981-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 O 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 16.1700 5.3347 0.0 0
M  V30 6 O 16.9400 4.0011 0.0 0
M  V30 7 O 16.9400 6.6684 0.0 0
M  V30 8 C 18.4800 4.0011 0.0 0
M  V30 9 N 10.0100 5.3347 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 9.2400 6.6685 0.0 0 CFG=1
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 12.3200 6.6685 0.0 0
M  V30 14 C 12.3200 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 10.0100 8.0021 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 N 13.8600 6.6685 0.0 0
M  V30 19 O 11.5500 8.0021 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0
M  V30 21 N 6.9300 5.3347 0.0 0
M  V30 22 C 14.6300 5.3347 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6674 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 29 H 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 29 CFG=1
M  V30 18 1 12 17
M  V30 19 2 13 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 1 15 21
M  V30 23 1 16 19
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 2 20 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (4aR)-1,2,4a,5-tetrahydro-8-[(methylamino)carbonyl]pyrazino[1,2-...
C20H22N4O4
2855981-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 O 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 16.1700 5.3347 0.0 0
M  V30 6 N 16.9400 4.0011 0.0 0
M  V30 7 O 16.9400 6.6685 0.0 0
M  V30 8 C 18.4800 4.0011 0.0 0
M  V30 9 N 10.0100 5.3347 0.0 0
M  V30 10 C 11.5500 5.3347 0.0 0
M  V30 11 C 9.2400 6.6685 0.0 0 CFG=1
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 12.3200 6.6685 0.0 0
M  V30 14 C 12.3200 4.0011 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 10.0100 8.0021 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 N 13.8600 6.6685 0.0 0
M  V30 19 O 11.5500 8.0021 0.0 0
M  V30 20 C 13.8600 4.0011 0.0 0
M  V30 21 N 6.9300 5.3347 0.0 0
M  V30 22 C 14.6300 5.3347 0.0 0
M  V30 23 C 2.3100 2.6674 0.0 0
M  V30 24 C 3.0800 1.3336 0.0 0
M  V30 25 C 0.7700 2.6674 0.0 0
M  V30 26 C 2.3100 0.0000 0.0 0
M  V30 27 C 0.0000 1.3336 0.0 0
M  V30 28 C 0.7700 0.0000 0.0 0
M  V30 29 H 8.4700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 29 CFG=1
M  V30 18 1 12 17
M  V30 19 2 13 18
M  V30 20 1 13 19
M  V30 21 1 14 20
M  V30 22 1 15 21
M  V30 23 1 16 19
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 2 20 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2855981-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2855981-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35013829
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine derivatives as PARP1 inhibitors useful in
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Trzoss, Lynnie; Dong, Qing; Kaldor, Stephen W.; Hoffman, Robert L.; Va,
Porino Jinjo; Pinchman, Joseph Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022225934 A1 2022-10-27

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-1-propanol, γ-phenyl-, 1-(4-methylbenzenesulfonate), (γR)-
C24H23NO3S
2873550-44-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0801 5.7534 0.0 0 CFG=2
M  V30 2 C 4.6201 5.7534 0.0 0
M  V30 3 C 5.3901 7.0871 0.0 0
M  V30 4 O 6.9301 7.0871 0.0 0
M  V30 5 S 7.7001 8.4207 0.0 0 VAL=6
M  V30 6 O 8.4702 9.7545 0.0 0
M  V30 7 O 6.3665 9.1907 0.0 0
M  V30 8 C 13.0351 5.3407 0.0 0
M  V30 9 N 2.3100 4.4197 0.0 0
M  V30 10 C 2.9365 3.0128 0.0 0
M  V30 11 C 0.7785 4.2586 0.0 0
M  V30 12 C 1.7920 1.9823 0.0 0
M  V30 13 C 4.4011 2.5369 0.0 0
M  V30 14 C 0.4583 2.7523 0.0 0
M  V30 15 C 2.1123 0.4759 0.0 0
M  V30 16 C 4.7214 1.0306 0.0 0
M  V30 17 C 3.5769 0.0000 0.0 0
M  V30 18 C 2.3100 7.0871 0.0 0
M  V30 19 C 0.7700 7.0871 0.0 0
M  V30 20 C 3.0801 8.4207 0.0 0
M  V30 21 C 0.0000 8.4207 0.0 0
M  V30 22 C 2.3100 9.7545 0.0 0
M  V30 23 C 0.7700 9.7545 0.0 0
M  V30 24 C 9.0340 7.6507 0.0 0
M  V30 25 C 10.3676 8.4207 0.0 0
M  V30 26 C 9.0340 6.1107 0.0 0
M  V30 27 C 11.7013 7.6507 0.0 0
M  V30 28 C 10.3676 5.3407 0.0 0
M  V30 29 C 11.7013 6.1107 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9 CFG=1
M  V30 3 1 1 18
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 24
M  V30 10 1 8 29
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 2 11 14
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-N-Methyl-γ-phenyl-1H-indole-1-propanamine
C18H20N2
915953-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 5.3348 0.0 0 CFG=2
M  V30 2 C 4.4608 4.0011 0.0 0
M  V30 3 C 5.2309 2.6673 0.0 0
M  V30 4 N 4.4608 1.3337 0.0 0
M  V30 5 C 5.2309 0.0000 0.0 0
M  V30 6 N 4.4608 6.6685 0.0 0
M  V30 7 C 2.9293 6.8296 0.0 0
M  V30 8 C 5.0873 8.0754 0.0 0
M  V30 9 C 2.6091 8.3359 0.0 0
M  V30 10 C 1.7849 5.7990 0.0 0
M  V30 11 C 3.9428 9.1059 0.0 0
M  V30 12 C 1.1444 8.8117 0.0 0
M  V30 13 C 0.3202 6.2748 0.0 0
M  V30 14 C 0.0000 7.7813 0.0 0
M  V30 15 C 6.7709 5.3348 0.0 0
M  V30 16 C 7.5409 4.0011 0.0 0
M  V30 17 C 7.5409 6.6685 0.0 0
M  V30 18 C 9.0809 4.0011 0.0 0
M  V30 19 C 9.0809 6.6685 0.0 0
M  V30 20 C 9.8509 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 6
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2873550-44-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915953-87-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34979800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed vessel, %ee = 94
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium-Catalyzed Asymmetric 1,4-Addition of α/β-(N-Indolyl) Acrylates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Shuting; Liu, Jian-Guo; Xu, Ming-Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(51), 9349-9354

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
2-[(1E)-2-(2-Bromophenyl)ethenyl]benzoic acid
C15H11BrO2
2874204-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3336 0.0 0
M  V30 4 O 4.6200 1.3336 0.0 0
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 Br 6.9300 8.0021 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1E)-2-(2-Bromophenyl)ethenyl]-N-methylbenzamide
C16H14BrNO
2242639-54-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 7.7001 4.0011 0.0 0
M  V30 4 N 9.2401 4.0011 0.0 0
M  V30 5 O 6.9301 5.3348 0.0 0
M  V30 6 C 10.0101 5.3348 0.0 0
M  V30 7 Br 0.0000 4.0011 0.0 0
M  V30 8 C 5.3901 2.6675 0.0 0
M  V30 9 C 6.9301 2.6675 0.0 0
M  V30 10 C 4.6201 1.3337 0.0 0
M  V30 11 C 7.7001 1.3337 0.0 0
M  V30 12 C 5.3901 0.0000 0.0 0
M  V30 13 C 6.9301 0.0000 0.0 0
M  V30 14 C 2.3100 5.3348 0.0 0
M  V30 15 C 0.7700 5.3348 0.0 0
M  V30 16 C 3.0800 6.6686 0.0 0
M  V30 17 C 0.0000 6.6686 0.0 0
M  V30 18 C 2.3100 8.0022 0.0 0
M  V30 19 C 0.7700 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2874204-17-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2242639-54-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35010597
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM 1.07 mmol scale used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metal- and Oxidant-Free Electrosynthesis of Heterocycles from
1,2-Diarylalkene Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yu, Eunsoo; Kim, Hyungguk; Park, Cheol-Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2022), 364(23), 4088-4096

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[[[[(3S)-Hexahydro-2-oxo-1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-azepin-3-yl]...
C29H32N6O6
288079-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 7.9110 0.0 0
M  V30 2 C 6.9301 9.2446 0.0 0
M  V30 3 N 8.4702 9.2446 0.0 0
M  V30 4 N 6.1601 10.5783 0.0 0
M  V30 5 C 4.6201 10.5783 0.0 0
M  V30 6 O 3.8501 9.2446 0.0 0
M  V30 7 C 7.7001 0.0000 0.0 0
M  V30 8 O 11.3385 9.0297 0.0 0
M  V30 9 C 13.2949 11.1383 0.0 0
M  V30 10 C 14.4239 12.1858 0.0 0
M  V30 11 O 14.0813 13.6872 0.0 0
M  V30 12 C 1.5400 15.9131 0.0 0
M  V30 13 O 0.0000 15.9131 0.0 0
M  V30 14 O 2.3100 17.2468 0.0 0
M  V30 15 C 6.9301 3.9098 0.0 0
M  V30 16 C 8.4702 3.9098 0.0 0
M  V30 17 C 6.1601 5.2435 0.0 0
M  V30 18 C 6.4543 2.4451 0.0 0
M  V30 19 C 9.2402 5.2435 0.0 0
M  V30 20 O 8.9460 2.4451 0.0 0
M  V30 21 C 6.9301 6.5772 0.0 0
M  V30 22 C 7.7001 1.5400 0.0 0
M  V30 23 C 8.4702 6.5772 0.0 0
M  V30 24 C 9.2402 10.5783 0.0 0 CFG=1
M  V30 25 C 10.7759 10.4633 0.0 0
M  V30 26 C 8.3727 11.8508 0.0 0
M  V30 27 N 11.8234 11.5921 0.0 0
M  V30 28 C 8.8265 13.3223 0.0 0
M  V30 29 C 11.5938 13.1150 0.0 0
M  V30 30 C 10.2601 13.8851 0.0 0
M  V30 31 C 3.8501 11.9120 0.0 0
M  V30 32 C 2.3100 11.9120 0.0 0
M  V30 33 C 4.6201 13.2458 0.0 0
M  V30 34 C 1.5400 13.2458 0.0 0
M  V30 35 N 3.8501 14.5795 0.0 0
M  V30 36 C 2.3100 14.5795 0.0 0
M  V30 37 N 15.8956 11.7318 0.0 0
M  V30 38 C 17.1278 12.6555 0.0 0
M  V30 39 C 16.3933 10.2745 0.0 0
M  V30 40 C 18.3870 11.7691 0.0 0
M  V30 41 C 17.9332 10.2974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 24 3 CFG=1
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 1 5 31
M  V30 9 1 7 22
M  V30 10 2 8 25
M  V30 11 1 9 10
M  V30 12 1 9 27
M  V30 13 2 10 11
M  V30 14 1 10 37
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 36
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 1 15 18
M  V30 21 2 16 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 2 21 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 36
M  V30 41 1 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N5-[[[(3S)-Hexahydro-2-oxo-1-[2-oxo-2-(1-pyrrolidinyl)ethyl]-1H-azepin-3-yl]i...
C30H35N7O5
288083-04-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.0024 6.0811 0.0 0
M  V30 2 C 9.0024 7.6211 0.0 0
M  V30 3 N 7.6687 8.3912 0.0 0
M  V30 4 N 10.3361 8.3912 0.0 0
M  V30 5 C 11.6699 7.6211 0.0 0
M  V30 6 O 11.6699 6.0811 0.0 0
M  V30 7 C 3.7132 0.0000 0.0 0
M  V30 8 O 5.0772 9.6392 0.0 0
M  V30 9 C 4.4371 12.4434 0.0 0
M  V30 10 C 3.9831 13.9151 0.0 0
M  V30 11 O 5.0307 15.0439 0.0 0
M  V30 12 C 17.0047 10.7012 0.0 0
M  V30 13 N 18.3383 9.9312 0.0 0
M  V30 14 O 17.0047 12.2412 0.0 0
M  V30 15 C 19.6720 10.7012 0.0 0
M  V30 16 C 6.3351 3.0011 0.0 0
M  V30 17 C 5.0012 3.7711 0.0 0
M  V30 18 C 7.6687 3.7711 0.0 0
M  V30 19 C 6.0149 1.4946 0.0 0
M  V30 20 C 5.0012 5.3111 0.0 0
M  V30 21 O 3.8568 2.7405 0.0 0
M  V30 22 C 7.6687 5.3111 0.0 0
M  V30 23 C 4.4832 1.3337 0.0 0
M  V30 24 C 6.3351 6.0811 0.0 0
M  V30 25 C 7.6687 9.9312 0.0 0 CFG=1
M  V30 26 C 6.2812 10.5994 0.0 0
M  V30 27 C 9.0563 10.5994 0.0 0
M  V30 28 N 5.9385 12.1008 0.0 0
M  V30 29 C 9.3989 12.1008 0.0 0
M  V30 30 C 6.8987 13.3048 0.0 0
M  V30 31 C 8.4387 13.3048 0.0 0
M  V30 32 C 13.0035 8.3912 0.0 0
M  V30 33 C 13.0035 9.9312 0.0 0
M  V30 34 C 14.3372 7.6211 0.0 0
M  V30 35 C 14.3372 10.7012 0.0 0
M  V30 36 N 15.6709 8.3912 0.0 0
M  V30 37 C 15.6709 9.9312 0.0 0
M  V30 38 N 2.4818 14.2577 0.0 0
M  V30 39 C 1.3220 13.2445 0.0 0
M  V30 40 C 1.8765 15.6738 0.0 0
M  V30 41 C 0.0000 14.0344 0.0 0
M  V30 42 C 0.3427 15.5358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 25 3 CFG=3
M  V30 6 1 4 5
M  V30 7 2 5 6
M  V30 8 1 5 32
M  V30 9 1 7 23
M  V30 10 2 8 26
M  V30 11 1 9 10
M  V30 12 1 9 28
M  V30 13 2 10 11
M  V30 14 1 10 38
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 1 12 37
M  V30 18 1 13 15
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 1 16 19
M  V30 22 2 17 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 2 19 23
M  V30 26 1 20 24
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 288079-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 288083-04-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10457155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):NOTES
$DATUM 83-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shi, Yan; Li, Chi; O'Connor, Stephen P.; Zhang, Jing; Shi, Mengxiao;
Bisaha, Sharon N.; Wang, Ying; Sitkoff, Doree; Pudzianowski, Andrew T.;
Huang, Christine; Klei, Herbert E.; Kish, Kevin; Yanchunas, Joseph; Liu,
Eddie C.-K.; Hartl, Karen S.; Seiler, Steve M.; Steinbacher, Thomas E.;
Schumacher, William A.; Atwal, Karnail S.; Stein, Philip D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(24), 6882-6889

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1R)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxoethyl]benzoate
C15H19NO5
2891467-98-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0 CFG=2
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 C 6.6685 6.1601 0.0 0
M  V30 4 C 4.0010 4.6201 0.0 0
M  V30 5 O 8.0022 6.9302 0.0 0
M  V30 6 O 2.6673 3.8501 0.0 0
M  V30 7 O 4.0010 6.1601 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 2.1037 5.9538 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 0.5637 3.2864 0.0 0
M  V30 12 C 12.0033 1.5400 0.0 0
M  V30 13 O 13.3370 2.3101 0.0 0
M  V30 14 O 12.0033 0.0000 0.0 0
M  V30 15 C 14.6707 1.5400 0.0 0
M  V30 16 C 8.0022 3.8501 0.0 0
M  V30 17 C 9.3358 4.6201 0.0 0
M  V30 18 C 8.0022 2.3101 0.0 0
M  V30 19 C 10.6697 3.8501 0.0 0
M  V30 20 C 9.3358 1.5400 0.0 0
M  V30 21 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1R)-1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-(methylamino)ethyl]b...
C16H24N2O4
2891467-99-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=2
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0
M  V30 5 N 6.1600 1.3338 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 O 3.0800 4.0011 0.0 0
M  V30 8 C 5.3900 0.0000 0.0 0
M  V30 9 C 1.5400 6.6685 0.0 0
M  V30 10 C 1.5400 8.2085 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 1.5400 5.1285 0.0 0
M  V30 13 C 12.3200 4.0011 0.0 0
M  V30 14 O 13.0900 5.3347 0.0 0
M  V30 15 O 13.0900 2.6674 0.0 0
M  V30 16 C 14.6300 5.3347 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 C 8.4700 2.6674 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 10.0100 2.6674 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2891467-98-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2891467-99-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35525527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of complement inhibitors and therapeutic uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meissner, Johannes Wilhelm Georg; Cook, Andrew Simon; Orme, Mark William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023278698 A1 2023-01-05

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichlorobenzoyl chloride
C7H3Cl3O
2905-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 Cl 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 Cl 0.0000 4.6200 0.0 0
M  V30 5 Cl 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichloro-N-methylbenzamide
C8H7Cl2NO
33244-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 Cl 0.0000 4.6200 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33244-92-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichlorobenzoyl chloride
C7H3Cl3O
2905-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 Cl 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 Cl 0.0000 4.6200 0.0 0
M  V30 5 Cl 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 C 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dichloro-N-methylbenzamide
C8H7Cl2NO
33244-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 N 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 Cl 0.0000 4.6200 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2905-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33244-92-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7354637
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 3,5-dichloro-N-methylbenzamide 1n. White solid.
Yield: (60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furo[2,3-d]pyrimidine, 4-chloro-5-(3-nitrophenyl)-6-phenyl-
C18H10ClN3O3
2913196-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.5991 3.0800 0.0 0
M  V30 2 N 9.6852 6.2348 0.0 0 VAL=5
M  V30 3 O 10.1611 4.7703 0.0 0
M  V30 4 O 10.7156 7.3794 0.0 0
M  V30 5 C 4.6115 4.5864 0.0 0
M  V30 6 C 3.0800 4.7474 0.0 0
M  V30 7 C 4.9317 3.0800 0.0 0
M  V30 8 O 2.4537 3.3406 0.0 0
M  V30 9 C 3.5981 2.3100 0.0 0
M  V30 10 C 6.2655 2.3100 0.0 0
M  V30 11 N 3.5981 0.7700 0.0 0
M  V30 12 N 6.2655 0.7700 0.0 0
M  V30 13 C 4.9317 0.0000 0.0 0
M  V30 14 C 5.6419 5.7308 0.0 0
M  V30 15 C 7.1484 5.4106 0.0 0
M  V30 16 C 5.1661 7.1955 0.0 0
M  V30 17 C 8.1788 6.5550 0.0 0
M  V30 18 C 6.1967 8.3399 0.0 0
M  V30 19 C 7.7029 8.0197 0.0 0
M  V30 20 C 2.3100 6.0810 0.0 0
M  V30 21 C 3.0800 7.4148 0.0 0
M  V30 22 C 0.7700 6.0810 0.0 0
M  V30 23 C 2.3100 8.7484 0.0 0
M  V30 24 C 0.0000 7.4148 0.0 0
M  V30 25 C 0.7700 8.7484 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 1 6 20
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 9
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Furo[2,3-d]pyrimidin-4-amine, N-methyl-5-(3-nitrophenyl)-6-phenyl-
C19H14N4O3
2913196-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.5991 3.0800 0.0 0
M  V30 2 C 8.9328 2.3100 0.0 0
M  V30 3 N 9.6852 6.2348 0.0 0 VAL=5
M  V30 4 O 10.1611 4.7703 0.0 0
M  V30 5 O 10.7156 7.3794 0.0 0
M  V30 6 C 4.6115 4.5864 0.0 0
M  V30 7 C 4.9317 3.0800 0.0 0
M  V30 8 C 3.0800 4.7474 0.0 0
M  V30 9 C 3.5981 2.3100 0.0 0
M  V30 10 C 6.2655 2.3100 0.0 0
M  V30 11 O 2.4537 3.3406 0.0 0
M  V30 12 N 3.5981 0.7700 0.0 0
M  V30 13 N 6.2655 0.7700 0.0 0
M  V30 14 C 4.9317 0.0000 0.0 0
M  V30 15 C 5.6419 5.7308 0.0 0
M  V30 16 C 7.1484 5.4106 0.0 0
M  V30 17 C 5.1661 7.1955 0.0 0
M  V30 18 C 8.1788 6.5550 0.0 0
M  V30 19 C 6.1967 8.3399 0.0 0
M  V30 20 C 7.7029 8.0197 0.0 0
M  V30 21 C 2.3100 6.0810 0.0 0
M  V30 22 C 3.0800 7.4148 0.0 0
M  V30 23 C 0.7700 6.0810 0.0 0
M  V30 24 C 2.3100 8.7484 0.0 0
M  V30 25 C 0.0000 7.4148 0.0 0
M  V30 26 C 0.7700 8.7484 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 18
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 8 21
M  V30 13 1 9 11
M  V30 14 2 9 12
M  V30 15 1 10 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2913196-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2913196-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35651103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR
Inhibitors for the Treatment of Non-Small Cell Lung Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mu-Chun; Coumar, Mohane Selvaraj; Lin, Shu-Yu; Lin, Yih-Shyan; Huang,
Guan-Lin; Chen, Chun-Hwa; Lien, Tzu-Wen; Wu, Yi-Wen; Chen, Yen-Ting;
Chen, Ching-Ping; Huang, Yu-Chen; Yeh, Kai-Chia; Yang, Chen-Ming; Kalita,
Bikashita; Pan, Shiow-Lin; Hsu, Tsu-An; Yeh, Teng-Kuang; Chen,
Chiung-Tong; Hsieh, Hsing-Pang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(4), 2566-2588

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-1-acetic acid, 4-[6-[[[3-[1-(1-methylethyl)-4-piperidinyl]-1-(5-m...
C28H32N8O3
2918188-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.8787 6.2698 0.0 0
M  V30 2 C 9.1245 7.1751 0.0 0
M  V30 3 O 8.9636 8.7066 0.0 0
M  V30 4 C 4.4942 0.0000 0.0 0
M  V30 5 C 1.5400 13.8983 0.0 0
M  V30 6 C 2.3100 15.2319 0.0 0
M  V30 7 C 0.0000 13.8983 0.0 0
M  V30 8 C 18.3400 8.5027 0.0 0
M  V30 9 C 19.1100 9.8363 0.0 0
M  V30 10 O 20.6500 9.8363 0.0 0
M  V30 11 O 18.3400 11.1700 0.0 0
M  V30 12 N 5.1381 6.1262 0.0 0
M  V30 13 C 6.4719 6.8962 0.0 0
M  V30 14 N 3.9937 7.1567 0.0 0
M  V30 15 C 6.1516 8.4026 0.0 0
M  V30 16 C 4.6200 8.5635 0.0 0
M  V30 17 C 4.9772 4.5946 0.0 0
M  V30 18 C 6.2230 3.6894 0.0 0
M  V30 19 N 3.5704 3.9683 0.0 0
M  V30 20 C 6.0621 2.1579 0.0 0
M  V30 21 C 3.4093 2.4368 0.0 0
M  V30 22 C 4.6551 1.5315 0.0 0
M  V30 23 C 3.8500 9.8972 0.0 0
M  V30 24 C 2.3100 9.8972 0.0 0
M  V30 25 C 4.6200 11.2310 0.0 0
M  V30 26 C 1.5400 11.2310 0.0 0
M  V30 27 C 3.8500 12.5646 0.0 0
M  V30 28 N 2.3100 12.5646 0.0 0
M  V30 29 C 10.5315 6.5487 0.0 0
M  V30 30 N 11.7774 7.4538 0.0 0
M  V30 31 C 10.6924 5.0170 0.0 0
M  V30 32 C 13.1842 6.8275 0.0 0
M  V30 33 C 12.0992 4.3907 0.0 0
M  V30 34 C 13.3452 5.2959 0.0 0
M  V30 35 C 14.4300 7.7327 0.0 0
M  V30 36 C 15.8947 7.2568 0.0 0
M  V30 37 C 14.4300 9.2727 0.0 0
M  V30 38 N 16.7999 8.5027 0.0 0
M  V30 39 N 15.8947 9.7486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 29
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 28
M  V30 9 1 8 9
M  V30 10 1 8 38
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 16 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 32 35
M  V30 38 2 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxamide, 6-[1-[2-(methylamino)-2-oxoethyl]-1H-pyrazol-4-yl]-N-[...
C29H35N9O2
2918188-24-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.8787 6.2698 0.0 0
M  V30 2 C 9.1245 7.1751 0.0 0
M  V30 3 O 8.9636 8.7066 0.0 0
M  V30 4 C 4.4942 0.0000 0.0 0
M  V30 5 C 1.5400 13.8983 0.0 0
M  V30 6 C 2.3100 15.2319 0.0 0
M  V30 7 C 0.0000 13.8983 0.0 0
M  V30 8 C 18.3400 8.5027 0.0 0
M  V30 9 C 19.1100 9.8363 0.0 0
M  V30 10 N 20.6500 9.8363 0.0 0
M  V30 11 O 18.3400 11.1700 0.0 0
M  V30 12 C 21.4200 11.1700 0.0 0
M  V30 13 N 5.1381 6.1262 0.0 0
M  V30 14 C 6.4719 6.8962 0.0 0
M  V30 15 N 3.9937 7.1567 0.0 0
M  V30 16 C 6.1516 8.4026 0.0 0
M  V30 17 C 4.6200 8.5635 0.0 0
M  V30 18 C 4.9772 4.5946 0.0 0
M  V30 19 C 6.2230 3.6894 0.0 0
M  V30 20 N 3.5704 3.9683 0.0 0
M  V30 21 C 6.0621 2.1579 0.0 0
M  V30 22 C 3.4093 2.4368 0.0 0
M  V30 23 C 4.6551 1.5315 0.0 0
M  V30 24 C 3.8500 9.8972 0.0 0
M  V30 25 C 2.3100 9.8972 0.0 0
M  V30 26 C 4.6200 11.2310 0.0 0
M  V30 27 C 1.5400 11.2310 0.0 0
M  V30 28 C 3.8500 12.5646 0.0 0
M  V30 29 N 2.3100 12.5646 0.0 0
M  V30 30 C 10.5315 6.5487 0.0 0
M  V30 31 N 11.7774 7.4538 0.0 0
M  V30 32 C 10.6924 5.0170 0.0 0
M  V30 33 C 13.1842 6.8275 0.0 0
M  V30 34 C 12.0992 4.3907 0.0 0
M  V30 35 C 13.3452 5.2959 0.0 0
M  V30 36 C 14.4300 7.7327 0.0 0
M  V30 37 C 15.8947 7.2568 0.0 0
M  V30 38 C 14.4300 9.2727 0.0 0
M  V30 39 N 16.7999 8.5027 0.0 0
M  V30 40 N 15.8947 9.7486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 30
M  V30 5 1 4 23
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 29
M  V30 9 1 8 9
M  V30 10 1 8 39
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 18
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 17 24
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 33 36
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2918188-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2918188-24-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36139404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-pyrazolyl picolinamides as potent and selective
inhibitors of IRAK4
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hatcher, John M.; Gray, Nathanael S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023039047 A1 2023-03-16

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-4-carboxylic acid, 5-(3-cyano-4-fluorophenoxy)-6-fluoro-1-[(4-methy...
C23H14F2N2O5S
2918342-35-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.5777 4.7114 0.0 0 VAL=6
M  V30 2 O 3.5473 3.5670 0.0 0
M  V30 3 O 5.6083 5.8557 0.0 0
M  V30 4 C 10.3085 1.3337 0.0 0
M  V30 5 O 9.5385 0.0000 0.0 0
M  V30 6 O 11.8485 1.3337 0.0 0
M  V30 7 F 10.3085 6.6684 0.0 0
M  V30 8 O 11.8485 4.0011 0.0 0
M  V30 9 C 0.0000 8.8332 0.0 0
M  V30 10 C 16.4686 6.6684 0.0 0
M  V30 11 N 18.0086 6.6684 0.0 0
M  V30 12 F 14.9286 9.3359 0.0 0
M  V30 13 C 7.2285 4.0011 0.0 0
M  V30 14 C 7.9985 2.6675 0.0 0
M  V30 15 N 5.7222 3.6809 0.0 0
M  V30 16 C 7.9985 5.3348 0.0 0
M  V30 17 C 9.5385 2.6675 0.0 0
M  V30 18 C 6.9681 1.5229 0.0 0
M  V30 19 C 5.5613 2.1494 0.0 0
M  V30 20 C 9.5385 5.3348 0.0 0
M  V30 21 C 10.3085 4.0011 0.0 0
M  V30 22 C 3.4333 5.7418 0.0 0
M  V30 23 C 1.9686 5.2659 0.0 0
M  V30 24 C 3.7535 7.2482 0.0 0
M  V30 25 C 0.8242 6.2963 0.0 0
M  V30 26 C 2.6091 8.2786 0.0 0
M  V30 27 C 1.1444 7.8028 0.0 0
M  V30 28 C 12.6186 5.3348 0.0 0
M  V30 29 C 14.1586 5.3348 0.0 0
M  V30 30 C 11.8485 6.6684 0.0 0
M  V30 31 C 14.9286 6.6684 0.0 0
M  V30 32 C 12.6186 8.0022 0.0 0
M  V30 33 C 14.1586 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 1 22
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 17
M  V30 8 1 7 20
M  V30 9 1 8 21
M  V30 10 1 8 28
M  V30 11 1 9 27
M  V30 12 3 10 11
M  V30 13 1 10 31
M  V30 14 1 12 33
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 19
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-4-carboxamide, 5-(3-cyano-4-fluorophenoxy)-6-fluoro-N-methyl-1-[(4-...
C24H17F2N3O4S
2918342-36-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.5777 6.0450 0.0 0 VAL=6
M  V30 2 O 3.5472 4.9006 0.0 0
M  V30 3 O 5.6082 7.1895 0.0 0
M  V30 4 C 10.3085 2.6673 0.0 0
M  V30 5 N 9.5385 1.3336 0.0 0
M  V30 6 O 11.8485 2.6673 0.0 0
M  V30 7 C 10.3085 0.0000 0.0 0
M  V30 8 F 10.3085 8.0021 0.0 0
M  V30 9 O 11.8485 5.3347 0.0 0
M  V30 10 C 0.0000 10.1668 0.0 0
M  V30 11 C 16.4685 8.0021 0.0 0
M  V30 12 N 18.0085 8.0020 0.0 0
M  V30 13 F 14.9285 10.6694 0.0 0
M  V30 14 C 7.2285 5.3347 0.0 0
M  V30 15 C 7.9985 4.0011 0.0 0
M  V30 16 N 5.7222 5.0145 0.0 0
M  V30 17 C 7.9985 6.6684 0.0 0
M  V30 18 C 9.5385 4.0011 0.0 0
M  V30 19 C 6.9680 2.8565 0.0 0
M  V30 20 C 5.5612 3.4830 0.0 0
M  V30 21 C 9.5385 6.6684 0.0 0
M  V30 22 C 10.3085 5.3347 0.0 0
M  V30 23 C 3.4333 7.0755 0.0 0
M  V30 24 C 3.7534 8.5818 0.0 0
M  V30 25 C 1.9686 6.5995 0.0 0
M  V30 26 C 2.6091 9.6122 0.0 0
M  V30 27 C 0.8242 7.6301 0.0 0
M  V30 28 C 1.1444 9.1364 0.0 0
M  V30 29 C 12.6185 6.6684 0.0 0
M  V30 30 C 14.1585 6.6684 0.0 0
M  V30 31 C 11.8485 8.0021 0.0 0
M  V30 32 C 14.9285 8.0021 0.0 0
M  V30 33 C 12.6185 9.3358 0.0 0
M  V30 34 C 14.1585 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 1 23
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 18
M  V30 8 1 5 7
M  V30 9 1 8 21
M  V30 10 1 9 22
M  V30 11 1 9 29
M  V30 12 1 10 28
M  V30 13 3 11 12
M  V30 14 1 11 32
M  V30 15 1 13 34
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 2 15 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2918342-35-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2918342-36-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36296117
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indole derivatives as CFTR correctors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liao, Junkai; Munson, Mark; Thurairatnam, Sukanthini; Hirth, Bradford;
Gao, Zhongli; Hurlbut, Gregory; Borcherding, David; Barrague, Matthieu;
Gillespy, Timothy Alan; Gross, Alexandre; Good, Andrew; Vaz, Roy; Liu,
Jinyu; Li, Yi; Metz, Markus; Ruvinsky, Anatoly; Barberis, Claude
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023034992 A1 2023-03-09

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinecarboxylic acid, 5-[[(3R)-1-[(1,1-dimethylethoxy)carbonyl]-3-methyl...
C17H24N2O5
2921726-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.8003 2.8771 0.0 0
M  V30 2 C 9.4371 0.9169 0.0 0
M  V30 3 C 4.0738 2.0193 0.0 0
M  V30 4 O 2.9293 0.9887 0.0 0
M  V30 5 O 3.7537 3.5256 0.0 0
M  V30 6 C 1.4647 1.4647 0.0 0
M  V30 7 C 0.9889 0.0000 0.0 0
M  V30 8 C 0.0000 1.9406 0.0 0
M  V30 9 C 1.9406 2.9293 0.0 0
M  V30 10 C 14.9604 2.8771 0.0 0
M  V30 11 O 15.7304 4.2107 0.0 0
M  V30 12 O 15.7304 1.5434 0.0 0
M  V30 13 C 17.2704 4.2107 0.0 0
M  V30 14 C 8.0303 1.5434 0.0 0 CFG=2
M  V30 15 C 6.7844 2.4485 0.0 0
M  V30 16 C 7.5544 0.0787 0.0 0
M  V30 17 N 5.5384 1.5434 0.0 0
M  V30 18 C 6.0144 0.0787 0.0 0
M  V30 19 C 10.3403 2.8771 0.0 0
M  V30 20 C 11.1104 4.2107 0.0 0
M  V30 21 C 11.1104 1.5434 0.0 0
M  V30 22 C 12.6504 4.2107 0.0 0
M  V30 23 N 12.6504 1.5434 0.0 0
M  V30 24 C 13.4204 2.8771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 1 19
M  V30 3 1 14 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-methyl-3-[[6-[(methylamino)carbonyl]-3-pyridi...
C17H25N3O4
2921726-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.8003 2.8771 0.0 0
M  V30 2 C 9.4371 0.9169 0.0 0
M  V30 3 C 4.0738 2.0193 0.0 0
M  V30 4 O 2.9293 0.9887 0.0 0
M  V30 5 O 3.7537 3.5256 0.0 0
M  V30 6 C 1.4647 1.4647 0.0 0
M  V30 7 C 1.9406 2.9293 0.0 0
M  V30 8 C 0.0000 1.9406 0.0 0
M  V30 9 C 0.9889 0.0000 0.0 0
M  V30 10 C 14.9604 2.8771 0.0 0
M  V30 11 N 15.7304 4.2107 0.0 0
M  V30 12 O 15.7304 1.5434 0.0 0
M  V30 13 C 17.2704 4.2107 0.0 0
M  V30 14 C 8.0303 1.5434 0.0 0 CFG=2
M  V30 15 C 6.7844 2.4485 0.0 0
M  V30 16 C 7.5544 0.0787 0.0 0
M  V30 17 N 5.5384 1.5434 0.0 0
M  V30 18 C 6.0144 0.0787 0.0 0
M  V30 19 C 10.3403 2.8771 0.0 0
M  V30 20 C 11.1104 1.5434 0.0 0
M  V30 21 C 11.1104 4.2107 0.0 0
M  V30 22 C 12.6504 1.5434 0.0 0
M  V30 23 N 12.6504 4.2107 0.0 0
M  V30 24 C 13.4204 2.8771 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=3
M  V30 2 1 1 19
M  V30 3 1 14 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 24
M  V30 14 1 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2921726-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2921726-90-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36115899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Azetidine for treating cancer and pharmaceutical composition thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffman, Robert L.; Dong, Qing; Trzoss, Lynnie; Va, Porino Jinjo; Kaldor,
Stephen W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023056039 A1 2023-04-06

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 2-[[(2,3-dihydro-2,2-dimethyl-5-nitro-7-benzofuranyl)oxy]...
C21H22N2O7
2925227-02-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2536 6.6684 0.0 0
M  V30 2 C 7.7936 6.6684 0.0 0
M  V30 3 C 0.0000 5.5326 0.0 0
M  V30 4 C 1.0304 7.3175 0.0 0
M  V30 5 N 6.2536 1.3336 0.0 0 VAL=5
M  V30 6 O 5.4836 0.0000 0.0 0
M  V30 7 O 7.7936 1.3336 0.0 0
M  V30 8 C 10.8736 6.6684 0.0 0
M  V30 9 C 10.1036 5.3347 0.0 0
M  V30 10 N 12.4136 6.6684 0.0 0
M  V30 11 O 10.8736 4.0011 0.0 0
M  V30 12 O 8.5636 5.3347 0.0 0
M  V30 13 O 13.1836 8.0021 0.0 0
M  V30 14 C 12.4136 4.0011 0.0 0
M  V30 15 C 14.7236 8.0021 0.0 0
M  V30 16 C 3.9436 5.3347 0.0 0
M  V30 17 C 3.1736 4.0011 0.0 0
M  V30 18 C 5.4836 5.3347 0.0 0
M  V30 19 O 2.9132 6.4791 0.0 0
M  V30 20 C 3.9436 2.6673 0.0 0
M  V30 21 C 1.6674 4.3212 0.0 0
M  V30 22 C 6.2536 4.0011 0.0 0
M  V30 23 C 1.5063 5.8528 0.0 0
M  V30 24 C 5.4836 2.6673 0.0 0
M  V30 25 C 8.5636 8.0021 0.0 0
M  V30 26 C 10.1036 8.0021 0.0 0
M  V30 27 C 7.7936 9.3358 0.0 0
M  V30 28 C 10.8736 9.3358 0.0 0
M  V30 29 C 8.5636 10.6694 0.0 0
M  V30 30 C 10.1036 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 25
M  V30 4 1 3 23
M  V30 5 1 4 23
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 2-[[(2,3-dihydro-2,2-dimethyl-5-nitro-7-benzofuranyl)oxy]me...
C21H23N3O6
2925227-07-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.2536 6.6684 0.0 0
M  V30 2 C 7.7936 6.6684 0.0 0
M  V30 3 C 0.0000 5.5326 0.0 0
M  V30 4 C 1.0304 7.3175 0.0 0
M  V30 5 N 6.2536 1.3336 0.0 0 VAL=5
M  V30 6 O 7.7936 1.3336 0.0 0
M  V30 7 O 5.4836 0.0000 0.0 0
M  V30 8 C 10.8736 6.6684 0.0 0
M  V30 9 C 10.1036 5.3347 0.0 0
M  V30 10 N 12.4136 6.6684 0.0 0
M  V30 11 N 10.8736 4.0011 0.0 0
M  V30 12 O 8.5636 5.3347 0.0 0
M  V30 13 O 13.1836 8.0021 0.0 0
M  V30 14 C 12.4136 4.0011 0.0 0
M  V30 15 C 14.7236 8.0021 0.0 0
M  V30 16 C 3.9436 5.3347 0.0 0
M  V30 17 C 3.1736 4.0011 0.0 0
M  V30 18 C 5.4836 5.3347 0.0 0
M  V30 19 O 2.9132 6.4791 0.0 0
M  V30 20 C 3.9436 2.6673 0.0 0
M  V30 21 C 1.6674 4.3212 0.0 0
M  V30 22 C 6.2536 4.0011 0.0 0
M  V30 23 C 1.5063 5.8528 0.0 0
M  V30 24 C 5.4836 2.6673 0.0 0
M  V30 25 C 8.5636 8.0021 0.0 0
M  V30 26 C 10.1036 8.0021 0.0 0
M  V30 27 C 7.7936 9.3358 0.0 0
M  V30 28 C 10.8736 9.3358 0.0 0
M  V30 29 C 8.5636 10.6694 0.0 0
M  V30 30 C 10.1036 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 25
M  V30 4 1 3 23
M  V30 5 1 4 23
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 8 26
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 29
M  V30 31 2 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2925227-02-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925227-07-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36471935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, crystal structure, biological evaluation, docking study and
DFT calculation of novel strobilurins containing oxime ether phenyl ring
or dihydrobenzofuran moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Mingfang; Li, Kangming; Yi, Yangjie; Luo, Xianfu; Qiu, Longjian;
Zhang, Lijuan; Wang, Man; Ye, Jiao; Ou, Xiaoming; Li, Jianming; Chen,
Yun; Hu, Aixi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2023), 1286135636

$RFMT $RIREG SCHEME119 STEP1
$RXN



  3  1
$MOL
L-Phenylglycine
C8H9NO2
2935-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 4.6201 0.0 0 CFG=2
M  V30 2 C 1.3337 5.3901 0.0 0
M  V30 3 N 4.0010 5.3901 0.0 0
M  V30 4 O 0.0000 4.6201 0.0 0
M  V30 5 O 1.3337 6.9302 0.0 0
M  V30 6 C 2.6673 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 11 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[[3-Chloro-4-(1-methylethoxy)benzoyl]amino]-N-methylbenzeneacetamide
C19H21ClN2O3
1208245-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 C 2.3100 5.3347 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 N 0.7700 5.3347 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 O 4.6200 6.6685 0.0 0
M  V30 8 C 0.0000 6.6685 0.0 0
M  V30 9 Cl 10.0100 8.0021 0.0 0
M  V30 10 O 11.5500 5.3347 0.0 0
M  V30 11 C 12.3200 4.0011 0.0 0
M  V30 12 C 13.8600 4.0011 0.0 0
M  V30 13 C 11.5500 2.6674 0.0 0
M  V30 14 C 2.3100 2.6674 0.0 0
M  V30 15 C 3.0800 1.3336 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 2.3100 0.0000 0.0 0
M  V30 18 C 0.0000 1.3336 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 C 7.7000 6.6685 0.0 0
M  V30 22 C 7.7000 4.0011 0.0 0
M  V30 23 C 9.2400 6.6685 0.0 0
M  V30 24 C 9.2400 4.0011 0.0 0
M  V30 25 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 4 20
M  V30 9 1 5 8
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2935-35-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4528464
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 3 in DMF (0.2 M) were added
amino acid (1.2 equiv.) and N, N-diisopropylethylamine (3 equiv.). The
reaction was monitored by LC/MS. After completion, amine (1.5 equiv.) and
HBTU (1.5 equiv.) were added to the reaction solution. The reaction
mixture was stirred for 4 h. The product was purified by either HPLC or
flash column chromatography. 3a – 3i (60-95% yield).
3-Chloro-4-isopropoxy-N-(2-(methylamino)-2-oxo-1-phenylethyl)benzamide
(3e) 1H NMR (400 MHz, CDCl3) δ 7.86 (d, J = 2.2, 1H), 7.69 (dd, J = 2.2,
8.6, 1H), 7.55 (d, J = 6.2, 1H), 7.48 – 7.41 (m, 2H), 7.39 – 7.28 (m,
3H), 7.26 (s, 1H), 6.93 (d, J = 8.7, 1H), 5.90 (s, 1H), 5.58 (d, J = 6.3,
1H), 5.30 (s, OH), 4.63 (m, 1H), 2.82 (d, J = 4.8, 3H), 1.39 (d, J = 6.1,
6H); LRMS (M+H+) m/z 361.0.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Alanine, N-[3-(1-methyl-1H-pyrazol-3-yl)[1,1′-biphenyl]-4-yl]-
C19H19N3O2
2944442-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2402 6.6365 0.0 0
M  V30 2 C 10.0102 7.9701 0.0 0
M  V30 3 C 11.5503 7.9701 0.0 0
M  V30 4 C 12.3203 9.3038 0.0 0
M  V30 5 O 13.8603 9.3038 0.0 0
M  V30 6 O 11.5503 10.6376 0.0 0
M  V30 7 C 8.0573 0.0000 0.0 0
M  V30 8 C 6.9302 5.3028 0.0 0
M  V30 9 C 7.7002 6.6365 0.0 0
M  V30 10 C 5.3901 5.3028 0.0 0
M  V30 11 C 6.9302 7.9701 0.0 0
M  V30 12 C 4.6201 6.6365 0.0 0
M  V30 13 C 5.3901 7.9701 0.0 0
M  V30 14 C 7.7002 3.9690 0.0 0
M  V30 15 C 9.2317 3.8080 0.0 0
M  V30 16 N 7.0738 2.5622 0.0 0
M  V30 17 C 9.5519 2.3017 0.0 0
M  V30 18 N 8.2182 1.5317 0.0 0
M  V30 19 C 3.0801 6.6365 0.0 0
M  V30 20 C 2.3101 7.9701 0.0 0
M  V30 21 C 2.3101 5.3028 0.0 0
M  V30 22 C 0.7700 7.9701 0.0 0
M  V30 23 C 0.7700 5.3028 0.0 0
M  V30 24 C 0.0000 6.6365 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 18
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 12 19
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanamide, N-methyl-3-[[3-(1-methyl-1H-pyrazol-3-yl)[1,1′-biphenyl]-4-yl]am...
C20H22N4O
2944442-82-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 5.1557 0.0 0
M  V30 2 C 9.3358 5.9257 0.0 0
M  V30 3 C 10.6697 5.1557 0.0 0
M  V30 4 C 12.0033 5.9257 0.0 0
M  V30 5 N 13.3370 5.1557 0.0 0
M  V30 6 O 12.0033 7.4658 0.0 0
M  V30 7 C 14.6707 5.9257 0.0 0
M  V30 8 C 3.6596 0.0000 0.0 0
M  V30 9 C 5.3348 5.1557 0.0 0
M  V30 10 C 6.6685 5.9257 0.0 0
M  V30 11 C 4.0010 5.9257 0.0 0
M  V30 12 C 6.6685 7.4658 0.0 0
M  V30 13 C 4.0010 7.4658 0.0 0
M  V30 14 C 5.3348 8.2358 0.0 0
M  V30 15 C 5.3348 3.6157 0.0 0
M  V30 16 N 4.0888 2.7105 0.0 0
M  V30 17 C 6.5807 2.7105 0.0 0
M  V30 18 N 4.5648 1.2459 0.0 0
M  V30 19 C 6.1048 1.2459 0.0 0
M  V30 20 C 2.6673 8.2358 0.0 0
M  V30 21 C 2.6673 9.7758 0.0 0
M  V30 22 C 1.3337 7.4658 0.0 0
M  V30 23 C 1.3337 10.5458 0.0 0
M  V30 24 C 0.0000 8.2358 0.0 0
M  V30 25 C 0.0000 9.7758 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 18
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 13 20
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2944442-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2944442-82-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37238019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrazole derivatives as YAP/TAZ-TEAD inhibitors and their preparation,
pharmaceutical compositions and use in the treatment of cancer and
fibrosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vanderhoydonck, Bart; Marchand, Arnaud; Gwaltney, Stephen L.; Spieser,
Stephane; Smets, Wim; Candi, Aurelie; Versele, Matthias; Halder, Georg
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023122780 A2 2023-06-29

$RFMT $RIREG SCHEME121 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-1-cyclohexyl-5-hydroxy-2-(1-pyrrolidinylmethyl)-1H-indole-3-car...
C22H29BrN2O3
294874-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6397 7.9107 0.0 0
M  V30 2 C 8.3502 5.9416 0.0 0
M  V30 3 O 9.4946 4.9110 0.0 0
M  V30 4 O 8.6704 7.4478 0.0 0
M  V30 5 C 10.9593 5.3870 0.0 0
M  V30 6 C 12.1036 4.3564 0.0 0
M  V30 7 Br 4.0997 0.0000 0.0 0
M  V30 8 O 7.1797 0.0000 0.0 0
M  V30 9 C 5.6397 6.3707 0.0 0
M  V30 10 N 4.3939 5.4657 0.0 0
M  V30 11 C 6.8856 5.4657 0.0 0
M  V30 12 C 4.8697 4.0010 0.0 0
M  V30 13 C 6.4097 4.0010 0.0 0
M  V30 14 C 4.0997 2.6674 0.0 0
M  V30 15 C 7.1797 2.6674 0.0 0
M  V30 16 C 4.8697 1.3338 0.0 0
M  V30 17 C 6.4097 1.3338 0.0 0
M  V30 18 C 2.9292 5.9416 0.0 0
M  V30 19 C 2.6090 7.4478 0.0 0
M  V30 20 C 1.7848 4.9110 0.0 0
M  V30 21 C 1.1444 7.9237 0.0 0
M  V30 22 C 0.3202 5.3870 0.0 0
M  V30 23 C 0.0000 6.8933 0.0 0
M  V30 24 N 6.9733 8.6807 0.0 0
M  V30 25 C 8.3803 8.0544 0.0 0
M  V30 26 C 7.1343 10.2124 0.0 0
M  V30 27 C 9.4107 9.1989 0.0 0
M  V30 28 C 8.6407 10.5325 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 11
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 16
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 10 18
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-7-cyclohexyl-1,2,3,7-tetrahydro-2-methyl-8-(1-pyrrolidinylmethy...
C25H34BrN3O3
958451-64-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7534 4.5910 0.0 0
M  V30 2 O 2.6091 5.6216 0.0 0
M  V30 3 O 3.4333 3.0848 0.0 0
M  V30 4 C 1.1444 5.1456 0.0 0
M  V30 5 C 0.0000 6.1762 0.0 0
M  V30 6 C 6.4640 2.6218 0.0 0
M  V30 7 Br 8.0040 10.5327 0.0 0
M  V30 8 C 1.0740 9.1989 0.0 0
M  V30 9 C 5.6940 6.5316 0.0 0
M  V30 10 C 7.2340 6.5316 0.0 0
M  V30 11 C 5.2181 5.0669 0.0 0
M  V30 12 C 4.9240 7.8652 0.0 0
M  V30 13 N 7.7099 5.0669 0.0 0
M  V30 14 C 8.0040 7.8652 0.0 0
M  V30 15 C 6.4640 4.1618 0.0 0
M  V30 16 C 5.6940 9.1990 0.0 0
M  V30 17 C 3.3840 7.8652 0.0 0
M  V30 18 C 7.2340 9.1990 0.0 0
M  V30 19 O 4.9240 10.5327 0.0 0
M  V30 20 N 2.6140 9.1989 0.0 0
M  V30 21 C 3.3840 10.5327 0.0 0
M  V30 22 C 9.1745 4.5910 0.0 0
M  V30 23 C 10.3189 5.6216 0.0 0
M  V30 24 C 9.4947 3.0848 0.0 0
M  V30 25 C 11.7836 5.1456 0.0 0
M  V30 26 C 10.9594 2.6089 0.0 0
M  V30 27 C 12.1038 3.6393 0.0 0
M  V30 28 N 5.1304 1.8518 0.0 0
M  V30 29 C 3.7234 2.4782 0.0 0
M  V30 30 C 4.9694 0.3202 0.0 0
M  V30 31 C 2.6930 1.3336 0.0 0
M  V30 32 C 3.4630 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 6 28
M  V30 8 1 7 18
M  V30 9 1 8 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 1 13 22
M  V30 20 2 14 18
M  V30 21 1 16 18
M  V30 22 1 16 19
M  V30 23 1 17 20
M  V30 24 1 19 21
M  V30 25 1 20 21
M  V30 26 1 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 294874-66-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958451-64-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-3038276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME122 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tungsten, pentacarbonyl[[(diethylamino)diphenylsilyl]ethoxymethylene]-, (OC-6...
C24H25NO6SiW
297742-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 W 3.6913 6.2854 0.0 0 CHG=2 VAL=7
M  V30 2 C 5.1137 3.8245 0.0 0 CHG=-2 VAL=4
M  V30 3 C 1.2304 7.7078 0.0 0
M  V30 4 C 6.1561 4.8630 0.0 0
M  V30 5 C 5.1137 8.7463 0.0 0
M  V30 6 C 2.2728 8.7463 0.0 0
M  V30 7 C 1.9044 4.0753 0.0 0
M  V30 8 Si 11.5872 3.8245 0.0 0
M  V30 9 O 4.4006 2.5941 0.0 0
M  V30 10 O 0.0000 6.9947 0.0 0 VAL=3
M  V30 11 O 7.3865 5.5761 0.0 0 VAL=3
M  V30 12 O 6.3442 8.0370 0.0 0 VAL=3
M  V30 13 O 2.2728 10.1648 0.0 0 VAL=3
M  V30 14 O 0.6740 4.7846 0.0 0 VAL=3
M  V30 15 N 11.5872 5.2470 0.0 0
M  V30 16 C 3.1701 3.3073 0.0 0
M  V30 17 C 12.8177 5.9562 0.0 0
M  V30 18 C 10.3568 5.9562 0.0 0
M  V30 19 C 1.9554 2.5745 0.0 0
M  V30 20 C 14.0481 5.2470 0.0 0
M  V30 21 C 9.1264 5.2470 0.0 0
M  V30 22 C 12.8177 3.1153 0.0 0
M  V30 23 C 12.8177 1.5713 0.0 0
M  V30 24 C 14.1578 3.8872 0.0 0
M  V30 25 C 14.1578 0.7994 0.0 0
M  V30 26 C 15.4901 3.1153 0.0 0
M  V30 27 C 15.4901 1.5713 0.0 0
M  V30 28 C 9.0245 2.3120 0.0 0
M  V30 29 C 7.6882 3.0839 0.0 0
M  V30 30 C 9.0245 0.7720 0.0 0
M  V30 31 C 6.3520 2.3120 0.0 0
M  V30 32 C 7.6882 0.0000 0.0 0
M  V30 33 C 6.3520 0.7720 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 9
M  V30 9 3 3 10
M  V30 10 3 4 11
M  V30 11 3 5 12
M  V30 12 3 6 13
M  V30 13 3 7 14
M  V30 14 1 8 15
M  V30 15 1 8 22
M  V30 16 1 8 28
M  V30 17 1 9 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 18 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 29 2 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 30 32
M  V30 33 2 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tungsten, pentacarbonyl[[(diethylamino)diphenylsilyl](methylamino)methylene]-...
C23H24N2O5SiW
297742-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 W 3.6837 6.2724 0.0 0 CHG=2 VAL=7
M  V30 2 C 5.1032 3.8166 0.0 0 CHG=-2 VAL=4
M  V30 3 C 1.2279 7.6919 0.0 0
M  V30 4 C 6.4875 5.8266 0.0 0
M  V30 5 C 5.1032 8.7282 0.0 0
M  V30 6 C 2.2681 8.7282 0.0 0
M  V30 7 C 1.9005 4.0669 0.0 0
M  V30 8 Si 11.5633 3.8166 0.0 0
M  V30 9 N 4.3915 2.5887 0.0 0
M  V30 10 O 0.0000 6.9802 0.0 0 VAL=3
M  V30 11 O 7.7154 6.5344 0.0 0 VAL=3
M  V30 12 O 6.3310 8.0204 0.0 0 VAL=3
M  V30 13 O 2.2681 10.1438 0.0 0 VAL=3
M  V30 14 O 0.6726 4.7747 0.0 0 VAL=3
M  V30 15 N 11.5633 5.2361 0.0 0
M  V30 16 C 2.7373 3.5468 0.0 0
M  V30 17 C 12.7911 5.9439 0.0 0
M  V30 18 C 10.3354 5.9439 0.0 0
M  V30 19 C 14.0190 5.2361 0.0 0
M  V30 20 C 9.1075 5.2361 0.0 0
M  V30 21 C 12.7911 3.1088 0.0 0
M  V30 22 C 12.7911 1.5681 0.0 0
M  V30 23 C 14.1285 3.8792 0.0 0
M  V30 24 C 14.1285 0.7977 0.0 0
M  V30 25 C 15.4581 3.1088 0.0 0
M  V30 26 C 15.4581 1.5681 0.0 0
M  V30 27 C 9.0058 2.3072 0.0 0
M  V30 28 C 7.6723 3.0775 0.0 0
M  V30 29 C 9.0058 0.7704 0.0 0
M  V30 30 C 6.3389 2.3072 0.0 0
M  V30 31 C 7.6723 0.0000 0.0 0
M  V30 32 C 6.3389 0.7704 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 9
M  V30 9 3 3 10
M  V30 10 3 4 11
M  V30 11 3 5 12
M  V30 12 3 6 13
M  V30 13 3 7 14
M  V30 14 1 8 15
M  V30 15 1 8 21
M  V30 16 1 8 27
M  V30 17 1 9 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 297742-37-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 297742-42-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-1049595
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Intramolecular stabilization of carbene complexes
(CO)4W=C(NRR')Si(aryl)2X (X = H, CMe=CHMe, NEt2) by interaction of the
metal center with the silicon substituent X
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schwarz, Matthias; Kickelbick, Guido; Schubert, Ulrich
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Inorganic Chemistry (2000), (8), 1811-1817

$RFMT $RIREG SCHEME123 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Quinoline, 8-bromo-4-chloro-3-(phenylsulfonyl)-
C15H9BrClNO2S
2983129-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3900 0.0000 0.0 0
M  V30 2 Br 0.0000 4.0011 0.0 0
M  V30 3 S 6.9300 2.6673 0.0 0 VAL=6
M  V30 4 O 6.9300 4.2073 0.0 0
M  V30 5 O 6.9300 1.1273 0.0 0
M  V30 6 C 3.0800 1.3336 0.0 0
M  V30 7 C 2.3100 2.6673 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 N 3.0800 4.0011 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 5.3900 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 0.0000 1.3336 0.0 0
M  V30 16 C 8.4700 2.6673 0.0 0
M  V30 17 C 9.2400 4.0011 0.0 0
M  V30 18 C 9.2400 1.3336 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 20 C 10.7800 1.3336 0.0 0
M  V30 21 C 11.5500 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 3 16
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Quinolinamine, 8-bromo-N-methyl-3-(phenylsulfonyl)-
C16H13BrN2O2S
2983129-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0009 0.0 0 VAL=6
M  V30 2 O 6.9300 5.5409 0.0 0
M  V30 3 O 6.9300 2.4609 0.0 0
M  V30 4 N 5.3900 1.3336 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 Br 0.0000 5.3347 0.0 0
M  V30 7 C 5.3900 4.0009 0.0 0
M  V30 8 C 4.6200 2.6673 0.0 0
M  V30 9 C 4.6200 5.3347 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 N 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0009 0.0 0
M  V30 13 C 2.3100 1.3336 0.0 0
M  V30 14 C 0.7700 4.0009 0.0 0
M  V30 15 C 0.7700 1.3336 0.0 0
M  V30 16 C 0.0000 2.6673 0.0 0
M  V30 17 C 8.4700 4.0009 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 C 9.2400 2.6673 0.0 0
M  V30 20 C 10.7800 5.3347 0.0 0
M  V30 21 C 10.7800 2.6673 0.0 0
M  V30 22 C 11.5500 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 17
M  V30 5 1 4 5
M  V30 6 1 4 8
M  V30 7 1 6 14
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2983129-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2983129-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37730824
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-Functionalized 4-Quinolones from Readily Available
Anthranilic Acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Deng, Lin; Deichert, Julie A.; Nguyen, Sierra; Young, Ian S.; Han, Chong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2023), 25(36), 6710-6714

$RFMT $RIREG SCHEME124 STEP1
$RXN



  5  1
$MOL
Quinoline
C9H7N
91-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 C 3.0801 2.6673 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 C 3.0801 0.0000 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 N 2.3101 4.0010 0.0 0
M  V30 7 C 0.0000 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 2 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
p-Tolyl isothiocyanate
C8H7NS
622-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 S 8.0022 1.5400 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-5-carboxaldehyde, 6-amino-2-(1-methylethenyl)-
C12H12N2O
2991873-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3912 5.2891 0.0 0
M  V30 2 C 8.3912 6.8291 0.0 0
M  V30 3 C 9.7250 4.5191 0.0 0
M  V30 4 C 0.7700 2.6673 0.0 0
M  V30 5 O 0.0000 4.0010 0.0 0
M  V30 6 N 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 5.6507 5.1455 0.0 0
M  V30 10 C 3.0801 4.0010 0.0 0
M  V30 11 N 6.8966 2.9875 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 7.0575 4.5191 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 2 4 5
M  V30 5 1 4 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
15cH-Indolizino[3,2-f]quino[1,2-c]quinazoline-13,14-dicarboxylic acid, 11-met...
C36H31N5O4
2991872-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8572 6.0323 0.0 0
M  V30 2 O 4.8881 7.2292 0.0 0
M  V30 3 O 7.3783 6.2733 0.0 0
M  V30 4 C 3.3671 6.9882 0.0 0
M  V30 5 C 12.6776 4.0097 0.0 0
M  V30 6 N 13.4476 2.6759 0.0 0
M  V30 7 C 14.9876 2.6759 0.0 0
M  V30 8 C 2.6527 4.8735 0.0 0
M  V30 9 O 1.2459 4.2472 0.0 0
M  V30 10 O 2.8136 6.4050 0.0 0
M  V30 11 C 0.0000 5.1522 0.0 0
M  V30 12 C 4.8225 0.0000 0.0 0
M  V30 13 N 11.1376 9.3444 0.0 0
M  V30 14 C 17.2976 9.3444 0.0 0
M  V30 15 C 8.0576 4.0097 0.0 0
M  V30 16 C 8.8276 5.3433 0.0 0
M  V30 17 N 6.5513 3.6895 0.0 0
M  V30 18 C 8.8276 2.6759 0.0 0
M  V30 19 C 8.0576 6.6770 0.0 0
M  V30 20 C 10.3676 5.3433 0.0 0
M  V30 21 C 5.3055 4.5946 0.0 0
M  V30 22 C 6.3904 2.1578 0.0 0
M  V30 23 C 7.7972 1.5315 0.0 0
M  V30 24 C 10.3676 2.6759 0.0 0
M  V30 25 N 8.8276 8.0106 0.0 0
M  V30 26 C 6.5176 6.6770 0.0 0
M  V30 27 C 11.1376 4.0097 0.0 0
M  V30 28 N 11.1376 6.6770 0.0 0
M  V30 29 C 3.8985 3.9683 0.0 0
M  V30 30 C 4.9834 1.5315 0.0 0
M  V30 31 C 10.3676 8.0106 0.0 0
M  V30 32 C 8.0576 9.3444 0.0 0
M  V30 33 C 5.7476 8.0106 0.0 0
M  V30 34 C 3.7376 2.4367 0.0 0
M  V30 35 C 6.5176 9.3444 0.0 0
M  V30 36 C 8.8276 10.6781 0.0 0
M  V30 37 C 5.7476 10.6781 0.0 0
M  V30 38 C 8.0576 12.0117 0.0 0
M  V30 39 C 6.5176 12.0117 0.0 0
M  V30 40 C 12.6776 9.3444 0.0 0
M  V30 41 C 13.4476 10.6781 0.0 0
M  V30 42 C 13.4476 8.0106 0.0 0
M  V30 43 C 14.9876 10.6781 0.0 0
M  V30 44 C 14.9876 8.0106 0.0 0
M  V30 45 C 15.7576 9.3444 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 2 5 6 CFG=2
M  V30 6 1 5 27
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 29
M  V30 11 1 9 11
M  V30 12 1 12 30
M  V30 13 1 13 31
M  V30 14 1 13 40
M  V30 15 1 14 45
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 18 24
M  V30 25 1 19 25
M  V30 26 1 19 26
M  V30 27 1 20 27
M  V30 28 1 20 28
M  V30 29 2 21 29
M  V30 30 2 22 23
M  V30 31 1 22 30
M  V30 32 2 24 27
M  V30 33 1 25 31
M  V30 34 1 25 32
M  V30 35 2 26 33
M  V30 36 2 28 31
M  V30 37 1 29 34
M  V30 38 2 30 34
M  V30 39 1 32 35
M  V30 40 2 32 36
M  V30 41 1 33 35
M  V30 42 2 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 39
M  V30 46 2 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 2 42 44
M  V30 50 2 43 45
M  V30 51 1 44 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 91-22-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 622-59-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2991873-09-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2991872-96-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37936687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, recyclable and reusable catalyst used, catalyst prepared
and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of new quinolinoquinazoline derivatives via one-pot
multicomponent reactions using ZnO/TiO2@MWCNTs as a new nanocatalyst
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasani, Leila; Ezzatzadeh, Elham; Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2023), 60(12), 2023-2035

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Ethoxycarbonyl)-4-piperidone
C8H13NO3
29976-53-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 O 0.0000 4.6201 0.0 0
M  V30 7 N 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 6 12
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-(methylamino)-, ethyl ester
C9H18N2O2
73733-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3360 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 N 1.3337 4.6201 0.0 0
M  V30 7 C 0.0000 3.8501 0.0 0
M  V30 8 N 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 29976-53-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73733-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8446479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reductive Amination
of Aldehydes with Methylamine Titanium(IV) isopropoxide (2 mL, 6.6 mmol)
was added to a commercially available solution of methylamine in methanol
(2 M, 7.5 mL) followed by the addition of the starting aldehyde (5 mmol).
The reaction mixture was stirred at ambient temperature for 5 h, after
which sodium borohydride (0.2 g, 5 mmol) was added and the resulting
mixture was further stirred for another period of 2 h. The reaction was
then quenched by the addition of water (1 mL), the resulting inorganic
precipitate was filtered and washed with diethyl ether (20 mL). The
organic layer was separated and the aqueous part was further extracted
with diethyl ether (20 mL x 2). The combined ether extracts were dried
(K2CO3) and concentrated in vacuo to give N-methyl secondary amines in
high purity. General Procedure for the Reductive Amination of Ketones
with Methylamine For the reductive amination of ketones, the same general
procedure was used except that the combined diethyl ether extracts were
next extracted with hydrochloric acid (2 M, 10 mL x 2) to separate the
neutral materials. The acidic aqueous solution containing the
N-methylated amine hydrochloride salt was made alkaline (pH = 10) by slow
addition of (10%, w/v) aqueous NaOH and extracted with diethyl ether (20
mL x 2). The combined organic extracts were dried (K2CO3) and
concentrated in vacuo to give pure N-methylated alkylamines. Table I,
Entry 4, yield 95%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of N-methyl secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumpaty, Hephzibah J.; Williamson, John S.; Bhattacharyya, Sukanta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2003), 33(8), 1411-1416

$RFMT $RIREG SCHEME126 STEP1
$RXN



  3  1
$MOL
(4S)-Dihydro-4-(2-propen-1-yl)-2(3H)-furanone
C7H10O2
301535-29-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 C 6.6363 1.8517 0.0 0
M  V30 3 C 7.9700 2.6218 0.0 0
M  V30 4 O 0.0000 1.4946 0.0 0
M  V30 5 C 3.9690 1.8517 0.0 0 CFG=2
M  V30 6 C 2.5620 2.4782 0.0 0
M  V30 7 C 3.8079 0.3202 0.0 0
M  V30 8 C 1.5316 1.3337 0.0 0
M  V30 9 O 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=3
M  V30 3 2 2 3
M  V30 4 2 4 8
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosylmethyl isocyanide
C9H9NO2S
36635-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 1.3337 0.0 0 VAL=6
M  V30 2 C 6.6685 0.5637 0.0 0
M  V30 3 O 4.5648 0.0000 0.0 0
M  V30 4 O 6.1048 2.6673 0.0 0
M  V30 5 N 8.0023 1.3337 0.0 0 CHG=1 VAL=4
M  V30 6 C 9.3360 2.1037 0.0 0 CHG=-1
M  V30 7 C 0.0000 4.4137 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 2.6675 1.3337 0.0 0
M  V30 10 C 4.0012 3.6437 0.0 0
M  V30 11 C 1.3337 2.1037 0.0 0
M  V30 12 C 2.6675 4.4137 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 3 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-Dihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone
C9H12N2O2
2416517-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.3628 0.0 0
M  V30 2 C 0.7104 0.0000 0.0 0
M  V30 3 O 9.0737 2.4899 0.0 0
M  V30 4 C 2.4374 2.1328 0.0 0
M  V30 5 N 1.0306 1.5064 0.0 0
M  V30 6 C 2.2764 3.6643 0.0 0
M  V30 7 C 0.0000 2.6508 0.0 0
M  V30 8 N 0.7700 3.9846 0.0 0
M  V30 9 C 5.1048 2.1328 0.0 0 CFG=2
M  V30 10 C 6.5116 1.5064 0.0 0
M  V30 11 C 5.2657 3.6643 0.0 0
M  V30 12 C 7.5420 2.6508 0.0 0
M  V30 13 O 6.7720 3.9846 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 9 1 CFG=3
M  V30 3 1 2 5
M  V30 4 2 3 12
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 301535-29-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 36635-61-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2416517-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27540787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 10028-15-6
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used (stage 3)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total synthesis of (+)-pilosinine via a stereodivergent conjugate
addition strategy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schrank, Cassandra L.; Danneman, Michael W.; Prebihalo, Emily A.;
Anderson, Robert E.; Gibson, Tyler J.; Wuest, William M.; Mullins,
Richard J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2020), 61(23), 151945

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2,4′-Bipyridine]-1′(2′H)-carboxylic acid, 4-formyl-3′,6′-dihydro-, 1,1-dimet...
C16H20N2O3
3032784-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3370 3.0801 0.0 0
M  V30 2 O 14.6707 2.3101 0.0 0
M  V30 3 C 4.0010 5.3901 0.0 0
M  V30 4 O 2.6673 4.6201 0.0 0
M  V30 5 O 4.0010 6.9302 0.0 0
M  V30 6 C 1.3337 5.3901 0.0 0
M  V30 7 C 0.5637 4.0564 0.0 0
M  V30 8 C 0.0000 6.1601 0.0 0
M  V30 9 C 2.1037 6.7238 0.0 0
M  V30 10 C 9.3358 2.3101 0.0 0
M  V30 11 C 10.6697 3.0801 0.0 0
M  V30 12 N 9.3358 0.7700 0.0 0
M  V30 13 C 12.0033 2.3101 0.0 0
M  V30 14 C 10.6697 0.0000 0.0 0
M  V30 15 C 12.0033 0.7700 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 8.0022 4.6201 0.0 0
M  V30 19 C 5.3348 3.0801 0.0 0
M  V30 20 C 6.6685 5.3901 0.0 0
M  V30 21 N 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 21
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Piperidinecarboxylic acid, 4-[4-[(methylamino)methyl]-2-pyridinyl]-, 1,1-di...
C17H27N3O2
3032784-78-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3372 3.0801 0.0 0
M  V30 2 N 14.6708 2.3101 0.0 0
M  V30 3 C 16.0046 3.0801 0.0 0
M  V30 4 C 4.0012 5.3901 0.0 0
M  V30 5 O 2.6675 4.6201 0.0 0
M  V30 6 O 4.0012 6.9302 0.0 0
M  V30 7 C 1.3338 5.3901 0.0 0
M  V30 8 C 0.5638 4.0564 0.0 0
M  V30 9 C 0.0000 6.1601 0.0 0
M  V30 10 C 2.1038 6.7238 0.0 0
M  V30 11 C 8.0023 3.0801 0.0 0
M  V30 12 C 8.0023 4.6201 0.0 0
M  V30 13 C 6.6687 2.3101 0.0 0
M  V30 14 C 6.6687 5.3901 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 N 5.3348 4.6201 0.0 0
M  V30 17 C 9.3360 2.3101 0.0 0
M  V30 18 C 10.6698 3.0801 0.0 0
M  V30 19 N 9.3360 0.7700 0.0 0
M  V30 20 C 12.0035 2.3101 0.0 0
M  V30 21 C 10.6698 0.0000 0.0 0
M  V30 22 C 12.0035 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3032784-77-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3032784-78-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38189409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Potent and Selective Coactivator-Associated Arginine
Methyltransferase 1 (CARM1) Degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Haibo; Bacabac, Megan S.; Ma, Min; Kim, Eui-Jun; Wang, Yidan; Wu,
Wenxin; Li, Lingjun; Xu, Wei; Tang, Weiping
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(18), 13028-13042

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
1,3-Propanediol, 1-[3-(cyclohexylmethoxy)phenyl]-
C16H24O3
3033823-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.0801 0.0 0
M  V30 2 C 12.0033 2.3101 0.0 0
M  V30 3 O 10.6697 4.6201 0.0 0
M  V30 4 C 13.3370 3.0801 0.0 0
M  V30 5 O 14.6707 2.3101 0.0 0
M  V30 6 O 5.3348 3.0801 0.0 0
M  V30 7 C 4.0010 2.3101 0.0 0
M  V30 8 C 9.3358 2.3101 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 C 9.3358 0.7700 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 8.0022 0.0000 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 7 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Cyclohexylmethoxy)-α-[2-(methylamino)ethyl]benzenemethanol
C17H27NO2
1141779-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6698 3.0801 0.0 0
M  V30 2 C 12.0035 2.3101 0.0 0
M  V30 3 O 10.6698 4.6201 0.0 0
M  V30 4 C 13.3372 3.0801 0.0 0
M  V30 5 N 14.6708 2.3101 0.0 0
M  V30 6 C 16.0046 3.0801 0.0 0
M  V30 7 O 5.3348 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 10 C 8.0023 3.0801 0.0 0
M  V30 11 C 9.3360 0.7700 0.0 0
M  V30 12 C 6.6687 2.3101 0.0 0
M  V30 13 C 8.0023 0.0000 0.0 0
M  V30 14 C 6.6687 0.7700 0.0 0
M  V30 15 C 2.6675 3.0801 0.0 0
M  V30 16 C 2.6675 4.6201 0.0 0
M  V30 17 C 1.3338 2.3101 0.0 0
M  V30 18 C 1.3338 5.3901 0.0 0
M  V30 19 C 0.0000 3.0801 0.0 0
M  V30 20 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 12
M  V30 9 1 8 15
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3033823-01-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1141779-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36886606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tuning the Metabolic Stability of Visual Cycle Modulators through
Modification of an RPE65 Recognition Motif
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bassetto, Marco; Zaluski, Jordan; Li, Bowen; Zhang, Jianye; Badiee,
Mohsen; Kiser, Philip D.; Tochtrop, Gregory P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2023), 66(12), 8140-8158

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Gossypol
C30H30O8
303-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.8600 4.0011 0.0 0
M  V30 2 C 15.4000 4.0011 0.0 0
M  V30 3 C 13.0900 2.6673 0.0 0
M  V30 4 C 10.7800 9.3358 0.0 0
M  V30 5 O 11.5500 10.6694 0.0 0
M  V30 6 O 8.4700 8.0021 0.0 0
M  V30 7 O 15.4000 6.6684 0.0 0
M  V30 8 C 8.4700 2.6673 0.0 0
M  V30 9 O 13.8600 9.3358 0.0 0
M  V30 10 O 6.9300 2.6673 0.0 0
M  V30 11 C 6.9300 8.0021 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 O 3.8500 0.0000 0.0 0
M  V30 14 C 1.5400 6.6684 0.0 0
M  V30 15 C 2.3100 8.0021 0.0 0
M  V30 16 C 0.0000 6.6684 0.0 0
M  V30 17 O 1.5400 1.3336 0.0 0
M  V30 18 O 0.0000 4.0011 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 10.7800 6.6684 0.0 0
M  V30 21 C 13.0900 5.3347 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 23 C 11.5500 8.0021 0.0 0
M  V30 24 C 9.2400 6.6684 0.0 0
M  V30 25 C 13.8600 6.6684 0.0 0
M  V30 26 C 9.2400 4.0011 0.0 0
M  V30 27 C 13.0900 8.0021 0.0 0
M  V30 28 C 8.4700 5.3347 0.0 0
M  V30 29 C 6.9300 5.3347 0.0 0
M  V30 30 C 6.1600 4.0011 0.0 0
M  V30 31 C 6.1600 6.6684 0.0 0
M  V30 32 C 4.6200 4.0011 0.0 0
M  V30 33 C 4.6200 6.6684 0.0 0
M  V30 34 C 3.8500 5.3347 0.0 0
M  V30 35 C 3.8500 2.6673 0.0 0
M  V30 36 C 2.3100 5.3347 0.0 0
M  V30 37 C 2.3100 2.6673 0.0 0
M  V30 38 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 2 4 5
M  V30 5 1 4 23
M  V30 6 1 6 24
M  V30 7 1 7 25
M  V30 8 1 8 26
M  V30 9 1 9 27
M  V30 10 1 10 30
M  V30 11 1 11 31
M  V30 12 2 12 13
M  V30 13 1 12 35
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 36
M  V30 17 1 17 37
M  V30 18 1 18 38
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 1 20 24
M  V30 24 2 21 25
M  V30 25 2 22 26
M  V30 26 2 23 27
M  V30 27 2 24 28
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 28 29
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 32 35
M  V30 37 1 33 34
M  V30 38 1 34 36
M  V30 39 2 35 37
M  V30 40 2 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′-Dimethyl-5,5′-bis(1-methylethyl)-8,8′-bis[(E)-(methylimino)methyl][2,2′-...
C32H36N2O6
307976-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 8.0020 0.0 0
M  V30 2 C 0.0000 8.0020 0.0 0
M  V30 3 C 2.3100 9.3358 0.0 0
M  V30 4 C 4.6200 2.6673 0.0 0
M  V30 5 N 3.8500 1.3336 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 O 6.9300 4.0009 0.0 0
M  V30 8 O 0.0000 5.3347 0.0 0
M  V30 9 C 6.9300 9.3358 0.0 0
M  V30 10 O 1.5400 2.6673 0.0 0
M  V30 11 O 8.4700 9.3358 0.0 0
M  V30 12 C 8.4700 4.0009 0.0 0
M  V30 13 C 10.7800 10.6694 0.0 0
M  V30 14 N 11.5500 12.0031 0.0 0
M  V30 15 C 10.7800 13.3367 0.0 0
M  V30 16 C 13.8600 5.3347 0.0 0
M  V30 17 C 13.0900 4.0009 0.0 0
M  V30 18 C 15.4000 5.3347 0.0 0
M  V30 19 O 13.8600 10.6694 0.0 0
M  V30 20 O 15.4000 8.0020 0.0 0
M  V30 21 C 3.8500 6.6684 0.0 0
M  V30 22 C 4.6200 5.3347 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 3.8500 4.0009 0.0 0
M  V30 26 C 6.1600 5.3347 0.0 0
M  V30 27 C 1.5400 5.3347 0.0 0
M  V30 28 C 6.1600 8.0020 0.0 0
M  V30 29 C 2.3100 4.0009 0.0 0
M  V30 30 C 6.9300 6.6684 0.0 0
M  V30 31 C 8.4700 6.6684 0.0 0
M  V30 32 C 9.2400 8.0020 0.0 0
M  V30 33 C 9.2400 5.3347 0.0 0
M  V30 34 C 10.7800 8.0020 0.0 0
M  V30 35 C 10.7800 5.3347 0.0 0
M  V30 36 C 11.5500 6.6684 0.0 0
M  V30 37 C 11.5500 9.3358 0.0 0
M  V30 38 C 13.0900 6.6684 0.0 0
M  V30 39 C 13.0900 9.3358 0.0 0
M  V30 40 C 13.8600 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 23
M  V30 4 2 4 5
M  V30 5 1 4 25
M  V30 6 1 5 6
M  V30 7 1 7 26
M  V30 8 1 8 27
M  V30 9 1 9 28
M  V30 10 1 10 29
M  V30 11 1 11 32
M  V30 12 1 12 33
M  V30 13 2 13 14
M  V30 14 1 13 37
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 38
M  V30 19 1 19 39
M  V30 20 1 20 40
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 26
M  V30 26 2 23 27
M  V30 27 2 24 28
M  V30 28 2 25 29
M  V30 29 2 26 30
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 30 31
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 34 37
M  V30 39 1 35 36
M  V30 40 1 36 38
M  V30 41 2 37 39
M  V30 42 2 38 40
M  V30 43 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 303-45-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 307976-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7709113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM ANALOGOUS AMINE HAVE SIMILAR REACTION
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and cytotoxicity of gossypol related compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dao, Vi-Thuy; Gaspard, Christiane; Mayer, Michel; Werner, Georges H.;
Nguyen, Suong N.; Michelot, Robert J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2000), 35(9), 805-813

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indazole-7-carboxaldehyde, 4-methoxy-1-[[2-(trimethylsilyl)ethoxy]methyl]-
C15H22N2O3Si
3034838-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9855 4.5603 0.0 0
M  V30 2 O 9.0161 5.7047 0.0 0
M  V30 3 C 10.5224 5.3846 0.0 0
M  V30 4 C 11.5530 6.5291 0.0 0
M  V30 5 Si 13.0593 6.2090 0.0 0
M  V30 6 C 14.5656 5.8888 0.0 0
M  V30 7 C 13.3795 7.7153 0.0 0
M  V30 8 C 12.7392 4.7025 0.0 0
M  V30 9 C 6.6685 1.5400 0.0 0
M  V30 10 O 6.6685 0.0000 0.0 0
M  V30 11 O 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 N 6.4792 4.8805 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0
M  V30 18 C 4.3212 6.1264 0.0 0
M  V30 19 N 5.8529 6.2875 0.0 0
M  V30 20 C 4.0010 1.5400 0.0 0
M  V30 21 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 1 9 16
M  V30 11 1 11 12
M  V30 12 1 11 17
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indazole-7-methanamine, 4-methoxy-N-methyl-1-[[2-(trimethylsilyl)ethoxy]me...
C16H27N3O2Si
2923693-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9855 5.3304 0.0 0
M  V30 2 O 9.0161 6.4748 0.0 0
M  V30 3 C 10.5224 6.1546 0.0 0
M  V30 4 C 11.5530 7.2991 0.0 0
M  V30 5 Si 13.0593 6.9790 0.0 0
M  V30 6 C 14.5656 6.6588 0.0 0
M  V30 7 C 13.3795 8.4853 0.0 0
M  V30 8 C 12.7392 5.4725 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 N 6.6685 0.7700 0.0 0
M  V30 11 C 8.0022 0.0000 0.0 0
M  V30 12 O 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 4.0010 5.3901 0.0 0
M  V30 16 N 6.4792 5.6505 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 2.6673 4.6201 0.0 0
M  V30 19 C 4.3212 6.8964 0.0 0
M  V30 20 N 5.8529 7.0575 0.0 0
M  V30 21 C 4.0010 2.3101 0.0 0
M  V30 22 C 2.6673 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 18
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3034838-66-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2923693-61-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39721234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of novel and potent indazole NLRP3 inhibitors enabled by
DNA-encoded library screening
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartman, George; Humphries, Paul; Hughes, Robert; Ho, Andrew; Montgomery,
Rusty; Deshpande, Aditi; Mahanta, Maitriyee; Tronnes, Sarah; Cowdin,
Samantha; He, Xu; Liu, Fangchao; Zhang, Lifang; Liu, Chuan; Dou,
Dengfeng; Li, Jin; Spasic, Aleksander; Coll, Rebecca; Marleaux, Michael;
Hochheiser, Inga V.; Geyer, Matthias; Rubin, Paul; Fortney, Kristen;
Wilhelmsen, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2024), 102129675

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-O-(2-Methoxy-2-oxoethyl)adenosine
C13H17N5O6
304442-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.9268 6.2078 0.0 0
M  V30 2 C 9.4668 6.2078 0.0 0
M  V30 3 C 10.2368 7.5415 0.0 0
M  V30 4 O 11.7769 7.5415 0.0 0
M  V30 5 O 9.4668 8.8751 0.0 0
M  V30 6 C 12.5469 8.8751 0.0 0
M  V30 7 O 9.2896 3.1470 0.0 0
M  V30 8 C 6.7997 0.9052 0.0 0
M  V30 9 O 5.5538 0.0000 0.0 0
M  V30 10 N 0.2787 8.6714 0.0 0
M  V30 11 N 4.5948 5.8576 0.0 0
M  V30 12 C 3.0631 5.6965 0.0 0
M  V30 13 C 4.9150 7.3639 0.0 0
M  V30 14 C 2.4368 7.1035 0.0 0
M  V30 15 N 2.1579 4.4507 0.0 0
M  V30 16 N 3.5812 8.1339 0.0 0
M  V30 17 C 0.9052 7.2644 0.0 0
M  V30 18 C 0.6263 4.6118 0.0 0
M  V30 19 N 0.0000 6.0186 0.0 0
M  V30 20 C 5.6252 4.7131 0.0 0 CFG=2
M  V30 21 C 7.1568 4.8742 0.0 0 CFG=2
M  V30 22 O 5.3051 3.2068 0.0 0
M  V30 23 C 7.7831 3.4672 0.0 0 CFG=2
M  V30 24 C 6.6387 2.4368 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 23 7 CFG=3
M  V30 8 1 8 9
M  V30 9 1 24 8 CFG=1
M  V30 10 1 10 17
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 20 11 CFG=1
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 21 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2′-O-[2-(Methylamino)-2-oxoethyl]adenosine
C13H18N6O5
847651-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.9268 6.2078 0.0 0
M  V30 2 C 9.4668 6.2078 0.0 0
M  V30 3 C 10.2368 7.5415 0.0 0
M  V30 4 N 11.7769 7.5415 0.0 0
M  V30 5 O 9.4668 8.8751 0.0 0
M  V30 6 C 12.5469 8.8751 0.0 0
M  V30 7 O 9.2896 3.1470 0.0 0
M  V30 8 C 6.7997 0.9052 0.0 0
M  V30 9 O 5.5538 0.0000 0.0 0
M  V30 10 N 0.2787 8.6714 0.0 0
M  V30 11 N 4.5948 5.8576 0.0 0
M  V30 12 C 3.0631 5.6965 0.0 0
M  V30 13 C 4.9150 7.3639 0.0 0
M  V30 14 C 2.4368 7.1035 0.0 0
M  V30 15 N 2.1579 4.4507 0.0 0
M  V30 16 N 3.5812 8.1339 0.0 0
M  V30 17 C 0.9052 7.2644 0.0 0
M  V30 18 C 0.6263 4.6118 0.0 0
M  V30 19 N 0.0000 6.0186 0.0 0
M  V30 20 C 5.6252 4.7131 0.0 0 CFG=2
M  V30 21 C 7.1568 4.8742 0.0 0 CFG=2
M  V30 22 O 5.3051 3.2068 0.0 0
M  V30 23 C 7.7831 3.4672 0.0 0 CFG=2
M  V30 24 C 6.6387 2.4368 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 21 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 23 7 CFG=3
M  V30 8 1 8 9
M  V30 9 1 24 8 CFG=1
M  V30 10 1 10 17
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 20 11 CFG=1
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 20 21 23 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 304442-35-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847651-43-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1360748
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2'-O-(Methoxycarbonylmethylene)adenosine (89.63 g, 155.15 mmol) was
dissolved in THF (1300 mL), N-methylamine (310 mmol, 350 mL, of 40 wt %
solution in water) was added, and the reaction mixture was stirred at
ambient temperature for 18 h. The mixture was concentrated to oil which
was dissolved in EtOAc (420 mL). The organic phase was washed with water
(3 x 350 mL) and brine (1 x 350 mL), dried (Na2SO4), and evaporated under
reduced pressure. Product, yield 84.80 g, 95%. White solid. 1H NMR (200
MHz, DMSO-d6) δ 2.60 (d, J = 4.7 Hz, 3H), 3.60-3.53 (m, 1H), 3.72-3.66
(m, 1H), 3.97 (s, 2H), 3.99-4.02 (m, 1H), 4.33 (q, J = 4.7, 4.3, 5.1 Hz,
1H), 4.50 (t, J = 5.1 Hz, 1H), 5.35 (t, J = 4.9 Hz, 1H), 5.48 (d, J = 5.3
Hz, 1H), 6.07 (d, J = 5.1 Hz, 1H), 7.34 (s, 2H), 7.83 (q, J = 4.1, 4.5
Hz, 1H), 8.14 (s, 1H), 8.36 (s, 1H); 13C NMR (75 MHz, DMSO-d6) δ 25.0,
61.1, 69.2, 69.3, 82.2, 85.4, 86.0, 119.3, 139.5, 148.9, 152.5, 156.1,
169.2; MS (ES) m/z 337.1 [M - H]-; HRMS (TOF MS ES) m/z calcd for
C13H17N6O5- 337.1260, found 337.1260.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Comparing In Vitro and In Vivo Activity of
2'-O-[2-(Methylamino)-2-oxoethyl]- and 2'-O-Methoxyethyl-Modified
Antisense Oligonucleotides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prakash, Thazha P.; Kawasaki, Andrew M.; Wancewicz, Edward V.; Shen,
Lijiang; Monia, Brett P.; Ross, Bruce S.; Bhat, Balkrishen; Manoharan,
Muthiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(9), 2766-2776

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 3-chloro-2-[[[(Z)-[3-(4-fluorophenyl)-1-(methoxymethyl)-2...
C22H20ClFN2O5
3047354-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.1601 0.0 0
M  V30 2 C 5.3348 6.9302 0.0 0
M  V30 3 N 2.6675 6.9302 0.0 0
M  V30 4 O 5.3348 8.4702 0.0 0
M  V30 5 O 6.6685 6.1601 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 6.6685 9.2402 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 O 8.0023 3.8501 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 13.3372 5.3901 0.0 0
M  V30 16 O 12.0035 1.5400 0.0 0
M  V30 17 C 12.0035 0.0000 0.0 0
M  V30 18 Cl 6.6685 1.5400 0.0 0
M  V30 19 F 18.6720 8.4702 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 4.0012 1.5400 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 14.6708 7.7002 0.0 0
M  V30 28 C 16.0045 5.3901 0.0 0
M  V30 29 C 16.0045 8.4702 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 31 C 17.3383 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 3 13 15
M  V30 16 1 14 16
M  V30 17 1 15 26
M  V30 18 1 16 17
M  V30 19 1 18 23
M  V30 20 1 19 31
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 3-chloro-2-[[[(Z)-[3-(4-fluorophenyl)-1-(methoxymethyl)-2-p...
C22H21ClFN3O4
3036385-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.1601 0.0 0
M  V30 2 C 5.3348 6.9302 0.0 0
M  V30 3 N 2.6675 6.9302 0.0 0
M  V30 4 N 5.3348 8.4702 0.0 0
M  V30 5 O 6.6685 6.1601 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 6.6685 9.2402 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 O 8.0023 3.8501 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 13.3372 5.3901 0.0 0
M  V30 16 O 12.0035 1.5400 0.0 0
M  V30 17 C 12.0035 0.0000 0.0 0
M  V30 18 Cl 6.6685 1.5400 0.0 0
M  V30 19 F 18.6720 8.4702 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 4.0012 1.5400 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 5.3901 0.0 0
M  V30 28 C 14.6708 7.7002 0.0 0
M  V30 29 C 17.3383 6.1601 0.0 0
M  V30 30 C 16.0045 8.4702 0.0 0
M  V30 31 C 17.3383 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 3 13 15
M  V30 16 1 14 16
M  V30 17 1 15 26
M  V30 18 1 16 17
M  V30 19 1 18 23
M  V30 20 1 19 31
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3047354-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036385-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40803579
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and use of strobilurin-type compounds for combating
phytopathogenic fungi containing an amino acid substitution F129L in the
mitochondrial cytochrome b protein conferring resistance to Qo inhibitors
XV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Chandan; Das, Saikat; Dietz, Jochen; Ludwig, Lydia; Khanna, Smriti;
Kulkarni, Sarang; Fehr, Marcus; Koch, Andreas; Le Vezouet, Ronan; Rath,
Rakesh; Grammenos, Wassilios; Siepe, Isabella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024088792 A1 2024-05-02

$RFMT $RIREG SCHEME132 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, 3-chloro-2-[[[(Z)-[3-(4-fluorophenyl)-1-(methoxymethyl)-2...
C22H20ClFN2O5
3047354-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.1601 0.0 0
M  V30 2 C 5.3348 6.9302 0.0 0
M  V30 3 N 2.6675 6.9302 0.0 0
M  V30 4 O 5.3348 8.4702 0.0 0
M  V30 5 O 6.6685 6.1601 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 6.6685 9.2402 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 O 8.0023 3.8501 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 13.3372 5.3901 0.0 0
M  V30 16 O 12.0035 1.5400 0.0 0
M  V30 17 C 12.0035 0.0000 0.0 0
M  V30 18 Cl 6.6685 1.5400 0.0 0
M  V30 19 F 18.6720 8.4702 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 4.0012 1.5400 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 14.6708 7.7002 0.0 0
M  V30 28 C 16.0045 5.3901 0.0 0
M  V30 29 C 16.0045 8.4702 0.0 0
M  V30 30 C 17.3383 6.1601 0.0 0
M  V30 31 C 17.3383 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 3 13 15
M  V30 16 1 14 16
M  V30 17 1 15 26
M  V30 18 1 16 17
M  V30 19 1 18 23
M  V30 20 1 19 31
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetamide, 3-chloro-2-[[[(Z)-[3-(4-fluorophenyl)-1-(methoxymethyl)-2-p...
C22H21ClFN3O4
3036385-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.1601 0.0 0
M  V30 2 C 5.3348 6.9302 0.0 0
M  V30 3 N 2.6675 6.9302 0.0 0
M  V30 4 N 5.3348 8.4702 0.0 0
M  V30 5 O 6.6685 6.1601 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 6.6685 9.2402 0.0 0
M  V30 8 C 0.0000 6.9302 0.0 0
M  V30 9 C 6.6685 4.6201 0.0 0
M  V30 10 O 8.0023 3.8501 0.0 0
M  V30 11 N 9.3360 4.6201 0.0 0
M  V30 12 C 10.6697 3.8501 0.0 0
M  V30 13 C 12.0035 4.6201 0.0 0
M  V30 14 C 10.6697 2.3101 0.0 0
M  V30 15 C 13.3372 5.3901 0.0 0
M  V30 16 O 12.0035 1.5400 0.0 0
M  V30 17 C 12.0035 0.0000 0.0 0
M  V30 18 Cl 6.6685 1.5400 0.0 0
M  V30 19 F 18.6720 8.4702 0.0 0
M  V30 20 C 4.0012 4.6201 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 3.8501 0.0 0
M  V30 23 C 5.3348 2.3101 0.0 0
M  V30 24 C 2.6675 2.3101 0.0 0
M  V30 25 C 4.0012 1.5400 0.0 0
M  V30 26 C 14.6708 6.1601 0.0 0
M  V30 27 C 16.0045 5.3901 0.0 0
M  V30 28 C 14.6708 7.7002 0.0 0
M  V30 29 C 17.3383 6.1601 0.0 0
M  V30 30 C 16.0045 8.4702 0.0 0
M  V30 31 C 17.3383 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 3 13 15
M  V30 16 1 14 16
M  V30 17 1 15 26
M  V30 18 1 16 17
M  V30 19 1 18 23
M  V30 20 1 19 31
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 27 2 26 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 2 28 30
M  V30 31 2 29 31
M  V30 32 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3047354-40-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3036385-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40803671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and use of strobilurin-type compounds for combating
phytopathogenic fungi containing an amino acid substitution F129L in the
mitochondrial cytochrome b protein conferring resistance to Qo inhibitors
XV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dey, Chandan; Das, Saikat; Dietz, Jochen; Ludwig, Lydia; Khanna, Smriti;
Kulkarni, Sarang; Fehr, Marcus; Koch, Andreas; Le Vezouet, Ronan; Rath,
Rakesh; Grammenos, Wassilios; Siepe, Isabella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP4361126 A1 2024-05-01

$RFMT $RIREG SCHEME133 STEP1
$RXN



  3  1
$MOL
3-Methyl-4-nitrobenzoic acid
C8H7NO4
3113-71-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6200 0.0 0
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 C 1.3336 4.6200 0.0 0
M  V30 5 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-2-nitrobenzene
C6H4ClNO2
88-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,3-Dimethyl-4-nitro-N-(2-nitrophenyl)benzamide
C15H13N3O5
2607698-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 O 4.6200 6.6685 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 10.0100 8.0021 0.0 0
M  V30 9 N 11.5500 5.3347 0.0 0 VAL=5
M  V30 10 O 12.3200 4.0011 0.0 0
M  V30 11 O 12.3200 6.6685 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3347 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 7.7000 6.6685 0.0 0
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 1 8 21
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3113-71-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 88-73-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2607698-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38215171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM see experimental details, autoclave used in stage 2, thermal in stage 2,
stage 1 product added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Optimized Synthesis of the Key Intermediate of Telmisartan via the
Cyclization of 2-Bromoarylamine with n-Butyronitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qin, Hongjian; Mintah Bonku, Emmanuel; Odilov, Abdullajon; Wu, Mingjun;
Liu, Yongjian; Shen, Jingshan; Zhu, Fuqiang; Aisa, Haji A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2023), 27(11), 2165-2173

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-1-methyl-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
C14H11ClN2O2
327602-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.2362 6.9964 0.0 0
M  V30 2 O 7.8635 2.9677 0.0 0
M  V30 3 C 3.0202 0.0000 0.0 0
M  V30 4 O 7.2968 8.3591 0.0 0
M  V30 5 C 9.5388 5.8692 0.0 0
M  V30 6 C 4.5864 3.6643 0.0 0
M  V30 7 C 3.0800 3.9844 0.0 0
M  V30 8 C 4.7474 2.1327 0.0 0
M  V30 9 C 2.3100 2.6508 0.0 0
M  V30 10 C 2.3100 5.3182 0.0 0
M  V30 11 N 3.3404 1.5064 0.0 0
M  V30 12 C 0.7700 2.6508 0.0 0
M  V30 13 C 0.7700 5.3182 0.0 0
M  V30 14 C 0.0000 3.9844 0.0 0
M  V30 15 C 5.7308 4.6948 0.0 0
M  V30 16 C 5.5699 6.2264 0.0 0
M  V30 17 C 7.2372 4.3747 0.0 0
M  V30 18 C 6.9767 6.8527 0.0 0
M  V30 19 N 8.0072 5.7083 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 2 2 17
M  V30 3 1 3 11
M  V30 4 2 4 18
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3-(methylamino)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione
C15H15N3O2
861891-47-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.6752 2.9677 0.0 0
M  V30 2 C 0.1437 2.8068 0.0 0
M  V30 3 O 5.3025 6.9964 0.0 0
M  V30 4 C 6.5185 0.0000 0.0 0
M  V30 5 O 0.0000 5.8692 0.0 0
M  V30 6 C 2.2419 8.3591 0.0 0
M  V30 7 C 4.9523 3.6643 0.0 0
M  V30 8 C 6.4588 3.9844 0.0 0
M  V30 9 C 4.7914 2.1327 0.0 0
M  V30 10 C 7.2288 2.6508 0.0 0
M  V30 11 C 7.2288 5.3182 0.0 0
M  V30 12 N 6.1983 1.5064 0.0 0
M  V30 13 C 8.7688 2.6508 0.0 0
M  V30 14 C 8.7688 5.3182 0.0 0
M  V30 15 C 9.5388 3.9844 0.0 0
M  V30 16 C 3.8080 4.6948 0.0 0
M  V30 17 C 2.3015 4.3747 0.0 0
M  V30 18 C 3.9689 6.2264 0.0 0
M  V30 19 C 1.5315 5.7083 0.0 0
M  V30 20 N 2.5621 6.8527 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 2 3 18
M  V30 4 1 4 12
M  V30 5 2 5 19
M  V30 6 1 6 20
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 16
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 327602-15-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 861891-47-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18768910
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indolylmaleimide Derivative IM-17 Shows Cardioprotective Effects in
Ischemia-Reperfusion Injury
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dodo, Kosuke; Shimizu, Tadashi; Sasamori, Jun; Aihara, Kazuyuki;
Terayama, Naoki; Nakao, Shuhei; Iuchi, Katsuya; Takahashi, Masahiro;
Sodeoka, Mikiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2018), 9(3), 182-187

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-[(3aR,3bR,4aS,5R,5aS)-hexahydro-2,2-dimethyl-3b-[(phenylmethoxy)me...
C22H23ClN4O3
328396-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.3222 5.3435 0.0 0
M  V30 2 O 11.0922 6.6771 0.0 0
M  V30 3 C 12.6323 6.6771 0.0 0
M  V30 4 C 9.6067 0.4284 0.0 0
M  V30 5 C 7.5908 0.0000 0.0 0
M  V30 6 Cl 0.0000 6.8242 0.0 0
M  V30 7 C 8.7822 5.3435 0.0 0 CFG=2
M  V30 8 C 7.3754 5.9698 0.0 0 CFG=1
M  V30 9 C 8.6213 3.8119 0.0 0 CFG=1
M  V30 10 C 8.6213 6.8750 0.0 0
M  V30 11 C 6.3448 4.8254 0.0 0 CFG=1
M  V30 12 C 7.1148 3.4917 0.0 0 CFG=1
M  V30 13 O 9.3913 2.4782 0.0 0
M  V30 14 O 6.9539 1.9602 0.0 0
M  V30 15 C 8.3608 1.3337 0.0 0
M  V30 16 N 4.8132 4.9863 0.0 0
M  V30 17 C 4.0432 6.3201 0.0 0
M  V30 18 C 3.7828 3.8419 0.0 0
M  V30 19 C 2.5369 5.9998 0.0 0
M  V30 20 N 4.5191 7.7847 0.0 0
M  V30 21 N 2.3758 4.4683 0.0 0
M  V30 22 C 1.5063 7.1444 0.0 0
M  V30 23 C 3.4886 8.9293 0.0 0
M  V30 24 N 1.9823 8.6089 0.0 0
M  V30 25 C 13.4023 8.0109 0.0 0
M  V30 26 C 12.6323 9.3446 0.0 0
M  V30 27 C 14.9423 8.0109 0.0 0
M  V30 28 C 13.4023 10.6783 0.0 0
M  V30 29 C 15.7123 9.3446 0.0 0
M  V30 30 C 14.9423 10.6783 0.0 0
M  V30 31 H 6.3448 7.1143 0.0 0
M  V30 32 H 10.1276 4.1321 0.0 0
M  V30 33 H 5.6085 3.1715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 25
M  V30 5 1 4 15
M  V30 6 1 5 15
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 8 31 CFG=3
M  V30 14 1 9 12
M  V30 15 1 9 13
M  V30 16 1 9 32 CFG=3
M  V30 17 1 11 12
M  V30 18 1 11 16 CFG=3
M  V30 19 1 12 14
M  V30 20 1 12 33 CFG=3
M  V30 21 1 13 15
M  V30 22 1 14 15
M  V30 23 1 16 17
M  V30 24 1 16 18
M  V30 25 1 17 19
M  V30 26 2 17 20
M  V30 27 2 18 21
M  V30 28 1 19 21
M  V30 29 2 19 22
M  V30 30 1 20 23
M  V30 31 1 22 24
M  V30 32 2 23 24
M  V30 33 2 25 26
M  V30 34 1 25 27
M  V30 35 1 26 28
M  V30 36 2 27 29
M  V30 37 2 28 30
M  V30 38 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 7 8 9 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[(3aR,3bR,4aS,5R,5aS)-Hexahydro-2,2-dimethyl-3b-[(phenylmethoxy)methyl]cycl...
C23H27N5O3
436847-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3434 0.0 0
M  V30 2 O 4.6201 6.6771 0.0 0
M  V30 3 C 3.0800 6.6771 0.0 0
M  V30 4 C 6.1057 0.4284 0.0 0
M  V30 5 C 8.1216 0.0000 0.0 0
M  V30 6 N 15.7122 6.8241 0.0 0
M  V30 7 C 16.7428 7.9685 0.0 0
M  V30 8 C 6.9301 5.3434 0.0 0 CFG=2
M  V30 9 C 8.3371 5.9697 0.0 0 CFG=1
M  V30 10 C 7.0912 3.8119 0.0 0 CFG=1
M  V30 11 C 7.0912 6.8750 0.0 0
M  V30 12 C 9.3675 4.8254 0.0 0 CFG=1
M  V30 13 C 8.5975 3.4917 0.0 0 CFG=1
M  V30 14 O 6.3212 2.4782 0.0 0
M  V30 15 O 8.7584 1.9601 0.0 0
M  V30 16 C 7.3516 1.3337 0.0 0
M  V30 17 N 10.8990 4.9863 0.0 0
M  V30 18 C 11.6691 6.3201 0.0 0
M  V30 19 C 11.9296 3.8419 0.0 0
M  V30 20 C 13.1755 5.9998 0.0 0
M  V30 21 N 11.1932 7.7847 0.0 0
M  V30 22 N 13.3364 4.4682 0.0 0
M  V30 23 C 14.2059 7.1443 0.0 0
M  V30 24 C 12.2236 8.9292 0.0 0
M  V30 25 N 13.7301 8.6089 0.0 0
M  V30 26 C 2.3100 8.0109 0.0 0
M  V30 27 C 0.7700 8.0109 0.0 0
M  V30 28 C 3.0800 9.3445 0.0 0
M  V30 29 C 0.0000 9.3445 0.0 0
M  V30 30 C 2.3100 10.6782 0.0 0
M  V30 31 C 0.7700 10.6782 0.0 0
M  V30 32 H 9.3675 7.1143 0.0 0
M  V30 33 H 5.5847 4.1320 0.0 0
M  V30 34 H 10.1038 3.1715 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 26
M  V30 5 1 4 16
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 32 CFG=1
M  V30 15 1 10 13
M  V30 16 1 10 14
M  V30 17 1 10 33 CFG=1
M  V30 18 1 12 13
M  V30 19 1 12 17 CFG=1
M  V30 20 1 13 15
M  V30 21 1 13 34 CFG=1
M  V30 22 1 14 16
M  V30 23 1 15 16
M  V30 24 1 17 18
M  V30 25 1 17 19
M  V30 26 1 18 20
M  V30 27 2 18 21
M  V30 28 2 19 22
M  V30 29 1 20 22
M  V30 30 2 20 23
M  V30 31 1 21 24
M  V30 32 1 23 25
M  V30 33 2 24 25
M  V30 34 2 26 27
M  V30 35 1 26 28
M  V30 36 1 27 29
M  V30 37 2 28 30
M  V30 38 2 29 31
M  V30 39 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 10 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 328396-54-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 436847-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9074071
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Phosphorylation Procedure: Synthesis
of (N)-Methanocarbaadenosine Derivatives (23-26). (1'S,2'
R,3'S,4'R,5'S)-4-(6-Amino-9H-purin-9-yl)-1-[(phenylmethoxy)
methyl]bicyclo[3.1.0]hexane-2,3-(O-isopropylidene) (23). To a solution of
21 (0.2 g, 0.47 mmol) in i-PrOH (3 mL) was added NH3 (2 M solution in
i-PrOH, 5 mL, 10 mmol), and the reaction mixture was heated at 90 °C in a
closed tube for 15 h for complete reaction. The resulting mixture was
concentrated under reduced pressure, and the residue obtained was
purified by flash chromatography using 9/1 CHCl3/MeOH. (1'S,2'
R,3'S,4'R,5'S)-4-(6-Methylamino-9H-purin-9-yl)-1-[(phenylmethoxy)methyl]bicyclo[3.1.0]hexane-2,3-(Oisopropylidene)
(24). 1H NMR (CDCl3) δ 8.41 (s, 1H), 8.22 (s, 1H), 7.40-7.30 (m, 5H),
6.01 (bs, 1H), 5.30 (d, 1H, J = 7.2 Hz), 5.12 (s, 1H), 4.62 (qAB 2H, J =
12.1, 20.9 Hz), 4.51 (d, 1H, J = 7.2 Hz), 3.94 (d, 1H, J = 9.9 Hz), 3.35
(d, 1H, J = 9.9 Hz), 3.21 (s, 3H), 1.70-1.62 (m, 1H), 1.55 (s, 3H),
1.29-1.25 (m, 1H), 1.22 (s, 3H), 0.98-0.92 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Adenine Nucleotide Analogues Locked in a Northern Methanocarba
Conformation: Enhanced Stability and Potency as P2Y1 Receptor Agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ravi, R. Gnana; Kim, Hak Sung; Servos, Joerg; Zimmermann, Herbert; Lee,
Kyeong; Maddileti, Savitri; Boyer, Jose L.; Harden, T. Kendall; Jacobson,
Kenneth A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2002), 45(10), 2090-2100

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[ethoxy[2-methoxy-5-(trimethylsilyl)phenyl]methylene]-...
C18H20CrO7Si
332847-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 7.6062 4.5653 0.0 0 CHG=2 VAL=7
M  V30 2 C 4.1627 6.5313 0.0 0 CHG=-2 VAL=4
M  V30 3 C 10.4439 4.5653 0.0 0
M  V30 4 C 4.7724 4.5653 0.0 0
M  V30 5 C 7.6062 1.7315 0.0 0
M  V30 6 C 10.0608 3.1504 0.0 0
M  V30 7 C 7.6062 7.3990 0.0 0
M  V30 8 O 4.1627 8.2902 0.0 0
M  V30 9 O 11.8588 4.5653 0.0 0 VAL=3
M  V30 10 O 3.3536 4.5653 0.0 0 VAL=3
M  V30 11 O 9.0250 1.7315 0.0 0 VAL=3
M  V30 12 O 11.4796 3.1504 0.0 0 VAL=3
M  V30 13 O 9.0250 7.3990 0.0 0 VAL=3
M  V30 14 C 5.3900 8.9977 0.0 0
M  V30 15 C 6.6173 8.2902 0.0 0
M  V30 16 O 1.6064 8.0088 0.0 0
M  V30 17 C 0.0000 8.9390 0.0 0
M  V30 18 Si 1.6064 2.0989 0.0 0
M  V30 19 C 0.0508 1.1999 0.0 0
M  V30 20 C 2.9393 1.3289 0.0 0
M  V30 21 C 1.6064 0.0000 0.0 0
M  V30 22 C 2.9354 5.8239 0.0 0
M  V30 23 C 1.6064 6.5939 0.0 0
M  V30 24 C 2.9354 4.2839 0.0 0
M  V30 25 C 0.2697 5.8239 0.0 0
M  V30 26 C 1.6064 3.5139 0.0 0
M  V30 27 C 0.2697 4.2839 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 22
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 23
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 26
M  V30 22 2 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 2 24 26
M  V30 26 2 25 27
M  V30 27 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, pentacarbonyl[[2-methoxy-5-(trimethylsilyl)phenyl](methylamino)meth...
C17H19CrNO6Si
332847-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cr 7.6177 4.5722 0.0 0 CHG=2 VAL=7
M  V30 2 C 4.1690 6.5412 0.0 0 CHG=-2 VAL=4
M  V30 3 C 10.4596 4.5722 0.0 0
M  V30 4 C 4.7796 4.5722 0.0 0
M  V30 5 C 7.6177 1.7302 0.0 0
M  V30 6 C 10.0760 3.1512 0.0 0
M  V30 7 C 7.6177 7.4102 0.0 0
M  V30 8 N 4.1690 7.9582 0.0 0
M  V30 9 O 11.8766 4.5722 0.0 0 VAL=3
M  V30 10 O 3.3587 4.5722 0.0 0 VAL=3
M  V30 11 O 9.0386 1.7302 0.0 0 VAL=3
M  V30 12 O 11.4969 3.1512 0.0 0 VAL=3
M  V30 13 O 9.0386 7.4102 0.0 0 VAL=3
M  V30 14 C 2.5131 8.9173 0.0 0
M  V30 15 O 1.6089 8.0208 0.0 0
M  V30 16 C 0.0000 8.9486 0.0 0
M  V30 17 Si 1.6089 2.0982 0.0 0
M  V30 18 C 0.0509 1.1978 0.0 0
M  V30 19 C 2.9437 1.3270 0.0 0
M  V30 20 C 1.6089 0.0000 0.0 0
M  V30 21 C 2.9398 5.8287 0.0 0
M  V30 22 C 1.6089 6.5999 0.0 0
M  V30 23 C 2.9398 4.2903 0.0 0
M  V30 24 C 0.2701 5.8287 0.0 0
M  V30 25 C 1.6089 3.5192 0.0 0
M  V30 26 C 0.2701 4.2903 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 1 6
M  V30 6 1 1 7
M  V30 7 1 2 8
M  V30 8 1 2 21
M  V30 9 3 3 9
M  V30 10 3 4 10
M  V30 11 3 5 11
M  V30 12 3 6 12
M  V30 13 3 7 13
M  V30 14 1 8 14
M  V30 15 1 15 16
M  V30 16 1 15 22
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 25
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 332847-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-3989934
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 45:55 syn:anti
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME137 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-ethoxy[2-methoxy-5-(trimethylsilyl)phenyl]meth...
C21H20Cr2O10Si
332847-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7335 0.7711 0.0 0
M  V30 2 O 7.5046 0.7711 0.0 0 VAL=3
M  V30 3 C 4.0656 0.7711 0.0 0
M  V30 4 O 3.2967 0.7711 0.0 0 VAL=3
M  V30 5 C 5.3996 0.0000 0.0 0
M  V30 6 O 6.1706 0.0000 0.0 0 VAL=3
M  V30 7 C 3.8617 9.5926 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 2.5277 10.3637 0.0 0 CHG=1 VAL=7
M  V30 9 O 4.5287 9.9792 0.0 0
M  V30 10 C 0.9856 10.3637 0.0 0
M  V30 11 C 4.9896 10.3637 0.0 0
M  V30 12 C 2.5277 11.9037 0.0 0
M  V30 13 C 1.1916 11.1347 0.0 0
M  V30 14 C 2.5277 8.8237 0.0 0
M  V30 15 C 5.1956 9.5926 0.0 0
M  V30 16 O 0.2145 10.3637 0.0 0 VAL=3
M  V30 17 O 5.7607 10.3637 0.0 0 VAL=3
M  V30 18 O 1.7567 11.9037 0.0 0 VAL=3
M  V30 19 O 0.4227 11.1347 0.0 0 VAL=3
M  V30 20 O 1.7567 8.8237 0.0 0 VAL=3
M  V30 21 C 5.8626 9.9792 0.0 0
M  V30 22 Si 9.9155 7.8041 0.0 0
M  V30 23 C 10.6398 7.3856 0.0 0
M  V30 24 C 9.9155 8.9426 0.0 0
M  V30 25 C 10.6398 8.2225 0.0 0
M  V30 26 O 0.7328 7.7722 0.0 0
M  V30 27 C 0.0000 7.3474 0.0 0
M  V30 28 Cr 5.3996 1.5421 0.0 0 CHG=1 VAL=9
M  V30 29 C 3.8617 8.8237 0.0 0 VAL=5
M  V30 30 C 9.1933 7.3856 0.0 0 VAL=5
M  V30 31 C 1.3998 7.3856 0.0 0 VAL=5
M  V30 32 C 6.7314 8.8237 0.0 0 VAL=5
M  V30 33 C 6.7314 5.9497 0.0 0 VAL=5
M  V30 34 C 3.8617 5.9497 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 28
M  V30 3 3 3 4
M  V30 4 1 3 28
M  V30 5 3 5 6
M  V30 6 1 5 28
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 29
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 15 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 25 1 22 30
M  V30 26 1 26 27
M  V30 27 1 26 31
M  V30 28 1 28 29
M  V30 29 1 28 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 32 1 28 33
M  V30 33 1 28 34
M  V30 34 1 29 31
M  V30 35 2 29 32
M  V30 36 1 30 32
M  V30 37 2 30 33
M  V30 38 2 31 34
M  V30 39 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chromium, octacarbonyl[μ-[η:η6-[2-methoxy-5-(trimethylsilyl)phenyl](methylami...
C20H19Cr2NO9Si
332847-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7318 0.7709 0.0 0
M  V30 2 O 7.5027 0.7709 0.0 0 VAL=3
M  V30 3 C 4.0646 0.7709 0.0 0
M  V30 4 O 3.2958 0.7709 0.0 0 VAL=3
M  V30 5 C 5.3982 0.0000 0.0 0
M  V30 6 O 6.1691 0.0000 0.0 0 VAL=3
M  V30 7 C 3.8607 9.5902 0.0 0 CHG=-2 VAL=4
M  V30 8 Cr 2.5271 10.3611 0.0 0 CHG=1 VAL=7
M  V30 9 N 4.5275 9.9767 0.0 0
M  V30 10 C 0.9854 10.3611 0.0 0
M  V30 11 C 5.9100 10.3611 0.0 0
M  V30 12 C 2.5271 11.9007 0.0 0
M  V30 13 C 1.1913 11.1319 0.0 0
M  V30 14 C 2.5271 8.8215 0.0 0
M  V30 15 C 5.2602 9.5520 0.0 0
M  V30 16 O 0.2145 10.3611 0.0 0 VAL=3
M  V30 17 O 6.6809 10.3611 0.0 0 VAL=3
M  V30 18 O 1.7562 11.9007 0.0 0 VAL=3
M  V30 19 O 0.4226 11.1319 0.0 0 VAL=3
M  V30 20 O 1.7562 8.8215 0.0 0 VAL=3
M  V30 21 O 0.7326 7.7703 0.0 0
M  V30 22 C 0.0000 7.3455 0.0 0
M  V30 23 Si 9.9130 7.8021 0.0 0
M  V30 24 C 10.6371 7.3838 0.0 0
M  V30 25 C 9.9130 8.9404 0.0 0
M  V30 26 C 10.6371 8.2205 0.0 0
M  V30 27 Cr 5.3982 1.5417 0.0 0 CHG=1 VAL=9
M  V30 28 C 3.8607 8.8215 0.0 0 VAL=5
M  V30 29 C 1.3995 7.3838 0.0 0 VAL=5
M  V30 30 C 9.1910 7.3838 0.0 0 VAL=5
M  V30 31 C 6.7297 8.8215 0.0 0 VAL=5
M  V30 32 C 3.8607 5.9482 0.0 0 VAL=5
M  V30 33 C 6.7297 5.9482 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 27
M  V30 3 3 3 4
M  V30 4 1 3 27
M  V30 5 3 5 6
M  V30 6 1 5 27
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 9
M  V30 9 1 7 28
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 3 10 16
M  V30 17 3 11 17
M  V30 18 3 12 18
M  V30 19 3 13 19
M  V30 20 3 14 20
M  V30 21 1 21 22
M  V30 22 1 21 29
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 30
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 27 31
M  V30 31 1 27 32
M  V30 32 1 27 33
M  V30 33 1 28 29
M  V30 34 2 28 31
M  V30 35 2 29 32
M  V30 36 1 30 31
M  V30 37 2 30 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 332847-69-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 332847-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-15203425
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Solution and solid state conformation of Fischer carbene complexes
vis-a-vis conformation of aryl carboxamides: complexation of the aromatic
ring by tricarbonylchromium makes a difference
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jayaprakash, K. N.; Hazra, Debasis; Hagen, Karl S.; Samanta, Uttamkumar;
Bhadbhade, Mohan M.; Puranik, Vedavati G.; Sarkar, Amitabha
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2001), 617-618709-722

$RFMT $RIREG SCHEME138 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-5-hydroxy-1-methyl-2-[(methylamino)methyl]-1H-indole-3-carboxylate
C14H17BrN2O3
332905-14-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2709 5.6420 0.0 0
M  V30 2 O 8.7356 5.1662 0.0 0
M  V30 3 O 6.9507 7.1485 0.0 0
M  V30 4 C 9.8800 6.1966 0.0 0
M  V30 5 C 11.3447 5.7207 0.0 0
M  V30 6 C 7.6211 2.3100 0.0 0
M  V30 7 N 7.6211 0.7700 0.0 0
M  V30 8 C 8.9549 0.0000 0.0 0
M  V30 9 C 4.5603 0.9473 0.0 0
M  V30 10 O 1.5400 7.5991 0.0 0
M  V30 11 Br 0.0000 4.9318 0.0 0
M  V30 12 C 4.6201 4.9318 0.0 0
M  V30 13 C 6.1265 4.6116 0.0 0
M  V30 14 C 3.8501 3.5981 0.0 0
M  V30 15 C 3.8501 6.2654 0.0 0
M  V30 16 C 6.2875 3.0800 0.0 0
M  V30 17 N 4.8806 2.4536 0.0 0
M  V30 18 C 2.3100 3.5981 0.0 0
M  V30 19 C 2.3100 6.2654 0.0 0
M  V30 20 C 1.5400 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 1 9 17
M  V30 10 1 10 19
M  V30 11 1 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 17
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-1,2,3,7-tetrahydro-2-methyl-8-[(methylamino)methyl]pyrrolo[3,2-...
C16H20BrN3O3
1641586-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 5.6421 0.0 0
M  V30 2 O 8.7355 5.1662 0.0 0
M  V30 3 O 6.9506 7.1484 0.0 0
M  V30 4 C 9.8799 6.1967 0.0 0
M  V30 5 C 11.3446 5.7208 0.0 0
M  V30 6 C 7.6210 2.3100 0.0 0
M  V30 7 N 7.6210 0.7700 0.0 0
M  V30 8 C 8.9548 0.0000 0.0 0
M  V30 9 Br 0.0000 4.9319 0.0 0
M  V30 10 C 4.6200 10.2666 0.0 0
M  V30 11 C 4.6200 4.9319 0.0 0
M  V30 12 C 3.8500 6.2655 0.0 0
M  V30 13 C 6.1264 4.6117 0.0 0
M  V30 14 C 3.8500 3.5981 0.0 0
M  V30 15 C 2.3100 6.2655 0.0 0
M  V30 16 C 4.6200 7.5991 0.0 0
M  V30 17 C 6.2874 3.0800 0.0 0
M  V30 18 N 4.8806 2.4537 0.0 0
M  V30 19 C 2.3100 3.5981 0.0 0
M  V30 20 C 1.5400 4.9319 0.0 0
M  V30 21 O 1.5400 7.5991 0.0 0
M  V30 22 N 3.8500 8.9328 0.0 0
M  V30 23 C 2.3100 8.9328 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 9 20
M  V30 10 1 10 22
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 15 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 332905-14-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1641586-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-3392832
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-methoxy-1-methyl-1H-indole-2-carboxylate
C12H13NO3
335032-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2794 0.0000 0.0 0
M  V30 2 C 2.3100 2.7104 0.0 0
M  V30 3 O 1.5400 4.0442 0.0 0
M  V30 4 O 1.5400 1.3768 0.0 0
M  V30 5 C 0.0000 4.0442 0.0 0
M  V30 6 O 10.2208 1.1704 0.0 0
M  V30 7 C 11.5546 1.9404 0.0 0
M  V30 8 C 6.2199 1.9404 0.0 0
M  V30 9 C 6.2199 3.4804 0.0 0
M  V30 10 N 4.7552 1.4645 0.0 0
M  V30 11 C 7.5535 1.1704 0.0 0
M  V30 12 C 4.7552 3.9564 0.0 0
M  V30 13 C 7.5535 4.2504 0.0 0
M  V30 14 C 3.8500 2.7104 0.0 0
M  V30 15 C 8.8872 1.9404 0.0 0
M  V30 16 C 8.8872 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-N,1-dimethyl-1H-indole-2-carboxamide
C12H14N2O2
335032-60-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2794 0.0000 0.0 0
M  V30 2 C 2.3100 2.7104 0.0 0
M  V30 3 N 1.5400 4.0442 0.0 0
M  V30 4 O 1.5400 1.3768 0.0 0
M  V30 5 C 0.0000 4.0442 0.0 0
M  V30 6 O 10.2208 1.1704 0.0 0
M  V30 7 C 11.5546 1.9404 0.0 0
M  V30 8 C 6.2199 1.9404 0.0 0
M  V30 9 C 6.2199 3.4804 0.0 0
M  V30 10 N 4.7552 1.4645 0.0 0
M  V30 11 C 7.5535 1.1704 0.0 0
M  V30 12 C 4.7552 3.9564 0.0 0
M  V30 13 C 7.5535 4.2504 0.0 0
M  V30 14 C 3.8500 2.7104 0.0 0
M  V30 15 C 8.8872 1.9404 0.0 0
M  V30 16 C 8.8872 3.4804 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 1 13 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 335032-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 335032-60-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8093215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: b) N,1-Dimethyl-1 H-indole-2-carboxamide. A
suspension of ethyl 1-methyl-1H-indole-2-carboxylate (27.10 g, 133.34
mmole) in 40% aqueous CH3NH2 (300 mL) and MeOH (30 mL) was stirred at RT.
A solid tended to gradually creep up the walls of the flask, and was
washed down periodically with MeOH. The flask was tightly stoppered to
keep the material inside the flask. As the reaction proceeded, the solid
dissolved, but eventually the product began to precipitate. The reaction
was stirred at RT for 5 days, then was concentrated to remove
approximately 200 25 mL of the solvent. The remaining residue was diluted
with H2O (300 mL), and the solid was collected by suction filtration and
washed with H2O. Drying at 50-60°C in high vacuum left the title
compound. N,1-Dimethyl-6-methoxy-1H-indole-2-carboxamide. According to
the procedure of Preparation 1 (b), except substituting
methyl-1-methyl-6-methoxy-1H-indole-2-carboxylate for
ethyl-1-methyl-1H-indole-2-carboxylate, the title compound (95%) was
prepared as an off-white solid. MS (ES) m/e 219.2 (M + H)+ and 437.4 (2M
+ H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-heteroarylmethyl acrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas,
Irene N.; Dewolf, Walter E., Jr.; Jakas, Dalia R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001027103 A1 2001-04-19

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Methyl 6-[1-hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidazol-4-yl]propyl]-...
C39H36N2O3
337521-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 C 7.6286 8.0297 0.0 0
M  V30 3 C 8.2549 9.4367 0.0 0
M  V30 4 O 6.2217 8.6562 0.0 0
M  V30 5 C 7.3498 10.6826 0.0 0
M  V30 6 C 9.7866 9.5976 0.0 0
M  V30 7 C 13.4171 3.9927 0.0 0
M  V30 8 C 15.9089 5.8030 0.0 0
M  V30 9 O 17.1549 6.7082 0.0 0
M  V30 10 O 16.0699 4.2714 0.0 0
M  V30 11 C 18.5617 6.0819 0.0 0
M  V30 12 N 5.3348 4.7712 0.0 0
M  V30 13 C 5.4958 6.3027 0.0 0
M  V30 14 C 6.7417 4.1447 0.0 0
M  V30 15 C 7.0022 6.6229 0.0 0
M  V30 16 N 7.7722 5.2892 0.0 0
M  V30 17 C 4.7712 2.6673 0.0 0
M  V30 18 C 6.3112 2.6673 0.0 0
M  V30 19 C 4.0012 1.3337 0.0 0
M  V30 20 C 7.0812 1.3337 0.0 0
M  V30 21 C 4.7712 0.0000 0.0 0
M  V30 22 C 6.3112 0.0000 0.0 0
M  V30 23 C 2.6673 3.2311 0.0 0
M  V30 24 C 2.6673 1.6911 0.0 0
M  V30 25 C 1.3337 4.0012 0.0 0
M  V30 26 C 1.3337 0.9211 0.0 0
M  V30 27 C 0.0000 3.2311 0.0 0
M  V30 28 C 0.0000 1.6911 0.0 0
M  V30 29 C 3.2311 5.3348 0.0 0
M  V30 30 C 1.6911 5.3348 0.0 0
M  V30 31 C 4.0012 6.6685 0.0 0
M  V30 32 C 0.9211 6.6685 0.0 0
M  V30 33 C 3.2311 8.0022 0.0 0
M  V30 34 C 1.6911 8.0022 0.0 0
M  V30 35 C 9.0354 7.4034 0.0 0
M  V30 36 C 10.2814 8.3086 0.0 0
M  V30 37 C 9.1965 5.8718 0.0 0
M  V30 38 C 11.6882 7.6823 0.0 0
M  V30 39 C 10.6033 5.2455 0.0 0
M  V30 40 C 11.8492 6.1506 0.0 0
M  V30 41 C 12.9341 8.5874 0.0 0
M  V30 42 C 13.2561 5.5243 0.0 0
M  V30 43 C 14.3411 7.9611 0.0 0
M  V30 44 C 14.5020 6.4295 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 1 29
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 2 15
M  V30 8 1 2 35
M  V30 9 1 3 5
M  V30 10 1 3 6
M  V30 11 1 7 42
M  V30 12 1 8 9
M  V30 13 2 8 10
M  V30 14 1 8 44
M  V30 15 1 9 11
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 38 41
M  V30 45 1 39 40
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[1-Hydroxy-2-methyl-1-[1-(triphenylmethyl)-1H-imidazol-4-yl]propyl]-N,1-dim...
C39H37N3O2
337522-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 4.0012 0.0 0
M  V30 2 C 7.6286 8.0297 0.0 0
M  V30 3 C 8.2549 9.4367 0.0 0
M  V30 4 O 6.2217 8.6562 0.0 0
M  V30 5 C 9.7866 9.5976 0.0 0
M  V30 6 C 7.3498 10.6826 0.0 0
M  V30 7 C 13.4171 3.9927 0.0 0
M  V30 8 C 15.9089 5.8030 0.0 0
M  V30 9 N 17.1549 6.7082 0.0 0
M  V30 10 O 16.0699 4.2714 0.0 0
M  V30 11 C 18.5617 6.0819 0.0 0
M  V30 12 N 5.3348 4.7712 0.0 0
M  V30 13 C 5.4958 6.3027 0.0 0
M  V30 14 C 6.7417 4.1447 0.0 0
M  V30 15 C 7.0022 6.6229 0.0 0
M  V30 16 N 7.7722 5.2892 0.0 0
M  V30 17 C 4.7712 2.6673 0.0 0
M  V30 18 C 4.0012 1.3337 0.0 0
M  V30 19 C 6.3112 2.6673 0.0 0
M  V30 20 C 4.7712 0.0000 0.0 0
M  V30 21 C 7.0812 1.3337 0.0 0
M  V30 22 C 6.3112 0.0000 0.0 0
M  V30 23 C 2.6673 3.2311 0.0 0
M  V30 24 C 2.6673 1.6911 0.0 0
M  V30 25 C 1.3337 4.0012 0.0 0
M  V30 26 C 1.3337 0.9211 0.0 0
M  V30 27 C 0.0000 3.2311 0.0 0
M  V30 28 C 0.0000 1.6911 0.0 0
M  V30 29 C 3.2311 5.3348 0.0 0
M  V30 30 C 1.6911 5.3348 0.0 0
M  V30 31 C 4.0012 6.6685 0.0 0
M  V30 32 C 0.9211 6.6685 0.0 0
M  V30 33 C 3.2311 8.0022 0.0 0
M  V30 34 C 1.6911 8.0022 0.0 0
M  V30 35 C 9.0354 7.4034 0.0 0
M  V30 36 C 10.2814 8.3086 0.0 0
M  V30 37 C 9.1965 5.8718 0.0 0
M  V30 38 C 11.6882 7.6823 0.0 0
M  V30 39 C 10.6033 5.2455 0.0 0
M  V30 40 C 11.8492 6.1506 0.0 0
M  V30 41 C 12.9341 8.5874 0.0 0
M  V30 42 C 13.2561 5.5243 0.0 0
M  V30 43 C 14.3411 7.9611 0.0 0
M  V30 44 C 14.5020 6.4295 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 17
M  V30 3 1 1 23
M  V30 4 1 1 29
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 2 15
M  V30 8 1 2 35
M  V30 9 1 3 5
M  V30 10 1 3 6
M  V30 11 1 7 42
M  V30 12 1 8 9
M  V30 13 2 8 10
M  V30 14 1 8 44
M  V30 15 1 9 11
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 2 13 15
M  V30 19 2 14 16
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 38 41
M  V30 45 1 39 40
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 337521-16-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 337522-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10005054
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 17,20-Lyase inhibitors. Part 4: Design, synthesis and structure-activity
relationships of naphthylmethylimidazole derivatives as novel 17,20-lyase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaku, Tomohiro; Matsunaga, Nobuyuki; Ojida, Akio; Tanaka, Toshimasa;
Hara, Takahito; Yamaoka, Masuo; Kusaka, Masami; Tasaka, Akihiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(5), 1751-1770

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
L-Alanine, N-[(phenylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester
C15H16N2O6
3401-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7711 3.3320 0.0 0
M  V30 2 C 5.1049 2.5620 0.0 0
M  V30 3 C 6.4386 3.3320 0.0 0 CFG=2
M  V30 4 O 5.1049 1.0220 0.0 0
M  V30 5 N 7.7722 2.5620 0.0 0
M  V30 6 C 6.4386 4.8720 0.0 0
M  V30 7 C 9.1059 3.3320 0.0 0
M  V30 8 O 10.4397 2.5620 0.0 0
M  V30 9 O 9.1059 4.8720 0.0 0
M  V30 10 C 11.7734 3.3320 0.0 0
M  V30 11 O 0.7104 4.6948 0.0 0
M  V30 12 O 3.4209 0.0000 0.0 0
M  V30 13 N 2.4374 2.5620 0.0 0
M  V30 14 C 1.0306 3.1885 0.0 0
M  V30 15 C 2.2765 1.0304 0.0 0
M  V30 16 C 0.0000 2.0439 0.0 0
M  V30 17 C 0.7700 0.7103 0.0 0
M  V30 18 C 13.1070 2.5620 0.0 0
M  V30 19 C 13.1070 1.0220 0.0 0
M  V30 20 C 14.4407 3.3320 0.0 0
M  V30 21 C 14.4407 0.2519 0.0 0
M  V30 22 C 15.7745 2.5620 0.0 0
M  V30 23 C 15.7745 1.0220 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6 CFG=3
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 18
M  V30 12 2 11 14
M  V30 13 2 12 15
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[(1S)-1-methyl-2-(methylamino)-2-oxoethyl]carbamate
C12H16N2O3
33628-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 N 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0 CFG=1
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 9.3360 4.6201 0.0 0
M  V30 9 N 12.0033 3.0801 0.0 0
M  V30 10 O 10.6697 0.7700 0.0 0
M  V30 11 C 13.3370 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 1.3337 3.0801 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8 CFG=1
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3401-36-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33628-84-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4051415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electron transfer-initiated asymmetric photocyclization of chiral
auxiliary-substituted N-acyl-α-dehydro(1-naphthyl)alaninamides to the
corresponding 3,4-dihydrobenzo[f]quinolinone derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maekawa, Kei; Kubo, Kanji; Igarashi, Tetsutaro; Sakurai, Tadamitsu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2005), 61(47), 11211-11224

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (3S,4S,21R)-9,14-diethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20...
C36H40N4O5
34278-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 50 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 12.5587 10.4617 0.0 0
M  V30 2 O 13.3545 11.7801 0.0 0
M  V30 3 O 13.3026 9.1133 0.0 0
M  V30 4 C 14.8942 11.7500 0.0 0
M  V30 5 C 13.2506 7.9123 0.0 0
M  V30 6 C 14.5842 7.1423 0.0 0
M  V30 7 C 15.9179 7.9123 0.0 0
M  V30 8 O 17.2515 7.1423 0.0 0
M  V30 9 O 15.9179 9.4523 0.0 0
M  V30 10 C 18.5851 7.9123 0.0 0
M  V30 11 O 10.6108 13.2190 0.0 0
M  V30 12 C 6.5347 13.1063 0.0 0
M  V30 13 C 12.8944 4.5657 0.0 0
M  V30 14 C 1.4520 9.3736 0.0 0
M  V30 15 C 0.0000 8.8609 0.0 0
M  V30 16 C 8.0290 0.9152 0.0 0
M  V30 17 C 1.1932 6.0137 0.0 0
M  V30 18 C 4.7084 1.4948 0.0 0
M  V30 19 C 5.0785 0.0000 0.0 0
M  V30 20 C 10.0582 9.2448 0.0 0
M  V30 21 C 8.6673 9.7398 0.0 0
M  V30 22 C 10.5004 7.7712 0.0 0
M  V30 23 C 11.0190 10.4917 0.0 0 CFG=1
M  V30 24 C 8.6247 11.2945 0.0 0
M  V30 25 N 7.2985 9.1677 0.0 0
M  V30 26 C 11.9170 7.1423 0.0 0 CFG=1
M  V30 27 N 9.4615 6.6201 0.0 0
M  V30 28 C 10.1183 11.7599 0.0 0
M  V30 29 C 7.1081 11.6770 0.0 0
M  V30 30 C 6.2815 10.3601 0.0 0
M  V30 31 C 11.7531 5.5996 0.0 0 CFG=2
M  V30 32 C 10.2346 5.2850 0.0 0
M  V30 33 C 4.7739 10.1092 0.0 0
M  V30 34 C 9.5581 3.9235 0.0 0
M  V30 35 C 4.1309 8.7294 0.0 0
M  V30 36 C 8.0652 3.6708 0.0 0
M  V30 37 C 2.6221 8.3723 0.0 0
M  V30 38 N 4.9414 7.4112 0.0 0
M  V30 39 N 6.9903 4.7808 0.0 0
M  V30 40 C 7.3475 2.2961 0.0 0
M  V30 41 C 2.5024 6.8246 0.0 0
M  V30 42 C 3.9408 6.2427 0.0 0
M  V30 43 C 5.6101 4.1003 0.0 0
M  V30 44 C 5.8180 2.5628 0.0 0
M  V30 45 C 4.2779 4.7828 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 26 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 28
M  V30 12 1 12 29
M  V30 13 1 31 13 CFG=3
M  V30 14 1 14 15
M  V30 15 1 14 37
M  V30 16 1 16 40
M  V30 17 1 17 41
M  V30 18 1 18 19
M  V30 19 1 18 44
M  V30 20 1 20 21
M  V30 21 2 20 22
M  V30 22 1 20 23
M  V30 23 2 21 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 22 27
M  V30 27 1 23 28
M  V30 28 1 24 28
M  V30 29 1 24 29
M  V30 30 1 25 30
M  V30 31 1 26 31
M  V30 32 2 27 32
M  V30 33 2 29 30
M  V30 34 1 30 33
M  V30 35 1 31 32
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 37
M  V30 40 1 35 38
M  V30 41 1 36 39
M  V30 42 1 36 40
M  V30 43 2 37 41
M  V30 44 2 38 42
M  V30 45 1 39 43
M  V30 46 2 40 44
M  V30 47 1 41 42
M  V30 48 1 42 45
M  V30 49 1 43 44
M  V30 50 2 43 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 23 26 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
21H,23H-Porphine-7-propanoic acid, 13,18-diethyl-7,8-dihydro-5-(2-methoxy-2-o...
C37H45N5O5
507230-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.4123 11.7595 0.0 0
M  V30 2 C 11.9439 11.9205 0.0 0
M  V30 3 O 12.5704 13.3273 0.0 0
M  V30 4 O 12.8491 10.6746 0.0 0
M  V30 5 C 14.1019 13.4884 0.0 0
M  V30 6 C 8.4232 13.4132 0.0 0
M  V30 7 N 7.6532 14.7471 0.0 0
M  V30 8 O 9.9632 13.4132 0.0 0
M  V30 9 C 8.4232 16.0807 0.0 0
M  V30 10 C 5.0910 13.0630 0.0 0
M  V30 11 C 13.3914 9.0757 0.0 0
M  V30 12 C 14.5176 8.0254 0.0 0
M  V30 13 C 15.9903 8.4757 0.0 0
M  V30 14 O 17.1167 7.4254 0.0 0
M  V30 15 O 16.3368 9.9762 0.0 0
M  V30 16 C 18.5894 7.8756 0.0 0
M  V30 17 C 13.4132 6.3238 0.0 0
M  V30 18 C 1.3337 8.4232 0.0 0
M  V30 19 C 0.0000 7.6532 0.0 0
M  V30 20 C 1.6839 5.0910 0.0 0
M  V30 21 C 9.6560 1.6839 0.0 0
M  V30 22 C 6.3238 1.3337 0.0 0
M  V30 23 C 7.0939 0.0000 0.0 0
M  V30 24 C 8.2795 10.6727 0.0 0
M  V30 25 C 9.7860 10.3526 0.0 0
M  V30 26 C 7.6532 12.0796 0.0 0
M  V30 27 N 7.1350 9.6423 0.0 0
M  V30 28 C 10.4123 8.9456 0.0 0
M  V30 29 C 6.1215 11.9186 0.0 0
M  V30 30 C 5.8013 10.4123 0.0 0
M  V30 31 C 11.9186 8.6254 0.0 0 CFG=1
M  V30 32 N 9.6423 7.6119 0.0 0
M  V30 33 C 4.3943 9.7860 0.0 0
M  V30 34 C 12.0796 7.0939 0.0 0 CFG=2
M  V30 35 C 10.6727 6.4675 0.0 0
M  V30 36 C 4.0743 8.2795 0.0 0
M  V30 37 C 10.3526 4.9611 0.0 0
M  V30 38 C 2.6675 7.6532 0.0 0
M  V30 39 N 5.1047 7.1351 0.0 0
M  V30 40 C 8.9456 4.3347 0.0 0
M  V30 41 C 2.8284 6.1215 0.0 0
M  V30 42 C 4.3347 5.8013 0.0 0
M  V30 43 N 7.6119 5.1047 0.0 0
M  V30 44 C 8.6254 2.8284 0.0 0
M  V30 45 C 4.9611 4.3943 0.0 0
M  V30 46 C 6.4675 4.0743 0.0 0
M  V30 47 C 7.0939 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 26
M  V30 9 1 7 9
M  V30 10 1 10 29
M  V30 11 1 11 12
M  V30 12 1 31 11 CFG=1
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 34 17 CFG=3
M  V30 18 1 18 19
M  V30 19 1 18 38
M  V30 20 1 20 41
M  V30 21 1 21 44
M  V30 22 1 22 23
M  V30 23 1 22 47
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 1 24 27
M  V30 27 2 25 28
M  V30 28 1 26 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 1 28 32
M  V30 32 2 29 30
M  V30 33 1 30 33
M  V30 34 1 31 34
M  V30 35 2 32 35
M  V30 36 2 33 36
M  V30 37 1 34 35
M  V30 38 1 35 37
M  V30 39 1 36 38
M  V30 40 1 36 39
M  V30 41 2 37 40
M  V30 42 2 38 41
M  V30 43 2 39 42
M  V30 44 1 40 43
M  V30 45 1 40 44
M  V30 46 1 41 42
M  V30 47 1 42 45
M  V30 48 1 43 46
M  V30 49 2 44 47
M  V30 50 2 45 46
M  V30 51 1 46 47
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 31 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34278-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 507230-55-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-160-CAS-9361714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of chlorin photosensitizing agents for use in photodynamic
therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Robinson, Byron C.; Phadke, Avinash; Small, Ward
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003028629 A2 2003-04-10

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzyl bromide
C7H6Br2
3433-80-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 Br 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzylamine
C8H10BrN
698-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3433-80-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-897793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Use of compounds having an amine nucleus in manufacture of a medicament
useful for treating factor VIIa-associated conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Herpin, Timothy; Bisacchi, Gregory S.; Pi, Zulan; Priestley, E. Scott;
Dhar, T. G. Murali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004000214 A2 2003-12-31

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (βR)-β-(3-cyclohexylpropyl)-3-[[[(4-methylphenyl)sulfonyl]o...
C26H38N2O6S
348623-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.4130 6.9302 0.0 0 CFG=2
M  V30 2 C 12.7467 7.7002 0.0 0
M  V30 3 C 11.4130 5.3901 0.0 0
M  V30 4 C 14.0804 6.9302 0.0 0
M  V30 5 C 10.0794 4.6201 0.0 0
M  V30 6 O 15.4142 7.7002 0.0 0
M  V30 7 O 14.0804 5.3901 0.0 0
M  V30 8 C 10.0794 3.0801 0.0 0
M  V30 9 C 16.7479 6.9302 0.0 0
M  V30 10 C 15.9779 5.5965 0.0 0
M  V30 11 C 18.0815 6.1601 0.0 0
M  V30 12 C 17.5179 8.2638 0.0 0
M  V30 13 C 7.7855 10.9589 0.0 0
M  V30 14 O 6.2539 11.1198 0.0 0
M  V30 15 S 5.6276 12.5268 0.0 0 VAL=6
M  V30 16 O 5.0011 13.9336 0.0 0
M  V30 17 O 7.0344 13.1531 0.0 0
M  V30 18 C 0.0000 10.0212 0.0 0
M  V30 19 C 10.0794 7.7002 0.0 0
M  V30 20 N 9.9183 9.2317 0.0 0
M  V30 21 O 8.6724 7.0738 0.0 0
M  V30 22 C 8.4120 9.5519 0.0 0
M  V30 23 N 7.6420 8.2182 0.0 0
M  V30 24 C 8.7455 2.3101 0.0 0
M  V30 25 C 8.7455 0.7700 0.0 0
M  V30 26 C 7.4119 3.0801 0.0 0
M  V30 27 C 7.4119 0.0000 0.0 0
M  V30 28 C 6.0782 2.3101 0.0 0
M  V30 29 C 6.0782 0.7700 0.0 0
M  V30 30 C 4.2206 11.9003 0.0 0
M  V30 31 C 4.0597 10.3687 0.0 0
M  V30 32 C 2.9747 12.8055 0.0 0
M  V30 33 C 2.6529 9.7424 0.0 0
M  V30 34 C 1.5679 12.1792 0.0 0
M  V30 35 C 1.4068 10.6475 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 22
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 2 15 17
M  V30 19 1 15 30
M  V30 20 1 18 35
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (βR)-β-(3-cyclohexylpropyl)-3-[(methylamino)methyl]-1,2,4-o...
C20H35N3O3
438630-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 8.0022 0.0 0 CFG=2
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 C 3.8500 9.3358 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 O 3.0800 10.6695 0.0 0
M  V30 7 O 3.0800 8.0022 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 1.5400 10.6695 0.0 0
M  V30 10 C 1.5400 9.1295 0.0 0
M  V30 11 C 0.0000 10.6695 0.0 0
M  V30 12 C 1.5400 12.2095 0.0 0
M  V30 13 C 11.3157 9.6773 0.0 0
M  V30 14 N 12.7226 9.0509 0.0 0
M  V30 15 C 13.9685 9.9562 0.0 0
M  V30 16 C 7.7000 8.0022 0.0 0
M  V30 17 N 8.6053 9.2481 0.0 0
M  V30 18 O 8.6053 6.7562 0.0 0
M  V30 19 C 10.0698 8.7722 0.0 0
M  V30 20 N 10.0698 7.2322 0.0 0
M  V30 21 C 6.1600 2.6673 0.0 0
M  V30 22 C 7.7000 2.6673 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 8.4700 1.3336 0.0 0
M  V30 25 C 6.1600 0.0000 0.0 0
M  V30 26 C 7.7000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 21
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 19
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 348623-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 438630-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3397952
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 41: tert-butyl
(3R)-6-cyclohexyl-3-{3-[(methylamino)methyl]-1,2,4-oxadiazol-5-
yl}hexanoate (103) (76: R = CH2NHMe). A solution of compound 99 (492mg,
0.97mmol) in THF (1ml) was treated with a solution of 2M methylamine in
THF (7ml, 14.4mmol) and stirred at 40°C in a sealed vessel for 75
minutes. The reaction mixture was allowed to cool to room temprature and
dissolved in EtOAc (100ml) which was washed with sat. NaHCO3 (100ml)
solution followed by brine. The organic extract was dried over MgSO4,
filtered and the solvent was removed under reduced pressure to afford the
title compound as a colourless oil (337mg, 95%). tert-butyl
(3R)-6-cyclohexyl-3-{3-[(methylamino)methyl]-1,2,4-oxadiazol-5-
yl}hexanoate (103) (76: R = CH2NHMe), yield (337mg, 95%) 1H nmr : (CDCl3)
0.82 (2H, m), 1.10-1.35 (8H, m), 1.39 (9H, s), 1.55-1.80 (7H, m), 2.43
(3H, s), 2.60 (1H, dd), 2.79 (1H, dd), 3.43 (1H, m), 3.83 (2H, s); MS :
366 (MH+); CHN : Found: C65.32%; H9.67%; N11.22%; C20H35N3O3 requires
C65.72%; H9.65%; N11.50%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Nonpeptidic Inhibitors of Procollagen C-Proteinase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fish, Paul V.; Allan, Gillian A.; Bailey, Simon; Blagg, Julian; Butt,
Richard; Collis, Michael G.; Greiling, Doris; James, Kim; Kendall,
Jackie; McElroy, Andrew; McCleverty, Dawn; Reed, Charlotte; Webster,
Robert; Whitlock, Gavin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2007), 50(15), 3442-3456

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (βR)-β-(3-cyclohexylpropyl)-3-[[[(4-methylphenyl)sulfonyl]o...
C26H38N2O6S
348623-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.4130 6.9302 0.0 0 CFG=2
M  V30 2 C 12.7467 7.7002 0.0 0
M  V30 3 C 11.4130 5.3901 0.0 0
M  V30 4 C 14.0804 6.9302 0.0 0
M  V30 5 C 10.0794 4.6201 0.0 0
M  V30 6 O 15.4142 7.7002 0.0 0
M  V30 7 O 14.0804 5.3901 0.0 0
M  V30 8 C 10.0794 3.0801 0.0 0
M  V30 9 C 16.7479 6.9302 0.0 0
M  V30 10 C 15.9779 5.5965 0.0 0
M  V30 11 C 18.0815 6.1601 0.0 0
M  V30 12 C 17.5179 8.2638 0.0 0
M  V30 13 C 7.7855 10.9589 0.0 0
M  V30 14 O 6.2539 11.1198 0.0 0
M  V30 15 S 5.6276 12.5268 0.0 0 VAL=6
M  V30 16 O 5.0011 13.9336 0.0 0
M  V30 17 O 7.0344 13.1531 0.0 0
M  V30 18 C 0.0000 10.0212 0.0 0
M  V30 19 C 10.0794 7.7002 0.0 0
M  V30 20 N 9.9183 9.2317 0.0 0
M  V30 21 O 8.6724 7.0738 0.0 0
M  V30 22 C 8.4120 9.5519 0.0 0
M  V30 23 N 7.6420 8.2182 0.0 0
M  V30 24 C 8.7455 2.3101 0.0 0
M  V30 25 C 8.7455 0.7700 0.0 0
M  V30 26 C 7.4119 3.0801 0.0 0
M  V30 27 C 7.4119 0.0000 0.0 0
M  V30 28 C 6.0782 2.3101 0.0 0
M  V30 29 C 6.0782 0.7700 0.0 0
M  V30 30 C 4.2206 11.9003 0.0 0
M  V30 31 C 4.0597 10.3687 0.0 0
M  V30 32 C 2.9747 12.8055 0.0 0
M  V30 33 C 2.6529 9.7424 0.0 0
M  V30 34 C 1.5679 12.1792 0.0 0
M  V30 35 C 1.4068 10.6475 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 24
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 22
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 2 15 17
M  V30 19 1 15 30
M  V30 20 1 18 35
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 32 2 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 2 32 34
M  V30 36 2 33 35
M  V30 37 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (βR)-β-(3-cyclohexylpropyl)-3-[(methylamino)methyl]-1,2,4-o...
C20H35N3O3
438630-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 8.0022 0.0 0 CFG=2
M  V30 2 C 5.3900 9.3358 0.0 0
M  V30 3 C 5.3900 6.6684 0.0 0
M  V30 4 C 3.8500 9.3358 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 O 3.0800 10.6695 0.0 0
M  V30 7 O 3.0800 8.0022 0.0 0
M  V30 8 C 5.3900 4.0011 0.0 0
M  V30 9 C 1.5400 10.6695 0.0 0
M  V30 10 C 1.5400 9.1295 0.0 0
M  V30 11 C 0.0000 10.6695 0.0 0
M  V30 12 C 1.5400 12.2095 0.0 0
M  V30 13 C 11.3157 9.6773 0.0 0
M  V30 14 N 12.7226 9.0509 0.0 0
M  V30 15 C 13.9685 9.9562 0.0 0
M  V30 16 C 7.7000 8.0022 0.0 0
M  V30 17 N 8.6053 9.2481 0.0 0
M  V30 18 O 8.6053 6.7562 0.0 0
M  V30 19 C 10.0698 8.7722 0.0 0
M  V30 20 N 10.0698 7.2322 0.0 0
M  V30 21 C 6.1600 2.6673 0.0 0
M  V30 22 C 7.7000 2.6673 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 8.4700 1.3336 0.0 0
M  V30 25 C 6.1600 0.0000 0.0 0
M  V30 26 C 7.7000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 21
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 19
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 348623-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 438630-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2092089
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-butyl(3R)-6-cyclohexyl-3-{3-[(methylamino)methyl]-1,2,4-oxadiazol-5-yl}hexanoate
A solution of
tert-butyl(3R)-6-cyclohexyl-3-[3-({[(4-methylphenyl)sulfonyl]oxy}methyl)-1,2,4-oxadiazol-5-yl]hexanoate
(preparation 177) (492 mg, 0.97 mmol) in THF (1 ml) was treated with a
solution of 2M methylamine in THF (7 ml, 14.4 mmol) and stirred at 40° C.
in a sealed vessel for 75 minutes. The reaction mixture was allowed to
cool to room temprature and dissolved in EtOAc (100 ml) which was washed
with sat. NaHCO3 (100 ml) solution followed by brine. The organic extract
was dried over MgSO4, filtered and the solvent was removed under reduced
pressure. The title compound as a colourless oil (337 mg, 95%). 1H nmr:
(CDCl3) 0.82 (2H, m), 1.10-1.35 (8H, m), 1.39 (9H, s), 1.55-1.80 (7H, m),
2.43 (3H, s), 2.60 (1H, dd), 2.79 (1H, dd), 3.43 (1H, m), 3.83 (2H, s).
MS: 366 (MH+), CHN: Found: C, 65.32%; H, 9.67%; N, 11.22%; C20H35N3O3
requires C, 65.72%; H, 9.65%; N, 11.50%.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-oxa(di)azolylpropanohydroxamic acids as procollagen
c-proteinase inhibitors for treatment of wounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Datta, Usa; Fish, Paul Vincent; James, Kim; Whitlock, Gavin Alistair
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002050046 A1 2002-06-27

$RFMT $RIREG SCHEME145 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-methoxy-α,γ-dioxobenzenebutanoate
C13H14O5
35322-20-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 0.0000 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 9.3358 0.0000 0.0 0
M  V30 7 O 12.0033 1.5400 0.0 0
M  V30 8 O 10.6697 3.8501 0.0 0
M  V30 9 C 13.3370 2.3101 0.0 0
M  V30 10 C 14.6707 1.5400 0.0 0
M  V30 11 O 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 1.5400 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,5′-[5H]pyrrolo[3,4-d]pyrimidine]-2,7′(1H,6′H)-dione, 3′-(1,...
C25H26N4O4
2925703-73-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3628 3.0917 0.0 0
M  V30 2 O 5.9660 6.0811 0.0 0
M  V30 3 O 5.1840 5.3286 0.0 0
M  V30 4 O 0.0000 6.1525 0.0 0
M  V30 5 C 6.4072 9.4917 0.0 0
M  V30 6 C 7.4962 10.5808 0.0 0
M  V30 7 C 7.4962 8.4028 0.0 0
M  V30 8 C 5.3183 10.5808 0.0 0
M  V30 9 O 11.2684 5.2685 0.0 0
M  V30 10 C 12.3574 6.3575 0.0 0
M  V30 11 C 3.6643 4.5865 0.0 0
M  V30 12 C 3.9845 6.0928 0.0 0
M  V30 13 C 3.3441 3.0800 0.0 0
M  V30 14 N 2.1328 4.4255 0.0 0
M  V30 15 C 5.1960 4.7474 0.0 0
M  V30 16 C 5.3183 6.8628 0.0 0
M  V30 17 C 2.6508 6.8628 0.0 0
M  V30 18 C 4.6778 2.3100 0.0 0
M  V30 19 C 2.0105 2.3100 0.0 0
M  V30 20 C 1.5064 5.8323 0.0 0
M  V30 21 N 5.8223 3.3406 0.0 0
M  V30 22 N 5.3183 8.4028 0.0 0
M  V30 23 N 2.6508 8.4028 0.0 0
M  V30 24 C 4.6778 0.7700 0.0 0
M  V30 25 C 2.0105 0.7700 0.0 0
M  V30 26 C 3.9845 9.1728 0.0 0
M  V30 27 C 3.3441 0.0000 0.0 0
M  V30 28 C 6.8058 6.4642 0.0 0
M  V30 29 C 7.2043 4.9767 0.0 0
M  V30 30 C 7.8947 7.5532 0.0 0
M  V30 31 C 8.6918 4.5782 0.0 0
M  V30 32 C 9.3822 7.1546 0.0 0
M  V30 33 C 9.7808 5.6671 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 15
M  V30 3 1 3 16
M  V30 4 2 4 20
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 22
M  V30 9 1 9 10
M  V30 10 1 9 33
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 2 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 16 22
M  V30 22 1 16 28
M  V30 23 1 17 20
M  V30 24 1 17 23
M  V30 25 1 18 21
M  V30 26 2 18 24
M  V30 27 1 19 25
M  V30 28 1 22 26
M  V30 29 2 23 26
M  V30 30 1 24 27
M  V30 31 2 25 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 35322-20-4
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925703-73-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36542797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM coated on titania
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM magnetite-coated titania-functionalized carbon nanotube-supported
$DTYPE RXN:VAR(1):CAT(4):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):CAT(5):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(5):AMD
$DATUM magnetite-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst,
optimization study, see experimental details, optimized on solvent,
temperature, time, catalyst and its stoichiometry, magnetite-coated
titania-functionalized carbon nanotube-supported silver nanocatalyst
prepared and used, stage 1 intermediate in added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Investigation of Biological Activity of New Spiro
Pyrrolo[3,4-d]Pyrimidine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tabarsaei, Navisa; Varasteh Moradi, Ali; Sayyed Alangi, S. Zahra;
Hossaini, Zinatossadat; Zafar Mmehrabian, Ramin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(9), 8388-8407

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
2-[(4-Nitrophenyl)methoxy]acetic acid
C9H9NO5
35513-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 O 12.0033 4.6201 0.0 0
M  V30 6 O 10.6697 2.3101 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-[(4-nitrophenyl)methoxy]acetamide
C10H12N2O4
1398047-10-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 O 8.0022 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 10.6697 3.8501 0.0 0
M  V30 8 N 12.0033 4.6201 0.0 0
M  V30 9 O 10.6697 2.3101 0.0 0
M  V30 10 C 13.3370 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 35513-01-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1398047-10-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7493145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [00286] Compound 51 (2.2 g) was dissolved in SOCL2 (15 mL) and stirred
for 2h at 30 °C. The solution was concentrated in vacuo and the residue
was dissolved in THF (10 mL) The mixture solution was dropped into
THF/NH2Me (5mL/15 mL) at 0 °C and stirred for 0.5h. The mixture solution
was extracted by EA (200 mL x 3), The combined organic layers were washed
with brine (100 mL x 2), dried over anhydrous Na2SO4 and concentrated to
get the crude product 52. (2.2g 95%). LCMS (M+1)+: 225.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted thioimidazolidinones as androgen receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tong, Youzhi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012119559 A1 2012-09-13

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
(-)-Valerenic acid
C15H22O2
3569-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4080 2.6507 0.0 0
M  V30 2 C 6.7417 3.4207 0.0 0
M  V30 3 C 8.0753 2.6507 0.0 0
M  V30 4 C 6.7417 4.9608 0.0 0
M  V30 5 O 9.4090 3.4207 0.0 0
M  V30 6 O 8.0753 1.1107 0.0 0
M  V30 7 C 3.4508 0.0000 0.0 0
M  V30 8 C 0.0732 5.7308 0.0 0
M  V30 9 C 2.7405 2.6507 0.0 0
M  V30 10 C 4.0742 3.4207 0.0 0 CFG=2
M  V30 11 C 1.4068 3.4207 0.0 0 CFG=1
M  V30 12 C 2.4203 1.1444 0.0 0
M  V30 13 C 4.0742 4.9608 0.0 0
M  V30 14 C 0.2624 2.3903 0.0 0
M  V30 15 C 1.4068 4.9608 0.0 0 CFG=2
M  V30 16 C 0.8888 0.9835 0.0 0
M  V30 17 C 2.7405 5.7308 0.0 0
M  V30 18 H 0.0000 4.0472 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 12
M  V30 8 1 15 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 11 18 CFG=1
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-[(4S,7R,7aR)-2,4,5,6,7,7a-Hexahydro-3,7-dimethyl-1H-inden-4-yl]-N,2-di...
C16H25NO
1227678-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 3.7035 0.0 0
M  V30 2 C 6.9300 5.0372 0.0 0
M  V30 3 C 8.4700 5.0372 0.0 0
M  V30 4 C 6.1600 6.3710 0.0 0
M  V30 5 N 9.2400 6.3710 0.0 0
M  V30 6 O 9.2400 3.7035 0.0 0
M  V30 7 C 10.7800 6.3710 0.0 0
M  V30 8 C 5.7906 0.4294 0.0 0
M  V30 9 C 0.0000 3.7035 0.0 0
M  V30 10 C 3.8500 2.3699 0.0 0
M  V30 11 C 4.6200 3.7035 0.0 0 CFG=2
M  V30 12 C 2.3100 2.3699 0.0 0 CFG=1
M  V30 13 C 4.3259 0.9052 0.0 0
M  V30 14 C 3.8500 5.0372 0.0 0
M  V30 15 C 1.8341 0.9052 0.0 0
M  V30 16 C 1.5400 3.7035 0.0 0 CFG=2
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 C 2.3100 5.0372 0.0 0
M  V30 19 H 0.7785 2.2090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 13
M  V30 9 1 16 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 19 CFG=1
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3569-10-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227678-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2151269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 26189-59-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM From Planning to Optimization: Total Synthesis of Valerenic Acid and Some
Bioactive Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ramharter, Juergen; Mulzer, Johann
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2012), 2012(10), 2041-2053,
S2041/1-S2041/32

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
(-)-Valerenic acid
C15H22O2
3569-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4080 2.6507 0.0 0
M  V30 2 C 6.7417 3.4207 0.0 0
M  V30 3 C 8.0753 2.6507 0.0 0
M  V30 4 C 6.7417 4.9608 0.0 0
M  V30 5 O 9.4090 3.4207 0.0 0
M  V30 6 O 8.0753 1.1107 0.0 0
M  V30 7 C 3.4508 0.0000 0.0 0
M  V30 8 C 0.0732 5.7308 0.0 0
M  V30 9 C 2.7405 2.6507 0.0 0
M  V30 10 C 4.0742 3.4207 0.0 0 CFG=2
M  V30 11 C 1.4068 3.4207 0.0 0 CFG=1
M  V30 12 C 2.4203 1.1444 0.0 0
M  V30 13 C 4.0742 4.9608 0.0 0
M  V30 14 C 0.2624 2.3903 0.0 0
M  V30 15 C 1.4068 4.9608 0.0 0 CFG=2
M  V30 16 C 0.8888 0.9835 0.0 0
M  V30 17 C 2.7405 5.7308 0.0 0
M  V30 18 H 0.0000 4.0472 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 12
M  V30 8 1 15 8 CFG=3
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 11 18 CFG=1
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-[(4S,7R,7aR)-2,4,5,6,7,7a-Hexahydro-3,7-dimethyl-1H-inden-4-yl]-N,2-di...
C16H25NO
1227678-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 3.7035 0.0 0
M  V30 2 C 6.9300 5.0372 0.0 0
M  V30 3 C 8.4700 5.0372 0.0 0
M  V30 4 C 6.1600 6.3710 0.0 0
M  V30 5 N 9.2400 6.3710 0.0 0
M  V30 6 O 9.2400 3.7035 0.0 0
M  V30 7 C 10.7800 6.3710 0.0 0
M  V30 8 C 5.7906 0.4294 0.0 0
M  V30 9 C 0.0000 3.7035 0.0 0
M  V30 10 C 3.8500 2.3699 0.0 0
M  V30 11 C 4.6200 3.7035 0.0 0 CFG=2
M  V30 12 C 2.3100 2.3699 0.0 0 CFG=1
M  V30 13 C 4.3259 0.9052 0.0 0
M  V30 14 C 3.8500 5.0372 0.0 0
M  V30 15 C 1.8341 0.9052 0.0 0
M  V30 16 C 1.5400 3.7035 0.0 0 CFG=2
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 C 2.3100 5.0372 0.0 0
M  V30 19 H 0.7785 2.2090 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 13
M  V30 9 1 16 9 CFG=3
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 12 19 CFG=1
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3569-10-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227678-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15367187
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56406-07-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Valerenic acid derivatives as novel subunit-selective GABAA receptor
ligands - in vitro and in vivo characterization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khom, S.; Strommer, B.; Ramharter, J.; Schwarz, T.; Schwarzer, C.; Erker,
T.; Ecker, G. F.; Mulzer, J.; Hering, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM British Journal of Pharmacology (2010), 161(1), 65-78

$RFMT $RIREG SCHEME148 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-1-fluoro-2-nitrobenzene
C6H3BrFNO2
364-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3338 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 F 1.3338 4.6201 0.0 0
M  V30 5 Br 6.6687 1.5400 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoyl isothiocyanate
C8H5NOS
532-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 N 5.3901 2.6673 0.0 0
M  V30 3 O 5.3901 0.0000 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 S 8.4702 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 2 4 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(5-Bromo-1-methyl-1H-benzimidazol-2-yl)benzamide
C15H12BrN3O
496837-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.3594 0.0000 0.0 0
M  V30 2 N 5.3900 2.7106 0.0 0
M  V30 3 C 4.6200 4.0442 0.0 0
M  V30 4 O 5.3900 5.3780 0.0 0
M  V30 5 Br 13.3010 4.2506 0.0 0
M  V30 6 C 9.2999 3.4806 0.0 0
M  V30 7 C 9.2999 1.9406 0.0 0
M  V30 8 N 7.8352 3.9564 0.0 0
M  V30 9 C 10.6335 4.2506 0.0 0
M  V30 10 N 7.8352 1.4647 0.0 0
M  V30 11 C 10.6335 1.1706 0.0 0
M  V30 12 C 6.9300 2.7106 0.0 0
M  V30 13 C 11.9672 3.4806 0.0 0
M  V30 14 C 11.9672 1.9406 0.0 0
M  V30 15 C 3.0800 4.0442 0.0 0
M  V30 16 C 2.3100 2.7106 0.0 0
M  V30 17 C 2.3100 5.3780 0.0 0
M  V30 18 C 0.7700 2.7106 0.0 0
M  V30 19 C 0.7700 5.3780 0.0 0
M  V30 20 C 0.0000 4.0442 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 2 3 4
M  V30 5 1 3 15
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 364-73-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 532-55-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 496837-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9400175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney nickel used in stage 2, Trisamine resin used in stage 4
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient solution phase synthesis of 2-(N-acylamino)benzimidazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seth, Punit P.; Robinson, Dale E.; Jefferson, Elizabeth A.; Swayze, Eric
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(41), 7303-7306

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Trifluoromethoxybenzoyl chloride
C8H4ClF3O2
36823-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 F 0.0000 4.6201 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 1.3337 2.3101 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 Cl 8.0023 0.0000 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethoxy)benzamide
C9H8F3NO2
60034-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 F 0.0000 1.3337 0.0 0
M  V30 4 F 0.7700 0.0000 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 8.4702 2.6673 0.0 0
M  V30 7 N 9.2402 4.0010 0.0 0
M  V30 8 O 9.2402 1.3337 0.0 0
M  V30 9 C 10.7802 4.0010 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 6.1601 4.0010 0.0 0
M  V30 14 C 6.1601 1.3337 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36823-88-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60034-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292390
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Trifluoromethoxybenzoyl chloride
C8H4ClF3O2
36823-88-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 4.6201 0.0 0
M  V30 2 C 1.3337 3.8501 0.0 0
M  V30 3 F 0.0000 4.6201 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 1.3337 2.3101 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 Cl 8.0023 0.0000 0.0 0
M  V30 8 O 9.3360 2.3101 0.0 0
M  V30 9 C 4.0012 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 6.6685 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-(trifluoromethoxy)benzamide
C9H8F3NO2
60034-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 2.6673 0.0 0
M  V30 2 C 1.5400 1.3337 0.0 0
M  V30 3 F 0.0000 1.3337 0.0 0
M  V30 4 F 0.7700 0.0000 0.0 0
M  V30 5 F 2.3101 0.0000 0.0 0
M  V30 6 C 8.4702 2.6673 0.0 0
M  V30 7 N 9.2402 4.0010 0.0 0
M  V30 8 O 9.2402 1.3337 0.0 0
M  V30 9 C 10.7802 4.0010 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 4.6201 4.0010 0.0 0
M  V30 12 C 4.6201 1.3337 0.0 0
M  V30 13 C 6.1601 4.0010 0.0 0
M  V30 14 C 6.1601 1.3337 0.0 0
M  V30 15 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 36823-88-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60034-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585785
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonyl fluoride
C4F10O2S
375-72-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 6.1600 1.5400 0.0 0
M  V30 4 F 4.6200 3.0800 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 C 1.5400 1.5400 0.0 0
M  V30 7 F 3.0800 3.0800 0.0 0
M  V30 8 F 3.0800 0.0000 0.0 0
M  V30 9 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 10 F 6.1600 3.0800 0.0 0
M  V30 11 F 6.1600 0.0000 0.0 0
M  V30 12 F 0.0000 1.5400 0.0 0
M  V30 13 F 1.5400 3.0800 0.0 0
M  V30 14 F 1.5400 0.0000 0.0 0
M  V30 15 F 9.2400 1.5400 0.0 0
M  V30 16 O 7.7000 0.0000 0.0 0
M  V30 17 O 7.7000 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 2 9 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylperfluorobutanesulfonamide
C5H4F9NO2S
68298-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.5400 0.0 0
M  V30 2 C 6.1600 1.5400 0.0 0
M  V30 3 C 3.0800 1.5400 0.0 0
M  V30 4 F 4.6200 3.0800 0.0 0
M  V30 5 F 4.6200 0.0000 0.0 0
M  V30 6 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 7 F 6.1600 3.0800 0.0 0
M  V30 8 F 6.1600 0.0000 0.0 0
M  V30 9 C 1.5400 1.5400 0.0 0
M  V30 10 F 3.0800 3.0800 0.0 0
M  V30 11 F 3.0800 0.0000 0.0 0
M  V30 12 N 9.2400 1.5400 0.0 0
M  V30 13 O 7.7000 0.0000 0.0 0
M  V30 14 O 7.7000 3.0800 0.0 0
M  V30 15 F 0.0000 1.5400 0.0 0
M  V30 16 F 1.5400 3.0800 0.0 0
M  V30 17 F 1.5400 0.0000 0.0 0
M  V30 18 C 10.0100 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 2 6 13
M  V30 13 2 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 375-72-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68298-12-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9819323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2.2.1. Synthesis of N-Methyl-perfluorobutane-1-sulfonamide (I).
Perfluorobutanesulfonyl fluoride (15.1, 50 mmol) and triethylamine (10.1
g, 100 mmol) were placed in a glass reaction vessel containing anhydrous
diethyl ether (100 mL) and equipped with a reflux condenser. The dry
methylamine (6.2 g, 200 mmol, anhydrated by sodium hydroxide) was
introduced slowly into the reaction mixture over a period of 4 h at
0-5°C, and a white precipitate gradually generated in the system. Then
the reaction continued for 14 h at ambient temperature and refluxed for 3
h. The reaction mixture was cooled to room temperature and acidified by
aqueous hydrochloric acid solution (9 wt %, 100 mL). The product layer
was washed by water until it had been neutral and then dried by anhydrous
sodium sulfate. The diethyl ether was removed by distillation under
reduced pressure, yielding a pale yellow solid product. The solid product
was purified by repeated precipitations from acetic acid solution into
water and finally dried in vacuum for several hours at room temperature.
95% yield. FT-IR spectrum of the product I exhibited that a -CH3 and -NH
vibration peak appeared at 2967 and 3334 cm-1, and -SO2F vibration peak
at 1474 cm-1 disappeared. 1H NMR (CDCl3, 400 MHz, δ ppm) for
N-methyl-perfluorobutane-1-sulfonamide: 3.03 (3H, s, -CH 3), 5.30 (1H, s,
-NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Performance of Novel Fluorinated Acrylate Polymers:
Preparation and Reactivity of Short Perfluoroalkyl Group Containing
Monomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Qinghua; Wang, Qiongyan; Zhan, Xiaoli; Chen, Fengqiu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Industrial & Engineering Chemistry Research (2014), 53(19), 8026-8034

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1S,3S)-2,3,4,9-tetrahydro-1-(4-methoxyphenyl)-1H-pyrido[3,4-b]indole-...
C20H20N2O3
380895-62-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 O 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=2
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=1
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 7.5823 8.4701 0.0 0
M  V30 22 C 8.9160 6.1601 0.0 0
M  V30 23 C 8.9160 9.2401 0.0 0
M  V30 24 C 10.2498 6.9301 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,3S)-2,3,4,9-Tetrahydro-1-(4-methoxyphenyl)-N-methyl-1H-pyrido[3,4-b]indol...
C20H21N3O2
2254177-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 2.3100 0.0 0
M  V30 2 N 3.5812 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5812 0.0000 0.0 0
M  V30 5 O 11.5834 9.2401 0.0 0
M  V30 6 C 12.9171 8.4701 0.0 0
M  V30 7 C 4.9150 6.9301 0.0 0
M  V30 8 C 3.5812 6.1601 0.0 0
M  V30 9 C 6.2486 6.1601 0.0 0 CFG=2
M  V30 10 N 4.5948 8.4364 0.0 0
M  V30 11 C 2.4368 7.1905 0.0 0
M  V30 12 C 3.5812 4.6201 0.0 0
M  V30 13 N 6.2486 4.6201 0.0 0
M  V30 14 C 3.0631 8.5973 0.0 0
M  V30 15 C 0.9052 7.0296 0.0 0
M  V30 16 C 4.9150 3.8501 0.0 0 CFG=1
M  V30 17 C 2.1579 9.8432 0.0 0
M  V30 18 C 0.0000 8.2755 0.0 0
M  V30 19 C 0.6263 9.6823 0.0 0
M  V30 20 C 7.5823 6.9301 0.0 0
M  V30 21 C 8.9160 6.1601 0.0 0
M  V30 22 C 7.5823 8.4701 0.0 0
M  V30 23 C 10.2498 6.9301 0.0 0
M  V30 24 C 8.9160 9.2401 0.0 0
M  V30 25 C 10.2498 8.4701 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 20 CFG=3
M  V30 14 1 10 14
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 13 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 380895-62-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2254177-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-19425563
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of all stereoisomers of
1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Onda, Momoko; Higashida, Ayaka; Hirano, Takako; Nishio, Toshiyuki;
Hakamata, Wataru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molbank (2018), (1), M973/1-M973/6

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4-chloroquinazoline
C8H4BrClN2
38267-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.0800 0.0000 0.0 0
M  V30 2 Br 6.9300 4.0011 0.0 0
M  V30 3 C 3.0800 2.6674 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 2.3100 1.3338 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.0800 5.3349 0.0 0
M  V30 8 N 0.7700 4.0011 0.0 0
M  V30 9 N 0.7700 1.3338 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 4.6200 5.3349 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 10
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-4-quinazolinamine
C9H8BrN3
32084-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 1.3338 0.0 0
M  V30 2 C 6.9300 1.3338 0.0 0
M  V30 3 Br 0.0000 0.0000 0.0 0
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 0.7700 4.0011 0.0 0
M  V30 9 N 3.0800 5.3349 0.0 0
M  V30 10 N 5.3900 4.0011 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 0.0000 2.6674 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38267-96-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 32084-60-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1186606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Method of synthesising quinazoline F.1 Quinazoline D*.13 (3.17 g, 13.0
mmol) is placed in DCM/MeCN (6 mL, 2:1), combined with DIPEA (0.33 mL)
and methylamine (0.81 mL, 2 M in THF) and stirred for 1.5 h at 20°C. Then
the solvent is removed, the residue is taken up in H2O (15 mL), filtered
off, washed with H2O(3x15 mL) and Et2O (3 mL), dried in vacuo and
quinazoline D.95 is obtained. 2.93 g, 95 %. HPLC-MS: MS(M+ H)+ =
238;tRet= 1.13 min; method LCMSBAS1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic carboxylic acid amides as PDK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Engelhardt, Harald; Kofink, Christiane; Mcconnell, Darryl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011131741 A1 2011-10-27

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
2-Chloro-6-(trifluoromethyl)-3-pyridinecarbonitrile
C7H2ClF3N2
386704-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 9.2400 2.6673 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 N 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Pyridinecarbonitrile, 2-(methylamino)-6-(trifluoromethyl)-
C8H6F3N3
1251235-78-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 1.3336 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 C 7.7000 4.0009 0.0 0
M  V30 4 N 9.2400 4.0009 0.0 0
M  V30 5 C 1.5400 4.0009 0.0 0
M  V30 6 F 1.5400 5.5409 0.0 0
M  V30 7 F 0.0000 4.0009 0.0 0
M  V30 8 F 1.5400 2.4609 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 6.1600 4.0009 0.0 0
M  V30 11 N 3.8500 2.6673 0.0 0
M  V30 12 C 5.3900 5.3347 0.0 0
M  V30 13 C 3.0800 4.0009 0.0 0
M  V30 14 C 3.8500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 3 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 386704-06-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1251235-78-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-368653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 17455-13-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Sulfonamidopyridine C-region analogs of
2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ann, Jihyae; Ki, Yooran; Yoon, Suyoung; Kim, Myeong Seop; Lee, Jung-Un;
Kim, Changhoon; Lee, Sunho; Jung, Aeran; Baek, Jisoo; Hong, Sunhye; Choi,
Sun; Pearce, Larry V.; Esch, Timothy E.; Turcios, Noe A.; Lewin, Nancy
E.; Ogunjirin, Adebowale E.; Herold, Brienna K. A.; McCall, Anna K.;
Blumberg, Peter M.; Lee, Jeewoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(6), 1231-1240

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromobenzenemethanamine
C7H8BrN
3959-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 Br 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-N-methylbenzylamine
C8H10BrN
698-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Br 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3959-05-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698-19-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-11230243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 47. Part A. (2-Bromo-benzyl)-methyl-amine. A solution of
2-bromobenzylamine (9 g, 36.1 mmol) in MeOH (60 ml) was added dropwise
over 30 min. to a solution of methylamine in MeOH (200 mL of a 2.0 M
solution, 0.4 mol). The resulting solution was stirred at rt for 2 h and
concentrated. The residue obtained was dissolved in DCM (100 mL) and
successively washed with saturated aqueous sodium carbonate, dried over
sodium sulphate, and concentrated. The resulting oil was distilled to
afforded the product. Yield: (7 g, 95%), colorless oil. (b.p. 110°C. at
0.1 mm Hg, LC/MS retention time=1.22 min.; M+=201.92 Column: Phenominex
4.6 mm×50 mm. Solvent A=10% MeOH, 90% H2O, 10 mM NH4Ac; Solvent B=90%
MeOH, 10% H2O, 10 nM NH4Ac, Flow rate: 4 mL/min, Gradient: 0%B-100%B 4
min.).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted oxazoles as IMPDH inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Chunjian; Dhar, T. G. Murali; Gu, Henry H.; Iwanowicz, Edwin J.;
Leftheris, Katerina; Pitts, William J.; Herpin, Timothy F.; Pi, Zulan;
Bisacchi, Gregory S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20020143176 A1 2002-10-03

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dichloro-2-methyl-5-pyrimidinamine
C5H5Cl2N3
39906-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 2.6674 0.0 0
M  V30 2 Cl 1.5400 0.0000 0.0 0
M  V30 3 Cl 1.5400 5.3349 0.0 0
M  V30 4 C 6.1600 2.6674 0.0 0
M  V30 5 C 1.5400 2.6674 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 N 3.8500 1.3338 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 7
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C6H9ClN4
859207-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 N 2.6674 6.1600 0.0 0
M  V30 4 Cl 0.0000 4.6200 0.0 0
M  V30 5 C 2.6674 0.0000 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 4.6200 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 1.5400 0.0 0
M  V30 11 N 1.3338 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39906-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 859207-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1101545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antiproliferative activity of 6-phenylaminopurines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Canela, Maria-Dolores; Liekens, Sandra; Camarasa, Maria-Jose; Priego, Eva
Maria; Perez-Perez, Maria-Jesus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2014), 87421-428

$RFMT $RIREG SCHEME156 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-2-[(dimethylamino)methyl]-5-hydroxy-1-phenyl-1H-indole-3-carbox...
C20H21BrN2O3
400823-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6398 7.9110 0.0 0
M  V30 2 N 6.9734 8.6810 0.0 0
M  V30 3 C 6.9734 10.2210 0.0 0
M  V30 4 C 8.3071 7.9110 0.0 0
M  V30 5 C 8.3503 5.9416 0.0 0
M  V30 6 O 9.4947 4.9112 0.0 0
M  V30 7 O 8.6705 7.4479 0.0 0
M  V30 8 C 10.9594 5.3871 0.0 0
M  V30 9 C 12.1038 4.3565 0.0 0
M  V30 10 Br 4.0998 0.0000 0.0 0
M  V30 11 O 7.1798 0.0000 0.0 0
M  V30 12 N 4.3939 5.4658 0.0 0
M  V30 13 C 4.8698 4.0011 0.0 0
M  V30 14 C 5.6398 6.3710 0.0 0
M  V30 15 C 6.4098 4.0011 0.0 0
M  V30 16 C 4.0998 2.6674 0.0 0
M  V30 17 C 6.8856 5.4658 0.0 0
M  V30 18 C 7.1798 2.6674 0.0 0
M  V30 19 C 4.8698 1.3338 0.0 0
M  V30 20 C 6.4098 1.3338 0.0 0
M  V30 21 C 2.9292 5.9416 0.0 0
M  V30 22 C 1.7849 4.9112 0.0 0
M  V30 23 C 2.6091 7.4479 0.0 0
M  V30 24 C 0.3202 5.3871 0.0 0
M  V30 25 C 1.1444 7.9239 0.0 0
M  V30 26 C 0.0000 6.8933 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 17
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 19
M  V30 11 1 11 20
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 2 13 16
M  V30 17 2 14 17
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 16 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-8-[(dimethylamino)methyl]-1,2,3,7-tetrahydro-2-methyl-7-phenylp...
C23H26BrN3O3
958488-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7534 4.2794 0.0 0
M  V30 2 O 2.6091 5.3098 0.0 0
M  V30 3 O 3.4333 2.7731 0.0 0
M  V30 4 C 1.1444 4.8339 0.0 0
M  V30 5 C 0.0000 5.8645 0.0 0
M  V30 6 C 6.4640 2.3100 0.0 0
M  V30 7 N 5.1304 1.5400 0.0 0
M  V30 8 C 5.1304 0.0000 0.0 0
M  V30 9 C 3.7967 2.3100 0.0 0
M  V30 10 Br 8.0040 10.2210 0.0 0
M  V30 11 C 1.0740 8.8872 0.0 0
M  V30 12 C 5.6940 6.2199 0.0 0
M  V30 13 C 5.2181 4.7552 0.0 0
M  V30 14 C 7.2340 6.2199 0.0 0
M  V30 15 C 4.9240 7.5535 0.0 0
M  V30 16 C 6.4640 3.8500 0.0 0
M  V30 17 N 7.7099 4.7552 0.0 0
M  V30 18 C 8.0040 7.5535 0.0 0
M  V30 19 C 5.6940 8.8872 0.0 0
M  V30 20 C 3.3840 7.5535 0.0 0
M  V30 21 C 7.2340 8.8872 0.0 0
M  V30 22 O 4.9240 10.2210 0.0 0
M  V30 23 N 2.6140 8.8872 0.0 0
M  V30 24 C 3.3840 10.2210 0.0 0
M  V30 25 C 9.1745 4.2794 0.0 0
M  V30 26 C 9.4947 2.7731 0.0 0
M  V30 27 C 10.3189 5.3098 0.0 0
M  V30 28 C 10.9594 2.2971 0.0 0
M  V30 29 C 11.7836 4.8339 0.0 0
M  V30 30 C 12.1038 3.3276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 21
M  V30 11 1 11 23
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 1 15 20
M  V30 20 1 16 17
M  V30 21 1 17 25
M  V30 22 2 18 21
M  V30 23 1 19 21
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 400823-33-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958488-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-599129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME157 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 6-bromo-2-[(dimethylamino)methyl]-5-hydroxy-1-methyl-1H-indole-3-carbox...
C15H19BrN2O3
401631-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5602 2.4581 0.0 0
M  V30 2 O 3.0957 1.9823 0.0 0
M  V30 3 O 5.7048 1.4277 0.0 0
M  V30 4 C 2.7755 0.4759 0.0 0
M  V30 5 C 1.3108 0.0000 0.0 0
M  V30 6 C 7.6210 3.8209 0.0 0
M  V30 7 N 8.9548 4.5909 0.0 0
M  V30 8 C 8.9548 6.1309 0.0 0
M  V30 9 C 10.2884 3.8209 0.0 0
M  V30 10 C 7.2708 7.1528 0.0 0
M  V30 11 O 0.0000 6.4426 0.0 0
M  V30 12 Br 1.5400 9.1100 0.0 0
M  V30 13 C 4.8806 3.9646 0.0 0
M  V30 14 C 3.8500 5.1089 0.0 0
M  V30 15 C 6.2874 4.5909 0.0 0
M  V30 16 C 4.6200 6.4426 0.0 0
M  V30 17 C 2.3100 5.1089 0.0 0
M  V30 18 N 6.1264 6.1224 0.0 0
M  V30 19 C 3.8500 7.7762 0.0 0
M  V30 20 C 1.5400 6.4426 0.0 0
M  V30 21 C 2.3100 7.7764 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 18
M  V30 11 1 11 20
M  V30 12 1 12 21
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 1 15 18
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-bromo-8-[(dimethylamino)methyl]-1,2,3,7-tetrahydro-2,7-dimethylpyrrol...
C18H24BrN3O3
958488-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 4.6245 0.0 0
M  V30 2 O 8.7355 5.1003 0.0 0
M  V30 3 O 6.9506 3.1182 0.0 0
M  V30 4 C 9.8799 4.0699 0.0 0
M  V30 5 C 11.3446 4.5458 0.0 0
M  V30 6 C 7.6210 7.9566 0.0 0
M  V30 7 N 7.6210 9.4966 0.0 0
M  V30 8 C 8.9548 10.2666 0.0 0
M  V30 9 C 6.2874 10.2666 0.0 0
M  V30 10 C 4.5602 9.3193 0.0 0
M  V30 11 Br 0.0000 5.3347 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 C 6.1264 5.6549 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 3.8500 6.6685 0.0 0
M  V30 17 C 6.2874 7.1866 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 4.6200 2.6674 0.0 0
M  V30 20 N 4.8806 7.8129 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 22 C 1.5400 5.3347 0.0 0
M  V30 23 O 1.5400 2.6674 0.0 0
M  V30 24 N 3.8500 1.3338 0.0 0
M  V30 25 C 2.3100 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 20
M  V30 11 1 11 22
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 21
M  V30 21 1 17 20
M  V30 22 1 18 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 21 22
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 401631-32-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 958488-18-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-4908448
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction followed by cyclization, product further converted into
HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Antiviral Activity of Substituted
2,4-bis-aminomethyl-5-hydroxy-1H-indole-3-carboxylic Acid Ethyl Esters
and their Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ivashchenko, A. V.; Yamanushkin, P. M.; Mit'kin, O. D.; Kisil', V. M.;
Korzinov, O. M.; Vedenskii, V. Yu.; Leneva, I. A.; Bulanova, E. A.;
Bychko, V. V.; Okun', I. M.; Ivashchenko, A. A.; Ivanenkov, Ya. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Pharmaceutical Chemistry Journal (2014), 48(9), 569-581

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-1-nitro-4-(trifluoromethyl)benzene
C7H3F4NO2
402-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6673 0.0 0
M  V30 2 F 6.9300 4.2073 0.0 0
M  V30 3 F 8.4700 2.6673 0.0 0
M  V30 4 F 6.9300 1.1273 0.0 0
M  V30 5 F 2.3100 0.0000 0.0 0
M  V30 6 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 7 O 0.0000 4.0011 0.0 0
M  V30 8 O 0.0000 1.3336 0.0 0
M  V30 9 C 5.3900 2.6673 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 3.0800 1.3336 0.0 0
M  V30 13 C 3.0800 4.0011 0.0 0
M  V30 14 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitro-5-trifluoromethylaniline
C8H7F3N2O2
883992-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 1.3336 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 N 0.7700 4.0009 0.0 0 VAL=5
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 O 0.0000 5.3347 0.0 0
M  V30 6 C 6.9300 4.0009 0.0 0
M  V30 7 F 6.9300 5.5409 0.0 0
M  V30 8 F 8.4700 4.0009 0.0 0
M  V30 9 F 6.9300 2.4609 0.0 0
M  V30 10 C 3.0800 2.6673 0.0 0
M  V30 11 C 2.3100 4.0009 0.0 0
M  V30 12 C 4.6200 2.6673 0.0 0
M  V30 13 C 3.0800 5.3347 0.0 0
M  V30 14 C 5.3900 4.0009 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-12-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883992-67-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38825120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis and Evaluation of New 1H-benzo[d]imidazole based PqsR
Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soukarieh, Fadi; Mashabi, Alaa; Richardson, William; Oton, Eduard Vico;
Romero, Manuel; Dubern, Jean-Frederic; Robertson, Shaun N.; Lucanto,
Simone; Markham-Lee, Zoe; Sou, Tomas; Kukavica-Ibrulj, Irena; Levesque,
Roger C.; Bergstrom, Christel A. S.; Halliday, Nigel; Kellam, Barrie;
Emsley, Jonas; Heeb, Stephan; Williams, Paul; Stocks, Michael J.; Camara,
Miguel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2024), 67(2), 1008-1023

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Chlorosulfonyl)benzoic acid
C7H5ClO4S
4025-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5637 1.7464 0.0 0
M  V30 4 O 2.1037 4.4137 0.0 0
M  V30 5 C 6.6687 3.0801 0.0 0
M  V30 6 O 6.6687 4.6201 0.0 0
M  V30 7 O 8.0023 2.3101 0.0 0
M  V30 8 C 2.6675 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)sulfonyl]benzoic acid
C8H9NO4S
35623-11-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4025-64-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35623-11-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5164533
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 19:
3-Methylsulfamoyl-N-[5-(3-pyridin-3-yl-5-trifluoromethyl-pyrazol-1-
yl)-pyridin-2-yl]-benzamide. Step a. Methylamine (1.1 mL of 2 M solution
in tetrahydrofuran, 2.2 mmol) and triethylamine (0.6 mL, 4.3 mmol) are
added to dichloromethane (10 mL) at 0 °C. The n 3-chlorosulfonyl-bcnzoic
acid (500 mg, 2.2 mmol) is added in small portions. The mixture is
stirred for 30 minutes at 0 °C before 1 M aqueous HCl (8 mL) is added.
The mixture is extracted with ethyl acetate (25 mL, 3 ×). The organic
layers are combined and dried over sodium sulfate. Removal of solvent
under vacuum affords 3-methylsulfamoyl-benzoic acid (480 mg) with 92%
purity (2.1 mmol, 95 %). This material is used in the next step without
further purification.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted pyrazole compounds useful as soluble epoxide hydrolase
inhibitors and their preparation and pharmaceutical compositions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fleck, Roman Wolfgang; Guo, Xin; Lo, Ho Yin; Man, Chuk Chui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007067836 A2 2007-06-14

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-ribo-2-Hexulofuranosonic acid, 2-deoxy-2-isothiocyanato-3,4-O-(1-methylet...
C18H19NO7S
402589-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0318 2.2249 0.0 0
M  V30 2 O 5.5383 1.9047 0.0 0
M  V30 3 O 3.0014 1.0805 0.0 0
M  V30 4 C 6.0141 0.4401 0.0 0
M  V30 5 N 2.1491 3.0633 0.0 0
M  V30 6 C 1.9880 1.5316 0.0 0
M  V30 7 S 1.8271 0.0000 0.0 0
M  V30 8 C 6.5570 6.3114 0.0 0
M  V30 9 O 7.8907 5.5413 0.0 0
M  V30 10 C 9.2243 6.3114 0.0 0
M  V30 11 O 9.2243 7.8514 0.0 0
M  V30 12 C 0.0000 7.1813 0.0 0
M  V30 13 C 1.3789 8.7129 0.0 0
M  V30 14 C 3.5559 3.6896 0.0 0 CFG=2
M  V30 15 C 2.7859 5.0233 0.0 0 CFG=2
M  V30 16 O 5.0622 4.0098 0.0 0
M  V30 17 C 3.8164 6.1678 0.0 0 CFG=2
M  V30 18 O 1.3789 5.6496 0.0 0
M  V30 19 C 5.2233 5.5413 0.0 0 CFG=2
M  V30 20 O 3.0463 7.5015 0.0 0
M  V30 21 C 1.5400 7.1813 0.0 0
M  V30 22 C 10.5582 5.5413 0.0 0
M  V30 23 C 10.5582 4.0013 0.0 0
M  V30 24 C 11.8918 6.3114 0.0 0
M  V30 25 C 11.8918 3.2313 0.0 0
M  V30 26 C 13.2255 5.5413 0.0 0
M  V30 27 C 13.2255 4.0013 0.0 0
M  V30 28 H 1.7555 3.8789 0.0 0
M  V30 29 H 4.8469 7.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 14 5 CFG=3
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 19 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 1 10 22
M  V30 13 1 12 21
M  V30 14 1 13 21
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 15 28 CFG=1
M  V30 20 1 16 19
M  V30 21 1 17 19
M  V30 22 1 17 20
M  V30 23 1 17 29 CFG=1
M  V30 24 1 18 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 14 15 17 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,6R,6aR)-6-[(Benzoyloxy)methyl]dihydro-1′,2,2-trimethyl-2′-thioxospiro[fu...
C18H20N2O6S
402589-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.8575 2.4899 0.0 0
M  V30 2 C 6.5570 6.6064 0.0 0
M  V30 3 O 7.8906 5.8364 0.0 0
M  V30 4 C 9.2243 6.6064 0.0 0
M  V30 5 O 9.2243 8.1464 0.0 0
M  V30 6 C 3.6157 0.0000 0.0 0
M  V30 7 S 0.5549 1.3628 0.0 0
M  V30 8 C 1.3789 9.0079 0.0 0
M  V30 9 C 0.0000 7.4762 0.0 0
M  V30 10 C 3.5559 3.9847 0.0 0 CFG=3
M  V30 11 C 2.7859 5.3183 0.0 0 CFG=2
M  V30 12 O 5.0622 4.3048 0.0 0
M  V30 13 C 4.3259 2.6508 0.0 0
M  V30 14 N 2.0495 3.6643 0.0 0
M  V30 15 C 3.8163 6.4627 0.0 0 CFG=2
M  V30 16 O 1.3789 5.9446 0.0 0
M  V30 17 C 5.2233 5.8364 0.0 0 CFG=2
M  V30 18 N 3.2955 1.5064 0.0 0
M  V30 19 C 1.8885 2.1328 0.0 0
M  V30 20 O 3.0463 7.7965 0.0 0
M  V30 21 C 1.5400 7.4762 0.0 0
M  V30 22 C 10.5581 5.8364 0.0 0
M  V30 23 C 11.8917 6.6064 0.0 0
M  V30 24 C 10.5581 4.2964 0.0 0
M  V30 25 C 13.2254 5.8364 0.0 0
M  V30 26 C 11.8917 3.5263 0.0 0
M  V30 27 C 13.2254 4.2964 0.0 0
M  V30 28 H 1.7555 4.1738 0.0 0
M  V30 29 H 4.8469 7.6072 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 3
M  V30 3 1 17 2 CFG=1
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 22
M  V30 7 1 6 18
M  V30 8 2 7 19
M  V30 9 1 8 21
M  V30 10 1 9 21
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 28 CFG=1
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 14 19
M  V30 21 1 15 17
M  V30 22 1 15 20
M  V30 23 1 15 29 CFG=1
M  V30 24 1 16 21
M  V30 25 1 18 19
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402589-16-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 402589-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-11663948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM mixture THF:water/solvent gave similar results
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isothiocyanatoulosonates, a new type of glycosyl isothiocyanate useful
for the stereocontrolled synthesis of thiohydantoin spironucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gasch, Consolacion; Salameh, Bader A. B.; Pradera, M. Angeles; Fuentes,
Jose
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2001), 42(49), 8615-8617

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
2-Fluoro-4-nitrobenzoic acid
C7H4FNO4
403-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 2 O 8.0021 3.8500 0.0 0
M  V30 3 O 6.6685 6.1600 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 C 1.3336 1.5400 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 O 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-N-methyl-4-nitrobenzamide
C8H7FN2O3
915087-24-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 N 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 4.0011 6.1601 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 403-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915087-24-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14554061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM slow addition of thionyl chloride in stage 1, gaseous methylamine used in
stage 2, scalable (multigram scale)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient synthesis of 4-amino-2-fluoro-N-methyl-benzamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Defeng; Xu, Xing; Zhu, Zhiling
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2013), 37(10), 615-616

$RFMT $RIREG SCHEME162 STEP1
$RXN



  4  1
$MOL
1-Phenyl-2-(triphenylphosphoranylidene)ethanone
C26H21OP
859-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 4.6200 4.6200 0.0 0 VAL=5
M  V30 2 C 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9537 0.0 0
M  V30 4 O 6.1600 7.2875 0.0 0
M  V30 5 C 3.0800 4.6200 0.0 0
M  V30 6 C 2.3100 5.9537 0.0 0
M  V30 7 C 2.3100 3.2864 0.0 0
M  V30 8 C 0.7700 5.9537 0.0 0
M  V30 9 C 0.7700 3.2864 0.0 0
M  V30 10 C 0.0000 4.6200 0.0 0
M  V30 11 C 4.6200 3.0800 0.0 0
M  V30 12 C 5.9537 2.3100 0.0 0
M  V30 13 C 3.2864 2.3100 0.0 0
M  V30 14 C 5.9537 0.7700 0.0 0
M  V30 15 C 3.2864 0.7700 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 4.2215 6.1075 0.0 0
M  V30 18 C 2.7340 6.5062 0.0 0
M  V30 19 C 5.3104 7.1964 0.0 0
M  V30 20 C 2.3353 7.9937 0.0 0
M  V30 21 C 4.9118 8.6841 0.0 0
M  V30 22 C 3.4242 9.0826 0.0 0
M  V30 23 C 8.4700 5.9537 0.0 0
M  V30 24 C 9.2400 4.6200 0.0 0
M  V30 25 C 9.2400 7.2875 0.0 0
M  V30 26 C 10.7800 4.6200 0.0 0
M  V30 27 C 10.7800 7.2875 0.0 0
M  V30 28 C 11.5500 5.9537 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 2 3
M  V30 6 2 3 4
M  V30 7 1 3 23
M  V30 8 2 5 6
M  V30 9 1 5 7
M  V30 10 1 6 8
M  V30 11 2 7 9
M  V30 12 2 8 10
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2,3-dihydro-2,3-dioxo-1H-indole-1-acetate
C12H11NO4
41042-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7534 4.0285 0.0 0
M  V30 2 C 7.0870 3.2585 0.0 0
M  V30 3 O 8.4207 4.0285 0.0 0
M  V30 4 O 7.0870 1.7185 0.0 0
M  V30 5 C 9.7545 3.2585 0.0 0
M  V30 6 C 11.0882 4.0285 0.0 0
M  V30 7 O 5.4032 0.6966 0.0 0
M  V30 8 O 2.1258 0.0000 0.0 0
M  V30 9 C 3.0127 3.8850 0.0 0
M  V30 10 N 4.4197 3.2585 0.0 0
M  V30 11 C 1.9823 2.7405 0.0 0
M  V30 12 C 2.5369 5.3496 0.0 0
M  V30 13 C 4.2586 1.7270 0.0 0
M  V30 14 C 2.7523 1.4068 0.0 0
M  V30 15 C 0.4759 3.0606 0.0 0
M  V30 16 C 1.0304 5.6697 0.0 0
M  V30 17 C 0.0000 4.5254 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 13
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-1-acetic acid, 2,3-dihydro-3-[(4R,5S)-4-hydroxy-3-methyl-4-phenyl-2...
C22H22N2O4S2
3052403-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.4266 2.5974 0.0 0
M  V30 2 O 4.6274 3.2379 0.0 0
M  V30 3 C 9.7724 2.4220 0.0 0
M  V30 4 C 11.3102 2.5025 0.0 0
M  V30 5 O 12.1491 1.2111 0.0 0
M  V30 6 O 12.0094 3.8746 0.0 0
M  V30 7 C 13.6869 1.2916 0.0 0
M  V30 8 C 14.5256 0.0000 0.0 0
M  V30 9 C 1.5559 5.8907 0.0 0
M  V30 10 S 3.5251 8.6012 0.0 0
M  V30 11 C 6.9972 5.2816 0.0 0 CFG=2
M  V30 12 C 8.2888 6.1204 0.0 0
M  V30 13 C 7.3957 3.7941 0.0 0
M  V30 14 C 9.4855 5.1512 0.0 0
M  V30 15 C 8.5296 7.6415 0.0 0
M  V30 16 N 8.9337 3.7136 0.0 0
M  V30 17 C 10.9232 5.7031 0.0 0
M  V30 18 C 9.9674 8.1933 0.0 0
M  V30 19 C 11.1641 7.2242 0.0 0
M  V30 20 C 5.4656 5.1207 0.0 0 CFG=1
M  V30 21 C 4.0009 4.6448 0.0 0 CFG=2
M  V30 22 S 5.4656 6.6607 0.0 0
M  V30 23 N 3.0959 5.8907 0.0 0
M  V30 24 C 4.0009 7.1365 0.0 0
M  V30 25 C 2.6673 3.8748 0.0 0
M  V30 26 C 1.3336 4.6448 0.0 0
M  V30 27 C 2.6673 2.3348 0.0 0
M  V30 28 C 0.0000 3.8748 0.0 0
M  V30 29 C 1.3336 1.5648 0.0 0
M  V30 30 C 0.0000 2.3348 0.0 0
M  V30 31 H 6.2980 6.6537 0.0 0
M  V30 32 H 5.7858 3.6144 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 21 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 23
M  V30 10 2 10 24
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 11 31 CFG=3
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 16
M  V30 18 1 14 16
M  V30 19 2 14 17
M  V30 20 1 15 18
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 20 32 CFG=1
M  V30 26 1 21 23
M  V30 27 1 21 25 CFG=1
M  V30 28 1 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 11 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 859-65-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 41042-21-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3052403-85-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41257927
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, stereoselective, Wittig reaction in
stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regio- and diastereoselective synthesis of
thioxothiazolidin-indolin-2-ones, oxoindolin-carbamodithioate hybrids,
and their base-catalyzed conversion into dispirocyclopentanebisoxindoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aghamiri, Bagher; Moghaddam, F. Matloubi; Badpa, Sara; Kavoosi, Leila
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2024), 14(1), 14222

$RFMT $RIREG SCHEME163 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,4,5,5,6,6,6-Tridecafluoro-1-hexanesulfonyl fluoride
C6F14O2S
423-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.5400 0.0 0
M  V30 2 C 4.6200 1.5400 0.0 0
M  V30 3 C 7.7000 1.5400 0.0 0
M  V30 4 F 6.1600 0.0000 0.0 0
M  V30 5 F 6.1600 3.0800 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 F 4.6200 0.0000 0.0 0
M  V30 8 F 4.6200 3.0800 0.0 0
M  V30 9 C 9.2400 1.5400 0.0 0
M  V30 10 F 7.7000 0.0000 0.0 0
M  V30 11 F 7.7000 3.0800 0.0 0
M  V30 12 C 1.5400 1.5400 0.0 0
M  V30 13 F 3.0800 0.0000 0.0 0
M  V30 14 F 3.0800 3.0800 0.0 0
M  V30 15 S 10.7800 1.5400 0.0 0 VAL=6
M  V30 16 F 9.2400 0.0000 0.0 0
M  V30 17 F 9.2400 3.0800 0.0 0
M  V30 18 F 0.0000 1.5400 0.0 0
M  V30 19 F 1.5400 0.0000 0.0 0
M  V30 20 F 1.5400 3.0800 0.0 0
M  V30 21 F 12.3200 1.5400 0.0 0
M  V30 22 O 10.7800 3.0800 0.0 0
M  V30 23 O 10.7800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 1 12 19
M  V30 19 1 12 20
M  V30 20 1 15 21
M  V30 21 2 15 22
M  V30 22 2 15 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,2,2,3,3,4,4,5,5,6,6,6-Tridecafluoro-N-methyl-1-hexanesulfonamide
C7H4F13NO2S
68259-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.5400 0.0 0
M  V30 2 C 7.7000 1.5400 0.0 0
M  V30 3 C 4.6200 1.5400 0.0 0
M  V30 4 F 6.1600 0.0000 0.0 0
M  V30 5 F 6.1600 3.0800 0.0 0
M  V30 6 C 9.2400 1.5400 0.0 0
M  V30 7 F 7.7000 0.0000 0.0 0
M  V30 8 F 7.7000 3.0800 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 F 4.6200 0.0000 0.0 0
M  V30 11 F 4.6200 3.0800 0.0 0
M  V30 12 S 10.7800 1.5400 0.0 0 VAL=6
M  V30 13 F 9.2400 0.0000 0.0 0
M  V30 14 F 9.2400 3.0800 0.0 0
M  V30 15 C 1.5400 1.5400 0.0 0
M  V30 16 F 3.0800 0.0000 0.0 0
M  V30 17 F 3.0800 3.0800 0.0 0
M  V30 18 N 12.3200 1.5400 0.0 0
M  V30 19 O 10.7800 0.0000 0.0 0
M  V30 20 O 10.7800 3.0800 0.0 0
M  V30 21 F 0.0000 1.5400 0.0 0
M  V30 22 F 1.5400 0.0000 0.0 0
M  V30 23 F 1.5400 3.0800 0.0 0
M  V30 24 C 13.0900 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 2 7
M  V30 7 1 2 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 6 14
M  V30 14 1 9 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 12 18
M  V30 18 2 12 19
M  V30 19 2 12 20
M  V30 20 1 15 21
M  V30 21 1 15 22
M  V30 22 1 15 23
M  V30 23 1 18 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 423-50-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 68259-15-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-10092652
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2.2.1. Synthesis of N-Methyl-perfluorohexane-1-sulfonamide (I).
Perfluorohexanesulfonyl fluoride (20.1 g, 50 mmol) and triethylamine
(10.1 g, 100 mmol) were placed in a glass reaction vessel containing
anhydrous diethyl ether (100 mL) and equipped with a reflux condenser.
The dry methylamine (6.2 g, 200 mmol, anhydrated by sodium hydroxide) was
introduced slowly into the reaction mixture over a period of 4 h at
0-5°C, and a white precipitate gradually generated in the system. Then
the reaction continued for 14 h at ambient temperature and refluxed for 3
h. The reaction mixture was cooled to room temperature and acidified by
aqueous hydrochloric acid solution (9 wt %, 100 mL). The product layer
was washed by water until it had been neutral and then dried by anhydrous
sodium sulfate. The diethyl ether was removed by distillation under
reduced pressure, yielding a pale yellow solid product. The solid product
was purified by repeated precipitations from acetic acid solution into
water and finally dried in vacuum for several hours at room temperature.
95% yield. FT-IR spectrum of the product I exhibited that a -CH3 and -NH
vibration peak appeared at 2967 and 3334 cm-1, and -SO2F vibration peak
at 1474 cm-1 disappeared. 1H NMR for
N-methyl-perfluorohexane-1-sulfonamide: 3.01 (3H, s, -CH 3), 5.28 (1H, s,
-NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Performance of Novel Fluorinated Acrylate Polymers:
Preparation and Reactivity of Short Perfluoroalkyl Group Containing
Monomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Qinghua; Wang, Qiongyan; Zhan, Xiaoli; Chen, Fengqiu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Industrial & Engineering Chemistry Research (2014), 53(19), 8026-8034

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-1-[[(Diphenylmethyl)amino]carbonyl]-2-methylpropyl (1R,4S,5R)-5-ethoxy-1...
C28H34N2O6
431070-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3266 0.0 0
M  V30 2 O 6.9300 6.6603 0.0 0
M  V30 3 O 6.9300 3.9929 0.0 0
M  V30 4 C 8.4700 6.6603 0.0 0 CFG=1
M  V30 5 C 9.2400 7.9940 0.0 0
M  V30 6 C 9.2400 5.3266 0.0 0
M  V30 7 N 10.7800 7.9940 0.0 0
M  V30 8 O 8.4700 9.3276 0.0 0
M  V30 9 C 8.4700 3.9929 0.0 0
M  V30 10 C 10.7800 5.3266 0.0 0
M  V30 11 C 11.5500 9.3276 0.0 0
M  V30 12 O 4.6223 2.6674 0.0 0
M  V30 13 C 3.8526 1.3336 0.0 0
M  V30 14 C 4.6228 0.0000 0.0 0
M  V30 15 O 4.6157 7.9948 0.0 0
M  V30 16 C 0.0000 5.3164 0.0 0
M  V30 17 C 1.5354 7.9897 0.0 0
M  V30 18 C 4.6200 5.3266 0.0 0 CFG=2
M  V30 19 C 3.8522 4.0009 0.0 0 CFG=2
M  V30 20 O 3.0792 5.7963 0.0 0
M  V30 21 C 3.8478 6.6599 0.0 0
M  V30 22 C 2.3122 3.9985 0.0 0
M  V30 23 C 1.5400 5.3215 0.0 0 CFG=2
M  V30 24 N 2.3078 6.6574 0.0 0
M  V30 25 C 13.0900 9.3276 0.0 0
M  V30 26 C 13.8600 10.6613 0.0 0
M  V30 27 C 13.8600 7.9940 0.0 0
M  V30 28 C 15.4000 10.6613 0.0 0
M  V30 29 C 15.4000 7.9940 0.0 0
M  V30 30 C 16.1700 9.3276 0.0 0
M  V30 31 C 10.7800 10.6613 0.0 0
M  V30 32 C 9.2400 10.6613 0.0 0
M  V30 33 C 11.5500 11.9951 0.0 0
M  V30 34 C 8.4700 11.9951 0.0 0
M  V30 35 C 10.7800 13.3287 0.0 0
M  V30 36 C 9.2400 13.3287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 11 25
M  V30 13 1 11 31
M  V30 14 1 12 13
M  V30 15 1 19 12 CFG=3
M  V30 16 1 13 14
M  V30 17 2 15 21
M  V30 18 1 16 23
M  V30 19 1 17 24
M  V30 20 1 18 19
M  V30 21 1 18 20 CFG=1
M  V30 22 1 18 21
M  V30 23 1 19 22
M  V30 24 1 23 20 CFG=1
M  V30 25 1 21 24
M  V30 26 1 22 23
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 18 19 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,4R,5R)-5-Ethoxy-N,1,2-trimethyl-3-oxo-7-oxa-2-azabicyclo[2.2.1]heptane-4-...
C11H18N2O4
431070-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 5.3265 0.0 0
M  V30 2 N 6.9300 6.6603 0.0 0
M  V30 3 O 6.9300 3.9929 0.0 0
M  V30 4 C 8.4700 6.6603 0.0 0
M  V30 5 O 4.6223 2.6674 0.0 0
M  V30 6 C 3.8526 1.3336 0.0 0
M  V30 7 C 4.6228 0.0000 0.0 0
M  V30 8 O 4.6157 7.9947 0.0 0
M  V30 9 C 0.0000 5.3164 0.0 0
M  V30 10 C 1.5354 7.9897 0.0 0
M  V30 11 C 4.6200 5.3265 0.0 0 CFG=2
M  V30 12 C 3.8522 4.0009 0.0 0 CFG=2
M  V30 13 O 3.0792 5.7962 0.0 0
M  V30 14 C 3.8478 6.6599 0.0 0
M  V30 15 C 2.3122 3.9985 0.0 0
M  V30 16 C 1.5400 5.3215 0.0 0 CFG=2
M  V30 17 N 2.3078 6.6574 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 12 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 8 14
M  V30 9 1 9 16
M  V30 10 1 10 17
M  V30 11 1 11 12
M  V30 12 1 11 13 CFG=1
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 1 16 13 CFG=1
M  V30 16 1 14 17
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 431070-07-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 431070-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10791688
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Cycloadduct (-)-36 (52 mg, 0.105 mmol) was
combined with methylamine (40% wt solution in water, 250 μL)in MeOH (1
mL) and sonicated at room temperature for 30 min until TLC indicated
completion of the reaction. Amide (-)-42 was recovered through silica gel
flash chromatography (50% EtOAc in hexanes).
(1R,4R,5R)-5-Ethoxy-1,2-dimethyl-3-oxo-7-oxa-2-aza-bicyclo-[2.2.1]heptane-4-carboxylic
acid amide[(-)-41], yield 95% (24 mg, 0.100 mmol), colorless oil. [α]23D
= - 81.9 0 (c 5.1, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 1.09 (t, J = 8.8 Hz,
3H), 1.62 (s, 3H), 1.63 (dd, J = 2.5, 12.2 Hz, 1H), 2.27 (dd, J = 8.2,
12.2 Hz, 1H), 2.82 (s, 3H), 2.90 (d, J = 5.1 Hz, 3H), 3.39-3.59 (m, 2H),
4.44 (dd, J = 2.5, 8.2 Hz, 1H), 8.07-8.17 (br, 1H); 13C NMR (CDCl3, 75
MHz) δ 15.2, 17.6, 25.2, 26.1, 41.1, 66.7, 81.0, 84.6, 95.0, 165.7,
170.6; FTIR (CHCl3) 3390, 3305, 2980, 2937, 2912, 2875, 1713, 1673, 1547,
1409, 1333, 1162, 1136, 1120, 1077, 1003 cm-1; LRMSFAB: 243.1 (M +H+);
HRMSFAB calcd for C11H19N2O4 243.1345, found 243.1342.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Evolution of a Chiral Auxiliary for the 1,3-Dipolar Cycloaddition
of Isomuenchnones with Vinyl Ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savinov, Sergey N.; Austin, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2002), 4(9), 1415-1418

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-1-[[(Diphenylmethyl)amino]carbonyl]-2-methylpropyl (1R,4S,5R)-1,2-dimeth...
C33H36N2O6
431070-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.2400 5.3366 0.0 0
M  V30 2 O 7.7000 5.3366 0.0 0
M  V30 3 O 10.0100 6.6702 0.0 0
M  V30 4 C 6.9300 6.6702 0.0 0 CFG=1
M  V30 5 C 5.3900 6.6702 0.0 0
M  V30 6 C 7.7000 8.0038 0.0 0
M  V30 7 N 4.6200 8.0038 0.0 0
M  V30 8 O 4.6200 5.3366 0.0 0
M  V30 9 C 9.2400 8.0038 0.0 0
M  V30 10 C 6.9300 9.3376 0.0 0
M  V30 11 C 3.0800 8.0038 0.0 0
M  V30 12 O 12.3118 5.3346 0.0 0
M  V30 13 C 13.8518 5.3347 0.0 0
M  V30 14 O 7.7014 2.6651 0.0 0
M  V30 15 C 12.3288 0.0069 0.0 0
M  V30 16 C 9.2460 0.0000 0.0 0
M  V30 17 C 10.0100 4.0029 0.0 0 CFG=2
M  V30 18 C 11.5420 4.0008 0.0 0 CFG=2
M  V30 19 O 10.3737 2.4337 0.0 0
M  V30 20 C 9.2414 2.6674 0.0 0
M  V30 21 C 12.3141 2.6684 0.0 0
M  V30 22 C 11.5545 1.3381 0.0 0 CFG=2
M  V30 23 N 10.0137 1.3350 0.0 0
M  V30 24 C 14.6215 6.6685 0.0 0
M  V30 25 C 13.8514 8.0021 0.0 0
M  V30 26 C 16.1615 6.6688 0.0 0
M  V30 27 C 14.6212 9.3359 0.0 0
M  V30 28 C 16.9314 8.0026 0.0 0
M  V30 29 C 16.1612 9.3361 0.0 0
M  V30 30 C 2.3100 9.3376 0.0 0
M  V30 31 C 0.7700 9.3376 0.0 0
M  V30 32 C 3.0800 10.6713 0.0 0
M  V30 33 C 0.0000 10.6713 0.0 0
M  V30 34 C 2.3100 12.0049 0.0 0
M  V30 35 C 0.7700 12.0049 0.0 0
M  V30 36 C 2.3100 6.6702 0.0 0
M  V30 37 C 0.7700 6.6702 0.0 0
M  V30 38 C 3.0800 5.3366 0.0 0
M  V30 39 C 0.0000 5.3366 0.0 0
M  V30 40 C 2.3100 4.0029 0.0 0
M  V30 41 C 0.7700 4.0029 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 11 30
M  V30 13 1 11 36
M  V30 14 1 12 13
M  V30 15 1 18 12 CFG=3
M  V30 16 1 13 24
M  V30 17 2 14 20
M  V30 18 1 15 22
M  V30 19 1 16 23
M  V30 20 1 17 18
M  V30 21 1 17 19 CFG=1
M  V30 22 1 17 20
M  V30 23 1 18 21
M  V30 24 1 22 19 CFG=1
M  V30 25 1 20 23
M  V30 26 1 21 22
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 2 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 4 17 18 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,4R,5R)-N,1,2-Trimethyl-3-oxo-5-(phenylmethoxy)-7-oxa-2-azabicyclo[2.2.1]h...
C16H20N2O4
431070-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6186 2.6673 0.0 0
M  V30 2 N 3.8486 1.3336 0.0 0
M  V30 3 O 6.1586 2.6673 0.0 0
M  V30 4 C 4.6186 0.0000 0.0 0
M  V30 5 O 6.1528 5.3286 0.0 0
M  V30 6 C 6.9229 6.6620 0.0 0
M  V30 7 O 1.5358 2.6705 0.0 0
M  V30 8 C 1.5474 8.0071 0.0 0
M  V30 9 C 0.0000 5.3409 0.0 0
M  V30 10 C 3.8486 4.0009 0.0 0 CFG=2
M  V30 11 C 4.6128 5.3287 0.0 0 CFG=2
M  V30 12 O 2.6714 5.1005 0.0 0
M  V30 13 C 2.3078 4.0031 0.0 0
M  V30 14 C 3.8449 6.6637 0.0 0
M  V30 15 C 2.3129 6.6710 0.0 0 CFG=2
M  V30 16 N 1.5400 5.3381 0.0 0
M  V30 17 C 8.4629 6.6619 0.0 0
M  V30 18 C 9.2328 5.3281 0.0 0
M  V30 19 C 9.2331 7.9955 0.0 0
M  V30 20 C 10.7728 5.3279 0.0 0
M  V30 21 C 10.7731 7.9952 0.0 0
M  V30 22 C 11.5429 6.6614 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 11 5 CFG=1
M  V30 7 1 6 17
M  V30 8 2 7 13
M  V30 9 1 8 15
M  V30 10 1 9 16
M  V30 11 1 10 11
M  V30 12 1 10 12 CFG=3
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 15 12 CFG=3
M  V30 16 1 13 16
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 431070-17-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 431070-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1660349
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Cycloadduct (-)-36 (52 mg, 0.105 mmol) was
combined with methylamine (40% wt solution in water, 250 μL)in MeOH (1
mL) and sonicated at room temperature for 30 min until TLC indicated
completion of the reaction. Amide (-)-42 was recovered through silica gel
flash chromatography (50% EtOAc in hexanes).
(1R,4R,5R)-5-Benzyloxy-1,2-dimethyl-3-oxo-7-oxa-2-aza-bicyclo[2.2.1]heptane-4-carboxylic
acid methylamide[(-)-44]. yield 95%, (41 mg, 0.136 mmol), colorless oil.
[α]23D = - 70.20 (c 6.4, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 1.63 (s, 3H),
1.65 (dd, J = 2.8, 12.4 Hz, 1H), 2.22 (dd, J = 8.1, 12.4 Hz, 1H), 2.84
(s, 3H), 2.93 (d, J = 4.5 Hz, 3H), 4.46 (d, J = 11.8 Hz, 1H), 4.56 (dd, J
= 2.8, 8.1 Hz, 1H), 4.59 (d, J = 11.8 Hz, 1H), 7.21-7.39 (m, 5H),
8.05-8.23 (br m, 1H); 13C NMR (CDCl3, 75 MHz) δ 17.6, 25.2, 26.2, 40.9,
73.0, 80.6, 84.6, 95.1, 127.8, 128.1, 128.5, 137.1, 165.6, 170.6; FTIR
(CDCl3) 3324, 2946, 1716, 1683, 1558, 1406, 1157, 1128, 1073 cm-1;
LRMSFAB: 305.1 (M +H+); HRMSFAB calcd for C16H21N2O4 305.1501, found
305.1501.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ultrasound
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Evolution of a Chiral Auxiliary for the 1,3-Dipolar Cycloaddition
of Isomuenchnones with Vinyl Ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savinov, Sergey N.; Austin, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2002), 4(9), 1415-1418

$RFMT $RIREG SCHEME166 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Phenylmethoxy)benzoyl chloride
C14H11ClO2
4349-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 Cl 2.3100 0.0000 0.0 0
M  V30 5 O 4.6200 1.3338 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 0.0000 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 6.6685 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 9.2400 6.6685 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 7
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-(phenylmethoxy)benzamide
C15H15NO2
104916-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 3.0800 4.0011 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 N 9.2400 4.0011 0.0 0
M  V30 5 O 6.9300 5.3347 0.0 0
M  V30 6 C 10.0100 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 7.7000 1.3336 0.0 0
M  V30 11 C 5.3900 0.0000 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 3.0800 6.6685 0.0 0
M  V30 15 C 0.7700 5.3347 0.0 0
M  V30 16 C 2.3100 8.0021 0.0 0
M  V30 17 C 0.0000 6.6685 0.0 0
M  V30 18 C 0.7700 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4349-62-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 104916-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20231793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chromium-catalyzed para-selective formation of quaternary carbon centers
by alkylation of benzamide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Pei; Chen, Changpeng; Cong, Xuefeng; Tang, Jinghua; Zeng, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2018), 9(1), 1-8

$RFMT $RIREG SCHEME167 STEP1
$RXN



  4  1
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Aminobenzylamine
C7H10N2
4403-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 N 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloronicotinoyl chloride
C6H3Cl2NO
58757-38-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-[4-[[[2-(methylamino)-4-quinazolinyl]amino]methyl]phenyl]-3-pyridi...
C22H19ClN6O
1039731-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 1.5400 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 N 13.0900 5.3347 0.0 0
M  V30 6 C 13.8600 6.6685 0.0 0
M  V30 7 O 13.0900 8.0021 0.0 0
M  V30 8 Cl 20.0200 6.6685 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3336 0.0 0
M  V30 13 N 3.8500 5.3347 0.0 0
M  V30 14 N 1.5400 4.0011 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 16 C 3.8500 0.0000 0.0 0
M  V30 17 C 2.3100 5.3347 0.0 0
M  V30 18 C 2.3100 0.0000 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 9.2400 6.6685 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 10.7800 6.6685 0.0 0
M  V30 23 C 10.7800 4.0011 0.0 0
M  V30 24 C 11.5500 5.3347 0.0 0
M  V30 25 C 15.4000 6.6685 0.0 0
M  V30 26 C 16.1700 8.0021 0.0 0
M  V30 27 C 16.1700 5.3347 0.0 0
M  V30 28 C 17.7100 8.0021 0.0 0
M  V30 29 N 17.7100 5.3347 0.0 0
M  V30 30 C 18.4800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 24
M  V30 8 2 6 7
M  V30 9 1 6 25
M  V30 10 1 8 30
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 11 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 17
M  V30 20 2 15 18
M  V30 21 1 16 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4403-71-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 58757-38-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1039731-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-114420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: General Procedure
for the Preparation of 2,4-Diaminoquinazoline Analogues. Procedure A
(Step1). To a stirred solution of 4-aminobenzylamine (122 mg, 1 mmol) and
triethylamine (202 mg, 2 mmol) in CHCl3 (5 mL) at 20 °C was added (1
mmol) of the appropriately substituted 2,4-dichloroquinazoline, and the
mixture was stirred for a minimum of 3 h. After TLC showed the complete
disappearance of the 2,4-dichloroquinazoline, aroyl chloride (1 mmol) in
CHCl3 (1 mL) was added slowly. The reaction mixture was allowed to stir
overnight. At the end, the reaction mixture was quenched with CHCl3 (50
mL) and water (15 mL). The reaction mixture was washed with water, and
the chloroform layer was dried over MgSO4. After removal of MgSO4 by
filtration and evaporation of solvents the crude product was purified by
column chromatography with hexane/ CH2Cl2/EA to give the
2-chloroquinazolines in yields between 50% and 95%. Procedure A (Step 2).
The appropriately substituted 2-chloroquinazoline derivatives (1 mmol)
obtained by procedure A (step 1) was taken up either in a sealed tube or
in a round-bottom flask and was suspended in THF (5 mL) or dioxane. (If
the reactant amine is monomethylamine or dimethylamine, a sealed tube was
used, and for other amines, a round-bottom flask can be used.) The
appropriate amine was added, and the mixture was heated over 16 h to 100
°C or alternatively heated for 40 min to 120 °C using a microwave. After
reaction was completed, the solvents were removed in vacuo, and the crude
compound was purified by silica gel column chromatography by using
CH2Cl2/ MeOH/NH3 mixtures as eluent to give the diaminoquinazolines in
yields between 65% and 95%. Preparation of
6-Chloro-N-[4-({[2-(methylamino)quinazolin-4-yl]amino}methyl)phenyl]nicotinamide
(9).
6-Chloro-N-[4-({[2-(methylamino)quinazolin-4-yl]amino}methyl)phenyl]nicotinamide
was prepared starting from 2,4-dichloroquinazoline, 4-aminobenzylamine,
and 6-chloronicotinoyl chloride following procedure A (step 1). The
intermediate product from step 1 was aminated usingmonomethylamine
following procedure A (step 2) to yield the final product. Starting from
2,4-dichloroquinazoline (0.15 g, 0.75 mmol), 140 mg (95% yield) of the
final product was isolated. 1H NMR (DMSO) δ 2.81 (d, J = 5.0 Hz, 3H),
4.70 (d, J = 5.0 Hz, 2H), 6.47 (br s, 1H), 7.29-7.24 (m, 1H), 7.39- 7.35
(m, 2H), 7.50-7.47 (m, 1H), 7.71-7.67 (m, 4H), 8.04-8.0 (m, 2H),
8.47-8.30 (m, 2H), 8.93 (d, J = 3.0 Hz, 1H), 10.47 (s, 1H) ppm;MS (ESI)
m/z 419.1. Anal. Calcd for C22H19ClN6O (%): C, 63.08; H, 4.57; N, 20.06.
Found: C, 63.31; H, 4.84; N, 20.25.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective, sealed tube in third step used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and Synthesis of Novel Diaminoquinazolines with in Vivo Efficacy
for β-Catenin/T-Cell Transcriptional Factor 4 Pathway Inhibition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dehnhardt, Christoph M.; Venkatesan, Aranapakam M.; Chen, Zecheng;
Ayral-Kaloustian, Semiramis; Dos Santos, Osvaldo; Delos Santos, Efren;
Curran, Kevin; Follettie, Max T.; Diesl, Veronica; Lucas, Judy; Geng, Yi;
DeJoy, Susan Quinn; Petersen, Rosanne; Chaudhary, Inder; Brooijmans,
Natasja; Mansour, Tarek S.; Arndt, Kim; Chen, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(2), 897-910

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
2-[4-[(7-Bromo-2-quinolinyl)oxy]phenoxy]propanoic acid
C18H14BrNO4
445041-70-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 4.6201 0.0 0
M  V30 2 Br 0.0000 4.6201 0.0 0
M  V30 3 O 13.3370 1.5400 0.0 0
M  V30 4 C 14.6707 2.3100 0.0 0
M  V30 5 C 16.0043 1.5400 0.0 0
M  V30 6 C 14.6707 3.8500 0.0 0
M  V30 7 O 16.0043 0.0000 0.0 0
M  V30 8 O 17.3381 2.3100 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 N 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 6.6686 2.3100 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6686 3.8500 0.0 0
M  V30 18 C 1.3338 3.8500 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 10.6695 4.6201 0.0 0
M  V30 21 C 9.3359 2.3100 0.0 0
M  V30 22 C 12.0034 3.8500 0.0 0
M  V30 23 C 10.6695 1.5400 0.0 0
M  V30 24 C 12.0034 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 19
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 24
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[(7-Bromo-2-quinolinyl)oxy]phenoxy]-N-methylpropanamide
C19H17BrN2O3
643752-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 4.6201 0.0 0
M  V30 2 Br 0.0000 4.6201 0.0 0
M  V30 3 O 13.3372 1.5400 0.0 0
M  V30 4 C 14.6708 2.3101 0.0 0
M  V30 5 C 16.0045 1.5400 0.0 0
M  V30 6 C 14.6708 3.8501 0.0 0
M  V30 7 N 17.3383 2.3101 0.0 0
M  V30 8 O 16.0045 0.0000 0.0 0
M  V30 9 C 18.6720 1.5400 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 N 5.3348 4.6201 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 9.3360 3.8501 0.0 0
M  V30 21 C 9.3360 2.3101 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 10.6697 1.5400 0.0 0
M  V30 24 C 12.0035 3.8501 0.0 0
M  V30 25 C 12.0035 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 20
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 445041-70-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 643752-98-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13205192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-{4-((7-Bromo-2-quinolinyl)oxy)phenoxy}propionmethylamide (14d) A
mixture of 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid 11c
(0.20 g, 0.52 mmol) and SOCl2 (0.40 mL, 0.66 g, 5.4 mmol) was heated for
1 h, then concentrated to give a yellowish solid. The latter was
dissolved in THF (10 mL); methylamine (2 M in THF) was added until the
mixture was basic and then concentrated to give a yellowish solid. Water
(10 mL) and saturated NaHCO3 were added until pH 8, and the mixture
extracted with AcOEt (2 x 25 mL). The combined extracts were washed with
saturated NaCl (10 mL) and after drying (MgSO4), filtered through silica
gel and concentrated to give an off white solid. The latter was
recrystallized from EtOH-heptane to give the title compound. 14d as white
crystals, yield 0.20 g, 95%. mp 150-151 °C ;1H NMR (400 MHz, CDCl3) δ 8
8.06 (d, J= 8.8 Hz, 1H), 7.93 (d, J= 1.6 Hz, 1H), 7.59 (d, J= 9.2 Hz,
1H), 7.48 (dd, J= 8.4, 1.6 Hz, 1H), 7.19-7. 14 (m, 2H), 7.07 (d, J = 8.8
Hz, 1H), 6. 97-6. 91 (m, 2H), 6.56 (bs, 1H), 4.68 (q, J= 6.4 Hz, 1H),
2.87 (d, J= 5. 2 Hz, 3H), 1.60 (d, J= 6.4 Hz, 3H). 13C NMR (100 MHz,
CDCl3) 6 173.0, 162.6, 154.2, 148.0, 147.3, 139.8, 130.4, 128.8, 128.4,
124.4, 124.2, 123.1, 116.5, 113.3, 75.9, 26.2, 19.1. MS (EI) m/z (%) 400
(M+, 33), 342 (40), 328 (6), 316 (22), 298 (7), 206 (17), 189 (5), 149
(6), 137 (18), 127 (17), 121 (10), 109 (9), 95 (16), 86 (20), 81 (51), 69
(100), 57 (19), 55 (21), 45 (7). HRMS (EI) m/z 400. 0426 (Calcd for
C19H17N2BrO3 400.0423).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-[4-[(7-halo-2-quinolinyl)oxy]phenoxy]propionic acid
derivatives and quinoxalinyl analogs as antineoplastic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Horwitz, Jerome P.; Corbett, Thomas H.; Palomino, Eduardo; Polin, Lisa;
Hazeldine, Stuart T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004005260 A1 2004-01-15

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
(2R)-2-[4-[(7-Bromo-2-quinolinyl)oxy]phenoxy]propanoic acid
C18H14BrNO4
445041-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 4.6201 0.0 0
M  V30 2 Br 0.0000 4.6201 0.0 0
M  V30 3 O 13.3370 1.5400 0.0 0
M  V30 4 C 14.6707 2.3100 0.0 0 CFG=2
M  V30 5 C 16.0043 1.5400 0.0 0
M  V30 6 C 14.6707 3.8500 0.0 0
M  V30 7 O 16.0043 0.0000 0.0 0
M  V30 8 O 17.3381 2.3100 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 5.3348 1.5400 0.0 0
M  V30 12 C 2.6675 1.5400 0.0 0
M  V30 13 N 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 6.6686 2.3100 0.0 0
M  V30 16 C 1.3338 2.3100 0.0 0
M  V30 17 C 6.6686 3.8500 0.0 0
M  V30 18 C 1.3338 3.8500 0.0 0
M  V30 19 C 9.3359 3.8500 0.0 0
M  V30 20 C 10.6695 4.6201 0.0 0
M  V30 21 C 9.3359 2.3100 0.0 0
M  V30 22 C 12.0034 3.8500 0.0 0
M  V30 23 C 10.6695 1.5400 0.0 0
M  V30 24 C 12.0034 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 19
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 3 24
M  V30 6 1 4 5
M  V30 7 1 4 6 CFG=3
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-[(7-Bromo-2-quinolinyl)oxy]phenoxy]-N-methylpropanamide
C19H17BrN2O3
643752-98-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 4.6201 0.0 0
M  V30 2 Br 0.0000 4.6201 0.0 0
M  V30 3 O 13.3372 1.5400 0.0 0
M  V30 4 C 14.6708 2.3101 0.0 0
M  V30 5 C 16.0045 1.5400 0.0 0
M  V30 6 C 14.6708 3.8501 0.0 0
M  V30 7 N 17.3383 2.3101 0.0 0
M  V30 8 O 16.0045 0.0000 0.0 0
M  V30 9 C 18.6720 1.5400 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 2.6675 1.5400 0.0 0
M  V30 14 N 5.3348 4.6201 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0
M  V30 19 C 1.3337 3.8501 0.0 0
M  V30 20 C 9.3360 3.8501 0.0 0
M  V30 21 C 9.3360 2.3101 0.0 0
M  V30 22 C 10.6697 4.6201 0.0 0
M  V30 23 C 10.6697 1.5400 0.0 0
M  V30 24 C 12.0035 3.8501 0.0 0
M  V30 25 C 12.0035 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 20
M  V30 3 1 2 19
M  V30 4 1 3 4
M  V30 5 1 3 25
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 7 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 445041-75-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 643752-98-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1551031
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of therapeutic amides as antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Horwitz, Jerome P.; Corbett, Thomas H.; Palomino, Eduardo; Polin, Lisa;
Hazeldine, Stuart T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004004651 A2 2004-01-15

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(4-amino-3-nitrophenoxy)-3,5-dibromobenzeneacetate
C15H12Br2N2O5
446300-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6687 1.5400 0.0 0
M  V30 2 Br 9.3360 0.0000 0.0 0
M  V30 3 Br 6.6687 4.6201 0.0 0
M  V30 4 C 12.0035 4.6201 0.0 0
M  V30 5 C 13.3372 3.8501 0.0 0
M  V30 6 O 14.6708 4.6201 0.0 0
M  V30 7 O 13.3372 2.3101 0.0 0
M  V30 8 C 16.0046 3.8501 0.0 0
M  V30 9 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 10 O 1.3338 0.0000 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 N 1.3338 4.6201 0.0 0
M  V30 13 C 8.0023 2.3101 0.0 0
M  V30 14 C 9.3360 1.5400 0.0 0
M  V30 15 C 8.0023 3.8501 0.0 0
M  V30 16 C 10.6698 2.3101 0.0 0
M  V30 17 C 9.3360 4.6201 0.0 0
M  V30 18 C 10.6698 3.8501 0.0 0
M  V30 19 C 5.3348 2.3101 0.0 0
M  V30 20 C 4.0012 1.5400 0.0 0
M  V30 21 C 5.3348 3.8501 0.0 0
M  V30 22 C 2.6675 2.3101 0.0 0
M  V30 23 C 4.0012 4.6201 0.0 0
M  V30 24 C 2.6675 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 22
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3,5-dibromo-4-[4-(methylamino)-3-nitrophenoxy]benzeneacetate
C16H14Br2N2O5
446300-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6686 4.6201 0.0 0
M  V30 2 Br 6.6686 1.5400 0.0 0
M  V30 3 Br 9.3359 6.1601 0.0 0
M  V30 4 C 12.0034 1.5400 0.0 0
M  V30 5 C 13.3370 2.3100 0.0 0
M  V30 6 O 14.6707 1.5400 0.0 0
M  V30 7 O 13.3370 3.8500 0.0 0
M  V30 8 C 16.0045 2.3100 0.0 0
M  V30 9 N 1.3338 4.6201 0.0 0 VAL=5
M  V30 10 O 0.0000 3.8500 0.0 0
M  V30 11 O 1.3338 6.1601 0.0 0
M  V30 12 N 1.3338 1.5400 0.0 0
M  V30 13 C 1.3338 0.0000 0.0 0
M  V30 14 C 8.0022 3.8500 0.0 0
M  V30 15 C 8.0022 2.3100 0.0 0
M  V30 16 C 9.3359 4.6201 0.0 0
M  V30 17 C 9.3359 1.5400 0.0 0
M  V30 18 C 10.6697 3.8500 0.0 0
M  V30 19 C 10.6697 2.3100 0.0 0
M  V30 20 C 5.3348 3.8500 0.0 0
M  V30 21 C 4.0011 4.6201 0.0 0
M  V30 22 C 5.3348 2.3100 0.0 0
M  V30 23 C 2.6675 3.8500 0.0 0
M  V30 24 C 4.0011 1.5400 0.0 0
M  V30 25 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 23
M  V30 13 1 12 13
M  V30 14 1 12 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 446300-77-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 446300-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-19758419
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 111-77-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3,5-dibromo-4-(2-phenyl-5-benzofuranyloxy)phenyl acetic
acid and related compounds as novel thyroid receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Malm, Johan; Floeistrup, Erik; Grivas, Spiros; Li, Yi-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002062780 A2 2002-08-15

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-4-nitro-1H-pyrazole-3-carboxylic acid
C5H5N3O4
4598-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.8385 0.0 0 VAL=5
M  V30 2 O 1.3337 6.3785 0.0 0
M  V30 3 O 0.0000 4.0685 0.0 0
M  V30 4 C 1.6839 1.5063 0.0 0
M  V30 5 O 0.2193 1.9823 0.0 0
M  V30 6 O 2.0040 0.0000 0.0 0
M  V30 7 C 6.6363 3.7113 0.0 0
M  V30 8 C 2.6673 4.0685 0.0 0
M  V30 9 C 2.8284 2.5369 0.0 0
M  V30 10 C 4.0743 4.6948 0.0 0
M  V30 11 N 4.3347 2.2167 0.0 0
M  V30 12 N 5.1048 3.5504 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,1-Dimethyl-4-nitro-1H-pyrazole-3-carboxamide
C6H8N4O3
405279-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 3.8549 0.0 0
M  V30 2 N 5.9256 5.1886 0.0 0
M  V30 3 O 5.9256 2.5213 0.0 0
M  V30 4 C 7.4656 5.1886 0.0 0
M  V30 5 N 3.1864 1.1444 0.0 0 VAL=5
M  V30 6 O 4.6927 0.8242 0.0 0
M  V30 7 O 2.1559 0.0000 0.0 0
M  V30 8 C 0.0000 5.5302 0.0 0
M  V30 9 C 3.6156 3.8549 0.0 0
M  V30 10 C 2.7104 2.6091 0.0 0
M  V30 11 N 2.7104 5.1008 0.0 0
M  V30 12 C 1.2459 3.0849 0.0 0
M  V30 13 N 1.2459 4.6250 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4598-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 405279-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11547358
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as
potent anaplastic lymphoma kinase (ALK) inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Peilong; Dong, Jiaqiang; Zhong, Boyu; Zhang, Deyi; Yuan, Hongbin;
Jin, Can; Xu, Xiangyuan; Li, Hailong; Zhou, Yong; Liang, Zhi; Ji,
Minghua; Xu, Tao; Song, Guowei; Zhang, Ling; Chen, Gang; Meng, Xuejing;
Sun, Desheng; Shih, Joe; Zhang, Ruihao; Hou, Guojun; Wang, Chengcheng;
Jin, Ying; Yang, Qiong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(8), 1910-1918

$RFMT $RIREG SCHEME172 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(6-Chloro-9H-purin-9-yl)benzenemethanol
C12H9ClN4O
469887-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.4224 0.0 0
M  V30 2 C 10.3090 3.0801 0.0 0
M  V30 3 O 11.6427 2.3101 0.0 0
M  V30 4 N 4.9742 3.0801 0.0 0
M  V30 5 C 3.5673 2.4536 0.0 0
M  V30 6 C 4.8132 4.6116 0.0 0
M  V30 7 C 2.5367 3.5981 0.0 0
M  V30 8 N 3.0915 0.9890 0.0 0
M  V30 9 N 3.3068 4.9318 0.0 0
M  V30 10 C 1.0304 3.2780 0.0 0
M  V30 11 C 1.5850 0.6688 0.0 0
M  V30 12 N 0.5546 1.8132 0.0 0
M  V30 13 C 6.3078 2.3101 0.0 0
M  V30 14 C 7.6416 3.0801 0.0 0
M  V30 15 C 6.3078 0.7700 0.0 0
M  V30 16 C 8.9753 2.3101 0.0 0
M  V30 17 C 7.6416 0.0000 0.0 0
M  V30 18 C 8.9753 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 16
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 2 6 9
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[6-(Methylamino)-9H-purin-9-yl]benzenemethanol
C13H13N5O
1200437-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5063 4.4224 0.0 0
M  V30 2 C 0.0000 4.1022 0.0 0
M  V30 3 C 11.8154 3.0801 0.0 0
M  V30 4 O 13.1491 2.3101 0.0 0
M  V30 5 N 6.4806 3.0801 0.0 0
M  V30 6 C 5.0736 2.4536 0.0 0
M  V30 7 C 6.3197 4.6116 0.0 0
M  V30 8 C 4.0432 3.5981 0.0 0
M  V30 9 N 4.5978 0.9890 0.0 0
M  V30 10 N 4.8132 4.9318 0.0 0
M  V30 11 C 2.5369 3.2780 0.0 0
M  V30 12 C 3.0915 0.6688 0.0 0
M  V30 13 N 2.0609 1.8132 0.0 0
M  V30 14 C 7.8143 2.3101 0.0 0
M  V30 15 C 9.1480 3.0801 0.0 0
M  V30 16 C 7.8143 0.7700 0.0 0
M  V30 17 C 10.4818 2.3101 0.0 0
M  V30 18 C 9.1480 0.0000 0.0 0
M  V30 19 C 10.4818 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 469887-23-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1200437-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8960445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-(Methylamino)-9-[3-(hydroxymethyl)phenyl]purine (14). A solution of 3
(70 mg, 0.2 mmol) in MeNH2 in MeOH (33%) (30 mL) was stirred at room
temperature for 3 h. Volatiles were removed, and the residue was purified
by CCTLC in the Chromatotron (CH2Cl2:MeOH, 20:1) to yield 65 mg (95%) of
14 as a white solid. Mp 197-199 °C.MS(ES, positive mode): m/z 256 (M +
H)+. 1H NMR (DMSO-d6) δ 3.04 (s, 3H, CH3), 4.66 (d, 2H, J=5.6 Hz, CH2O),
5.45 (t, 1H, J=5.7 Hz, OH), 7.45 (d, 1H, J=7.6 Hz, Ar), 7.60 (t, 1H,
J=7.8 Hz, Ar), 7.79 (d, 1H, J=8.0 Hz, Ar), 7.92 (s, 1H, Ar), 7.93 (br s,
1H, NH), 8.36, 8.62 (s, 2H, H-2, H-8). Anal. (C13H13N5O) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 9-Arylpurines as a Novel Class of Enterovirus Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aguado, Leire; Thibaut, Hendrik Jan; Priego, Eva-Maria; Jimeno,
Maria-Luisa; Camarasa, Maria-Jose; Neyts, Johan; Perez-Perez, Maria-Jesus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(1), 316-324

$RFMT $RIREG SCHEME173 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)-3-oxobutanamide
C10H10N2O4
4835-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 C 10.6695 3.8500 0.0 0
M  V30 6 C 12.0032 4.6201 0.0 0
M  V30 7 O 10.6695 2.3100 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 3.8500 0.0 0
M  V30 16 C 2.6673 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-N-(4-nitrophenyl)-2-butenamide
C11H13N3O3
2754314-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 8.0022 2.3101 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 N 12.0033 4.6201 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 C 13.3370 3.8501 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 O 0.0000 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 4.0010 4.6201 0.0 0
M  V30 15 C 4.0010 1.5400 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 17 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4835-39-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2754314-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24906857
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1643-19-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Tandem Hofmann-Type Rearrangement and Cyclization Reaction
of α-Acyl-β-aminoacrylamides: Access to Polysubstituted Oxazol-2(3H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Baibin; Yuan, Jingwen; Ye, Xuebei; Zhang, Rui; Li, Jiacheng; Wang,
Yu; Hu, Jiana; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2021), 86(24), 17944-17954

$RFMT $RIREG SCHEME174 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2,3,4,7-tetrahydro-2-oxo-1...
C15H24N2O5
486439-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 2.3450 0.0 0
M  V30 2 C 4.0011 3.1150 0.0 0
M  V30 3 O 2.6675 2.3450 0.0 0
M  V30 4 O 4.0011 4.6550 0.0 0
M  V30 5 C 1.3338 3.1150 0.0 0
M  V30 6 C 2.1038 4.4487 0.0 0
M  V30 7 C 0.0000 3.8850 0.0 0
M  V30 8 C 0.5638 1.7812 0.0 0
M  V30 9 O 7.7115 0.7246 0.0 0
M  V30 10 C 10.4601 1.5724 0.0 0
M  V30 11 C 11.9615 1.9152 0.0 0
M  V30 12 O 13.0090 0.7862 0.0 0
M  V30 13 O 12.4153 3.3867 0.0 0
M  V30 14 C 14.5104 1.1288 0.0 0
M  V30 15 C 15.5579 0.0000 0.0 0
M  V30 16 C 6.6686 3.1150 0.0 0 CFG=1
M  V30 17 C 7.9410 2.2473 0.0 0
M  V30 18 C 6.5534 4.6507 0.0 0
M  V30 19 N 9.4126 2.7013 0.0 0
M  V30 20 C 7.6824 5.6981 0.0 0
M  V30 21 C 9.9752 4.1349 0.0 0
M  V30 22 C 9.2052 5.4686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 17
M  V30 10 1 10 11
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(3S)-2,3,4,7-tetrahydro-1-[2-(methylamino)-2-oxoethyl]-2-oxo-...
C14H23N3O4
486439-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 3.3532 0.0 0
M  V30 2 C 4.0011 2.5832 0.0 0
M  V30 3 O 2.6674 3.3532 0.0 0
M  V30 4 O 4.0011 1.0432 0.0 0
M  V30 5 C 1.3338 2.5832 0.0 0
M  V30 6 C 0.5638 3.9168 0.0 0
M  V30 7 C 0.0000 1.8132 0.0 0
M  V30 8 C 2.1038 1.2496 0.0 0
M  V30 9 O 7.7114 4.9736 0.0 0
M  V30 10 C 10.4598 4.1257 0.0 0
M  V30 11 C 11.9613 3.7830 0.0 0
M  V30 12 N 13.0087 4.9120 0.0 0
M  V30 13 O 12.4152 2.3114 0.0 0
M  V30 14 C 14.5102 4.5692 0.0 0
M  V30 15 C 6.6685 2.5832 0.0 0 CFG=1
M  V30 16 C 7.9409 3.4507 0.0 0
M  V30 17 C 6.5533 1.0475 0.0 0
M  V30 18 N 9.4125 2.9968 0.0 0
M  V30 19 C 7.6823 0.0000 0.0 0
M  V30 20 C 9.9750 1.5633 0.0 0
M  V30 21 C 9.2050 0.2296 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 16
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 486439-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 486439-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1568803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
(5-tert-Butoxycarbonylamino-6-oxo-3,6-dihydro-2H-pyridin-1-yl)acetic Acid
Methyl Amide (11a). Compound 9a (41 mg, 0.41 mmol) was added to a
solution of methylamine in EtOH (5 mL, 8.03 M). The mixture was stirred
overnight when evaporation followed by flash chromatography (CH2Cl2-MeOH,
95:5) of the resulting residue.
(S)-(3-tert-Butoxycarbonylamino-2-oxo-2,3,4,7-tetrahydroazepin-1-yl)acetic
Acid Methyl Amide (11b). Obtained from 9b (20 mg, 0.064 mmol) and a
solution of methylamine in EtOH (6 mL, 8.03 M) as described for 11a.
Purification by flash chromatography (CH2Cl2-MeOH, 95:5) yielded 11b (18
mg, 95%). 11b: colorless solid. mp 63-65 °C; Rf 0.33 (CH2Cl2-MeOH, 95:5);
[α]22 D +23.0 (c = 0.34, CHCl3); IR (film) 3417, 3324, 1706, 1654 cm-1;
1H NMR (2 mM, CDCl3) δ 1.45 (s, 9H), 2.24 (ddd, J = 17.1, 12.8, 3.9, 1H),
2.70 (ddd, J = 18.4, 6.7, 2.9, 1H), 2.79 (d, J = 4.9, 3H), 3.55-3.60 (m,
1H), 4.05 (d, J = 15.6, 1H), 4.14 (d, J = 15.6, 1H), 4.51 (ddd, J = 17.7,
3.7, 3.7, 1H), 4.98 (ddd, J = 12.1, 7.0, 4.6, 1H) 5.66 (d, J = 6.9, 1H),
5.75-5.88 (m, 2H), 6.02 (br s, 1H); 1H NMR (2 mM, DMSO-d 6) δ 1.39 (s,
9H), 2.10-2.22 (m, 1H), 2.30-2.44 (m, 1H), 2.58 (d, J = 4.6, 3H), 3.47
(dd, J = 17.9, 7.3, 1H), 3.71 (d, J = 16.3, 1H), 4.19 (d, J = 16.3, 1H),
4.38-4.51 (m, 1H), 4.79 (ddd, J = 12.1, 7.1, 4.4, 1H), 5.60-5.80 (m, 2H),
6.49 (d, J = 7.1, 1H), 7.71 (br q, J = 4.4, 1H); 13C NMR (CDCl3) δ 26.2,
28.3, 33.1, 47.2, 50.1, 53.0, 79.9, 124.1, 130.3, 155.1, 168.9, 173.3;
EIMS 297 (M+); HRMS m/z calcd for C14H23N3O4 297.1689, found 297.1670.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A General Approach to Dehydro-Freidinger Lactams: Ex-Chiral Pool
Synthesis and Spectroscopic Evaluation as Potential Reverse Turn Inducers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hoffmann, Tobias; Waibel, Reiner; Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(1), 62-69

$RFMT $RIREG SCHEME175 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-Pentadecafluoroheptyl)-5-(trichloromethyl)-1...
C10Cl3F15N2O
500129-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 2.9211 0.0 0
M  V30 2 C 9.2400 2.9211 0.0 0
M  V30 3 F 10.7800 4.4611 0.0 0
M  V30 4 F 10.7800 1.3811 0.0 0
M  V30 5 C 7.7000 2.9211 0.0 0
M  V30 6 F 9.2400 4.4611 0.0 0
M  V30 7 F 9.2400 1.3811 0.0 0
M  V30 8 C 6.1600 2.9211 0.0 0
M  V30 9 F 7.7000 4.4611 0.0 0
M  V30 10 F 7.7000 1.3811 0.0 0
M  V30 11 C 4.6200 2.9211 0.0 0
M  V30 12 F 6.1600 4.4611 0.0 0
M  V30 13 F 6.1600 1.3811 0.0 0
M  V30 14 C 3.0800 2.9211 0.0 0
M  V30 15 F 4.6200 4.4611 0.0 0
M  V30 16 F 4.6200 1.3811 0.0 0
M  V30 17 C 1.5400 2.9211 0.0 0
M  V30 18 F 3.0800 4.4611 0.0 0
M  V30 19 F 3.0800 1.3811 0.0 0
M  V30 20 F 0.0000 2.9211 0.0 0
M  V30 21 F 1.5400 4.4611 0.0 0
M  V30 22 F 1.5400 1.3811 0.0 0
M  V30 23 C 15.9356 1.2459 0.0 0
M  V30 24 Cl 15.0304 0.0000 0.0 0
M  V30 25 Cl 17.1815 0.3406 0.0 0
M  V30 26 Cl 16.8408 2.4917 0.0 0
M  V30 27 C 12.3200 2.9211 0.0 0
M  V30 28 N 13.2251 1.6752 0.0 0
M  V30 29 N 13.2251 4.1669 0.0 0
M  V30 30 C 14.6898 2.1511 0.0 0
M  V30 31 O 14.6898 3.6911 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 27
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 23 30
M  V30 27 1 27 28
M  V30 28 2 27 29
M  V30 29 2 28 30
M  V30 30 1 29 31
M  V30 31 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoroheptyl)-1,2,4-oxadia...
C10H4F15N3O
500129-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7800 1.5400 0.0 0
M  V30 2 C 9.2400 1.5400 0.0 0
M  V30 3 F 10.7800 0.0000 0.0 0
M  V30 4 F 10.7800 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 F 9.2400 0.0000 0.0 0
M  V30 7 F 9.2400 3.0800 0.0 0
M  V30 8 C 6.1600 1.5400 0.0 0
M  V30 9 F 7.7000 0.0000 0.0 0
M  V30 10 F 7.7000 3.0800 0.0 0
M  V30 11 C 4.6200 1.5400 0.0 0
M  V30 12 F 6.1600 0.0000 0.0 0
M  V30 13 F 6.1600 3.0800 0.0 0
M  V30 14 C 3.0800 1.5400 0.0 0
M  V30 15 F 4.6200 0.0000 0.0 0
M  V30 16 F 4.6200 3.0800 0.0 0
M  V30 17 C 1.5400 1.5400 0.0 0
M  V30 18 F 3.0800 0.0000 0.0 0
M  V30 19 F 3.0800 3.0800 0.0 0
M  V30 20 F 0.0000 1.5400 0.0 0
M  V30 21 F 1.5400 0.0000 0.0 0
M  V30 22 F 1.5400 3.0800 0.0 0
M  V30 23 N 15.9358 3.2152 0.0 0
M  V30 24 C 17.3426 2.5889 0.0 0
M  V30 25 C 12.3200 1.5400 0.0 0
M  V30 26 N 13.2252 2.7859 0.0 0
M  V30 27 N 13.2252 0.2941 0.0 0
M  V30 28 C 14.6898 2.3100 0.0 0
M  V30 29 O 14.6898 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 25
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 5 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 17 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 23 24
M  V30 24 1 23 28
M  V30 25 1 25 26
M  V30 26 2 25 27
M  V30 27 2 26 28
M  V30 28 1 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 500129-58-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500129-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-185-CAS-21125678
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fluorinated heterocyclic compounds. Synthesis of 5-amino-,
5-N-alkylamino-, and
5-N,N-dialkylamino-3-perfluoroheptyl-1,2,4-oxadiazoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buscemi, Silvestre; Pace, Andrea; Pibiri, Ivana; Vivona, Nicolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2002), 57(10), 1891-1896

$RFMT $RIREG SCHEME176 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-(3,3-dimethyl-1-butyn-1-yl)-2-methyl-3(2H)-pyridazinone
C11H13ClN2O
501371-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6673 0.0 0
M  V30 2 C 7.7000 2.6673 0.0 0
M  V30 3 C 9.2400 2.6673 0.0 0
M  V30 4 C 9.2400 4.2073 0.0 0
M  V30 5 C 10.7800 2.6673 0.0 0
M  V30 6 C 9.2400 1.1273 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 4.6200 2.6673 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 2.3100 1.3336 0.0 0
M  V30 14 N 2.3100 4.0011 0.0 0
M  V30 15 N 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 11
M  V30 8 2 8 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1,1-Dimethylethyl)-1,6-dihydro-1,6-dimethyl-7H-pyrrolo[2,3-d]pyridazin-7-one
C12H17N3O
637772-60-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5094 0.3694 0.0 0
M  V30 2 O 6.7835 0.0000 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.7700 1.7464 0.0 0
M  V30 5 C 0.0000 3.0800 0.0 0
M  V30 6 C 0.7700 4.4136 0.0 0
M  V30 7 C 9.4510 1.5400 0.0 0
M  V30 8 C 5.4499 2.3100 0.0 0
M  V30 9 C 5.4499 3.8500 0.0 0
M  V30 10 N 3.9852 1.8341 0.0 0
M  V30 11 C 6.7835 1.5400 0.0 0
M  V30 12 C 3.9852 4.3259 0.0 0
M  V30 13 C 6.7835 4.6200 0.0 0
M  V30 14 C 3.0800 3.0800 0.0 0
M  V30 15 N 8.1172 2.3100 0.0 0
M  V30 16 N 8.1172 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 14
M  V30 7 1 7 15
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 501371-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 637772-60-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11593641
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 141-52-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 5-Alkynyl-4-chloro- and 4-alkynyl-5-chloro-2-methylpyridazin-3(2H)-ones:
Convenient precursors for the preparation of 2-substituted
pyrrolo[2,3-d]pyridazinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM R'kyek, Omar; Maes, Bert U. W.; Lemiere, Guy L. F.; Dommisse, Roger A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2003), 60(11), 2471-2483

$RFMT $RIREG SCHEME177 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodopyridine
C5H4IN
5029-67-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)pyridine
C6H8N2
4597-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5029-67-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4597-87-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11296057
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, oxime catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3(2H)-Pyridazinone, 6-(4-methylphenyl)-2-(2-methylpropyl)-4-[[(methylsulfonyl...
C17H22N2O4S
503825-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 9.2402 0.0 0
M  V30 2 O 9.3360 8.4702 0.0 0
M  V30 3 S 10.6697 9.2402 0.0 0 VAL=6
M  V30 4 C 11.4397 7.9065 0.0 0
M  V30 5 O 12.0033 10.0102 0.0 0
M  V30 6 O 9.8996 10.5739 0.0 0
M  V30 7 C 2.6673 9.2402 0.0 0
M  V30 8 C 1.3337 8.4702 0.0 0
M  V30 9 C 0.0000 9.2402 0.0 0
M  V30 10 C 1.3337 6.9302 0.0 0
M  V30 11 O 5.3348 10.7802 0.0 0
M  V30 12 C 5.3348 0.0000 0.0 0
M  V30 13 C 5.3348 6.1601 0.0 0
M  V30 14 C 6.6685 6.9302 0.0 0
M  V30 15 N 4.0012 6.9302 0.0 0
M  V30 16 C 6.6685 8.4702 0.0 0
M  V30 17 N 4.0012 8.4702 0.0 0
M  V30 18 C 5.3348 9.2402 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 6.6685 3.8501 0.0 0
M  V30 21 C 4.0012 3.8501 0.0 0
M  V30 22 C 6.6685 2.3101 0.0 0
M  V30 23 C 4.0012 2.3101 0.0 0
M  V30 24 C 5.3348 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 18
M  V30 12 1 12 24
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 19
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylamino)methyl]-6-(4-methylphenyl)-2-(2-methylpropyl)-3(2H)-pyridazinone
C17H23N3O
503823-20-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 8.0023 0.0 0
M  V30 2 C 2.3101 9.3360 0.0 0
M  V30 3 C 3.8501 9.3360 0.0 0
M  V30 4 C 1.5400 10.6697 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 N 2.3101 1.3337 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 O 0.0000 5.3348 0.0 0
M  V30 9 C 10.7802 5.3348 0.0 0
M  V30 10 C 4.6201 5.3348 0.0 0
M  V30 11 N 3.8501 6.6685 0.0 0
M  V30 12 C 3.8501 4.0012 0.0 0
M  V30 13 N 2.3101 6.6685 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 1.5400 5.3348 0.0 0
M  V30 16 C 6.1601 5.3348 0.0 0
M  V30 17 C 6.9302 6.6685 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 8.4702 6.6685 0.0 0
M  V30 20 C 8.4702 4.0012 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 8 15
M  V30 9 1 9 21
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 503825-08-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 503823-20-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12483966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4) Preparation of
2-cyclopropylmethyl-6-(3-fluoro-4-methoxyphenyl)-4-methylaminomethyl-2H-pyridazin-3-one
A solution of
2-cyclopropylmethyl-6-(3-fluoro-4-methoxyphenyl)-4-methanesulfonyloxymethyl-2H-pyridazin-3-one
(160 mg, 0.42 mmol) in 30% methylamine/ethanol (5 mL) was stirred at
80°C. for 4 hours in a sealed tube. The solvent was distilled off under
reduced pressure, and the residue was purified by preparative thin-layer
chromatography on silica gel [developing solvent: chloroform/methanol
(10/1)]. Preparation of
2-isobutyl-4-methylaminomethyl-6-(4-methylphenyl)-2H-pyridazin-3-one
Following the procedure of Example 9 (4),
2-isobutyl-4-methanesulfonyloxymethyl-6-(4-methylphenyl)-2H-pyridazin-3-one
and methylamine were reacted. the title compound as a slightly yellow oil
(yield: 94.5%). 1H NMR (400 MHz, CDCl3) δ: 0.98 (6H, d, J=6.6 Hz), 1.87
(1H, br), 2.29-2.42 (1H, m), 2.40 (3H, s), 2.50 (3H, s), 3.76 (2H, d,
J=1.2 Hz), 4.07 (2H, d, J=7.3 Hz), 7.26 (2H, d, J=8.1 Hz), 7.67 (1H, t,
J=1.2 Hz), 7.71 (2H, d, J=8.1 Hz). IR (Neat) cm-1: 3317, 1652, 1607. Mass
m/z: 285 (M+).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used, product further converted to HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of water-soluble phenylpyridazine derivatives as IL-β
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kyotani, Yoshinori; Koshi, Tomoyuki; Shigyo, Hiromichi; Yoshizaki, Hideo;
Kitamura, Takahiro; Takemura, Shunji; Yasuoka, Kyoko; Totsuka, Junko;
Sato, Seiichi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040002497 A1 2004-01-01

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-1-carboximidothioic acid, 3-(4-chlorophenyl)-4,5-dihydro-4-phenyl...
C22H25ClN4O2S2
505031-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 6.8423 0.0 0
M  V30 2 N 5.3348 6.0723 0.0 0
M  V30 3 S 6.6686 8.3823 0.0 0
M  V30 4 S 4.0011 6.8423 0.0 0 VAL=6
M  V30 5 C 8.0023 9.1524 0.0 0
M  V30 6 O 3.2311 5.5087 0.0 0
M  V30 7 O 4.7711 8.1761 0.0 0
M  V30 8 Cl 16.5660 6.1981 0.0 0
M  V30 9 C 10.4397 5.5542 0.0 0
M  V30 10 C 9.6697 4.2206 0.0 0
M  V30 11 N 9.4091 6.6988 0.0 0
M  V30 12 C 8.1632 4.5408 0.0 0
M  V30 13 N 8.0023 6.0723 0.0 0
M  V30 14 C 11.9712 5.7153 0.0 0
M  V30 15 C 12.8764 4.4693 0.0 0
M  V30 16 C 12.5975 7.1221 0.0 0
M  V30 17 C 14.4080 4.6304 0.0 0
M  V30 18 C 14.1293 7.2831 0.0 0
M  V30 19 C 15.0343 6.0372 0.0 0
M  V30 20 C 10.2960 2.8138 0.0 0
M  V30 21 C 9.3908 1.5677 0.0 0
M  V30 22 C 11.8275 2.6527 0.0 0
M  V30 23 C 10.0172 0.1609 0.0 0
M  V30 24 C 12.4540 1.2459 0.0 0
M  V30 25 C 11.5488 0.0000 0.0 0
M  V30 26 N 2.6675 7.6123 0.0 0
M  V30 27 C 1.3338 6.8423 0.0 0
M  V30 28 C 2.6675 9.1524 0.0 0
M  V30 29 C 0.0000 7.6123 0.0 0
M  V30 30 C 1.3338 9.9224 0.0 0
M  V30 31 C 0.0000 9.1524 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 26
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 10 20
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-4,5-dihydro-N-methyl-4-phenyl-N′-(1-piperidinylsulfonyl)-1...
C22H26ClN5O2S
505031-07-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 6.8423 0.0 0
M  V30 2 N 5.3348 6.0723 0.0 0
M  V30 3 N 6.6686 8.3823 0.0 0
M  V30 4 S 4.0011 6.8423 0.0 0 VAL=6
M  V30 5 C 8.0023 9.1524 0.0 0
M  V30 6 O 3.2311 5.5087 0.0 0
M  V30 7 O 4.7711 8.1761 0.0 0
M  V30 8 Cl 16.5660 6.1981 0.0 0
M  V30 9 C 10.4397 5.5542 0.0 0
M  V30 10 C 9.6697 4.2206 0.0 0
M  V30 11 N 9.4091 6.6988 0.0 0
M  V30 12 C 8.1632 4.5408 0.0 0
M  V30 13 N 8.0023 6.0723 0.0 0
M  V30 14 C 11.9712 5.7153 0.0 0
M  V30 15 C 12.8764 4.4693 0.0 0
M  V30 16 C 12.5975 7.1221 0.0 0
M  V30 17 C 14.4080 4.6304 0.0 0
M  V30 18 C 14.1293 7.2831 0.0 0
M  V30 19 C 15.0343 6.0372 0.0 0
M  V30 20 C 10.2960 2.8138 0.0 0
M  V30 21 C 11.8275 2.6527 0.0 0
M  V30 22 C 9.3908 1.5677 0.0 0
M  V30 23 C 12.4540 1.2459 0.0 0
M  V30 24 C 10.0172 0.1609 0.0 0
M  V30 25 C 11.5488 0.0000 0.0 0
M  V30 26 N 2.6675 7.6123 0.0 0
M  V30 27 C 1.3338 6.8423 0.0 0
M  V30 28 C 2.6675 9.1524 0.0 0
M  V30 29 C 0.0000 7.6123 0.0 0
M  V30 30 C 1.3338 9.9224 0.0 0
M  V30 31 C 0.0000 9.1524 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 26
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 10 20
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 505031-17-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 505031-07-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1649621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor
antagonists with lower lipophilicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lange, Jos H. M.; Van Stuivenberg, Herman H.; Veerman, Willem; Wals,
Henri C.; Stork, Bob; Coolen, Hein K. A. C.; McCreary, Andrew C.; Adolfs,
Tiny J. P.; Kruse, Chris G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(21), 4794-4798

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-1-carboximidothioic acid, 3-(4-chlorophenyl)-4,5-dihydro-N-(4-mor...
C21H23ClN4O3S2
505031-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 6.8423 0.0 0
M  V30 2 N 5.3348 6.0723 0.0 0
M  V30 3 S 6.6686 8.3823 0.0 0
M  V30 4 S 4.0011 6.8423 0.0 0 VAL=6
M  V30 5 C 8.0023 9.1524 0.0 0
M  V30 6 O 3.2311 5.5087 0.0 0
M  V30 7 O 4.7711 8.1761 0.0 0
M  V30 8 Cl 16.5660 6.1981 0.0 0
M  V30 9 C 10.4397 5.5542 0.0 0
M  V30 10 C 9.6697 4.2206 0.0 0
M  V30 11 N 9.4091 6.6988 0.0 0
M  V30 12 C 8.1632 4.5408 0.0 0
M  V30 13 N 8.0023 6.0723 0.0 0
M  V30 14 C 11.9712 5.7153 0.0 0
M  V30 15 C 12.8764 4.4693 0.0 0
M  V30 16 C 12.5975 7.1221 0.0 0
M  V30 17 C 14.4080 4.6304 0.0 0
M  V30 18 C 14.1293 7.2831 0.0 0
M  V30 19 C 15.0343 6.0372 0.0 0
M  V30 20 C 10.2960 2.8138 0.0 0
M  V30 21 C 9.3908 1.5677 0.0 0
M  V30 22 C 11.8275 2.6527 0.0 0
M  V30 23 C 10.0172 0.1609 0.0 0
M  V30 24 C 12.4540 1.2459 0.0 0
M  V30 25 C 11.5488 0.0000 0.0 0
M  V30 26 N 2.6675 7.6123 0.0 0
M  V30 27 C 1.3338 6.8423 0.0 0
M  V30 28 C 2.6675 9.1524 0.0 0
M  V30 29 C 0.0000 7.6123 0.0 0
M  V30 30 C 1.3338 9.9224 0.0 0
M  V30 31 O 0.0000 9.1524 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 26
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 10 20
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(4-Chlorophenyl)-4,5-dihydro-N-methyl-N′-(4-morpholinylsulfonyl)-4-phenyl-1...
C21H24ClN5O3S
869278-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6686 6.8423 0.0 0
M  V30 2 N 5.3348 6.0723 0.0 0
M  V30 3 N 6.6686 8.3823 0.0 0
M  V30 4 S 4.0011 6.8423 0.0 0 VAL=6
M  V30 5 C 8.0023 9.1524 0.0 0
M  V30 6 O 3.2311 5.5087 0.0 0
M  V30 7 O 4.7711 8.1761 0.0 0
M  V30 8 Cl 16.5660 6.1981 0.0 0
M  V30 9 C 10.4397 5.5542 0.0 0
M  V30 10 C 9.6697 4.2206 0.0 0
M  V30 11 N 9.4091 6.6988 0.0 0
M  V30 12 C 8.1632 4.5408 0.0 0
M  V30 13 N 8.0023 6.0723 0.0 0
M  V30 14 C 11.9712 5.7153 0.0 0
M  V30 15 C 12.8764 4.4693 0.0 0
M  V30 16 C 12.5975 7.1221 0.0 0
M  V30 17 C 14.4080 4.6304 0.0 0
M  V30 18 C 14.1293 7.2831 0.0 0
M  V30 19 C 15.0343 6.0372 0.0 0
M  V30 20 C 10.2960 2.8138 0.0 0
M  V30 21 C 11.8275 2.6527 0.0 0
M  V30 22 C 9.3908 1.5677 0.0 0
M  V30 23 C 12.4540 1.2459 0.0 0
M  V30 24 C 10.0172 0.1609 0.0 0
M  V30 25 C 11.5488 0.0000 0.0 0
M  V30 26 N 2.6675 7.6123 0.0 0
M  V30 27 C 1.3338 6.8423 0.0 0
M  V30 28 C 2.6675 9.1524 0.0 0
M  V30 29 C 0.0000 7.6123 0.0 0
M  V30 30 C 1.3338 9.9224 0.0 0
M  V30 31 O 0.0000 9.1524 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 4 7
M  V30 8 1 4 26
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 14
M  V30 13 1 10 12
M  V30 14 1 10 20
M  V30 15 1 11 13
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 505031-26-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869278-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3761666
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor
antagonists with lower lipophilicity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lange, Jos H. M.; Van Stuivenberg, Herman H.; Veerman, Willem; Wals,
Henri C.; Stork, Bob; Coolen, Hein K. A. C.; McCreary, Andrew C.; Adolfs,
Tiny J. P.; Kruse, Chris G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(21), 4794-4798

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloromethyl-3-p-tolyl[1,2,4]oxadiazole
C10H9ClN2O
50737-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 3.0089 0.0 0
M  V30 2 Cl 11.1826 2.3825 0.0 0
M  V30 3 C 0.0000 1.3336 0.0 0
M  V30 4 C 6.1600 1.3336 0.0 0
M  V30 5 N 7.0652 2.5795 0.0 0
M  V30 6 N 7.0652 0.0878 0.0 0
M  V30 7 C 8.5298 2.1037 0.0 0
M  V30 8 O 8.5298 0.5636 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(4-methylphenyl)-1,2,4-oxadiazole-5-methanamine
C11H13N3O
890324-79-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7757 3.0089 0.0 0
M  V30 2 N 11.1826 2.3824 0.0 0
M  V30 3 C 12.4285 3.2876 0.0 0
M  V30 4 C 0.0000 1.3336 0.0 0
M  V30 5 C 6.1600 1.3336 0.0 0
M  V30 6 N 7.0652 2.5795 0.0 0
M  V30 7 N 7.0652 0.0878 0.0 0
M  V30 8 C 8.5298 2.1037 0.0 0
M  V30 9 O 8.5298 0.5636 0.0 0
M  V30 10 C 4.6200 1.3336 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 15 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 50737-29-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 890324-79-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10443775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
Isopropyl-(3-p-tolyl-[1,2,4]oxadiazol-5-ylmethyl)-amine (10a)9 (10a): To
a solution of 9a (100 mg, 0.48 mmol) in acetonitrile (10 mL) was added
isopropyl amine (57 mg, 0.96 mmol) and potassium carbonate (199 mg, 1.44
mmol) and the mixture was refluxed for 30 minutes. Acetonitrile was
evaporated and the residue was dissolved in ethyl acetate and washed with
water. Organic solvent was dried (MgSO4) and evaporated to give the pure
compound 10a. Methyl-(3-p-tolyl-[1,2,4]oxadiazol-5-ylmethyl)-amine (10k):
This compound was synthesized using the same protocol described for 10a
except using 9a (85 mg, 0.41 mmol) and methylamine (1 mL from 40%
solution in water) and potassium carbonate (283 mg, 2.05 mmol). The
compound 10k was obtained. Yellow viscous liquid (79 mg, 95%). 1H NMR
(400 MHz, CDCl3) δ 7.97 (d, J = 8.2 Hz, 2H), 7.29 (d, J = 7.9 Hz, 2H),
4.07 (s, 2H), 2.55 (s, 3H), 2.41 (s, 3H). LC-MS (ESI+) m/z 204.12 (M+H)+;
HRMS (ESI+ve) m/z calculated for C11H14N3O (M+H)+ 204.1131, found
204.1141.$$1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 8.2 Hz, 2H), 7.29 (d, J
= 7.9 Hz, 2H), 4.07 (s, 2H), 2.55 (s, 3H), 2.41 (s, 3H). LC-MS (ESI+) m/z
204.12 (M+H)+; HRMS (ESI+ve) m/z calculated for C11H14N3O (M+H)+
204.1131, found 204.1141.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Oxadiazole-isopropylamides as Potent and Noncovalent Proteasome
Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ozcan, Sevil; Kazi, Aslamuzzaman; Marsilio, Frank; Fang, Bin; Guida,
Wayne C.; Koomen, John; Lawrence, Harshani R.; Sebti, Said M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(10), 3783-3805

$RFMT $RIREG SCHEME182 STEP1
$RXN



  3  1
$MOL
trans-β-Nitrostyrene
C8H7NO2
5153-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl P-(2-phenylacetyl)phosphonate
C10H13O4P
51463-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 O 0.7700 2.3100 0.0 0
M  V30 4 O 2.3100 0.7700 0.0 0
M  V30 5 O 2.3100 3.8500 0.0 0
M  V30 6 C 4.6200 3.6436 0.0 0
M  V30 7 O 4.6200 0.9762 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 C 6.1600 3.6436 0.0 0
M  V30 11 C 6.9300 4.9773 0.0 0
M  V30 12 C 6.9300 2.3100 0.0 0
M  V30 13 C 8.4700 4.9773 0.0 0
M  V30 14 C 8.4700 2.3100 0.0 0
M  V30 15 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-N-Methyl-β-(nitromethyl)-α-phenylbenzenepropanamide
C17H18N2O3
1457935-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 4.0012 0.0 0 CFG=2
M  V30 2 C 4.6201 5.3348 0.0 0 CFG=1
M  V30 3 C 4.6201 2.6675 0.0 0
M  V30 4 C 5.3901 6.6685 0.0 0
M  V30 5 N 5.3901 1.3337 0.0 0
M  V30 6 O 3.0801 2.6675 0.0 0
M  V30 7 N 4.6201 8.0023 0.0 0 VAL=5
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 O 5.3901 9.3360 0.0 0
M  V30 10 O 3.0801 8.0023 0.0 0
M  V30 11 C 6.9302 4.0012 0.0 0
M  V30 12 C 7.7002 2.6675 0.0 0
M  V30 13 C 7.7002 5.3348 0.0 0
M  V30 14 C 9.2402 2.6675 0.0 0
M  V30 15 C 9.2402 5.3348 0.0 0
M  V30 16 C 10.0102 4.0012 0.0 0
M  V30 17 C 3.0801 5.3348 0.0 0
M  V30 18 C 2.3101 4.0012 0.0 0
M  V30 19 C 2.3101 6.6685 0.0 0
M  V30 20 C 0.7700 4.0012 0.0 0
M  V30 21 C 0.7700 6.6685 0.0 0
M  V30 22 C 0.0000 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 11
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 17
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 51463-66-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-2613553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 78% ee, Michael addition, optimization study
(catalyst, solvent)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME183 STEP1
$RXN



  3  1
$MOL
trans-β-Nitrostyrene
C8H7NO2
5153-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [(4-chlorophenyl)acetyl]-, dimethyl ester
C10H12ClO4P
87600-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.6436 0.0 0
M  V30 2 C 3.8500 2.3100 0.0 0
M  V30 3 P 2.3100 2.3100 0.0 0 VAL=5
M  V30 4 O 4.6200 0.9762 0.0 0
M  V30 5 O 0.7700 2.3100 0.0 0
M  V30 6 O 2.3100 0.7700 0.0 0
M  V30 7 O 2.3100 3.8500 0.0 0
M  V30 8 C 0.0000 3.6436 0.0 0
M  V30 9 C 0.9764 0.0000 0.0 0
M  V30 10 Cl 10.7800 3.6436 0.0 0
M  V30 11 C 6.1600 3.6436 0.0 0
M  V30 12 C 6.9300 4.9773 0.0 0
M  V30 13 C 6.9300 2.3100 0.0 0
M  V30 14 C 8.4700 4.9773 0.0 0
M  V30 15 C 8.4700 2.3100 0.0 0
M  V30 16 C 9.2400 3.6436 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-α-(4-Chlorophenyl)-N-methyl-β-(nitromethyl)benzenepropanamide
C17H17ClN2O3
1457935-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 5.3348 0.0 0 CFG=1
M  V30 2 C 5.3901 4.0012 0.0 0 CFG=2
M  V30 3 C 5.3901 6.6685 0.0 0
M  V30 4 C 4.6201 2.6675 0.0 0
M  V30 5 N 4.6201 8.0023 0.0 0 VAL=5
M  V30 6 N 5.3901 1.3337 0.0 0
M  V30 7 O 3.0801 2.6675 0.0 0
M  V30 8 O 5.3901 9.3360 0.0 0
M  V30 9 O 3.0801 8.0023 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 Cl 11.5503 4.0012 0.0 0
M  V30 12 C 3.0801 5.3348 0.0 0
M  V30 13 C 2.3101 6.6685 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 0.7700 6.6685 0.0 0
M  V30 16 C 0.7700 4.0012 0.0 0
M  V30 17 C 0.0000 5.3348 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 7.7002 5.3348 0.0 0
M  V30 20 C 7.7002 2.6675 0.0 0
M  V30 21 C 9.2402 5.3348 0.0 0
M  V30 22 C 9.2402 2.6675 0.0 0
M  V30 23 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 12
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 2 5 9
M  V30 11 1 6 10
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87600-54-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-49-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-181012
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 76% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME184 STEP1
$RXN



  3  1
$MOL
trans-β-Nitrostyrene
C8H7NO2
5153-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 4 O 8.0021 2.3100 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphonic acid, [(4-methoxyphenyl)acetyl]-, dimethyl ester
C11H15O5P
87600-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9775 2.3101 0.0 0
M  V30 2 C 3.6437 3.0801 0.0 0
M  V30 3 P 2.3101 2.3101 0.0 0 VAL=5
M  V30 4 O 3.6437 4.6201 0.0 0
M  V30 5 O 0.9764 1.5400 0.0 0
M  V30 6 O 1.5400 3.6437 0.0 0
M  V30 7 O 3.0801 0.9764 0.0 0
M  V30 8 C 0.9764 0.0000 0.0 0
M  V30 9 C 0.0000 3.6437 0.0 0
M  V30 10 O 10.3124 5.3901 0.0 0
M  V30 11 C 11.6460 4.6201 0.0 0
M  V30 12 C 6.3112 3.0801 0.0 0
M  V30 13 C 6.3112 4.6201 0.0 0
M  V30 14 C 7.6449 2.3101 0.0 0
M  V30 15 C 7.6449 5.3901 0.0 0
M  V30 16 C 8.9786 3.0801 0.0 0
M  V30 17 C 8.9786 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αR,βS)-α-(4-Methoxyphenyl)-N-methyl-β-(nitromethyl)benzenepropanamide
C18H20N2O4
1457935-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0 CFG=2
M  V30 2 C 4.6201 4.0012 0.0 0 CFG=1
M  V30 3 C 4.6201 6.6685 0.0 0
M  V30 4 C 5.3901 2.6675 0.0 0
M  V30 5 N 5.3901 8.0023 0.0 0
M  V30 6 O 3.0801 6.6685 0.0 0
M  V30 7 N 4.6201 1.3337 0.0 0 VAL=5
M  V30 8 C 4.6201 9.3360 0.0 0
M  V30 9 O 5.3901 0.0000 0.0 0
M  V30 10 O 3.0801 1.3337 0.0 0
M  V30 11 O 11.5503 5.3348 0.0 0
M  V30 12 C 12.3203 6.6685 0.0 0
M  V30 13 C 6.9302 5.3348 0.0 0
M  V30 14 C 7.7002 6.6685 0.0 0
M  V30 15 C 7.7002 4.0012 0.0 0
M  V30 16 C 9.2402 6.6685 0.0 0
M  V30 17 C 9.2402 4.0012 0.0 0
M  V30 18 C 10.0102 5.3348 0.0 0
M  V30 19 C 3.0801 4.0012 0.0 0
M  V30 20 C 2.3101 5.3348 0.0 0
M  V30 21 C 2.3101 2.6675 0.0 0
M  V30 22 C 0.7700 5.3348 0.0 0
M  V30 23 C 0.7700 2.6675 0.0 0
M  V30 24 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 13
M  V30 4 1 2 4 CFG=3
M  V30 5 1 2 19
M  V30 6 1 3 5
M  V30 7 2 3 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 2 7 9
M  V30 11 2 7 10
M  V30 12 1 11 12
M  V30 13 1 11 18
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5153-67-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87600-56-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1457935-47-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-11381160
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1457935-39-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr=>95:5, 80% ee, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalyzed asymmetric Michael reaction of β-aryl-α-ketophosphonates
and nitroalkenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guang, Jie; Zhao, John Cong-Gui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2013), 54(42), 5703-5706

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-Methyl-4-(methylphenylamino)pyrazolo[1,5-a]-1,3,5-triazin-8-yl]phenylmetha...
C20H17N5O
515880-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6201 5.3348 0.0 0
M  V30 2 C 5.3901 6.6686 0.0 0
M  V30 3 C 10.3510 1.9572 0.0 0
M  V30 4 O 10.0306 0.4508 0.0 0
M  V30 5 C 4.6201 0.0000 0.0 0
M  V30 6 N 6.9301 4.0011 0.0 0
M  V30 7 C 7.7001 2.6675 0.0 0
M  V30 8 C 5.3901 4.0011 0.0 0
M  V30 9 N 7.9605 5.1457 0.0 0
M  V30 10 C 9.2064 2.9876 0.0 0
M  V30 11 N 6.9301 1.3338 0.0 0
M  V30 12 N 4.6201 2.6675 0.0 0
M  V30 13 C 9.3674 4.5192 0.0 0
M  V30 14 C 5.3901 1.3338 0.0 0
M  V30 15 C 3.0800 5.3348 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 6.6686 0.0 0
M  V30 18 C 0.7700 4.0011 0.0 0
M  V30 19 C 0.7700 6.6686 0.0 0
M  V30 20 C 0.0000 5.3348 0.0 0
M  V30 21 C 11.8155 2.4331 0.0 0
M  V30 22 C 12.1357 3.9394 0.0 0
M  V30 23 C 12.9601 1.4027 0.0 0
M  V30 24 C 13.6004 4.4152 0.0 0
M  V30 25 C 14.4246 1.8785 0.0 0
M  V30 26 C 14.7448 3.3848 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 15
M  V30 4 2 3 4
M  V30 5 1 3 10
M  V30 6 1 3 21
M  V30 7 1 5 14
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 2 7 10
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 2 9 13
M  V30 15 1 10 13
M  V30 16 2 11 14
M  V30 17 1 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-Methyl-4-(methylamino)pyrazolo[1,5-a]-1,3,5-triazin-8-yl]phenylmethanone
C14H13N5O
515880-25-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.1059 0.0 0
M  V30 2 O 4.0012 1.5659 0.0 0
M  V30 3 N 10.3091 5.2182 0.0 0
M  V30 4 C 11.8154 4.8981 0.0 0
M  V30 5 C 9.1999 0.0000 0.0 0
M  V30 6 C 6.7417 3.2495 0.0 0
M  V30 7 C 5.3348 3.8760 0.0 0
M  V30 8 N 7.7722 4.3940 0.0 0
M  V30 9 N 7.2177 1.7849 0.0 0
M  V30 10 C 5.4958 5.4075 0.0 0
M  V30 11 C 9.2785 4.0739 0.0 0
M  V30 12 N 7.0022 5.7277 0.0 0
M  V30 13 C 8.7240 1.4647 0.0 0
M  V30 14 N 9.7544 2.6091 0.0 0
M  V30 15 C 2.6673 3.8760 0.0 0
M  V30 16 C 2.6673 5.4160 0.0 0
M  V30 17 C 1.3337 3.1059 0.0 0
M  V30 18 C 1.3337 6.1860 0.0 0
M  V30 19 C 0.0000 3.8760 0.0 0
M  V30 20 C 0.0000 5.4160 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 15
M  V30 4 1 3 4
M  V30 5 1 3 11
M  V30 6 1 5 13
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 12
M  V30 15 2 11 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 515880-11-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 515880-25-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-13311681
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient synthesis of 8-substituted pyrazolo[1,5-a]-1,3,5-triazines by
regioselective acylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raboisson, Pierre; Schultz, Dominique; Lugnier, Claire; Bourguignon,
Jean-Jacques
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2002), 43(52), 9501-9503

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-4-methylbenzoyl chloride
C8H6ClIO
52107-98-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 I 5.3901 0.0000 0.0 0
M  V30 5 C 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-N,4-dimethylbenzamide
C9H10INO
165803-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 6.9302 4.0010 0.0 0
M  V30 3 O 6.9302 1.3337 0.0 0
M  V30 4 C 8.4702 4.0010 0.0 0
M  V30 5 I 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 2.6673 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 3.8501 1.3337 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 10 C 2.3101 1.3337 0.0 0
M  V30 11 C 2.3101 4.0010 0.0 0
M  V30 12 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52107-98-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 165803-58-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10209653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: To a cooled (0°C) solution of 3-iodo-4-methylbenzoyl chloride
(2.80 g; 10.0 mmol) in DCM (10 mL) was slowly added a 2 M solution of
methylamine in THF (11 mL, 2.2 eq.). Upon completion of the addition, the
ice bath was removed and the mixture was stirred overnight. All volatiles
were removed in vacuo and the residue was treated with aq. NaHCO3 (25 mL)
and subsequently extracted with ethyl acetate (3 x 15 mL). The combined
organic layers were dried over MgSO4 and evaporated. The target compound
3-iodo-N,4-dimethylbenzamide (2.62 g, 95 % yield) was used without
further purification. 3-iodo-N,4-dimethylbenzamide, yield (2.62 g, 95 %)
1H-NMR (300 MHz, DMSO): 8.39-8.53 (m, 1 H); 8.22 (d, 1 H); 7.73 (dd, 1
H); 7.38 (d, 1 H); 2.72 (d, 3 H); 2.36 (s, 3 H). MS (ESI): [M+H]+ = 276.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of alkynylpyrimidines as Tie2 kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hartung, Ingo; Bothe, Ulrich; Kettschau, Georg; Luecking, Ulrich; Mengel,
Anne; Krueger, Martin; Thierauch, Karl-Heinz; Lienau, Philip; Boemer, Ulf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008155140 A1 2008-12-24

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarbonyl chloride
C5H3ClOS
5271-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 Cl 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 S 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-thiophenecarboxamide
C6H7NOS
39880-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 S 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5271-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 39880-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-5221827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. N-methylthiophene-2-carboxamide 1l. White solid.
Yield: (60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Furancarbonyl chloride
C5H3ClO2
527-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 Cl 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 O 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-furancarboxamide
C6H7NO2
21402-85-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 C 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 O 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 527-69-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21402-85-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11636828
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. N-methylfuran-2-carboxamide 1p. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Oxo-4H-1-benzopyran-3-carboxamide
C10H7NO3
52817-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 N 8.0021 2.3100 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 O 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(Methylamino)methylene]-2H-1-benzopyran-2,4(3H)-dione
C11H9NO3
754177-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 0.0000 0.0 0
M  V30 2 O 6.6685 4.6201 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0023 2.3101 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 C 2.6675 3.8501 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 O 4.0012 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 0.0000 3.8501 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 0.0000 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 2 3 14 CFG=2
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 52817-14-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 754177-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25505750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ring transformation of chromone-3-carboxamide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ibrahim, Magdy A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2009), 65(36), 7687-7690

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
3,4-Dinitrobenzoic acid
C7H4N2O6
528-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8501 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 O 6.6687 0.0000 0.0 0
M  V30 9 O 8.0023 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,4-dinitrobenzamide
C8H7N3O5
1448603-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3337 6.1601 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 C 6.6684 4.6201 0.0 0
M  V30 8 N 8.0022 3.8500 0.0 0
M  V30 9 O 6.6684 6.1601 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 528-45-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448603-06-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23056042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bifunctional aminocyclopropenium catalysts and for use in epoxide-based
ring-opening polymerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Coates, Geoffrey W.; Abel, Brooks; Lidston, Claire
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20200384450 A1 2020-12-10

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
3,4-Dinitrobenzoic acid
C7H4N2O6
528-45-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 6.1601 0.0 0 VAL=5
M  V30 2 O 5.3348 6.9302 0.0 0
M  V30 3 O 2.6675 6.9302 0.0 0
M  V30 4 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 5 O 0.0000 3.8501 0.0 0
M  V30 6 O 1.3337 6.1601 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 O 6.6687 0.0000 0.0 0
M  V30 9 O 8.0023 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3,4-dinitrobenzamide
C8H7N3O5
1448603-06-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 2 O 1.3337 6.1601 0.0 0
M  V30 3 O 0.0000 3.8500 0.0 0
M  V30 4 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3337 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 C 6.6684 4.6201 0.0 0
M  V30 8 N 8.0022 3.8500 0.0 0
M  V30 9 O 6.6684 6.1601 0.0 0
M  V30 10 C 9.3359 4.6201 0.0 0
M  V30 11 C 2.6675 3.8500 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 5.3348 3.8500 0.0 0
M  V30 16 C 5.3348 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 528-45-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448603-06-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20440834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mechanism-Inspired Design of Bifunctional Catalysts for the Alternating
Ring-Opening Copolymerization of Epoxides and Cyclic Anhydrides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abel, Brooks A.; Lidston, Claire A. L.; Coates, Geoffrey W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2019), 141(32), 12760-12769

$RFMT $RIREG SCHEME191 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Euparin
C13H12O3
532-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2447 3.0800 0.0 0
M  V30 2 C 10.0147 4.4137 0.0 0
M  V30 3 C 10.0147 1.7464 0.0 0
M  V30 4 O 1.3338 4.6200 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 O 6.7994 4.3259 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 4.0011 1.5400 0.0 0
M  V30 13 C 6.7994 1.8341 0.0 0
M  V30 14 C 7.7047 3.0800 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C15H16N2O2
2415287-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.1116 1.5400 0.0 0
M  V30 2 C 1.1116 0.0000 0.0 0
M  V30 3 C 3.0717 0.9031 0.0 0
M  V30 4 N 0.0000 3.5559 0.0 0
M  V30 5 C 10.4871 3.5559 0.0 0
M  V30 6 C 11.2571 4.8895 0.0 0
M  V30 7 C 11.2571 2.2222 0.0 0
M  V30 8 C 3.9099 2.7859 0.0 0
M  V30 9 C 3.9099 4.3259 0.0 0
M  V30 10 C 2.4452 2.3100 0.0 0
M  V30 11 C 5.2436 2.0159 0.0 0
M  V30 12 C 5.2436 5.0959 0.0 0
M  V30 13 O 2.4452 4.8017 0.0 0
M  V30 14 C 1.5400 3.5559 0.0 0
M  V30 15 C 6.5772 2.7859 0.0 0
M  V30 16 C 6.5772 4.3259 0.0 0
M  V30 17 C 8.0419 2.3100 0.0 0
M  V30 18 O 8.0419 4.8017 0.0 0
M  V30 19 C 8.9471 3.5559 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 10
M  V30 4 2 4 14
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 532-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2415287-33-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26590701
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ZnO-nanorods prepared and used as catalyst, optimization
study (optimized on catalyst, solvent, time, temperature and
stoichiometry of catalyst), reusable catalyst, Strecker reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel one-pot three-component synthesis of benzofuran derivatives via
Strecker reaction: Study of antioxidant activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ezzatzadeh, Elham; Hossaini, Zinatossadat
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Natural Product Research (2020), 34(7), 923-929

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
trans-4-[(tert-Butoxycarbonyl)amino]cyclohexanecarboxylic acid
C12H21NO4
53292-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 1.5400 0.0 0
M  V30 2 O 12.0033 2.3101 0.0 0
M  V30 3 O 10.6697 0.0000 0.0 0
M  V30 4 N 5.3348 4.6201 0.0 0
M  V30 5 C 4.0012 3.8501 0.0 0
M  V30 6 O 2.6673 4.6201 0.0 0
M  V30 7 O 4.0012 2.3101 0.0 0
M  V30 8 C 1.3337 3.8501 0.0 0
M  V30 9 C 0.5637 5.1838 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 2.1037 2.5164 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0 CFG=2
M  V30 13 C 8.0022 1.5400 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 6.6685 2.3101 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=1
M  V30 4 1 4 5
M  V30 5 1 17 4 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[trans-4-[(methylamino)carbonyl]cyclohexyl]carbamate
C13H24N2O3
1013111-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 1.5400 0.0 0
M  V30 2 N 12.0033 2.3101 0.0 0
M  V30 3 O 10.6697 0.0000 0.0 0
M  V30 4 C 13.3370 1.5400 0.0 0
M  V30 5 N 5.3348 4.6201 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 O 2.6673 4.6201 0.0 0
M  V30 8 O 4.0010 2.3101 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 C 2.1037 2.5164 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 0.5637 5.1838 0.0 0
M  V30 13 C 9.3360 2.3101 0.0 0 CFG=2
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 8.0022 1.5400 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 6.6685 2.3101 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 13 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 18 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53292-89-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1013111-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37600061
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
5-(2-fluoro-6-hydroxyphenyl)-1,1-dioxo-1,2,5-thiadiazolidin-3-one
derivatives for treatment of cancer as protein tyrosine phosphatase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Haibo; D'Agostino, Laura Akullian; Posy, Shoshana L.; Pendri,
Annapurna; Jacutin-Porte, Swanee E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023147531 A1 2023-08-03

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-methylbenzaldehyde
C10H12O2
532965-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 6.9300 1.3338 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N,3-dimethylbenzenemethanamine
C11H17NO
709649-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 N 6.6685 4.6200 0.0 0
M  V30 6 C 8.0021 3.8500 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 4.0011 6.1600 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 532965-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-3442364
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 67 Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine b)
(2-Ethoxy-3-methyl-benzyl)methylamine [0832] According to the procedure
of Preparation 67, except substituting 2-ethoxy-3-methyl-benzaldehyde for
1-propyl-naphthalene-2-carbaldehyde, the title compound (11.2 g, 95%) was
prepared as a yellow oil. MS (ESI) m/e 180 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-methylbenzaldehyde
C10H12O2
532965-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 6.9300 1.3338 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N,3-dimethylbenzenemethanamine
C11H17NO
709649-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 N 6.6685 4.6200 0.0 0
M  V30 6 C 8.0021 3.8500 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 4.0011 6.1600 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 532965-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10547994
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-3-methylbenzaldehyde
C10H12O2
532965-62-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 0.7700 1.3338 0.0 0
M  V30 3 C 0.0000 0.0000 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 6.9300 1.3338 0.0 0
M  V30 6 C 0.7700 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 5.3900 4.0011 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethoxy-N,3-dimethylbenzenemethanamine
C11H17NO
709649-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 C 5.3347 3.8500 0.0 0
M  V30 5 N 6.6685 4.6200 0.0 0
M  V30 6 C 8.0021 3.8500 0.0 0
M  V30 7 C 0.0000 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 4.0011 6.1600 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 5 6
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 532965-62-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 709649-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12398632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of
Methyl-(1-propyl-naphthalen-2-ylmethyl)amine A solution of 2.0 M
methylamine in methanol (20 mL) was added to
1-propylnaphthalene-2-carbaldehyde (0.983 g, 4.95 mmol) under N2 and
allowed to stir for 18 h. The solution was concentrated under reduced
pressure. Then the resulting dark yellow oil was solvated in EtOH (20 mL)
under N2. To the solution was added NaBH4 (0.187 g, 4.95 mmol) and the
mixture allowed to stir for 6.5 h. The reaction was concentrated under
reduced pressure, then solvated in 1 N NaOH (20 mL) and extracted with
Et2O (3 x 50 mL). The organics were combined, washed with brine (2 x 100
mL), dried over Na2SO4, filtered and concentrated to yield the title
compound as a yellow oil. b) (2-Ethoxy-3-methyl-benzyl)methylamine
According to the procedure of Preparation 1, except substituting
2-ethoxy-3-methylbenzaldehyde for 1-propyl-naphthalene-2-carbaldehyde,
the title compound (11.2 g, 95%) was prepared as a yellow oil. MS (ESI)
m/e 180 (M + H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd; Sampson, Peter; Pauls, Heinz W.; Ramnauth, Jailall;
Manning, David Douglas; Surman, Matthew David; Xie, Dejian; Decornez,
Helene Yvonne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004052890 A1 2004-06-24

$RFMT $RIREG SCHEME194 STEP1
$RXN



  4  1
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tosyl azide
C7H7N3O2S
941-55-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 1.3337 0.0 0 VAL=6
M  V30 2 N 6.6685 0.5637 0.0 0
M  V30 3 O 4.5648 0.0000 0.0 0
M  V30 4 O 6.1048 2.6673 0.0 0
M  V30 5 N 8.0023 1.3337 0.0 0 CHG=1 VAL=4
M  V30 6 N 9.3360 2.1037 0.0 0 CHG=-1
M  V30 7 C 0.0000 4.4137 0.0 0
M  V30 8 C 4.0012 2.1037 0.0 0
M  V30 9 C 4.0012 3.6437 0.0 0
M  V30 10 C 2.6675 1.3337 0.0 0
M  V30 11 C 2.6675 4.4137 0.0 0
M  V30 12 C 1.3337 2.1037 0.0 0
M  V30 13 C 1.3337 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 2 5
M  V30 6 2 5 6
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(methylamino)-5-[[(4-methylphenyl)sulfonyl]amino]-3-oxo-4-phenyl-1,4...
C21H20N2O5S
2135726-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.8690 6.2078 0.0 0
M  V30 2 S 7.4090 6.2078 0.0 0 VAL=6
M  V30 3 O 7.4090 4.6678 0.0 0
M  V30 4 O 7.4090 7.7478 0.0 0
M  V30 5 C 7.2316 3.1470 0.0 0
M  V30 6 O 7.7076 1.6825 0.0 0
M  V30 7 O 8.2621 4.2915 0.0 0
M  V30 8 C 9.2139 1.3623 0.0 0
M  V30 9 O 1.8403 2.5804 0.0 0
M  V30 10 N 4.7418 0.9052 0.0 0
M  V30 11 C 3.4960 0.0000 0.0 0
M  V30 12 C 13.5690 6.2078 0.0 0
M  V30 13 C 5.0990 4.8741 0.0 0
M  V30 14 C 3.5673 4.7132 0.0 0
M  V30 15 C 5.7253 3.4672 0.0 0
M  V30 16 C 3.2471 3.2068 0.0 0
M  V30 17 C 4.5809 2.4368 0.0 0
M  V30 18 C 2.5369 5.8576 0.0 0
M  V30 19 C 3.0127 7.3223 0.0 0
M  V30 20 C 1.0306 5.5374 0.0 0
M  V30 21 C 1.9823 8.4667 0.0 0
M  V30 22 C 0.0000 6.6818 0.0 0
M  V30 23 C 0.4760 8.1465 0.0 0
M  V30 24 C 8.9490 6.2078 0.0 0
M  V30 25 C 9.7190 7.5414 0.0 0
M  V30 26 C 9.7190 4.8741 0.0 0
M  V30 27 C 11.2590 7.5414 0.0 0
M  V30 28 C 11.2590 4.8741 0.0 0
M  V30 29 C 12.0290 6.2078 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 24
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 9 16
M  V30 11 1 10 11
M  V30 12 1 10 17
M  V30 13 1 12 29
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 941-55-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2135726-21-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-250-CAS-18583174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM ZnO-nanoparticles used as catalyst (stage 2), intermediate from stage 1
added in stage 2 after 10 minutes (stage 2), catalyst prepared and used
(stage 2), optimization study (stage 2), optimized on catalyst (stage 2),
optimized on stoichiometry of catalyst (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO-nanoparticles as an efficient catalyst for the synthesis of
tetrasubstituted cyclopentadienones using sulfonoketenimides and
enaminoesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Varasteh Moradi, Ali
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2018), 193(1),
45-49

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-pyridinecarbonyl chloride
C6H3Cl2NO
53750-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 N 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53750-66-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42561165
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel process for the synthesis of regorafenib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gill, Manjinder Singh; Ramteke, Prachi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202311005527 A 2024-08-02

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-pyridinecarbonyl chloride
C6H3Cl2NO
53750-66-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 N 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 53750-66-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42434718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel, convergent and efficient synthesis of sorafenib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gill, Manjinder Singh; Ramteke, Prachi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN202311003978 A 2024-07-26

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloropurine riboside
C10H11ClN4O4
5399-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 Cl 10.5369 3.9148 0.0 0
M  V30 3 C 0.6966 1.4646 0.0 0
M  V30 4 O 1.1724 0.0000 0.0 0
M  V30 5 O 0.0000 4.7418 0.0 0
M  V30 6 N 5.3914 4.1752 0.0 0
M  V30 7 C 6.5359 3.1447 0.0 0
M  V30 8 C 6.0178 5.5820 0.0 0
M  V30 9 C 7.8696 3.9148 0.0 0
M  V30 10 N 6.5359 1.6047 0.0 0
M  V30 11 N 7.5494 5.4211 0.0 0
M  V30 12 C 9.2032 3.1447 0.0 0
M  V30 13 C 7.8696 0.8347 0.0 0
M  V30 14 N 9.2032 1.6047 0.0 0
M  V30 15 C 3.8850 3.8550 0.0 0 CFG=1
M  V30 16 O 3.2586 2.4480 0.0 0
M  V30 17 C 2.7405 4.8854 0.0 0 CFG=2
M  V30 18 C 1.7270 2.6091 0.0 0 CFG=2
M  V30 19 C 1.4068 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=3
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N6-Methyladenosine
C11H15N5O4
1867-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 N 10.5371 3.9148 0.0 0
M  V30 3 C 11.8709 3.1447 0.0 0
M  V30 4 C 0.6967 1.4646 0.0 0
M  V30 5 O 1.1726 0.0000 0.0 0
M  V30 6 O 0.0000 4.7418 0.0 0
M  V30 7 N 5.3915 4.1752 0.0 0
M  V30 8 C 6.5361 3.1447 0.0 0
M  V30 9 C 6.0178 5.5820 0.0 0
M  V30 10 C 7.8697 3.9148 0.0 0
M  V30 11 N 6.5361 1.6047 0.0 0
M  V30 12 N 7.5496 5.4211 0.0 0
M  V30 13 C 9.2034 3.1447 0.0 0
M  V30 14 C 7.8697 0.8347 0.0 0
M  V30 15 N 9.2034 1.6047 0.0 0
M  V30 16 C 3.8852 3.8550 0.0 0 CFG=1
M  V30 17 O 3.2587 2.4480 0.0 0
M  V30 18 C 2.7406 4.8854 0.0 0 CFG=2
M  V30 19 C 1.7271 2.6091 0.0 0 CFG=2
M  V30 20 C 1.4070 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5399-87-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1867-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35133576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM closed reaction vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Label-free affinity screening, design and synthesis of inhibitors
targeting the Mycobacterium tuberculosis L-alanine dehydrogenase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Heung-Bok; Bacik, John-Paul; Wu, Ruilian; Jha, Ramesh K.; Hebron,
Michaeline; Triandafillou, Catherine; McCown, Joseph E.; Baek, Nam-In;
Kim, Jeong Han; Kim, Young Jae; Goulding, Celia W.; Strauss, Charlie E.
M.; Schmidt, Jurgen G.; Shetye, Gauri S.; Ryoo, Sungweon; Jo, Eun-Kyeong;
Jeon, Young Ho; Hung, Li-Wei; Terwilliger, Thomas C.; Kim, Chang-Yub
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM PLoS One (2022), 17(11), e0277670

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloropurine riboside
C10H11ClN4O4
5399-87-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 Cl 10.5369 3.9148 0.0 0
M  V30 3 C 0.6966 1.4646 0.0 0
M  V30 4 O 1.1724 0.0000 0.0 0
M  V30 5 O 0.0000 4.7418 0.0 0
M  V30 6 N 5.3914 4.1752 0.0 0
M  V30 7 C 6.5359 3.1447 0.0 0
M  V30 8 C 6.0178 5.5820 0.0 0
M  V30 9 C 7.8696 3.9148 0.0 0
M  V30 10 N 6.5359 1.6047 0.0 0
M  V30 11 N 7.5494 5.4211 0.0 0
M  V30 12 C 9.2032 3.1447 0.0 0
M  V30 13 C 7.8696 0.8347 0.0 0
M  V30 14 N 9.2032 1.6047 0.0 0
M  V30 15 C 3.8850 3.8550 0.0 0 CFG=1
M  V30 16 O 3.2586 2.4480 0.0 0
M  V30 17 C 2.7405 4.8854 0.0 0 CFG=2
M  V30 18 C 1.7270 2.6091 0.0 0 CFG=2
M  V30 19 C 1.4068 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 17 1 CFG=1
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 18 3 CFG=3
M  V30 5 1 19 5 CFG=1
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 17 18 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N6-Methyladenosine
C11H15N5O4
1867-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 6.4170 0.0 0
M  V30 2 N 10.5371 3.9148 0.0 0
M  V30 3 C 11.8709 3.1447 0.0 0
M  V30 4 C 0.6967 1.4646 0.0 0
M  V30 5 O 1.1726 0.0000 0.0 0
M  V30 6 O 0.0000 4.7418 0.0 0
M  V30 7 N 5.3915 4.1752 0.0 0
M  V30 8 C 6.5361 3.1447 0.0 0
M  V30 9 C 6.0178 5.5820 0.0 0
M  V30 10 C 7.8697 3.9148 0.0 0
M  V30 11 N 6.5361 1.6047 0.0 0
M  V30 12 N 7.5496 5.4211 0.0 0
M  V30 13 C 9.2034 3.1447 0.0 0
M  V30 14 C 7.8697 0.8347 0.0 0
M  V30 15 N 9.2034 1.6047 0.0 0
M  V30 16 C 3.8852 3.8550 0.0 0 CFG=1
M  V30 17 O 3.2587 2.4480 0.0 0
M  V30 18 C 2.7406 4.8854 0.0 0 CFG=2
M  V30 19 C 1.7271 2.6091 0.0 0 CFG=2
M  V30 20 C 1.4070 4.1154 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 18 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 19 4 CFG=3
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 16 7 CFG=3
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 18 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5399-87-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1867-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1662287
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of
Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhattarai, Sanjay; Freundlieb, Marianne; Pippel, Jan; Meyer, Anne;
Abdelrahman, Aliaa; Fiene, Amelie; Lee, Sang-Yong; Zimmermann, Herbert;
Yegutkin, Gennady G.; Straeter, Norbert; El-Tayeb, Ali; Mueller, Christa
E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(15), 6248-6263

$RFMT $RIREG SCHEME197 STEP1
$RXN



  3  1
$MOL
4-Iodoaniline
C6H6IN
540-37-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 0.0000 1.3337 0.0 0
M  V30 2 N 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Iodophenyl)amino]-1-methyl-1H-pyrrole-2,5-dione
C11H9IN2O2
1613024-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3028 1.3628 0.0 0
M  V30 2 O 2.2420 0.0000 0.0 0
M  V30 3 C 0.0000 2.4898 0.0 0
M  V30 4 O 1.6752 5.3914 0.0 0
M  V30 5 I 10.6376 4.4428 0.0 0
M  V30 6 C 3.9690 2.1328 0.0 0
M  V30 7 C 2.5622 1.5063 0.0 0
M  V30 8 C 3.8080 3.6644 0.0 0
M  V30 9 N 1.5317 2.6509 0.0 0
M  V30 10 C 2.3017 3.9845 0.0 0
M  V30 11 C 6.6365 2.1328 0.0 0
M  V30 12 C 7.9701 1.3628 0.0 0
M  V30 13 C 6.6365 3.6728 0.0 0
M  V30 14 C 9.3038 2.1328 0.0 0
M  V30 15 C 7.9701 4.4428 0.0 0
M  V30 16 C 9.3038 3.6728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 2 2 7
M  V30 4 1 3 9
M  V30 5 2 4 10
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 540-37-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1613024-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-12524028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-3-pyridinecarbonyl chloride
C7H5BrClNO2
54916-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 Cl 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-N-methyl-3-pyridinecarboxamide
C8H9BrN2O2
1072854-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 N 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54916-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072854-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-22830103
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Optimization of a Novel, Weak Bromo and Extra Terminal Domain (BET)
Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain
(BD2) Inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Seal, Jonathan T.; Atkinson, Stephen J.; Aylott, Helen; Bamborough, Paul;
Chung, Chun-wa; Copley, Royston C. B.; Gordon, Laurie; Grandi, Paola;
Gray, James R. J.; Harrison, Lee A.; Hayhow, Thomas G.; Lindon, Matthew;
Messenger, Cassie; Michon, Anne-Marie; Mitchell, Darren; Preston, Alex;
Prinjha, Rab K.; Rioja, Inmaculada; Taylor, Simon; Wall, Ian D.; Watson,
Robert J.; Woolven, James M.; Demont, Emmanuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(17), 9093-9126

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-3-pyridinecarbonyl chloride
C7H5BrClNO2
54916-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 Cl 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-N-methyl-3-pyridinecarboxamide
C8H9BrN2O2
1072854-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 N 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54916-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072854-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17408639
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Oxo-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain
inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Hayhow, Thomas George Christopher; Lindon, Matthew J.; Preston, Alexander
G.; Seal, Jonathan Thomas; Wall, Ian David; Watson, Robert J.; Woolven,
James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017060180 A1 2017-04-13

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-3-pyridinecarbonyl chloride
C7H5BrClNO2
54916-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 Cl 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-N-methyl-3-pyridinecarboxamide
C8H9BrN2O2
1072854-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 N 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54916-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072854-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17455055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinone-dicarboxamide for use as bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Demont, Emmanuel Hubert; Harrison, Lee Andrew;
Hayhow, Thomas George Christopher; House, David; Lindon, Matthew J.;
Preston, Alexander G.; Seal, Jonathan Thomas; Wall, Ian David; Watson,
Robert J.; Woolven, James Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017050714 A1 2017-03-30

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-3-pyridinecarbonyl chloride
C7H5BrClNO2
54916-68-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 Cl 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 1.3338 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 Br 6.9300 4.0011 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 N 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-methoxy-N-methyl-3-pyridinecarboxamide
C8H9BrN2O2
1072854-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 O 5.3900 5.3347 0.0 0
M  V30 6 C 6.9300 5.3347 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 N 5.3900 2.6674 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 54916-68-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1072854-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17538149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 96-47-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridinone dicarboxamide derivatives for use as
bromodomain inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Atkinson, Stephen John; Aylott, Helen Elizabeth; Cooper, Anthony William
James; Demont, Emmanuel Hubert; Harrison, Lee Andrew; Hayhow, Thomas
George Christopher; Lindon, Matthew J.; Preston, Alexander G.; Seal,
Jonathan Thomas; Wall, Ian David; Watson, Robert J.; Woolven, James
Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017037116 A1 2017-03-09

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Sclerotiorin
C21H23ClO5
549-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3568 0.0493 0.0 0
M  V30 2 Cl 5.3568 6.2093 0.0 0
M  V30 3 O 2.5065 2.6268 0.0 0
M  V30 4 C 1.5166 1.4470 0.0 0
M  V30 5 C 2.0433 0.0000 0.0 0
M  V30 6 O 0.0000 1.7145 0.0 0
M  V30 7 C 3.4963 0.9123 0.0 0
M  V30 8 O 2.6893 4.6693 0.0 0
M  V30 9 C 10.6916 4.6693 0.0 0
M  V30 10 C 12.0252 3.8993 0.0 0
M  V30 11 C 13.3589 4.6693 0.0 0
M  V30 12 C 14.6927 3.8993 0.0 0
M  V30 13 C 13.3589 6.2093 0.0 0
M  V30 14 C 16.0263 4.6693 0.0 0 CFG=1
M  V30 15 C 17.3600 3.8993 0.0 0
M  V30 16 C 16.0263 6.2093 0.0 0
M  V30 17 C 18.6936 4.6693 0.0 0
M  V30 18 C 6.6904 2.3593 0.0 0
M  V30 19 C 6.6904 3.8993 0.0 0
M  V30 20 C 5.3568 1.5893 0.0 0
M  V30 21 C 8.0241 1.5893 0.0 0
M  V30 22 C 5.3568 4.6693 0.0 0
M  V30 23 C 8.0241 4.6693 0.0 0
M  V30 24 C 4.0231 2.3593 0.0 0 CFG=1
M  V30 25 O 9.3579 2.3593 0.0 0
M  V30 26 C 4.0231 3.8993 0.0 0
M  V30 27 C 9.3579 3.8993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 22
M  V30 3 1 3 4
M  V30 4 1 24 3 CFG=1
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 24 7 CFG=3
M  V30 8 2 8 26
M  V30 9 2 9 10
M  V30 10 1 9 27
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16 CFG=1
M  V30 17 1 15 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 2 18 21
M  V30 21 2 19 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 2 23 27
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(7R)-7-(Acetyloxy)-5-chloro-3-[(1E,3E,5S)-3,5-dimethyl-1,3-heptadien-1-yl]-2,...
C22H26ClNO4
61227-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 6.8866 6.6685 0.0 0
M  V30 2 O 3.8066 1.3338 0.0 0
M  V30 3 O 3.8066 6.6685 0.0 0
M  V30 4 C 10.7366 2.6674 0.0 0
M  V30 5 C 11.5066 4.0011 0.0 0
M  V30 6 C 13.0466 4.0011 0.0 0
M  V30 7 C 13.8166 5.3347 0.0 0
M  V30 8 C 13.8166 2.6674 0.0 0
M  V30 9 C 15.3566 5.3347 0.0 0 CFG=1
M  V30 10 C 16.1266 6.6685 0.0 0
M  V30 11 C 16.1266 4.0011 0.0 0
M  V30 12 C 17.6666 6.6685 0.0 0
M  V30 13 O 2.6268 3.0112 0.0 0
M  V30 14 C 1.1798 3.5378 0.0 0
M  V30 15 C 0.9123 5.0546 0.0 0
M  V30 16 O 0.0000 2.5481 0.0 0
M  V30 17 C 2.6268 4.9910 0.0 0
M  V30 18 C 9.1966 0.0000 0.0 0
M  V30 19 C 6.8866 4.0011 0.0 0
M  V30 20 C 6.1166 2.6674 0.0 0
M  V30 21 C 6.1166 5.3347 0.0 0
M  V30 22 C 8.4266 4.0011 0.0 0
M  V30 23 C 4.5766 2.6674 0.0 0
M  V30 24 C 6.8866 1.3338 0.0 0
M  V30 25 C 4.5766 5.3347 0.0 0
M  V30 26 C 9.1966 2.6674 0.0 0
M  V30 27 C 3.8066 4.0011 0.0 0 CFG=1
M  V30 28 N 8.4266 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 21
M  V30 2 2 2 23
M  V30 3 2 3 25
M  V30 4 2 4 5
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 27 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 27 17 CFG=3
M  V30 18 1 18 28
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 19 22
M  V30 22 1 20 23
M  V30 23 2 20 24
M  V30 24 1 21 25
M  V30 25 2 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 549-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61227-47-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15089945
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The selectivity for N-methylation was confirmed by alternative synthesis
of 25 by treatment of (+)-sclerotiorin 2 with methylamine (>95%).22.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of the Azaphilones (+)-Sclerotiorin and
(+)-8-O-Methylsclerotiorinamine Utilizing (+)-Sparteine Surrogates in
Copper-Mediated Oxidative Dearomatization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Germain, Andrew R.; Bruggemeyer, Daniel M.; Zhu, Jianglong; Genet,
Cedric; O'Brien, Peter; Porco, John A. Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(8), 2577-2584

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-(1-Methylethoxy)-3,4-dioxo-1-cyclobuten-1-yl]ferrocene
C17H16FeO3
551959-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.7151 7.8480 0.0 0
M  V30 2 C 7.4736 8.2852 0.0 0
M  V30 3 C 8.2321 7.8480 0.0 0
M  V30 4 C 7.4736 9.1620 0.0 0
M  V30 5 O 4.3842 9.8553 0.0 0
M  V30 6 O 6.5750 9.8553 0.0 0
M  V30 7 Fe 2.1281 4.5798 0.0 0 CHG=2 VAL=10
M  V30 8 C 4.2465 7.8480 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.9155 7.0774 0.0 0 VAL=5
M  V30 10 C 2.1281 9.1983 0.0 0 VAL=5
M  V30 11 C 0.0483 7.8480 0.0 0 VAL=5
M  V30 12 C 1.3768 7.0774 0.0 0 VAL=5
M  V30 13 C 0.0000 1.3527 0.0 0 CHG=-1 VAL=4
M  V30 14 C 4.2006 1.3527 0.0 0 VAL=5
M  V30 15 C 2.8672 2.1232 0.0 0 VAL=5
M  V30 16 C 1.3261 2.1232 0.0 0 VAL=5
M  V30 17 C 2.0822 0.0000 0.0 0 VAL=5
M  V30 18 C 5.0049 8.2852 0.0 0
M  V30 19 C 5.9567 8.2852 0.0 0
M  V30 20 C 5.0049 9.2369 0.0 0
M  V30 21 C 5.9567 9.2369 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 20
M  V30 6 2 6 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 14
M  V30 14 1 7 15
M  V30 15 1 7 16
M  V30 16 1 7 17
M  V30 17 1 8 9
M  V30 18 1 8 10
M  V30 19 1 8 18
M  V30 20 2 9 12
M  V30 21 2 10 11
M  V30 22 1 11 12
M  V30 23 1 13 16
M  V30 24 1 13 17
M  V30 25 1 14 15
M  V30 26 2 14 17
M  V30 27 2 15 16
M  V30 28 2 18 19
M  V30 29 1 18 20
M  V30 30 1 19 21
M  V30 31 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-(Methylamino)-3,4-dioxo-1-cyclobuten-1-yl]ferrocene
C15H13FeNO2
1313019-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.7103 7.8424 0.0 0
M  V30 2 C 7.5431 8.3228 0.0 0
M  V30 3 O 4.3834 9.8483 0.0 0
M  V30 4 O 6.5703 9.8483 0.0 0
M  V30 5 Fe 2.1266 4.5766 0.0 0 CHG=2 VAL=10
M  V30 6 C 4.2434 7.8424 0.0 0 CHG=-1 VAL=4
M  V30 7 C 2.9134 7.0724 0.0 0 VAL=5
M  V30 8 C 2.1266 9.1917 0.0 0 VAL=5
M  V30 9 C 0.0483 7.8424 0.0 0 VAL=5
M  V30 10 C 1.3759 7.0724 0.0 0 VAL=5
M  V30 11 C 0.0000 1.3517 0.0 0 CHG=-1 VAL=4
M  V30 12 C 4.1976 1.3517 0.0 0 VAL=5
M  V30 13 C 2.8652 2.1217 0.0 0 VAL=5
M  V30 14 C 1.3252 2.1217 0.0 0 VAL=5
M  V30 15 C 2.0807 0.0000 0.0 0 VAL=5
M  V30 16 C 5.0014 8.2793 0.0 0
M  V30 17 C 5.9524 8.2793 0.0 0
M  V30 18 C 5.0014 9.2303 0.0 0
M  V30 19 C 5.9524 9.2303 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 2 3 18
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 5 12
M  V30 12 1 5 13
M  V30 13 1 5 14
M  V30 14 1 5 15
M  V30 15 1 6 7
M  V30 16 1 6 8
M  V30 17 1 6 16
M  V30 18 2 7 10
M  V30 19 2 8 9
M  V30 20 1 9 10
M  V30 21 1 11 14
M  V30 22 1 11 15
M  V30 23 1 12 13
M  V30 24 2 12 15
M  V30 25 2 13 14
M  V30 26 2 16 17
M  V30 27 1 16 18
M  V30 28 1 17 19
M  V30 29 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 551959-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1313019-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2721478
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Study of the reactivity of squarylferrocenes. Addition of amines and
aminoesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Villanueva-Garcia, Fabian; Reyes, Priscilla; Pannell, Keith H.;
Alvarez-Hernandez, Alejandro; Valois, Ismael; Juarez-Ruiz, Juan M.;
Flores-Rizo, Juan O.; Pena-Cabrera, Eduardo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2011), (9), 105-124

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimellitic anhydride
C9H4O5
552-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 C 7.2706 3.9844 0.0 0
M  V30 4 O 8.0406 5.3182 0.0 0
M  V30 5 O 8.0406 2.6508 0.0 0
M  V30 6 C 3.4206 2.6508 0.0 0
M  V30 7 C 2.6506 3.9844 0.0 0
M  V30 8 C 4.9606 2.6508 0.0 0
M  V30 9 C 2.3902 1.5064 0.0 0
M  V30 10 C 1.1444 3.6643 0.0 0
M  V30 11 C 3.4206 5.3182 0.0 0
M  V30 12 C 5.7306 3.9844 0.0 0
M  V30 13 O 0.9834 2.1327 0.0 0
M  V30 14 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-methyl-1,3-dioxo-1H-isoindole-5-carboxylic acid
C10H7NO4
42710-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4210 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 7.9108 4.2504 0.0 0
M  V30 4 O 7.9108 5.7904 0.0 0
M  V30 5 O 9.2446 3.4804 0.0 0
M  V30 6 C 0.0000 2.7104 0.0 0
M  V30 7 C 3.9099 3.4804 0.0 0
M  V30 8 C 3.9099 1.9404 0.0 0
M  V30 9 C 5.2436 4.2504 0.0 0
M  V30 10 C 2.4452 3.9564 0.0 0
M  V30 11 C 2.4452 1.4645 0.0 0
M  V30 12 C 5.2436 1.1704 0.0 0
M  V30 13 C 6.5772 3.4804 0.0 0
M  V30 14 N 1.5400 2.7104 0.0 0
M  V30 15 C 6.5772 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 42710-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-21913695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of xanthine oxidase inhibitor properties on
isoindoline-1,3-dion derivatives and calculation of interaction mechanism
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gundugdu, Ozlem; Noma, Samir Abbas Ali; Taskin-Tok, Tugba; Ates, Burhan;
Kishali, Nurhan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2020), 1204127523

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimellitic anhydride
C9H4O5
552-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7104 0.0000 0.0 0
M  V30 2 O 0.0000 4.6948 0.0 0
M  V30 3 C 7.2706 3.9844 0.0 0
M  V30 4 O 8.0406 5.3182 0.0 0
M  V30 5 O 8.0406 2.6508 0.0 0
M  V30 6 C 3.4206 2.6508 0.0 0
M  V30 7 C 2.6506 3.9844 0.0 0
M  V30 8 C 4.9606 2.6508 0.0 0
M  V30 9 C 2.3902 1.5064 0.0 0
M  V30 10 C 1.1444 3.6643 0.0 0
M  V30 11 C 3.4206 5.3182 0.0 0
M  V30 12 C 5.7306 3.9844 0.0 0
M  V30 13 O 0.9834 2.1327 0.0 0
M  V30 14 C 4.9606 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-2-methyl-1,3-dioxo-1H-isoindole-5-carboxylic acid
C10H7NO4
42710-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.9694 5.4210 0.0 0
M  V30 2 O 1.9694 0.0000 0.0 0
M  V30 3 C 7.9108 4.2504 0.0 0
M  V30 4 O 7.9108 5.7904 0.0 0
M  V30 5 O 9.2446 3.4804 0.0 0
M  V30 6 C 0.0000 2.7104 0.0 0
M  V30 7 C 3.9099 3.4804 0.0 0
M  V30 8 C 3.9099 1.9404 0.0 0
M  V30 9 C 5.2436 4.2504 0.0 0
M  V30 10 C 2.4452 3.9564 0.0 0
M  V30 11 C 2.4452 1.4645 0.0 0
M  V30 12 C 5.2436 1.1704 0.0 0
M  V30 13 C 6.5772 3.4804 0.0 0
M  V30 14 N 1.5400 2.7104 0.0 0
M  V30 15 C 6.5772 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-30-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 42710-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-21424327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigation of the inhibitory effects of isoindoline-1,3-dion
derivatives on hCA-I and hCA-II enzyme activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nadaroglu, Hayrunnisa; Gungor, Azize Alayli; Gundogdu, Ozlem; Kishali,
Nurhan Horasan; Kishali, Belgin; Altintop, Mehlika Dilek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2019), 1197386-392

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzaldehyde
C7H5NO3
552-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-nitrobenzenemethanamine
C8H10N2O2
56222-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.5400 4.0011 0.0 0 VAL=5
M  V30 2 O 2.3100 5.3349 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 N 6.1600 4.0011 0.0 0
M  V30 6 C 6.9300 5.3349 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 1.5400 1.3338 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 2.3100 0.0000 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56222-08-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-16686300
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stable and rapid thiol bioconjugation by light-triggered thiomaleimide
ring hydrolysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kalia, Dimpy; Pawar, Sharad P.; Thopate, Jyoti S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(7), 1885-1889

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[2-(cyclopentylthio)-2-(3,4-dichlorophenyl)acetyl]amino]-4-thiazole...
C19H20Cl2N2O3S2
557798-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.1047 0.0 0
M  V30 2 S 3.8500 3.7710 0.0 0
M  V30 3 C 6.1600 5.1047 0.0 0
M  V30 4 N 6.9300 6.4383 0.0 0
M  V30 5 O 6.9300 3.7710 0.0 0
M  V30 6 Cl 0.0000 7.7721 0.0 0
M  V30 7 Cl 1.5400 10.4394 0.0 0
M  V30 8 C 12.0858 8.1135 0.0 0
M  V30 9 C 13.4926 7.4872 0.0 0
M  V30 10 O 14.7385 8.3924 0.0 0
M  V30 11 O 13.6536 5.9557 0.0 0
M  V30 12 C 16.1454 7.7660 0.0 0
M  V30 13 C 3.8500 6.4383 0.0 0
M  V30 14 C 2.3100 6.4383 0.0 0
M  V30 15 C 4.6200 7.7721 0.0 0
M  V30 16 C 1.5400 7.7721 0.0 0
M  V30 17 C 3.8500 9.1058 0.0 0
M  V30 18 C 2.3100 9.1058 0.0 0
M  V30 19 C 4.6200 2.4374 0.0 0
M  V30 20 C 3.9937 1.0304 0.0 0
M  V30 21 C 6.1516 2.2763 0.0 0
M  V30 22 C 5.1381 0.0000 0.0 0
M  V30 23 C 6.4717 0.7700 0.0 0
M  V30 24 C 8.4700 6.4383 0.0 0
M  V30 25 N 9.3753 7.6843 0.0 0
M  V30 26 S 9.3753 5.1924 0.0 0
M  V30 27 C 10.8400 7.2083 0.0 0
M  V30 28 C 10.8400 5.6683 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 24
M  V30 8 1 6 16
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 8 27
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-(Cyclopentylthio)-2-(3,4-dichlorophenyl)acetyl]amino]-N-methyl-4-thiazo...
C19H21Cl2N3O2S2
557798-74-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 5.1047 0.0 0
M  V30 2 S 3.8500 3.7710 0.0 0
M  V30 3 C 6.1600 5.1047 0.0 0
M  V30 4 N 6.9300 6.4383 0.0 0
M  V30 5 O 6.9300 3.7710 0.0 0
M  V30 6 Cl 0.0000 7.7721 0.0 0
M  V30 7 Cl 1.5400 10.4394 0.0 0
M  V30 8 C 12.0858 8.1135 0.0 0
M  V30 9 C 13.4926 7.4872 0.0 0
M  V30 10 N 14.7385 8.3924 0.0 0
M  V30 11 O 13.6536 5.9557 0.0 0
M  V30 12 C 16.1454 7.7660 0.0 0
M  V30 13 C 3.8500 6.4383 0.0 0
M  V30 14 C 2.3100 6.4383 0.0 0
M  V30 15 C 4.6200 7.7721 0.0 0
M  V30 16 C 1.5400 7.7721 0.0 0
M  V30 17 C 3.8500 9.1058 0.0 0
M  V30 18 C 2.3100 9.1058 0.0 0
M  V30 19 C 4.6200 2.4374 0.0 0
M  V30 20 C 3.9937 1.0304 0.0 0
M  V30 21 C 6.1516 2.2763 0.0 0
M  V30 22 C 5.1381 0.0000 0.0 0
M  V30 23 C 6.4717 0.7700 0.0 0
M  V30 24 C 8.4700 6.4383 0.0 0
M  V30 25 N 9.3753 7.6843 0.0 0
M  V30 26 S 9.3753 5.1924 0.0 0
M  V30 27 C 10.8400 7.2083 0.0 0
M  V30 28 C 10.8400 5.6683 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 19
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 24
M  V30 8 1 6 16
M  V30 9 1 7 18
M  V30 10 1 8 9
M  V30 11 1 8 27
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 557798-73-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 557798-74-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10288543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl amide derivatives as glucokinase (GK) activators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lau, Jesper; Kodra, Janos Tibor; Guzel, Mustafa; Santosh, Kalpathy
Chidambareswaran; Mjalli, Adnan M. M.; Andrews, Robert Carl; Polisetti,
Dharma Rao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003055482 A1 2003-07-10

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Difluoromethyl)benzaldehyde
C8H6F2O
55805-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 F 0.0000 2.3101 0.0 0
M  V30 3 F 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Difluoromethyl)-N-methylbenzenemethanamine
C9H11F2N
1549390-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 F 1.3337 0.0000 0.0 0
M  V30 3 F 0.0000 2.3101 0.0 0
M  V30 4 C 6.6685 4.6201 0.0 0
M  V30 5 N 8.0023 3.8501 0.0 0
M  V30 6 C 9.3360 4.6201 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 4.0012 1.5400 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 12
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 55805-29-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1549390-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40490538
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Defluorination of Trifluoromethyl Substituents by
Conformationally Induced Remote Substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jesani, Mehul H.; Schwarz, Maria; Kim, Shiwhu; Evans, Finlay L.; White,
Alexander; Browning, Alex; Abrams, Roman; Clayden, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(24), e202403477

$RFMT $RIREG SCHEME205 STEP1
$RXN



  3  1
$MOL
Glycine
C2H5NO2
56-40-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 1.3337 2.3101 0.0 0
M  V30 5 N 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-[2-(methylamino)-2-oxoethyl]-4-(1-methylethoxy)benzamide
C13H17ClN2O3
1208245-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 2.6674 0.0 0
M  V30 2 N 9.2400 4.0011 0.0 0
M  V30 3 O 9.2400 1.3338 0.0 0
M  V30 4 C 10.7800 4.0011 0.0 0
M  V30 5 C 11.5500 5.3347 0.0 0
M  V30 6 N 13.0900 5.3347 0.0 0
M  V30 7 O 10.7800 6.6685 0.0 0
M  V30 8 C 13.8600 6.6685 0.0 0
M  V30 9 Cl 3.8500 0.0000 0.0 0
M  V30 10 O 2.3100 2.6674 0.0 0
M  V30 11 C 1.5400 4.0011 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 C 2.3100 5.3347 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 6.1600 1.3338 0.0 0
M  V30 16 C 6.1600 4.0011 0.0 0
M  V30 17 C 4.6200 1.3338 0.0 0
M  V30 18 C 4.6200 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-40-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-19-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11519548
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of 3 in DMF (0.2 M) were added amino acid (1.2 equiv.) and
N, N-diisopropylethylamine (3 equiv.). The reaction was monitored by
LC/MS. After completion, amine (1.5 equiv.) and HBTU (1.5 equiv.) were
added to the reaction solution. The reaction mixture was stirred for 4 h.
The product was purified by either HPLC or flash column chromatography.
3a – 3i (60-95% yield).
3-Chloro-4-isopropoxy-N-(2-(methylamino)-2-oxoethyl)benzamide (3a) 1H NMR
(400 MHz, MeOD) δ 7.94 (d, J = 2.3, 1H), 7.80 (dd, J = 2.3, 8.7, 1H),
7.15 (d, J = 8.8, 1H), 4.76 (dt, J = 6.1, 12.1, 1H), 3.97 (s, 2H), 2.75
(s, 3H), 1.38 (d, J = 6.0, 6H); LRMS (M+H+) m/z 285.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME206 STEP1
$RXN



  3  1
$MOL
L-Serine
C3H7NO3
56-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0 CFG=1
M  V30 2 C 1.3337 3.0801 0.0 0
M  V30 3 C 2.6673 0.7700 0.0 0
M  V30 4 N 4.0010 3.0801 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 4.0010 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-[(1S)-1-(hydroxymethyl)-2-(methylamino)-2-oxoethyl]-4-(1-methyleth...
C14H19ClN2O4
1208245-21-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 5 C 2.3100 5.3347 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 N 0.7700 5.3347 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 O 0.7700 2.6674 0.0 0
M  V30 10 C 0.0000 6.6685 0.0 0
M  V30 11 Cl 10.0100 0.0000 0.0 0
M  V30 12 O 11.5500 2.6674 0.0 0
M  V30 13 C 12.3200 4.0011 0.0 0
M  V30 14 C 11.5500 5.3347 0.0 0
M  V30 15 C 13.8600 4.0011 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 7.7000 1.3338 0.0 0
M  V30 18 C 7.7000 4.0011 0.0 0
M  V30 19 C 9.2400 1.3338 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 10.0100 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 11 19
M  V30 12 1 12 13
M  V30 13 1 12 21
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 56-45-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-21-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-243018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 3 in DMF (0.2 M) were added
amino acid (1.2 equiv.) and N, N-diisopropylethylamine (3 equiv.). The
reaction was monitored by LC/MS. After completion, amine (1.5 equiv.) and
HBTU (1.5 equiv.) were added to the reaction solution. The reaction
mixture was stirred for 4 h. The product was purified by either HPLC or
flash column chromatography. 3a – 3i (60-95% yield).
3-Chloro-N-(3-hydroxy-1-(methylamino)-1-oxopropan-2-yl)-4-isopropoxybenzamide
(3c) 1H NMR (400 MHz, MeOD) δ 7.87 (d, J = 2.3, 1H), 7.72 (dd, J = 2.3,
8.7, 1H), 7.05 (d, J = 8.8, 1H), 4.66 (dt, J = 6.0, 12.1, 1H), 4.47 (t, J
= 5.4, 1H), 3.77 (d, J = 5.3, 2H), 2.66 (s, 3H), 1.28 (d, J = 6.0, 6H);
LRMS (M+H+) m/z 315.0.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-phenylthieno[2,3-d]pyrimidine
C12H7ClN2S
56843-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.6672 0.0000 0.0 0
M  V30 2 C 1.6672 2.6673 0.0 0
M  V30 3 C 2.4372 4.0011 0.0 0
M  V30 4 C 2.4372 1.3337 0.0 0
M  V30 5 C 0.1609 2.9876 0.0 0
M  V30 6 N 3.9772 4.0011 0.0 0
M  V30 7 S 1.4068 5.1455 0.0 0
M  V30 8 N 3.9772 1.3337 0.0 0
M  V30 9 C 0.0000 4.5192 0.0 0
M  V30 10 C 4.7473 2.6673 0.0 0
M  V30 11 C 6.2873 2.6673 0.0 0
M  V30 12 C 7.0573 4.0011 0.0 0
M  V30 13 C 7.0573 1.3337 0.0 0
M  V30 14 C 8.5973 4.0011 0.0 0
M  V30 15 C 8.5973 1.3337 0.0 0
M  V30 16 C 9.3673 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 1 10 11
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2-phenylthieno[2,3-d]pyrimidin-4-amine
C13H11N3S
1285389-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.6672 1.3337 0.0 0
M  V30 2 C 2.4373 0.0000 0.0 0
M  V30 3 C 1.6672 4.0012 0.0 0
M  V30 4 C 2.4373 5.3348 0.0 0
M  V30 5 C 2.4373 2.6673 0.0 0
M  V30 6 C 0.1609 4.3213 0.0 0
M  V30 7 N 3.9773 5.3348 0.0 0
M  V30 8 S 1.4068 6.4792 0.0 0
M  V30 9 N 3.9773 2.6673 0.0 0
M  V30 10 C 0.0000 5.8529 0.0 0
M  V30 11 C 4.7473 4.0012 0.0 0
M  V30 12 C 6.2873 4.0012 0.0 0
M  V30 13 C 7.0574 5.3348 0.0 0
M  V30 14 C 7.0574 2.6673 0.0 0
M  V30 15 C 8.5974 5.3348 0.0 0
M  V30 16 C 8.5974 2.6673 0.0 0
M  V30 17 C 9.3674 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 56843-80-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1285389-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34552018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thieno[2,3-d]pyrimidine-Core Compounds Show Activity against Clinically
Relevant Gram-Positive Bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Riabova, Olga; Egorova, Anna; Lepioshkin, Alexander; Li, Yan; Voigt,
Kerstin; Kloss, Florian; Makarov, Vadim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2022), 17(17), e202200207

$RFMT $RIREG SCHEME208 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-[(2-Methoxyphenyl)methylene]-2-phenyl-5(4H)-oxazolone
C17H13NO3
57427-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3659 4.6201 0.0 0
M  V30 2 O 8.0157 7.9521 0.0 0
M  V30 3 O 11.0332 3.0800 0.0 0
M  V30 4 C 12.3670 2.3100 0.0 0
M  V30 5 C 4.5948 5.9081 0.0 0
M  V30 6 N 5.6252 4.7636 0.0 0
M  V30 7 O 5.3648 7.2418 0.0 0
M  V30 8 C 7.0322 5.3901 0.0 0
M  V30 9 C 6.8711 6.9216 0.0 0
M  V30 10 C 3.0633 5.7472 0.0 0
M  V30 11 C 2.4368 4.3402 0.0 0
M  V30 12 C 2.1580 6.9931 0.0 0
M  V30 13 C 0.9052 4.1793 0.0 0
M  V30 14 C 0.6265 6.8320 0.0 0
M  V30 15 C 0.0000 5.4252 0.0 0
M  V30 16 C 8.3659 3.0800 0.0 0
M  V30 17 C 9.6995 2.3100 0.0 0
M  V30 18 C 7.0322 2.3100 0.0 0
M  V30 19 C 9.6995 0.7700 0.0 0
M  V30 20 C 7.0322 0.7700 0.0 0
M  V30 21 C 8.3659 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 1 16
M  V30 3 2 2 9
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 10
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-3,5-Dihydro-5-[(2-methoxyphenyl)methylene]-3-methyl-2-phenyl-4H-imidazol...
C18H16N2O2
1338081-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.7385 8.6488 0.0 0
M  V30 2 C 8.3659 4.6201 0.0 0
M  V30 3 O 8.0157 7.9522 0.0 0
M  V30 4 O 11.0332 3.0801 0.0 0
M  V30 5 C 12.3670 2.3100 0.0 0
M  V30 6 C 4.5948 5.9082 0.0 0
M  V30 7 N 5.6253 4.7638 0.0 0
M  V30 8 N 5.3648 7.2418 0.0 0
M  V30 9 C 7.0322 5.3901 0.0 0
M  V30 10 C 6.8711 6.9217 0.0 0
M  V30 11 C 3.0633 5.7472 0.0 0
M  V30 12 C 2.1580 6.9931 0.0 0
M  V30 13 C 2.4368 4.3403 0.0 0
M  V30 14 C 0.6265 6.8322 0.0 0
M  V30 15 C 0.9052 4.1793 0.0 0
M  V30 16 C 0.0000 5.4252 0.0 0
M  V30 17 C 8.3659 3.0801 0.0 0
M  V30 18 C 9.6996 2.3100 0.0 0
M  V30 19 C 7.0322 2.3100 0.0 0
M  V30 20 C 9.6996 0.7700 0.0 0
M  V30 21 C 7.0322 0.7700 0.0 0
M  V30 22 C 8.3659 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 2 17
M  V30 4 2 3 10
M  V30 5 1 4 5
M  V30 6 1 4 18
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 6 11
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57427-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1338081-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9000029
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4.2.2.
(Z)-4-(2-Methoxybenzylidene)-1-methyl-2-phenyl-1H-imidazol-5(4H)-one
(2a). (Z)-4-(2-Methoxybenzylidene)-2-phenyloxazol-5(4H)-one (3a; 1.0 g,
3.6 mmol) was added to potassium carbonate (0.5 g, 3.6 mmol) in a 50 mL
round-bottom flask, in which 20 mL of ethanol (95%) and 1.0 mL of
methylamine (40% aqueous) were then added. The reaction mixture was
refluxed for 4 h. After cooling, the mixture was neutralized with 10% HCl
and extracted with CH2Cl2 (3 × 25 mL). After solvent was removed, the
crude product was purified by silica gel column chromatography with ethyl
acetate/nhexane (1/2) as eluent to afford 2a. Yellow solid; yield 0.7 g
(67%). mp 126−127 °C; 1H NMR (400 MHz, CDCl3, ppm) 8.92 (d, J = 7.6 Hz,
1H), 7.85−7.83 (m, 3H), 7.56−7.52 (m, 3H), 7.37 (t, J = 8.4 Hz, 1H), 7.04
(t, J = 7.6 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 3.90 (s, 3H), 3.37 (s,
3H); 13C NMR (100 MHz, CDCl3, ppm) 171.7, 161.8, 159.3, 138.4, 133.3,
131.9, 131.3, 129.5, 128.7, 128.6, 123.4, 122.9, 120.9, 110.5, 55.5,
29.0; MS (EI, 70 eV) m/z (relative intensity) 292 (M+, 100); HRMS calcd
for C18H16O2N2 292.1212, found 292.1219. Anal. Calcd for C18H16O2N2: C,
73.95; H, 5.52; N, 9.58. Found: C, 73.69; H, 5.56; N, 9.80.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Excited-State Intramolecular Proton Transfer Molecules Bearing o-Hydroxy
Analogues of Green Fluorescent Protein Chromophore
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chuang, Wei-Ti; Hsieh, Cheng-Chih; Lai, Chin-Hung; Lai, Cheng-Hsuan;
Shih, Chun-Wei; Chen, Kew-Yu; Hung, Wen-Yi; Hsu, Yu-Hsiang; Chou, Pi-Tai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(20), 8189-8202

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-2-propenoic acid
C20H24O3Si
574741-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 3.0800 0.0 0
M  V30 2 O 6.1600 3.0800 0.0 0
M  V30 3 C 4.6200 1.5400 0.0 0
M  V30 4 C 6.9300 4.4136 0.0 0
M  V30 5 C 6.1600 1.5400 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 8.4700 4.4136 0.0 0
M  V30 9 C 9.2400 5.7474 0.0 0
M  V30 10 C 9.2400 3.0800 0.0 0
M  V30 11 O 10.7800 5.7474 0.0 0
M  V30 12 O 8.4700 7.0811 0.0 0
M  V30 13 C 3.0800 3.0800 0.0 0
M  V30 14 C 2.3100 4.4136 0.0 0
M  V30 15 C 2.3100 1.7464 0.0 0
M  V30 16 C 0.7700 4.4136 0.0 0
M  V30 17 C 0.7700 1.7464 0.0 0
M  V30 18 C 0.0000 3.0800 0.0 0
M  V30 19 C 4.6200 4.6200 0.0 0
M  V30 20 C 3.2864 5.3900 0.0 0
M  V30 21 C 5.9536 5.3900 0.0 0
M  V30 22 C 3.2864 6.9300 0.0 0
M  V30 23 C 5.9536 6.9300 0.0 0
M  V30 24 C 4.6200 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-N-methyl-2-propenamide
C21H27NO2Si
2407861-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 4.7712 0.0 0
M  V30 3 C 3.2311 5.3348 0.0 0
M  V30 4 C 6.6685 4.0012 0.0 0
M  V30 5 C 4.5648 6.1048 0.0 0
M  V30 6 C 2.4611 6.6687 0.0 0
M  V30 7 C 1.8973 4.5648 0.0 0
M  V30 8 C 8.0022 4.7712 0.0 0
M  V30 9 C 9.3360 4.0012 0.0 0
M  V30 10 C 8.0022 6.3112 0.0 0
M  V30 11 N 10.6697 4.7712 0.0 0
M  V30 12 O 9.3360 2.4611 0.0 0
M  V30 13 C 12.0033 4.0012 0.0 0
M  V30 14 C 2.6673 3.2311 0.0 0
M  V30 15 C 1.3337 4.0012 0.0 0
M  V30 16 C 2.6673 1.6911 0.0 0
M  V30 17 C 0.0000 3.2311 0.0 0
M  V30 18 C 1.3337 0.9211 0.0 0
M  V30 19 C 0.0000 1.6911 0.0 0
M  V30 20 C 4.7712 2.6675 0.0 0
M  V30 21 C 6.3112 2.6675 0.0 0
M  V30 22 C 4.0012 1.3338 0.0 0
M  V30 23 C 7.0812 1.3338 0.0 0
M  V30 24 C 4.7712 0.0000 0.0 0
M  V30 25 C 6.3112 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 574741-55-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2407861-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-22310906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Covalent Labeling with an α,β-Unsaturated Carbonyl Scaffold for Studying
Protein Structure and Interactions by Mass Spectrometry
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Bo; Zhuang, Jiaming; Xu, Miaowei; Liu, Tianying; Limpikirati,
Patanachai; Thayumanavan, S.; Vachet, Richard W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Analytical Chemistry (Washington, DC, United States) (2020), 92(9),
6637-6644

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-2-propenoic acid
C20H24O3Si
574741-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 3.0800 0.0 0
M  V30 2 O 6.1600 3.0800 0.0 0
M  V30 3 C 4.6200 1.5400 0.0 0
M  V30 4 C 6.9300 4.4136 0.0 0
M  V30 5 C 6.1600 1.5400 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 8.4700 4.4136 0.0 0
M  V30 9 C 9.2400 5.7474 0.0 0
M  V30 10 C 9.2400 3.0800 0.0 0
M  V30 11 O 10.7800 5.7474 0.0 0
M  V30 12 O 8.4700 7.0811 0.0 0
M  V30 13 C 3.0800 3.0800 0.0 0
M  V30 14 C 2.3100 4.4136 0.0 0
M  V30 15 C 2.3100 1.7464 0.0 0
M  V30 16 C 0.7700 4.4136 0.0 0
M  V30 17 C 0.7700 1.7464 0.0 0
M  V30 18 C 0.0000 3.0800 0.0 0
M  V30 19 C 4.6200 4.6200 0.0 0
M  V30 20 C 3.2864 5.3900 0.0 0
M  V30 21 C 5.9536 5.3900 0.0 0
M  V30 22 C 3.2864 6.9300 0.0 0
M  V30 23 C 5.9536 6.9300 0.0 0
M  V30 24 C 4.6200 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-N-methyl-2-propenamide
C21H27NO2Si
2407861-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 4.7712 0.0 0
M  V30 3 C 3.2311 5.3348 0.0 0
M  V30 4 C 6.6685 4.0012 0.0 0
M  V30 5 C 4.5648 6.1048 0.0 0
M  V30 6 C 2.4611 6.6687 0.0 0
M  V30 7 C 1.8973 4.5648 0.0 0
M  V30 8 C 8.0022 4.7712 0.0 0
M  V30 9 C 9.3360 4.0012 0.0 0
M  V30 10 C 8.0022 6.3112 0.0 0
M  V30 11 N 10.6697 4.7712 0.0 0
M  V30 12 O 9.3360 2.4611 0.0 0
M  V30 13 C 12.0033 4.0012 0.0 0
M  V30 14 C 2.6673 3.2311 0.0 0
M  V30 15 C 1.3337 4.0012 0.0 0
M  V30 16 C 2.6673 1.6911 0.0 0
M  V30 17 C 0.0000 3.2311 0.0 0
M  V30 18 C 1.3337 0.9211 0.0 0
M  V30 19 C 0.0000 1.6911 0.0 0
M  V30 20 C 4.7712 2.6675 0.0 0
M  V30 21 C 6.3112 2.6675 0.0 0
M  V30 22 C 4.0012 1.3338 0.0 0
M  V30 23 C 7.0812 1.3338 0.0 0
M  V30 24 C 4.7712 0.0000 0.0 0
M  V30 25 C 6.3112 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 574741-55-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2407861-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21754836
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions and methods for protein labeling, modification, analysis,
and targeted delivery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thayumanavan, Sankaran; Vachet, Richard W.; Zhuang, Jiaming; Zhao, Bo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020006340 A1 2020-01-02

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-2-propenoic acid
C20H24O3Si
574741-55-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.6200 3.0800 0.0 0
M  V30 2 O 6.1600 3.0800 0.0 0
M  V30 3 C 4.6200 1.5400 0.0 0
M  V30 4 C 6.9300 4.4136 0.0 0
M  V30 5 C 6.1600 1.5400 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 8.4700 4.4136 0.0 0
M  V30 9 C 9.2400 5.7474 0.0 0
M  V30 10 C 9.2400 3.0800 0.0 0
M  V30 11 O 10.7800 5.7474 0.0 0
M  V30 12 O 8.4700 7.0811 0.0 0
M  V30 13 C 3.0800 3.0800 0.0 0
M  V30 14 C 2.3100 4.4136 0.0 0
M  V30 15 C 2.3100 1.7464 0.0 0
M  V30 16 C 0.7700 4.4136 0.0 0
M  V30 17 C 0.7700 1.7464 0.0 0
M  V30 18 C 0.0000 3.0800 0.0 0
M  V30 19 C 4.6200 4.6200 0.0 0
M  V30 20 C 3.2864 5.3900 0.0 0
M  V30 21 C 5.9536 5.3900 0.0 0
M  V30 22 C 3.2864 6.9300 0.0 0
M  V30 23 C 5.9536 6.9300 0.0 0
M  V30 24 C 4.6200 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-N-methyl-2-propenamide
C21H27NO2Si
2407861-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 4.7712 0.0 0
M  V30 3 C 3.2311 5.3348 0.0 0
M  V30 4 C 6.6685 4.0012 0.0 0
M  V30 5 C 4.5648 6.1048 0.0 0
M  V30 6 C 2.4611 6.6687 0.0 0
M  V30 7 C 1.8973 4.5648 0.0 0
M  V30 8 C 8.0022 4.7712 0.0 0
M  V30 9 C 9.3360 4.0012 0.0 0
M  V30 10 C 8.0022 6.3112 0.0 0
M  V30 11 N 10.6697 4.7712 0.0 0
M  V30 12 O 9.3360 2.4611 0.0 0
M  V30 13 C 12.0033 4.0012 0.0 0
M  V30 14 C 2.6673 3.2311 0.0 0
M  V30 15 C 1.3337 4.0012 0.0 0
M  V30 16 C 2.6673 1.6911 0.0 0
M  V30 17 C 0.0000 3.2311 0.0 0
M  V30 18 C 1.3337 0.9211 0.0 0
M  V30 19 C 0.0000 1.6911 0.0 0
M  V30 20 C 4.7712 2.6675 0.0 0
M  V30 21 C 6.3112 2.6675 0.0 0
M  V30 22 C 4.0012 1.3338 0.0 0
M  V30 23 C 7.0812 1.3338 0.0 0
M  V30 24 C 4.7712 0.0000 0.0 0
M  V30 25 C 6.3112 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 1 20
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 574741-55-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2407861-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21614437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A programmable chemical switch based on triggerable Michael acceptors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhuang, Jiaming; Zhao, Bo; Meng, Xiangxi; Schiffman, Jessica D.; Perry,
Sarah L.; Vachet, Richard W.; Thayumanavan, S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2020), 11(8), 2103-2111

$RFMT $RIREG SCHEME210 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatin
C8H5NO2
91-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6079 0.0000 0.0 0
M  V30 2 O 6.5771 2.7104 0.0 0
M  V30 3 C 2.6673 3.4804 0.0 0
M  V30 4 C 2.6673 1.9404 0.0 0
M  V30 5 N 4.1320 3.9565 0.0 0
M  V30 6 C 1.3337 4.2504 0.0 0
M  V30 7 C 4.1320 1.4646 0.0 0
M  V30 8 C 1.3337 1.1704 0.0 0
M  V30 9 C 5.0371 2.7104 0.0 0
M  V30 10 C 0.0000 3.4804 0.0 0
M  V30 11 C 0.0000 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 11
M  V30 12 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-methyl-α,γ-dioxobenzenebutanoate
C13H14O4
5814-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 O 8.0022 0.0000 0.0 0
M  V30 7 O 10.6697 1.5400 0.0 0
M  V30 8 O 9.3360 3.8501 0.0 0
M  V30 9 C 12.0033 2.3101 0.0 0
M  V30 10 C 13.3370 1.5400 0.0 0
M  V30 11 C 0.0000 4.6201 0.0 0
M  V30 12 C 4.0010 2.3101 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 4.0010 3.8501 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[3H-indole-3,5′-[5H]pyrrolo[3,4-d]pyrimidine]-2,7′(1H,6′H)-dione, 3′-(1,...
C25H26N4O3
2925703-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5522 7.4902 0.0 0
M  V30 2 O 4.6618 4.9984 0.0 0
M  V30 3 O 5.7045 5.2993 0.0 0
M  V30 4 O 7.5829 10.2007 0.0 0
M  V30 5 C 1.4875 6.3216 0.0 0
M  V30 6 C 0.0000 5.9230 0.0 0
M  V30 7 C 1.0889 7.8091 0.0 0
M  V30 8 C 1.8861 4.8341 0.0 0
M  V30 9 C 2.7144 0.0000 0.0 0
M  V30 10 C 7.1070 6.2443 0.0 0
M  V30 11 C 5.6424 6.7201 0.0 0
M  V30 12 C 8.5717 5.7684 0.0 0
M  V30 13 N 8.0122 7.4902 0.0 0
M  V30 14 C 6.2018 4.9984 0.0 0
M  V30 15 C 4.3086 5.9501 0.0 0
M  V30 16 C 5.6424 8.2602 0.0 0
M  V30 17 C 8.5717 4.2284 0.0 0
M  V30 18 C 9.9054 6.5384 0.0 0
M  V30 19 C 7.1070 8.7360 0.0 0
M  V30 20 N 7.1070 3.7525 0.0 0
M  V30 21 N 2.9750 6.7201 0.0 0
M  V30 22 N 4.3086 9.0302 0.0 0
M  V30 23 C 9.9054 3.4584 0.0 0
M  V30 24 C 11.2390 5.7684 0.0 0
M  V30 25 C 2.9750 8.2602 0.0 0
M  V30 26 C 11.2390 4.2284 0.0 0
M  V30 27 C 3.9101 4.4626 0.0 0
M  V30 28 C 4.9990 3.3737 0.0 0
M  V30 29 C 2.4226 4.0641 0.0 0
M  V30 30 C 4.6005 1.8862 0.0 0
M  V30 31 C 2.0240 2.5764 0.0 0
M  V30 32 C 3.1130 1.4875 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 2 2 14
M  V30 3 1 3 15
M  V30 4 2 4 19
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 21
M  V30 9 1 9 32
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 21
M  V30 21 1 15 27
M  V30 22 1 16 19
M  V30 23 1 16 22
M  V30 24 1 17 20
M  V30 25 2 17 23
M  V30 26 1 18 24
M  V30 27 1 21 25
M  V30 28 2 22 25
M  V30 29 1 23 26
M  V30 30 2 24 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 91-56-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 5814-37-9
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2925703-82-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36542794
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 631-61-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1317-61-9
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM coated on titania
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(3):AMD
$DATUM magnetite-coated titania-functionalized carbon nanotube-supported
$DTYPE RXN:VAR(1):CAT(4):CAS_RN
$DATUM 7440-44-0
$DTYPE RXN:VAR(1):CAT(5):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):CAT(5):AMD
$DATUM magnetite-coated
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, reusable catalyst, see
experimental details, magnetite-coated titania-functionalized carbon
nanotube-supported silver nanocatalyst prepared and used, stage 1
intermediate in added in stage 3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Investigation of Biological Activity of New Spiro
Pyrrolo[3,4-d]Pyrimidine Derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tabarsaei, Navisa; Varasteh Moradi, Ali; Sayyed Alangi, S. Zahra;
Hossaini, Zinatossadat; Zafar Mmehrabian, Ramin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2023), 43(9), 8388-8407

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[4-(bromomethyl)phenoxy]-2-methylpropanoate
C13H17BrO3
58336-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 2.6673 0.0 0
M  V30 2 C 7.7002 1.3337 0.0 0
M  V30 3 C 9.0340 2.1037 0.0 0
M  V30 4 C 6.3665 0.5637 0.0 0
M  V30 5 C 8.4702 0.0000 0.0 0
M  V30 6 O 10.3677 1.3337 0.0 0
M  V30 7 O 9.0340 3.6437 0.0 0
M  V30 8 C 11.7013 2.1037 0.0 0
M  V30 9 C 13.0352 1.3337 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 Br 0.0000 4.0010 0.0 0
M  V30 12 C 5.3901 2.6673 0.0 0
M  V30 13 C 4.6201 1.3337 0.0 0
M  V30 14 C 4.6201 4.0010 0.0 0
M  V30 15 C 3.0801 1.3337 0.0 0
M  V30 16 C 3.0801 4.0010 0.0 0
M  V30 17 C 2.3101 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-methyl-2-[4-[(methylamino)methyl]phenoxy]propanoate
C14H21NO3
639784-56-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1050 2.6673 0.0 0
M  V30 2 C 5.3350 1.3337 0.0 0
M  V30 3 C 4.0012 2.1037 0.0 0
M  V30 4 C 4.5650 0.0000 0.0 0
M  V30 5 C 6.6687 0.5637 0.0 0
M  V30 6 O 2.6675 1.3337 0.0 0
M  V30 7 O 4.0012 3.6437 0.0 0
M  V30 8 C 1.3338 2.1037 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 10 C 12.2651 2.6673 0.0 0
M  V30 11 N 13.0352 4.0010 0.0 0
M  V30 12 C 14.5752 4.0010 0.0 0
M  V30 13 C 7.6450 2.6673 0.0 0
M  V30 14 C 8.4151 1.3337 0.0 0
M  V30 15 C 8.4151 4.0010 0.0 0
M  V30 16 C 9.9551 1.3337 0.0 0
M  V30 17 C 9.9551 4.0010 0.0 0
M  V30 18 C 10.7251 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 58336-71-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 639784-56-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6481515
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-[4-(heteroarylaminomethyl)phenoxy]-2-methylpropanoates
for treating a hPPAR mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dodic, Nerina; Dumaitre, Bernard Andre; Gellibert, Francoise Jeanne;
Sierra, Michael Lawrence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004000785 A2 2003-12-31

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-3-(3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzothiazin-7-yl)-2-oxo-5-o...
C14H14N2O5S
590421-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.8994 0.0000 0.0 0
M  V30 2 C 12.0857 4.3858 0.0 0
M  V30 3 O 13.4926 3.7593 0.0 0
M  V30 4 O 11.9247 5.9173 0.0 0
M  V30 5 C 14.7385 4.6645 0.0 0
M  V30 6 C 1.5400 1.3769 0.0 0
M  V30 7 O 0.0000 4.0442 0.0 0
M  V30 8 C 6.9300 2.7106 0.0 0
M  V30 9 C 6.1600 4.0442 0.0 0
M  V30 10 C 6.1600 1.3769 0.0 0
M  V30 11 C 4.6200 4.0442 0.0 0
M  V30 12 C 4.6200 1.3769 0.0 0
M  V30 13 C 3.8500 2.7106 0.0 0
M  V30 14 S 3.8500 5.3779 0.0 0
M  V30 15 N 2.3100 2.7106 0.0 0
M  V30 16 C 2.3100 5.3779 0.0 0
M  V30 17 C 1.5400 4.0442 0.0 0
M  V30 18 N 8.4700 2.7106 0.0 0
M  V30 19 C 9.3753 3.9564 0.0 0
M  V30 20 C 9.3753 1.4647 0.0 0
M  V30 21 C 10.8398 3.4806 0.0 0 CFG=2
M  V30 22 O 10.8398 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 21 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 2 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-3-(3,4-Dihydro-4-methyl-3-oxo-2H-1,4-benzothiazin-7-yl)-N-methyl-2-oxo-5...
C14H15N3O4S
590421-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.8994 0.0000 0.0 0
M  V30 2 C 12.0857 4.3858 0.0 0
M  V30 3 N 13.4926 3.7593 0.0 0
M  V30 4 O 11.9247 5.9173 0.0 0
M  V30 5 C 14.7385 4.6645 0.0 0
M  V30 6 C 1.5400 1.3769 0.0 0
M  V30 7 O 0.0000 4.0442 0.0 0
M  V30 8 C 6.9300 2.7106 0.0 0
M  V30 9 C 6.1600 4.0442 0.0 0
M  V30 10 C 6.1600 1.3769 0.0 0
M  V30 11 C 4.6200 4.0442 0.0 0
M  V30 12 C 4.6200 1.3769 0.0 0
M  V30 13 C 3.8500 2.7106 0.0 0
M  V30 14 S 3.8500 5.3779 0.0 0
M  V30 15 N 2.3100 2.7106 0.0 0
M  V30 16 C 2.3100 5.3779 0.0 0
M  V30 17 C 1.5400 4.0442 0.0 0
M  V30 18 N 8.4700 2.7106 0.0 0
M  V30 19 C 9.3753 3.9564 0.0 0
M  V30 20 C 9.3753 1.4647 0.0 0
M  V30 21 C 10.8398 3.4806 0.0 0 CFG=2
M  V30 22 O 10.8398 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 21 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 2 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 590421-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 590421-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15015603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-aryl-2-oxo-5-oxazolidinecarboxamides and analogs as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomas, Richard Charles; Poel, Toni-jo; Barbachyn, Michael Robert;
Gordeev, Mikhail Fedor; Luehr, Gary W.; Renslo, Adam; Singh, Upinder;
Josyula, Vara Prasad Venkata Nagendra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040147760 A1 2004-07-29

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (5R)-3-(3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzothiazin-7-yl)-2-oxo-5-o...
C14H14N2O5S
590421-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.8994 0.0000 0.0 0
M  V30 2 C 12.0857 4.3858 0.0 0
M  V30 3 O 13.4926 3.7593 0.0 0
M  V30 4 O 11.9247 5.9173 0.0 0
M  V30 5 C 14.7385 4.6645 0.0 0
M  V30 6 C 1.5400 1.3769 0.0 0
M  V30 7 O 0.0000 4.0442 0.0 0
M  V30 8 C 6.9300 2.7106 0.0 0
M  V30 9 C 6.1600 4.0442 0.0 0
M  V30 10 C 6.1600 1.3769 0.0 0
M  V30 11 C 4.6200 4.0442 0.0 0
M  V30 12 C 4.6200 1.3769 0.0 0
M  V30 13 C 3.8500 2.7106 0.0 0
M  V30 14 S 3.8500 5.3779 0.0 0
M  V30 15 N 2.3100 2.7106 0.0 0
M  V30 16 C 2.3100 5.3779 0.0 0
M  V30 17 C 1.5400 4.0442 0.0 0
M  V30 18 N 8.4700 2.7106 0.0 0
M  V30 19 C 9.3753 3.9564 0.0 0
M  V30 20 C 9.3753 1.4647 0.0 0
M  V30 21 C 10.8398 3.4806 0.0 0 CFG=2
M  V30 22 O 10.8398 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 21 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 2 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5R)-3-(3,4-Dihydro-4-methyl-3-oxo-2H-1,4-benzothiazin-7-yl)-N-methyl-2-oxo-5...
C14H15N3O4S
590421-48-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.8994 0.0000 0.0 0
M  V30 2 C 12.0857 4.3858 0.0 0
M  V30 3 N 13.4926 3.7593 0.0 0
M  V30 4 O 11.9247 5.9173 0.0 0
M  V30 5 C 14.7385 4.6645 0.0 0
M  V30 6 C 1.5400 1.3769 0.0 0
M  V30 7 O 0.0000 4.0442 0.0 0
M  V30 8 C 6.9300 2.7106 0.0 0
M  V30 9 C 6.1600 4.0442 0.0 0
M  V30 10 C 6.1600 1.3769 0.0 0
M  V30 11 C 4.6200 4.0442 0.0 0
M  V30 12 C 4.6200 1.3769 0.0 0
M  V30 13 C 3.8500 2.7106 0.0 0
M  V30 14 S 3.8500 5.3779 0.0 0
M  V30 15 N 2.3100 2.7106 0.0 0
M  V30 16 C 2.3100 5.3779 0.0 0
M  V30 17 C 1.5400 4.0442 0.0 0
M  V30 18 N 8.4700 2.7106 0.0 0
M  V30 19 C 9.3753 3.9564 0.0 0
M  V30 20 C 9.3753 1.4647 0.0 0
M  V30 21 C 10.8398 3.4806 0.0 0 CFG=2
M  V30 22 O 10.8398 1.9406 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 21 2 CFG=3
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 2 7 17
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 590421-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 590421-48-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5114974
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 3-aryl-2-oxo-5-oxazolidinecarboxamides and analogs as
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Thomas, Richard C.; Poel, Toni-Jo; Barbachyn, Michael R.; Gordeev,
Mikhail F.; Luehr, Gary W.; Renslo, Adam; Singh, Upinder
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003072553 A1 2003-09-04

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-formyl-, 1,1-dimethylethyl ester
C10H17NO3
59379-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 9.0058 4.5489 0.0 0
M  V30 9 O 10.4126 3.9225 0.0 0
M  V30 10 N 5.3900 2.8736 0.0 0
M  V30 11 C 6.2952 4.1195 0.0 0
M  V30 12 C 6.2952 1.6278 0.0 0
M  V30 13 C 7.7598 3.6436 0.0 0
M  V30 14 C 7.7598 2.1036 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 13
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, 3-[(methylamino)methyl]-, 1,1-dimethylethyl ester
C11H22N2O2
872716-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 2.1037 0.2064 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 0.5637 2.8737 0.0 0
M  V30 8 C 9.3038 2.6672 0.0 0
M  V30 9 N 10.2090 3.9131 0.0 0
M  V30 10 C 11.7406 3.7521 0.0 0
M  V30 11 N 5.3348 2.3101 0.0 0
M  V30 12 C 6.7417 1.6836 0.0 0
M  V30 13 C 5.4958 3.8416 0.0 0
M  V30 14 C 7.7722 2.8281 0.0 0
M  V30 15 C 7.0022 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 59379-02-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 872716-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10227440
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
(±)-N-[(1-{2-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]-N-methyl-3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]thiazine-6-carboxamide.
(±)-1,1-Dimethylethyl 3-[(methylamino)methyl]-1-pyrrolidinecarboxylate.
To a solution of 1,1-dimethylethyl 3-formyl-1-pyrrolidinecarboxylate (500
mg, 2.51 mmol) in MeOH/DCM (6 mL, 1:1) were added NaHCO (1.05 g, 12.6
mmol) followed by methylamine (2.51 mL, 5.02 mmol, 2.0 M in MeOH). After
12 h at 25°C, NaSH (1.05 g, 12.6 mmol) was added. After 1h, the reaction
was concentrated and the residue was partitioned between DCM and H O. The
aqueous phase was extracted several times with DCM and the combined
organic fractions were dried over MgSO4, concentrated and purified via
column chromatography (silica, 4% MeOH in DCM (1% NH OH)) yielding the
title compound (512 mg, 95%) as a brown oil. LC/MS (ES) m/e 215 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of naphthalenes, quinolines, quinoxalines and naphthyridines
as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, William Henry; Pendrak, Israil; Seefeld, Mark Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006002047 A2 2006-01-05

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-3-nitropyridine
C5H2Cl2N2O2
5975-12-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6675 0.0 0 VAL=5
M  V30 2 O 0.0000 1.3338 0.0 0
M  V30 3 O 0.0000 4.0012 0.0 0
M  V30 4 Cl 2.3101 5.3350 0.0 0
M  V30 5 Cl 2.3101 0.0000 0.0 0
M  V30 6 C 2.3101 2.6675 0.0 0
M  V30 7 C 3.0801 4.0012 0.0 0
M  V30 8 C 3.0801 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 N 4.6201 1.3338 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-3-nitro-4-pyridinamine
C6H6ClN3O2
1239719-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 4.6201 0.0 0 VAL=5
M  V30 2 O 4.0012 5.3901 0.0 0
M  V30 3 O 1.3338 5.3901 0.0 0
M  V30 4 N 5.3348 3.0801 0.0 0
M  V30 5 C 6.6687 2.3101 0.0 0
M  V30 6 Cl 0.0000 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 N 1.3338 0.7700 0.0 0
M  V30 12 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 8
M  V30 6 1 6 9
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5975-12-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1239719-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39442432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Imidazo[4,5-c]pyridine-piperidine Hybrids as Potential Anti-cancer
Agents and In-Silico Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rejinthala, Swathi; Endoori, Srinivas; Thumma, Vishnu; Mondal, T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2024), 9(2), e202303299

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanobenzoyl chloride
C8H4ClNO
6068-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyano-N-methylbenzamide
C9H8N2O
36268-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4701 1.3337 0.0 0
M  V30 6 N 10.0101 1.3337 0.0 0
M  V30 7 C 3.8500 1.3337 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 4.6201 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.1601 2.6673 0.0 0
M  V30 12 C 6.9301 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6068-72-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 36268-62-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-984323
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 4-cyano-N-methylbenzamide 1m. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloroquinazoline
C8H4Cl2N2
607-68-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 0.0000 0.0 0
M  V30 2 Cl 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 N 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-4-quinazolinamine
C9H8ClN3
83260-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 5.3349 0.0 0
M  V30 2 C 6.9300 5.3349 0.0 0
M  V30 3 Cl 5.3900 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 N 3.0800 1.3338 0.0 0
M  V30 9 C 0.7700 2.6674 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 607-68-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83260-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15747192
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, biological evaluation, and physicochemical property assessment
of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Sheng-Biao; Cui, Mu-Tian; Wang, Xiao-Feng; Ohkoshi, Emika; Goto,
Masuo; Yang, De-Xuan; Li, Linna; Yuan, Shoujun; Morris-Natschke, Susan
L.; Lee, Kuo-Hsiung; Xie, Lan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2016), 24(13), 3083-3092

$RFMT $RIREG SCHEME217 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzoyl chloride
C7H4Cl2O
609-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 Cl 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 Cl 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methylbenzamide
C8H8ClNO
3400-31-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 Cl 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 609-65-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-31-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloroquinoline
C9H6ClN
612-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-quinolinamine
C10H10N2
83407-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 612-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83407-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12423507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1148148-01-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE TWENTY-SEVEN: Synthesis of N-methylquinolin-6-amine (Figure 11,
Table 7, entry 4) Following general procedure A, a mixture of
6-chloroquinoline (164 mg, 1.0 mmol), 2M methylamine (1 mL, 2.0 mmol),
NaO t-Bu (120 mg, 1.2 mmol), BrettPhos precatalyst 10 (8 mg, 0.01 mmol),
and E-BuOH (1 mL) was stirred at room temperature for 17 h. The crude
product was purified via column chromatography (99:1 to 97:3 CH2Cl2/MeOH
gradient) to provide the title compound as a yellow oil (150 mg, 95%).
N-methylquinolin-6-amine, yield (150 mg, 95%) 1H NMR (400 MHz, CDCl3) δ:
8.62 (dd, J = 4.2, 1.7 Hz, 1H), 7.94 (d, J = 8.3 Hz, 1H), 7.88 (d, J =
9.1 Hz, 1H), 7.26 (dd, J = 8.3, 4.2 Hz, 1H), 7.09 (dd, J = 9.1, 2.6 Hz,
1H), 6.68 (d, J = 2.6 Hz, 1H), 4.19 (bs, 1H), 2.93 (s, 3H) ppm. 13C NMR
(75 MHz, CDCl3) δ: 147.4, 146.1, 143.3, 133.9, 130.3, 130.2, 121.5,
102.4, 30.8 ppm.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligands for transition-metal-catalyzed cross-couplings, and methods of
use thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buchwald, Stephen L.; Fors, Brett P.; Surry, David S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009076622 A2 2009-06-18

$RFMT $RIREG SCHEME218 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloroquinoline
C9H6ClN
612-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 N 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-quinolinamine
C10H10N2
83407-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 N 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 612-57-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 83407-38-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5865097
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1070663-78-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1070663-84-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Procedure B: An oven-dried test tube, which
was equipped with a magnetic stir bar and fitted with a teflon septum,
was charged with the precatalyst (0.01 equiv.) and NaOt-Bu (120 mg, 1.2
mmol). The vessel was evacuated and backfilled with argon (this process
was repeated a total of 3 times) and then the aryl chloride (1.0 mmol),
2M methylamine solution in THF (1 mL, 2.0 mmol), and t-BuOH (1mL) were
added in succession via syringe (aryl chlorides that were solids at room
temperature were added with the precatalyst and base). The solution was
allowed to stir at room temperature until starting aryl chloride was
completely consumed as monitored by GC. The reaction mixture was then
diluted with ethyl acetate, washed with aqueous NH4Cl, dried over Na2SO4,
concentrated in vacuo, and purified via column chromatography on silica
gel. N-methylquinolin-6-amine. (RT, 1% Pd): Following general procedure
B, a mixture of 6-chloroquinoline (164 mg, 1.0 mmol), 2M methylamine (1
mL, 2.0 mmol), NaOt-Bu (120 mg, 1.2 mmol), BrettPhos precatalyst (8 mg,
0.01 mmol), and t-BuOH (1 mL) was stirred at room temperature for 17 h.
The crude product was purified via column chromatography (99:1 to 97:3
CH2Cl2/MeOH gradient) to provide the title compound as a viscous yellow
oil (150 mg, 95%). 1H NMR (400 MHz, CDCl3) δ: 8.62 (dd, J = 4.2, 1.7 Hz,
1H), 7.94 (d, J = 8.3 Hz, 1H), 7.88 (d, J = 9.1 Hz, 1H), 7.26 (dd, J =
8.3, 4.2 Hz, 1H), 7.09 (dd, J = 9.1, 2.6 Hz, 1H), 6.68 (d, J = 2.6 Hz,
1H), 4.19 (bs, 1H), 2.93 (s, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ: 147.4,
146.1, 143.3, 133.9, 130.3, 130.2, 121.5, 102.4, 30.8 ppm.
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Highly Active Catalyst for Pd-Catalyzed Amination Reactions:
Cross-Coupling Reactions Using Aryl Mesylates and the Highly Selective
Monoarylation of Primary Amines Using Aryl Chlorides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fors, Brett P.; Watson, Donald A.; Biscoe, Mark R.; Buchwald, Stephen L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(41), 13552-13554

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl itaconate
C7H10O4
617-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 6.6684 2.3100 0.0 0
M  V30 6 O 1.3337 2.3100 0.0 0
M  V30 7 O 2.6675 0.0000 0.0 0
M  V30 8 O 8.0022 1.5400 0.0 0
M  V30 9 O 6.6684 3.8500 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 9.3359 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-4-methoxycarbonyl-2-pyrrolidone
C7H11NO3
59857-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 O 6.6363 3.2587 0.0 0
M  V30 3 O 5.3026 5.5688 0.0 0
M  V30 4 C 7.9700 4.0287 0.0 0
M  V30 5 O 0.0000 2.9016 0.0 0
M  V30 6 C 1.6751 0.0000 0.0 0
M  V30 7 C 3.9690 3.2587 0.0 0
M  V30 8 C 2.5620 3.8850 0.0 0
M  V30 9 C 3.8079 1.7271 0.0 0
M  V30 10 C 1.5316 2.7406 0.0 0
M  V30 11 N 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 617-52-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59857-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6364846
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrrolo[2,3-d][1,2,3]thiadiazole-6-carboxylates via the
Hurd-Mori reaction. Investigating the effect of the N-protecting group on
the cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stanetty, Peter; Turner, Martin; Mihovilovic, Marko D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2005), 10(2), 367-375

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
620175-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6948 1.4647 0.0 0
M  V30 2 O 4.2189 0.0000 0.0 0
M  V30 3 O 6.6520 4.1156 0.0 0
M  V30 4 C 7.9857 4.8856 0.0 0
M  V30 5 C 0.0000 4.1753 0.0 0
M  V30 6 C 3.9845 4.1156 0.0 0
M  V30 7 C 2.6509 4.8856 0.0 0
M  V30 8 C 3.6644 2.6091 0.0 0
M  V30 9 C 5.3182 4.8856 0.0 0
M  V30 10 N 1.5065 3.8550 0.0 0
M  V30 11 C 2.6509 6.4256 0.0 0
M  V30 12 C 2.1328 2.4482 0.0 0
M  V30 13 C 5.3182 6.4256 0.0 0
M  V30 14 C 3.9845 7.1957 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
620175-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 N 7.1955 4.2189 0.0 0
M  V30 3 C 8.3399 5.2495 0.0 0
M  V30 4 O 3.0801 6.6520 0.0 0
M  V30 5 C 2.3101 7.9857 0.0 0
M  V30 6 C 3.0203 0.0000 0.0 0
M  V30 7 C 3.0801 3.9845 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 4.5864 3.6644 0.0 0
M  V30 10 C 2.3101 5.3182 0.0 0
M  V30 11 N 3.3405 1.5065 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 4.7473 2.1328 0.0 0
M  V30 14 C 0.7700 5.3182 0.0 0
M  V30 15 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-75-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-44651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: c)
1,3-Dimethyl-2-(methylaminomethyl)-1H-indole b)
4-Methoxy-1-methyl-3-(methylaminomethyl)-1H-indole [0750] According to
the procedure of Preparation 13 (c), except substituting
1-methyl-4-methoxy-1H-indole-3-carboxaldehyde for the
1,3-dimethyl-1H-indole-2-carboxaldehyde, the title compound (2.0 g, 95%)
was obtained as a white solid. MS (ES) m/e 205.2 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
620175-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6948 1.4647 0.0 0
M  V30 2 O 4.2189 0.0000 0.0 0
M  V30 3 O 6.6520 4.1156 0.0 0
M  V30 4 C 7.9857 4.8856 0.0 0
M  V30 5 C 0.0000 4.1753 0.0 0
M  V30 6 C 3.9845 4.1156 0.0 0
M  V30 7 C 2.6509 4.8856 0.0 0
M  V30 8 C 3.6644 2.6091 0.0 0
M  V30 9 C 5.3182 4.8856 0.0 0
M  V30 10 N 1.5065 3.8550 0.0 0
M  V30 11 C 2.6509 6.4256 0.0 0
M  V30 12 C 2.1328 2.4482 0.0 0
M  V30 13 C 5.3182 6.4256 0.0 0
M  V30 14 C 3.9845 7.1957 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
620175-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 N 7.1955 4.2189 0.0 0
M  V30 3 C 8.3399 5.2495 0.0 0
M  V30 4 O 3.0801 6.6520 0.0 0
M  V30 5 C 2.3101 7.9857 0.0 0
M  V30 6 C 3.0203 0.0000 0.0 0
M  V30 7 C 3.0801 3.9845 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 4.5864 3.6644 0.0 0
M  V30 10 C 2.3101 5.3182 0.0 0
M  V30 11 N 3.3405 1.5065 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 4.7473 2.1328 0.0 0
M  V30 14 C 0.7700 5.3182 0.0 0
M  V30 15 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-75-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-14427368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004082586 A2 2004-09-30

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-1-methyl-1H-indole-3-carboxaldehyde
C11H11NO2
620175-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6948 1.4647 0.0 0
M  V30 2 O 4.2189 0.0000 0.0 0
M  V30 3 O 6.6520 4.1156 0.0 0
M  V30 4 C 7.9857 4.8856 0.0 0
M  V30 5 C 0.0000 4.1753 0.0 0
M  V30 6 C 3.9845 4.1156 0.0 0
M  V30 7 C 2.6509 4.8856 0.0 0
M  V30 8 C 3.6644 2.6091 0.0 0
M  V30 9 C 5.3182 4.8856 0.0 0
M  V30 10 N 1.5065 3.8550 0.0 0
M  V30 11 C 2.6509 6.4256 0.0 0
M  V30 12 C 2.1328 2.4482 0.0 0
M  V30 13 C 5.3182 6.4256 0.0 0
M  V30 14 C 3.9845 7.1957 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 1 11 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N,1-dimethyl-1H-indole-3-methanamine
C12H16N2O
620175-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 4.6948 0.0 0
M  V30 2 N 7.1955 4.2189 0.0 0
M  V30 3 C 8.3399 5.2495 0.0 0
M  V30 4 O 3.0801 6.6520 0.0 0
M  V30 5 C 2.3101 7.9857 0.0 0
M  V30 6 C 3.0203 0.0000 0.0 0
M  V30 7 C 3.0801 3.9845 0.0 0
M  V30 8 C 2.3101 2.6509 0.0 0
M  V30 9 C 4.5864 3.6644 0.0 0
M  V30 10 C 2.3101 5.3182 0.0 0
M  V30 11 N 3.3405 1.5065 0.0 0
M  V30 12 C 0.7700 2.6509 0.0 0
M  V30 13 C 4.7473 2.1328 0.0 0
M  V30 14 C 0.7700 5.3182 0.0 0
M  V30 15 C 0.0000 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 620175-74-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 620175-75-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12139153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(heteroaryl)methylacrylamides as Fab I inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burgess, Walter J.; Jakas, Dalia; Huffman, William F.; Miller, William
H.; Newlander, Kenneth A.; Seefeld, Mark A.; Uzinskas, Irene N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003088897 A2 2003-10-30

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Phenyl-5-hexyn-2-one
C12H12O
62248-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 6.1601 2.6673 0.0 0
M  V30 3 C 7.7002 2.6673 0.0 0
M  V30 4 C 8.4702 1.3337 0.0 0
M  V30 5 C 10.0102 1.3337 0.0 0
M  V30 6 C 10.7802 0.0000 0.0 0
M  V30 7 O 10.7802 2.6673 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 0.7700 1.3337 0.0 0
M  V30 12 C 0.7700 4.0010 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-6-phenyl-5-hexyn-2-amine
C13H17N
131529-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 6.1601 2.6673 0.0 0
M  V30 3 C 7.7001 2.6673 0.0 0
M  V30 4 C 8.4701 1.3337 0.0 0
M  V30 5 C 10.0101 1.3337 0.0 0
M  V30 6 N 10.7801 0.0000 0.0 0
M  V30 7 C 10.7801 2.6673 0.0 0
M  V30 8 C 12.3201 0.0000 0.0 0
M  V30 9 C 3.0800 2.6673 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 11 C 2.3100 4.0010 0.0 0
M  V30 12 C 0.7700 1.3337 0.0 0
M  V30 13 C 0.7700 4.0010 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 62248-76-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 131529-78-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-6592547
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Na(CN)BH3, MeOH, 25 C, Alkylation, Amination,
C-Amination, Condensation, N-Alkylation, Reduction, Reductive alkylation,
Reductive amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reductive aminations of carbonyl compounds with borohydride and borane
reducing agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baxter, Ellen W.; Reitz, Allen B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Reactions (Hoboken, NJ, United States) (2002), 59No pp. given

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyrimidinecarboxylic acid, 2,6-dichloro-, methyl ester
C6H4Cl2N2O2
6299-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 O 6.6685 3.8500 0.0 0
M  V30 3 O 5.3347 6.1600 0.0 0
M  V30 4 C 8.0021 4.6200 0.0 0
M  V30 5 Cl 0.0000 4.6200 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 C 4.0011 3.8500 0.0 0
M  V30 8 C 2.6674 4.6200 0.0 0
M  V30 9 N 4.0011 2.3100 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 2.6674 1.5400 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyrimidinecarboxylic acid, 2-chloro-6-(methylamino)-, methyl ester
C7H8ClN3O2
1263870-80-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 Cl 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 N 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 N 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 1 7 12
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6299-85-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1263870-80-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14044128
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of pyrimido[4,5-c]azepine- and pyrimido[4,5-c]oxepine-based
γ-secretase modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wu, Yong-Jin; Zhang, Yunhui; Toyn, Jeremy H.; Macor, John E.; Thompson,
Lorin A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2016), 26(6), 1554-1557

$RFMT $RIREG SCHEME223 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodobenzenesulfonyl chloride
C6H4ClIO2S
63059-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 I 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Iodo-N-methylbenzenesulfonamide
C7H8INO2S
125259-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 I 3.0800 0.0000 0.0 0
M  V30 7 C 3.0800 2.6673 0.0 0
M  V30 8 C 2.3100 1.3336 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 0.7700 1.3336 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 5
M  V30 6 1 6 8
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63059-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 125259-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23305866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel isoflavone/benzo-δ-sultam hybrids as potential
anti-inflammatory drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mengheres, Gabriel; Rice, Craig R.; Olajide, Olumayokun A.; Hemming, Karl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2021), 34127761

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-fluoro-β-oxobenzenepropanoate
C10H9FO3
63131-29-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 3.8501 1.3337 0.0 0
M  V30 3 O 3.8501 4.0010 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 O 1.5400 2.6673 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 F 10.7802 2.6673 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.9302 4.0010 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 8.4702 4.0010 0.0 0
M  V30 13 C 8.4702 1.3337 0.0 0
M  V30 14 C 9.2402 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(4-fluorophenyl)-3-(methylamino)-2-propenoate
C11H12FNO2
2304416-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 N 3.8500 1.3338 0.0 0
M  V30 4 C 2.3100 4.0011 0.0 0
M  V30 5 C 4.6200 0.0000 0.0 0
M  V30 6 O 1.5400 5.3349 0.0 0
M  V30 7 O 1.5400 2.6674 0.0 0
M  V30 8 C 0.0000 5.3349 0.0 0
M  V30 9 F 10.7800 2.6674 0.0 0
M  V30 10 C 6.1600 2.6674 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.9300 1.3338 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 8.4700 1.3338 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63131-29-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-13-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(diphenylphosphino)ethyl]-2-formyl-, (1S)-
C25H23FeOP
634919-22-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0254 8.3191 0.0 0
M  V30 2 P 5.7870 7.8801 0.0 0
M  V30 3 C 5.0254 9.1995 0.0 0
M  V30 4 C 2.1368 10.1163 0.0 0
M  V30 5 O 1.3752 10.5553 0.0 0
M  V30 6 Fe 2.1368 4.5985 0.0 0 CHG=2 VAL=10
M  V30 7 C 4.2638 7.8801 0.0 0 CHG=-1 VAL=4
M  V30 8 C 2.1368 9.2359 0.0 0 VAL=5
M  V30 9 C 2.9274 7.1064 0.0 0 VAL=5
M  V30 10 C 0.0485 7.8801 0.0 0 VAL=5
M  V30 11 C 1.3825 7.1064 0.0 0 VAL=5
M  V30 12 C 0.0000 1.3582 0.0 0 CHG=-1 VAL=4
M  V30 13 C 4.2177 1.3582 0.0 0 VAL=5
M  V30 14 C 2.8789 2.1319 0.0 0 VAL=5
M  V30 15 C 1.3315 2.1319 0.0 0 VAL=5
M  V30 16 C 2.0907 0.0000 0.0 0 VAL=5
M  V30 17 C 6.5485 8.3191 0.0 0
M  V30 18 C 6.5485 9.2747 0.0 0
M  V30 19 C 7.3780 7.8437 0.0 0
M  V30 20 C 7.3780 9.7525 0.0 0
M  V30 21 C 8.2027 8.3191 0.0 0
M  V30 22 C 8.2027 9.2747 0.0 0
M  V30 23 C 5.7870 6.9997 0.0 0
M  V30 24 C 4.9575 6.5243 0.0 0
M  V30 25 C 6.6116 6.5243 0.0 0
M  V30 26 C 4.9575 5.5687 0.0 0
M  V30 27 C 6.6116 5.5687 0.0 0
M  V30 28 C 5.7870 5.0909 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 17
M  V30 5 1 2 23
M  V30 6 2 4 5
M  V30 7 1 4 8
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 6 12
M  V30 14 1 6 13
M  V30 15 1 6 14
M  V30 16 1 6 15
M  V30 17 1 6 16
M  V30 18 1 7 8
M  V30 19 1 7 9
M  V30 20 2 8 10
M  V30 21 2 9 11
M  V30 22 1 10 11
M  V30 23 1 12 15
M  V30 24 1 12 16
M  V30 25 1 13 14
M  V30 26 2 13 16
M  V30 27 2 14 15
M  V30 28 2 17 18
M  V30 29 1 17 19
M  V30 30 1 18 20
M  V30 31 2 19 21
M  V30 32 2 20 22
M  V30 33 1 21 22
M  V30 34 2 23 24
M  V30 35 1 23 25
M  V30 36 1 24 26
M  V30 37 2 25 27
M  V30 38 2 26 28
M  V30 39 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, 1-[(1R)-1-(diphenylphosphino)ethyl]-2-[(methylimino)methyl]-, (1S)-
C26H26FeNP
634919-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1765 10.2246 0.0 0
M  V30 2 P 7.1125 9.6851 0.0 0
M  V30 3 C 6.1765 11.3067 0.0 0
M  V30 4 C 2.6262 12.4335 0.0 0
M  V30 5 N 1.6902 12.9731 0.0 0
M  V30 6 C 0.6618 12.3799 0.0 0
M  V30 7 Fe 2.6262 5.6519 0.0 0 CHG=2 VAL=10
M  V30 8 C 5.2405 9.6851 0.0 0 CHG=-1 VAL=4
M  V30 9 C 2.6262 11.3514 0.0 0 VAL=5
M  V30 10 C 3.5980 8.7342 0.0 0 VAL=5
M  V30 11 C 0.0596 9.6851 0.0 0 VAL=5
M  V30 12 C 1.6991 8.7342 0.0 0 VAL=5
M  V30 13 C 0.0000 1.6693 0.0 0 CHG=-1 VAL=4
M  V30 14 C 5.1839 1.6693 0.0 0 VAL=5
M  V30 15 C 3.5384 2.6203 0.0 0 VAL=5
M  V30 16 C 1.6365 2.6203 0.0 0 VAL=5
M  V30 17 C 2.5696 0.0000 0.0 0 VAL=5
M  V30 18 C 8.0486 10.2246 0.0 0
M  V30 19 C 8.0486 11.3991 0.0 0
M  V30 20 C 9.0680 9.6404 0.0 0
M  V30 21 C 9.0680 11.9864 0.0 0
M  V30 22 C 10.0816 10.2246 0.0 0
M  V30 23 C 10.0816 11.3991 0.0 0
M  V30 24 C 7.1125 8.6030 0.0 0
M  V30 25 C 6.0931 8.0187 0.0 0
M  V30 26 C 8.1261 8.0187 0.0 0
M  V30 27 C 6.0931 6.8443 0.0 0
M  V30 28 C 8.1261 6.8443 0.0 0
M  V30 29 C 7.1125 6.2570 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 18
M  V30 5 1 2 24
M  V30 6 2 4 5 CFG=2
M  V30 7 1 4 9
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 7 13
M  V30 15 1 7 14
M  V30 16 1 7 15
M  V30 17 1 7 16
M  V30 18 1 7 17
M  V30 19 1 8 9
M  V30 20 1 8 10
M  V30 21 2 9 11
M  V30 22 2 10 12
M  V30 23 1 11 12
M  V30 24 1 13 16
M  V30 25 1 13 17
M  V30 26 1 14 15
M  V30 27 2 14 17
M  V30 28 2 15 16
M  V30 29 2 18 19
M  V30 30 1 18 20
M  V30 31 1 19 21
M  V30 32 2 20 22
M  V30 33 2 21 23
M  V30 34 1 22 23
M  V30 35 2 24 25
M  V30 36 1 24 26
M  V30 37 1 25 27
M  V30 38 2 26 28
M  V30 39 2 27 29
M  V30 40 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 634919-22-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 634919-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15541550
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (R)-1-[(S)-2-Ferrocenylidenemethylamine]ethyldiphenylphosphine (4ae) A
solution of 3a (0.160 g, 0.346 mmol) and MeNH2 (0.072 mL of a 35% aq
soln, 0.727 mmol) in degassed EtOH (5 mL) was stirred in a sealed flask
at 78 °C for 30 min. The solution was then cooled to r.t. and benzene (2
mL) was added. The solvents were removed in vacuo, affording 4ae. Since
this imine undergoes fast hydrolysis on either alumina or silica gel, it
was used without any further purification Dark-orange colour, yield 0.148
g, >95% (estimated yield). 1H NMR (400 MHz, 294 K, CDCl3, selected data):
δ = 7.47 (s, 1 H, HC=N), 4.64 (m, 1 H, HCp), 4.36 (t, JHH = 2.5 Hz, 1 H,
HCp), 4.29 (m, 1 H, HCp), 4.14 (s, 5 H, HCp'), 3.55 (quin, JHH = JHP =
6.0 Hz, 1 H, HCMe), 2.98 (s, 3 H, NMe), 1.61 (dd, JHH = 7.0 Hz, JHP =
14.7 Hz, 3 H, HCCH3). 13C{1H} NMR (100.61 MHz, 294 K, CDCl3, selected
data): δ = 159.81 (s, C=N), 68.89 (s, HCp), 68.82 (s, HCp), 65.87 (s,
HCp), 69.29 (s, Cp'), 29.77 (d, JCP = 16.5 Hz, HCMe), 48.10 (s, NMe),
18.59 (d, JCP = 19.8 Hz, HCCH3). 31P{1H} NMR (161.98 MHz, 294 K, CDCl3):
δ = 11.02 (s).
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Large-scale synthesis of chiral ferrocenyl imino-phosphines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barbaro, Pierluigi; Bianchini, Claudio; Giambastiani, Giuliano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2005), (14), 2445-2448

$RFMT $RIREG SCHEME226 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-2(1H)-quinoxalinone
C10H10N2O
63536-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 3.8501 2.6673 0.0 0
M  V30 5 C 4.6201 1.3337 0.0 0
M  V30 6 N 2.3101 2.6673 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 3.8501 0.0000 0.0 0
M  V30 9 C 6.1601 1.3337 0.0 0
M  V30 10 C 1.5400 1.3337 0.0 0
M  V30 11 C 6.1601 4.0010 0.0 0
M  V30 12 C 2.3101 0.0000 0.0 0
M  V30 13 C 6.9302 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-3-(methylamino)-2(1H)-quinoxalinone
C11H13N3O
586348-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 5.3901 1.3338 0.0 0
M  V30 4 N 6.9301 4.0011 0.0 0
M  V30 5 C 7.7001 5.3348 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 3.0800 5.3348 0.0 0
M  V30 8 N 3.0800 2.6675 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 N 4.6201 5.3348 0.0 0
M  V30 11 C 2.3100 6.6686 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 C 0.0000 5.3348 0.0 0
M  V30 14 C 5.3901 4.0011 0.0 0
M  V30 15 C 0.7700 6.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63536-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 586348-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39944656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, 30 W purple LED used, reaction conducted
in the presence of air, sealed vial used, scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoinduced Dehydrogenative Amination of Quinoxalin-2(1H)-ones with Air
as an Oxidant
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiao, Haoran; Jing, Yue; Niu, Kaikai; Song, Hongjian; Liu, Yuxiu; Wang,
Qingmin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(8), 5371-5381

$RFMT $RIREG SCHEME227 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chlorosalicylaldehyde
C7H5ClO2
635-93-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 Cl 6.1600 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 1.5400 4.0011 0.0 0
M  V30 7 C 3.8500 2.6674 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-[(methylimino)methyl]phenol
C8H8ClNO
49649-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 N 5.3900 4.0011 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 Cl 0.0000 5.3349 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 1.3338 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3338 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 7
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 635-93-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 49649-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27641428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lithium Half-Salen Complexes: Synthesis, Structural Characterization and
Studies as Catalysts for rac-Lactide Ring-Opening Polymerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Yali; Nichol, Gary S.; Garden, Jennifer A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(40), 5557-5568

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl azidoacetate
C4H7N3O2
637-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 2.6675 2.3101 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 N 8.0023 2.3101 0.0 0 CHG=1 VAL=4
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 N 9.3360 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Azido-N-methylacetamide
C3H6N4O
98025-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 N 6.6687 2.3101 0.0 0 CHG=1 VAL=4
M  V30 8 N 8.0023 3.0801 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 5 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 637-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98025-59-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31494451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Synthesis of 3-Alkyl-2-thiohydantoins from Azidoacetamides and
Carbon Disulfide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sokolov, Anatolii I.; Mikhaylov, Andrey A.; Baleeva, Nadezhda S.;
Baranov, Mikhail S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2022), 7(7), e202104565

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Chloro-4-iodobenzene
C6H4ClI
637-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 1.3337 0.0 0
M  V30 2 I 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylbenzenamine
C7H8ClN
932-96-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 637-87-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 932-96-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9557394
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, oxime catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
1H-Indole-3-carboxylic acid, 1-ethyl-6-methoxy-2-methyl-
C13H15NO3
638218-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1752 1.0304 0.0 0
M  V30 2 C 3.0307 0.0000 0.0 0
M  V30 3 C 1.4647 5.7252 0.0 0
M  V30 4 O 1.7848 7.2315 0.0 0
M  V30 5 O 0.0000 5.2492 0.0 0
M  V30 6 C 1.1145 2.3931 0.0 0
M  V30 7 O 8.7354 5.0148 0.0 0
M  V30 8 C 9.5054 6.3486 0.0 0
M  V30 9 C 4.8855 3.6812 0.0 0
M  V30 10 C 4.1155 5.0148 0.0 0
M  V30 11 N 3.8549 2.5368 0.0 0
M  V30 12 C 6.4255 3.6812 0.0 0
M  V30 13 C 2.6091 4.6947 0.0 0
M  V30 14 C 4.8855 6.3486 0.0 0
M  V30 15 C 2.4481 3.1631 0.0 0
M  V30 16 C 7.1954 5.0148 0.0 0
M  V30 17 C 6.4255 6.3486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 2 13 15
M  V30 17 1 14 17
M  V30 18 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Indole-3-carboxamide, 1-ethyl-6-methoxy-N,2-dimethyl-
C14H18N2O2
638218-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 5.7253 0.0 0
M  V30 2 N 1.1444 5.2492 0.0 0
M  V30 3 O 2.9292 7.2315 0.0 0
M  V30 4 C 0.0000 6.2798 0.0 0
M  V30 5 C 5.3195 1.0304 0.0 0
M  V30 6 C 4.1751 0.0000 0.0 0
M  V30 7 C 2.2587 2.3932 0.0 0
M  V30 8 O 9.8797 5.0149 0.0 0
M  V30 9 C 10.6497 6.3486 0.0 0
M  V30 10 C 5.2597 5.0149 0.0 0
M  V30 11 C 6.0297 3.6812 0.0 0
M  V30 12 C 3.7534 4.6947 0.0 0
M  V30 13 C 6.0297 6.3486 0.0 0
M  V30 14 N 4.9993 2.5368 0.0 0
M  V30 15 C 7.5697 3.6812 0.0 0
M  V30 16 C 3.5925 3.1632 0.0 0
M  V30 17 C 7.5697 6.3486 0.0 0
M  V30 18 C 8.3397 5.0149 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 16
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 1 15 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 638218-25-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 638218-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1410062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzofused heteroaryl amide derivatives of thienopyridines
as tyrosine kinase inhibitors useful against hyperproliferative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Romines, William Henry, III; Kania, Robert Steven; Lou, Jihong; Collins,
Michael Raymond; Cripps, Stephan James; He, Mingying; Zhou, Ru; Palmer,
Cynthia Louise; Deal, Judith Gail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003106462 A1 2003-12-24

$RFMT $RIREG SCHEME231 STEP1
$RXN



  3  1
$MOL
L-Phenylalanine
C9H11NO2
63-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.0800 0.0 0
M  V30 2 C 2.6674 4.6200 0.0 0 CFG=2
M  V30 3 C 1.3338 5.3900 0.0 0
M  V30 4 N 4.0011 5.3900 0.0 0
M  V30 5 O 0.0000 4.6200 0.0 0
M  V30 6 O 1.3338 6.9300 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 5.3347 3.0800 0.0 0
M  V30 10 C 5.3347 0.0000 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[[3-Chloro-4-(1-methylethoxy)benzoyl]amino]-N-methylbenzenepropanamide
C20H23ClN2O3
1208245-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 N 4.6200 5.3347 0.0 0
M  V30 3 O 4.6200 8.0021 0.0 0
M  V30 4 C 3.0800 5.3347 0.0 0 CFG=2
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 6.6684 0.0 0
M  V30 7 N 0.7700 6.6684 0.0 0
M  V30 8 O 3.0800 8.0021 0.0 0
M  V30 9 C 0.0000 8.0021 0.0 0
M  V30 10 Cl 10.0100 9.3358 0.0 0
M  V30 11 O 11.5500 6.6684 0.0 0
M  V30 12 C 12.3200 5.3347 0.0 0
M  V30 13 C 13.8600 5.3347 0.0 0
M  V30 14 C 11.5500 4.0011 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.0100 6.6684 0.0 0
M  V30 21 C 3.0800 2.6674 0.0 0
M  V30 22 C 4.6200 2.6674 0.0 0
M  V30 23 C 2.3100 1.3336 0.0 0
M  V30 24 C 5.3900 1.3336 0.0 0
M  V30 25 C 3.0800 0.0000 0.0 0
M  V30 26 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 21
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 10 18
M  V30 12 1 11 12
M  V30 13 1 11 20
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 63-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-520242
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 3 in DMF (0.2 M) were added
amino acid (1.2 equiv.) and N, N-diisopropylethylamine (3 equiv.). The
reaction was monitored by LC/MS. After completion, amine (1.5 equiv.) and
HBTU (1.5 equiv.) were added to the reaction solution. The reaction
mixture was stirred for 4 h. The product was purified by either HPLC or
flash column chromatography. 3a – 3i (60-95% yield).
3-Chloro-4-isopropoxy-N-(1-(methylamino)-1-oxo-3-phenylpropan-2-yl)benzamide
(3g) 1H NMR (400 MHz, MeOD) δ 7.80 (d, J = 2.2, 1H), 7.66 (dd, J = 2.2,
8.7, 1H), 7.29 – 7.24 (m, 4H), 7.22 – 7.17 (m, 1H), 7.10 (d, J = 8.7,
1H), 4.72 (m, 2H), 3.21 (dd, J = 6.2, 13.7, 1H), 3.01 (dd, J = 9.1, 13.7,
1H), 2.69 (s, 3H), 1.36 (d, J = 6.0, 6H); LRMS (M+H+) m/z 375.0.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Dioctylamino)benzaldehyde
C23H39NO
640773-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 6.6684 0.0 0
M  V30 2 C 10.7800 6.6684 0.0 0
M  V30 3 C 8.4700 8.0020 0.0 0
M  V30 4 C 11.5500 8.0020 0.0 0
M  V30 5 C 6.9300 8.0020 0.0 0
M  V30 6 C 13.0900 8.0020 0.0 0
M  V30 7 C 6.1600 9.3358 0.0 0
M  V30 8 C 13.8600 9.3358 0.0 0
M  V30 9 C 4.6200 9.3358 0.0 0
M  V30 10 C 15.4000 9.3358 0.0 0
M  V30 11 C 3.8500 10.6694 0.0 0
M  V30 12 C 16.1700 10.6694 0.0 0
M  V30 13 C 2.3100 10.6694 0.0 0
M  V30 14 C 17.7100 10.6694 0.0 0
M  V30 15 C 1.5400 12.0031 0.0 0
M  V30 16 C 18.4800 12.0031 0.0 0
M  V30 17 C 0.0000 12.0031 0.0 0
M  V30 18 C 6.1600 1.3336 0.0 0
M  V30 19 O 6.9300 0.0000 0.0 0
M  V30 20 C 8.4700 5.3347 0.0 0
M  V30 21 C 9.2400 4.0011 0.0 0
M  V30 22 C 6.9300 5.3347 0.0 0
M  V30 23 C 8.4700 2.6673 0.0 0
M  V30 24 C 6.1600 4.0011 0.0 0
M  V30 25 C 6.9300 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 18 19
M  V30 19 1 18 25
M  V30 20 2 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 2 22 24
M  V30 24 2 23 25
M  V30 25 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(Methylimino)methyl]-N,N-dioctylbenzenamine
C24H42N2
1512863-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.2400 8.0020 0.0 0
M  V30 2 C 10.7800 8.0020 0.0 0
M  V30 3 C 8.4700 9.3358 0.0 0
M  V30 4 C 11.5500 9.3358 0.0 0
M  V30 5 C 6.9300 9.3358 0.0 0
M  V30 6 C 13.0900 9.3358 0.0 0
M  V30 7 C 6.1600 10.6694 0.0 0
M  V30 8 C 13.8600 10.6694 0.0 0
M  V30 9 C 4.6200 10.6694 0.0 0
M  V30 10 C 15.4000 10.6694 0.0 0
M  V30 11 C 3.8500 12.0031 0.0 0
M  V30 12 C 16.1700 12.0031 0.0 0
M  V30 13 C 2.3100 12.0031 0.0 0
M  V30 14 C 17.7100 12.0031 0.0 0
M  V30 15 C 1.5400 13.3367 0.0 0
M  V30 16 C 18.4800 13.3367 0.0 0
M  V30 17 C 0.0000 13.3367 0.0 0
M  V30 18 C 6.1600 2.6673 0.0 0
M  V30 19 N 6.9300 1.3336 0.0 0
M  V30 20 C 6.1600 0.0000 0.0 0
M  V30 21 C 8.4700 6.6684 0.0 0
M  V30 22 C 6.9300 6.6684 0.0 0
M  V30 23 C 9.2400 5.3347 0.0 0
M  V30 24 C 6.1600 5.3347 0.0 0
M  V30 25 C 8.4700 4.0009 0.0 0
M  V30 26 C 6.9300 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 18 19 CFG=2
M  V30 19 1 18 26
M  V30 20 1 19 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 640773-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512863-12-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9917104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aggregation-induced emission of GFP-like chromophores via exclusion of
solvent-solute hydrogen bonding
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tou, Sio-Lon; Huang, Guan-Jhih; Chen, Po-Cheng; Chang, Huan-Tsung; Tsai,
Jun-Yun; Yang, Jye-Shane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(5),
620-622

$RFMT $RIREG SCHEME233 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phthalaldehyde
C8H6O2
643-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 4.0010 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.8501 2.6673 0.0 0
M  V30 7 C 1.5400 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 2.3101 0.0000 0.0 0
M  V30 10 C 3.8501 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl bromopyruvate
C5H7BrO3
70-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6675 2.3100 0.0 0
M  V30 3 O 5.3348 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 O 2.6675 3.8500 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 8 Br 0.0000 2.3100 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl 3,4,6-trimethyl 4a-methoxy-4aH,13bH-benzo[a]pyrano[4,3-h]quinolizine-...
C26H25NO10
2624254-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.3947 4.0011 0.0 0
M  V30 2 C 9.9347 4.0011 0.0 0
M  V30 3 C 7.6247 2.6673 0.0 0
M  V30 4 O 6.8546 1.3337 0.0 0
M  V30 5 O 9.1647 2.6673 0.0 0
M  V30 6 C 7.6247 0.0000 0.0 0
M  V30 7 C 4.0530 7.5518 0.0 0
M  V30 8 O 2.6573 6.9010 0.0 0
M  V30 9 O 4.1873 9.0860 0.0 0
M  V30 10 C 1.3957 7.7842 0.0 0
M  V30 11 C 0.0000 7.1334 0.0 0
M  V30 12 C 4.5446 2.6673 0.0 0
M  V30 13 O 3.0046 2.6673 0.0 0
M  V30 14 O 5.3146 1.3337 0.0 0
M  V30 15 C 2.2346 1.3337 0.0 0
M  V30 16 C 11.4747 6.6685 0.0 0
M  V30 17 O 12.2447 8.0021 0.0 0
M  V30 18 O 12.2447 5.3348 0.0 0
M  V30 19 C 13.7847 8.0021 0.0 0
M  V30 20 C 7.6247 5.3348 0.0 0
M  V30 21 C 6.8546 6.6685 0.0 0
M  V30 22 C 6.8546 4.0011 0.0 0
M  V30 23 C 9.1647 5.3348 0.0 0
M  V30 24 C 7.6247 8.0021 0.0 0
M  V30 25 C 5.3146 6.6685 0.0 0
M  V30 26 C 5.3146 4.0011 0.0 0
M  V30 27 C 9.9347 6.6685 0.0 0
M  V30 28 N 9.1647 8.0021 0.0 0
M  V30 29 C 6.8546 9.3359 0.0 0
M  V30 30 O 4.5446 5.3348 0.0 0
M  V30 31 C 9.9347 9.3359 0.0 0
M  V30 32 C 7.6247 10.6696 0.0 0
M  V30 33 C 5.3146 9.3359 0.0 0
M  V30 34 C 9.1647 10.6696 0.0 0
M  V30 35 C 6.8546 12.0032 0.0 0
M  V30 36 C 4.5446 10.6696 0.0 0
M  V30 37 C 5.3146 12.0032 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 22
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 25
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 26
M  V30 15 1 13 15
M  V30 16 1 16 17
M  V30 17 2 16 18
M  V30 18 1 16 27
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 1 21 24
M  V30 24 2 21 25
M  V30 25 2 22 26
M  V30 26 2 23 27
M  V30 27 1 24 28
M  V30 28 1 24 29
M  V30 29 1 25 30
M  V30 30 1 26 30
M  V30 31 1 27 28
M  V30 32 1 28 31
M  V30 33 1 29 32
M  V30 34 2 29 33
M  V30 35 2 31 34
M  V30 36 1 32 34
M  V30 37 2 32 35
M  V30 38 1 33 36
M  V30 39 1 35 37
M  V30 40 2 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 643-79-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 70-23-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2624254-45-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29038119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 603-35-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, phosphonium salt prepared in stage 3 was
added in stage 4 to isoquinolinium intermediate prepared in stages 1-2,
alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ultrasound-promoted Green Synthesis of Pyrido[2,1-a]isoquinoline
Derivatives and Studies on their Antioxidant Activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharafian, Shirin; Hossaini, Zinatossadat; Rostami-Charati, Faramarz;
Khalilzadeh, Mohammad A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2021), 24(1),
119-128

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate
C16H15ClO5
644971-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]-N-methylbenzamide
C16H16ClNO4
1003567-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 644971-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003567-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1759281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 7: 5-Chloro-2-hydroxy-4-(4-methoxybenzyloxy)-N-methylbenzamide An
aqueous solution of methylamine (40% w/w, 500 ml) was added to a stirred
suspension of 5-chloro-2-hydroxy-4-(4-methoxybenzyloxy)benzoic acid
methyl ester (100 g, 0.31 moles) in THF (500 ml). The mixture was heated
to 50 - 56 °C and the resulting clear solution held at this temperature
for 4 h, then cooled to ambient temperature and stirred overnight.
Solvent was distilled off under reduced pressure until 600 ml had been
removed, maintaining a roughly constant reaction volume by the dropwise
addition of water (600 ml). The temperature of the reaction mixture
increased from 22 °C to 47 °C during the course of the distillation. The
resulting suspension was cooled to 5 °C and stirred for 30 min. The
product was collected by filtration and dried under vacuum at 50 °C to
leave 5-chloro-2-hydroxy-4-(4-methoxybenzyloxy)-N-methylbenzamide as a
solid (94.6 g, 95% yield). 1H NMR (399.826 MHz, D6-DMSO) δ 8.93 (br s,
1H), 7.93 (s, 1H), 7.39 (d, J = 9.5 Hz, 2H), 6.96 (d, J = 9.5 Hz, 2H),
6.69 (s, 1H), 5.11 (s, 2H), 3.76 (s, 3H), 2.78 (s, 3H) APCI-MS: m/z
322/324 (MH+)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A process for the preparation of intermediates and their use in the
synthesis of spiropiperidine compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cooper, Martin; Elkins, Barry; Gibson, Scott; Gu, Eric; Hassall, Ian;
Hemmerling, Martin; Ivanova, Svetlana; Josefsson, Bo-Goeran;
Mensonides-Harsema, Marguerite; Merifield, Eric; Pavey, John; Rogers,
Mike; Zhengyu, Wang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009011653 A1 2009-01-22

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate
C16H15ClO5
644971-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]-N-methylbenzamide
C16H16ClNO4
1003567-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 644971-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003567-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11894411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 7: 5-Chloro-2-hydroxy-4-(4-methoxybenzyloxy)-N-methylbenzamide An
aqueous solution of methylamine (40% w/w, 500 ml) was added to a stirred
suspension of 5-chloro-2-hydroxy-4-(4-methoxybenzyloxy)benzoic acid
methyl ester (100 g, 0.31 moles) in THF (500 ml). The mixture was heated
to 50-56 °C and the resulting clear solution held at this temperature for
4 h, then cooled to ambient temperature and stirred overnight. Solvent
was distilled off under reduced pressure until 600 ml had been removed,
maintaining a roughly constant reaction volume by the dropwise addition
of water (600 ml). The temperature of the reaction mixture increased from
22 °C to 47 °C during the course of the distillation. The resulting
suspension was cooled to 5 °C and stirred for 30 min. The product was
collected by filtration and dried under vacuum at 50 °C to leave
5-chloro-2-hydroxy-4-(4-methoxybenzyloxy)-N-methylbenzamide as a solid
(94.6 g, 95% yield). 1H NMR (399.826 MHz, D6-DMSO) δ 8.93 (br s, 1H),
7.93 (s, 1H), 7.39 (d, J = 9.5 Hz, 2H), 6.96 (d, J = 9.5 Hz, 2H), 6.69
(s, 1H), 5.11 (s, 2H), 3.76 (s, 3H), 2.78 (s, 3H) APCI-MS: m/z 322/324
(MH+)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Spiropiperidine derivatives as CCR1 receptor inhibitors and processes of
their preparation, pharmaceutical compositions containing them, and their
use in the treatment of airway and inflammatory diseases, COPD and asthma
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hemmerling, Martin; Ivanova, Svetlana; Mensonides-Harsema, Marguerite;
Schulz, Haakan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009011655 A1 2009-01-22

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]benzoate
C16H15ClO5
644971-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 O 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Chloro-2-hydroxy-4-[(4-methoxyphenyl)methoxy]-N-methylbenzamide
C16H16ClNO4
1003567-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 4.0011 0.0 0
M  V30 3 Cl 6.9300 0.0000 0.0 0
M  V30 4 O 3.8500 5.3349 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 N 1.5400 1.3338 0.0 0
M  V30 7 O 1.5400 4.0011 0.0 0
M  V30 8 C 0.0000 1.3338 0.0 0
M  V30 9 O 15.4000 4.0011 0.0 0
M  V30 10 C 16.1700 5.3349 0.0 0
M  V30 11 C 6.9300 2.6674 0.0 0
M  V30 12 C 6.1600 1.3338 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 4.6200 4.0011 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3349 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3349 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 1 3 12
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 16
M  V30 9 1 6 8
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 644971-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1003567-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2328963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 7: 5-Chloro-2-hydroxy-4-(4-methoxybenzyloxy)-N-methylbenzamide An
aqueous solution of methylamine (40% w/w, 500 ml) was added to a stirred
suspension of 5-chloro-2-hydroxy-4-(4-methoxybenzyloxy)benzoic acid
methyl ester (100 g, 0.31 moles) in THF (500 ml). The mixture was heated
to 50 - 56°C and the resulting clear solution held at this temperature
for 4 h, then cooled to ambient temperature and stirred overnight.
Solvent was distilled off under reduced pressure until 600 ml had been
removed, maintaining a roughly constant reaction volume by the dropwise
addition of water (600 ml). The temperature of the reaction mixture
increased from 22 °C to 47°C during the course of the distillation. The
resulting suspension was cooled to 5°C and stirred for 30 min. The
product was collected by filtration and dried under vacuum at 50 °C to
leave 5-chloro-2-hydroxy-4-(4-methoxybenzyloxy)-N-methylbenzamide as a
solid (94.6 g, 95% yield). 1H NMR (399.826 MHz, D6-DMSO) δ 8.93 (br s,
1H), 7.93 (s, 1H), 7.39 (d, J = 9.5 Hz, 2H), 6.96 (d, J = 9.5 Hz, 2H),
6.69 (s, 1H), 5.11 (s, 2H), 3.76 (s, 3H), 2.78 (s, 3H) APCI-MS: m/z
322/324 (MH+)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spirobenzofuranpiperidines as modulators of chemokine CCR1
receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Elkins, Barry; Ennis, David; Eriksson, Tomas; Gibson, Scott; Gu, Eric;
Hassall, Ian; Hemmerling, Martin; Josefsson, Bo-Goeran; Ivanova,
Svetlana; Kavitake, Santosh; Kumar, Sythana Suresh; Kumar, Vinod;
Lingesha, Sidda; Mensonides-Harsema, Marguerite; Merifield, Eric; Mo,
John; Pavey, John; Pimm, Austen; Reuberson, James; Rogers, Mike; Schulz,
Haakan; Strandberg, Per; Wang, Zhengyu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008010765 A1 2008-01-24

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
6,7-Dichloro-5,8-quinolinedione
C9H3Cl2NO2
6541-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 N 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Chloro-6-(methylamino)-5,8-quinolinedione
C10H7ClN2O2
35682-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 Cl 6.6685 1.5400 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 4.6200 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 N 1.3336 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6541-19-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35682-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3742543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7791-20-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The anti-cancer, anti-inflammatory and tuberculostatic activities of a
series of 6,7-substituted-5,8-quinolinequinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mulchin, Benjamin J.; Newton, Christopher G.; Baty, James W.; Grasso,
Carole H.; Martin, William John; Walton, Michaela C.; Dangerfield, Emma
M.; Plunkett, Catherine H.; Berridge, Michael V.; Harper, Jacquie L.;
Timmer, Mattie S. M.; Stocker, Bridget L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2010), 18(9), 3238-3251

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Chloro-2,3-dihydro-1,4-dioxino[2,3-f]quinoline-9-carboxaldehyde
C12H8ClNO3
681441-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 1.3338 0.0 0
M  V30 2 O 6.9300 0.0000 0.0 0
M  V30 3 Cl 9.2400 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 5.3900 5.3347 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 O 2.3100 2.6674 0.0 0
M  V30 10 C 4.6200 6.6685 0.0 0
M  V30 11 N 6.9300 5.3347 0.0 0
M  V30 12 C 6.9300 2.6674 0.0 0
M  V30 13 C 3.0800 6.6685 0.0 0
M  V30 14 O 0.7700 5.3347 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 3 16
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 13
M  V30 16 2 11 16
M  V30 17 1 12 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-8-(methylamino)-1,4-dioxino[2,3-f]quinoline-9-carboxaldehyde
C13H12N2O3
681441-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 1.3338 0.0 0
M  V30 2 O 6.9301 0.0000 0.0 0
M  V30 3 N 9.2401 4.0011 0.0 0
M  V30 4 C 10.0101 5.3348 0.0 0
M  V30 5 C 4.6201 4.0011 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 5.3901 5.3348 0.0 0
M  V30 8 C 5.3901 2.6675 0.0 0
M  V30 9 C 2.3100 5.3348 0.0 0
M  V30 10 O 2.3100 2.6675 0.0 0
M  V30 11 N 6.9301 5.3348 0.0 0
M  V30 12 C 4.6201 6.6686 0.0 0
M  V30 13 C 6.9301 2.6675 0.0 0
M  V30 14 C 3.0800 6.6686 0.0 0
M  V30 15 O 0.7700 5.3348 0.0 0
M  V30 16 C 0.7700 2.6675 0.0 0
M  V30 17 C 7.7001 4.0011 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 13
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 2 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 2 11 17
M  V30 17 1 12 14
M  V30 18 1 13 17
M  V30 19 1 15 18
M  V30 20 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 681441-48-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 681441-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10127554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of novel 2,3-dihydro-1,4-dioxino[2,3-g]quinoline derivatives as
potential antitumor agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vazquez, M. T.; Romero, M.; Pujol, M. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(5), 949-956

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Methoxyphenyl)acetyl chloride
C9H9ClO2
6834-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 O 1.3337 0.7700 0.0 0
M  V30 5 O 8.0023 3.0801 0.0 0
M  V30 6 C 9.3360 2.3101 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxy-N-methylbenzeneacetamide
C10H13NO2
53102-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 O 1.3337 3.0801 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6834-42-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53102-68-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10265935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biocatalytic Enantioselective Oxidative C-C Coupling by Aerobic C-H
Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schrittwieser, Joerg H.; Resch, Verena; Sattler, Johann H.; Lienhart,
Wolf-Dieter; Durchschein, Katharina; Winkler, Andreas; Gruber, Karl;
Macheroux, Peter; Kroutil, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2011), 50(5), 1068-1071,
S1068/1-S1068/144

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Benzodioxole-5-acetyl chloride
C9H7ClO3
6845-81-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 Cl 7.7047 0.7700 0.0 0
M  V30 4 O 9.0383 3.0800 0.0 0
M  V30 5 C 2.3699 2.3100 0.0 0
M  V30 6 C 2.3699 0.7700 0.0 0
M  V30 7 C 3.7036 3.0800 0.0 0
M  V30 8 O 0.9052 2.7859 0.0 0
M  V30 9 C 3.7036 0.0000 0.0 0
M  V30 10 O 0.9052 0.2941 0.0 0
M  V30 11 C 5.0372 2.3100 0.0 0
M  V30 12 C 0.0000 1.5400 0.0 0
M  V30 13 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1,3-benzodioxole-5-acetamide
C10H11NO3
127901-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 C 7.7045 2.3100 0.0 0
M  V30 3 N 9.0383 3.0800 0.0 0
M  V30 4 O 7.7045 0.7700 0.0 0
M  V30 5 C 10.3720 2.3100 0.0 0
M  V30 6 C 2.3698 2.3100 0.0 0
M  V30 7 C 2.3698 0.7700 0.0 0
M  V30 8 C 3.7036 3.0800 0.0 0
M  V30 9 O 0.9052 2.7859 0.0 0
M  V30 10 C 3.7036 0.0000 0.0 0
M  V30 11 O 0.9052 0.2941 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 1.5400 0.0 0
M  V30 14 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6845-81-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 127901-41-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-13005132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biocatalytic Enantioselective Oxidative C-C Coupling by Aerobic C-H
Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schrittwieser, Joerg H.; Resch, Verena; Sattler, Johann H.; Lienhart,
Wolf-Dieter; Durchschein, Katharina; Winkler, Andreas; Gruber, Karl;
Macheroux, Peter; Kroutil, Wolfgang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2011), 50(5), 1068-1071,
S1068/1-S1068/144

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Amonafide
C16H17N3O2
69408-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 O 8.0022 2.3101 0.0 0
M  V30 3 C 8.0022 5.3901 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 10.6697 5.3901 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 C 10.6697 6.9302 0.0 0
M  V30 8 N 0.0000 5.3901 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 N 6.6685 4.6201 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 15
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 20
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 19
M  V30 21 1 16 21
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-(Dimethylamino)ethyl]-10-methylbenzo[de][1,2,3]triazolo[4,5-g]isoquinoli...
C17H17N5O2
1353887-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0408 1.1444 0.0 0
M  V30 2 O 8.0408 6.4792 0.0 0
M  V30 3 C 0.0000 3.1885 0.0 0
M  V30 4 C 9.5809 3.8119 0.0 0
M  V30 5 C 10.3509 5.1456 0.0 0
M  V30 6 N 11.8909 5.1456 0.0 0
M  V30 7 C 12.6609 6.4792 0.0 0
M  V30 8 C 12.6609 3.8119 0.0 0
M  V30 9 C 4.9608 3.8119 0.0 0
M  V30 10 C 3.4207 3.8119 0.0 0
M  V30 11 C 5.7308 2.4781 0.0 0
M  V30 12 C 5.7308 5.1456 0.0 0
M  V30 13 C 2.6507 2.4781 0.0 0
M  V30 14 C 2.6507 5.1456 0.0 0
M  V30 15 C 7.2708 2.4781 0.0 0
M  V30 16 C 4.9608 1.1444 0.0 0
M  V30 17 C 7.2708 5.1456 0.0 0
M  V30 18 C 4.9608 6.4792 0.0 0
M  V30 19 C 3.4207 1.1444 0.0 0
M  V30 20 N 1.1444 2.1579 0.0 0
M  V30 21 C 3.4207 6.4792 0.0 0
M  V30 22 N 8.0408 3.8119 0.0 0
M  V30 23 N 2.3903 0.0000 0.0 0
M  V30 24 N 0.9835 0.6263 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 2 2 17
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 2 12 18
M  V30 18 2 13 19
M  V30 19 1 13 20
M  V30 20 2 14 21
M  V30 21 1 15 22
M  V30 22 1 16 19
M  V30 23 1 17 22
M  V30 24 1 18 21
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 69408-81-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353887-16-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26816339
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 14635-75-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM intermediate of stage 1 added in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unprecedented synthesis, in vitro and in vivo anti-cancer evaluation of
novel triazolonaphthalimide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Shasha; Zhong, Wenhe; Li, Zhongjun; Meng, Xiangbao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2012), 47546-552

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoanisole
C7H7IO
696-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 I 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-methylbenzenamine
C8H11NO
5961-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5961-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14806168
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 58509-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed tube used, alternative preparation shown, oxime
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Copper-Catalyzed Arylation of Dimethylamine and
Methylamine in Neat Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Deping; Kuang, Daizhi; Zhang, Fuxing; Yang, Chunlin; Zhu, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2015), 357(4), 714-718

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorosulfonyl)benzoate
C8H7ClO4S
69812-51-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 O 8.4700 2.8736 0.0 0
M  V30 7 O 8.4700 0.2064 0.0 0
M  V30 8 C 10.0100 2.8736 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 2.8736 0.0 0
M  V30 11 C 3.8500 0.2064 0.0 0
M  V30 12 C 5.3900 2.8736 0.0 0
M  V30 13 C 5.3900 0.2064 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(methylamino)sulfonyl]benzoate
C9H11NO4S
474398-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 N 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 O 2.3100 3.0800 0.0 0
M  V30 5 C 0.0000 2.8736 0.0 0
M  V30 6 C 8.4700 1.5400 0.0 0
M  V30 7 O 9.2400 0.2064 0.0 0
M  V30 8 O 9.2400 2.8736 0.0 0
M  V30 9 C 10.7800 0.2064 0.0 0
M  V30 10 C 3.8500 1.5400 0.0 0
M  V30 11 C 4.6200 0.2064 0.0 0
M  V30 12 C 4.6200 2.8736 0.0 0
M  V30 13 C 6.1600 0.2064 0.0 0
M  V30 14 C 6.1600 2.8736 0.0 0
M  V30 15 C 6.9300 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 69812-51-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 474398-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24821741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Aroylsulfonamide-Photofragmentation (ASAP)-A Versatile Route to Biaryls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wessig, Pablo; Krebs, Saskia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2021), 2021(46), 6367-6374

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
3-[3-[(Cyclopropylcarbonyl)[(8-methoxy-2,2-dimethyl-2H-1-benzopyran-7-yl)meth...
C26H27NO5
698354-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.2085 0.0 0
M  V30 2 C 5.2970 9.5421 0.0 0
M  V30 3 C 7.6070 5.5411 0.0 0
M  V30 4 N 8.3770 4.2074 0.0 0
M  V30 5 C 7.6070 2.8738 0.0 0
M  V30 6 O 6.0670 2.8738 0.0 0
M  V30 7 C 1.7145 9.7251 0.0 0
M  V30 8 C 0.0000 8.7352 0.0 0
M  V30 9 C 12.9970 6.8747 0.0 0
M  V30 10 C 14.5370 6.8747 0.0 0
M  V30 11 C 15.3070 8.2085 0.0 0
M  V30 12 O 16.8470 8.2085 0.0 0
M  V30 13 O 14.5370 9.5421 0.0 0
M  V30 14 C 3.7570 6.8747 0.0 0
M  V30 15 C 5.2970 6.8747 0.0 0
M  V30 16 C 2.9870 5.5411 0.0 0
M  V30 17 O 2.9870 8.2085 0.0 0
M  V30 18 C 6.0670 5.5411 0.0 0
M  V30 19 C 3.7570 4.2074 0.0 0
M  V30 20 C 1.4470 5.5411 0.0 0
M  V30 21 C 1.4470 8.2085 0.0 0
M  V30 22 C 5.2970 4.2074 0.0 0
M  V30 23 C 0.6770 6.8747 0.0 0
M  V30 24 C 9.9170 4.2074 0.0 0
M  V30 25 C 10.6870 5.5411 0.0 0
M  V30 26 C 10.6870 2.8738 0.0 0
M  V30 27 C 12.2270 5.5411 0.0 0
M  V30 28 C 12.2270 2.8738 0.0 0
M  V30 29 C 12.9970 4.2074 0.0 0
M  V30 30 C 8.3770 1.5400 0.0 0
M  V30 31 C 8.3770 0.0000 0.0 0
M  V30 32 C 9.7108 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 24
M  V30 7 2 5 6
M  V30 8 1 5 30
M  V30 9 1 7 21
M  V30 10 1 8 21
M  V30 11 2 9 10 CFG=2
M  V30 12 1 9 27
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(8-Methoxy-2,2-dimethyl-2H-1-benzopyran-7-yl)methyl]-N-[3-[3-(methylamino)...
C27H30N2O4
698355-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.2085 0.0 0
M  V30 2 C 5.2970 9.5421 0.0 0
M  V30 3 C 7.6070 5.5411 0.0 0
M  V30 4 N 8.3770 4.2074 0.0 0
M  V30 5 C 7.6070 2.8738 0.0 0
M  V30 6 O 6.0670 2.8738 0.0 0
M  V30 7 C 1.7145 9.7251 0.0 0
M  V30 8 C 0.0000 8.7352 0.0 0
M  V30 9 C 12.9970 6.8747 0.0 0
M  V30 10 C 14.5370 6.8747 0.0 0
M  V30 11 C 15.3070 8.2085 0.0 0
M  V30 12 N 16.8470 8.2085 0.0 0
M  V30 13 O 14.5370 9.5421 0.0 0
M  V30 14 C 17.6170 9.5421 0.0 0
M  V30 15 C 3.7570 6.8747 0.0 0
M  V30 16 C 5.2970 6.8747 0.0 0
M  V30 17 C 2.9870 5.5411 0.0 0
M  V30 18 O 2.9870 8.2085 0.0 0
M  V30 19 C 6.0670 5.5411 0.0 0
M  V30 20 C 3.7570 4.2074 0.0 0
M  V30 21 C 1.4470 5.5411 0.0 0
M  V30 22 C 1.4470 8.2085 0.0 0
M  V30 23 C 5.2970 4.2074 0.0 0
M  V30 24 C 0.6770 6.8747 0.0 0
M  V30 25 C 9.9170 4.2074 0.0 0
M  V30 26 C 10.6870 5.5411 0.0 0
M  V30 27 C 10.6870 2.8738 0.0 0
M  V30 28 C 12.2270 5.5411 0.0 0
M  V30 29 C 12.2270 2.8738 0.0 0
M  V30 30 C 12.9970 4.2074 0.0 0
M  V30 31 C 8.3770 1.5400 0.0 0
M  V30 32 C 9.7108 0.7700 0.0 0
M  V30 33 C 8.3770 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 2 5 6
M  V30 8 1 5 31
M  V30 9 1 7 22
M  V30 10 1 8 22
M  V30 11 2 9 10 CFG=2
M  V30 12 1 9 28
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 1 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 698354-95-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698355-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2070042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 29 is hydrolyzed (4.0 equiv. of LiOH, THF: H2O(10:l),25°C.,24h. 88%) to
the acid which is aminated by mixed anhydride formation followed by
exposure to an amine, (1.2 equiv. of EtOC(O)Cl, 1.5 equiv. of Et3N, 0.1
60 equiv. of 4-DMAP, CH2Cl2, 25°C, 1 h, then 3.0 equiv. of NH3, MeNH2,
PbNH2 or ((CH2)5)N, CH2Cl2, 25°C, 12 h., 85%-95%) to provide amides
37-40. Compound 38, yield 95%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Non-steroidal farnesoid x receptor modulators and methods for the use
thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Downes, Michael R.; Evans, Ronald M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US7671085 B2 2010-03-02

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
3-[3-[(Cyclopropylcarbonyl)[(8-methoxy-2,2-dimethyl-2H-1-benzopyran-7-yl)meth...
C26H27NO5
698354-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.2085 0.0 0
M  V30 2 C 5.2970 9.5421 0.0 0
M  V30 3 C 7.6070 5.5411 0.0 0
M  V30 4 N 8.3770 4.2074 0.0 0
M  V30 5 C 7.6070 2.8738 0.0 0
M  V30 6 O 6.0670 2.8738 0.0 0
M  V30 7 C 1.7145 9.7251 0.0 0
M  V30 8 C 0.0000 8.7352 0.0 0
M  V30 9 C 12.9970 6.8747 0.0 0
M  V30 10 C 14.5370 6.8747 0.0 0
M  V30 11 C 15.3070 8.2085 0.0 0
M  V30 12 O 16.8470 8.2085 0.0 0
M  V30 13 O 14.5370 9.5421 0.0 0
M  V30 14 C 3.7570 6.8747 0.0 0
M  V30 15 C 5.2970 6.8747 0.0 0
M  V30 16 C 2.9870 5.5411 0.0 0
M  V30 17 O 2.9870 8.2085 0.0 0
M  V30 18 C 6.0670 5.5411 0.0 0
M  V30 19 C 3.7570 4.2074 0.0 0
M  V30 20 C 1.4470 5.5411 0.0 0
M  V30 21 C 1.4470 8.2085 0.0 0
M  V30 22 C 5.2970 4.2074 0.0 0
M  V30 23 C 0.6770 6.8747 0.0 0
M  V30 24 C 9.9170 4.2074 0.0 0
M  V30 25 C 10.6870 5.5411 0.0 0
M  V30 26 C 10.6870 2.8738 0.0 0
M  V30 27 C 12.2270 5.5411 0.0 0
M  V30 28 C 12.2270 2.8738 0.0 0
M  V30 29 C 12.9970 4.2074 0.0 0
M  V30 30 C 8.3770 1.5400 0.0 0
M  V30 31 C 8.3770 0.0000 0.0 0
M  V30 32 C 9.7108 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 24
M  V30 7 2 5 6
M  V30 8 1 5 30
M  V30 9 1 7 21
M  V30 10 1 8 21
M  V30 11 2 9 10 CFG=2
M  V30 12 1 9 27
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(8-Methoxy-2,2-dimethyl-2H-1-benzopyran-7-yl)methyl]-N-[3-[3-(methylamino)...
C27H30N2O4
698355-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.2085 0.0 0
M  V30 2 C 5.2970 9.5421 0.0 0
M  V30 3 C 7.6070 5.5411 0.0 0
M  V30 4 N 8.3770 4.2074 0.0 0
M  V30 5 C 7.6070 2.8738 0.0 0
M  V30 6 O 6.0670 2.8738 0.0 0
M  V30 7 C 1.7145 9.7251 0.0 0
M  V30 8 C 0.0000 8.7352 0.0 0
M  V30 9 C 12.9970 6.8747 0.0 0
M  V30 10 C 14.5370 6.8747 0.0 0
M  V30 11 C 15.3070 8.2085 0.0 0
M  V30 12 N 16.8470 8.2085 0.0 0
M  V30 13 O 14.5370 9.5421 0.0 0
M  V30 14 C 17.6170 9.5421 0.0 0
M  V30 15 C 3.7570 6.8747 0.0 0
M  V30 16 C 5.2970 6.8747 0.0 0
M  V30 17 C 2.9870 5.5411 0.0 0
M  V30 18 O 2.9870 8.2085 0.0 0
M  V30 19 C 6.0670 5.5411 0.0 0
M  V30 20 C 3.7570 4.2074 0.0 0
M  V30 21 C 1.4470 5.5411 0.0 0
M  V30 22 C 1.4470 8.2085 0.0 0
M  V30 23 C 5.2970 4.2074 0.0 0
M  V30 24 C 0.6770 6.8747 0.0 0
M  V30 25 C 9.9170 4.2074 0.0 0
M  V30 26 C 10.6870 5.5411 0.0 0
M  V30 27 C 10.6870 2.8738 0.0 0
M  V30 28 C 12.2270 5.5411 0.0 0
M  V30 29 C 12.2270 2.8738 0.0 0
M  V30 30 C 12.9970 4.2074 0.0 0
M  V30 31 C 8.3770 1.5400 0.0 0
M  V30 32 C 9.7108 0.7700 0.0 0
M  V30 33 C 8.3770 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 2 5 6
M  V30 8 1 5 31
M  V30 9 1 7 22
M  V30 10 1 8 22
M  V30 11 2 9 10 CFG=2
M  V30 12 1 9 28
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 1 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 698354-95-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698355-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1067850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-acyl-N-benzylaniline acrylates as nonsteroidal farnesoid X receptor
(FXR) modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Downes, Michael R.; Evans, Ronald Mark; Hughes, Robert; Nicolaou,
Kyriacos C.; Roecker, Anthony J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004045511 A2 2004-06-03

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
3-[3-[(Cyclopropylcarbonyl)[(8-methoxy-2,2-dimethyl-2H-1-benzopyran-7-yl)meth...
C26H27NO5
698354-95-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.2085 0.0 0
M  V30 2 C 5.2970 9.5421 0.0 0
M  V30 3 C 7.6070 5.5411 0.0 0
M  V30 4 N 8.3770 4.2074 0.0 0
M  V30 5 C 7.6070 2.8738 0.0 0
M  V30 6 O 6.0670 2.8738 0.0 0
M  V30 7 C 1.7145 9.7251 0.0 0
M  V30 8 C 0.0000 8.7352 0.0 0
M  V30 9 C 12.9970 6.8747 0.0 0
M  V30 10 C 14.5370 6.8747 0.0 0
M  V30 11 C 15.3070 8.2085 0.0 0
M  V30 12 O 16.8470 8.2085 0.0 0
M  V30 13 O 14.5370 9.5421 0.0 0
M  V30 14 C 3.7570 6.8747 0.0 0
M  V30 15 C 5.2970 6.8747 0.0 0
M  V30 16 C 2.9870 5.5411 0.0 0
M  V30 17 O 2.9870 8.2085 0.0 0
M  V30 18 C 6.0670 5.5411 0.0 0
M  V30 19 C 3.7570 4.2074 0.0 0
M  V30 20 C 1.4470 5.5411 0.0 0
M  V30 21 C 1.4470 8.2085 0.0 0
M  V30 22 C 5.2970 4.2074 0.0 0
M  V30 23 C 0.6770 6.8747 0.0 0
M  V30 24 C 9.9170 4.2074 0.0 0
M  V30 25 C 10.6870 5.5411 0.0 0
M  V30 26 C 10.6870 2.8738 0.0 0
M  V30 27 C 12.2270 5.5411 0.0 0
M  V30 28 C 12.2270 2.8738 0.0 0
M  V30 29 C 12.9970 4.2074 0.0 0
M  V30 30 C 8.3770 1.5400 0.0 0
M  V30 31 C 8.3770 0.0000 0.0 0
M  V30 32 C 9.7108 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 4 24
M  V30 7 2 5 6
M  V30 8 1 5 30
M  V30 9 1 7 21
M  V30 10 1 8 21
M  V30 11 2 9 10 CFG=2
M  V30 12 1 9 27
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 2 20 23
M  V30 26 1 21 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(8-Methoxy-2,2-dimethyl-2H-1-benzopyran-7-yl)methyl]-N-[3-[3-(methylamino)...
C27H30N2O4
698355-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.0670 8.2085 0.0 0
M  V30 2 C 5.2970 9.5421 0.0 0
M  V30 3 C 7.6070 5.5411 0.0 0
M  V30 4 N 8.3770 4.2074 0.0 0
M  V30 5 C 7.6070 2.8738 0.0 0
M  V30 6 O 6.0670 2.8738 0.0 0
M  V30 7 C 1.7145 9.7251 0.0 0
M  V30 8 C 0.0000 8.7352 0.0 0
M  V30 9 C 12.9970 6.8747 0.0 0
M  V30 10 C 14.5370 6.8747 0.0 0
M  V30 11 C 15.3070 8.2085 0.0 0
M  V30 12 N 16.8470 8.2085 0.0 0
M  V30 13 O 14.5370 9.5421 0.0 0
M  V30 14 C 17.6170 9.5421 0.0 0
M  V30 15 C 3.7570 6.8747 0.0 0
M  V30 16 C 5.2970 6.8747 0.0 0
M  V30 17 C 2.9870 5.5411 0.0 0
M  V30 18 O 2.9870 8.2085 0.0 0
M  V30 19 C 6.0670 5.5411 0.0 0
M  V30 20 C 3.7570 4.2074 0.0 0
M  V30 21 C 1.4470 5.5411 0.0 0
M  V30 22 C 1.4470 8.2085 0.0 0
M  V30 23 C 5.2970 4.2074 0.0 0
M  V30 24 C 0.6770 6.8747 0.0 0
M  V30 25 C 9.9170 4.2074 0.0 0
M  V30 26 C 10.6870 5.5411 0.0 0
M  V30 27 C 10.6870 2.8738 0.0 0
M  V30 28 C 12.2270 5.5411 0.0 0
M  V30 29 C 12.2270 2.8738 0.0 0
M  V30 30 C 12.9970 4.2074 0.0 0
M  V30 31 C 8.3770 1.5400 0.0 0
M  V30 32 C 9.7108 0.7700 0.0 0
M  V30 33 C 8.3770 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 3 4
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 25
M  V30 7 2 5 6
M  V30 8 1 5 31
M  V30 9 1 7 22
M  V30 10 1 8 22
M  V30 11 2 9 10 CFG=2
M  V30 12 1 9 28
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 2 19 23
M  V30 25 1 20 23
M  V30 26 2 21 24
M  V30 27 1 22 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 698354-95-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 698355-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3529156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 541-41-3
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-acyl-N-arylmethylaniline acrylates as nonsteroidal farnesoid X receptor
modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Downes, Michael R.; Evans, Ronald M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004046068 A2 2004-06-03

$RFMT $RIREG SCHEME243 STEP1
$RXN



  3  1
$MOL
(-)-Asparagine
C4H8N2O3
70-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 3.8500 0.0 0 CFG=2
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 1.3338 4.6200 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 4.0011 1.5400 0.0 0
M  V30 6 O 0.0000 3.8500 0.0 0
M  V30 7 O 1.3338 6.1600 0.0 0
M  V30 8 N 4.0011 0.0000 0.0 0
M  V30 9 O 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-[[3-Chloro-4-(1-methylethoxy)benzoyl]amino]-N1-methylbutanediamide
C15H20ClN3O4
1208245-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 N 4.6200 4.0011 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 5.3347 0.0 0
M  V30 7 N 3.0800 1.3336 0.0 0
M  V30 8 O 0.7700 2.6674 0.0 0
M  V30 9 C 0.7700 5.3347 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 N 0.0000 4.0011 0.0 0
M  V30 12 O 0.0000 6.6685 0.0 0
M  V30 13 Cl 10.0100 8.0021 0.0 0
M  V30 14 O 11.5500 5.3347 0.0 0
M  V30 15 C 12.3200 4.0011 0.0 0
M  V30 16 C 13.8600 4.0011 0.0 0
M  V30 17 C 11.5500 2.6674 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 7.7000 6.6685 0.0 0
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 13 21
M  V30 14 1 14 15
M  V30 15 1 14 23
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 2 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 2 20 22
M  V30 22 2 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 70-47-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2403528
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 3 in DMF (0.2 M) were added
amino acid (1.2 equiv.) and N, N-diisopropylethylamine (3 equiv.). The
reaction was monitored by LC/MS. After completion, amine (1.5 equiv.) and
HBTU (1.5 equiv.) were added to the reaction solution. The reaction
mixture was stirred for 4 h. The product was purified by either HPLC or
flash column chromatography. 3a – 3i (60-95% yield).
2-(3-Chloro-4-isopropoxybenzamido)-N1 -methylsuccinamide (3d) 1H NMR (400
MHz, MeOD) δ 7.92 (d, J = 2.3, 1H), 7.78 (dd, J = 2.3, 8.7, 1H), 7.15 (d,
J = 8.8, 1H), 4.86 (d, J = 6.0, 1H), 4.76 (dt, J = 6.0, 12.1, 1H), 2.82 –
2.75 (m, 2H), 2.75 (s, 3H), 1.38 (d, J = 6.0, 6H); LRMS (M+H+) m/z 342.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-amino-1,3-benzodioxole-5-carboxylate
C9H9NO4
7112-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7036 0.0000 0.0 0
M  V30 2 C 6.3709 1.5400 0.0 0
M  V30 3 O 7.7047 2.3100 0.0 0
M  V30 4 O 6.3709 0.0000 0.0 0
M  V30 5 C 9.0383 1.5400 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 O 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Amino-N-methyl-1,3-benzodioxole-5-carboxamide
C9H10N2O3
1022948-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7036 0.0000 0.0 0
M  V30 2 C 6.3709 1.5400 0.0 0
M  V30 3 N 7.7047 2.3100 0.0 0
M  V30 4 O 6.3709 0.0000 0.0 0
M  V30 5 C 9.0383 1.5400 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 C 2.3699 3.8500 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 O 0.9052 1.8341 0.0 0
M  V30 10 C 3.7036 4.6200 0.0 0
M  V30 11 O 0.9052 4.3259 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 C 0.0000 3.0800 0.0 0
M  V30 14 C 5.0372 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7112-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1022948-50-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10145174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 544-92-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1479a) 4-Amino-benzo[1,3]dioxole-5-carboxylic acid methylamide was
prepared by heating a mixture of 4-amino-benzo[1,3]dioxole-5-carboxylic
acid methyl ester (198 mg, 1.01 mmol, Dallacker, Franz, et al. Justus
Liebigs Ann Chem 1966, 694 117-22) with 2.0 M methanolic MeNHz (7 mL, 14
mmol) and CuCN (1.42 g, 28.6 mmol) to 50 °C for 72 h. Excess catalyst was
removed by filtration; filtrate was extracted into CH2Cl2, washed with
water and dried by passing through a plug of Na2SO4. Evaporation of
solvent afforded a white powder (187 mg, 95%) that was used in subsequent
steps without further purification.
4-Amino-benzo[1,3]dioxole-5-carboxylic acid methylamide, yield 187 mg,
95%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK
and c-Met kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmed, Gulzar; Bohnstedt, Adolph; Breslin, Henry Joseph; Burke, Jason;
Curry, Matthew A.; Diebold, James L.; Dorsey, Bruce; Dugan, Benjamin J.;
Feng, Daming; Gingrich, Diane E.; Guo, Tao; Ho, Koc-Kan; Learn, Keith S.;
Lisko, Joseph G.; Liu, Rong-Qiang; Mesaros, Eugen F.; Milkiewicz, Karen;
Ott, Gregory R.; Parrish, Jonathan; Theroff, Jay P.; Thieu, Tho V.;
Tripathy, Rabindranath; Underiner, Theodore L.; Wagner, Jason C.;
Weinberg, Linda; Wells, Gregory J.; You, Ming; Zificsak, Craig A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008051547 A1 2008-05-02

$RFMT $RIREG SCHEME245 STEP1
$RXN



  5  1
$MOL
2-Methyl-1-buten-3-yne
C5H6
78-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 0.0000 2.3101 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′,4′-Dihydroxyacetophenone
C8H8O3
89-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 2.3101 0.0000 0.0 0
M  V30 5 O 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl isocyanide
C5H9N
7188-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 N 3.0800 1.5400 0.0 0 CHG=1 VAL=4
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1,1-Dimethylethyl)amino]-6-hydroxy-α,3-dimethyl-α-(methylamino)-1H-cyclop...
C20H25N3O2
2447577-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.9523 3.0127 0.0 0
M  V30 2 C 4.6322 1.5064 0.0 0
M  V30 3 C 6.1386 1.1863 0.0 0
M  V30 4 C 4.3120 0.0000 0.0 0
M  V30 5 C 3.1259 1.8266 0.0 0
M  V30 6 C 0.0000 5.2177 0.0 0
M  V30 7 C 8.8495 8.0528 0.0 0
M  V30 8 C 10.3895 8.0528 0.0 0
M  V30 9 N 8.8495 9.5928 0.0 0
M  V30 10 C 8.8495 6.5128 0.0 0
M  V30 11 N 11.9295 8.0528 0.0 0
M  V30 12 C 10.1831 10.3628 0.0 0
M  V30 13 O 7.3095 10.7202 0.0 0
M  V30 14 C 3.9689 5.5748 0.0 0
M  V30 15 C 4.9995 6.7192 0.0 0
M  V30 16 C 2.5621 6.2011 0.0 0
M  V30 17 C 3.8080 4.0431 0.0 0
M  V30 18 C 4.2295 8.0528 0.0 0
M  V30 19 C 6.5395 6.7192 0.0 0
M  V30 20 O 2.7230 7.7326 0.0 0
M  V30 21 C 1.5317 5.0567 0.0 0
M  V30 22 C 2.3017 3.7230 0.0 0
M  V30 23 C 4.9995 9.3866 0.0 0
M  V30 24 C 7.3095 8.0528 0.0 0
M  V30 25 C 6.5395 9.3866 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 6 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 24
M  V30 11 3 8 11
M  V30 12 1 9 12
M  V30 13 1 13 25
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 2 15 19
M  V30 19 1 16 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 18 20
M  V30 23 2 18 23
M  V30 24 1 19 24
M  V30 25 2 21 22
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 78-80-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-84-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 7188-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2447577-92-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-22564608
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, catalyst prepared and used, reusable
catalyst used, recyclable catalyst used, optimization study, optimized on
catalyst, solvent, time and temperature, Strecker-type reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnO-nanorods Promoted Synthesis of α-amino Nitrile Benzofuran Derivatives
using One-pot Multicomponent Reaction of Isocyanides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Najar, Asef H.; Hossaini, Zinatossadat; Abdolmohammadi, Shahrzad;
Zareyee, Daryoush
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Combinatorial Chemistry & High Throughput Screening (2020), 23(4),
345-355

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
1-(1,1-Dimethylethyl) 2-chloro-1H-indole-1,3-dicarboxylate
C14H14ClNO4
721443-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 3.7827 0.0 0
M  V30 2 O 7.3326 5.1163 0.0 0
M  V30 3 O 7.3326 2.4491 0.0 0
M  V30 4 C 8.8726 5.1163 0.0 0
M  V30 5 C 8.8726 3.5763 0.0 0
M  V30 6 C 10.4126 5.1163 0.0 0
M  V30 7 C 8.8726 6.6563 0.0 0
M  V30 8 Cl 4.5932 6.4933 0.0 0
M  V30 9 C 1.4068 5.4579 0.0 0
M  V30 10 O 1.5679 6.9894 0.0 0
M  V30 11 O 0.0000 4.8314 0.0 0
M  V30 12 C 4.1173 2.5368 0.0 0
M  V30 13 N 5.0226 3.7827 0.0 0
M  V30 14 C 2.6528 3.0127 0.0 0
M  V30 15 C 4.4375 1.0304 0.0 0
M  V30 16 C 4.1173 5.0286 0.0 0
M  V30 17 C 2.6528 4.5527 0.0 0
M  V30 18 C 1.5083 1.9823 0.0 0
M  V30 19 C 3.2931 0.0000 0.0 0
M  V30 20 C 1.8284 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 2 16 17
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-chloro-3-[(methylamino)carbonyl]-1H-indole-1-carboxylate
C15H17ClN2O3
721443-59-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8084 3.7827 0.0 0
M  V30 2 O 8.5784 5.1163 0.0 0
M  V30 3 O 8.5784 2.4491 0.0 0
M  V30 4 C 10.1184 5.1163 0.0 0
M  V30 5 C 10.1184 3.5763 0.0 0
M  V30 6 C 11.6584 5.1163 0.0 0
M  V30 7 C 10.1184 6.6563 0.0 0
M  V30 8 C 2.6528 5.4579 0.0 0
M  V30 9 N 1.2459 4.8314 0.0 0
M  V30 10 O 2.8137 6.9894 0.0 0
M  V30 11 C 0.0000 5.7367 0.0 0
M  V30 12 Cl 5.8391 6.4933 0.0 0
M  V30 13 C 5.3632 2.5368 0.0 0
M  V30 14 C 3.8987 3.0127 0.0 0
M  V30 15 N 6.2684 3.7827 0.0 0
M  V30 16 C 5.6834 1.0304 0.0 0
M  V30 17 C 3.8987 4.5527 0.0 0
M  V30 18 C 2.7541 1.9823 0.0 0
M  V30 19 C 5.3632 5.0286 0.0 0
M  V30 20 C 4.5390 0.0000 0.0 0
M  V30 21 C 3.0743 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 9 11
M  V30 12 1 12 19
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 1 14 17
M  V30 17 2 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 2 17 19
M  V30 21 1 18 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 721443-57-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 721443-59-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16859525
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biotransformation of rutabaga phytoalexins by the fungus Alternaria
brassicicola: Unveiling the first hybrid metabolite derived from a
phytoalexin and a fungal polyketide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pedras, M. Soledade C.; Abdoli, Abbas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(2), 557-567

$RFMT $RIREG SCHEME247 STEP1
$RXN



  3  1
$MOL
L-Valine
C5H11NO2
72-18-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0 CFG=2
M  V30 2 C 2.6673 0.7700 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 N 4.0010 3.0801 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 4.0010 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-4-(1-methylethoxy)-N-[(1S)-2-methyl-1-[(methylamino)carbonyl]propyl]...
C16H23ClN2O3
1208245-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 N 4.6201 4.0011 0.0 0
M  V30 3 O 4.6201 1.3338 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0 CFG=1
M  V30 5 C 2.3100 5.3348 0.0 0
M  V30 6 C 2.3100 2.6675 0.0 0
M  V30 7 N 0.7700 5.3348 0.0 0
M  V30 8 O 3.0800 6.6686 0.0 0
M  V30 9 C 0.7700 2.6675 0.0 0
M  V30 10 C 3.0800 1.3338 0.0 0
M  V30 11 C 0.0000 6.6686 0.0 0
M  V30 12 Cl 10.0101 0.0000 0.0 0
M  V30 13 O 11.5501 2.6675 0.0 0
M  V30 14 C 12.3201 4.0011 0.0 0
M  V30 15 C 11.5501 5.3348 0.0 0
M  V30 16 C 13.8602 4.0011 0.0 0
M  V30 17 C 6.9301 2.6675 0.0 0
M  V30 18 C 7.7001 1.3338 0.0 0
M  V30 19 C 7.7001 4.0011 0.0 0
M  V30 20 C 9.2401 1.3338 0.0 0
M  V30 21 C 9.2401 4.0011 0.0 0
M  V30 22 C 10.0101 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 12 20
M  V30 13 1 13 14
M  V30 14 1 13 22
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 72-18-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13656038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 3 in DMF (0.2 M) were added
amino acid (1.2 equiv.) and N, N-diisopropylethylamine (3 equiv.). The
reaction was monitored by LC/MS. After completion, amine (1.5 equiv.) and
HBTU (1.5 equiv.) were added to the reaction solution. The reaction
mixture was stirred for 4 h. The product was purified by either HPLC or
flash column chromatography. 3a – 3i (60-95% yield).
3-Chloro-4-isopropoxy-N-(3-methyl-1-(methylamino)-1-oxobutan-2-yl)benzamide
(3b) 1H NMR (400 MHz, MeOD) δ 7.71 (d, J = 2.2, 1H), 7.57 (dd, J = 2.2,
8.7, 1H), 6.93 (d, J = 8.7, 1H), 4.55 (dt, J = 6.1, 12.1, 1H), 4.05 (d, J
= 8.3, 1H), 2.54 (s, 3H), 2.01 – 1.88 (m, 1H), 1.17 (d, J = 6.0, 6H),
0.78 (dd, J = 6.8, 11.2, 6H); LRMS (M+H+) m/z 327.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanoic acid, 4-[(4-methoxyphenyl)methoxy]-3-oxo-, ethyl ester
C14H18O5
727382-81-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 10.6697 2.3101 0.0 0
M  V30 5 C 12.0035 3.0801 0.0 0
M  V30 6 O 10.6697 0.7700 0.0 0
M  V30 7 C 13.3372 2.3101 0.0 0
M  V30 8 O 14.6708 3.0801 0.0 0
M  V30 9 O 13.3372 0.7700 0.0 0
M  V30 10 C 16.0045 2.3101 0.0 0
M  V30 11 C 17.3383 3.0801 0.0 0
M  V30 12 O 1.3338 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 4.0012 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 2.6675 2.3101 0.0 0
M  V30 18 C 4.0012 0.0000 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(4-methoxyphenyl)methoxy]-3-(methylamino)-2-butenoate
C15H21NO4
1240195-08-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0011 0.0 0
M  V30 2 O 6.1601 4.0011 0.0 0
M  V30 3 C 6.9301 2.6675 0.0 0
M  V30 4 C 8.4701 2.6675 0.0 0
M  V30 5 C 9.2401 4.0011 0.0 0
M  V30 6 N 9.2401 1.3337 0.0 0
M  V30 7 C 10.7801 4.0011 0.0 0
M  V30 8 C 8.4701 0.0000 0.0 0
M  V30 9 O 11.5501 5.3348 0.0 0
M  V30 10 O 11.5501 2.6675 0.0 0
M  V30 11 C 13.0901 5.3348 0.0 0
M  V30 12 C 13.8602 6.6684 0.0 0
M  V30 13 O 1.5400 9.3359 0.0 0
M  V30 14 C 0.0000 9.3359 0.0 0
M  V30 15 C 3.8500 5.3348 0.0 0
M  V30 16 C 2.3100 5.3348 0.0 0
M  V30 17 C 4.6201 6.6684 0.0 0
M  V30 18 C 1.5400 6.6684 0.0 0
M  V30 19 C 3.8500 8.0022 0.0 0
M  V30 20 C 2.3100 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 4 5 CFG=2
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 13 14
M  V30 14 1 13 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 727382-81-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240195-08-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-71799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (E/Z)-Ethyl 4-(4-methoxybenzyloxy)-3-(methylamino)but-2-enoate. A
solution of methylamine (25% w/v in water; 0.59 mL, 4.7 mmol) was added
in a single portion to a stirred suspension of silica gel (0.5 g) and
ethyl 4-(4-methoxybenzyloxy)-3-oxobutanoate (1.142 g, 4.3 mmol) at room
temperature, and the resulting mixture was stirred at room temperature
for 15 h. The mixture was diluted with dichloromethane (10 mL), dried
(MgSO4), filtered and concentrated in vacuo to give the title compound as
a pale yellow oil (1.143 g, 95%, 1:1 E:Z). (Found: M+Na+, 302.1358.
C15H21NO4Na requires 302.1363); νmax (CHCl3)/cm-1 3429, 3011, 2869, 1654,
1612, 1590, 1515 1251; δH (400 MHz; CDCl3) E isomer: 7.28 (2H, d, J7.6,
ArH), 6.91 (2H, d, J7.6, ArH), 5.72 (1H, br s, NH), 4.82 (2H, s, CH2),
4.51 (1H, s, CH), 4.14- 4.07 (4H, m, 2 × CH2), 3.83 (3H, s, OMe), 2.75
(3H, d, J4.8, NMe), 1.27 (3H, m, CH2 CH3); Z isomer: 8.25 (1H, br s, NH),
7.28 (2H, d, J7.6, ArH), 6.91 (2H, d, J7.6, ArH), 4.68 (1H, s, CH),
4.14-4.07 (6H, m, 3 × CH2), 3.83 (3H, s, OMe), 2.97 (3H, d, J5.2, NMe),
1.27 (3H, m, CH2 CH3); δC (75 MHz; CDCl3) mixture: 170.7, 168.7, 160.7,
160.3, 159.5, 159.4, 129.6 (CH), 129.5, 128.6 113.9 (CH), 83.1 (CH), 79.1
(CH), 73.2 (CH2), 71.9 (CH2), 68.6 (CH2), 68.3 (CH2), 58.6 (CH2), 58.4
(CH2), 46.1 (Me), 29.7 (Me), 29.6 (Me), 14.7 (Me), 14.1 (Me); m/z (EI)
581 (2M+Na+, 100%), 302 (M+Na+, 38), 280 (M+H+, 14).
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indolequinones from Bromoquinones and Enamines Mediated by
Cu(OAc)2·H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(17), 6023-6026

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-nitro-6-phenylpyrimidine
C10H6ClN3O2
736143-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3347 4.6200 0.0 0 VAL=5
M  V30 2 O 4.0011 5.3900 0.0 0
M  V30 3 O 6.6685 5.3900 0.0 0
M  V30 4 Cl 8.0021 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 5.3347 3.0800 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 9 C 5.3347 0.0000 0.0 0
M  V30 10 N 6.6685 0.7700 0.0 0
M  V30 11 C 2.6674 3.0800 0.0 0
M  V30 12 C 2.6674 4.6200 0.0 0
M  V30 13 C 1.3336 2.3100 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-5-nitro-6-phenyl-4-pyrimidinamine
C11H10N4O2
736143-10-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0 VAL=5
M  V30 2 O 4.0012 5.3901 0.0 0
M  V30 3 O 6.6685 5.3901 0.0 0
M  V30 4 N 8.0023 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 5.3348 3.0801 0.0 0
M  V30 8 N 4.0012 0.7700 0.0 0
M  V30 9 C 6.6685 2.3101 0.0 0
M  V30 10 C 5.3348 0.0000 0.0 0
M  V30 11 N 6.6685 0.7700 0.0 0
M  V30 12 C 2.6675 3.0801 0.0 0
M  V30 13 C 2.6675 4.6201 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 3.0801 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 736143-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 736143-10-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11702102
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Methyl-(5-nitro-6-phenylpyrimidin-4-yl)amine (35). A solution of 33 (1.54
g, 6.55 mmol) and methylamine (20 mL, 40% in water) in dioxane (25 mL)
was refluxed for 1 h. After evaporation of the volatiles, the residue was
dissolved in ethanol and the solution filtered over SiO2 (CH2Cl2/EtOH
9:1). The filtrate was evaporated in vacuo to give 35 (1.43 g; 95%). mp
142 °C; 1H NMR δ 2.97 (d, 3H, CH3, 3 J(H,H) ) 3.9 Hz), 7.50 (s, br, 5H,
Ph), 8.14 (s, br, 1H, N-H, exchangeable), 8.67 (s, 1H); GC (temperature
program A) 19.7 min; MS m/z (%) 230 (95, M+), 216 (46), 200 (90), 173
(39), 156 (57), 128 (85), 102 (67), 77 (100), 57 (63).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Testing of Purine Derivatives as Potential
ATP-Competitive Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laufer, Stefan A.; Domeyer, David M.; Scior, Thomas R. F.; Albrecht,
Wolfgang; Hauser, Dominik R. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(3), 710-722

$RFMT $RIREG SCHEME250 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6-(4-fluorophenyl)-5-nitropyrimidine
C10H5ClFN3O2
736143-09-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 4.6200 0.0 0 VAL=5
M  V30 2 O 1.3336 5.3900 0.0 0
M  V30 3 O 4.0011 5.3900 0.0 0
M  V30 4 Cl 0.0000 3.0800 0.0 0
M  V30 5 F 9.3358 5.3900 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 N 4.0011 0.7700 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 0.0000 0.0 0
M  V30 11 N 1.3336 0.7700 0.0 0
M  V30 12 C 5.3347 3.0800 0.0 0
M  V30 13 C 6.6684 2.3100 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 8.0021 3.0800 0.0 0
M  V30 16 C 6.6684 5.3900 0.0 0
M  V30 17 C 8.0021 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Fluorophenyl)-N-methyl-5-nitro-4-pyrimidinamine
C11H9FN4O2
736143-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 N 1.5400 1.3338 0.0 0
M  V30 5 C 0.0000 1.3338 0.0 0
M  V30 6 F 10.7800 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 N 3.8500 5.3349 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 12 N 1.5400 4.0011 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 6.9300 5.3349 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3349 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 736143-09-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 736143-11-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13833797
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [6-(4-Fluorophenyl)-5-nitropyrimidin-4-yl]methylamine (36). A solution of
34 (1.58 g, 6.25 mmol) and methylamine (20 mL, 40% in water) in dioxane
(25 mL) was refluxed for 1 h. After evaporation of the volatiles, the
residue was dissolved in ethanol and the solution filtered over SiO2
(CH2- Cl2/EtOH 9:1). The filtrate was evaporated in vacuo to give 35
(1.47 g; 95%). mp 114 °C; 1H NMR (CDCl3) δ 3.19 (d, 3H, CH3, 3 J(H,H) )
4.9 Hz), 7.09-7.18 (m, 2H, 4-F-Ph), 7.36 (s, br, 1H, N-H, exchangeable),
7.49-7.56 (m, 2H, 4-F), 8.66 (s, 1H); GC (temperature program A) 18.8
min; MS m/z (%) 248 (100, M+), 224 (44), 218 (72), 174 (64), 146 (71),
121 (66), 81 (57), 57 (65).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Testing of Purine Derivatives as Potential
ATP-Competitive Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Laufer, Stefan A.; Domeyer, David M.; Scior, Thomas R. F.; Albrecht,
Wolfgang; Hauser, Dominik R. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(3), 710-722

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-Bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl]-6-iodo-8-methyl-4H-3,1-b...
C17H9BrClIN4O2
736995-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.8369 0.0 0
M  V30 2 Br 2.0424 0.0000 0.0 0
M  V30 3 O 7.0036 7.8788 0.0 0
M  V30 4 C 9.6711 1.7187 0.0 0
M  V30 5 I 12.3384 6.3388 0.0 0
M  V30 6 N 2.9293 3.8850 0.0 0
M  V30 7 C 4.3363 3.2587 0.0 0
M  V30 8 N 1.8989 2.7406 0.0 0
M  V30 9 C 4.1752 1.7271 0.0 0
M  V30 10 C 2.6689 1.4070 0.0 0
M  V30 11 C 2.6091 5.3915 0.0 0
M  V30 12 C 1.1444 5.8674 0.0 0
M  V30 13 N 3.7535 6.4219 0.0 0
M  V30 14 C 0.8242 7.3737 0.0 0
M  V30 15 C 3.4334 7.9284 0.0 0
M  V30 16 C 1.9688 8.4043 0.0 0
M  V30 17 C 5.6699 4.0287 0.0 0
M  V30 18 N 7.0036 3.2587 0.0 0
M  V30 19 O 5.6699 5.5688 0.0 0
M  V30 20 C 8.3373 4.0287 0.0 0
M  V30 21 C 7.0036 6.3388 0.0 0
M  V30 22 C 8.3373 5.5688 0.0 0
M  V30 23 C 9.6711 3.2587 0.0 0
M  V30 24 C 9.6711 6.3388 0.0 0
M  V30 25 C 11.0048 4.0287 0.0 0
M  V30 26 C 11.0048 5.5688 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 10
M  V30 3 2 3 21
M  V30 4 1 4 23
M  V30 5 1 5 26
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 20 23
M  V30 25 1 21 22
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-1-(3-chloro-2-pyridinyl)-N-[4-iodo-2-methyl-6-[(methylamino)carbonyl]...
C18H14BrClIN5O2
500009-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8690 5.3027 0.0 0
M  V30 2 N 7.4090 5.3027 0.0 0
M  V30 3 O 5.0990 6.6364 0.0 0
M  V30 4 Cl 0.5546 3.1677 0.0 0
M  V30 5 Br 4.7419 0.0000 0.0 0
M  V30 6 C 10.4891 5.3027 0.0 0
M  V30 7 N 12.0291 5.3027 0.0 0
M  V30 8 O 9.7190 3.9689 0.0 0
M  V30 9 C 12.7991 3.9689 0.0 0
M  V30 10 C 5.8690 7.9701 0.0 0
M  V30 11 I 10.4891 10.6375 0.0 0
M  V30 12 N 3.5673 3.8080 0.0 0
M  V30 13 C 5.0990 3.9689 0.0 0
M  V30 14 N 3.2471 2.3017 0.0 0
M  V30 15 C 5.7253 2.5621 0.0 0
M  V30 16 C 4.5809 1.5317 0.0 0
M  V30 17 C 2.5369 4.9525 0.0 0
M  V30 18 C 1.0306 4.6322 0.0 0
M  V30 19 N 3.0127 6.4171 0.0 0
M  V30 20 C 0.0000 5.7768 0.0 0
M  V30 21 C 1.9823 7.5616 0.0 0
M  V30 22 C 0.4760 7.2413 0.0 0
M  V30 23 C 8.1790 6.6364 0.0 0
M  V30 24 C 9.7190 6.6364 0.0 0
M  V30 25 C 7.4090 7.9701 0.0 0
M  V30 26 C 10.4891 7.9701 0.0 0
M  V30 27 C 8.1790 9.3037 0.0 0
M  V30 28 C 9.7190 9.3037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 23
M  V30 5 1 4 18
M  V30 6 1 5 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 1 10 25
M  V30 12 1 11 28
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 17
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 736995-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 500009-01-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7099411
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rynaxypyr: A new insecticidal anthranilic diamide that acts as a potent
and selective ryanodine receptor activator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lahm, George P.; Stevenson, Thomas M.; Selby, Thomas P.; Freudenberger,
John H.; Cordova, Daniel; Flexner, Lindsey; Bellin, Cheryl A.; Dubas,
Christine M.; Smith, Ben K.; Hughes, Kenneth A.; Hollingshaus, J. Gary;
Clark, Christopher E.; Benner, Eric A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2007), 17(22), 6274-6279

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorocarbonyl)benzoate
C9H7ClO3
7377-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(methylamino)carbonyl]benzoate
C10H11NO3
23754-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7377-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23754-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorocarbonyl)benzoate
C9H7ClO3
7377-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(methylamino)carbonyl]benzoate
C10H11NO3
23754-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7377-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23754-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20585787
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhenium-Catalyzed Phthalide Synthesis from Benzamides and Aldehydes via
C-H Bond Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jia, Bing; Yang, Yunhui; Jin, Xiqing; Mao, Guoliang; Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(16), 6259-6263

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(chlorocarbonyl)benzoate
C9H7ClO3
7377-26-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 O 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 C 1.3337 1.5400 0.0 0
M  V30 6 Cl 1.3337 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(methylamino)carbonyl]benzoate
C10H11NO3
23754-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7377-26-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23754-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14108186
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. methyl 4-(methylcarbamoyl) benzoate 1f. White
solid. Yield: (60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME253 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyltin dichloride
C2H6Cl2Sn
753-73-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Sn 1.5400 1.5400 0.0 0
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 C 3.0800 1.5400 0.0 0
M  V30 4 Cl 1.5400 0.0000 0.0 0
M  V30 5 Cl 1.5400 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C6H14N2S4Sn
1448221-71-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3791 0.0000 0.0 0 CHG=-1 VAL=4
M  V30 2 C 4.3791 4.8287 0.0 0 CHG=-1 VAL=4
M  V30 3 N 1.1522 3.0171 0.0 0
M  V30 4 C 0.0000 2.3544 0.0 0
M  V30 5 N 7.6060 3.0171 0.0 0
M  V30 6 C 8.7548 2.3544 0.0 0
M  V30 7 Sn 4.3791 2.4143 0.0 0 CHG=4 VAL=6
M  V30 8 S 3.2868 1.3254 0.0 0 CHG=-1 VAL=2
M  V30 9 S 5.4680 1.3254 0.0 0 CHG=-1 VAL=2
M  V30 10 S 5.4680 3.5033 0.0 0 VAL=3
M  V30 11 S 3.2868 3.5033 0.0 0 VAL=3
M  V30 12 C 2.1979 2.4143 0.0 0
M  V30 13 C 6.5603 2.4143 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 7
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 753-73-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1448221-71-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-318-CAS-2026075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, properties and spectroscopic characterization of some
diorganotin(IV) dithiocarbamates complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jain, Disha; Chaturvedi, Alok; Upadhyay, Rajesh Kumar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Research Journal of Pharmaceutical, Biological and Chemical Sciences
(2012), 3(3), 1311-1318

$RFMT $RIREG SCHEME254 STEP1
$RXN



  3  1
$MOL
3-(Trifluoromethyl)aniline
C7H6F3N
98-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 F 2.1038 4.4137 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 0.5638 1.7464 0.0 0
M  V30 5 N 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-3-[[3-(trifluoromethyl)phenyl]amino]-1H-pyrrole-2,5-dione
C12H9F3N2O2
920874-75-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 4.0286 0.0 0
M  V30 2 O 9.7293 5.3914 0.0 0
M  V30 3 C 11.9713 2.9016 0.0 0
M  V30 4 O 10.2960 0.0000 0.0 0
M  V30 5 C 1.3338 4.0286 0.0 0
M  V30 6 F 0.5638 2.6949 0.0 0
M  V30 7 F 0.0000 4.7986 0.0 0
M  V30 8 F 2.1038 5.3624 0.0 0
M  V30 9 C 8.0023 3.2586 0.0 0
M  V30 10 C 9.4091 3.8850 0.0 0
M  V30 11 C 8.1633 1.7270 0.0 0
M  V30 12 N 10.4397 2.7405 0.0 0
M  V30 13 C 9.6697 1.4068 0.0 0
M  V30 14 C 5.3348 3.2586 0.0 0
M  V30 15 C 4.0012 4.0286 0.0 0
M  V30 16 C 5.3348 1.7185 0.0 0
M  V30 17 C 2.6675 3.2586 0.0 0
M  V30 18 C 4.0012 0.9485 0.0 0
M  V30 19 C 2.6675 1.7185 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 14
M  V30 3 2 2 10
M  V30 4 1 3 12
M  V30 5 2 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 17
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-16-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920874-75-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8276601
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of fused pyrrolo[3,4-d]tetrahydropyrimidine derivatives by
proline-catalyzed multicomponent reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zhi-Peng; Wang, Hai-Bo; Wang, Yu-Qin; Zhu, Qiu-Hua; Xie, Yang; Liu,
Shu-Wen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(29), 4379-4385

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
3-Chlorobenzonitrile
C7H4ClN
766-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 N 6.6687 3.8501 0.0 0
M  V30 3 Cl 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-methylbenzenecarbothioamide
C8H8ClNS
1290535-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 S 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 C 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 766-84-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1290535-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26240766
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12135-76-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 349081-21-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a mixture of nitrile (1 mmol) in
C6(mim)2Cl2 (1.1 mmol), ammonium sulfide (1.2 mmol) was added. The
resulting mixture was stirred at 70 °C for the appropriate time shown in
Table 2. After the completion of the reaction, as indicated by TLC, amine
(5 mmol) was added to the reaction and stirred at 70 °C for 10 min to 5 h
(Table 3). Then the reaction took place, was quenched with ice-water (10
ml) and stirred at room temperature for 10 min. The above mixture was
extracted with ethyl acetate (3 × 5 ml) and the organic layers were
combined. When the residue was dried and concentrated in vacuo, it was
chromatographied on silica gel (n-heptane/ethyl acetate as eluent) to
afford the pure products in 70-95% yields. Compound: 3c, Yield (%): 95,
Time (min): 10.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, ionic liquid used (catalytic media)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient and green protocol for the synthesis of thioamides in
C6(mim)2Cl2 as a dicationic ionic liquid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khosropour, A. R.; Noei, J.; Mirjafari, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Iranian Chemical Society (2010), 7(3), 752-758

$RFMT $RIREG SCHEME256 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Benzoylbenzoyl chloride
C14H9ClO2
77301-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 C 9.3359 1.5400 0.0 0
M  V30 4 Cl 9.3359 0.0000 0.0 0
M  V30 5 O 10.6695 2.3100 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 10 C 6.6684 4.6201 0.0 0
M  V30 11 C 8.0022 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzamide, 3-benzoyl-N-methyl-
C15H13NO2
1427042-16-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 4.0012 0.0000 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 N 10.6697 2.3101 0.0 0
M  V30 5 O 9.3360 0.0000 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 6.6685 4.6201 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 0.0000 2.3101 0.0 0
M  V30 17 C 1.3337 4.6201 0.0 0
M  V30 18 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 10
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77301-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427042-16-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-3103018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation of amides from acid chloride:
MeNH2 methanol solution (33.3%) (1.5 equiv.), acid chloride (1.0 equiv.),
Et3N (2.0 equiv.) and Et2O (0.5 M) were added into a round bottom flask
capped with a septum. The mixture was stirred at room temperature. After
1 h, the crude reaction mixture was extracted with Et2O, purified by
flash chromatography. 3-benzoyl-N-methylbenzamide 1k. White solid. Yield:
(60-95%).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Re/Mg Bimetallic Tandem Catalysis for [4+2] Annulation of Benzamides and
Alkynes via C-H/N-H Functionalization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Qiuzheng; Xia, Dexin; Jin, Xiqing; Zhang, Qing; Sun, Xiao-Qiang;
Wang, Congyang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2013), 135(12), 4628-4631

$RFMT $RIREG SCHEME257 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1H-indole-3-acetate
C12H13NO2
778-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7532 1.6412 0.0 0
M  V30 2 C 7.0869 2.4112 0.0 0
M  V30 3 O 8.4205 1.6412 0.0 0
M  V30 4 O 7.0869 3.9511 0.0 0
M  V30 5 C 9.7543 2.4112 0.0 0
M  V30 6 C 11.0879 1.6412 0.0 0
M  V30 7 C 3.0127 1.7848 0.0 0
M  V30 8 C 4.4196 2.4112 0.0 0
M  V30 9 C 1.9823 2.9292 0.0 0
M  V30 10 C 2.5368 0.3202 0.0 0
M  V30 11 C 4.2585 3.9428 0.0 0
M  V30 12 N 2.7523 4.2630 0.0 0
M  V30 13 C 0.4759 2.6090 0.0 0
M  V30 14 C 1.0304 0.0000 0.0 0
M  V30 15 C 0.0000 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-3-acetamide
C11H12N2O
132906-25-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 1.6412 0.0 0
M  V30 2 C 7.0869 2.4112 0.0 0
M  V30 3 N 8.4206 1.6412 0.0 0
M  V30 4 O 7.0869 3.9512 0.0 0
M  V30 5 C 9.7544 2.4112 0.0 0
M  V30 6 C 3.0127 1.7849 0.0 0
M  V30 7 C 4.4196 2.4112 0.0 0
M  V30 8 C 1.9823 2.9292 0.0 0
M  V30 9 C 2.5368 0.3202 0.0 0
M  V30 10 C 4.2586 3.9429 0.0 0
M  V30 11 N 2.7523 4.2630 0.0 0
M  V30 12 C 0.4759 2.6091 0.0 0
M  V30 13 C 1.0306 0.0000 0.0 0
M  V30 14 C 0.0000 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 11
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 778-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132906-25-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8051745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To a solution of ethyl 3-indoleacetate (4.064 g, 20 mmol) in MeOH 120 mL
was added 40 mL 40% MeNH2/MeOH solution. The mixture was stirred at rt
for 72h until no ethyl 3-indoleacetate remained. Concentrated and
purified by flash chromatography on silica gel using 70-90% EtOAc in
hexane to provide the title compound.
2-(1H-indol-3-yl)-N-methylacetamide. White solid, yield 95% IR (thin
film) 3406, 3279, 1636, 1538, 1411, 1340, 1172, 1101, 1010 cm-1; 1H NMR
(500 MHz, CDCl3) δ: 8.72 (s, 1H), 7.58 (d, J = 6.9 Hz, 1H), 7.44 (d, J =
7.4 Hz, 1H), 7.33 - 7.22 (m, 1H), 7.22 - 7.11 (m, 2H), 5.76 (s, 1H), 3.78
(s, 2H), 2.74 (s, 3H); 13C NMR (126 MHz, CDCl3) 172.46, 136.58, 127.13,
124.10, 122.69, 120.16, 118.79, 111.62, 108.90, 33.35, 26.51; HRMS
(ESI-TOF) calculated for C11H13N2O [M+H]+ m/z 189.1022, found 189.1023.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Copper-Catalyzed Construction of Aryl Pyrroloindolines
via an Arylation-Cyclization Cascade
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Shaolin; MacMillan, David W. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2012), 134(26), 10815-10818

$RFMT $RIREG SCHEME258 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylpropyl β-oxobenzenepropanoate
C13H16O3
81749-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 O 8.0022 2.3101 0.0 0
M  V30 6 O 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 12.0033 3.0801 0.0 0
M  V30 10 C 10.6697 0.7700 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylpropyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C14H19NO2
2304416-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 C 2.6673 0.0000 0.0 0
M  V30 6 O 8.0022 3.0801 0.0 0
M  V30 7 O 6.6685 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 10.6697 3.0801 0.0 0
M  V30 10 C 12.0033 2.3101 0.0 0
M  V30 11 C 10.6697 4.6201 0.0 0
M  V30 12 C 2.6673 3.0801 0.0 0
M  V30 13 C 1.3337 2.3101 0.0 0
M  V30 14 C 2.6673 4.6201 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 1.3337 5.3901 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 81749-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-23-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946815
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME259 STEP1
$RXN



  2  1
$MOL
rel-(1R,5S,6S,8S)-8-Chloro-1,6-dimethylbicyclo[3.2.1]octane-6-carboxylic acid
C11H17ClO2
819078-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.4311 2.5791 0.0 0
M  V30 2 O 5.4311 1.0391 0.0 0
M  V30 3 O 6.7648 3.3491 0.0 0
M  V30 4 C 4.2993 4.8759 0.0 0
M  V30 5 Cl 0.1974 4.9352 0.0 0
M  V30 6 C 0.0000 2.5013 0.0 0
M  V30 7 C 2.4848 2.9190 0.0 0 CFG=1
M  V30 8 C 4.0974 3.3491 0.0 0 CFG=2
M  V30 9 C 1.1455 3.7216 0.0 0 CFG=1
M  V30 10 C 1.8202 1.2043 0.0 0
M  V30 11 C 3.0080 2.5123 0.0 0
M  V30 12 C 1.5383 2.4314 0.0 0 CFG=2
M  V30 13 C 2.2238 0.0000 0.0 0
M  V30 14 C 0.8758 0.8030 0.0 0
M  V30 15 H 2.6991 4.4439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 8 4 CFG=1
M  V30 5 1 9 5 CFG=3
M  V30 6 1 12 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 15 CFG=3
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 7 8 9 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,5S,6S,8S)-8-Chloro-N,1,6-trimethylbicyclo[3.2.1]octane-6-carboxamide
C12H20ClNO
726188-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7102 3.8371 0.0 0
M  V30 2 N 6.4802 5.1708 0.0 0
M  V30 3 O 6.4802 2.5035 0.0 0
M  V30 4 C 8.0202 5.1708 0.0 0
M  V30 5 C 3.5817 5.2602 0.0 0
M  V30 6 Cl 0.0000 3.2607 0.0 0
M  V30 7 C 1.0458 1.0543 0.0 0
M  V30 8 C 4.1702 3.8371 0.0 0 CFG=2
M  V30 9 C 2.9889 2.6583 0.0 0 CFG=1
M  V30 10 C 3.6453 2.5677 0.0 0
M  V30 11 C 1.4279 2.6837 0.0 0 CFG=1
M  V30 12 C 3.2707 0.8411 0.0 0
M  V30 13 C 2.4131 1.7628 0.0 0 CFG=1
M  V30 14 C 4.2223 0.0000 0.0 0
M  V30 15 C 2.6535 0.0214 0.0 0
M  V30 16 H 2.4119 4.0862 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 8 5 CFG=1
M  V30 6 1 11 6 CFG=3
M  V30 7 1 13 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 16 CFG=3
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 8 9 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 819078-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 726188-19-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4514527
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 8-substituted bicyclo[3.2.1]octane-6-carboxylic acids and
anti-convulsant properties of the corresponding amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, J. A.; Harris, J.; Miller, A. A.; Ullah, G. M.; Welsh, G. M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(22), 4323-4327

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-5-(bromomethyl)quinoline
C10H7Br2N
823803-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 Br 6.9300 5.3349 0.0 0
M  V30 3 Br 0.0000 4.0011 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 4.6200 4.0011 0.0 0
M  V30 7 C 4.6200 1.3338 0.0 0
M  V30 8 C 1.5400 4.0011 0.0 0
M  V30 9 N 1.5400 1.3338 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 3.8500 0.0000 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
8-Bromo-N-methyl-5-quinolinemethanamine
C11H11BrN2
823803-55-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 N 6.9300 5.3349 0.0 0
M  V30 3 C 8.4700 5.3349 0.0 0
M  V30 4 Br 0.0000 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 N 1.5400 1.3338 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 13 C 2.3100 5.3349 0.0 0
M  V30 14 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 823803-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 823803-55-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11009628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl product formation from cross-coupling in palladium-catalyzed
borylation of a Boc-protected aminobromoquinoline compound
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fang, Hao; Yan, Jun; Wang, Binghe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2004), 9(3), 178-184

$RFMT $RIREG SCHEME261 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-hydroxy-3-[(2-methylpropyl)[[2-(methylthio)-6-benzoxazolyl]...
C27H37N3O6S2
849611-71-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.0812 6.8291 0.0 0 VAL=6
M  V30 2 N 6.8512 8.1628 0.0 0
M  V30 3 O 4.7474 7.5991 0.0 0
M  V30 4 O 7.4148 6.0591 0.0 0
M  V30 5 C 8.3912 8.1628 0.0 0
M  V30 6 C 6.0812 9.4964 0.0 0
M  V30 7 C 9.1612 6.8291 0.0 0
M  V30 8 C 4.5412 9.4964 0.0 0
M  V30 9 C 10.7012 6.8291 0.0 0
M  V30 10 O 8.3912 5.4955 0.0 0
M  V30 11 C 3.7712 10.8302 0.0 0
M  V30 12 C 3.7712 8.1628 0.0 0
M  V30 13 C 11.4712 8.1628 0.0 0
M  V30 14 N 11.4712 5.4955 0.0 0
M  V30 15 C 13.0112 5.4955 0.0 0
M  V30 16 O 13.7812 4.1617 0.0 0
M  V30 17 O 13.7812 6.8291 0.0 0
M  V30 18 C 15.3212 4.1617 0.0 0
M  V30 19 C 15.3212 2.6217 0.0 0
M  V30 20 C 16.8612 4.1617 0.0 0
M  V30 21 C 15.3212 5.7017 0.0 0
M  V30 22 S 0.0002 1.5400 0.0 0
M  V30 23 C 0.0000 0.0000 0.0 0
M  V30 24 C 3.0012 4.1617 0.0 0
M  V30 25 C 3.7712 2.8281 0.0 0
M  V30 26 C 3.7712 5.4955 0.0 0
M  V30 27 O 1.4947 3.8415 0.0 0
M  V30 28 N 2.7406 1.6837 0.0 0
M  V30 29 C 5.3112 2.8281 0.0 0
M  V30 30 C 5.3112 5.4955 0.0 0
M  V30 31 C 1.3338 2.3100 0.0 0
M  V30 32 C 6.0812 4.1617 0.0 0
M  V30 33 C 10.7012 9.4964 0.0 0
M  V30 34 C 9.1612 9.4964 0.0 0
M  V30 35 C 11.4712 10.8302 0.0 0
M  V30 36 C 8.3912 10.8302 0.0 0
M  V30 37 C 10.7012 12.1638 0.0 0
M  V30 38 C 9.1612 12.1638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 30
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 13 33
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 1 22 31
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 1 24 27
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 2 30 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [2-hydroxy-3-[[[2-(methylamino)-6-benzoxazolyl]sulfonyl](2-met...
C27H38N4O6S
849611-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.0812 6.8291 0.0 0 VAL=6
M  V30 2 N 6.8512 8.1628 0.0 0
M  V30 3 O 4.7474 7.5991 0.0 0
M  V30 4 O 7.4148 6.0591 0.0 0
M  V30 5 C 8.3912 8.1628 0.0 0
M  V30 6 C 6.0812 9.4964 0.0 0
M  V30 7 C 9.1612 6.8291 0.0 0
M  V30 8 C 4.5412 9.4964 0.0 0
M  V30 9 C 10.7012 6.8291 0.0 0
M  V30 10 O 8.3912 5.4955 0.0 0
M  V30 11 C 3.7712 10.8302 0.0 0
M  V30 12 C 3.7712 8.1628 0.0 0
M  V30 13 C 11.4712 8.1628 0.0 0
M  V30 14 N 11.4712 5.4955 0.0 0
M  V30 15 C 13.0112 5.4955 0.0 0
M  V30 16 O 13.7812 4.1617 0.0 0
M  V30 17 O 13.7812 6.8291 0.0 0
M  V30 18 C 15.3212 4.1617 0.0 0
M  V30 19 C 15.3212 5.7017 0.0 0
M  V30 20 C 16.8612 4.1617 0.0 0
M  V30 21 C 15.3212 2.6217 0.0 0
M  V30 22 N 0.0000 1.5400 0.0 0
M  V30 23 C 0.0000 0.0000 0.0 0
M  V30 24 C 3.0012 4.1617 0.0 0
M  V30 25 C 3.7712 2.8281 0.0 0
M  V30 26 C 3.7712 5.4955 0.0 0
M  V30 27 O 1.4947 3.8415 0.0 0
M  V30 28 N 2.7406 1.6837 0.0 0
M  V30 29 C 5.3112 2.8281 0.0 0
M  V30 30 C 5.3112 5.4955 0.0 0
M  V30 31 C 1.3338 2.3100 0.0 0
M  V30 32 C 6.0812 4.1617 0.0 0
M  V30 33 C 10.7012 9.4964 0.0 0
M  V30 34 C 11.4712 10.8302 0.0 0
M  V30 35 C 9.1612 9.4964 0.0 0
M  V30 36 C 10.7012 12.1638 0.0 0
M  V30 37 C 8.3912 10.8302 0.0 0
M  V30 38 C 9.1612 12.1638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 30
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 9 14
M  V30 15 1 13 33
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 22 23
M  V30 24 1 22 31
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 1 24 27
M  V30 28 1 25 28
M  V30 29 2 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 2 30 32
M  V30 35 2 33 34
M  V30 36 1 33 35
M  V30 37 1 34 36
M  V30 38 2 35 37
M  V30 39 2 36 38
M  V30 40 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 849611-71-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 849611-76-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-4014289
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Subsequently, a suspension of 16.6 kg wet intermediate e-2 was charged
into a 150 L reactor. Then 150 kg EtOAc was added and the suspension was
stirred while heating to 78° C. The water in the reaction mixture was
removed by an azeotropic distillation. The distillation was stopped when
KF of the reaction mixture showed less then 0.15 w/w % water. The reactor
contained about 4800 g of intermediate e-2 TIC 1662 after the azeotropic
distillation (±95% yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Methods for the preparation of aminohydroxypropyl
benzooxazolesulfonamides as intermediates in the preparation of HIV
protease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Kock, Herman Augustinus; Filliers, Walter Ferdinand Maria; Aelterman,
Wim Albert Alex
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005030739 A1 2005-04-07

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-Methoxy-3-(phenylmethoxy)phenyl]cyclopropanecarboxaldehyde
C18H18O3
853771-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.1798 6.1417 0.0 0
M  V30 2 O 0.0000 7.1316 0.0 0
M  V30 3 O 7.2469 4.0011 0.0 0
M  V30 4 C 8.0169 5.3347 0.0 0
M  V30 5 O 5.7069 1.3338 0.0 0
M  V30 6 C 4.9369 0.0000 0.0 0
M  V30 7 C 2.6269 6.6685 0.0 0
M  V30 8 C 3.8066 7.6583 0.0 0
M  V30 9 C 2.3594 8.1851 0.0 0
M  V30 10 C 3.3969 5.3347 0.0 0
M  V30 11 C 4.9369 5.3347 0.0 0
M  V30 12 C 2.6269 4.0011 0.0 0
M  V30 13 C 5.7069 4.0011 0.0 0
M  V30 14 C 3.3969 2.6674 0.0 0
M  V30 15 C 4.9369 2.6674 0.0 0
M  V30 16 C 9.5569 5.3347 0.0 0
M  V30 17 C 10.3269 4.0011 0.0 0
M  V30 18 C 10.3269 6.6685 0.0 0
M  V30 19 C 11.8669 4.0011 0.0 0
M  V30 20 C 11.8669 6.6685 0.0 0
M  V30 21 C 12.6369 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 5 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-2-[1-[4-Methoxy-3-(phenylmethoxy)phenyl]cyclopropyl]ethenamine
C19H21NO2
853771-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.4571 6.1417 0.0 0
M  V30 2 C 12.6368 7.1316 0.0 0
M  V30 3 N 14.0839 6.6049 0.0 0
M  V30 4 O 5.3900 4.0011 0.0 0
M  V30 5 C 4.6200 5.3347 0.0 0
M  V30 6 O 6.9300 1.3338 0.0 0
M  V30 7 C 7.7000 0.0000 0.0 0
M  V30 8 C 10.0100 6.6685 0.0 0
M  V30 9 C 10.2773 8.1851 0.0 0
M  V30 10 C 8.8302 7.6583 0.0 0
M  V30 11 C 9.2400 5.3347 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 10.0100 4.0011 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 9.2400 2.6674 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 3.0800 5.3347 0.0 0
M  V30 18 C 2.3100 4.0011 0.0 0
M  V30 19 C 2.3100 6.6685 0.0 0
M  V30 20 C 0.7700 4.0011 0.0 0
M  V30 21 C 0.7700 6.6685 0.0 0
M  V30 22 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 16
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 853771-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 853771-63-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27123052
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7487-88-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5: Methylamine (2.0M in THF, 44.6 mL, 89.3 mmol) was added to a
mixture of 1-[3-(benzyloxy)-4-methoxyphenyl]cyclopropanecarbaldehyde,
prepared in step 4, (12.60 g, 44.6 mmol) and MgSO4 (17 g) in
1,2-dichloroethane (45 mL). The mixture was stirred at rt. over night for
22 h. The solid material was filtered off, rinsed with ether and the
organic phase was concentrated to give
((1E)-{1-[3-(benzyloxy)-4-methoxyphenyl]cyclopropyl}methylene)methylamine
(12.45 g, 95%) as a yellow solid. 1H NMR (400 MHz, CHLOROFORM-D) ppm
1.05-1.08 (m, 2H) 1.20-1.22 (m, 2H) 3.20 (d, J=1.51 Hz, 3H) 3.86 (s, 3H)
5.13 (s, 2 H) 6.82-6.85 (m, 1 H) 6.86-6.89 (m, 2H) 7.27-7.32 (m, 1H)
7.34-7.38 (m, 2H) 7.42-7.46 (m, 2H) 7.48-7.51 (m, 1 H); GC-MS (EI) for
C19H21NO2; m/z 295 (M+).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted urea-octahydroindoles as antagonists of
melanin concentrating hormone receptor 1 (MCH1R)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Browning, Andrew; Nilsson, Jonas; Scobie, Martin; Angbrant, Johan;
Ringom, Rune
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005051381 A1 2005-06-09

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-5-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-2-(methylthio)pyrimidine
C10H9ClN4OS
866884-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.6873 0.0000 0.0 0
M  V30 2 S 11.3073 2.6674 0.0 0
M  V30 3 C 12.0773 4.0011 0.0 0
M  V30 4 C 6.6873 2.6674 0.0 0
M  V30 5 C 7.4573 1.3336 0.0 0
M  V30 6 C 7.4573 4.0011 0.0 0
M  V30 7 N 8.9973 1.3336 0.0 0
M  V30 8 N 8.9973 4.0011 0.0 0
M  V30 9 C 9.7673 2.6674 0.0 0
M  V30 10 C 5.1473 2.6674 0.0 0
M  V30 11 O 4.2421 3.9133 0.0 0
M  V30 12 N 4.2421 1.4214 0.0 0
M  V30 13 C 2.7774 3.4374 0.0 0
M  V30 14 N 2.7774 1.8974 0.0 0
M  V30 15 C 1.5315 4.3425 0.0 0
M  V30 16 C 0.0000 4.5036 0.0 0
M  V30 17 C 0.9052 5.7494 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 1 2 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(5-Cyclopropyl-1,3,4-oxadiazol-2-yl)-N-methyl-2-(methylthio)-4-pyrimidinamine
C11H13N5OS
1089723-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6873 1.3336 0.0 0
M  V30 2 C 7.4573 0.0000 0.0 0
M  V30 3 S 11.3074 4.0011 0.0 0
M  V30 4 C 12.0774 5.3347 0.0 0
M  V30 5 C 5.1473 4.0011 0.0 0
M  V30 6 O 4.2421 5.2470 0.0 0
M  V30 7 N 4.2421 2.7552 0.0 0
M  V30 8 C 2.7774 4.7711 0.0 0
M  V30 9 N 2.7774 3.2311 0.0 0
M  V30 10 C 6.6873 4.0011 0.0 0
M  V30 11 C 7.4573 2.6673 0.0 0
M  V30 12 C 7.4573 5.3347 0.0 0
M  V30 13 N 8.9973 2.6673 0.0 0
M  V30 14 N 8.9973 5.3347 0.0 0
M  V30 15 C 9.7673 4.0011 0.0 0
M  V30 16 C 1.5315 5.6763 0.0 0
M  V30 17 C 0.9052 7.0831 0.0 0
M  V30 18 C 0.0000 5.8372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 8 16
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 866884-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1089723-78-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12135479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel and orally active 5-(1,3,4-oxadiazol-2-yl)pyrimidine derivatives as
selective FLT3 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishida, Hiroshi; Isami, Shoichi; Matsumura, Tsutomu; Umehara, Hiroshi;
Yamashita, Yoshinori; Kajita, Jiro; Fuse, Eiichi; Kiyoi, Hitoshi; Naoe,
Tomoki; Akinaga, Shiro; Shiotsu, Yukimasa; Arai, Hitoshi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(20), 5472-5477

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4,5-Trimethoxybenzaldehyde
C10H12O4
86-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 6.6686 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3,4,5-Trimethoxyphenyl)methylene]methanamine
C11H15NO3
73608-65-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 O 4.0012 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9302 0.0 0
M  V30 7 C 6.6685 5.3901 0.0 0
M  V30 8 N 8.0023 4.6201 0.0 0
M  V30 9 C 9.3360 5.3901 0.0 0
M  V30 10 C 2.6675 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 4.0012 5.3901 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8 CFG=2
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 73608-65-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17668090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of diketoindenoisoquinolines as antineoplastic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cushman, Mark S.; Nagafuji, Pamela M.; Jayaraman, Muthusamy; Pommier,
Yves G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000021537 A1 2000-04-20

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
1-Cyclopropyl-1,4-dihydro-6-iodo-4-oxo-3-quinolinecarboxylic acid
C13H10INO3
869310-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 7.4937 0.0 0
M  V30 2 C 1.3337 5.9537 0.0 0
M  V30 3 O 0.0000 5.1837 0.0 0
M  V30 4 O 1.3337 7.4937 0.0 0
M  V30 5 I 9.3359 5.9537 0.0 0
M  V30 6 C 5.3348 3.6437 0.0 0
M  V30 7 N 4.0011 2.8737 0.0 0
M  V30 8 C 5.3348 5.1837 0.0 0
M  V30 9 C 6.6684 2.8737 0.0 0
M  V30 10 C 2.6675 3.6437 0.0 0
M  V30 11 C 4.0011 5.9537 0.0 0
M  V30 12 C 6.6684 5.9537 0.0 0
M  V30 13 C 8.0022 3.6437 0.0 0
M  V30 14 C 2.6675 5.1837 0.0 0
M  V30 15 C 8.0022 5.1837 0.0 0
M  V30 16 C 4.0011 1.3337 0.0 0
M  V30 17 C 4.7711 0.0000 0.0 0
M  V30 18 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 16
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Cyclopropyl-1,4-dihydro-6-iodo-N-methyl-4-oxo-3-quinolinecarboxamide
C14H13IN2O2
2304353-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 7.4938 0.0 0
M  V30 2 C 8.0023 5.9538 0.0 0
M  V30 3 N 9.3360 5.1838 0.0 0
M  V30 4 O 8.0023 7.4938 0.0 0
M  V30 5 C 10.6697 5.9538 0.0 0
M  V30 6 I 0.0000 5.9538 0.0 0
M  V30 7 C 4.0012 3.6437 0.0 0
M  V30 8 N 5.3348 2.8737 0.0 0
M  V30 9 C 4.0012 5.1838 0.0 0
M  V30 10 C 2.6673 2.8737 0.0 0
M  V30 11 C 6.6685 3.6437 0.0 0
M  V30 12 C 5.3348 5.9538 0.0 0
M  V30 13 C 2.6673 5.9538 0.0 0
M  V30 14 C 1.3337 3.6437 0.0 0
M  V30 15 C 6.6685 5.1838 0.0 0
M  V30 16 C 1.3337 5.1838 0.0 0
M  V30 17 C 5.3348 1.3337 0.0 0
M  V30 18 C 4.5648 0.0000 0.0 0
M  V30 19 C 6.1048 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 6 16
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 17
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 869310-69-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304353-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20110920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and structure-activity relationships of novel
macrolones: Hybrids of 2-fluoro 9-oxime ketolides and carbamoyl
quinolones with highly improved activity against resistant pathogens
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Cong-Xuan; Lv, Wei; Li, Ya-Xin; Fan, Bing-Zhi; Han, Xu; Kong,
Fan-Sheng; Tian, Jing-Chao; Cushman, Mark; Liang, Jian-Hua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 1691-20

$RFMT $RIREG SCHEME266 STEP1
$RXN



  3  1
$MOL
L-Homophenylalanine
C10H13NO2
943-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 2.6674 5.3900 0.0 0
M  V30 3 C 2.6674 6.9300 0.0 0 CFG=2
M  V30 4 C 1.3338 7.7000 0.0 0
M  V30 5 N 4.0011 7.7000 0.0 0
M  V30 6 O 0.0000 6.9300 0.0 0
M  V30 7 O 1.3338 9.2400 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 5.3349 2.3100 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 5.3349 0.7700 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=1
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl 3-chloro-4-(1-methylethoxy)benzoate
C16H10ClF5O3
869566-16-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1601 4.0012 0.0 0
M  V30 2 C 6.9302 2.6675 0.0 0
M  V30 3 O 6.1601 1.3338 0.0 0
M  V30 4 F 4.6201 1.3338 0.0 0
M  V30 5 F 4.6201 6.6687 0.0 0
M  V30 6 F 1.5400 1.3338 0.0 0
M  V30 7 F 1.5400 6.6687 0.0 0
M  V30 8 F 0.0000 4.0012 0.0 0
M  V30 9 Cl 11.5503 0.0000 0.0 0
M  V30 10 O 13.0903 2.6675 0.0 0
M  V30 11 C 13.8603 4.0012 0.0 0
M  V30 12 C 13.0903 5.3348 0.0 0
M  V30 13 C 15.4003 4.0012 0.0 0
M  V30 14 C 4.6201 4.0012 0.0 0
M  V30 15 C 3.8501 2.6675 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 8.4702 2.6675 0.0 0
M  V30 21 C 9.2402 1.3338 0.0 0
M  V30 22 C 9.2402 4.0012 0.0 0
M  V30 23 C 10.7802 1.3338 0.0 0
M  V30 24 C 10.7802 4.0012 0.0 0
M  V30 25 C 11.5503 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 2 3
M  V30 4 1 2 20
M  V30 5 1 4 15
M  V30 6 1 5 16
M  V30 7 1 6 17
M  V30 8 1 7 18
M  V30 9 1 8 19
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 1 10 25
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αS)-α-[[3-Chloro-4-(1-methylethoxy)benzoyl]amino]-N-methylbenzenebutanamide
C21H25ClN2O3
1208245-24-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7001 5.3348 0.0 0
M  V30 2 N 6.9301 4.0011 0.0 0
M  V30 3 O 6.9301 6.6684 0.0 0
M  V30 4 C 5.3901 4.0011 0.0 0 CFG=1
M  V30 5 C 4.6201 2.6675 0.0 0
M  V30 6 C 4.6201 5.3348 0.0 0
M  V30 7 N 5.3901 1.3337 0.0 0
M  V30 8 O 3.0800 2.6675 0.0 0
M  V30 9 C 3.0800 5.3348 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 Cl 12.3201 8.0022 0.0 0
M  V30 12 O 13.8602 5.3348 0.0 0
M  V30 13 C 14.6302 4.0011 0.0 0
M  V30 14 C 13.8602 2.6675 0.0 0
M  V30 15 C 16.1702 4.0011 0.0 0
M  V30 16 C 9.2401 5.3348 0.0 0
M  V30 17 C 10.0101 6.6684 0.0 0
M  V30 18 C 10.0101 4.0011 0.0 0
M  V30 19 C 11.5501 6.6684 0.0 0
M  V30 20 C 11.5501 4.0011 0.0 0
M  V30 21 C 12.3201 5.3348 0.0 0
M  V30 22 C 2.3100 6.6684 0.0 0
M  V30 23 C 3.0800 8.0022 0.0 0
M  V30 24 C 0.7700 6.6684 0.0 0
M  V30 25 C 2.3100 9.3359 0.0 0
M  V30 26 C 0.0000 8.0022 0.0 0
M  V30 27 C 0.7700 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 22
M  V30 12 1 11 19
M  V30 13 1 12 13
M  V30 14 1 12 21
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 943-73-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 869566-16-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1208245-24-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13934762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of 3 in DMF (0.2 M) were added
amino acid (1.2 equiv.) and N, N-diisopropylethylamine (3 equiv.). The
reaction was monitored by LC/MS. After completion, amine (1.5 equiv.) and
HBTU (1.5 equiv.) were added to the reaction solution. The reaction
mixture was stirred for 4 h. The product was purified by either HPLC or
flash column chromatography. 3a – 3i (60-95% yield).
3-Chloro-4-isopropoxy-N-(1-(methylamino)-1-oxo-4-phenylbutan-2-yl)benzamide
(3f) 1H NMR (400 MHz, MeOD) δ 7.94 (d, J = 2.2, 1H), 7.81 (dd, J = 2.2,
8.7, 1H), 7.22 (m, 6H), 4.78 (dt, J = 6.1, 12.1, 1H), 4.50 (dd, J = 5.2,
9.2, 1H), 2.82 – 2.63 (m, 5H), 2.26 – 2.05 (m, 2H), 1.40 (d, J = 6.0,
6H); LRMS (M+H+) m/z 389.0.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of the First Potent and Selective Inhibitor of
Centromere-Associated Protein E: GSK923295
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qian, Xiangping; McDonald, Andrew; Zhou, Han-Jie; Adams, Nicholas D.;
Parrish, Cynthia A.; Duffy, Kevin J.; Fitch, Duke M.; Tedesco, Rosanna;
Ashcraft, Luke W.; Yao, Bing; Jiang, Hong; Huang, Jennifer K.; Marin,
Melchor V.; Aroyan, Carrie E.; Wang, Jianchao; Ahmed, Seyed; Burgess,
Joelle L.; Chaudhari, Amita M.; Donatelli, Carla A.; Darcy, Michael G.;
Ridgers, Lance H.; Newlander, Ken A.; Schmidt, Stanley J.; Chai, Deping;
Colon, Mariela; Zimmerman, Michael N.; Lad, Latesh; Sakowicz, Roman;
Schauer, Stephen; Belmont, Lisa; Baliga, Ramesh; Pierce, Daniel W.;
Finer, Jeffrey T.; Wang, Zhengping; Morgan, Bradley P.; Morgans, David J.
Jr.; Auger, Kurt R.; Sung, Chiu-Mei; Carson, Jeff D.; Luo, Lusong;
Hugger, Erin D.; Copeland, Robert A.; Sutton, David; Elliott, John D.;
Jackson, Jeffrey R.; Wood, Kenneth W.; Dhanak, Dashyant; Bergnes,
Gustave; Knight, Steven D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(1), 30-34

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methoxyphenyl)methyl β-oxobenzenepropanoate
C17H16O4
870673-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 6.6686 1.5400 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 O 6.6686 0.0000 0.0 0
M  V30 7 C 9.3359 1.5400 0.0 0
M  V30 8 O 14.6707 4.6201 0.0 0
M  V30 9 C 16.0045 3.8500 0.0 0
M  V30 10 C 2.6675 2.3100 0.0 0
M  V30 11 C 1.3338 1.5400 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 0.0000 2.3100 0.0 0
M  V30 14 C 1.3338 4.6201 0.0 0
M  V30 15 C 0.0000 3.8500 0.0 0
M  V30 16 C 10.6697 2.3100 0.0 0
M  V30 17 C 12.0034 1.5400 0.0 0
M  V30 18 C 10.6697 3.8500 0.0 0
M  V30 19 C 13.3370 2.3100 0.0 0
M  V30 20 C 12.0034 4.6201 0.0 0
M  V30 21 C 13.3370 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 16
M  V30 9 1 8 9
M  V30 10 1 8 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methoxyphenyl)methyl (2Z)-3-(methylamino)-3-phenyl-2-propenoate
C18H19NO3
2304416-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0
M  V30 4 C 6.6687 2.3101 0.0 0
M  V30 5 C 2.6675 0.0000 0.0 0
M  V30 6 O 8.0023 3.0801 0.0 0
M  V30 7 O 6.6687 0.7700 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 O 14.6708 5.3901 0.0 0
M  V30 10 C 16.0046 4.6201 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 2.6675 4.6201 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 1.3338 5.3901 0.0 0
M  V30 15 C 0.0000 3.0801 0.0 0
M  V30 16 C 0.0000 4.6201 0.0 0
M  V30 17 C 10.6698 3.0801 0.0 0
M  V30 18 C 10.6698 4.6201 0.0 0
M  V30 19 C 12.0035 2.3101 0.0 0
M  V30 20 C 12.0035 5.3901 0.0 0
M  V30 21 C 13.3372 3.0801 0.0 0
M  V30 22 C 13.3372 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 6 8
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 870673-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304416-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-19946818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Functionalized Imidazolium Salts via Iodine-Mediated
Annulations of Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xia, Biao; Chen, Wenjun; Zhao, Qiongli; Yu, Wenquan; Chang, Junbiao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(8), 2583-2587

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Silver, [12,17-bis(4-methylphenyl)-2,7-diphenyl-4-oxa-21,22,23-triazapentacyc...
C46H30AgN3O2
871237-67-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  52 63 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.7326 12.1618 0.0 0
M  V30 2 C 7.9555 0.0000 0.0 0
M  V30 3 C 17.4510 9.4955 0.0 0
M  V30 4 Ag 7.9555 9.4955 0.0 0 CHG=3 VAL=4
M  V30 5 C 6.6476 10.8035 0.0 0 CHG=-1 VAL=4
M  V30 6 N 6.6476 8.1876 0.0 0 CHG=-1 VAL=3
M  V30 7 N 9.2635 8.1876 0.0 0 VAL=4
M  V30 8 N 9.2635 10.8035 0.0 0 CHG=-1 VAL=3
M  V30 9 C 6.6509 12.2910 0.0 0
M  V30 10 C 5.1600 10.8001 0.0 0
M  V30 11 C 5.1600 8.1910 0.0 0
M  V30 12 C 6.6509 6.7001 0.0 0
M  V30 13 C 10.7510 8.1910 0.0 0
M  V30 14 C 9.2601 6.7001 0.0 0
M  V30 15 C 9.2601 12.2910 0.0 0
M  V30 16 C 10.7510 10.8001 0.0 0
M  V30 17 C 7.9555 12.8309 0.0 0
M  V30 18 O 5.4131 13.1833 0.0 0
M  V30 19 C 4.6201 9.4955 0.0 0
M  V30 20 C 4.2677 12.0380 0.0 0
M  V30 21 C 4.2677 6.9531 0.0 0
M  V30 22 C 7.9555 6.1601 0.0 0
M  V30 23 C 5.4131 5.8078 0.0 0
M  V30 24 C 11.2909 9.4955 0.0 0
M  V30 25 C 11.6433 6.9531 0.0 0
M  V30 26 C 10.4979 5.8078 0.0 0
M  V30 27 C 10.4979 13.1833 0.0 0
M  V30 28 C 11.6433 12.0380 0.0 0
M  V30 29 C 7.9555 14.3710 0.0 0
M  V30 30 C 9.2892 15.1410 0.0 0
M  V30 31 C 6.6218 15.1410 0.0 0
M  V30 32 C 9.2892 16.6810 0.0 0
M  V30 33 C 6.6218 16.6810 0.0 0
M  V30 34 C 7.9555 17.4510 0.0 0
M  V30 35 C 3.0801 9.4955 0.0 0
M  V30 36 C 2.3101 10.8292 0.0 0
M  V30 37 C 2.3101 8.1619 0.0 0
M  V30 38 C 0.7700 10.8292 0.0 0
M  V30 39 C 0.7700 8.1619 0.0 0
M  V30 40 C 0.0000 9.4955 0.0 0
M  V30 41 C 7.9555 4.6201 0.0 0
M  V30 42 C 6.6218 3.8501 0.0 0
M  V30 43 C 9.2892 3.8501 0.0 0
M  V30 44 C 6.6218 2.3101 0.0 0
M  V30 45 C 9.2892 2.3101 0.0 0
M  V30 46 C 7.9555 1.5400 0.0 0
M  V30 47 C 12.8309 9.4955 0.0 0
M  V30 48 C 13.6010 8.1619 0.0 0
M  V30 49 C 13.6010 10.8292 0.0 0
M  V30 50 C 15.1410 8.1619 0.0 0
M  V30 51 C 15.1410 10.8292 0.0 0
M  V30 52 C 15.9110 9.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 20
M  V30 2 1 2 46
M  V30 3 1 3 52
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 2 7 13
M  V30 13 1 7 14
M  V30 14 1 8 15
M  V30 15 1 8 16
M  V30 16 1 9 17
M  V30 17 1 9 18
M  V30 18 2 10 19
M  V30 19 1 10 20
M  V30 20 1 11 19
M  V30 21 2 11 21
M  V30 22 1 12 22
M  V30 23 2 12 23
M  V30 24 1 13 24
M  V30 25 1 13 25
M  V30 26 2 14 22
M  V30 27 1 14 26
M  V30 28 2 15 17
M  V30 29 1 15 27
M  V30 30 2 16 24
M  V30 31 1 16 28
M  V30 32 1 17 29
M  V30 33 1 18 20
M  V30 34 1 19 35
M  V30 35 1 21 23
M  V30 36 1 22 41
M  V30 37 1 24 47
M  V30 38 2 25 26
M  V30 39 2 27 28
M  V30 40 2 29 30
M  V30 41 1 29 31
M  V30 42 1 30 32
M  V30 43 2 31 33
M  V30 44 2 32 34
M  V30 45 1 33 34
M  V30 46 2 35 36
M  V30 47 1 35 37
M  V30 48 1 36 38
M  V30 49 2 37 39
M  V30 50 2 38 40
M  V30 51 1 39 40
M  V30 52 2 41 42
M  V30 53 1 41 43
M  V30 54 1 42 44
M  V30 55 2 43 45
M  V30 56 2 44 46
M  V30 57 1 45 46
M  V30 58 2 47 48
M  V30 59 1 47 49
M  V30 60 1 48 50
M  V30 61 2 49 51
M  V30 62 2 50 52
M  V30 63 1 51 52
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
24-(Methylamino)-12,17-bis(4-methylphenyl)-2,7-diphenyl-4-oxa-21,22,23-triaza...
C47H36N4O2
1196071-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 61 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.9293 10.5174 0.0 0
M  V30 2 C 7.5308 9.0299 0.0 0
M  V30 3 O 5.4682 15.3476 0.0 0
M  V30 4 C 8.4534 0.0000 0.0 0
M  V30 5 C 18.4467 9.9934 0.0 0
M  V30 6 C 5.3193 11.3655 0.0 0
M  V30 7 C 4.6200 9.9934 0.0 0
M  V30 8 C 6.8404 11.6064 0.0 0
M  V30 9 O 4.6202 12.7376 0.0 0
M  V30 10 C 5.3193 8.6212 0.0 0
M  V30 11 C 7.0812 13.1274 0.0 0
M  V30 12 C 5.7091 13.8266 0.0 0
M  V30 13 N 6.8404 8.3804 0.0 0
M  V30 14 C 4.6202 7.2491 0.0 0
M  V30 15 C 8.4534 13.8267 0.0 0
M  V30 16 C 7.0812 6.8593 0.0 0
M  V30 17 C 5.7091 6.1602 0.0 0
M  V30 18 C 9.8255 13.1274 0.0 0
M  V30 19 C 8.4534 6.1600 0.0 0
M  V30 20 N 10.0664 11.6064 0.0 0
M  V30 21 C 11.1976 13.8266 0.0 0
M  V30 22 C 9.8255 6.8593 0.0 0
M  V30 23 C 11.5874 11.3655 0.0 0
M  V30 24 C 12.2866 12.7376 0.0 0
M  V30 25 N 10.0664 8.3804 0.0 0
M  V30 26 C 11.1976 6.1602 0.0 0
M  V30 27 C 12.2867 9.9934 0.0 0
M  V30 28 C 11.5874 8.6212 0.0 0
M  V30 29 C 12.2866 7.2491 0.0 0
M  V30 30 C 3.0800 9.9934 0.0 0
M  V30 31 C 2.3100 11.3270 0.0 0
M  V30 32 C 2.3100 8.6597 0.0 0
M  V30 33 C 0.7700 11.3270 0.0 0
M  V30 34 C 0.7700 8.6597 0.0 0
M  V30 35 C 0.0000 9.9934 0.0 0
M  V30 36 C 8.4534 15.3667 0.0 0
M  V30 37 C 7.1197 16.1367 0.0 0
M  V30 38 C 9.7870 16.1367 0.0 0
M  V30 39 C 7.1197 17.6767 0.0 0
M  V30 40 C 9.7870 17.6767 0.0 0
M  V30 41 C 8.4534 18.4467 0.0 0
M  V30 42 C 8.4534 4.6200 0.0 0
M  V30 43 C 7.1197 3.8500 0.0 0
M  V30 44 C 9.7870 3.8500 0.0 0
M  V30 45 C 7.1197 2.3100 0.0 0
M  V30 46 C 9.7870 2.3100 0.0 0
M  V30 47 C 8.4534 1.5400 0.0 0
M  V30 48 C 13.8267 9.9934 0.0 0
M  V30 49 C 14.5967 11.3270 0.0 0
M  V30 50 C 14.5967 8.6597 0.0 0
M  V30 51 C 16.1367 11.3270 0.0 0
M  V30 52 C 16.1367 8.6597 0.0 0
M  V30 53 C 16.9067 9.9934 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 12
M  V30 4 1 4 47
M  V30 5 1 5 53
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 30
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 12
M  V30 16 1 11 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 2 15 18
M  V30 20 1 15 36
M  V30 21 2 16 17
M  V30 22 1 16 19
M  V30 23 1 18 20
M  V30 24 1 18 21
M  V30 25 2 19 22
M  V30 26 1 19 42
M  V30 27 1 20 23
M  V30 28 2 21 24
M  V30 29 1 22 25
M  V30 30 1 22 26
M  V30 31 1 23 24
M  V30 32 2 23 27
M  V30 33 2 25 28
M  V30 34 2 26 29
M  V30 35 1 27 28
M  V30 36 1 27 48
M  V30 37 1 28 29
M  V30 38 2 30 31
M  V30 39 1 30 32
M  V30 40 1 31 33
M  V30 41 2 32 34
M  V30 42 2 33 35
M  V30 43 1 34 35
M  V30 44 2 36 37
M  V30 45 1 36 38
M  V30 46 1 37 39
M  V30 47 2 38 40
M  V30 48 2 39 41
M  V30 49 1 40 41
M  V30 50 2 42 43
M  V30 51 1 42 44
M  V30 52 1 43 45
M  V30 53 2 44 46
M  V30 54 2 45 47
M  V30 55 1 46 47
M  V30 56 2 48 49
M  V30 57 1 48 50
M  V30 58 1 49 51
M  V30 59 2 50 52
M  V30 60 2 51 53
M  V30 61 1 52 53
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 871237-67-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1196071-47-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25016734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5,20-Diphenyl-10,15-ditolyl-2-oxa-3-oxo-21-N-methylaminoporphyrin (5). 2
(8 mg, 0.0104 mmol) was dissolved in freshly distilled toluene (2 mL).
Subsequently 30 mL of methylamine (33% solution in ethanol) were added.
The resulting mixture was stirred for 10 min and then dried on a rotary
evaporator. A crude green solid was dissolved in toluene and
chromatographed on a basic alumina (GIII) column. The intensive green
band, which eluted slowly with toluene/dichloromethane v/v (1/1), was
collected and evaporated to give 5. Yield 60%. 1H NMR (500.13 MHz,
benzene-d 6, 298 K): δ =8.65 (d, 1H, 3 J = 4.1 Hz, 13), 8.55-8.52 (m, 2H,
7, 12), 8.3 (d, 1H, 3 J = 6.9 Hz, 15- o), 8.27-8.23 (m, 3H,5-o, 8), 8.22
(d, 1H, 3 J = 4.1 Hz, 18), 8.2 (d, 1H, 3 J = 4.1 Hz, 17), 8.15 (d, 2H, 3
J = 7.5 Hz, 20-o), 8.1-7.8 (m, 2H, 10-o), 7.92 (d, 1H, 3 J = 6.9 Hz,
15-o), 7.71 (t, 2H, 3 J = 7.5 Hz, 5-m), 7.64-7.54 (m, 3H, 5-p, 20-m),
7.45-7.34 (m, 20-p, 10-m, 15-m, this group of signal is partially covered
by solvent signal), 2.49 (s, 3H, 10-p), 2.47 (s, 3H, 15-p), -1.42 (s, 3H,
N-CH3) ppm; 13C NMR (150.90 MHz, benzene-d 6, 300 K): δ = 181.0, 161.6,
152.4, 141.8, 141.1, 140.1, 139.4, 138.6, 138.1, 138.0, 137.7, 137.6,
136.9, 135.6, 135.5, 135.3 (20-o), 135.1 (5- o), 134.8 (10, 15-o), 134.6
(13), 134.0, 132.6 (12), 129.1, 128.9 (7), 128.8 (20-m), 128.7, 128.0,
127.7 (8), 124.8, 123.7 (17 or 18), 123.6 (17 or 18), 120.7, 115.0,
114.3, 109.4, 28.4 (N-(CH3)), 21.7 (10, 15-p). Some signals are hidden
under the solvent signal; UV-vis (benzene, λ max [nm], log ε): 334
(4.24), 445 (4.75), 601 (3.90), 693 (3.49). HRMS, m/z: observed 689.2883
(expected 689.2911 calculated for (C47H36N4O2 + H+ )).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective Amination of Carbaporpholactone and N-Confused Porphyrin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grzegorzek, Norbert; Pawlicki, Milosz; Latos-Grazynski, Lechoslaw
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(22), 8547-8553

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-(1,1-Dimethylethyl)phenyl]-7-[4-[(3-fluoro-4-nitrophenyl)methyl]-1-piper...
C28H30FN5O2
874279-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 8.0021 0.0 0
M  V30 2 C 19.3221 6.2655 0.0 0
M  V30 3 C 19.3221 7.8055 0.0 0
M  V30 4 C 20.6557 7.0355 0.0 0
M  V30 5 C 20.6557 5.4955 0.0 0
M  V30 6 F 2.3100 10.6694 0.0 0
M  V30 7 N 0.7700 8.0021 0.0 0 VAL=5
M  V30 8 O 0.0000 6.6684 0.0 0
M  V30 9 O 0.0000 9.3358 0.0 0
M  V30 10 C 11.5500 2.6673 0.0 0
M  V30 11 C 10.0100 2.6673 0.0 0
M  V30 12 C 12.3200 1.3336 0.0 0
M  V30 13 N 12.5804 3.8118 0.0 0
M  V30 14 C 9.2400 1.3336 0.0 0
M  V30 15 N 13.8263 1.6538 0.0 0
M  V30 16 C 11.5500 0.0000 0.0 0
M  V30 17 C 13.9874 3.1855 0.0 0
M  V30 18 C 10.0100 0.0000 0.0 0
M  V30 19 N 9.2400 4.0011 0.0 0
M  V30 20 C 10.0100 5.3347 0.0 0
M  V30 21 C 7.7000 4.0011 0.0 0
M  V30 22 C 9.2400 6.6684 0.0 0
M  V30 23 C 6.9300 5.3347 0.0 0
M  V30 24 N 7.7000 6.6684 0.0 0
M  V30 25 C 15.3210 3.9555 0.0 0
M  V30 26 C 16.6546 3.1855 0.0 0
M  V30 27 C 15.3210 5.4955 0.0 0
M  V30 28 C 17.9884 3.9555 0.0 0
M  V30 29 C 16.6546 6.2655 0.0 0
M  V30 30 C 17.9883 5.4955 0.0 0
M  V30 31 C 5.3900 8.0021 0.0 0
M  V30 32 C 4.6200 9.3358 0.0 0
M  V30 33 C 4.6200 6.6684 0.0 0
M  V30 34 C 3.0800 9.3358 0.0 0
M  V30 35 C 3.0800 6.6684 0.0 0
M  V30 36 C 2.3100 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 1 31
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 30
M  V30 7 1 6 34
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 36
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 19
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 2 15 17
M  V30 21 1 16 18
M  V30 22 1 17 25
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[4-[2-[4-(1,1-Dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]me...
C29H34N6O2
1140503-26-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9302 4.0012 0.0 0
M  V30 2 C 19.3225 5.7379 0.0 0
M  V30 3 C 20.6562 6.5079 0.0 0
M  V30 4 C 20.6562 4.9678 0.0 0
M  V30 5 C 19.3225 4.1978 0.0 0
M  V30 6 N 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 9 O 0.0000 2.6673 0.0 0
M  V30 10 O 0.0000 5.3348 0.0 0
M  V30 11 C 11.5503 9.3360 0.0 0
M  V30 12 C 10.0102 9.3360 0.0 0
M  V30 13 C 12.3203 10.6697 0.0 0
M  V30 14 N 12.5807 8.1914 0.0 0
M  V30 15 C 9.2402 10.6697 0.0 0
M  V30 16 N 13.8266 10.3495 0.0 0
M  V30 17 C 11.5503 12.0033 0.0 0
M  V30 18 C 13.9877 8.8179 0.0 0
M  V30 19 C 10.0102 12.0033 0.0 0
M  V30 20 N 9.2402 8.0022 0.0 0
M  V30 21 C 10.0102 6.6685 0.0 0
M  V30 22 C 7.7002 8.0022 0.0 0
M  V30 23 C 9.2402 5.3348 0.0 0
M  V30 24 C 6.9302 6.6685 0.0 0
M  V30 25 N 7.7002 5.3348 0.0 0
M  V30 26 C 15.3213 8.0479 0.0 0
M  V30 27 C 15.3213 6.5079 0.0 0
M  V30 28 C 16.6550 8.8179 0.0 0
M  V30 29 C 16.6550 5.7379 0.0 0
M  V30 30 C 17.9888 8.0479 0.0 0
M  V30 31 C 17.9887 6.5079 0.0 0
M  V30 32 C 5.3901 4.0012 0.0 0
M  V30 33 C 4.6201 2.6673 0.0 0
M  V30 34 C 4.6201 5.3348 0.0 0
M  V30 35 C 3.0801 2.6673 0.0 0
M  V30 36 C 3.0801 5.3348 0.0 0
M  V30 37 C 2.3101 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 25
M  V30 2 1 1 32
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 31
M  V30 7 1 6 7
M  V30 8 1 6 35
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 37
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 20
M  V30 17 1 13 16
M  V30 18 2 13 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 18
M  V30 22 1 17 19
M  V30 23 1 18 26
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 874279-41-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1140503-26-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2823272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-((4-(2-(4-tert-butylphenyl)-1H-benzo[d]imidazol-4-yl)-piperazin-1-yl)methyl)-N-methyl-2-nitroaniline:
To asolution of
2-(4-tert-butylphenyl)-4-(4-(3-fluoro-4-nitrobenzyppiperazin-1-yl)-1H-benzo[d]imidnzole
(11, 7a 0.20 g, 0.41 mmol) in N,N-dimethylformamide (5 mL) under nitrogen
was added methylamine (2M in THF,1.03mL) and the solution was stirred at
room temperature for fortyeight hours.The reaction waspartitioned between
ethyl acetate (150 mL) and water (75 mL). The organic layer was washed
with water (3 X 50 mL), brine (75 mL), dried (MgSO4), and evaporated
under reduced pressure to yield the product as a yellow-orange solid
(0.19 g, 95%).
5-((4-(2-(4-tert-butylphenyl)-1H-benzo[d]imidazol-4-yl)-piperazin-1-yl)methyl)-N-methyl-2-nitroaniline,
Yield (0.19 g, 95%). 1H NMR (300 MHz, DMSO-d6) δ 12.69 (s, 1H), 8.21 (m,
1H), 8.04 (m, 3H), 7.55 (d, 2H, J= 8.6 Hz), 7.03 (m, 3H), 6.74 (dd, 1H,
J= 8.8 Hz, J= 1.5 Hz), 6.51 (dd, 1H, J= 7.1 Hz, J= 1.5 Hz), 3.60 (m,
611), 2.99 (d, 3H, J= 5.0 Hz), 2.67 (m, 4H), 1.33 (s, 9H). LC/MS (Method
A) Rt = 1.24 min (purity = 100 q), [M+H]+ = 499.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline
(WAY-207024): An Orally Active Antagonist of the Gonadotropin Releasing
Hormone Receptor (GnRH-R)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pelletier, Jeffrey C.; Chengalvala, Murty V.; Cottom, Joshua E.;
Feingold, Irene B.; Green, Daniel M.; Hauze, Diane B.; Huselton,
Christine A.; Jetter, James W.; Kopf, Gregory S.; Lundquist, Joseph T.
IV; Magolda, Ronald L.; Mann, Charles W.; Mehlmann, John F.; Rogers, John
F.; Shanno, Linda K.; Adams, William R.; Tio, Cesario O.; Wrobel, Jay E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2009), 52(7), 2148-2152

$RFMT $RIREG SCHEME270 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 5-fluoro-2-nitro-4-(trifluoromethyl)-, methyl ester
C9H5F4NO4
875155-17-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 O 8.4700 5.3347 0.0 0
M  V30 3 O 8.4700 2.6674 0.0 0
M  V30 4 C 10.0100 5.3347 0.0 0
M  V30 5 N 6.1600 1.3338 0.0 0 VAL=5
M  V30 6 O 5.3900 0.0000 0.0 0
M  V30 7 O 7.7000 1.3338 0.0 0
M  V30 8 F 3.0800 6.6685 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 F 1.5400 2.4611 0.0 0
M  V30 11 F 0.0000 4.0011 0.0 0
M  V30 12 F 1.5400 5.5411 0.0 0
M  V30 13 C 6.1600 4.0011 0.0 0
M  V30 14 C 5.3900 2.6674 0.0 0
M  V30 15 C 5.3900 5.3347 0.0 0
M  V30 16 C 3.8500 2.6674 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 8 17
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(methylamino)-2-nitro-4-(trifluoromethyl)benzoate
C10H9F3N2O4
875155-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 4.0011 0.0 0
M  V30 2 O 8.4700 2.6674 0.0 0
M  V30 3 O 8.4700 5.3347 0.0 0
M  V30 4 C 10.0100 2.6674 0.0 0
M  V30 5 N 6.1600 6.6685 0.0 0 VAL=5
M  V30 6 O 5.3900 8.0021 0.0 0
M  V30 7 O 7.7000 6.6685 0.0 0
M  V30 8 N 3.0800 1.3336 0.0 0
M  V30 9 C 3.8500 0.0000 0.0 0
M  V30 10 C 1.5400 4.0011 0.0 0
M  V30 11 F 1.5400 2.4611 0.0 0
M  V30 12 F 0.0000 4.0011 0.0 0
M  V30 13 F 1.5400 5.5411 0.0 0
M  V30 14 C 6.1600 4.0011 0.0 0
M  V30 15 C 5.3900 5.3347 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 3.8500 5.3347 0.0 0
M  V30 18 C 3.8500 2.6674 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 15
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 875155-17-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875155-48-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2892611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5-Fluoro-2-nitro-4-trifluoromethyl-benzoic acid methyl ester (300 mg,
1.12 mmoles) is dissolved in dioxane and after addition of methylamine
(0.490 ml, 3.5 eq.) the yellow mixture is stirred at room temperature for
2 days. The mixture is evaporated to dryness. Dichloromethane is added
and the suspension is filtrated. Evaporation of the filtrate yielded
2-nitro-5-methylamino-4-trifluoromethyl-benzoic acid methyl ester as a
yellow solid (291.3 mg, 95.4% yield). The product is used in the next
step without further purification.
2-nitro-5-methylamino-4-trifluoromethyl-benzoic acid methyl ester, (291.3
mg, 95.4% yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives as AMPA receptor antagonist and
for the treatment or delay of progression of epilepsy or schizophrenia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allgeier, Hans; Froestl, Wolfgang; Koller, Manuel; Mattes, Henri;
Nozulak, Joachim; Ofner, Silvio; Orain, David; Rasetti, Vittorio; Renaud,
Johanne; Soldermann, Nicolas; Floersheim, Philipp
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006010591 A2 2006-02-02

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)benzoyl chloride
C8H6Cl2O
876-08-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 Cl 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-N-methylbenzamide
C9H10ClNO
220875-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 Cl 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 876-08-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220875-88-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24292359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Pd-catalyzed synthesis of difluoroethyl and difluorovinyl compounds
with a chlorodifluoroethyl iodonium salt (CDFI)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Niu, Yaru; Cao, Chengyao Kimmy; Ge, Chenxin; Qu, Hongmei; Chen, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2022), 33(3), 1541-1544

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-2-chloroquinazoline
C8H4BrClN2
882672-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6673 0.0 0
M  V30 2 Cl 8.4702 1.3337 0.0 0
M  V30 3 C 3.8501 1.3337 0.0 0
M  V30 4 C 4.6201 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 N 6.1601 2.6673 0.0 0
M  V30 8 C 3.8501 4.0010 0.0 0
M  V30 9 C 1.5400 2.6673 0.0 0
M  V30 10 N 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 2.3101 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 11
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 12
M  V30 13 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-N-methyl-2-quinazolinamine
C9H8BrN3
882670-77-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 Br 0.0000 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 N 5.3348 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 N 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 12
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 882672-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 882670-77-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38351857
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridine sulfonamides as GCN2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Whitlock, Gavin; Fuchter, Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023218195 A1 2023-11-16

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methylphenyl)-4-(methylthio)-2(1H)-pyrimidinethione
C12H12N2S2
883130-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3901 0.0000 0.0 0
M  V30 2 S 0.7700 2.6673 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 C 11.5503 2.6673 0.0 0
M  V30 5 N 5.3901 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 6.9302 2.6673 0.0 0
M  V30 12 C 7.7002 4.0010 0.0 0
M  V30 13 C 7.7002 1.3337 0.0 0
M  V30 14 C 9.2402 4.0010 0.0 0
M  V30 15 C 9.2402 1.3337 0.0 0
M  V30 16 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-1-(4-methylphenyl)-2(1H)-pyrimidinethione
C12H13N3S
883130-79-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3901 0.0000 0.0 0
M  V30 2 N 0.7700 2.6673 0.0 0
M  V30 3 C 0.0000 4.0010 0.0 0
M  V30 4 C 11.5503 2.6673 0.0 0
M  V30 5 N 5.3901 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 C 4.6201 4.0010 0.0 0
M  V30 8 N 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 6.9302 2.6673 0.0 0
M  V30 12 C 7.7002 4.0010 0.0 0
M  V30 13 C 7.7002 1.3337 0.0 0
M  V30 14 C 9.2402 4.0010 0.0 0
M  V30 15 C 9.2402 1.3337 0.0 0
M  V30 16 C 10.0102 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 3
M  V30 3 1 2 10
M  V30 4 1 4 16
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 883130-31-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883130-79-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18153218
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Straightforward pyrimidine ring construction: a versatile tool for the
synthesis of nucleobase and nucleoside analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Robin, Aelig; Julienne, Karine; Meslin, Jean-Claude; Deniaud, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (3), 634-643

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-cyclohexyl-2-(2-formylphenyl)-6-(methoxycarbonyl)-1H-indo...
C29H33NO5
886041-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 4.8980 0.0 0
M  V30 2 C 6.0798 3.7536 0.0 0
M  V30 3 O 5.6039 2.2889 0.0 0
M  V30 4 O 7.5862 4.0738 0.0 0
M  V30 5 C 6.6343 1.1445 0.0 0
M  V30 6 C 5.4899 0.1140 0.0 0
M  V30 7 C 7.6649 0.0000 0.0 0
M  V30 8 C 7.7788 2.1749 0.0 0
M  V30 9 C 3.0800 4.9411 0.0 0
M  V30 10 O 2.3100 3.6075 0.0 0
M  V30 11 C 10.9908 6.0685 0.0 0
M  V30 12 O 12.3246 6.8385 0.0 0
M  V30 13 O 10.9908 4.5285 0.0 0
M  V30 14 C 13.6583 6.0685 0.0 0
M  V30 15 C 4.6200 7.6085 0.0 0
M  V30 16 C 5.5252 8.8544 0.0 0
M  V30 17 N 5.5252 6.3627 0.0 0
M  V30 18 C 6.9899 8.3785 0.0 0
M  V30 19 C 6.9899 6.8385 0.0 0
M  V30 20 C 8.3235 9.1485 0.0 0
M  V30 21 C 8.3235 6.0685 0.0 0
M  V30 22 C 9.6572 8.3785 0.0 0
M  V30 23 C 9.6572 6.8385 0.0 0
M  V30 24 C 3.0800 7.6085 0.0 0
M  V30 25 C 2.3100 6.2749 0.0 0
M  V30 26 C 2.3100 8.9422 0.0 0
M  V30 27 C 0.7700 6.2749 0.0 0
M  V30 28 C 0.7700 8.9422 0.0 0
M  V30 29 C 0.0000 7.6085 0.0 0
M  V30 30 C 5.0494 10.3191 0.0 0
M  V30 31 C 3.5429 10.6392 0.0 0
M  V30 32 C 6.0798 11.4635 0.0 0
M  V30 33 C 3.0671 12.1038 0.0 0
M  V30 34 C 5.6039 12.9281 0.0 0
M  V30 35 C 4.0975 13.2483 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 1 9 25
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 1 11 23
M  V30 14 1 12 14
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 24
M  V30 18 1 16 18
M  V30 19 1 16 30
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 1 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-cyclohexyl-6-(methoxycarbonyl)-2-[2-[(methylamino)methyl]...
C30H38N2O4
1132679-47-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0494 4.8980 0.0 0
M  V30 2 C 6.0798 3.7536 0.0 0
M  V30 3 O 5.6039 2.2889 0.0 0
M  V30 4 O 7.5862 4.0738 0.0 0
M  V30 5 C 6.6343 1.1445 0.0 0
M  V30 6 C 7.7788 2.1749 0.0 0
M  V30 7 C 7.6649 0.0000 0.0 0
M  V30 8 C 5.4899 0.1140 0.0 0
M  V30 9 C 3.0800 4.9411 0.0 0
M  V30 10 N 2.3100 3.6075 0.0 0
M  V30 11 C 0.7700 3.6075 0.0 0
M  V30 12 C 10.9908 6.0685 0.0 0
M  V30 13 O 12.3246 6.8385 0.0 0
M  V30 14 O 10.9908 4.5285 0.0 0
M  V30 15 C 13.6583 6.0685 0.0 0
M  V30 16 C 4.6200 7.6085 0.0 0
M  V30 17 C 5.5252 8.8544 0.0 0
M  V30 18 N 5.5252 6.3627 0.0 0
M  V30 19 C 6.9899 8.3785 0.0 0
M  V30 20 C 6.9899 6.8385 0.0 0
M  V30 21 C 8.3235 9.1485 0.0 0
M  V30 22 C 8.3235 6.0685 0.0 0
M  V30 23 C 9.6572 8.3785 0.0 0
M  V30 24 C 9.6572 6.8385 0.0 0
M  V30 25 C 3.0800 7.6085 0.0 0
M  V30 26 C 2.3100 6.2749 0.0 0
M  V30 27 C 2.3100 8.9422 0.0 0
M  V30 28 C 0.7700 6.2749 0.0 0
M  V30 29 C 0.7700 8.9422 0.0 0
M  V30 30 C 0.0000 7.6085 0.0 0
M  V30 31 C 5.0494 10.3191 0.0 0
M  V30 32 C 6.0798 11.4635 0.0 0
M  V30 33 C 3.5429 10.6392 0.0 0
M  V30 34 C 5.6039 12.9281 0.0 0
M  V30 35 C 3.0671 12.1038 0.0 0
M  V30 36 C 4.0976 13.2483 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 12 24
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 25
M  V30 19 1 17 19
M  V30 20 1 17 31
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 886041-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1132679-47-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1315351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM 88-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stansfield, Ian; Ercolani, Caterina; Mackay, Angela; Conte, Immacolata;
Pompei, Marco; Koch, Uwe; Gennari, Nadia; Giuliano, Claudio; Rowley,
Michael; Narjes, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(3), 627-632

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Picryl chloride
C6H2ClN3O6
88-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 2 O 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9301 0.0 0
M  V30 4 Cl 4.0011 6.9301 0.0 0
M  V30 5 N 6.6686 5.3901 0.0 0 VAL=5
M  V30 6 O 6.6686 6.9301 0.0 0
M  V30 7 O 8.0022 4.6201 0.0 0
M  V30 8 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 9 O 5.3348 0.0000 0.0 0
M  V30 10 O 2.6675 0.0000 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 4.0011 5.3901 0.0 0
M  V30 13 C 2.6675 3.0800 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0
M  V30 16 C 5.3348 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 15
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-2,4,6-trinitroaniline
C7H6N4O6
1022-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 2.3101 0.0 0
M  V30 2 C 0.0000 3.0801 0.0 0
M  V30 3 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 7 O 1.3337 6.9302 0.0 0
M  V30 8 O 0.0000 4.6201 0.0 0
M  V30 9 N 6.6687 5.3901 0.0 0 VAL=5
M  V30 10 O 8.0023 4.6201 0.0 0
M  V30 11 O 6.6687 6.9302 0.0 0
M  V30 12 C 2.6675 3.0801 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 4.0012 5.3901 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 88-88-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1022-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2752398
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and characterization of methyl nitramino -2, 4,
6-trinitrobenzenes using bismuth nitrate pentahydrate as an eco friendly
nitrating agent
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Badgujar, D. M.; Talawar, M. B.; Asthana, S. N.; Mahulikar, P. P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Scientific & Industrial Research (2010), 69(3), 208-210

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Chlorosulfonyl)-2-methylbenzoic acid
C8H7ClO4S
89001-57-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 S 1.3337 3.0801 0.0 0 VAL=6
M  V30 6 Cl 0.0000 3.8501 0.0 0
M  V30 7 O 2.1037 4.4137 0.0 0
M  V30 8 O 0.5637 1.7464 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-5-[(methylamino)sulfonyl]benzoic acid
C9H11NO4S
926249-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 3.0801 0.0 0 VAL=6
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 5.8985 4.4137 0.0 0
M  V30 4 O 7.4385 1.7464 0.0 0
M  V30 5 C 9.3360 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 15 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 1 2 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 13
M  V30 9 1 9 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89001-57-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926249-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-23170931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Deal;Structure-activity relationships of benzamides and isoindolines
designed as SARS-CoV protease inhibitors effective against SARS-CoV-2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Welker, Armin; Kersten, Christian; Mueller, Christin; Madhugiri,
Ramakanth; Zimmer, Collin; Mueller, Patrick; Zimmermann, Robert;
Hammerschmidt, Stefan; Maus, Hannah; Ziebuhr, John; Sotriffer, Christoph;
Schirmeister, Tanja
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2021), 16(2), 340-354

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1-Methylethyl)-2-propoxybenzaldehyde
C13H18O2
894851-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 6.1600 1.3338 0.0 0
M  V30 9 O 6.9300 0.0000 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 1.5400 1.3338 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(1-methylethyl)-2-propoxybenzenemethanamine
C14H23NO
894851-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 5.3901 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 2.6675 6.9302 0.0 0
M  V30 16 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-42-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-43-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1342656
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (3-Isopropyl-2-propoxybenzyl)methylamine [1299] A solution of
methylamine (30 mL of a 2.0 M solution in MeOH, 60 mmol) was added to
3-isopropyl-2-propoxybenzaldehyde (1.49 g, 7.22 mmol) and the mixture was
stirred for 72 h. The solution was concentrated under reduced pressure.
The resulting dark yellow oil was dissolved in EtOH (30 mL) and treated
with NaBH 4 (0.273 g, 7.22 mmol). After 18 h, the reaction mixture was
concentrated under reduced pressure and dissolved in 1 N NaOH (30 mL).
The mixture was extracted with Et2O (3×75 mL). The combined organics were
dried (Na2SO4) and concentrated to yield the title compound (1.52 g, 95%)
as an orange oil. 1H NMR (300 MHz, DMSO-d6) δ 7.21-7.14 (m, 2H), 7.04 (t,
J=7.5 Hz, 1H), 3.70 (t, J=6.3 Hz, 2H), 3.63 (s, 2H), 3.32-3.23 (m, 1H),
2.28 (s, 3H), 1.78 (br s, 1H), 1.76-1.71 (m, 2H), 1.16 (d, J=6.9 Hz, 6H),
1.03 (t, J=7.3 Hz, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(1-Methylethyl)-2-propoxybenzaldehyde
C13H18O2
894851-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 4.0011 0.0 0
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 C 6.9300 5.3349 0.0 0
M  V30 4 C 8.4700 5.3349 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 C 6.1600 1.3338 0.0 0
M  V30 9 O 6.9300 0.0000 0.0 0
M  V30 10 C 3.8500 2.6674 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 4.6200 1.3338 0.0 0
M  V30 13 C 1.5400 1.3338 0.0 0
M  V30 14 C 3.8500 0.0000 0.0 0
M  V30 15 C 2.3100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(1-methylethyl)-2-propoxybenzenemethanamine
C14H23NO
894851-43-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0012 3.0801 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 5.3348 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 6.6685 4.6201 0.0 0
M  V30 6 N 8.0023 5.3901 0.0 0
M  V30 7 C 9.3360 4.6201 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 0.0000 5.3901 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 5.3901 0.0 0
M  V30 13 C 2.6675 5.3901 0.0 0
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 C 2.6675 6.9302 0.0 0
M  V30 16 C 4.0012 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 13
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 894851-42-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 894851-43-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-2271980
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) (3-Isopropyl-2-propoxybenzyl)methylamine A solution of methylamine (30
mL of a 2.0 M solution in MeOH, 60 mmol) was added to
3-isopropyl-2-propoxybenzaldehyde (1.49 g, 7.22 mmol) and the mixture was
stirred for 72 h. The solution was concentrated under reduced pressure.
The resulting dark yellow oil was dissolved in EtOH (30 mL) and treated
with NaBH4 (0.273 g, 7.22 mmol). After 18 h, the reaction mixture was
concentrated under reduced pressure and dissolved in 1 N NaOH (30 mL).
The mixture was extracted with Et2O (3×75 mL). The combined organics were
dried (Na2SO4) and concentrated to yield the title compound (1.52 g, 95%)
as an orange oil: 1H NMR (300 MHz, DMSO-d6 ) δ 7.21-7.14 (m, 2H), 7.04
(t, J = 7.5 Hz, 1H), 3.70 (t, J = 6.3 Hz, 2H), 3.63 (s, 2H), 3.32-3.23
(m, 1H), 2.28 (s, 3H), 1.78 (br s, 1H), 1.76-1.71 (m, 2H), 1.16 (d, J =
6.9 Hz, 6H), 1.03 (t, J = 7.3 Hz, 3H). C14H23NO Exact Mass: 221.18.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyrimidinecarboxylic acid, 5-bromo-, methyl ester
C6H5BrN2O2
89581-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 4.6201 0.0000 0.0 0
M  V30 8 N 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-methyl-2-pyrimidinecarboxamide
C6H6BrN3O
1346819-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Br 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 4.6201 2.6673 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 C 6.1601 2.6673 0.0 0
M  V30 10 C 6.1601 0.0000 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89581-38-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1346819-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34334180
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of
5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide
(AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2
and Other PARPs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johannes, Jeffrey W.; Balazs, Amber; Barratt, Derek; Bista, Michal;
Chuba, Matthew D.; Cosulich, Sabina; Critchlow, Susan E.; Degorce,
Sebastien L.; Di Fruscia, Paolo; Edmondson, Scott D.; Embrey, Kevin;
Fawell, Stephen; Ghosh, Avipsa; Gill, Sonja J.; Gunnarsson, Anders;
Hande, Sudhir M.; Heightman, Tom D.; Hemsley, Paul; Illuzzi, Giuditta;
Lane, Jordan; Larner, Carrie; Leo, Elisabetta; Liu, Lina; Madin, Andrew;
Martin, Scott; McWilliams, Lisa; O'Connor, Mark J.; Orme, Jonathan P.;
Pachl, Fiona; Packer, Martin J.; Pei, Xiaohui; Pike, Andrew; Schimpl,
Marianne; She, Hongyao; Staniszewska, Anna D.; Talbot, Verity; Underwood,
Elizabeth; Varnes, Jeffrey G.; Xue, Lin; Yao, Tieguang; Zhang, Ke; Zhang,
Andrew X.; Zheng, Xiaolan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(19), 14498-14512

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chlorobenzaldehyde
C7H5ClO
89-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(2-Chlorophenyl)methylene]methanamine
C8H8ClN
17972-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 4.0010 0.0 0
M  V30 3 C 6.9302 4.0010 0.0 0
M  V30 4 Cl 3.0801 0.0000 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 89-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 17972-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10764093
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM 85-95% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gamma-lactams-A novel scaffold for highly potent and selective α7
nicotinic acetylcholine receptor agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enz, Albert; Feuerbach, Dominik; Frederiksen, Mathias U.; Gentsch,
Conrad; Hurth, Konstanze; Muller, Werner; Nozulak, Joachim; Roy, Bernard
L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(5), 1287-1291

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dichloro-7H-pyrrolo[2,3-d]pyrimidine
C6H3Cl2N3
90213-66-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 Cl 6.3710 4.6200 0.0 0
M  V30 3 C 2.3699 3.8500 0.0 0
M  V30 4 C 2.3699 2.3100 0.0 0
M  V30 5 N 3.7036 4.6200 0.0 0
M  V30 6 N 0.9052 4.3259 0.0 0
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 C 0.9052 1.8341 0.0 0
M  V30 9 C 5.0372 3.8500 0.0 0
M  V30 10 C 0.0000 3.0800 0.0 0
M  V30 11 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-methoxy-7H-pyrrolo[2,3-d]pyrimidine
C7H6ClN3O
96022-77-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.1456 4.6201 0.0 0
M  V30 2 C 6.4792 3.8501 0.0 0
M  V30 3 Cl 2.4781 0.0000 0.0 0
M  V30 4 C 2.4781 4.6201 0.0 0
M  V30 5 C 1.1444 3.8501 0.0 0
M  V30 6 C 3.8119 3.8501 0.0 0
M  V30 7 C 2.1579 6.1264 0.0 0
M  V30 8 N 1.1444 2.3101 0.0 0
M  V30 9 N 0.0000 4.8805 0.0 0
M  V30 10 N 3.8119 2.3101 0.0 0
M  V30 11 C 0.6263 6.2873 0.0 0
M  V30 12 C 2.4781 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 90213-66-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 96022-77-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-170-CAS-21387303
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM LRRK2 inhibitors and methods of making and using the same
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Hatcher, John; Choi, Hwan Geun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016130920 A2 2016-08-18

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-1-[[(1,1-Dimethylethoxy)carbonyl]amino]-2,3-dihydro-4-methyl-1H-indene-5...
C16H21NO4
903557-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 8.0409 3.3777 0.0 0
M  V30 2 C 9.5054 2.9017 0.0 0
M  V30 3 O 10.6499 3.9323 0.0 0
M  V30 4 O 9.8257 1.3954 0.0 0
M  V30 5 C 12.1145 3.4564 0.0 0
M  V30 6 C 12.5905 4.9210 0.0 0
M  V30 7 C 13.5792 2.9804 0.0 0
M  V30 8 C 11.6386 1.9917 0.0 0
M  V30 9 C 2.3100 0.0000 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 O 0.0000 1.3336 0.0 0
M  V30 12 O 0.0000 4.0011 0.0 0
M  V30 13 C 5.3900 2.6673 0.0 0
M  V30 14 C 4.6200 1.3336 0.0 0
M  V30 15 C 6.8963 2.3471 0.0 0 CFG=1
M  V30 16 C 4.6200 4.0011 0.0 0
M  V30 17 C 3.0800 1.3336 0.0 0
M  V30 18 C 5.6505 0.1893 0.0 0
M  V30 19 C 7.0574 0.8156 0.0 0
M  V30 20 C 3.0800 4.0011 0.0 0
M  V30 21 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 17
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 21
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2,3-dihydro-4-methyl-5-[(methylamino)carbonyl]-1H-i...
C17H24N2O3
916210-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 9.5808 3.3777 0.0 0
M  V30 2 C 11.0453 2.9017 0.0 0
M  V30 3 O 12.1899 3.9322 0.0 0
M  V30 4 O 11.3657 1.3954 0.0 0
M  V30 5 C 13.6544 3.4564 0.0 0
M  V30 6 C 13.1786 1.9917 0.0 0
M  V30 7 C 15.1191 2.9804 0.0 0
M  V30 8 C 14.1304 4.9209 0.0 0
M  V30 9 C 3.8500 0.0000 0.0 0
M  V30 10 C 2.3100 2.6673 0.0 0
M  V30 11 N 1.5400 4.0011 0.0 0
M  V30 12 O 1.5400 1.3336 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 C 6.9300 2.6673 0.0 0
M  V30 15 C 6.1600 1.3336 0.0 0
M  V30 16 C 8.4363 2.3471 0.0 0 CFG=1
M  V30 17 C 6.1600 4.0011 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 7.1904 0.1893 0.0 0
M  V30 20 C 8.5974 0.8156 0.0 0
M  V30 21 C 4.6200 4.0011 0.0 0
M  V30 22 C 3.8500 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 18
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 903557-91-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 916210-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2222709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparative Example 45 Step A To a solution of title compound from the
Preparative Example 7, Step B (35 mg) in DMF (3 mL) were added HATU (60
mg), HOAt (20 mg) and a 2M solution of MeNH2 in THF (150 μL). The mixture
was stirred for 16 h, concentrated, diluted with EtOAc, washed with
saturated aqueous NaHCO3 and saturated aqueous NaCl, dried (MgSO4),
filtered, concentrated and purified by chromatography (silica,
CH2Cl2/acetone). The title compound (35 mg, 95%). [MH]+=291.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amide containing heterobicyclic metalloprotease inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Steeneck, Christoph; Gege, Christian; Richter, Frank; Kroth, Heiko;
Hochguertel, Matthias; Essers, Michael; Van Veldhuizen, Joshua; Nolte,
Bert; Gallagher, Brian; Feuerstein, Tim; Schneider, Matthias; Arndt,
Torsten; Deng, Hongbo; Biesinger, Ralf; Wu, Xinyuan; Bluhm, Harald;
Sucholeiki, Irving; Taveras, Arthur G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20070155738 A1 2007-07-05

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Iodo-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine-4-carboxaldehyde
C9H4F3IN2O
909718-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4149 5.3348 0.0 0
M  V30 2 O 8.9549 5.3348 0.0 0
M  V30 3 I 4.3349 0.0000 0.0 0
M  V30 4 C 1.3338 5.2892 0.0 0
M  V30 5 F 2.1038 6.6230 0.0 0
M  V30 6 F 0.0000 6.0592 0.0 0
M  V30 7 F 0.5638 3.9556 0.0 0
M  V30 8 C 5.1049 4.0011 0.0 0
M  V30 9 N 4.3349 2.6675 0.0 0
M  V30 10 C 6.6449 4.0011 0.0 0
M  V30 11 C 4.0743 5.1457 0.0 0
M  V30 12 N 2.8284 2.9876 0.0 0
M  V30 13 C 5.1049 1.3338 0.0 0
M  V30 14 C 7.4149 2.6675 0.0 0
M  V30 15 C 2.6675 4.5192 0.0 0
M  V30 16 C 6.6449 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-(Methylamino)-2-(trifluoromethyl)pyrazolo[1,5-a]pyridine-4-carboxaldehyde
C10H8F3N3O
1009602-66-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4149 6.6686 0.0 0
M  V30 2 O 8.9549 6.6686 0.0 0
M  V30 3 N 4.3348 1.3338 0.0 0
M  V30 4 C 5.1048 0.0000 0.0 0
M  V30 5 C 1.3338 6.6228 0.0 0
M  V30 6 F 2.1038 7.9566 0.0 0
M  V30 7 F 0.0000 7.3928 0.0 0
M  V30 8 F 0.5638 5.2892 0.0 0
M  V30 9 C 5.1048 5.3348 0.0 0
M  V30 10 N 4.3348 4.0011 0.0 0
M  V30 11 C 6.6448 5.3348 0.0 0
M  V30 12 C 4.0743 6.4793 0.0 0
M  V30 13 C 5.1048 2.6675 0.0 0
M  V30 14 N 2.8284 4.3213 0.0 0
M  V30 15 C 7.4149 4.0011 0.0 0
M  V30 16 C 2.6675 5.8528 0.0 0
M  V30 17 C 6.6448 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 2 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 909718-81-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009602-66-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4232280
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphodiesterase inhibitors. Design, synthesis, and structure-activity
relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with
anti-inflammatory activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kojima, Akihiko; Takita, Satoshi; Sumiya, Tatsunobu; Ochiai, Koji; Iwase,
Kazuhiko; Kishi, Tetsuya; Ohinata, Akira; Yageta, Yuichi; Yasue,
Tokutaro; Kohno, Yasushi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2013), 23(19), 5311-5316

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
4-[7-[4-Cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oc...
C24H20F3N3O3S
915086-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4665 1.6421 0.0 0
M  V30 2 S 8.6530 6.0277 0.0 0
M  V30 3 C 15.2423 3.3172 0.0 0
M  V30 4 C 16.0123 4.6510 0.0 0
M  V30 5 C 17.5523 4.6510 0.0 0
M  V30 6 C 18.3223 5.9846 0.0 0
M  V30 7 O 19.8623 5.9846 0.0 0
M  V30 8 O 17.5523 7.3182 0.0 0
M  V30 9 C 1.4069 4.6448 0.0 0
M  V30 10 F 2.0333 3.2380 0.0 0
M  V30 11 F 0.0000 4.0185 0.0 0
M  V30 12 F 0.7806 6.0517 0.0 0
M  V30 13 C 1.7288 7.7080 0.0 0
M  V30 14 N 0.4829 8.6132 0.0 0
M  V30 15 C 8.1771 2.0713 0.0 0
M  V30 16 N 9.0823 3.3172 0.0 0
M  V30 17 C 6.7124 2.5472 0.0 0
M  V30 18 C 9.5492 1.3721 0.0 0
M  V30 19 C 7.4779 0.6992 0.0 0
M  V30 20 C 8.1771 4.5632 0.0 0
M  V30 21 N 6.7124 4.0872 0.0 0
M  V30 22 C 8.8501 0.0000 0.0 0
M  V30 23 C 10.6223 3.3172 0.0 0
M  V30 24 C 11.3923 4.6510 0.0 0
M  V30 25 C 11.3923 1.9835 0.0 0
M  V30 26 C 12.9323 4.6510 0.0 0
M  V30 27 C 12.9323 1.9835 0.0 0
M  V30 28 C 13.7023 3.3172 0.0 0
M  V30 29 C 5.4665 4.9924 0.0 0
M  V30 30 C 4.0598 4.3661 0.0 0
M  V30 31 C 5.6275 6.5241 0.0 0
M  V30 32 C 2.8137 5.2713 0.0 0
M  V30 33 C 4.3816 7.4291 0.0 0
M  V30 34 C 2.9748 6.8028 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 20
M  V30 3 1 3 4
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 32
M  V30 13 3 13 14
M  V30 14 1 13 34
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[7-[4-Cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oc...
C24H21F3N4O2S
915086-90-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4665 6.9711 0.0 0
M  V30 2 S 8.6530 2.5855 0.0 0
M  V30 3 C 15.2423 5.2961 0.0 0
M  V30 4 C 16.0123 3.9623 0.0 0
M  V30 5 C 17.5523 3.9623 0.0 0
M  V30 6 N 18.3223 2.6286 0.0 0
M  V30 7 O 18.3223 5.2961 0.0 0
M  V30 8 C 19.8623 2.6286 0.0 0
M  V30 9 C 1.4069 3.9684 0.0 0
M  V30 10 F 2.0333 5.3752 0.0 0
M  V30 11 F 0.0000 4.5947 0.0 0
M  V30 12 F 0.7806 2.5615 0.0 0
M  V30 13 C 1.7288 0.9052 0.0 0
M  V30 14 N 0.4829 0.0000 0.0 0
M  V30 15 C 8.1771 6.5419 0.0 0
M  V30 16 N 9.0823 5.2961 0.0 0
M  V30 17 C 6.7124 6.0661 0.0 0
M  V30 18 C 9.5492 7.2411 0.0 0
M  V30 19 C 7.4779 7.9141 0.0 0
M  V30 20 C 8.1771 4.0500 0.0 0
M  V30 21 N 6.7124 4.5261 0.0 0
M  V30 22 C 8.8501 8.6132 0.0 0
M  V30 23 C 10.6223 5.2961 0.0 0
M  V30 24 C 11.3923 3.9623 0.0 0
M  V30 25 C 11.3923 6.6297 0.0 0
M  V30 26 C 12.9323 3.9623 0.0 0
M  V30 27 C 12.9323 6.6297 0.0 0
M  V30 28 C 13.7023 5.2961 0.0 0
M  V30 29 C 5.4665 3.6208 0.0 0
M  V30 30 C 4.0597 4.2472 0.0 0
M  V30 31 C 5.6275 2.0892 0.0 0
M  V30 32 C 2.8137 3.3420 0.0 0
M  V30 33 C 4.3816 1.1841 0.0 0
M  V30 34 C 2.9748 1.8104 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 20
M  V30 3 1 3 4
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 32
M  V30 13 3 13 14
M  V30 14 1 13 34
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 915086-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915086-90-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27689119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3-{4-[7-(4-Cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-
diazaspiro[3.4]oct-5-yl]phenyl}-N-methylpropanamide, 82. To a suspension
of 81c (0.094 g, 0.2 mmol) in THF (10 mL) cooled to -5 °C was added
thionyl chloride (0.019mL, 0.26mmol). The mixture was stirred at -5 °C
for 1 h. Then methylamine was bubbled into the mixture at -5 °C for 30
min. The medium was filtered. The filtrate was concentrated and
chromatographed (dichloromethane/acetone, 75:25) to yield 82 (0.092 g,
0.19mmol, 95%) as an off-white powder.
3-{4-[7-(4-Cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-
diazaspiro[3.4]oct-5-yl]phenyl}-N-methylpropanamide, 82, yield (0.092 g,
0.19mmol, 95%) 1HNMR(acetone-d6, 400MHz) δ 1.51-1.60 (m, 1H), 2.01-2.11
(m, 1H), 2.48-2.58 (m, 4H), 2.61-2.67 (m, 2H), 2.77 (d, J= 4.6 Hz, 3H),
2.98 (t, J= 7.5 Hz, 2H), 7.03 (bs,NH), 7.33 (d, J=8.2 Hz, 2H), 7.42 (d,
J=8.2 Hz, 2H), 8.01 (dd, J=8.3, 1.8 Hz, 1H), 8.13 (d, J=1.8 Hz, 1H), 8.20
(d, J=8.3 Hz, 1H); 13C NMR(acetone-d6, 100MHz) δ 13.4, 25.3, 30.0, 31.2,
37.0, 67.6, 109.0, 114.8, 122.5 (q, J=271.5 Hz), 127.4 (q, J=4.7Hz),
129.5, 130.0, 131.9 (q, J=32.5Hz), 133.3, 133.8, 135.6, 138.4, 143.1,
171.7, 175.0, 178.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Relationship for Thiohydantoin Androgen Receptor
Antagonists for Castration-Resistant Prostate Cancer (CRPC)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Michael E.; Ouk, Samedy; Yoo, Dongwon; Sawyers, Charles L.; Chen,
Charlie; Tran, Chris; Wongvipat, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(7), 2779-2796

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
4-[7-[4-Cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oc...
C24H20F3N3O3S
915086-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4665 1.6421 0.0 0
M  V30 2 S 8.6530 6.0277 0.0 0
M  V30 3 C 15.2423 3.3172 0.0 0
M  V30 4 C 16.0123 4.6510 0.0 0
M  V30 5 C 17.5523 4.6510 0.0 0
M  V30 6 C 18.3223 5.9846 0.0 0
M  V30 7 O 19.8623 5.9846 0.0 0
M  V30 8 O 17.5523 7.3182 0.0 0
M  V30 9 C 1.4069 4.6448 0.0 0
M  V30 10 F 2.0333 3.2380 0.0 0
M  V30 11 F 0.0000 4.0185 0.0 0
M  V30 12 F 0.7806 6.0517 0.0 0
M  V30 13 C 1.7288 7.7080 0.0 0
M  V30 14 N 0.4829 8.6132 0.0 0
M  V30 15 C 8.1771 2.0713 0.0 0
M  V30 16 N 9.0823 3.3172 0.0 0
M  V30 17 C 6.7124 2.5472 0.0 0
M  V30 18 C 9.5492 1.3721 0.0 0
M  V30 19 C 7.4779 0.6992 0.0 0
M  V30 20 C 8.1771 4.5632 0.0 0
M  V30 21 N 6.7124 4.0872 0.0 0
M  V30 22 C 8.8501 0.0000 0.0 0
M  V30 23 C 10.6223 3.3172 0.0 0
M  V30 24 C 11.3923 4.6510 0.0 0
M  V30 25 C 11.3923 1.9835 0.0 0
M  V30 26 C 12.9323 4.6510 0.0 0
M  V30 27 C 12.9323 1.9835 0.0 0
M  V30 28 C 13.7023 3.3172 0.0 0
M  V30 29 C 5.4665 4.9924 0.0 0
M  V30 30 C 4.0598 4.3661 0.0 0
M  V30 31 C 5.6275 6.5241 0.0 0
M  V30 32 C 2.8137 5.2713 0.0 0
M  V30 33 C 4.3816 7.4291 0.0 0
M  V30 34 C 2.9748 6.8028 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 20
M  V30 3 1 3 4
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 32
M  V30 13 3 13 14
M  V30 14 1 13 34
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[7-[4-Cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oc...
C25H23F3N4O2S
915086-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4665 1.6421 0.0 0
M  V30 2 S 8.6530 6.0277 0.0 0
M  V30 3 C 15.2423 3.3172 0.0 0
M  V30 4 C 16.0123 4.6510 0.0 0
M  V30 5 C 17.5523 4.6510 0.0 0
M  V30 6 C 18.3223 5.9846 0.0 0
M  V30 7 N 19.8623 5.9846 0.0 0
M  V30 8 O 17.5523 7.3182 0.0 0
M  V30 9 C 20.6323 7.3182 0.0 0
M  V30 10 C 1.4069 4.6448 0.0 0
M  V30 11 F 2.0333 3.2380 0.0 0
M  V30 12 F 0.0000 4.0185 0.0 0
M  V30 13 F 0.7806 6.0517 0.0 0
M  V30 14 C 1.7288 7.7080 0.0 0
M  V30 15 N 0.4829 8.6132 0.0 0
M  V30 16 C 8.1771 2.0713 0.0 0
M  V30 17 N 9.0823 3.3172 0.0 0
M  V30 18 C 6.7124 2.5472 0.0 0
M  V30 19 C 9.5492 1.3721 0.0 0
M  V30 20 C 7.4779 0.6992 0.0 0
M  V30 21 C 8.1771 4.5632 0.0 0
M  V30 22 N 6.7124 4.0872 0.0 0
M  V30 23 C 8.8501 0.0000 0.0 0
M  V30 24 C 10.6223 3.3172 0.0 0
M  V30 25 C 11.3923 4.6510 0.0 0
M  V30 26 C 11.3923 1.9835 0.0 0
M  V30 27 C 12.9323 4.6510 0.0 0
M  V30 28 C 12.9323 1.9835 0.0 0
M  V30 29 C 13.7023 3.3172 0.0 0
M  V30 30 C 5.4665 4.9924 0.0 0
M  V30 31 C 4.0598 4.3661 0.0 0
M  V30 32 C 5.6275 6.5241 0.0 0
M  V30 33 C 2.8137 5.2713 0.0 0
M  V30 34 C 4.3816 7.4291 0.0 0
M  V30 35 C 2.9748 6.8028 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 2 2 21
M  V30 3 1 3 4
M  V30 4 1 3 29
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 33
M  V30 14 3 14 15
M  V30 15 1 14 35
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 24
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 1 22 30
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 915086-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915086-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2388094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-4-{4-[7-(4-cyano-3-trifluoromethylphenyl)-8-oxo-6-
thioxo-5,7-diazaspiro[3.4]oct-5-yl]phenyl}butanamide, 80. To a suspension
of 79c (0.097 g, 0.2 mmol) in THF (10 mL) cooled to -5 °C was added
thionyl chloride (0.019 mL, 0.26 mmol). The mixture was stirred at -5 °C
for 1 h. Then methylamine was bubbled into the mixture at -5 °C for 30
min. The mixture was filtered. The filtrate was concentrated and
chromatographed (dichloromethane/acetone, 75:25) to yield 80 (0.095 g,
0.19 mmol, 95%) as an off-white powder.
N-Methyl-4-{4-[7-(4-cyano-3-trifluoromethylphenyl)-8-oxo-6-
thioxo-5,7-diazaspiro[3.4]oct-5-yl]phenyl}butanamide, 80, yield (0.095 g,
0.19 mmol, 95%) 1H NMR (CDCl3, 400 MHz) δ 1.52-1.64 (m, 1H), 1.94-2.01
(m, 2H), 2.10-2.17 (m, 1H), 2.20 (t, J=7.3 Hz, 2H), 2.46-2.62 (m, 4H),
2.69 (t, J=7.3 Hz, 2H), 2.73 (d, J=4.7 Hz, 3H), 6.09 (bs, 1H), 7.16 (d,
J=8.2 Hz, 2H), 7.33 (d, J=8.2 Hz, 2H), 7.82 (dd, J=8.3, 1.8 Hz, 1H), 7.91
(d, J= 8.3 Hz, 1H), 7.94 (d, J= 1.8 Hz, 1H); 13C NMR (CDCl3, 100 MHz) δ
13.7, 26.2, 26.8, 31.4, 35.0, 35.7, 67.5, 109.7, 114.9, 121.9 (q, J=
272.7 Hz), 127.1 (q, J= 4.7 Hz), 129.7, 130.0, 132.3, 133.3 (q, J= 33.2
Hz), 133.8, 135.2, 137.3, 143.7, 173.3, 174.9, 179.8.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Relationship for Thiohydantoin Androgen Receptor
Antagonists for Castration-Resistant Prostate Cancer (CRPC)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Michael E.; Ouk, Samedy; Yoo, Dongwon; Sawyers, Charles L.; Chen,
Charlie; Tran, Chris; Wongvipat, John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(7), 2779-2796

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
4-[7-[4-Cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oc...
C24H20F3N3O3S
915086-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4665 1.6421 0.0 0
M  V30 2 S 8.6530 6.0277 0.0 0
M  V30 3 C 15.2423 3.3172 0.0 0
M  V30 4 C 16.0123 4.6510 0.0 0
M  V30 5 C 17.5523 4.6510 0.0 0
M  V30 6 C 18.3223 5.9846 0.0 0
M  V30 7 O 19.8623 5.9846 0.0 0
M  V30 8 O 17.5523 7.3182 0.0 0
M  V30 9 C 1.4069 4.6448 0.0 0
M  V30 10 F 2.0333 3.2380 0.0 0
M  V30 11 F 0.0000 4.0185 0.0 0
M  V30 12 F 0.7806 6.0517 0.0 0
M  V30 13 C 1.7288 7.7080 0.0 0
M  V30 14 N 0.4829 8.6132 0.0 0
M  V30 15 C 8.1771 2.0713 0.0 0
M  V30 16 N 9.0823 3.3172 0.0 0
M  V30 17 C 6.7124 2.5472 0.0 0
M  V30 18 C 9.5492 1.3721 0.0 0
M  V30 19 C 7.4779 0.6992 0.0 0
M  V30 20 C 8.1771 4.5632 0.0 0
M  V30 21 N 6.7124 4.0872 0.0 0
M  V30 22 C 8.8501 0.0000 0.0 0
M  V30 23 C 10.6223 3.3172 0.0 0
M  V30 24 C 11.3923 4.6510 0.0 0
M  V30 25 C 11.3923 1.9835 0.0 0
M  V30 26 C 12.9323 4.6510 0.0 0
M  V30 27 C 12.9323 1.9835 0.0 0
M  V30 28 C 13.7023 3.3172 0.0 0
M  V30 29 C 5.4665 4.9924 0.0 0
M  V30 30 C 4.0598 4.3661 0.0 0
M  V30 31 C 5.6275 6.5241 0.0 0
M  V30 32 C 2.8137 5.2713 0.0 0
M  V30 33 C 4.3816 7.4291 0.0 0
M  V30 34 C 2.9748 6.8028 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 2 2 20
M  V30 3 1 3 4
M  V30 4 1 3 28
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 9 32
M  V30 13 3 13 14
M  V30 14 1 13 34
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 23
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 25 1 21 29
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[7-[4-Cyano-3-(trifluoromethyl)phenyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oc...
C25H23F3N4O2S
915086-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.4665 1.6421 0.0 0
M  V30 2 S 8.6530 6.0277 0.0 0
M  V30 3 C 15.2423 3.3172 0.0 0
M  V30 4 C 16.0123 4.6510 0.0 0
M  V30 5 C 17.5523 4.6510 0.0 0
M  V30 6 C 18.3223 5.9846 0.0 0
M  V30 7 N 19.8623 5.9846 0.0 0
M  V30 8 O 17.5523 7.3182 0.0 0
M  V30 9 C 20.6323 7.3182 0.0 0
M  V30 10 C 1.4069 4.6448 0.0 0
M  V30 11 F 2.0333 3.2380 0.0 0
M  V30 12 F 0.0000 4.0185 0.0 0
M  V30 13 F 0.7806 6.0517 0.0 0
M  V30 14 C 1.7288 7.7080 0.0 0
M  V30 15 N 0.4829 8.6132 0.0 0
M  V30 16 C 8.1771 2.0713 0.0 0
M  V30 17 N 9.0823 3.3172 0.0 0
M  V30 18 C 6.7124 2.5472 0.0 0
M  V30 19 C 9.5492 1.3721 0.0 0
M  V30 20 C 7.4779 0.6992 0.0 0
M  V30 21 C 8.1771 4.5632 0.0 0
M  V30 22 N 6.7124 4.0872 0.0 0
M  V30 23 C 8.8501 0.0000 0.0 0
M  V30 24 C 10.6223 3.3172 0.0 0
M  V30 25 C 11.3923 4.6510 0.0 0
M  V30 26 C 11.3923 1.9835 0.0 0
M  V30 27 C 12.9323 4.6510 0.0 0
M  V30 28 C 12.9323 1.9835 0.0 0
M  V30 29 C 13.7023 3.3172 0.0 0
M  V30 30 C 5.4665 4.9924 0.0 0
M  V30 31 C 4.0598 4.3661 0.0 0
M  V30 32 C 5.6275 6.5241 0.0 0
M  V30 33 C 2.8137 5.2713 0.0 0
M  V30 34 C 4.3816 7.4291 0.0 0
M  V30 35 C 2.9748 6.8028 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 2 2 21
M  V30 3 1 3 4
M  V30 4 1 3 29
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 33
M  V30 14 3 14 15
M  V30 15 1 14 35
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 17 24
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 23
M  V30 25 1 21 22
M  V30 26 1 22 30
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 915086-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915086-96-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9788642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 42-5)
4-{4-[7-(4-Cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-diaza-spiro[3.4]oct-5-yl]-phenyl}-N-methyl-butyramide
(88) [ND-6] To a suspension of
4-{4-[7-(4-cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-diaza-spiro[3.4]oct-5-yl]-phenyl}-butyric
acid (89) (0.097 g, 0.2 mmol) in THF (10 ml) at -5 °C was added thionyl
chloride (0.019 ml, 0.26 mmol). The medium was stirred at -5 °C for one
hour. Then methylamine was bubbled into the mixture at -5 °C for 30
minutes. The medium was filtered. The filtrate was concentrated and
chromatographed (dichloromethane:acetone, 75:25) to yield
4-{4-[7-(4-Cyano-3-trifluoromethylphenyl)-8-oxo-6-thioxo-5,7-diaza-spiro[3.4]oct-5-yl]-phenyl}-N-methyl-butyramide
(88) [ND-6] (0.095 g, 0.19 mmol, 95%) as an off-white powder.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diarylhydantoin derivatives as androgen receptor inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
hormone refractory prostate cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Michael E.; Yoo, Dongwon; Sawyers, Charles L.; Tran, Chris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009055053 A2 2009-04-30

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R)-3-Chloro-1-phenylpropyl]-1H-indole
C17H16ClN
915954-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 4.0012 0.0 0 CFG=2
M  V30 2 C 4.4609 2.6675 0.0 0
M  V30 3 C 5.2309 1.3337 0.0 0
M  V30 4 Cl 4.4609 0.0000 0.0 0
M  V30 5 N 4.4609 5.3348 0.0 0
M  V30 6 C 2.9293 5.4958 0.0 0
M  V30 7 C 5.0873 6.7418 0.0 0
M  V30 8 C 2.6091 7.0022 0.0 0
M  V30 9 C 1.7849 4.4653 0.0 0
M  V30 10 C 3.9428 7.7722 0.0 0
M  V30 11 C 1.1444 7.4781 0.0 0
M  V30 12 C 0.3202 4.9412 0.0 0
M  V30 13 C 0.0000 6.4477 0.0 0
M  V30 14 C 6.7709 4.0012 0.0 0
M  V30 15 C 7.5409 2.6675 0.0 0
M  V30 16 C 7.5409 5.3348 0.0 0
M  V30 17 C 9.0810 2.6675 0.0 0
M  V30 18 C 9.0810 5.3348 0.0 0
M  V30 19 C 9.8510 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 5
M  V30 3 1 1 14
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γR)-N-Methyl-γ-phenyl-1H-indole-1-propanamine
C18H20N2
915953-87-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2309 5.3348 0.0 0 CFG=2
M  V30 2 C 4.4608 4.0011 0.0 0
M  V30 3 C 5.2309 2.6673 0.0 0
M  V30 4 N 4.4608 1.3337 0.0 0
M  V30 5 C 5.2309 0.0000 0.0 0
M  V30 6 N 4.4608 6.6685 0.0 0
M  V30 7 C 2.9293 6.8296 0.0 0
M  V30 8 C 5.0873 8.0754 0.0 0
M  V30 9 C 2.6091 8.3359 0.0 0
M  V30 10 C 1.7849 5.7990 0.0 0
M  V30 11 C 3.9428 9.1059 0.0 0
M  V30 12 C 1.1444 8.8117 0.0 0
M  V30 13 C 0.3202 6.2748 0.0 0
M  V30 14 C 0.0000 7.7813 0.0 0
M  V30 15 C 6.7709 5.3348 0.0 0
M  V30 16 C 7.5409 4.0011 0.0 0
M  V30 17 C 7.5409 6.6685 0.0 0
M  V30 18 C 9.0809 4.0011 0.0 0
M  V30 19 C 9.0809 6.6685 0.0 0
M  V30 20 C 9.8509 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 6
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 915954-09-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 915953-87-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10496399
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iridium-Catalyzed Regio- and Enantioselective N-Allylation of Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stanley, Levi M.; Hartwig, John F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2009), 48(42), 7841-7844,
S7841/1-S7841/25

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Methyl (1S,3S,6S,7aS)-6-[[(1,1-dimethylethoxy)carbonyl]amino]hexahydro-1-hydr...
C14H22N2O6
928629-96-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 4.6948 0.0 0
M  V30 2 O 1.1444 4.2189 0.0 0
M  V30 3 O 2.9293 6.2013 0.0 0
M  V30 4 C 0.0000 5.2494 0.0 0
M  V30 5 O 5.9702 6.6354 0.0 0
M  V30 6 O 5.3196 0.0000 0.0 0
M  V30 7 N 9.0309 5.2726 0.0 0
M  V30 8 C 10.3647 4.5026 0.0 0
M  V30 9 O 11.6984 5.2726 0.0 0
M  V30 10 O 10.3647 2.9626 0.0 0
M  V30 11 C 13.0321 4.5026 0.0 0
M  V30 12 C 12.2621 3.1689 0.0 0
M  V30 13 C 14.3657 3.7326 0.0 0
M  V30 14 C 13.8021 5.8363 0.0 0
M  V30 15 N 5.2598 3.9845 0.0 0
M  V30 16 C 6.0298 2.6509 0.0 0 CFG=2
M  V30 17 C 3.7535 3.6644 0.0 0 CFG=2
M  V30 18 C 6.2904 5.1291 0.0 0
M  V30 19 C 7.5363 2.9710 0.0 0
M  V30 20 C 4.9994 1.5063 0.0 0 CFG=1
M  V30 21 C 3.5926 2.1328 0.0 0
M  V30 22 C 7.6972 4.5026 0.0 0 CFG=1
M  V30 23 H 6.7999 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 18
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 16 23 CFG=3
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2S,5S,7S,7aS)-hexahydro-7-hydroxy-5-[(methylamino)carbo...
C14H23N3O5
928629-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 4.6948 0.0 0
M  V30 2 N 1.1444 4.2189 0.0 0
M  V30 3 O 2.9293 6.2013 0.0 0
M  V30 4 C 0.0000 5.2494 0.0 0
M  V30 5 O 5.9702 6.6354 0.0 0
M  V30 6 O 5.3196 0.0000 0.0 0
M  V30 7 N 9.0309 5.2726 0.0 0
M  V30 8 C 10.3647 4.5026 0.0 0
M  V30 9 O 11.6984 5.2726 0.0 0
M  V30 10 O 10.3647 2.9626 0.0 0
M  V30 11 C 13.0321 4.5026 0.0 0
M  V30 12 C 12.2621 3.1689 0.0 0
M  V30 13 C 14.3657 3.7326 0.0 0
M  V30 14 C 13.8021 5.8363 0.0 0
M  V30 15 N 5.2598 3.9845 0.0 0
M  V30 16 C 6.0298 2.6509 0.0 0 CFG=2
M  V30 17 C 3.7535 3.6644 0.0 0 CFG=2
M  V30 18 C 6.2904 5.1291 0.0 0
M  V30 19 C 7.5363 2.9710 0.0 0
M  V30 20 C 4.9994 1.5063 0.0 0 CFG=1
M  V30 21 C 3.5926 2.1328 0.0 0
M  V30 22 C 7.6972 4.5026 0.0 0 CFG=1
M  V30 23 H 6.7999 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 18
M  V30 6 1 20 6 CFG=1
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 16 23 CFG=3
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 928629-96-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928629-98-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4072679
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-65-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (3S,5S,6R,8S)-N
'-Methyl-3-[N-(Boc)amino]-6-hydroxy-1-azabicyclo[ 3.3.0]octan-2-one
8-Carboxamide (6R)-21. To a solution of (6R)-24 (10 mg, 0.03 mmol) in
MeOH at 0 °C was added a 2 N solution of methylamine in MeOH (10 mL). The
reaction mixture was stirred for 18 h, evaporated under vacuum to a
residue, and purified by flash chromatography to yield carbamate (6R)-21
(9 mg, 95%): (3S,5S,6S,8S)-N '-Methyl
3-[N-(Boc)amino]-6-hydroxy-1-azabicyclo[ 3.3.0]octan-2-one-8-carboxamide
(6S)-21. Ester (6S)-1 (9.2 mg, 0.029 mmol) was transformed following a
procedure similar to (6R)-21 to obtain (6S)-21 (8 mg, 95%): [α]20 D +6.5
(c = 0.4, MeOH); 1H NMR (CDCl3) δ 1.41 (s, 9H), 2.19 (m, 1H), 2.38 (dd,
1H, J = 7.8, 14.7 Hz), 2.57 (m, 1H), 2.77 (d, 3H, J = 4.9 Hz), 3.90 (ddd,
3H, J = 2.7, 3.5, 7.6 Hz), 4.16 (t, 1H, J = 3.3 Hz), 4.40 (t, 1H, J = 8.9
Hz), 4.47 (t, 1H, J = 8.9 Hz), 5.34 (d, 1H, J = 7.8 Hz), 7.11 (br s, 1H);
13C NMR (CDCl3) δ 28.3 (3C), 29.7, 31.9, 38.8, 55.2, 55.5, 62.5, 70.0,
80.7, 155.8, 170.5, 174.3; HRMS calcd for C14H23N3O5Na (M + Na)+
336.1529, found 336.1522.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rigid dipeptide mimics: synthesis of enantiopure C6-functionalized
pyrrolizidinone amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rao, Mallem H. V. Ramana; Pinyol, Eulalia; Lubell, William D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(3), 736-743

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,3S,6S,7aS)-6-[[(1,1-Dimethylethoxy)carbonyl]amino]hexahydro-1-hydroxy-5-o...
C13H20N2O6
928630-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.4647 4.6948 0.0 0
M  V30 2 O 1.7849 6.2013 0.0 0
M  V30 3 O 0.0000 4.2189 0.0 0
M  V30 4 O 4.8258 6.6354 0.0 0
M  V30 5 O 4.1753 0.0000 0.0 0
M  V30 6 N 7.8867 5.2726 0.0 0
M  V30 7 C 9.2203 4.5026 0.0 0
M  V30 8 O 10.5540 5.2726 0.0 0
M  V30 9 O 9.2203 2.9626 0.0 0
M  V30 10 C 11.8877 4.5026 0.0 0
M  V30 11 C 11.1177 3.1689 0.0 0
M  V30 12 C 13.2215 3.7326 0.0 0
M  V30 13 C 12.6578 5.8363 0.0 0
M  V30 14 N 4.1156 3.9845 0.0 0
M  V30 15 C 4.8856 2.6509 0.0 0 CFG=2
M  V30 16 C 2.6091 3.6644 0.0 0 CFG=2
M  V30 17 C 5.1460 5.1291 0.0 0
M  V30 18 C 6.3919 2.9710 0.0 0
M  V30 19 C 3.8550 1.5063 0.0 0 CFG=2
M  V30 20 C 2.4482 2.1328 0.0 0
M  V30 21 C 6.5528 4.5026 0.0 0 CFG=1
M  V30 22 H 5.6556 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 16 1 CFG=1
M  V30 4 2 4 17
M  V30 5 1 19 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 21 6 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 1 15 22 CFG=3
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 21
M  V30 23 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 15 16 19 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2S,5S,7R,7aS)-hexahydro-7-hydroxy-5-[(methylamino)carbo...
C14H23N3O5
928629-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6091 4.6948 0.0 0
M  V30 2 N 1.1444 4.2189 0.0 0
M  V30 3 O 2.9293 6.2013 0.0 0
M  V30 4 C 0.0000 5.2494 0.0 0
M  V30 5 O 5.9702 6.6354 0.0 0
M  V30 6 O 5.3196 0.0000 0.0 0
M  V30 7 N 9.0309 5.2726 0.0 0
M  V30 8 C 10.3647 4.5026 0.0 0
M  V30 9 O 11.6984 5.2726 0.0 0
M  V30 10 O 10.3647 2.9626 0.0 0
M  V30 11 C 13.0321 4.5026 0.0 0
M  V30 12 C 12.2621 3.1689 0.0 0
M  V30 13 C 14.3657 3.7326 0.0 0
M  V30 14 C 13.8021 5.8363 0.0 0
M  V30 15 N 5.2598 3.9845 0.0 0
M  V30 16 C 6.0298 2.6509 0.0 0 CFG=2
M  V30 17 C 3.7535 3.6644 0.0 0 CFG=2
M  V30 18 C 6.2904 5.1291 0.0 0
M  V30 19 C 7.5363 2.9710 0.0 0
M  V30 20 C 4.9994 1.5063 0.0 0 CFG=2
M  V30 21 C 3.5926 2.1328 0.0 0
M  V30 22 C 7.6972 4.5026 0.0 0 CFG=1
M  V30 23 H 6.7999 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 17 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 18
M  V30 6 1 20 6 CFG=3
M  V30 7 1 7 8
M  V30 8 1 22 7 CFG=1
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 16 23 CFG=3
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 22
M  V30 24 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 20 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 928630-01-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 928629-97-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1991142
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3S,5S,6R,8S)-N '-Methyl-3-[N-(Boc)amino]-6-hydroxy-1-azabicyclo[
3.3.0]octan-2-one 8-Carboxamide (6R)-21. To a solution of (6R)-24 (10 mg,
0.03 mmol) in MeOH at 0 °C was added a 2 N solution of methylamine in
MeOH (10 mL). The reaction mixture was stirred for 18 h, evaporated under
vacuum to a residue, and purified by flash chromatography to yield
carbamate (6R)-21 (9 mg, 95%): [α]20 D -6.5 (c = 0.4, MeOH); 1H NMR
(CDCl3) δ 1.37 (s, 9H), 1.61-1.82 (br s, 1H), 2.08 (dd, 1H, J = 11.0,
21.7 Hz), 2.27 (dd, 1H, J = 10.9, 21.7 Hz), 2.55 (dd, 1H, J = 5.8, 12.5
Hz), 2.70 (ddd, 1H, J = 5.6, 8.4, 12.0 Hz), 2.75 (d, 3H, J = 4.6 Hz),
3.58 (ddd, 1H, J = 5.6, 8.7, 9.0 Hz), 4.02-4.29 (m, 3H), 5.16 (d, 1H, J =
5.5 Hz), 6.93 (br s, 1H); 13C NMR (CDCl3) δ 28.3 (3C), 29.7, 31.1, 34.3,
56.4, 57.1, 63.1, 72.9, 80.5, 155.7, 170.2, 170.7; HRMS calcd for
C14H23N3O5Na (M + Na)+ 336.1529, found 336.1532.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rigid dipeptide mimics: synthesis of enantiopure C6-functionalized
pyrrolizidinone amino acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rao, Mallem H. V. Ramana; Pinyol, Eulalia; Lubell, William D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(3), 736-743

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S,4S)-2-Chlorobicyclo[2.2.1]heptane-2-carbonyl chloride
C8H10Cl2O
929601-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5789 0.9911 0.0 0
M  V30 2 Cl 1.4002 0.0000 0.0 0
M  V30 3 O 4.0266 0.4658 0.0 0
M  V30 4 Cl 0.8639 1.9778 0.0 0
M  V30 5 C 2.3100 2.5074 0.0 0 CFG=2
M  V30 6 C 1.5400 3.8318 0.0 0 CFG=2
M  V30 7 C 3.8500 2.5074 0.0 0
M  V30 8 C 3.0800 4.3040 0.0 0
M  V30 9 C 2.3100 5.1664 0.0 0
M  V30 10 C 4.6200 3.8318 0.0 0 CFG=1
M  V30 11 C 3.8500 5.1664 0.0 0
M  V30 12 H 0.0000 3.8292 0.0 0
M  V30 13 H 6.1600 3.8292 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 5 1 CFG=1
M  V30 4 1 5 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 6 12
M  V30 10 1 7 10
M  V30 11 1 10 8 CFG=1
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 1 10 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 5 6 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S,4S)-2-Chloro-N-methylbicyclo[2.2.1]heptane-2-carboxamide
C9H14ClNO
929601-69-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3584 3.3922 0.0 0
M  V30 2 N 5.6920 2.6222 0.0 0
M  V30 3 O 4.3584 4.9321 0.0 0
M  V30 4 C 7.0255 3.3922 0.0 0
M  V30 5 Cl 4.0157 1.4435 0.0 0
M  V30 6 C 3.0246 2.6222 0.0 0 CFG=2
M  V30 7 C 2.0423 1.4468 0.0 0 CFG=2
M  V30 8 C 2.4995 4.0699 0.0 0
M  V30 9 C 1.0732 2.7334 0.0 0
M  V30 10 C 0.5253 1.7153 0.0 0
M  V30 11 C 0.9919 4.3420 0.0 0 CFG=1
M  V30 12 C 0.0000 3.1631 0.0 0
M  V30 13 H 2.5700 0.0000 0.0 0
M  V30 14 H 0.4691 5.7905 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 6 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9 CFG=1
M  V30 9 1 7 10
M  V30 10 1 7 13
M  V30 11 1 8 11
M  V30 12 1 11 9 CFG=1
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 11 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 7 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 929601-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 929601-69-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-14393876
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Gaseous dry 8a was introduced during 0.5 h
into a stirred solution of exo-13b (10.0 g, 51.8 mmol) in dry
dichloromethane (80 mL), kept at 0 °C. Stirring was continued without
cooling for 4 h followed by extraction of the mixture with aq HCl (2M,
2×20 mL), water (2×20 mL) and sat aq NaHCO3 (2×20 mL), drying with NaCO3
and distillation of the solvent under vacuum to afford a pale yellow
solid (9.02 g, 92%, mp 84-85 °C). Recrystallization from pet ether (50
mL) yielded colorless needles (8.85 g, 91%). According to the procedure
described for exo-13c: Colorless needles (9.20 g, 95%). mp 91-92 °C, 1H
NMR (600 MHz, C6D6, Fig. 7, 9): δ = 1.06 (tdd, J = 1.6, 3.4, 10.1 Hz, 1
H; 7-Hanti), 1.18-1.23 (m, 1 H; 5-Hendo), 1.23-1.30 (m, 1 H; 6-Hexo),
1.30-1.37 (m, 1 H; 5-Hexo), 1.41 (dd, J = 3.4, 13.4 Hz, 1 H; 3-Hendo),
1.90 (dm, J = 10.1 Hz, 1 H; 7-Hsyn), 2.00 (br t, J = 4.2 Hz, 1 H; 4-H),
2.11-2.16 (m, 1 H; 6-Hendo), 2.37 (br d, J = 3.9 Hz, 1 H; 1-H), 3.40 (d,
J = 4.8 Hz, 3 H; CH3), 3.03 (ddd, J = 2.9, 4.6, 13.4 Hz, 1 H; 3-Hexo),
5.76 (br s, 1 H; NH).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, Configuration, and 15N NMR Spectra of Iminoaziridines.
Synthons Equivalent to Three Components of the Ugi Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Quast, Helmut; Aldenkortt, Sven; Freudenreich, Bernd; Schaefer, Peter;
Hagedorn, Manfred; Lehmann, Jens; Banert, Klaus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2007), 72(5), 1659-1666

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(methylsulfonyl)-2-oxo-6-phenyl-2H-pyran-3-carboxylate
C14H12O6S
932022-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.8501 1.3338 0.0 0 VAL=6
M  V30 2 C 3.0801 0.0000 0.0 0
M  V30 3 O 2.5164 2.1038 0.0 0
M  V30 4 O 5.1838 0.5638 0.0 0
M  V30 5 O 3.8501 6.6687 0.0 0
M  V30 6 C 2.3101 4.0012 0.0 0
M  V30 7 O 1.5400 5.3348 0.0 0
M  V30 8 O 1.5400 2.6675 0.0 0
M  V30 9 C 0.0000 5.3348 0.0 0
M  V30 10 C 6.9302 4.0012 0.0 0
M  V30 11 C 6.1601 2.6675 0.0 0
M  V30 12 O 6.1601 5.3348 0.0 0
M  V30 13 C 4.6201 2.6675 0.0 0
M  V30 14 C 4.6201 5.3348 0.0 0
M  V30 15 C 3.8501 4.0012 0.0 0
M  V30 16 C 8.4702 4.0012 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.7802 5.3348 0.0 0
M  V30 20 C 10.7802 2.6675 0.0 0
M  V30 21 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 2 5 14
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(methylamino)-2-oxo-6-phenyl-2H-pyran-3-carboxylate
C14H13NO4
905578-21-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 4.0012 0.0 0
M  V30 2 O 10.0102 5.3348 0.0 0
M  V30 3 O 10.0102 2.6675 0.0 0
M  V30 4 C 11.5503 5.3348 0.0 0
M  V30 5 N 7.7002 1.3338 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 O 7.7002 6.6687 0.0 0
M  V30 8 C 7.7002 4.0012 0.0 0
M  V30 9 C 6.9302 2.6675 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 12 O 5.3901 5.3348 0.0 0
M  V30 13 C 4.6201 4.0012 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 2.6675 0.0 0
M  V30 16 C 2.3101 5.3348 0.0 0
M  V30 17 C 0.7700 2.6675 0.0 0
M  V30 18 C 0.7700 5.3348 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 9
M  V30 7 2 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 932022-29-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 905578-21-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28754996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and fluorescence of 2H-pyrone derivatives for organic
light-emitting diodes (OLED)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mizuyama, Naoko; Murakami, Yuka; Kohra, Shinya; Ueda, Kazuo; Hiraoka,
Kyoko; Nagaoka, Junko; Takahashi, Kojiro; Shigemitsu, Yasuhiro; Tominaga,
Yoshinori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2007), 44(1), 115-132

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoylacetone
C10H10O2
93-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 C 8.0021 2.3100 0.0 0
M  V30 6 O 6.6685 4.6200 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 1.3336 3.0800 0.0 0
M  V30 9 C 2.6674 0.7700 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 1.3336 0.0000 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(Methylamino)-1-phenyl-2-buten-1-one
C11H13NO
14091-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 O 4.0011 4.6200 0.0 0
M  V30 4 C 6.6684 3.0800 0.0 0
M  V30 5 N 8.0021 2.3100 0.0 0
M  V30 6 C 6.6684 4.6200 0.0 0
M  V30 7 C 9.3358 3.0800 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 0.7700 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 0.0000 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4 CFG=2
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 93-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14091-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34167417
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, reusable catalyst, Cu-supported SiO2 catalyst
prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly Active and Efficient Cu@SiO2 Catalyst: Enabled Nucleophilic and
Electrophilic Activation of Active Methylene Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naikwadi, Dhanaji R.; Bankar, Balasaheb D.; Kachgunde, Hanuman G.;
Biradar, Ankush V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2022), 11(10), e202200473

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (γR,4S)-3-[(1,1-dimethylethoxy)carbonyl]-2,2-dimethyl-γ-[[[...
C27H43NO8S
942143-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2822 3.2912 0.0 0
M  V30 2 O 5.8062 1.8265 0.0 0
M  V30 3 O 5.2517 4.4356 0.0 0
M  V30 4 C 4.2999 1.5063 0.0 0
M  V30 5 C 4.6201 0.0000 0.0 0
M  V30 6 C 2.7936 1.1861 0.0 0
M  V30 7 C 3.9797 3.0128 0.0 0
M  V30 8 C 7.6450 6.3520 0.0 0
M  V30 9 C 8.4150 7.6857 0.0 0 CFG=1
M  V30 10 C 7.6450 9.0193 0.0 0
M  V30 11 C 9.9551 7.6857 0.0 0
M  V30 12 O 6.1050 9.0193 0.0 0
M  V30 13 C 10.7251 9.0193 0.0 0
M  V30 14 S 5.3350 10.3530 0.0 0 VAL=6
M  V30 15 C 12.2651 9.0193 0.0 0
M  V30 16 O 4.5650 11.6868 0.0 0
M  V30 17 O 6.6686 11.1230 0.0 0
M  V30 18 O 13.0351 10.3530 0.0 0
M  V30 19 O 13.0351 7.6857 0.0 0
M  V30 20 C 14.5750 10.3530 0.0 0
M  V30 21 C 14.5750 11.8930 0.0 0
M  V30 22 C 16.1152 10.3530 0.0 0
M  V30 23 C 14.5751 8.8130 0.0 0
M  V30 24 C 7.7885 1.5503 0.0 0
M  V30 25 C 9.8382 1.3349 0.0 0
M  V30 26 C 0.0000 7.2729 0.0 0
M  V30 27 N 7.7885 3.6114 0.0 0
M  V30 28 C 8.4150 5.0182 0.0 0 CFG=1
M  V30 29 C 8.9331 2.5809 0.0 0
M  V30 30 C 9.9466 4.8573 0.0 0
M  V30 31 O 10.2668 3.3509 0.0 0
M  V30 32 C 4.0011 9.5830 0.0 0
M  V30 33 C 4.0011 8.0430 0.0 0
M  V30 34 C 2.6675 10.3530 0.0 0
M  V30 35 C 2.6675 7.2729 0.0 0
M  V30 36 C 1.3338 9.5830 0.0 0
M  V30 37 C 1.3338 8.0430 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 27
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 28 8 CFG=1
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 14 17
M  V30 18 1 14 32
M  V30 19 1 15 18
M  V30 20 2 15 19
M  V30 21 1 18 20
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 20 23
M  V30 25 1 24 29
M  V30 26 1 25 29
M  V30 27 1 26 37
M  V30 28 1 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 1 30 31
M  V30 33 2 32 33
M  V30 34 1 32 34
M  V30 35 1 33 35
M  V30 36 2 34 36
M  V30 37 2 35 37
M  V30 38 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (γR,4S)-3-[(1,1-dimethylethoxy)carbonyl]-2,2-dimethyl-γ-[(m...
C21H40N2O5
942143-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.3520 4.8514 0.0 0
M  V30 2 C 7.6857 5.6214 0.0 0 CFG=2
M  V30 3 C 9.0195 4.8514 0.0 0
M  V30 4 C 7.6857 7.1615 0.0 0
M  V30 5 C 10.3532 5.6214 0.0 0
M  V30 6 N 9.0195 7.9315 0.0 0
M  V30 7 C 11.6869 4.8514 0.0 0
M  V30 8 C 9.0195 9.4715 0.0 0
M  V30 9 O 13.0205 5.6214 0.0 0
M  V30 10 O 11.6869 3.3114 0.0 0
M  V30 11 C 14.3543 4.8514 0.0 0
M  V30 12 C 15.1244 6.1851 0.0 0
M  V30 13 C 15.6880 4.0814 0.0 0
M  V30 14 C 13.5843 3.5177 0.0 0
M  V30 15 C 3.2912 3.4886 0.0 0
M  V30 16 O 1.8266 3.0128 0.0 0
M  V30 17 O 4.4358 2.4582 0.0 0
M  V30 18 C 1.5065 1.5063 0.0 0
M  V30 19 C 3.0128 1.1861 0.0 0
M  V30 20 C 1.1861 0.0000 0.0 0
M  V30 21 C 0.0000 1.8266 0.0 0
M  V30 22 C 1.3351 7.0447 0.0 0
M  V30 23 C 1.5505 4.9951 0.0 0
M  V30 24 C 5.0184 5.6214 0.0 0 CFG=1
M  V30 25 N 3.6114 4.9951 0.0 0
M  V30 26 C 4.8574 7.1530 0.0 0
M  V30 27 C 2.5809 6.1395 0.0 0
M  V30 28 O 3.3510 7.4732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 24 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 25
M  V30 18 1 16 18
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 22 27
M  V30 23 1 23 27
M  V30 24 1 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 942143-98-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 942143-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8903314
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2. (S)-tert-butyl
4-((R)-5-tert-butoxy-2-((methylamino)methyl)-5-oxopentyl)-2,2-dimethyloxazolidine-3-carboxylate.
(S)-tert-butyl
4-((R)-5-tert-butoxy-5-oxo-2-(tosyloxymethyl)pentyl)-2,2-dimethyloxazolidine-3-carboxylate
(300 mg, 0.55 mmol) was dissolved in 30% MeNH2 in EtOH (60 mL), the
solution was heated to 70 °C for 2 h in a pressure sealed vessel. After
cooling to rt, the solvent was removed under reduced pressure to give
(S)-tert-butyl
4-((R)-5-tert-butoxy-2-((methylamino)methyl)-5-oxopentyl)-2,2-dimethyloxazolidine-3-carboxylate
(212 mg, 95%). MS ESI +ve m/z 401 (M+H).
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure sealed vessel
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Piperidine derivatives as aspartic protease inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
aspartic protease mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baldwin, John J.; Claremon, David A.; Tice, Colin; Cacatian, Salvation;
Dillard, Lawrence W.; Ishchenko, Alexey V.; Yuan, Jing; Xu, Zhenrong;
McGeehan, Gerard; Simpson, Robert D.; Singh, Suresh B.; Zhao, Wei;
Flaherty, Patrick T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007070201 A1 2007-06-21

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
4-[(3-Chloro-5-nitrophenoxy)methyl]benzoic acid
C14H10ClNO5
943619-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6201 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 4 O 1.3337 6.1601 0.0 0
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 Cl 4.0010 0.0000 0.0 0
M  V30 7 C 13.3369 6.9301 0.0 0
M  V30 8 O 14.6705 6.1601 0.0 0
M  V30 9 O 13.3369 8.4701 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 5.3348 2.3100 0.0 0
M  V30 13 C 2.6673 3.8500 0.0 0
M  V30 14 C 4.0010 1.5400 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 C 9.3357 4.6201 0.0 0
M  V30 17 C 10.6695 3.8500 0.0 0
M  V30 18 C 9.3357 6.1601 0.0 0
M  V30 19 C 12.0032 4.6201 0.0 0
M  V30 20 C 10.6695 6.9301 0.0 0
M  V30 21 C 12.0032 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(3-Chloro-5-nitrophenoxy)methyl]-N-methylbenzamide
C15H13ClN2O4
943619-76-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6200 0.0 0
M  V30 2 C 8.0021 3.8500 0.0 0
M  V30 3 N 1.3338 4.6200 0.0 0 VAL=5
M  V30 4 O 1.3338 6.1600 0.0 0
M  V30 5 O 0.0000 3.8500 0.0 0
M  V30 6 Cl 4.0011 0.0000 0.0 0
M  V30 7 C 13.3369 6.9300 0.0 0
M  V30 8 N 14.6705 6.1600 0.0 0
M  V30 9 O 13.3369 8.4700 0.0 0
M  V30 10 C 16.0043 6.9300 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 4.0011 4.6200 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 9.3358 4.6200 0.0 0
M  V30 18 C 9.3358 6.1600 0.0 0
M  V30 19 C 10.6696 3.8500 0.0 0
M  V30 20 C 10.6696 6.9300 0.0 0
M  V30 21 C 12.0032 4.6200 0.0 0
M  V30 22 C 12.0032 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 17
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 6 15
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 22
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 943619-75-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943619-76-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15018808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 195c. 4-(3-Chloro-5-nitro-phenoxymethyl)-N-methyl-benzamide. The
product from Example 195b (0.70 g, 2.3 mmol) and SOCl2 (2.50 ml, 34.1
mmol) was refluxed for 1 hour. Excess SOCl2 was removed under reduced
pressure to give the corresponding acid chloride as pale brown solid. To
a solution of 2N MeNH2 / THF solution (11.4 mL, 22.8 mmol) was added a
solution of the acid chloride obtained above in THF (7 mL) dropwise at 5
°C. The mixture was stirred at 5 °C for 1 hour and then evaporated. The
residue was treated with H2O, acidified to pH 2 with 10 % HCl, and then
the resulting solid was collected by filtration. The solid was washed
with H2 O and i-Pr2O, and dried in vacuum to give the title compound as a
pale brown crystal (0.69 g. 95 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 1,6- and 1,8-naphthyridines as antiviral compounds for
treatment of HCV infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rockway, Todd W.; Betebenner, David A.; Krueger, Allan C.; Iwasaki,
Nobuhiko; Cooper, Curt S.; Anderson, David D.; Kempf, Dale J.; Madigan,
Darold L.; Motter, Christopher E.; Shanley, Jason P.; Tufano, Michael D.;
Wagner, Rolf; Zhang, Rong; Molla, Akhteruzzaman; Mo, Hongmei;
Pilot-Matias, Tami; Masse, Sherie V. L.; Carrick, Robert J.; He, Weping;
Lu, Liangjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007076035 A2 2007-07-05

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-methoxy-O-methyl-L-tyrosyl-L-alanine methy...
C20H30N2O7
944416-29-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 3 N 7.7000 5.3347 0.0 0
M  V30 4 C 7.7000 8.0020 0.0 0
M  V30 5 C 6.9300 4.0009 0.0 0
M  V30 6 N 9.2400 8.0020 0.0 0
M  V30 7 O 6.9300 9.3358 0.0 0
M  V30 8 O 7.7000 2.6673 0.0 0
M  V30 9 O 5.3900 4.0009 0.0 0
M  V30 10 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 11 C 6.9300 1.3336 0.0 0
M  V30 12 C 11.5500 9.3358 0.0 0
M  V30 13 C 9.2400 10.6694 0.0 0
M  V30 14 C 8.2636 0.5636 0.0 0
M  V30 15 C 6.1600 0.0000 0.0 0
M  V30 16 C 5.5964 2.1036 0.0 0
M  V30 17 O 12.3200 10.6694 0.0 0
M  V30 18 O 12.3200 8.0020 0.0 0
M  V30 19 C 13.8600 10.6694 0.0 0
M  V30 20 O 0.7700 9.3358 0.0 0
M  V30 21 C 0.0000 8.0020 0.0 0
M  V30 22 O 2.3100 12.0031 0.0 0
M  V30 23 C 3.0800 13.3367 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 3.0800 8.0020 0.0 0
M  V30 26 C 5.3900 9.3358 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 4.6200 10.6694 0.0 0
M  V30 29 C 3.0800 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 27
M  V30 22 1 22 23
M  V30 23 1 22 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-3-methoxy-O-methyl-L-tyrosyl-N-methyl-L-alan...
C20H31N3O6
944416-30-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 6.6684 0.0 0
M  V30 2 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 3 N 7.7000 5.3347 0.0 0
M  V30 4 C 7.7000 8.0020 0.0 0
M  V30 5 C 6.9300 4.0009 0.0 0
M  V30 6 N 9.2400 8.0020 0.0 0
M  V30 7 O 6.9300 9.3358 0.0 0
M  V30 8 O 7.7000 2.6673 0.0 0
M  V30 9 O 5.3900 4.0009 0.0 0
M  V30 10 C 10.0100 9.3358 0.0 0 CFG=1
M  V30 11 C 6.9300 1.3336 0.0 0
M  V30 12 C 11.5500 9.3358 0.0 0
M  V30 13 C 9.2400 10.6694 0.0 0
M  V30 14 C 8.2636 0.5636 0.0 0
M  V30 15 C 6.1600 0.0000 0.0 0
M  V30 16 C 5.5964 2.1036 0.0 0
M  V30 17 N 12.3200 10.6694 0.0 0
M  V30 18 O 12.3200 8.0020 0.0 0
M  V30 19 C 13.8600 10.6694 0.0 0
M  V30 20 O 0.7700 9.3358 0.0 0
M  V30 21 C 0.0000 8.0020 0.0 0
M  V30 22 O 2.3100 12.0031 0.0 0
M  V30 23 C 3.0800 13.3367 0.0 0
M  V30 24 C 4.6200 8.0020 0.0 0
M  V30 25 C 3.0800 8.0020 0.0 0
M  V30 26 C 5.3900 9.3358 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 28 C 4.6200 10.6694 0.0 0
M  V30 29 C 3.0800 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3 CFG=1
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 10 13 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 2 12 18
M  V30 19 1 17 19
M  V30 20 1 20 21
M  V30 21 1 20 27
M  V30 22 1 22 23
M  V30 23 1 22 29
M  V30 24 2 24 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 2 26 28
M  V30 28 2 27 29
M  V30 29 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 944416-29-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 944416-30-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-418860
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of tetrahydroisoquinoline-based pseudopeptides and their
characterization as suitable reverse turn mimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Meschini, Elisa; Recca, Teresa; Sacchetti, Alessandro;
Silvani, Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2007), 63(25), 5567-5578

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1-Methyl (2R,5R)-2,5-dihydro-2-methyl-5-(phenylmethyl)-1H-pyrrole-1,2-dic...
C15H17NO4
946057-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5063 4.0432 0.0 0
M  V30 2 O 1.9822 2.5786 0.0 0
M  V30 3 O 0.0000 4.3635 0.0 0
M  V30 4 C 1.2909 6.0930 0.0 0
M  V30 5 C 3.2472 2.5369 0.0 0
M  V30 6 O 4.3916 1.5065 0.0 0
M  V30 7 O 1.7824 2.0610 0.0 0
M  V30 8 C 4.0714 0.0000 0.0 0
M  V30 9 C 6.3080 3.8997 0.0 0
M  V30 10 C 2.5369 5.1878 0.0 0 CFG=1
M  V30 11 N 3.5673 4.0432 0.0 0
M  V30 12 C 3.3069 6.5214 0.0 0
M  V30 13 C 4.9742 4.6697 0.0 0 CFG=2
M  V30 14 C 4.8132 6.2013 0.0 0
M  V30 15 C 7.6416 4.6697 0.0 0
M  V30 16 C 7.6416 6.2097 0.0 0
M  V30 17 C 8.9753 3.8997 0.0 0
M  V30 18 C 8.9753 6.9797 0.0 0
M  V30 19 C 10.3090 4.6697 0.0 0
M  V30 20 C 10.3090 6.2097 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 10 1 CFG=1
M  V30 4 1 10 4 CFG=3
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 13 9 CFG=1
M  V30 10 1 9 15
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-Methyl (2R,5R)-2,5-dihydro-2-methyl-2-[(methylamino)carbonyl]-5-(phenylme...
C16H20N2O3
946057-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 4.6379 0.0 0
M  V30 2 N 1.3338 5.4079 0.0 0
M  V30 3 O 2.6675 3.0979 0.0 0
M  V30 4 C 0.0000 4.6379 0.0 0
M  V30 5 C 3.0959 6.6538 0.0 0
M  V30 6 C 3.8576 2.6673 0.0 0
M  V30 7 O 4.6276 1.3337 0.0 0
M  V30 8 O 2.3176 2.6673 0.0 0
M  V30 9 C 3.8576 0.0000 0.0 0
M  V30 10 C 7.1896 3.0175 0.0 0
M  V30 11 C 4.0011 5.4079 0.0 0 CFG=1
M  V30 12 N 4.6276 4.0011 0.0 0
M  V30 13 C 5.1457 6.4383 0.0 0
M  V30 14 C 6.1591 4.1620 0.0 0 CFG=2
M  V30 15 C 6.4793 5.6683 0.0 0
M  V30 16 C 8.6960 3.3378 0.0 0
M  V30 17 C 9.1719 4.8024 0.0 0
M  V30 18 C 9.7264 2.1933 0.0 0
M  V30 19 C 10.6782 5.1226 0.0 0
M  V30 20 C 11.2327 2.5135 0.0 0
M  V30 21 C 11.7087 3.9782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 11 5 CFG=3
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 14 10 CFG=1
M  V30 11 1 10 16
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946057-56-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 946057-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8595311
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Amide Coupling of
16{1- 5,1-3} (Protocol F). A 5 mL microwave tube was charged with
3,4-dehydroproline 16{1,2} (20 mg, 0.073 mmol, 1 equiv), PS-carbodiimide
(11 mg, 0.15 mmol, 2 equiv), 1-hydroxybenzotriazole (9.9 mg, 0.073 mmol,
1 equiv), and methylamine 13{1} (33 wt % in water) (0.021 mL, 0.22 mmol,
3 equiv) in dichloromethane (1 mL) and capped. The suspension was
irradiated in an Emrys Optimizer microwave reactor (250 W) at 60 °C for
30 min (for nonvolatile amines irradiation was performed at 100 °C for 10
min). After it was cool to room temperature, the reaction mixture was
filtered through an SPE-cartridge (prepacked with 500 mg silica-bound
carbonate and preconditioned with 2 mL of CH2Cl2) and washed with
dichloromethane (3 x 2 mL). The eluants were collected via gravity
filtration. Evaporation of all volatile components in a centrifugal
vacuum evaporator (Genevac HT-4) provided the desired amide 10{1,2,1}
(21.0 mg, 99%). 10{4,3,1}, yield 95%. Purity 99%.
$DTYPE RXN:VAR(1):NOTES
$DATUM photochemical, polystyrene-carbodiimide added
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design and synthesis of a 3,4-dehydroproline amide discovery library
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Werner, Stefan; Kasi, Dhanalakshmi; Brummond, Kay M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2007), 9(4), 677-683

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-fluoro-3-nitro-, methyl ester
C8H6FNO4
946126-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 3.0800 0.0 0
M  V30 2 O 8.0022 2.3100 0.0 0
M  V30 3 O 6.6684 4.6201 0.0 0
M  V30 4 C 9.3359 3.0800 0.0 0
M  V30 5 F 4.0011 4.6201 0.0 0
M  V30 6 N 1.3337 3.0800 0.0 0 VAL=5
M  V30 7 O 1.3337 4.6201 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 2-(methylamino)-3-nitro-, methyl ester
C9H10N2O4
913297-15-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 4.6201 0.0 0
M  V30 2 C 2.6675 5.3901 0.0 0
M  V30 3 C 6.6685 3.0801 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 9.3360 3.0801 0.0 0
M  V30 7 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 0.7700 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 4 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 946126-94-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 913297-15-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2600814
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole derivatives as bromodomain inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aktoudianakis, Evangelos; Chin, Gregory; Corkey, Britton Kenneth; Du,
Jinfa; Elbel, Kristyna; Jiang, Robert H.; Kobayashi, Tetsuya; Lee, Rick;
Martinez, Ruben; Metobo, Samuel E.; Mish, Michael; Munoz, Manuel;
Shevick, Sophie; Sperandio, David; Yang, Hai; Zablocki, Jeff
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014182929 A1 2014-11-13

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 9-(tetrahydro-2H-pyran-2-yl)-9H-purine-6-acetate
C14H18N4O3
948037-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6648 3.0801 0.0 0
M  V30 2 C 10.9985 2.3101 0.0 0
M  V30 3 O 12.3321 3.0801 0.0 0
M  V30 4 O 10.9985 0.7700 0.0 0
M  V30 5 C 13.6660 2.3101 0.0 0
M  V30 6 C 14.9996 3.0801 0.0 0
M  V30 7 C 5.6636 2.3101 0.0 0
M  V30 8 C 6.9973 3.0801 0.0 0
M  V30 9 N 4.5192 3.3405 0.0 0
M  V30 10 N 5.6636 0.7700 0.0 0
M  V30 11 C 8.3311 2.3101 0.0 0
M  V30 12 N 6.6771 4.5864 0.0 0
M  V30 13 C 5.1456 4.7473 0.0 0
M  V30 14 C 6.9973 0.0000 0.0 0
M  V30 15 N 8.3311 0.7700 0.0 0
M  V30 16 C 3.0128 3.0203 0.0 0
M  V30 17 C 1.9823 4.1647 0.0 0
M  V30 18 O 2.5369 1.5556 0.0 0
M  V30 19 C 0.4759 3.8445 0.0 0
M  V30 20 C 1.0304 1.2354 0.0 0
M  V30 21 C 0.0000 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 16
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9-(tetrahydro-2H-pyran-2-yl)-9H-purine-6-acetamide
C13H17N5O2
1204520-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6648 3.0801 0.0 0
M  V30 2 C 10.9985 2.3101 0.0 0
M  V30 3 N 12.3321 3.0801 0.0 0
M  V30 4 O 10.9985 0.7700 0.0 0
M  V30 5 C 13.6660 2.3101 0.0 0
M  V30 6 C 5.6636 2.3101 0.0 0
M  V30 7 C 6.9973 3.0801 0.0 0
M  V30 8 N 4.5192 3.3405 0.0 0
M  V30 9 N 5.6636 0.7700 0.0 0
M  V30 10 C 8.3311 2.3101 0.0 0
M  V30 11 N 6.6771 4.5864 0.0 0
M  V30 12 C 5.1456 4.7473 0.0 0
M  V30 13 C 6.9973 0.0000 0.0 0
M  V30 14 N 8.3311 0.7700 0.0 0
M  V30 15 C 3.0128 3.0203 0.0 0
M  V30 16 C 2.5369 1.5556 0.0 0
M  V30 17 O 1.9823 4.1647 0.0 0
M  V30 18 C 1.0306 1.2354 0.0 0
M  V30 19 C 0.4759 3.8445 0.0 0
M  V30 20 C 0.0000 2.3800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 8 15
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 948037-39-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1204520-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7784297
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 143-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of (purin-6-yl)acetates and their transformations to
6-(2-hydroxyethyl)- and 6-(carbamoylmethyl)purines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hasnik, Zbynek; Pohl, Radek; Klepetarova, Blanka; Hocek, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Collection of Czechoslovak Chemical Communications (2009), 74(7-8),
1035-1059

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-N-[(1E)-1-(methylthio)-2-nitroethenyl]benzenepropanamine
C14H20N2O2S
949143-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 3.0801 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 4.0012 4.6201 0.0 0
M  V30 5 C 1.3337 3.0801 0.0 0
M  V30 6 S 2.6673 0.7700 0.0 0
M  V30 7 C 6.6685 3.0801 0.0 0
M  V30 8 C 5.3348 5.3901 0.0 0
M  V30 9 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 10 C 1.3337 0.0000 0.0 0
M  V30 11 C 8.0022 2.3101 0.0 0
M  V30 12 O 0.0000 5.3901 0.0 0
M  V30 13 O 2.6673 5.3901 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 10.6697 2.3101 0.0 0
M  V30 16 C 9.3360 4.6201 0.0 0
M  V30 17 C 12.0033 3.0801 0.0 0
M  V30 18 C 10.6697 5.3901 0.0 0
M  V30 19 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 9 12
M  V30 12 2 9 13
M  V30 13 1 11 14
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-N-Ethyl-N′-methyl-2-nitro-N-(3-phenylpropyl)-1,1-ethenediamine
C14H21N3O2
949143-30-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 3.0800 2.6674 0.0 0
M  V30 3 C 5.3900 4.0011 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 2.3100 1.3338 0.0 0
M  V30 7 C 6.9300 4.0011 0.0 0
M  V30 8 C 6.9300 1.3338 0.0 0
M  V30 9 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 7.7000 5.3347 0.0 0
M  V30 12 O 0.0000 5.3347 0.0 0
M  V30 13 O 0.0000 2.6674 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 6.6685 0.0 0
M  V30 16 C 10.0100 4.0011 0.0 0
M  V30 17 C 11.5500 6.6685 0.0 0
M  V30 18 C 11.5500 4.0011 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 9 12
M  V30 12 2 9 13
M  V30 13 1 11 14
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 949143-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 949143-30-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2737418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 3.6
1-[N-(benzyl)ethylamino]-1-(methylamino)-2-nitroethene (1a). - Typical
procedure 1-[N-(benzyl)ethylamino]-1-(methylthio)-2-nitroethene 6a (756
mg, 3 mmol) and the aqueous solution of methylamine (5.2 mL, 6 mmol) were
heated together in refluxing 95% ethanol (25 mL) under nitrogen. The
reaction was monitored by thin-layer chromatography (CH2Cl2/MeOH: 20/1).
After disappearance of the starting compound 6a (2 h) and cooling, the
mixture was concentrated under reduced pressure and the resulting oily
product was purified by flash chromatography (eluent CH2Cl2/MeOH (20 : 1)
to afford compound 1a 3.8
1-(N-ethyl-3-phenylpropylamino)-1-(methylamino)-2-nitroethene (1c) From
1-(N-ethyl-3-phenylpropylamino)-1-(methylthio)-2-nitroethene 6c (840 mg,
3 mmol) and the aqueous solution of methylamine (5.2 mL, 6 mmol) was
obtained the expected nitroethene derivative 1c (747 mg, 95%) as a yellow
oil. - Rf = 0.35 (CH2Cl2/ MeOH 20 : 1). - 1H NMR (CDCl3): δ H = 1.15 (t,
3H, J = 7.0 Hz, CH3), 1.92 (m, 2H, J = 7.3 Hz, J = 7.5 Hz, CH2), 2.62 (t,
2H, J = 7.3 Hz, CH2-Ph), 2.90 (d, 3H, J = 5.1 Hz, CH3-N), 3.17 (t, 2H, J
= 7.8 Hz, CH2-N<), 3.23 (q, J = 7.0 Hz, CH2-Me), 6.55 (s, 1H, vinylic H),
7.15 (d, 2H, J = 7.2 Hz, ar. o-H), 7.26 (d, 1H, J = 6.9 Hz, ar. p-H),
7.30 (dd, 2H, J = 6.9 Hz, J = 7.2 Hz, ar. m-H), 9.91 (broad s, NH). - 13C
NMR (CDCl3): δ C = 12.8 (CH3), 29.0 (CH2), 32.2 (CH3N), 32.8 (CH2-Ph),
44.8 (CH2-Me), 48.7 (CH2N), 103.3 (=CH-NO2), 126.3 (ar. CH), 128.3 (ar.
CH), 128.6 (ar. CH), 140.4 (ipso-C), 163.0 (-NEt-C=). - HRMS for
C14H21N3O2 [M]+: calcd. 263.1633, found 263.1613. HRMS for C14H21N2 [M-
NO2]+: calcd. 217.1704, found 217.1701.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New amidines from intramolecular cyclization in triflic acid of
nitroketene aminals with a tethered phenyl ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yaya, Soro; Fante, Bamba; Sorho, Siaka; Jean-Marie, Coustard; Augustin,
Adima A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Sciences (Bangalore, India) (2007), 119(3), 259-265

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chlorobenzotrifluoride
C7H4ClF3
98-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 3.0801 0.0 0
M  V30 2 F 2.1038 4.4137 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 0.5638 1.7464 0.0 0
M  V30 5 Cl 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-(trifluoromethyl)benzenamine
C8H8F3N
2026-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 F 0.5637 1.7464 0.0 0
M  V30 3 F 0.0000 3.8501 0.0 0
M  V30 4 F 2.1037 4.4137 0.0 0
M  V30 5 N 6.6687 3.0801 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 98-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2026-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18951156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2225857-68-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM glovebox used, sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Application of Diazaphospholidine/Diazaphospholene-Based Bisphosphines in
Room-Temperature Nickel-Catalyzed C(sp2)-N Cross-Couplings of Primary
Alkylamines with (Hetero)aryl Chlorides and Bromides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gatien, Alexandre V.; Lavoie, Christopher M.; Bennett, Raymond N.;
Ferguson, Michael J.; McDonald, Robert; Johnson, Erin R.; Speed,
Alexander W. H.; Stradiotto, Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2018), 8(6), 5328-5339

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Picolinic acid
C6H5NO2
98-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 N 3.0801 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-methylpicolinamide
C7H7ClN2O
220000-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 6.6685 2.3100 0.0 0
M  V30 3 O 5.3347 0.0000 0.0 0
M  V30 4 C 8.0021 1.5400 0.0 0
M  V30 5 Cl 0.0000 1.5400 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 C 2.6674 1.5400 0.0 0
M  V30 8 N 4.0011 3.8500 0.0 0
M  V30 9 C 1.3336 2.3100 0.0 0
M  V30 10 C 2.6674 4.6200 0.0 0
M  V30 11 C 1.3336 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-98-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 220000-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37924154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Practical and Efficient Method for the Synthesis of Sorafenib and
Regorafenib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prachi, Ramteke; Gill, Manjinder Singh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM SynOpen (2023), 7(3), 422-429

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-6,7-dimethoxy-3-nitroquinoline
C11H9ClN2O4
99011-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.3100 2.6674 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0 VAL=5
M  V30 3 O 0.0000 4.0011 0.0 0
M  V30 4 O 0.0000 6.6685 0.0 0
M  V30 5 O 7.7000 1.3338 0.0 0
M  V30 6 C 6.9300 0.0000 0.0 0
M  V30 7 O 9.2400 4.0011 0.0 0
M  V30 8 C 10.0100 5.3347 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 5.3900 5.3347 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 5.3900 2.6674 0.0 0
M  V30 13 C 6.9300 5.3347 0.0 0
M  V30 14 N 4.6200 6.6685 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 6.9300 2.6674 0.0 0
M  V30 17 C 7.7000 4.0011 0.0 0
M  V30 18 C 3.0800 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 15
M  V30 5 1 5 6
M  V30 6 1 5 16
M  V30 7 1 7 8
M  V30 8 1 7 17
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Quinolinamine, 6,7-dimethoxy-N-methyl-3-nitro-
C12H13N3O4
2376601-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 2.6675 0.0 0
M  V30 2 C 3.0800 1.3338 0.0 0
M  V30 3 N 0.7700 5.3348 0.0 0 VAL=5
M  V30 4 O 0.0000 4.0011 0.0 0
M  V30 5 O 0.0000 6.6686 0.0 0
M  V30 6 O 7.7001 1.3338 0.0 0
M  V30 7 C 6.9301 0.0000 0.0 0
M  V30 8 O 9.2401 4.0011 0.0 0
M  V30 9 C 10.0101 5.3348 0.0 0
M  V30 10 C 4.6201 4.0011 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 5.3901 5.3348 0.0 0
M  V30 13 C 5.3901 2.6675 0.0 0
M  V30 14 C 2.3100 5.3348 0.0 0
M  V30 15 C 6.9301 5.3348 0.0 0
M  V30 16 N 4.6201 6.6686 0.0 0
M  V30 17 C 6.9301 2.6675 0.0 0
M  V30 18 C 3.0800 6.6686 0.0 0
M  V30 19 C 7.7001 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 1 6 7
M  V30 7 1 6 17
M  V30 8 1 8 9
M  V30 9 1 8 19
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 99011-29-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376601-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21675903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM autoclave used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Imidazoquinolines as ectonucleotide pyrophosphatase-phosphodiesterase 1
(ENPP-1) inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gallatin, William Michael; Odingo, Joshua; Dietsch, Gregory N.; Florio,
Vincent; Venkateshappa, Chandregowda; Duraiswamy, Athisayamani Jeyaraj
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019177971 A1 2019-09-19

$RFMT $RIREG SCHEME301 STEP1
$RXN



  1  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

CH5N.H4N.H.Mo3O10
2241383-02-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.3027 8.6436 0.0 0
M  V30 2 O 6.4282 11.7677 0.0 0
M  V30 3 O 0.0000 8.6436 0.0 0
M  V30 4 O 1.8745 11.7677 0.0 0
M  V30 5 O 2.2942 4.6200 0.0 0
M  V30 6 O 6.0054 4.6200 0.0 0
M  V30 7 O 4.1498 8.3722 0.0 0 CHG=-2 VAL=3
M  V30 8 Mo 5.4720 9.1422 0.0 0 CHG=2 VAL=7
M  V30 9 Mo 2.8307 9.1422 0.0 0 CHG=2 VAL=7
M  V30 10 Mo 4.1498 6.8322 0.0 0 CHG=2 VAL=7
M  V30 11 O 5.4720 7.6022 0.0 0 CHG=-2 VAL=2
M  V30 12 O 4.1498 9.9122 0.0 0 CHG=-2 VAL=2
M  V30 13 O 2.8307 7.6022 0.0 0 CHG=-2 VAL=2
M  V30 14 H 4.1514 3.0800 0.0 0 CHG=1 VAL=-1
M  V30 15 N 4.1514 1.5400 0.0 0 CHG=1 VAL=4
M  V30 16 C 3.3814 0.0000 0.0 0
M  V30 17 N 4.9214 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 8
M  V30 3 2 3 9
M  V30 4 2 4 9
M  V30 5 2 5 10
M  V30 6 2 6 10
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 10 13
M  V30 16 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2241383-02-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-575-CAS-19324226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-91-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ionic ammonium and anilinium based polymolybdate hybrid catalysts for
olefin epoxidation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bozek, Barbara; Neves, Patricia; Lasocha, Wieslaw; Valente, Anabela A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Catalysis, A: General (2018), 56413-25

$RFMT $RIREG SCHEME302 STEP1
$RXN



  1  1
$MOL
2H-1-Benzopyran-2-one, 3-acetyl-5,6,7,8-tetrafluoro-4-hydroxy-, compd. with m...
C11H4F4O4.CH5N
926318-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 7.7000 0.0 0
M  V30 2 F 2.6674 7.7000 0.0 0
M  V30 3 F 2.6674 1.5400 0.0 0
M  V30 4 C 8.0021 6.1600 0.0 0
M  V30 5 C 9.3358 5.3900 0.0 0
M  V30 6 O 8.0021 7.7000 0.0 0
M  V30 7 F 0.0000 6.1600 0.0 0
M  V30 8 F 0.0000 3.0800 0.0 0
M  V30 9 O 8.0021 3.0800 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 C 2.6674 6.1600 0.0 0
M  V30 14 C 2.6674 3.0800 0.0 0
M  V30 15 O 5.3347 3.0800 0.0 0
M  V30 16 C 6.6684 5.3900 0.0 0
M  V30 17 C 1.3336 5.3900 0.0 0
M  V30 18 C 1.3336 3.8500 0.0 0
M  V30 19 C 6.6684 3.8500 0.0 0
M  V30 20 C 3.8979 0.0000 0.0 0
M  V30 21 N 5.4379 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 17
M  V30 8 1 8 18
M  V30 9 2 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,6,7,8-Tetrafluoro-3-[1-(methylamino)ethylidene]-2H-1-benzopyran-2,4(3H)-dione
C12H7F4NO3
926318-61-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 5.3348 0.0 0
M  V30 2 O 6.9302 1.3338 0.0 0
M  V30 3 F 4.6201 0.0000 0.0 0
M  V30 4 O 6.9302 6.6687 0.0 0
M  V30 5 F 0.0000 2.6675 0.0 0
M  V30 6 C 8.4702 4.0012 0.0 0
M  V30 7 N 9.2402 5.3348 0.0 0
M  V30 8 C 9.2402 2.6675 0.0 0
M  V30 9 C 10.7802 5.3348 0.0 0
M  V30 10 F 1.5400 0.0000 0.0 0
M  V30 11 C 3.8501 4.0012 0.0 0
M  V30 12 C 4.6201 2.6675 0.0 0
M  V30 13 O 4.6201 5.3348 0.0 0
M  V30 14 C 2.3101 4.0012 0.0 0
M  V30 15 C 6.1601 2.6675 0.0 0
M  V30 16 C 3.8501 1.3338 0.0 0
M  V30 17 C 6.1601 5.3348 0.0 0
M  V30 18 C 1.5400 2.6675 0.0 0
M  V30 19 C 6.9302 4.0012 0.0 0
M  V30 20 C 2.3101 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 15
M  V30 3 1 3 16
M  V30 4 2 4 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 19 CFG=2
M  V30 9 1 7 9
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 926318-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926318-61-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26228151
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transformations of 4-hydroxy-5,6,7,8-tetrafluorocoumarin derivatives with
monoamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shcherbakov, Konstantin V.; Burgart, Yanina V.; Saloutin, Victor I.;
Chupakhin, Oleg N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2006), 69319-331

$RFMT $RIREG SCHEME303 STEP1
$RXN



  1  1
$MOL
2H-1-Benzopyran-2-one, 3-acetyl-5,6,7,8-tetrafluoro-4-hydroxy-, compd. with m...
C11H4F4O4.CH5N
926318-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3347 7.7000 0.0 0
M  V30 2 F 2.6674 7.7000 0.0 0
M  V30 3 F 2.6674 1.5400 0.0 0
M  V30 4 C 8.0021 6.1600 0.0 0
M  V30 5 C 9.3358 5.3900 0.0 0
M  V30 6 O 8.0021 7.7000 0.0 0
M  V30 7 F 0.0000 6.1600 0.0 0
M  V30 8 F 0.0000 3.0800 0.0 0
M  V30 9 O 8.0021 3.0800 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 C 5.3347 6.1600 0.0 0
M  V30 13 C 2.6674 6.1600 0.0 0
M  V30 14 C 2.6674 3.0800 0.0 0
M  V30 15 O 5.3347 3.0800 0.0 0
M  V30 16 C 6.6684 5.3900 0.0 0
M  V30 17 C 1.3336 5.3900 0.0 0
M  V30 18 C 1.3336 3.8500 0.0 0
M  V30 19 C 6.6684 3.8500 0.0 0
M  V30 20 C 3.8979 0.0000 0.0 0
M  V30 21 N 5.4379 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 13
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 16
M  V30 7 1 7 17
M  V30 8 1 8 18
M  V30 9 2 9 19
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 2 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 19
M  V30 20 2 17 18
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-5,6,7,8-Tetrafluoro-3-[1-(methylamino)ethylidene]-2H-1-benzopyran-2,4(3H...
C12H7F4NO3
947380-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 1.5400 1.3338 0.0 0
M  V30 2 O 6.9302 5.3348 0.0 0
M  V30 3 F 4.6201 6.6687 0.0 0
M  V30 4 O 6.9302 0.0000 0.0 0
M  V30 5 F 0.0000 4.0012 0.0 0
M  V30 6 C 8.4702 2.6675 0.0 0
M  V30 7 N 9.2402 4.0012 0.0 0
M  V30 8 C 9.2402 1.3338 0.0 0
M  V30 9 C 10.7802 4.0012 0.0 0
M  V30 10 F 1.5400 6.6687 0.0 0
M  V30 11 C 3.8501 2.6675 0.0 0
M  V30 12 C 4.6201 4.0012 0.0 0
M  V30 13 O 4.6201 1.3338 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 6.1601 4.0012 0.0 0
M  V30 16 C 3.8501 5.3348 0.0 0
M  V30 17 C 6.1601 1.3338 0.0 0
M  V30 18 C 1.5400 4.0012 0.0 0
M  V30 19 C 6.9302 2.6675 0.0 0
M  V30 20 C 2.3101 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 2 2 15
M  V30 3 1 3 16
M  V30 4 2 4 17
M  V30 5 1 5 18
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 19
M  V30 9 1 7 9
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 926318-57-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 947380-99-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28798080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 95
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM b. A mixture of 307 mg (1 mmol) of salt V and 10 ml of DMSO was stirred
for 8 h. Recrystallization from ethanol gave compound VI Yield 275 mg
(95%).
5,6,7,8-Tetrafluoro-3-(1-methylaminoethylidene)-3,4-dihydro-2H-chromene-2,4-dione
(VI). mp 174-175°C. mp 174-175°C. IR spectrum, ν , cm-1: 3194, 1594
(N-H); 1710 (C2=O); 1654 (C4=O); 1617, 1531, 1491 (C=C); 987 (C-Farom).
1H NMR spectrum, δ , ppm: 2.61 s (3H, CH3), 3.23 d (3H, NHCH3, 3JHH = 5.0
Hz), 13.40 br.s (1H, NH). 19F NMR spectrum, δF , ppm: -2.82 m (1F), 1.89
m (1F), 11.51 m (1F), 16.74 m (1F). 13C NMR spectrum, δC, ppm: 18.5 s
(C10), 31.2 s (C11), 95.7 s (C3), 107.2 m (C4a), 134.99 d.m (C6, JCF =
248.4 Hz), 136.17 d.m (C7, JCF = 247.0 Hz), 138.3 m (C8a), 142.54 d.m
(C5, JCF = 249.8 Hz), 144.88 d.m (C8, JCF = 254.0 Hz), 160.4 d (C2, 4JCF
= 1.0 Hz), 176.5 br.m (C4), 176.9 m (C9). Mass spectrum, m/z (Irel, %):
289 (100) M+, 274 (42) [M - Me]+, 272 (22) [M - OH]+, 97 (20)
[HOC=C-C(=NMe)Me]+, 82 (20) [HOC=C-C(=N)Me]+, 69 (30) [HOC=C-C=O]+, 56
(76) [C(=NMe)Me]+. Found, %: C 49.63; H 2.62; F 26.51; N 4.65.
C12H7F4NO3. Calculated, %: C 49.84; H 2.44; F 26.28; N 4.84. M 289.19.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reactions of 5,6,7,8-tetrafluoro-4-hydroxy-2H-chromen-2-ones with
methylamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shcherbakov, K. V.; Burgart, Ya. V.; Saloutin, V. I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Journal of Organic Chemistry (2006), 42(12), 1838-1844

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxybenzaldehyde
C9H10O3
120-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 2 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dimethoxy-N-methylbenzenemethanamine
C10H15NO2
63-64-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 N 7.7000 5.3349 0.0 0
M  V30 7 C 9.2400 5.3349 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 2.6674 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 120-14-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63-64-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8664900
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multigram synthesis of
1-O-acetyl-3-O-(4-methoxybenzyl)-4-N-(9-fluorenylmethoxycarbonyl)-4-N-methyl-L-pyrrolosamine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Burk, Matthew; Wilson, Nolan; Herzon, Seth B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2015), 56(23), 3231-3234

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-(methylamino)-, ethyl ester
C7H13NO2
870-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6675 1.5400 0.0 0
M  V30 4 O 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 N 1.3337 2.3101 0.0 0
M  V30 7 C 2.6675 0.0000 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 870-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20430119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, single crystal X-ray analysis, and vibrational spectral
studies of ethyl 6-bromo-5-((5-bromopyrimidin-2-yl)oxy)-2-((2,
6-dimethylmorpholino)methyl)-1-methyl-1H-indole-3-carboxylate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Dali; Ma, Lanlan; Zhou, Zhixu; Huang, Zhuyan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Structure (2019), 1198126857pp.

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12-Tetraoxatetradecane-1,14-diol, 1-4-methylbenzenesulfonate
C17H28O8S
155130-15-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.0801 5.3348 0.0 0 VAL=6
M  V30 2 O 4.4137 4.5648 0.0 0
M  V30 3 O 1.7464 6.1048 0.0 0
M  V30 4 O 3.8501 6.6687 0.0 0
M  V30 5 C 5.7474 5.3348 0.0 0
M  V30 6 C 7.0812 4.5648 0.0 0
M  V30 7 O 8.4149 5.3348 0.0 0
M  V30 8 C 9.7486 4.5648 0.0 0
M  V30 9 C 11.0824 5.3348 0.0 0
M  V30 10 O 12.4161 4.5648 0.0 0
M  V30 11 C 13.7497 5.3348 0.0 0
M  V30 12 C 15.0834 4.5648 0.0 0
M  V30 13 O 16.4172 5.3348 0.0 0
M  V30 14 C 17.7509 4.5648 0.0 0
M  V30 15 C 19.0846 5.3348 0.0 0
M  V30 16 O 20.4182 4.5648 0.0 0
M  V30 17 C 21.7521 5.3348 0.0 0
M  V30 18 C 23.0857 4.5648 0.0 0
M  V30 19 O 24.4194 5.3348 0.0 0
M  V30 20 C 0.0000 0.0000 0.0 0
M  V30 21 C 2.3101 4.0012 0.0 0
M  V30 22 C 3.0801 2.6675 0.0 0
M  V30 23 C 0.7700 4.0012 0.0 0
M  V30 24 C 2.3101 1.3338 0.0 0
M  V30 25 C 0.0000 2.6675 0.0 0
M  V30 26 C 0.7700 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 21
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 20 26
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 2 23 25
M  V30 25 2 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6,9,12-Tetraoxa-15-azahexadecan-1-ol
C11H25NO5
2248764-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 0.7700 0.0 0
M  V30 2 C 12.0033 0.0000 0.0 0
M  V30 3 O 9.3360 0.0000 0.0 0
M  V30 4 O 13.3370 0.7700 0.0 0
M  V30 5 C 8.0022 0.7700 0.0 0
M  V30 6 C 14.6708 0.0000 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 16.0045 0.7700 0.0 0
M  V30 9 O 5.3348 0.7700 0.0 0
M  V30 10 O 17.3382 0.0000 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 18.6720 0.7700 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 20.0057 0.0000 0.0 0
M  V30 15 N 1.3337 0.0000 0.0 0
M  V30 16 O 21.3393 0.7700 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155130-15-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2248764-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20994911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptide conjugates as IRAK4 protein kinase degraders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mainolfi, Nello; Ji, Nan; Kluge, Arthur F.; Weiss, Matthew M.; Zhang, Yi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20190192668 A1 2019-06-27

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-bromo-2-(bromomethyl)-4,5-dimethoxybenzoate
C11H12Br2O4
1042722-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 8.0023 4.6201 0.0 0
M  V30 3 O 6.6685 6.9302 0.0 0
M  V30 4 C 9.3360 5.3901 0.0 0
M  V30 5 C 4.0012 6.9302 0.0 0
M  V30 6 Br 2.6675 7.7002 0.0 0
M  V30 7 Br 1.3337 5.3901 0.0 0
M  V30 8 O 4.0012 0.7700 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 O 1.3337 2.3101 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 4.0012 5.3901 0.0 0
M  V30 14 C 5.3348 3.0801 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 4.0012 2.3101 0.0 0
M  V30 17 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 13
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 16
M  V30 10 1 10 11
M  V30 11 1 10 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,3-dihydro-5,6-dimethoxy-2-methyl-1H-isoindol-1-one
C11H12BrNO3
1042722-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.0812 6.6686 0.0 0
M  V30 2 O 0.3504 3.2909 0.0 0
M  V30 3 O 7.6213 4.0011 0.0 0
M  V30 4 C 8.3913 5.3348 0.0 0
M  V30 5 C 0.0000 6.6229 0.0 0
M  V30 6 O 6.0812 1.3338 0.0 0
M  V30 7 C 5.3112 0.0000 0.0 0
M  V30 8 C 3.7712 5.3348 0.0 0
M  V30 9 C 3.0012 4.0011 0.0 0
M  V30 10 C 5.3112 5.3348 0.0 0
M  V30 11 C 2.7406 6.4793 0.0 0
M  V30 12 C 3.7712 2.6675 0.0 0
M  V30 13 C 1.4947 4.3213 0.0 0
M  V30 14 C 6.0812 4.0011 0.0 0
M  V30 15 N 1.3338 5.8529 0.0 0
M  V30 16 C 5.3112 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 2 2 13
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1042722-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1042722-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8191503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4-Bromo-5,6-dimethoxy-2-methylisoindolin-1-one (16). To a solution of
2-(bromomethyl)benzoate 14 (15.6 g, 40.5 mmol) in 100 mL of THF was added
methylamine (17.5 mL of 40 wt% in H2O, 202.5 mmol). The mixture was
stirred at room temperature for 2 h and THF was removed under reduced
pressure. The residue was diluted with H2O (50 mL) and extracted with
EtOAc (3 × 50 mL). The combined extracts were washed with brine, dried
over MgSO4, and concentrated in vacuo. The residue was purified by
recrystallization (EtOAc/hexanes) to provide isoindolin-1-one 16 (10.9 g)
in 94% yield as a white solid:
4-Bromo-5,6-dimethoxy-2-methylisoindolin-1-one (16), (10.9 g) in 94%
yield mp 165 °C; 1H NMR (300MHz, CDCl3) δ 7.31 (s, 1H), 4.21 (s, 2H),
3.93 (s, 3H), 3.91 (s, 3H), 3.20 (s, 3H); 13C NMR (75 MHz, CDCl3) δ
167.9, 154.2, 149.3, 134.4, 129.3, 112.3, 105.9, 60.8, 56.4, 52.2, 29.5,
14.1; IR (neat) 2840, 1673, 1473, 1414, 1394, 1310, 1045, 1022, 984, 929,
757 cm-1; MS (EI) m/z 284 (M+, 95), 255 (100), 206 (42); HRMS (EI) calcd
for C11H12BrNO3 [M+] 285.0001, found 284.9997.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Total Synthesis of Aristolactams via a One-Pot Suzuki-Miyaura
Coupling/Aldol Condensation Cascade Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joa Kyum; Kim, Young Ha; Nam, Ho Tae; Kim, Bum Tae; Heo, Jung-Nyoung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(16), 3543-3546

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-3-penten-2-one
C6H11NO
14092-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14092-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6244573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-Mediated Synthesis of Indolequinones from Bromoquinones and
Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2013), 2013(11), 2179-2187

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenol
C6H5NO3
100-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitroanisole
C7H7NO3
100-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(1):AMD
$DATUM reaction products with divinylbenzene-styrene copolymer diazonium salt
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-02-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 100-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-008-CAS-10584166
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, conversion depends on time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer-supported triazenes as smart reagents for the alkylation of
carboxylic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Erb, Bernhard; Kucma, Jean-Philippe; Mourey, Sandrine; Struber, Fritz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2003), 9(11), 2582-2588

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxybenzaldehyde
C9H10O2
10031-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxy-N-[(4-ethoxyphenyl)methyl]-N-methylbenzenemethanamine
C19H25NO2
113062-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 0.0000 0.0 0
M  V30 2 N 9.3360 0.7700 0.0 0
M  V30 3 C 8.0023 0.0000 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 16.0045 3.0801 0.0 0
M  V30 6 C 17.3383 2.3101 0.0 0
M  V30 7 C 18.6720 3.0801 0.0 0
M  V30 8 O 2.6675 3.0801 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 12.0035 0.7700 0.0 0
M  V30 12 C 12.0035 2.3101 0.0 0
M  V30 13 C 13.3372 0.0000 0.0 0
M  V30 14 C 13.3372 3.0801 0.0 0
M  V30 15 C 14.6708 0.7700 0.0 0
M  V30 16 C 14.6708 2.3101 0.0 0
M  V30 17 C 6.6685 0.7700 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 5.3348 0.0000 0.0 0
M  V30 20 C 5.3348 3.0801 0.0 0
M  V30 21 C 4.0012 0.7700 0.0 0
M  V30 22 C 4.0012 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 17
M  V30 6 1 5 6
M  V30 7 1 5 16
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 22
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10031-82-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 113062-38-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13977779
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-06-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM nanowire
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel synthesis of N-alkyl amines from tandem coupling of either
methylamine or nitroalkane with aldehyde
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Shuanglong; Peng, Jie; Wu, Junjie; Li, Chao; Cao, Xueqin; Gu, Hongwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2016), 52(4),
760-763

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylpyridine
C7H7N
100-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-pyridineethanamine
C8H12N2
55496-55-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3348 2.3100 0.0 0
M  V30 3 N 6.6686 3.0800 0.0 0
M  V30 4 C 8.0022 2.3100 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 1.3337 3.0800 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 1.3337 0.0000 0.0 0
M  V30 10 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-43-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55496-55-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-2854625
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1309-38-2
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on diatomite
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 914770-47-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, ionic liquid used,
ionic liquid incorporated polytungstate anion immobilized on magnetic
diatomaceous earth nanocatalyst prepared and used, Aza-Michael-type
addition, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aza-Michael-type addition reaction catalysed by a supported ionic liquid
phase incorporating an anionic heteropoly acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghasemi, Mohammad Hadi; Kowsari, Elaheh; Shafiee, Abbas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(10), 1150-1153

$RFMT $RIREG SCHEME312 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(T-4)-(Methanamine)tri-2-propen-1-ylboron
C10H20BN
2229897-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 4.0012 4.0012 0.0 0 CHG=3 VAL=4
M  V30 2 C 2.6675 4.7712 0.0 0 CHG=-1 VAL=4
M  V30 3 C 5.3348 3.2311 0.0 0 CHG=-1 VAL=4
M  V30 4 C 3.2311 2.6675 0.0 0 CHG=-1 VAL=4
M  V30 5 N 4.7712 5.3348 0.0 0 VAL=4
M  V30 6 C 1.3337 4.0012 0.0 0
M  V30 7 C 6.6687 4.0012 0.0 0
M  V30 8 C 4.0012 1.3338 0.0 0
M  V30 9 C 4.0012 6.6687 0.0 0
M  V30 10 C 0.0000 4.7712 0.0 0
M  V30 11 C 8.0023 3.2311 0.0 0
M  V30 12 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-α-2-propen-1-ylbenzenemethanamine
C11H15N
49603-23-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 C 5.3348 3.0800 0.0 0
M  V30 3 N 4.0011 0.7700 0.0 0
M  V30 4 C 6.6686 2.3100 0.0 0
M  V30 5 C 5.3348 0.0000 0.0 0
M  V30 6 C 8.0022 3.0800 0.0 0
M  V30 7 C 2.6675 3.0800 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 1.3337 2.3100 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2229897-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 49603-23-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30732766
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Adducts of Triallylborane with Ammonia and Aliphatic Amines as
Stoichiometric Allylating Agents for Aminoallylation Reaction of Carbonyl
Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuznetsov, Nikolai Yu.; Tikhov, Rabdan M.; Strelkova, Tatiana V.; Bubnov,
Yuri N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(12), 3549-3552

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
3-(3-Amino-4-fluorophenyl)-1-ethyl-3,4-dihydro-7-(methylthio)pyrimido[4,5-d]p...
C15H16FN5OS
1011463-84-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 O 7.7000 1.3338 0.0 0
M  V30 4 S 0.7700 5.3347 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 N 12.3200 6.6685 0.0 0
M  V30 7 F 13.8600 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 N 7.7000 4.0011 0.0 0
M  V30 17 N 3.0800 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 23 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 14
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 6 21
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Amino-4-fluorophenyl)-1-ethyl-3,4-dihydro-7-(methylamino)pyrimido[4,5-d]...
C15H17FN6O
1011463-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 C 5.3900 0.0000 0.0 0
M  V30 3 O 7.7000 1.3338 0.0 0
M  V30 4 N 0.7700 5.3347 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 N 12.3200 6.6685 0.0 0
M  V30 7 F 13.8600 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 5.3900 5.3347 0.0 0
M  V30 10 N 5.3900 2.6674 0.0 0
M  V30 11 N 3.0800 4.0011 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 4.6200 6.6685 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 N 7.7000 4.0011 0.0 0
M  V30 17 N 3.0800 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 10.0100 2.6674 0.0 0
M  V30 21 C 11.5500 5.3347 0.0 0
M  V30 22 C 11.5500 2.6674 0.0 0
M  V30 23 C 12.3200 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 14
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 6 21
M  V30 7 1 7 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1011463-84-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1011463-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7145731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7631-90-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example A2: To a solution of Example A1 (400
mg, 1.3 mmol) in CH2Cl2 (5 mL) was added 3-chloroperoxybenzoic acid
(mCPBA) (430 mg, 2.5 mmol) in one portion. After stirring for 2h, the
reaction mixture was quenched with aq NaHCO3 and aq NaHSO3. The organic
layer was separated and was washed with brine, dried (Na2SO4) and
concentrated in vacuo. The crude product was dissolved in DMSO (2 mL) and
was treated with a solution of ammonia in dioxane (2 M, 30 ml, 60 mmol).
The mixture stirred overnight at RT. The reaction was concentrated under
reduced pressure and the residue was purified by silica gel
chromatography to provide
7-amino-3-(3-amina-4-fluorophenyl)-1-methyl-3,4-dihydropyrimida[4,5-d]pyrimidin-2(1H)-one
(276 mg, 77 % yield) as a yellow solid. Example A7: Using a procedure
analogous to Example A2, Example A6 (0.65 g, 1.9 mmol) was treated with
mCPBA (70% wt, 0.58 g, 2.3 mmol) and then N-methylamine (2.0M in THF, 3.9
mL, 7.8 mmol) to afford
3-(3-amino-4-fluorophenyl)-1-ethyl-7-(methylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one
(1.79 g, 94% yield). 1H NMR (400 MHz, DMSO-d6, major tautomer): δ 8.00
(5, 1 H), 7.04 (m, 2 H), 6.76 (dd, J= 8.4, 2.8 Hz, 1 H),6.52 (m, 1 H),
5.27 (s, 2H), 4.57 (s, 2 H), 3.99 (q, J= 6.4 Hz, 2 H), 2.84 (d, J= 4.8
Hz, 3 H), 1.22 (t, J= 6.4 Hz, 3 H); MS (ESI) m/z: 317.0 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic ureas as kinase inhibitors useful for the
treatment of proliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Petillo, Peter A.; Kaufman, Michael D.; Patt, William
C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008033999 A2 2008-03-20

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
N-[5-[7,8-Dihydro-8-methyl-2-(methylthio)-7-oxopyrido[2,3-d]pyrimidin-6-yl]-2...
C24H26FN7O2S
1012881-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 1.5400 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 N 16.0045 3.8501 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 F 13.3370 6.9302 0.0 0
M  V30 9 S 1.3337 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 21.3071 4.9772 0.0 0
M  V30 12 C 21.4681 6.5088 0.0 0
M  V30 13 C 22.8387 4.8163 0.0 0
M  V30 14 C 21.1462 3.4457 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 N 4.0012 1.5400 0.0 0
M  V30 23 N 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 2.3101 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 10.6697 3.8501 0.0 0
M  V30 27 C 9.3360 6.1601 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 10.6697 6.9302 0.0 0
M  V30 30 C 12.0033 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 C 18.7451 3.9938 0.0 0
M  V30 33 C 17.4991 6.1517 0.0 0
M  V30 34 N 19.7756 5.1382 0.0 0
M  V30 35 N 19.0056 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 27
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 31
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-[7,8-Dihydro-8-methyl-2-(methylamino)-7-oxopyrido[2,3-d]pyrimidin-6-yl]-...
C24H27FN8O2
1012873-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.3360 1.5400 0.0 0
M  V30 2 C 8.0022 6.9302 0.0 0
M  V30 3 C 6.6685 0.0000 0.0 0
M  V30 4 N 13.3370 3.8501 0.0 0
M  V30 5 C 14.6708 4.6201 0.0 0
M  V30 6 N 16.0045 3.8501 0.0 0
M  V30 7 O 14.6708 6.1601 0.0 0
M  V30 8 F 13.3370 6.9302 0.0 0
M  V30 9 N 1.3337 1.5400 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 21.3071 4.9772 0.0 0
M  V30 12 C 21.4681 6.5088 0.0 0
M  V30 13 C 22.8387 4.8163 0.0 0
M  V30 14 C 21.1462 3.4457 0.0 0
M  V30 15 C 8.0022 3.8501 0.0 0
M  V30 16 C 6.6685 4.6201 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 6.6685 1.5400 0.0 0
M  V30 20 C 5.3348 2.3101 0.0 0
M  V30 21 C 4.0012 4.6201 0.0 0
M  V30 22 N 4.0012 1.5400 0.0 0
M  V30 23 N 2.6673 3.8501 0.0 0
M  V30 24 C 2.6673 2.3101 0.0 0
M  V30 25 C 9.3360 4.6201 0.0 0
M  V30 26 C 10.6697 3.8501 0.0 0
M  V30 27 C 9.3360 6.1601 0.0 0
M  V30 28 C 12.0033 4.6201 0.0 0
M  V30 29 C 10.6697 6.9302 0.0 0
M  V30 30 C 12.0033 6.1601 0.0 0
M  V30 31 C 17.3382 4.6201 0.0 0
M  V30 32 C 18.7451 3.9938 0.0 0
M  V30 33 C 17.4991 6.1517 0.0 0
M  V30 34 N 19.7756 5.1382 0.0 0
M  V30 35 N 19.0056 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 27
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 28
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 31
M  V30 9 1 8 30
M  V30 10 1 9 10
M  V30 11 1 9 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 25
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 18 21
M  V30 23 1 19 20
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1012881-81-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1012873-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9913420
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 937-14-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7631-90-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure: Example A1: To a
solution of Example A3 (6.0 g, 19 mmol) in CH2Cl2 (50 mL) was added
m-chloroperoxybenzoic acid (mCPBA, 6.5 g, 38 mmol) in one portion. After
stirring for 2h at RT, sat. aq NaHCO3and aq NaHSO3 solution were added
and stirring was continued for a few minutes. The combined organic layer
was washed with brine, dried and concentrated in vacuo. The residue was
dissolved in DMSO (5 mL) and ammonia in dioxane (2 M, 200 mL, 400 mmol)
was added. The resultant reaction mixture was stirred overnight at RT.
The solvent was removed under reduced pressure and the residue was
purified by reverse phase prep-HPLC.
1-(1-tert-butyl-1H-pyrazol-4-yl)-3-(2-fluoro-4-methyl-5-(8-methyl-2-(methylamino)-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)urea
as an off-white solid (0.174 g, 94% yield). 1H NMR (400 MHz, DMSO-d6): δ
8.63 (s, 1H), 8.60 (s, 1H), 8.40 (d, J = 1.6 Hz, 1H), 7.94 (d, J = 8.8
Hz, 1H), 7.80-7.77 (m, 2H), 7.66 (s, 1H), 7.36 (s, 1H), 7.10 (d, J = 8.4
Hz, 1H), 3.59-3.51 (m, 3H), 2.90 (d, J = 4.4 Hz, 1H), 2.05 (s, 3H), 1.45
(s, 9H); (ESI) m/z: 479.2 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic ureas as kinase inhibitors useful for the
treatment of proliferative and inflammatory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flynn, Daniel L.; Kaufman, Michael D.; Patt, William C.; Petillo, Peter
A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008034008 A2 2008-03-20

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Propyn-1-yloxy)-2-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-4H-pyran-4-one
C14H16O5
1017279-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 O 4.6200 4.0011 0.0 0
M  V30 3 O 10.0100 0.0000 0.0 0
M  V30 4 O 11.5500 2.6674 0.0 0
M  V30 5 C 12.3200 4.0011 0.0 0
M  V30 6 C 13.8600 4.0011 0.0 0
M  V30 7 C 15.4000 4.0011 0.0 0
M  V30 8 C 6.9300 2.6674 0.0 0
M  V30 9 C 7.7000 1.3338 0.0 0
M  V30 10 O 7.7000 4.0011 0.0 0
M  V30 11 C 9.2400 1.3338 0.0 0
M  V30 12 C 9.2400 4.0011 0.0 0
M  V30 13 C 10.0100 2.6674 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 O 2.3100 5.3349 0.0 0
M  V30 17 C 0.7700 2.6674 0.0 0
M  V30 18 C 0.7700 5.3349 0.0 0
M  V30 19 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 3 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Methyl-5-(2-propyn-1-yloxy)-2-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]-4(1H)...
C15H19NO4
1017279-86-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 2.6674 0.0 0
M  V30 2 O 4.6200 4.0011 0.0 0
M  V30 3 C 6.9300 0.0000 0.0 0
M  V30 4 O 10.0100 5.3349 0.0 0
M  V30 5 O 11.5500 2.6674 0.0 0
M  V30 6 C 12.3200 1.3338 0.0 0
M  V30 7 C 13.8600 1.3338 0.0 0
M  V30 8 C 15.4000 1.3338 0.0 0
M  V30 9 C 6.9300 2.6674 0.0 0
M  V30 10 N 7.7000 1.3338 0.0 0
M  V30 11 C 7.7000 4.0011 0.0 0
M  V30 12 C 9.2400 1.3338 0.0 0
M  V30 13 C 9.2400 4.0011 0.0 0
M  V30 14 C 10.0100 2.6674 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 O 2.3100 5.3349 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.7700 5.3349 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 15
M  V30 4 1 3 10
M  V30 5 2 4 13
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 6 7
M  V30 9 3 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1017279-51-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1017279-86-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27419119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-Methyl-5-prop-2-ynyloxy-2-(tetrahydropyran-2-yloxymethyl)-1H-pyridin-4-one
(18), To a solution of 8 (1.32 g, 5.0 mmol) in H2O/EtOH (1:1) (50 mL) was
added methylamine (33% wt in EtOH) (0.94 g, 10 mmol) and the mixture was
stirred at 70 °C for 3 h. The reaction mixture was then cooled to room
temperature and concentrated in vacuo to a residue that was partitioned
between water (30 mL) and CHCl3/i-PrOH (4:1) (25 mL). The layers were
separated, and the aqueous layer was extracted with CHCl3/i-PrOH (4:1) (2
x 10 mL). The combined organic layers were dride (MgSO4) and evaporated
in vacuo. Purification of the crude product by flash column
chromatography on silica eluting with CH2Cl2-MeOH (10:1) gave the title
compound (1.30 g, 94%) as a pale yellow solid.
1-Methyl-5-prop-2-ynyloxy-2-(tetrahydropyran-2-yloxymethyl)-1H-pyridin-4-one
(18), yield 94%. mp 93.5–95.5 °C: Rf = 0.38 (CH2Cl2/MeOH 10:1); IR (neat)
3250, 2945, 1634, 1572, 1533, 1194, 1115, 1015, 985, 968, 903, 870 cm-1;
1H NMR (300 MHz, CDCl3) δ 7.25 (1H, s), 6.51 (1H, s), 4.86 (2H, d, J =
2.4 Hz), 4.67 (1H, m), 4.60 (1H, d, J = 12.9 Hz), 4.33 (1H, d, J = 12.9
Hz), 3.82 (1H, m), 3.68 (3H, s), 3.54 (1H, m), 2.48 (1H, t, J = 2.4 Hz),
1.85−1.52 (6 H, m);13C NMR (75 MHz, CDCl3) δ 173.6, 146.8, 145.1, 131.7,
119.4, 98.5, 79.2, 76.1, 65.2, 62.9, 58.0, 40.8, 30.6, 25.4, 19.5; HRMS
calcd for C15H19NO4H+ (M+H)+ 278.1388, found 278.1398.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Modular Synthesis of Candidate Indole-based Insulin Mimics by Claisen
Rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiong, Xin; Pirrung, Michael C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(6), 1151-1154

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-6-chloro-4-benzothiazolecarboxylate
C9H7ClN2O2S
1023531-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 O 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Cl 2.3100 0.0000 0.0 0
M  V30 6 N 8.3912 5.2891 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 N 5.6506 5.1456 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 S 6.8964 2.9876 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 7.0574 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-chloro-N-methyl-4-benzothiazolecarboxamide
C9H8ClN3OS
1620991-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 Cl 2.3100 0.0000 0.0 0
M  V30 6 N 8.3912 5.2891 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 N 5.6506 5.1456 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 S 6.8964 2.9876 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 7.0574 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023531-08-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620991-27-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7583661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-catalyzed N-arylation of
2-aminobenzothiazole-4-carboxylates/carboxamides: facile synthesis of
PARP14 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Pingyuan; Li, Jian; Jiang, Xue; Liu, Zhiqing; Ye, Na; Xu, Youjun;
Yang, Guangfu; Xu, Yechun; Zhang, Ao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(35), 5666-5673

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzothiadiazole, 1-(5-bromopentyl)-3-(2-fluorophenyl)-1,3-dihydro-, 2,...
C17H18BrFN2O2S
1033225-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1517 6.4354 0.0 0
M  V30 2 O 4.1916 5.7986 0.0 0
M  V30 3 F 3.0800 1.1153 0.0 0
M  V30 4 C 8.2358 5.4579 0.0 0
M  V30 5 C 9.6426 4.8315 0.0 0
M  V30 6 C 10.8886 5.7367 0.0 0
M  V30 7 C 12.2954 5.1103 0.0 0
M  V30 8 C 13.5413 6.0154 0.0 0
M  V30 9 Br 14.9482 5.3891 0.0 0
M  V30 10 N 4.6200 3.7827 0.0 0
M  V30 11 C 5.5252 2.5367 0.0 0
M  V30 12 S 5.5252 5.0286 0.0 0 VAL=6
M  V30 13 C 6.9899 3.0127 0.0 0
M  V30 14 C 5.2051 1.0304 0.0 0
M  V30 15 N 6.9899 4.5527 0.0 0
M  V30 16 C 8.1343 1.9821 0.0 0
M  V30 17 C 6.3496 0.0000 0.0 0
M  V30 18 C 7.8141 0.4759 0.0 0
M  V30 19 C 3.0800 3.7827 0.0 0
M  V30 20 C 2.3100 2.4489 0.0 0
M  V30 21 C 2.3100 5.1164 0.0 0
M  V30 22 C 0.7700 2.4489 0.0 0
M  V30 23 C 0.7700 5.1164 0.0 0
M  V30 24 C 0.0000 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 12
M  V30 3 1 3 20
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 19
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,1,3-Benzothiadiazole-1(3H)-pentanamine, 3-(2-fluorophenyl)-N-methyl-, 2,2-d...
C18H22FN3O2S
1033214-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1516 6.4354 0.0 0
M  V30 2 O 4.1916 5.7986 0.0 0
M  V30 3 F 3.0800 1.1153 0.0 0
M  V30 4 C 8.2358 5.4579 0.0 0
M  V30 5 C 9.6426 4.8315 0.0 0
M  V30 6 C 10.8885 5.7367 0.0 0
M  V30 7 C 12.2954 5.1104 0.0 0
M  V30 8 C 13.5413 6.0154 0.0 0
M  V30 9 N 14.9482 5.3891 0.0 0
M  V30 10 C 16.1941 6.2943 0.0 0
M  V30 11 N 4.6200 3.7827 0.0 0
M  V30 12 C 5.5252 2.5367 0.0 0
M  V30 13 S 5.5252 5.0286 0.0 0 VAL=6
M  V30 14 C 6.9899 3.0127 0.0 0
M  V30 15 C 5.2051 1.0304 0.0 0
M  V30 16 N 6.9899 4.5527 0.0 0
M  V30 17 C 8.1343 1.9821 0.0 0
M  V30 18 C 6.3495 0.0000 0.0 0
M  V30 19 C 7.8142 0.4759 0.0 0
M  V30 20 C 3.0800 3.7827 0.0 0
M  V30 21 C 2.3100 2.4489 0.0 0
M  V30 22 C 2.3100 5.1164 0.0 0
M  V30 23 C 0.7700 2.4489 0.0 0
M  V30 24 C 0.7700 5.1164 0.0 0
M  V30 25 C 0.0000 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 13
M  V30 3 1 3 21
M  V30 4 1 4 5
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 14 16
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1033225-93-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1033214-72-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6083458
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 3:
1-(3-Bromo-propyl)-3-(4-chloro-phenyl)-1,3-dihydro
benzo[1,2,5]thiadiazole 2,2-dioxide (0.12 g, 0.29 mmol) was dissolved in
8N methylamine in methanol (20 mL) and stirred for 16 hours in a sealed
flask. The mixture was concentrated in vacuo to give the crude product.
The crude product was purified via chromatography (silica, 5% methanol
saturated with ammonia in chloroform) to give 70 mg of
3-[3-(4-chlorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-N-methylpropan-1-amine
Example 81: Preparation of
5-[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-N-methylpentan-1-amine
In an analogous manner to general procedure A, step 3,
1-(5-bromopentyl)-3-(2-fluorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole
2,2-dioxide (0.08 g, 0.19 mmol) was treated with methylamine (10 mL) to
provide 0.06 g (94%) of
5-[3-(2-fluorophenyl)-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-N-methylpentan-1-amine.
MS (ES) m/z 364.0; HRMS: calculated for C18H22FN3O2S + H+, 364.14895;
found (ESI, [M+H]+), 364.1494; HPLC purity 100.0% at 210-370 nm, 8.7
minutes; Xterra RP18, 3.5u, 150 x 4.6 mm column, 1.2 mL/minutes
85/15-5/95 (Ammon. Bicarb Buff. pH=9.5/ACN+MeOH) for 10 minutes hold 4
minutes
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a sealed flask
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfamide derivatives as monoamine reuptake inhibitors and their
preparation and methods of their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Cohn, Stephen Todd; Crawley, Matthew L.; Fensome,
Andrew; Goldberg, Joel Adam; Jenkins, Douglas John; Kim, Callain
Younghee; Mahaney, Paige Erin; Mann, Charles William; Marella, Michael
Anthony; O'Neill, David John; Sabatucci, Joseph P.; Terefenko, Eugene
Anthony; Trybulski, Eugene John; Vu, An Thien; Woodworth, Richard Page,
Jr.; Zhang, Puwen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008073459 A1 2008-06-19

$RFMT $RIREG SCHEME318 STEP1
$RXN



  4  1
$MOL
4-Methoxyaniline
C7H9NO
104-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 N 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethyl acetylenedicarboxylate
C6H6O4
762-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 O 8.0023 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 O 1.3337 3.0801 0.0 0
M  V30 9 O 2.6675 5.3901 0.0 0
M  V30 10 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Formylchromone
C10H6O3
17422-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 0.0000 0.0 0
M  V30 2 C 6.6686 1.5400 0.0 0
M  V30 3 O 8.0022 2.3100 0.0 0
M  V30 4 C 2.6675 2.3100 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3337 1.5400 0.0 0
M  V30 8 O 4.0011 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 3
M  V30 3 1 2 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C22H16N2O5
3007812-49-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9855 3.0608 0.0 0
M  V30 2 O 0.0000 5.3110 0.0 0
M  V30 3 O 3.2907 0.3503 0.0 0
M  V30 4 C 6.6228 0.0000 0.0 0
M  V30 5 O 10.6694 8.3912 0.0 0
M  V30 6 C 12.0031 7.6212 0.0 0
M  V30 7 N 5.3347 5.3112 0.0 0
M  V30 8 C 4.0011 6.0812 0.0 0
M  V30 9 C 5.3347 3.7712 0.0 0
M  V30 10 C 2.6673 5.3112 0.0 0
M  V30 11 O 4.0011 7.6212 0.0 0
M  V30 12 C 4.0011 3.0012 0.0 0
M  V30 13 C 6.4791 2.7406 0.0 0
M  V30 14 C 2.6673 3.7712 0.0 0
M  V30 15 C 1.3336 6.0812 0.0 0
M  V30 16 C 2.6673 8.3912 0.0 0
M  V30 17 C 4.3212 1.4947 0.0 0
M  V30 18 N 5.8528 1.3338 0.0 0
M  V30 19 C 1.3336 7.6212 0.0 0
M  V30 20 C 2.6673 9.9310 0.0 0
M  V30 21 C 0.0000 8.3910 0.0 0
M  V30 22 C 1.3336 10.7012 0.0 0
M  V30 23 C 0.0000 9.9312 0.0 0
M  V30 24 C 6.6684 6.0812 0.0 0
M  V30 25 C 8.0020 5.3112 0.0 0
M  V30 26 C 6.6684 7.6212 0.0 0
M  V30 27 C 9.3358 6.0812 0.0 0
M  V30 28 C 8.0020 8.3912 0.0 0
M  V30 29 C 9.3358 7.6212 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 15
M  V30 3 2 3 17
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 1 5 29
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 24
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 2 10 14
M  V30 15 1 10 15
M  V30 16 1 11 16
M  V30 17 1 12 14
M  V30 18 1 12 17
M  V30 19 1 13 18
M  V30 20 1 15 19
M  V30 21 1 16 19
M  V30 22 2 16 20
M  V30 23 1 17 18
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-94-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-42-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 17422-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3007812-49-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38332504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient Synthesis of Functionalized Tetracyclic
Dihydrochromeno[2,3-b]pyrrolo[3,4-e]pyridine-triones via Four-Component
Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alizadeh, Abdolali; Rostampoor, Azar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2024), 56(2), 267-274

$RFMT $RIREG SCHEME319 STEP1
$RXN



  2  1
$MOL
1-Fluoro-2,2,3,3-tetramethylcyclopropanecarboxylic acid
C8H13FO2
1050497-15-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3668 2.5775 0.0 0
M  V30 2 O 5.7005 1.8075 0.0 0
M  V30 3 O 4.3668 4.1175 0.0 0
M  V30 4 F 3.5599 0.3604 0.0 0
M  V30 5 C 0.7096 3.7571 0.0 0
M  V30 6 C 3.0332 4.1669 0.0 0
M  V30 7 C 1.5166 0.0000 0.0 0
M  V30 8 C 0.0000 1.8075 0.0 0
M  V30 9 C 3.0332 1.8075 0.0 0
M  V30 10 C 2.0433 2.9871 0.0 0
M  V30 11 C 1.5166 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 11
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-N,2,2,3,3-pentamethylcyclopropanecarboxamide
C9H16FNO
1050496-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3668 2.5775 0.0 0
M  V30 2 N 5.7005 1.8075 0.0 0
M  V30 3 O 4.3668 4.1175 0.0 0
M  V30 4 C 7.0341 2.5775 0.0 0
M  V30 5 F 3.5599 0.3604 0.0 0
M  V30 6 C 0.7096 3.7571 0.0 0
M  V30 7 C 3.0332 4.1669 0.0 0
M  V30 8 C 1.5166 0.0000 0.0 0
M  V30 9 C 0.0000 1.8075 0.0 0
M  V30 10 C 3.0332 1.8075 0.0 0
M  V30 11 C 2.0433 2.9871 0.0 0
M  V30 12 C 1.5166 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 11
M  V30 8 1 8 12
M  V30 9 1 9 12
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1050497-15-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1050496-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9003744
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of N-methyl
α-fluoro-,2,2,3,3-tetramethylcyclopropanecarboxamide (Compound 2):
α-Fluoro-2,2,3, -tetramethylcyclopropanecarbonyl chloride
(α-fluoro-TMC-Cl, 0.017 moles), was prepared as described hereinabove,
and dissolved in anhydrous dichloromethane, and the dichloromethane
solution was added drop-wise to a stirred cooled solution of methyl amine
in THF (2 M, 10 ml). The progress of the reaction monitored by GC-MS, and
once the reaction was completed the organic solvent was evaporated under
reduced pressure and the product was dissolved in ethyl acetate and
washed with water, HCl (1N) and brine. The organic fraction was dried
over magnesium sulfate, filtered and the solvent was evaporated under
reduced pressure. The product was obtained as a yellowish oil. The
overall yield was 94 % and the chemical structure of the product was
determined by spectroscopic methods (NMR, GC-MS). 1H NMR (300MHz, CDCl3,
TMS): δ = 1.07-1.27 (18H), 2.87 (3H) 6.43 (IH) ppm. MS-EI: m/z (%) = 173
(M+). TLC (dichloromethane: methanol, 97:3): single spot having a
retention factor of 0.18. Chemical analysis for C9H16FNO: calculated
-C62.40, H9.31, N8.09, F10.97; found -C62.38, H9.48, N7.79, F11.17.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclopropylcarboxy derivatives for use in the treatment of
neurological diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bialer, Meir; Yagen, Boris; Pessah, Neta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008102348 A1 2008-08-28

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2,2,3,3-tetramethylcyclopropanecarbonyl chloride
C8H12ClFO
1050497-18-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3668 2.5775 0.0 0
M  V30 2 Cl 5.7005 1.8075 0.0 0
M  V30 3 O 4.3668 4.1175 0.0 0
M  V30 4 F 3.5599 0.3604 0.0 0
M  V30 5 C 0.7096 3.7571 0.0 0
M  V30 6 C 3.0332 4.1669 0.0 0
M  V30 7 C 1.5166 0.0000 0.0 0
M  V30 8 C 0.0000 1.8075 0.0 0
M  V30 9 C 3.0332 1.8075 0.0 0
M  V30 10 C 2.0433 2.9871 0.0 0
M  V30 11 C 1.5166 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 10
M  V30 7 1 7 11
M  V30 8 1 8 11
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-N,2,2,3,3-pentamethylcyclopropanecarboxamide
C9H16FNO
1050496-98-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3668 2.5775 0.0 0
M  V30 2 N 5.7005 1.8075 0.0 0
M  V30 3 O 4.3668 4.1175 0.0 0
M  V30 4 C 7.0341 2.5775 0.0 0
M  V30 5 F 3.5599 0.3604 0.0 0
M  V30 6 C 0.7096 3.7571 0.0 0
M  V30 7 C 3.0332 4.1669 0.0 0
M  V30 8 C 1.5166 0.0000 0.0 0
M  V30 9 C 0.0000 1.8075 0.0 0
M  V30 10 C 3.0332 1.8075 0.0 0
M  V30 11 C 2.0433 2.9871 0.0 0
M  V30 12 C 1.5166 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 1 7 11
M  V30 8 1 8 12
M  V30 9 1 9 12
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1050497-18-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1050496-98-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-10014409
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Compounds 11, 12, 15, 17, and 19. Thionyl chloride was added dropwise to
the α-substituted TMC acids (10, 14, 16, 18) dissolved in dry
dichloromethane (DCM) and kept at 0 °C. The reaction mixture was stirred
for 10 h, and the solvent and excess of thionyl chloride were removed by
distillation. The appropriate acyl chlorides were used without further
purification. The corresponding acyl chlorides (0.01 mol), dissolved in
dry dichloromehane (4 mL), were slowly added at 0 °C to a stirred
solution of 25% NH4OH in water (10-20 mL) and dichloromethane (8 mL) or
to a solution of methylamine (10 mL, 2 M in THF). The mixtures were kept
at 0 °C for 60 min and then extracted three times with 25 mL of ethyl
acetate. The extracts were combined and washed with 25 mL of water, 25 mL
of HCl (1 N), and 25 mL of brine. The organic layer was dried over MgSO4,
filtered, and evaporated. The obtained amides were purified by
crystallization from ethyl acetate.
N-Methyl-1-fluoro-2,2,3,3-tetramethylcyclopropanecarbox amide (12). Yield
94%; yellow oil. MS-EI, m/z (%) 173 (M+, 0.01) 158 (100), 138 (24), 81
(40), 58 (69); Rf = 0.15 (DCM/MeOH, 98:2); 1H NMR (300 MHz, CDCl3 δ TMS)
1.13-1.32 (ddd, J = 42 Hz, 11, 6, 18H), 2.8 (d, J = 9 Hz, 3H) 6.43 (s,
1H). Anal. (C9H16FNO) C, H, N, F. Compound 12 (C9H16FNO): found
(calculated) C 62.4 (62.38), H 9.31 (9.48), N 8.09 (7.99), F 10.97
(11.17).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Fluoro-2,2,3,3-Tetramethylcyclopropanecarboxamide, a Novel Potent
Anticonvulsant Derivative of a Cyclic Analogue of Valproic Acid
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pessah, Neta; Bialer, Meir; Wlodarczyk, Bogdan; Finnell, Richard H.;
Yagen, Boris
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2009), 52(8), 2233-2242

$RFMT $RIREG SCHEME321 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl chloroacetate
C4H7ClO2
105-39-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 Cl 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[1,2-Dihydro-2-oxo-1-(2-propen-1-yl)-3H-indol-3-ylidene]propanedinitrile
C14H9N3O
519168-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0127 2.9292 0.0 0
M  V30 2 C 1.5064 3.2494 0.0 0
M  V30 3 C 3.4887 1.4647 0.0 0
M  V30 4 N 0.0000 3.5696 0.0 0
M  V30 5 N 3.9646 0.0000 0.0 0
M  V30 6 O 6.3448 2.5790 0.0 0
M  V30 7 C 7.7075 5.6398 0.0 0
M  V30 8 C 8.7380 4.4953 0.0 0
M  V30 9 C 10.2444 4.8154 0.0 0
M  V30 10 C 3.7231 5.5800 0.0 0
M  V30 11 C 4.0433 4.0738 0.0 0
M  V30 12 C 5.0567 6.3500 0.0 0
M  V30 13 C 2.3893 6.3500 0.0 0
M  V30 14 C 5.5748 3.9127 0.0 0
M  V30 15 N 6.2011 5.3196 0.0 0
M  V30 16 C 5.0567 7.8900 0.0 0
M  V30 17 C 2.3893 7.8900 0.0 0
M  V30 18 C 3.7231 8.6600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 11
M  V30 4 3 2 4
M  V30 5 3 3 5
M  V30 6 2 6 14
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 2 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 15
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3Z)-1,3-Dihydro-3-(3-methyl-4-oxo-2-thioxo-5-thiazolidinylidene)-1-(2-propen...
C15H12N2O2S2
2758146-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6670 6.5772 0.0 0
M  V30 2 O 2.7106 2.1626 0.0 0
M  V30 3 C 9.3774 4.6078 0.0 0
M  V30 4 C 9.6975 6.1143 0.0 0
M  V30 5 C 11.1622 6.5901 0.0 0
M  V30 6 C 0.0000 4.1320 0.0 0
M  V30 7 S 1.0353 7.3184 0.0 0
M  V30 8 C 5.4210 4.1320 0.0 0
M  V30 9 C 5.8970 2.6674 0.0 0
M  V30 10 C 6.6670 5.0372 0.0 0
M  V30 11 C 7.4370 2.6674 0.0 0
M  V30 12 C 5.1270 1.3336 0.0 0
M  V30 13 N 7.9128 4.1320 0.0 0
M  V30 14 C 8.2070 1.3336 0.0 0
M  V30 15 C 5.8970 0.0000 0.0 0
M  V30 16 C 7.4370 0.0000 0.0 0
M  V30 17 C 3.9564 4.6078 0.0 0
M  V30 18 C 2.7106 3.7026 0.0 0
M  V30 19 S 3.4806 6.0725 0.0 0
M  V30 20 N 1.4647 4.6078 0.0 0
M  V30 21 C 1.9406 6.0725 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 18
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 4 5
M  V30 6 1 6 20
M  V30 7 2 7 21
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 17
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 105-39-5
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 519168-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2758146-13-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30037332
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1310-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 25322-68-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, stereoselective, product formed via Michael
addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A facile one-pot, four-component synthesis of (Z)-isomer of
rhodanine-oxindole derivatives under environmentally benevolent
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moghaddam, F. Matloubi; Aghamiri, Bagher; Jalalinik, Mahbod
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2022), 52(2), 175-184

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-2-butenoate
C6H11NO2
21759-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 2.3101 1.3337 0.0 0
M  V30 3 C 4.6201 2.6673 0.0 0
M  V30 4 N 1.5400 2.6673 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 O 6.1601 2.6673 0.0 0
M  V30 7 O 3.8501 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9302 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7962009
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7631-86-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-Mediated Synthesis of Indolequinones from Bromoquinones and
Enamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2013), 2013(11), 2179-2187

$RFMT $RIREG SCHEME322 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2Z)-3-(methylamino)-2-butenoate
C6H11NO2
21759-68-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 1.3337 0.0 0
M  V30 2 C 2.3101 1.3337 0.0 0
M  V30 3 C 4.6201 2.6673 0.0 0
M  V30 4 N 1.5400 2.6673 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 O 6.1601 2.6673 0.0 0
M  V30 7 O 3.8501 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 9 C 6.9302 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21759-68-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6505244
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (Z)-Methyl 3-(methylamino)but-2-enoate 5. A solution of methylamine (25%
w/v in water; 14.8 mL, 120 mmol) was added in a single portion to a
stirred suspension of silica gel (1.0 g) and methyl acetoacetate (11.5 g,
100 mmol) at room temperature, and the resulting mixture was stirred at
room temperature for 15 h. The mixture was extracted with dichloromethane
(3 × 25 mL), and the combined organic phases were dried (MgSO4), filtered
and concentrated in vacuo to give the title compound as an off-white
solid (12.18 g, 94%). mp 58-60 °C (lit., 2 mp 63-66 °C). (Found: M+Na+,
152.0681. C6H11NO2Na requires 152.0682); δH (400 MHz; CDCl3) 8.50 (1H, br
s, NH), 4.51 (1H, s, CH), 3.66 (3H, s, OMe), 2.95 (3H, d, J5.2, NMe),
1.96 (3H, s, Me); δC (75 MHz; CDCl3) 171.0, 162.9, 81.5 (CH), 50.0 (Me),
30.0 (Me), 19.2 (Me); m/z (EI) 152 (M+Na+, 100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM silica gel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Indolequinones from Bromoquinones and Enamines Mediated by
Cu(OAc)2·H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Inman, Martyn; Moody, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2010), 75(17), 6023-6026

$RFMT $RIREG SCHEME323 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Bis(methylthio)imidazo[2,1-f][1,2,4]triazine-7-carbonitrile
C8H7N5S2
1062136-01-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 5.3304 0.0 0
M  V30 2 N 9.4922 5.0102 0.0 0
M  V30 3 S 1.3338 5.3901 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 S 4.0012 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 N 5.3348 4.6201 0.0 0
M  V30 8 C 4.0012 5.3901 0.0 0
M  V30 9 C 6.4794 5.6505 0.0 0
M  V30 10 N 5.3348 3.0801 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 N 4.3213 6.8964 0.0 0
M  V30 13 C 5.8529 7.0574 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 N 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Methylamino)-2-(methylthio)imidazo[2,1-f][1,2,4]triazine-7-carbonitrile
C8H8N6S
2098468-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9857 5.3304 0.0 0
M  V30 2 N 9.4922 5.0102 0.0 0
M  V30 3 N 1.3338 5.3901 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 S 4.0012 0.7700 0.0 0
M  V30 6 C 2.6675 0.0000 0.0 0
M  V30 7 N 5.3348 4.6201 0.0 0
M  V30 8 C 4.0012 5.3901 0.0 0
M  V30 9 C 6.4794 5.6505 0.0 0
M  V30 10 N 5.3348 3.0801 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 N 4.3213 6.8964 0.0 0
M  V30 13 C 5.8529 7.0574 0.0 0
M  V30 14 C 4.0012 2.3101 0.0 0
M  V30 15 N 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 11
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1062136-01-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098468-28-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28963611
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridazine compounds useful as modulators of IL-12,
IL-23 and/or INFα responses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Weinstein, David S.; Moslin, Ryan M.; Zhang, Yanlei; Gardner, Daniel S.;
Santella, Joseph B.; Langevine, Charles M.; Stachura, Sylwia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017087590 A1 2017-05-26

$RFMT $RIREG SCHEME324 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(1,1-dimethylethyl)-6-(4-methyl-1-piperazinyl)pyrimidine
C13H21ClN4
1070214-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 C 0.0000 1.3338 0.0 0
M  V30 3 C 0.7700 0.0000 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 Cl 1.5400 6.6685 0.0 0
M  V30 6 C 10.7800 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 N 3.8500 5.3347 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 N 1.5400 4.0011 0.0 0
M  V30 13 N 6.1600 4.0011 0.0 0
M  V30 14 C 6.9300 2.6674 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 N 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 11
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl)-N-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinamine
C14H25N5
1070215-23-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.3338 0.0 0
M  V30 2 C 2.3100 0.0000 0.0 0
M  V30 3 C 0.7700 0.0000 0.0 0
M  V30 4 C 0.0000 1.3338 0.0 0
M  V30 5 N 1.5400 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 C 10.7800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 N 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 N 1.5400 4.0011 0.0 0
M  V30 14 N 6.1600 4.0011 0.0 0
M  V30 15 C 6.9300 2.6674 0.0 0
M  V30 16 C 6.9300 5.3347 0.0 0
M  V30 17 C 8.4700 2.6674 0.0 0
M  V30 18 C 8.4700 5.3347 0.0 0
M  V30 19 N 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1070214-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1070215-23-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9217868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-86-4
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [4-tert-Butyl-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl]methylamine (34).
A mixture of compound 10 (30 mg, 0.11 mmol), 40% aqueous H2NMe (5 drops),
and 2-methoxyethanol (1 mL) was heated in a sealed tube to 110 °C for 16
h and was cooled, treated with 1 M NaOH (10 mL), and extracted with
CH2Cl2 (2 × 25 mL). The combined CH2Cl2 layers were dried (MgSO4),
filtered, concentrated, and chromatographed by elution with gradients of
2, 3.5, and 5% MeOH/concd NH4OH (9:1) in CH2Cl2 to provide 27 mg (94%) of
the title compound. 1H NMR (CDCl3, δ): 1.25 (s, 9H), 2.33 (s, 3H), 2.46
(t, J= 5.4 Hz, 4H), 2.94 (d, J= 4.7 Hz, 3H), 3.62 (m, 4H), 4.64 (bs, 1H),
5.87 (s, 1H). MS (DCI/NH3) m/z: 264 (M + H)+. Anal. Calcd for (C14H25N5 ·
0.09CH2Cl2): C, H, N.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-Activity Studies on a Series of a 2-Aminopyrimidine-Containing
Histamine H4 Receptor Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Altenbach, Robert J.; Adair, Ronald M.; Bettencourt, Brian M.; Black,
Lawrence A.; Fix-Stenzel, Shannon R.; Gopalakrishnan, Sujatha M.; Hsieh,
Gin C.; Liu, Huaqing; Marsh, Kennan C.; McPherson, Michael J.; Milicic,
Ivan; Miller, Thomas R.; Vortherms, Timothy A.; Warrior, Usha; Wetter,
Jill M.; Wishart, Neil; Witte, David G.; Honore, Prisca; Esbenshade,
Timothy A.; Hancock, Arthur A.; Brioni, Jorge D.; Cowart, Marlon D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(20), 6571-6580

$RFMT $RIREG SCHEME325 STEP1
$RXN



  3  1
$MOL
4-Bromo-1,5-dimethyl-1H-pyrazole-3-methanol
C6H9BrN2O
1073067-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0286 0.0 0
M  V30 2 O 6.6363 3.2586 0.0 0
M  V30 3 Br 2.2418 5.3914 0.0 0
M  V30 4 C 0.0000 2.9016 0.0 0
M  V30 5 C 1.6752 0.0000 0.0 0
M  V30 6 C 3.9690 3.2586 0.0 0
M  V30 7 C 2.5620 3.8850 0.0 0
M  V30 8 N 3.8079 1.7270 0.0 0
M  V30 9 C 1.5316 2.7405 0.0 0
M  V30 10 N 2.3016 1.4068 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 7
M  V30 4 1 4 9
M  V30 5 1 5 10
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-bromo-1,5-dimethyl-1H-pyrazol-3-yl)methyl]-N-methylca...
C12H20BrN3O2
2413932-50-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 4.0287 0.0 0
M  V30 2 N 6.6365 3.2587 0.0 0
M  V30 3 C 7.9701 4.0287 0.0 0
M  V30 4 C 6.6365 1.7187 0.0 0
M  V30 5 O 9.3038 3.2587 0.0 0
M  V30 6 O 7.9701 5.5688 0.0 0
M  V30 7 C 10.6375 4.0287 0.0 0
M  V30 8 C 9.8675 5.3624 0.0 0
M  V30 9 C 11.9713 4.7987 0.0 0
M  V30 10 C 11.4075 2.6951 0.0 0
M  V30 11 Br 2.2420 5.3915 0.0 0
M  V30 12 C 0.0000 2.9016 0.0 0
M  V30 13 C 1.6752 0.0000 0.0 0
M  V30 14 C 3.9690 3.2587 0.0 0
M  V30 15 C 2.5622 3.8850 0.0 0
M  V30 16 N 3.8080 1.7271 0.0 0
M  V30 17 C 1.5316 2.7406 0.0 0
M  V30 18 N 2.3016 1.4070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 15
M  V30 12 1 12 17
M  V30 13 1 13 18
M  V30 14 1 14 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1073067-93-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2413932-50-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-22326606
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of macrocyclic compounds as inhibitors of ALK, TrkA, TrkB,
TrkC, and ROS1 for the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gray, Nathanael S.; Hatcher, John M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020069118 A1 2020-04-02

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-4-carboxaldehyde
C9H7NO
1074-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 O 6.4792 2.3101 0.0 0
M  V30 3 C 2.4781 3.0801 0.0 0
M  V30 4 C 1.1444 2.3101 0.0 0
M  V30 5 C 3.8119 2.3101 0.0 0
M  V30 6 C 2.1579 4.5864 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 C 1.1444 0.7700 0.0 0
M  V30 9 C 3.8119 0.7700 0.0 0
M  V30 10 C 0.6263 4.7473 0.0 0
M  V30 11 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-4-methanamine
C10H12N2
3468-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 N 6.4792 2.3101 0.0 0
M  V30 3 C 7.8129 3.0801 0.0 0
M  V30 4 C 2.4781 3.0801 0.0 0
M  V30 5 C 1.1444 2.3101 0.0 0
M  V30 6 C 3.8119 2.3101 0.0 0
M  V30 7 C 2.1579 4.5864 0.0 0
M  V30 8 N 0.0000 3.3405 0.0 0
M  V30 9 C 1.1444 0.7700 0.0 0
M  V30 10 C 3.8119 0.7700 0.0 0
M  V30 11 C 0.6263 4.7473 0.0 0
M  V30 12 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1074-86-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3468-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-1340429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) (1H-Indol-4-ylmethyl)-methyl-amine [1430] 1H-Indole-4-carbaldehyde
(219 mg, 1.51 mmol) was dissolved in anhydrous methanol (7 ml).
Methylamine (0.60 ml of 33% solution in ethanol, 4.82 mmol) was added and
the reaction was stirred for 3 h. The solution was concentrated to an
orange solid and then dissolved in anhydrous methanol (7 ml). Sodium
borohydride (58.0 mg, 1.53 mmol) was added and the mixture was stirred
overnight at room temperature. Water (10 ml) was added and the solution
was concentrated. Sodium hydroxide (10 ml, 1N) was added and the aqueous
layer was extracted with ethyl acetate (3×20 ml). Combined organic layers
were dried over MgSO4, filtered and concentrated to afford
(1H-indol-4-ylmethyl)-methyl-amine (229 mg, 94%) as a brown solid. 1H NMR
(400 MHz, DMSO-d6) δ 11.03 (bs, 1H), 7.29-7.24 (m, 2H), 7.03-6.93 (m,
2H), 6.51-6.50 (m, 1H), 3.88 (s, 2H), 2.30 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Compositions comprising multiple antibiotic agents including a FabI
inhibitor, methods of using the same, and preparation of the heterocycle
FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berman, Judd M.; Schmid, Molly B.; Mendlein, John D.; Kaplan, Nachum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20060142265 A1 2006-06-29

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-4-carboxaldehyde
C9H7NO
1074-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 O 6.4792 2.3101 0.0 0
M  V30 3 C 2.4781 3.0801 0.0 0
M  V30 4 C 1.1444 2.3101 0.0 0
M  V30 5 C 3.8119 2.3101 0.0 0
M  V30 6 C 2.1579 4.5864 0.0 0
M  V30 7 N 0.0000 3.3405 0.0 0
M  V30 8 C 1.1444 0.7700 0.0 0
M  V30 9 C 3.8119 0.7700 0.0 0
M  V30 10 C 0.6263 4.7473 0.0 0
M  V30 11 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-1H-indole-4-methanamine
C10H12N2
3468-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 N 6.4792 2.3101 0.0 0
M  V30 3 C 7.8129 3.0801 0.0 0
M  V30 4 C 2.4781 3.0801 0.0 0
M  V30 5 C 1.1444 2.3101 0.0 0
M  V30 6 C 3.8119 2.3101 0.0 0
M  V30 7 C 2.1579 4.5864 0.0 0
M  V30 8 N 0.0000 3.3405 0.0 0
M  V30 9 C 1.1444 0.7700 0.0 0
M  V30 10 C 3.8119 0.7700 0.0 0
M  V30 11 C 0.6263 4.7473 0.0 0
M  V30 12 C 2.4781 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1074-86-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3468-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5377169
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) (1H-Indol-4-ylmethyl)-methyl-amine 1H-Indole-4-carbaldehyde (219 mg,
1.51 mmol) was dissolved in anhydrous methanol (7 ml). Methylamine (0.60
ml of 33% solution in ethanol, 4.82 mmol) was added and the reaction was
stirred for 3 h. The solution was concentrated to an orange solid and
then dissolved in anhydrous methanol (7 ml). Sodium borohydride (58.0 mg,
1.53 mmol) was added and the mixture was stirred overnight at room
temperature. Water (10 ml) was added and the solution was concentrated.
Sodium hydroxide (10 ml, 1N) was added and the aqueous layer was
extracted with ethyl acetate (3×20 ml). Combined organic layers were
dried over MgSO4, filtered and concentrated to afford
(1H-indol-4-ylmethyl)-methyl-amine (229 mg, 94%) as a brown solid: 1H NMR
(400 MHz, DMSO-d6) δ 11.03 (bs, 1H), 7.29-7.24 (m, 2H), 7.03-6.93 (m,
2H), 6.51-6.50 (m, 1H), 3.88 (s, 2H), 2.30 (s, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclyl acrylamide compounds as FabI inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manning, David Douglas; Decornez, Helene Yvonne; Surman, Matthew David;
Martin, Fernando J. L.; Ramnauth, Jailall; Toro, Andras; Berman, Judd M.;
Sampson, Peter; Pauls, Henry; Sargent, Bruce Jeremy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2568914 A1 2005-12-04

$RFMT $RIREG SCHEME327 STEP1
$RXN



  5  1
$MOL
N-(9-Fluorenylmethoxycarbonyl)-N-methylglycine
C18H17NO4
77128-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2309 0.0 0
M  V30 2 O 7.0869 4.4609 0.0 0
M  V30 3 C 8.4206 5.2309 0.0 0
M  V30 4 N 9.7542 4.4609 0.0 0
M  V30 5 O 8.4206 6.7709 0.0 0
M  V30 6 C 11.0880 5.2309 0.0 0
M  V30 7 C 9.7542 2.9209 0.0 0
M  V30 8 C 12.4216 4.4609 0.0 0
M  V30 9 O 13.7553 5.2309 0.0 0
M  V30 10 O 12.4216 2.9209 0.0 0
M  V30 11 C 4.4195 4.4609 0.0 0
M  V30 12 C 4.2586 2.9292 0.0 0
M  V30 13 C 3.0127 5.0872 0.0 0
M  V30 14 C 2.7523 2.6091 0.0 0
M  V30 15 C 5.2890 1.7849 0.0 0
M  V30 16 C 1.9823 3.9429 0.0 0
M  V30 17 C 2.5368 6.5519 0.0 0
M  V30 18 C 2.2763 1.1445 0.0 0
M  V30 19 C 4.8131 0.3202 0.0 0
M  V30 20 C 0.4759 4.2630 0.0 0
M  V30 21 C 1.0304 6.8721 0.0 0
M  V30 22 C 3.3068 0.0000 0.0 0
M  V30 23 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 2 21 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C21H22N2O5
2313534-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7531 5.2309 0.0 0
M  V30 2 O 7.0868 4.4609 0.0 0
M  V30 3 C 8.4206 5.2309 0.0 0
M  V30 4 N 9.7542 4.4609 0.0 0
M  V30 5 O 8.4206 6.7709 0.0 0
M  V30 6 C 11.0878 5.2309 0.0 0
M  V30 7 C 9.7542 2.9209 0.0 0
M  V30 8 C 12.4215 4.4609 0.0 0
M  V30 9 N 13.7553 5.2309 0.0 0
M  V30 10 O 12.4215 2.9209 0.0 0
M  V30 11 C 15.0889 4.4609 0.0 0
M  V30 12 C 13.7553 6.7709 0.0 0
M  V30 13 C 16.4226 5.2309 0.0 0
M  V30 14 O 16.4226 6.7709 0.0 0
M  V30 15 O 17.7562 4.4609 0.0 0
M  V30 16 C 4.4195 4.4609 0.0 0
M  V30 17 C 4.2586 2.9292 0.0 0
M  V30 18 C 3.0125 5.0872 0.0 0
M  V30 19 C 2.7521 2.6091 0.0 0
M  V30 20 C 5.2890 1.7849 0.0 0
M  V30 21 C 1.9821 3.9429 0.0 0
M  V30 22 C 2.5367 6.5519 0.0 0
M  V30 23 C 2.2763 1.1445 0.0 0
M  V30 24 C 4.8131 0.3202 0.0 0
M  V30 25 C 0.4759 4.2630 0.0 0
M  V30 26 C 1.0304 6.8721 0.0 0
M  V30 27 C 3.3067 0.0000 0.0 0
M  V30 28 C 0.0000 5.7276 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 2 26 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bromoacetic acid
C2H3BrO2
79-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 0.0000 2.3101 0.0 0
M  V30 5 Br 4.0010 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Acetic anhydride
C4H6O3
108-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C20H34N6O8
2313534-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 13.3369 1.5400 0.0 0
M  V30 2 N 14.6705 2.3100 0.0 0
M  V30 3 C 12.0032 2.3100 0.0 0
M  V30 4 O 13.3369 0.0000 0.0 0
M  V30 5 C 16.0041 1.5400 0.0 0
M  V30 6 C 14.6705 3.8500 0.0 0
M  V30 7 N 10.6694 1.5400 0.0 0
M  V30 8 C 17.3379 2.3100 0.0 0
M  V30 9 C 9.3358 2.3100 0.0 0
M  V30 10 C 10.6694 0.0000 0.0 0
M  V30 11 N 18.6716 1.5400 0.0 0
M  V30 12 O 17.3379 3.8500 0.0 0
M  V30 13 C 8.0021 1.5400 0.0 0
M  V30 14 O 9.3358 3.8500 0.0 0
M  V30 15 C 20.0052 2.3100 0.0 0
M  V30 16 C 18.6716 0.0000 0.0 0
M  V30 17 N 6.6685 2.3100 0.0 0
M  V30 18 C 21.3390 1.5400 0.0 0
M  V30 19 C 5.3347 1.5400 0.0 0
M  V30 20 C 6.6685 3.8500 0.0 0
M  V30 21 N 22.6727 2.3100 0.0 0
M  V30 22 O 21.3390 0.0000 0.0 0
M  V30 23 C 4.0011 2.3100 0.0 0
M  V30 24 O 5.3347 0.0000 0.0 0
M  V30 25 C 24.0063 1.5400 0.0 0
M  V30 26 C 22.6727 3.8500 0.0 0
M  V30 27 N 2.6674 1.5400 0.0 0
M  V30 28 C 25.3399 2.3100 0.0 0
M  V30 29 C 1.3338 2.3100 0.0 0
M  V30 30 C 2.6674 0.0000 0.0 0
M  V30 31 O 26.6737 1.5400 0.0 0
M  V30 32 O 25.3399 3.8500 0.0 0
M  V30 33 C 1.3338 3.8500 0.0 0
M  V30 34 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 5 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 1 13 17
M  V30 17 1 15 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 18 21
M  V30 21 2 18 22
M  V30 22 1 19 23
M  V30 23 2 19 24
M  V30 24 1 21 25
M  V30 25 1 21 26
M  V30 26 1 23 27
M  V30 27 1 25 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 28 31
M  V30 31 2 28 32
M  V30 32 1 29 33
M  V30 33 2 29 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 77128-70-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2313534-20-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 79-08-3
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(5):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2313534-22-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23438775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 8
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-89-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 693-13-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 920-66-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported reaction, Fmoc deprotection procedure repeated once in
stages 2 and 4,attachment to 2-chlorotrityl chloride resin in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ligand-drug-conjugate comprising a single molecular weight polysarcosine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Viricel, Warren
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019081455 A1 2019-05-02

$RFMT $RIREG SCHEME328 STEP1
$RXN



  3  1
$MOL
Acetic anhydride
C4H6O3
108-24-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 5.3349 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (4aR,6S,8aR)-decahydro-8-oxo-6-phenyl-1,7-naphthyridine-6-carboxylate
C16H20N2O3
393860-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8615 2.6268 0.0 0
M  V30 2 O 4.8716 1.4471 0.0 0
M  V30 3 O 7.3781 2.3594 0.0 0
M  V30 4 C 5.3983 0.0000 0.0 0
M  V30 5 O 4.0011 7.9239 0.0 0
M  V30 6 C 5.3347 4.0739 0.0 0 CFG=2
M  V30 7 C 4.0011 3.3039 0.0 0
M  V30 8 N 5.3347 5.6139 0.0 0
M  V30 9 C 2.6674 4.0739 0.0 0 CFG=1
M  V30 10 C 4.0011 6.3839 0.0 0
M  V30 11 C 2.6674 5.6139 0.0 0 CFG=1
M  V30 12 C 1.3338 3.3039 0.0 0
M  V30 13 N 1.3338 6.3839 0.0 0
M  V30 14 C 0.0000 4.0739 0.0 0
M  V30 15 C 0.0000 5.6139 0.0 0
M  V30 16 C 6.8513 4.3414 0.0 0
M  V30 17 C 7.3781 5.7886 0.0 0
M  V30 18 C 7.8412 3.1616 0.0 0
M  V30 19 C 8.8947 6.0559 0.0 0
M  V30 20 C 9.3578 3.4291 0.0 0
M  V30 21 C 9.8846 4.8763 0.0 0
M  V30 22 H 2.6674 2.5339 0.0 0
M  V30 23 H 2.6674 7.1539 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 6 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 22 CFG=3
M  V30 14 1 10 11
M  V30 15 1 11 13
M  V30 16 1 11 23 CFG=3
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 6 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4aR,6S,8aR)-1-Acetyldecahydro-N-methyl-8-oxo-6-phenyl-1,7-naphthyridine-...
C18H23N3O3
595581-83-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6268 2.5065 0.0 0
M  V30 2 N 2.8943 0.9899 0.0 0
M  V30 3 O 1.1798 3.0332 0.0 0
M  V30 4 C 1.7146 0.0000 0.0 0
M  V30 5 O 6.8866 6.1638 0.0 0
M  V30 6 C 9.1966 4.8301 0.0 0
M  V30 7 C 8.4266 6.1638 0.0 0
M  V30 8 O 10.7366 4.8301 0.0 0
M  V30 9 C 3.8066 3.4964 0.0 0 CFG=2
M  V30 10 C 4.5766 2.1628 0.0 0
M  V30 11 N 4.5766 4.8301 0.0 0
M  V30 12 C 6.1166 2.1628 0.0 0 CFG=1
M  V30 13 C 6.1166 4.8301 0.0 0
M  V30 14 C 6.8866 3.4964 0.0 0 CFG=1
M  V30 15 C 6.8866 0.8290 0.0 0
M  V30 16 N 8.4266 3.4964 0.0 0
M  V30 17 C 8.4266 0.8291 0.0 0
M  V30 18 C 9.1966 2.1628 0.0 0
M  V30 19 C 2.6268 4.4863 0.0 0
M  V30 20 C 2.8943 6.0029 0.0 0
M  V30 21 C 1.1798 3.9596 0.0 0
M  V30 22 C 1.7145 6.9928 0.0 0
M  V30 23 C 0.0000 4.9496 0.0 0
M  V30 24 C 0.2675 6.4662 0.0 0
M  V30 25 H 5.3466 0.8290 0.0 0
M  V30 26 H 7.6566 4.8301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=3
M  V30 4 1 2 4
M  V30 5 2 5 13
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 19 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 12 25 CFG=1
M  V30 17 1 13 14
M  V30 18 1 14 16
M  V30 19 1 14 26 CFG=1
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 9 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 393860-89-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 595581-83-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-8719215
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a functionalizable external β-turn mimic based on a
cis-fused 1,7-naphthyridine scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rombouts, Frederik J. R.; De Borggraeve, Wim M.; Delaere, David; Froeyen,
Matheus; Toppet, Suzanne M.; Compernolle, Frans; Hoornaert, Georges J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2003), (10), 1868-1878

$RFMT $RIREG SCHEME329 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7′,8′-Dihydro-1′,7′,7′-trimethylspiro[cyclohexane-1,4′(1′H)-quinoline]-2′,5′(...
C17H25NO2
1800597-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 6.9300 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 7.1952 7.6070 0.0 0
M  V30 5 C 8.1851 5.8925 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 6.1600 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 1.3338 3.0800 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 N 5.3347 2.3100 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 1.3338 6.1600 0.0 0
M  V30 19 C 6.6685 6.1600 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 14
M  V30 3 2 3 16
M  V30 4 1 4 19
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 16
M  V30 20 1 15 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800597-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-23563139
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 90-02-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM reaction products with silylated carbon nanotube and complexes with
copper
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 919-30-2
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM reaction products wit hydroxylated carbon nanotube, Schiff base with
2-hydroxybenzaldehyde and complexes with copper
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, supported on carbon, catalyst prepared and
used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper(II)-Schiff Base Complex Embedded on multiwalled Carbon Nanotubes
(APTMS@MWCNTs/Schiff Base/Cu): A Novel Versatile Nanostructure to Promote
Four-Component Preparation of
Dihydro-spiro[cycloalkane-1,4'-quinoline]-2',5'-diones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nikoofar, Kobra; Mehrikaram, Fatemeh; Lashanizadegan, Maryam; Aghaei,
Arezoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polycyclic Aromatic Compounds (2021), 41(3), 663-675

$RFMT $RIREG SCHEME329 STEP1
$RXN



  4  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimedone
C8H12O2
126-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 C 1.5166 2.3101 0.0 0
M  V30 7 C 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-1,3-dioxane-4,6-dione
C6H8O4
2033-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 3.5826 0.0 0
M  V30 2 C 0.9898 5.2971 0.0 0
M  V30 3 O 2.8503 0.0000 0.0 0
M  V30 4 O 5.5176 4.6201 0.0 0
M  V30 5 C 1.5166 3.8501 0.0 0
M  V30 6 O 1.5166 2.3101 0.0 0
M  V30 7 O 2.8503 4.6201 0.0 0
M  V30 8 C 2.8503 1.5400 0.0 0
M  V30 9 C 4.1840 3.8501 0.0 0
M  V30 10 C 4.1840 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 5
M  V30 3 2 3 8
M  V30 4 2 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7′,8′-Dihydro-1′,7′,7′-trimethylspiro[cyclohexane-1,4′(1′H)-quinoline]-2′,5′(...
C17H25NO2
1800597-68-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 6.9300 0.0 0
M  V30 2 C 6.6685 1.5400 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 7.1952 7.6070 0.0 0
M  V30 5 C 8.1851 5.8925 0.0 0
M  V30 6 C 4.0011 4.6200 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 6.1600 0.0 0
M  V30 10 C 2.6674 2.3100 0.0 0
M  V30 11 C 1.3338 3.0800 0.0 0
M  V30 12 C 2.6674 5.3900 0.0 0
M  V30 13 C 6.6685 4.6200 0.0 0
M  V30 14 N 5.3347 2.3100 0.0 0
M  V30 15 C 5.3347 6.9300 0.0 0
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 17 C 0.0000 3.8500 0.0 0
M  V30 18 C 1.3338 6.1600 0.0 0
M  V30 19 C 6.6685 6.1600 0.0 0
M  V30 20 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 14
M  V30 3 2 3 16
M  V30 4 1 4 19
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 16
M  V30 20 1 15 19
M  V30 21 1 17 20
M  V30 22 1 18 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 126-81-8
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2033-24-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1800597-68-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8059850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1314-98-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, ultrasound, optimization study, reusable catalyst, ZnS
nanoparticles used, optimized on solvent, catalyst and time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM ZnS Nanoparticle Catalysed Four Component Syntheses of Novel
Spiropolyhydroquinoline Derivatives in Aqueous Medium Under Ultrasonic
Irradiation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dandia, Anshu; Singh, Ruby; Gupta, Shyam L.; Rathore, Kuldeep S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Proceedings of the National Academy of Sciences, India, Section A:
Physical Sciences (2015), 85(1), 19-27

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(Dimethylamino)methylene]-N-(2,4-dimethylphenyl)-3-oxobutanamide
C15H20N2O2
1092368-99-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 4.0012 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 C 3.0801 2.6675 0.0 0
M  V30 4 O 5.3901 1.3338 0.0 0
M  V30 5 C 2.3101 4.0012 0.0 0
M  V30 6 C 2.3101 1.3338 0.0 0
M  V30 7 N 0.7700 4.0012 0.0 0
M  V30 8 C 3.0801 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 2.6675 0.0 0
M  V30 11 C 0.0000 5.3348 0.0 0
M  V30 12 C 6.9302 6.6687 0.0 0
M  V30 13 C 11.5503 4.0012 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 7.7002 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 12 15
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butanamide, N-(2,4-dimethylphenyl)-2-[(methylamino)methylene]-3-oxo-
C14H18N2O2
2197964-31-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3901 4.0011 0.0 0
M  V30 2 C 4.6201 2.6675 0.0 0
M  V30 3 C 3.0800 2.6675 0.0 0
M  V30 4 O 5.3901 1.3338 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 C 2.3100 1.3338 0.0 0
M  V30 7 N 0.7700 4.0011 0.0 0
M  V30 8 C 3.0800 0.0000 0.0 0
M  V30 9 O 0.7700 1.3338 0.0 0
M  V30 10 C 0.0000 5.3348 0.0 0
M  V30 11 C 6.9301 6.6686 0.0 0
M  V30 12 C 11.5501 4.0011 0.0 0
M  V30 13 C 6.9301 4.0011 0.0 0
M  V30 14 C 7.7001 5.3348 0.0 0
M  V30 15 C 7.7001 2.6675 0.0 0
M  V30 16 C 9.2401 5.3348 0.0 0
M  V30 17 C 9.2401 2.6675 0.0 0
M  V30 18 C 10.0101 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 3 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 14
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1092368-99-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2197964-31-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18916621
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PIFA-Mediated Oxidative Cyclization Reactions of α-Acyl Acrylamides: A
Synthetic Route to Substituted Isoxazol-3(2H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yuan, Jingwen; Rao, Chitturi Bhujanga; Zhang, Qian; Zhang, Rui; Liang,
Yongjiu; Zhang, Ning; Dong, Dewen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2018), 50(9), 1875-1882

$RFMT $RIREG SCHEME331 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Di-tert-butyl dicarbonate
C10H18O5
24424-99-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 O 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 O 8.0023 0.5637 0.0 0
M  V30 11 O 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 C 10.1060 0.0000 0.0 0
M  V30 14 C 10.6697 2.1037 0.0 0
M  V30 15 C 8.5660 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(4-bromophenyl)methyl]-N-methylcarbamate
C13H18BrNO2
260809-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.2073 0.0 0
M  V30 2 N 5.3900 2.8736 0.0 0
M  V30 3 C 3.8500 2.8736 0.0 0
M  V30 4 C 6.1600 1.5400 0.0 0
M  V30 5 O 3.0800 1.5400 0.0 0
M  V30 6 O 3.0800 4.2073 0.0 0
M  V30 7 C 1.5400 1.5400 0.0 0
M  V30 8 C 1.5400 3.0800 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 1.5400 0.0000 0.0 0
M  V30 11 Br 12.3200 4.2073 0.0 0
M  V30 12 C 7.7000 4.2073 0.0 0
M  V30 13 C 8.4700 2.8736 0.0 0
M  V30 14 C 8.4700 5.5409 0.0 0
M  V30 15 C 10.0100 2.8736 0.0 0
M  V30 16 C 10.0100 5.5409 0.0 0
M  V30 17 C 10.7800 4.2073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 260809-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23993262
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-Mediated Radiosynthesis of [18F]Rucaparib
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Zijun; Destro, Gianluca; Guibbal, Florian; Chan, Chung Ying;
Cornelissen, Bart; Gouverneur, Veronique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2021), 23(18), 7290-7294

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluorophen...
C17H13ClFN3O2S
1138037-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3172 4.3755 0.0 0
M  V30 2 F 1.6472 3.5673 0.0 0
M  V30 3 C 3.6896 8.4043 0.0 0
M  V30 4 O 2.1580 8.5652 0.0 0
M  V30 5 O 4.5948 9.6502 0.0 0
M  V30 6 C 1.5317 9.9722 0.0 0
M  V30 7 C 0.0000 10.1331 0.0 0
M  V30 8 Cl 12.6520 7.4556 0.0 0
M  V30 9 N 4.5765 4.5192 0.0 0
M  V30 10 C 5.9833 5.1456 0.0 0
M  V30 11 N 3.5461 5.6636 0.0 0
M  V30 12 C 5.8224 6.6771 0.0 0
M  V30 13 C 4.3161 6.9973 0.0 0
M  V30 14 C 4.2563 3.0128 0.0 0
M  V30 15 C 2.7916 2.5369 0.0 0
M  V30 16 C 5.4007 1.9823 0.0 0
M  V30 17 C 2.4714 1.0306 0.0 0
M  V30 18 C 5.0806 0.4759 0.0 0
M  V30 19 C 3.6160 0.0000 0.0 0
M  V30 20 C 8.6508 5.1456 0.0 0
M  V30 21 C 9.9845 4.3755 0.0 0
M  V30 22 C 8.6508 6.6856 0.0 0
M  V30 23 C 11.3182 5.1456 0.0 0
M  V30 24 N 9.9845 7.4556 0.0 0
M  V30 25 C 11.3182 6.6856 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2-fluorophenyl)-...
C16H12ClFN4OS
1138037-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8689 7.7394 0.0 0
M  V30 2 F 0.5546 5.6044 0.0 0
M  V30 3 C 4.7418 2.4367 0.0 0
M  V30 4 N 3.4960 1.5317 0.0 0
M  V30 5 O 6.1486 1.8104 0.0 0
M  V30 6 C 3.6569 0.0000 0.0 0
M  V30 7 Cl 12.0289 7.7394 0.0 0
M  V30 8 N 3.5673 6.2447 0.0 0
M  V30 9 C 5.0989 6.4056 0.0 0
M  V30 10 N 3.2471 4.7384 0.0 0
M  V30 11 C 5.7253 4.9988 0.0 0
M  V30 12 C 4.5809 3.9684 0.0 0
M  V30 13 C 2.5368 7.3892 0.0 0
M  V30 14 C 1.0306 7.0689 0.0 0
M  V30 15 C 3.0127 8.8538 0.0 0
M  V30 16 C 0.0000 8.2134 0.0 0
M  V30 17 C 1.9823 9.9983 0.0 0
M  V30 18 C 0.4760 9.6781 0.0 0
M  V30 19 C 7.4089 7.7394 0.0 0
M  V30 20 C 8.1789 6.4056 0.0 0
M  V30 21 C 8.1789 9.0731 0.0 0
M  V30 22 C 9.7189 6.4056 0.0 0
M  V30 23 N 9.7189 9.0731 0.0 0
M  V30 24 C 10.4889 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 1 4 6
M  V30 8 1 7 24
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 13
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-18-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8270996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 273
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2-fluorophenyl)-1H-pyrazole-3-carboxylate
(1.73 g (including impurity)) in methanol (20 mL) was added 40%
methylamine-methanol solution (20 mL) under ice-cooling. The mixture was
stirred at room temperature for 1 hr, and concentrated under reduced
pressure. The residue was purified by silica gel column chromatography
(eluent: hexane-ethyl acetate=9:1&#x2192;ethyl acetate) to give the title
compound as a pale-yellow solid (1.56 g, yield 94%). 1H-NMR (CDCl3)
&#x03B4; : 2.98 (3H, d, J=4.9 Hz), 6.79-6.90 (1H, m), 7.13-7.32 (5H, m),
7.37 (1H, dd, J=8.3, 2.7 Hz), 7.45-7.55 (1H, m), 8.02 (1H, d, J=1.9 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxylic acid, 5-[(6-chloro-3-pyridinyl)thio]-1-(2,3-difluoro...
C17H12ClF2N3O2S
1138037-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3751 8.6446 0.0 0
M  V30 2 F 2.0608 6.5096 0.0 0
M  V30 3 C 6.2481 3.3420 0.0 0
M  V30 4 O 5.0021 2.4369 0.0 0
M  V30 5 O 7.6549 2.7156 0.0 0
M  V30 6 C 5.1632 0.9052 0.0 0
M  V30 7 C 3.9173 0.0000 0.0 0
M  V30 8 F 0.0000 8.7985 0.0 0
M  V30 9 Cl 13.5351 8.6446 0.0 0
M  V30 10 N 5.0735 7.1499 0.0 0
M  V30 11 C 6.6051 7.3108 0.0 0
M  V30 12 N 4.7534 5.6436 0.0 0
M  V30 13 C 7.2315 5.9041 0.0 0
M  V30 14 C 6.0870 4.8736 0.0 0
M  V30 15 C 4.0431 8.2944 0.0 0
M  V30 16 C 2.5367 7.9741 0.0 0
M  V30 17 C 4.5190 9.7590 0.0 0
M  V30 18 C 1.5063 9.1186 0.0 0
M  V30 19 C 3.4886 10.9035 0.0 0
M  V30 20 C 1.9821 10.5832 0.0 0
M  V30 21 C 8.9151 8.6446 0.0 0
M  V30 22 C 9.6851 9.9783 0.0 0
M  V30 23 C 9.6851 7.3108 0.0 0
M  V30 24 C 11.2251 9.9783 0.0 0
M  V30 25 N 11.2251 7.3108 0.0 0
M  V30 26 C 11.9951 8.6446 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 21
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 14
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 8 18
M  V30 10 1 9 26
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 15
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrazole-3-carboxamide, 5-[(6-chloro-3-pyridinyl)thio]-1-(2,3-difluorophen...
C16H11ClF2N4OS
1138037-56-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 7.3751 7.7394 0.0 0
M  V30 2 F 2.0608 5.6044 0.0 0
M  V30 3 C 6.2481 2.4367 0.0 0
M  V30 4 N 5.0021 1.5317 0.0 0
M  V30 5 O 7.6549 1.8104 0.0 0
M  V30 6 C 5.1632 0.0000 0.0 0
M  V30 7 F 0.0000 7.8933 0.0 0
M  V30 8 Cl 13.5351 7.7394 0.0 0
M  V30 9 N 5.0735 6.2447 0.0 0
M  V30 10 C 6.6051 6.4056 0.0 0
M  V30 11 N 4.7534 4.7384 0.0 0
M  V30 12 C 7.2315 4.9988 0.0 0
M  V30 13 C 6.0870 3.9684 0.0 0
M  V30 14 C 4.0431 7.3892 0.0 0
M  V30 15 C 2.5367 7.0689 0.0 0
M  V30 16 C 4.5190 8.8538 0.0 0
M  V30 17 C 1.5063 8.2134 0.0 0
M  V30 18 C 3.4886 9.9983 0.0 0
M  V30 19 C 1.9821 9.6780 0.0 0
M  V30 20 C 8.9151 7.7394 0.0 0
M  V30 21 C 9.6851 9.0731 0.0 0
M  V30 22 C 9.6851 6.4056 0.0 0
M  V30 23 C 11.2251 9.0731 0.0 0
M  V30 24 N 11.2251 6.4056 0.0 0
M  V30 25 C 11.9951 7.7394 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 13
M  V30 7 1 4 6
M  V30 8 1 7 17
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 14
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138037-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1138037-56-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3379959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 278
5-[(6-chloropyridin-3-yl)thio]-1-(2,3-difluorophenyl)-N-methyl-1H-pyrazole-3-carboxamide
To a solution of ethyl
5-[(6-chloropyridin-3-yl)thio]-1-(2,3-difluorophenyl)-1H-pyrazole-3-carboxylate
(528 mg) in methanol (5 mL) was added 40% methylamine-methanol solution
(5 mL) at room temperature. The mixture was stirred for 1 hr, and
concentrated under reduced pressure, and the residue was purified by
silica gel column chromatography (eluent: hexane-ethyl
acetate=3:1&#x2192;1:2) to give the title compound as a pale-yellow solid
(478 mg, yield 94%). 1H-NMR (CDCl3) &#x03B4; : 2.98 (3H, d, J=4.8 Hz),
6.83 (1H, br), 7.04-7.10 (1H, m), 7.15-7.23 (3H, m), 7.30-7.40 (2H, m),
8.04-8.06 (1H, m).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thiophene and pyrazole derivatives and related analogous
as acid secretion inhibitors and antiulcer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nishida, Haruyuki; Arikawa, Yasuyoshi; Hirase, Keizo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009041705 A2 2009-04-02

$RFMT $RIREG SCHEME334 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxamide, 4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-N-[[2-(tri...
C18H18Cl2F3N5O
1142087-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.2074 3.0800 0.0 0
M  V30 2 N 5.5411 3.8500 0.0 0
M  V30 3 C 6.8747 3.0800 0.0 0
M  V30 4 O 6.8747 1.5400 0.0 0
M  V30 5 C 1.5400 1.5400 0.0 0
M  V30 6 F 0.0000 1.5400 0.0 0
M  V30 7 F 1.5400 0.0000 0.0 0
M  V30 8 F 3.0800 1.5400 0.0 0
M  V30 9 N 12.2096 6.1600 0.0 0
M  V30 10 Cl 17.5443 6.1600 0.0 0
M  V30 11 Cl 14.8769 1.5400 0.0 0
M  V30 12 C 2.8738 3.8500 0.0 0
M  V30 13 C 1.5400 3.0800 0.0 0
M  V30 14 C 2.8738 5.3900 0.0 0
M  V30 15 C 0.2064 3.8500 0.0 0
M  V30 16 C 1.5400 6.1600 0.0 0
M  V30 17 C 0.2064 5.3900 0.0 0
M  V30 18 C 8.2085 3.8500 0.0 0 CFG=1
M  V30 19 C 8.2085 5.3900 0.0 0
M  V30 20 C 9.5421 3.0800 0.0 0
M  V30 21 C 9.5421 6.1600 0.0 0
M  V30 22 C 10.8758 3.8500 0.0 0
M  V30 23 C 10.8758 5.3900 0.0 0 CFG=2
M  V30 24 C 13.5432 5.3900 0.0 0
M  V30 25 N 14.8769 6.1600 0.0 0
M  V30 26 N 13.5432 3.8500 0.0 0
M  V30 27 C 16.2105 5.3900 0.0 0
M  V30 28 C 14.8769 3.0800 0.0 0
M  V30 29 N 16.2105 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 18 3 CFG=3
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 13
M  V30 10 1 23 9 CFG=3
M  V30 11 1 9 24
M  V30 12 1 10 27
M  V30 13 1 11 28
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 18 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxamide, 4-[[4-chloro-6-(methylamino)-1,3,5-triazin-2-yl]amino...
C19H22ClF3N6O
1142087-41-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 3.0800 1.5400 0.0 0
M  V30 3 F 1.5400 0.0000 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 C 4.2074 3.0800 0.0 0
M  V30 6 N 5.5411 3.8500 0.0 0
M  V30 7 C 6.8747 3.0800 0.0 0
M  V30 8 O 6.8747 1.5400 0.0 0
M  V30 9 N 12.2094 6.1600 0.0 0
M  V30 10 N 17.5441 6.1600 0.0 0
M  V30 11 C 18.8779 5.3900 0.0 0
M  V30 12 Cl 14.8769 1.5400 0.0 0
M  V30 13 C 1.5400 3.0800 0.0 0
M  V30 14 C 2.8738 3.8500 0.0 0
M  V30 15 C 0.2064 3.8500 0.0 0
M  V30 16 C 2.8738 5.3900 0.0 0
M  V30 17 C 0.2064 5.3900 0.0 0
M  V30 18 C 1.5400 6.1600 0.0 0
M  V30 19 C 8.2085 3.8500 0.0 0 CFG=1
M  V30 20 C 9.5421 3.0800 0.0 0
M  V30 21 C 8.2085 5.3900 0.0 0
M  V30 22 C 10.8758 3.8500 0.0 0
M  V30 23 C 9.5421 6.1600 0.0 0
M  V30 24 C 10.8758 5.3900 0.0 0 CFG=2
M  V30 25 C 13.5432 5.3900 0.0 0
M  V30 26 N 14.8769 6.1600 0.0 0
M  V30 27 N 13.5432 3.8500 0.0 0
M  V30 28 C 16.2105 5.3900 0.0 0
M  V30 29 C 14.8769 3.0800 0.0 0
M  V30 30 N 16.2105 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 13
M  V30 5 1 5 6
M  V30 6 1 5 14
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 19 7 CFG=1
M  V30 10 1 24 9 CFG=1
M  V30 11 1 9 25
M  V30 12 1 10 11
M  V30 13 1 10 28
M  V30 14 1 12 29
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 19 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1142087-45-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1142087-41-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9998098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2:
cis-4-{[4-({2-[(phenylmethylthiolethyl}amino)-1,3,5-triazin-2-yl]amino}-N-{[2-(trifluoromethyl)phenyl]methyl}cyclohexanecarboxamide
A premixed solution of diisopropylethylamine (DIEA, 0.872 mL, 4.98 mmol,
3 equiv) and methylamine (0.830 mL, 1.66 mmol, 1 equiv) in CH2Cl2 (3 mL)
was added dropwise to the crude reaction mixture obtained in Step 1. The
mixture was stirred for 3 h. The volatile components were removed under
reduced pressure yielding 695 mg (94%) of the title compound. A portion
of this material was purified via reverse-phase HPLC purification, and
the remainder was used without purification.
cis-4-{[4-({2-[(phenylmethylthiolethyl}amino)-1,3,5-triazin-2-yl]amino}-N-{[2-(trifluoromethyl)phenyl]methyl}cyclohexanecarboxamide,
yield 695 mg (94%). MS (ES+): m/e 443.9 [M + H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-amino-1,3,5-triazine derivatives as soluble epoxide
hydrolase (sEH) inhibitors and their use
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Yun; Thalji, Reema K.; Marino, Joseph Paul, Jr.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009049157 A1 2009-04-16

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimino)benzen...
C19H17Cl2NO4
1159341-92-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 N 2.6674 5.3900 0.0 0
M  V30 4 O 5.3347 6.9300 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 O 1.3338 4.6200 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0
M  V30 8 C 0.0000 5.3900 0.0 0
M  V30 9 C 6.6685 3.0800 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 11 C 13.3369 5.3900 0.0 0
M  V30 12 C 14.6705 4.6200 0.0 0
M  V30 13 Cl 16.0043 5.3900 0.0 0
M  V30 14 Cl 14.6705 3.0800 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 2.6674 0.7700 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 21 C 9.3358 3.0800 0.0 0
M  V30 22 C 10.6696 2.3100 0.0 0
M  V30 23 C 9.3358 4.6200 0.0 0
M  V30 24 C 12.0032 3.0800 0.0 0
M  V30 25 C 10.6696 5.3900 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 21
M  V30 12 2 11 12
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[4-(2,2-Dichloroethenyl)phenoxy]methyl]-α-(methoxyimino)-N-methylbenz...
C19H18Cl2N2O3
1159341-93-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 4.6200 0.0 0
M  V30 2 C 5.3347 5.3900 0.0 0
M  V30 3 N 2.6674 5.3900 0.0 0
M  V30 4 N 5.3347 6.9300 0.0 0
M  V30 5 O 6.6685 4.6200 0.0 0
M  V30 6 O 1.3338 4.6200 0.0 0
M  V30 7 C 6.6685 7.7000 0.0 0
M  V30 8 C 0.0000 5.3900 0.0 0
M  V30 9 C 6.6685 3.0800 0.0 0
M  V30 10 O 8.0021 2.3100 0.0 0
M  V30 11 C 13.3369 5.3900 0.0 0
M  V30 12 C 14.6705 4.6200 0.0 0
M  V30 13 Cl 14.6705 3.0800 0.0 0
M  V30 14 Cl 16.0043 5.3900 0.0 0
M  V30 15 C 4.0011 3.0800 0.0 0
M  V30 16 C 5.3347 2.3100 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 5.3347 0.7700 0.0 0
M  V30 19 C 2.6674 0.7700 0.0 0
M  V30 20 C 4.0011 0.0000 0.0 0
M  V30 21 C 9.3358 3.0800 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 2.3100 0.0 0
M  V30 24 C 10.6696 5.3900 0.0 0
M  V30 25 C 12.0032 3.0800 0.0 0
M  V30 26 C 12.0032 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 1 10 21
M  V30 12 2 11 12
M  V30 13 1 11 26
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159341-92-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159341-93-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2196402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 2: Preparation of
(E)-2-(2-((3-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyimino-N-methylacetamide
Example 4: Preparation of
(E)-2-(2-((4-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 2 was repeated except for using
methyl-(E)-2-(2-((4-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyiminoacetate(0.39g,
1mmol) obtained in Example 3 instead of
methyl-(E)-2-(2-((3-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyiminoacetate
to obtain the title compound (0.37g, 94%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.80(s, 3H), 3.93(s, 3H), 4.96(s, 2H), 6.71(s, 1H), 6.78-7.50(m, 8H)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME336 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[2-chloro-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimi...
C19H16Cl3NO4
1159342-30-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 O 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Cl 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Cl 16.0043 2.3100 0.0 0
M  V30 15 Cl 14.6705 4.6200 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[2-Chloro-4-(2,2-dichloroethenyl)phenoxy]methyl]-α-(methoxyimino)-N-m...
C19H17Cl3N2O3
1159342-31-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 N 2.6674 2.3100 0.0 0
M  V30 4 N 5.3347 0.7700 0.0 0
M  V30 5 O 6.6685 3.0800 0.0 0
M  V30 6 O 1.3338 3.0800 0.0 0
M  V30 7 C 6.6685 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 6.6685 4.6200 0.0 0
M  V30 10 O 8.0021 5.3900 0.0 0
M  V30 11 Cl 10.6696 6.9300 0.0 0
M  V30 12 C 13.3369 2.3100 0.0 0
M  V30 13 C 14.6705 3.0800 0.0 0
M  V30 14 Cl 16.0043 2.3100 0.0 0
M  V30 15 Cl 14.6705 4.6200 0.0 0
M  V30 16 C 4.0011 4.6200 0.0 0
M  V30 17 C 5.3347 5.3900 0.0 0
M  V30 18 C 2.6674 5.3900 0.0 0
M  V30 19 C 5.3347 6.9300 0.0 0
M  V30 20 C 2.6674 6.9300 0.0 0
M  V30 21 C 4.0011 7.7000 0.0 0
M  V30 22 C 9.3358 4.6200 0.0 0
M  V30 23 C 10.6696 5.3900 0.0 0
M  V30 24 C 9.3358 3.0800 0.0 0
M  V30 25 C 12.0032 4.6200 0.0 0
M  V30 26 C 10.6696 2.3100 0.0 0
M  V30 27 C 12.0032 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 23
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-30-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-31-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-12114253
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and SAR of methoxyiminoacetate and methoxyiminoacetamide
derivatives as strobilurin analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hwang, In-Cheon; Kim, Joo-Kyung; Kim, Hyung-Ho; Kyung, Suk-Hun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2009), 30(7), 1475-1480

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[[3-chloro-4-(2,2-dibromoethenyl)phenoxy]methyl]-α-(methoxyimin...
C19H16Br2ClNO4
1159342-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 4.6201 0.0 0
M  V30 2 C 9.3358 5.3901 0.0 0
M  V30 3 N 12.0033 5.3901 0.0 0
M  V30 4 O 9.3358 6.9302 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 8.0022 7.7002 0.0 0
M  V30 8 C 14.6707 5.3901 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 Cl 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 Br 0.0000 7.7002 0.0 0
M  V30 15 Br 2.6673 7.7002 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 9.3358 0.7700 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 21 C 10.6697 0.0000 0.0 0
M  V30 22 C 5.3348 3.0801 0.0 0
M  V30 23 C 4.0010 2.3101 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 2.6673 3.0801 0.0 0
M  V30 26 C 4.0010 5.3901 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 25
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(αE)-2-[[3-Chloro-4-(2,2-dibromoethenyl)phenoxy]methyl]-α-(methoxyimino)-N-me...
C19H17Br2ClN2O3
1159342-76-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 4.6201 0.0 0
M  V30 2 C 9.3358 5.3901 0.0 0
M  V30 3 N 12.0033 5.3901 0.0 0
M  V30 4 N 9.3358 6.9302 0.0 0
M  V30 5 O 8.0022 4.6201 0.0 0
M  V30 6 O 13.3370 4.6201 0.0 0
M  V30 7 C 8.0022 7.7002 0.0 0
M  V30 8 C 14.6707 5.3901 0.0 0
M  V30 9 C 8.0022 3.0801 0.0 0
M  V30 10 O 6.6685 2.3101 0.0 0
M  V30 11 Cl 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 1.3337 6.9302 0.0 0
M  V30 14 Br 0.0000 7.7002 0.0 0
M  V30 15 Br 2.6673 7.7002 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3358 2.3101 0.0 0
M  V30 18 C 12.0033 2.3101 0.0 0
M  V30 19 C 9.3358 0.7700 0.0 0
M  V30 20 C 12.0033 0.7700 0.0 0
M  V30 21 C 10.6697 0.0000 0.0 0
M  V30 22 C 5.3348 3.0801 0.0 0
M  V30 23 C 4.0010 2.3101 0.0 0
M  V30 24 C 5.3348 4.6201 0.0 0
M  V30 25 C 2.6673 3.0801 0.0 0
M  V30 26 C 4.0010 5.3901 0.0 0
M  V30 27 C 2.6673 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 17
M  V30 11 1 10 22
M  V30 12 1 11 25
M  V30 13 2 12 13
M  V30 14 1 12 27
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1159342-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1159342-76-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7730732
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 40: Preparation of
(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
Example 82: Preparation of
(E)-2-(2-((4-(2,2-dibromovinyl)-3-chlorophenoxy)methyl)phenyl)-2-methoxyimino-N-methylacetamide
The procedure of Example 40 was repeated except for using
methyl-(E)-2-(2-((4-(2,2-dibromovinyl)-3-chlorophenoxy)methyl)phenyl)-2-methoxyiminoacetate(0.518g,
1mmol) obtained in Example 81 instead of
methyl-(E)-2-(2-((2-chloro-4-(2,2-dichlorovinyl)phenoxy)methyl)phenyl)-2-methoxyiminoacetate
to obtain the title compound (0.486g, 94%). 1H-NMR(CDCl3, TMS)δ(ppm):
2.93(d, 3H), 4.00(s, 3H), 5.06(s, 2H), 6.84(s, 1H), 6.89-6.92(m, 1H),
7.11(s, 1H), 7.24-7.56(m, 6H) MS : 513.9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of methoxyiminobenzene compounds as agrochemical fungicidal
agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Joo-Kyung; Kim, Hyung-Ho; Hwang, In-Cheon; Nam, Ho-Tae
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009072837 A2 2009-06-11

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
1,1-Difluoro-4-phenyl-3-butyn-2-one
C10H6F2O
117710-72-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 C 6.1601 2.6673 0.0 0
M  V30 3 C 7.7002 2.6673 0.0 0
M  V30 4 C 8.4702 1.3337 0.0 0
M  V30 5 O 8.4702 4.0010 0.0 0
M  V30 6 F 7.7002 0.0000 0.0 0
M  V30 7 F 10.0102 1.3337 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 C 2.3101 4.0010 0.0 0
M  V30 11 C 0.7700 1.3337 0.0 0
M  V30 12 C 0.7700 4.0010 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[1-(Difluoromethyl)-3-phenyl-2-propyn-1-ylidene]methanamine
C11H9F2N
2432912-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 2.6674 0.0 0
M  V30 2 C 6.1600 2.6674 0.0 0
M  V30 3 C 7.7000 2.6674 0.0 0
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 N 8.4700 1.3338 0.0 0
M  V30 6 F 7.7000 5.3349 0.0 0
M  V30 7 F 10.0100 4.0011 0.0 0
M  V30 8 C 7.7000 0.0000 0.0 0
M  V30 9 C 3.0800 2.6674 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 0.7700 4.0011 0.0 0
M  V30 14 C 0.0000 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5 CFG=2
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 117710-72-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2432912-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-22222176
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 1-Fluoroalkyl-prop-2-yne 1-imines and 1-iminium salts as building blocks:
A new synthesis of α-(trifluoromethyl)pyrroles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schneider, Thomas; Seitz, Bianca; Schiwek, Maximilian; Maas, Gerhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Fluorine Chemistry (2020), 235109567

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dithiole-4,5-dicarboxylic acid, 2-(5,6-dihydro-1,3-dithiolo[4,5-b][1,4]di...
C12H10O4S6
118148-21-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1580 5.5544 0.0 0
M  V30 2 O 1.5315 6.9612 0.0 0
M  V30 3 O 1.2528 4.3083 0.0 0
M  V30 4 C 0.0000 7.1221 0.0 0
M  V30 5 C 3.8332 2.6528 0.0 0
M  V30 6 O 4.7385 1.4068 0.0 0
M  V30 7 O 2.3015 2.4917 0.0 0
M  V30 8 C 4.1120 0.0000 0.0 0
M  V30 9 C 6.1269 5.9113 0.0 0
M  V30 10 S 4.7200 6.5378 0.0 0
M  V30 11 S 5.9658 4.3798 0.0 0
M  V30 12 C 3.6896 5.3933 0.0 0
M  V30 13 C 4.4596 4.0596 0.0 0
M  V30 14 C 7.4606 6.6813 0.0 0
M  V30 15 S 7.6215 8.2130 0.0 0
M  V30 16 S 8.8674 6.0550 0.0 0
M  V30 17 C 9.1280 8.5332 0.0 0
M  V30 18 C 9.8980 7.1994 0.0 0
M  V30 19 S 9.8980 9.8669 0.0 0
M  V30 20 S 11.4380 7.1994 0.0 0
M  V30 21 C 11.4380 9.8669 0.0 0
M  V30 22 C 12.2080 8.5332 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(5,6-Dihydro-1,3-dithiolo[4,5-b][1,4]dithiin-2-ylidene)-N4,N5-dimethyl-1,3-...
C12H12N2O2S6
793710-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.1580 5.5544 0.0 0
M  V30 2 N 1.5315 6.9612 0.0 0
M  V30 3 O 1.2528 4.3083 0.0 0
M  V30 4 C 0.0000 7.1221 0.0 0
M  V30 5 C 3.8332 2.6528 0.0 0
M  V30 6 N 4.7383 1.4068 0.0 0
M  V30 7 O 2.3015 2.4917 0.0 0
M  V30 8 C 4.1120 0.0000 0.0 0
M  V30 9 C 6.1269 5.9113 0.0 0
M  V30 10 S 4.7200 6.5378 0.0 0
M  V30 11 S 5.9658 4.3798 0.0 0
M  V30 12 C 3.6896 5.3933 0.0 0
M  V30 13 C 4.4596 4.0596 0.0 0
M  V30 14 C 7.4606 6.6813 0.0 0
M  V30 15 S 7.6215 8.2130 0.0 0
M  V30 16 S 8.8674 6.0550 0.0 0
M  V30 17 C 9.1280 8.5332 0.0 0
M  V30 18 C 9.8980 7.1994 0.0 0
M  V30 19 S 9.8980 9.8669 0.0 0
M  V30 20 S 11.4380 7.1994 0.0 0
M  V30 21 C 11.4380 9.8669 0.0 0
M  V30 22 C 12.2080 8.5332 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 14
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118148-21-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 793710-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14586094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structural isomerism in crystals of redox-active secondary
ortho-diamides: The role of competing intra- and intermolecular hydrogen
bonds in directing crystalline topologies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baudron, Stephane A.; Avarvari, Narcis; Canadell, Enric; Auban-Senzier,
Pascale; Batail, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2004), 10(18), 4498-4511

$RFMT $RIREG SCHEME340 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isatoic anhydride
C8H5NO3
118-48-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 O 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzaldehyde
C7H5NO3
552-89-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 6.1600 1.3338 0.0 0
M  V30 3 N 1.5400 1.3338 0.0 0 VAL=5
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 3.8500 2.6674 0.0 0
M  V30 7 C 2.3100 2.6674 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 1.5400 4.0011 0.0 0
M  V30 10 C 3.8500 5.3349 0.0 0
M  V30 11 C 2.3100 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 3 4
M  V30 4 2 3 5
M  V30 5 1 3 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3-Dihydro-3-methyl-2-(2-nitrophenyl)-4(1H)-quinazolinone
C15H13N3O3
1085704-50-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 6.6687 0.0 0
M  V30 2 N 3.0801 1.3338 0.0 0 VAL=5
M  V30 3 O 2.3101 0.0000 0.0 0
M  V30 4 O 4.6201 1.3338 0.0 0
M  V30 5 O 7.7002 6.6687 0.0 0
M  V30 6 C 4.6201 4.0012 0.0 0
M  V30 7 N 5.3901 2.6675 0.0 0
M  V30 8 N 5.3901 5.3348 0.0 0
M  V30 9 C 6.9302 2.6675 0.0 0
M  V30 10 C 6.9302 5.3348 0.0 0
M  V30 11 C 7.7002 4.0012 0.0 0
M  V30 12 C 7.7002 1.3338 0.0 0
M  V30 13 C 9.2402 4.0012 0.0 0
M  V30 14 C 9.2402 1.3338 0.0 0
M  V30 15 C 10.0102 2.6675 0.0 0
M  V30 16 C 3.0801 4.0012 0.0 0
M  V30 17 C 2.3101 2.6675 0.0 0
M  V30 18 C 2.3101 5.3348 0.0 0
M  V30 19 C 0.7700 2.6675 0.0 0
M  V30 20 C 0.7700 5.3348 0.0 0
M  V30 21 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 17
M  V30 5 2 5 10
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 11
M  V30 14 2 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 118-48-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 552-89-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1085704-50-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-21403220
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13463-67-7
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic activity of TiO2 nanoparticles in the synthesis of some
2,3-disubstituted dihydroquinazolin-4(1H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bharathi, A.; Roopan, Selvaraj Mohana; Kajbafvala, Amir; Padmaja, R. D.;
Darsana, M. S.; Nandhini Kumari, G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Chemical Letters (2014), 25(2), 324-326

$RFMT $RIREG SCHEME341 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Iodo-3-[(4-methoxyphenyl)methyl]-1-[(3aS,4R,6aR)-tetrahydro-2,2-dimethyl-4H...
C20H23IN2O5
1187441-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.8908 0.3117 0.0 0
M  V30 2 I 5.2233 4.9318 0.0 0
M  V30 3 C 1.3791 5.0233 0.0 0
M  V30 4 C 0.0000 3.4917 0.0 0
M  V30 5 C 10.5582 1.8517 0.0 0
M  V30 6 O 10.5582 4.9318 0.0 0
M  V30 7 O 15.8930 4.9318 0.0 0
M  V30 8 C 17.2268 4.1618 0.0 0
M  V30 9 C 5.2233 1.8517 0.0 0 CFG=2
M  V30 10 C 3.8165 2.4782 0.0 0 CFG=2
M  V30 11 C 5.0624 0.3202 0.0 0
M  V30 12 C 2.7861 1.3337 0.0 0 CFG=2
M  V30 13 O 3.0465 3.8119 0.0 0
M  V30 14 C 3.5561 0.0000 0.0 0
M  V30 15 O 1.3791 1.9602 0.0 0
M  V30 16 C 1.5400 3.4917 0.0 0
M  V30 17 N 6.5572 2.6218 0.0 0
M  V30 18 C 7.8908 1.8517 0.0 0
M  V30 19 C 6.5572 4.1618 0.0 0
M  V30 20 N 9.2245 2.6218 0.0 0
M  V30 21 C 7.8908 4.9318 0.0 0
M  V30 22 C 9.2245 4.1618 0.0 0
M  V30 23 C 11.8920 2.6218 0.0 0
M  V30 24 C 13.2257 1.8517 0.0 0
M  V30 25 C 11.8920 4.1618 0.0 0
M  V30 26 C 14.5593 2.6218 0.0 0
M  V30 27 C 13.2257 4.9318 0.0 0
M  V30 28 C 14.5593 4.1618 0.0 0
M  V30 29 H 4.8469 3.6226 0.0 0
M  V30 30 H 1.7555 0.1893 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 19
M  V30 3 1 3 16
M  V30 4 1 4 16
M  V30 5 1 5 20
M  V30 6 1 5 23
M  V30 7 2 6 22
M  V30 8 1 7 8
M  V30 9 1 7 28
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 17 CFG=3
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 29 CFG=3
M  V30 16 1 11 14
M  V30 17 1 12 14
M  V30 18 1 12 15
M  V30 19 1 12 30 CFG=3
M  V30 20 1 13 16
M  V30 21 1 15 16
M  V30 22 1 17 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 21
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 9 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-[(4-Methoxyphenyl)methyl]-6-(methylamino)-1-[(3aS,4R,6aR)-tetrahydro-2,2-di...
C21H27N3O5
1187441-90-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3743 1.3336 0.0 0
M  V30 2 C 6.1443 0.0000 0.0 0
M  V30 3 O 5.3743 6.6684 0.0 0
M  V30 4 C 8.4543 6.6684 0.0 0
M  V30 5 C 2.0909 8.6696 0.0 0
M  V30 6 C 0.1309 8.0328 0.0 0
M  V30 7 O 9.9943 4.0009 0.0 0
M  V30 8 O 14.6143 6.6684 0.0 0
M  V30 9 C 15.3843 8.0020 0.0 0
M  V30 10 C 3.8343 4.0009 0.0 0 CFG=2
M  V30 11 C 2.9292 5.2469 0.0 0 CFG=2
M  V30 12 C 2.9292 2.7551 0.0 0
M  V30 13 C 1.4645 4.7709 0.0 0 CFG=2
M  V30 14 O 2.9292 6.7870 0.0 0
M  V30 15 C 1.4645 3.2309 0.0 0
M  V30 16 O 0.5593 6.0169 0.0 0
M  V30 17 C 1.4645 7.2628 0.0 0
M  V30 18 N 5.3743 4.0009 0.0 0
M  V30 19 C 6.1443 2.6673 0.0 0
M  V30 20 C 6.1443 5.3347 0.0 0
M  V30 21 C 7.6843 2.6673 0.0 0
M  V30 22 N 7.6843 5.3347 0.0 0
M  V30 23 C 8.4543 4.0009 0.0 0
M  V30 24 C 9.9943 6.6684 0.0 0
M  V30 25 C 10.7643 5.3347 0.0 0
M  V30 26 C 10.7643 8.0020 0.0 0
M  V30 27 C 12.3043 5.3347 0.0 0
M  V30 28 C 12.3043 8.0020 0.0 0
M  V30 29 C 13.0743 6.6684 0.0 0
M  V30 30 H 4.3938 5.7228 0.0 0
M  V30 31 H 0.0000 4.2951 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 2 3 20
M  V30 4 1 4 22
M  V30 5 1 4 24
M  V30 6 1 5 17
M  V30 7 1 6 17
M  V30 8 2 7 23
M  V30 9 1 8 9
M  V30 10 1 8 29
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 18 CFG=3
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 11 30 CFG=3
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 19 1 13 16
M  V30 20 1 13 31 CFG=3
M  V30 21 1 14 17
M  V30 22 1 16 17
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 2 19 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 10 11 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1187441-87-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1187441-90-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12689823
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic strategies toward carbocyclic purine-pyrimidine hybrid
nucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sadler, Joshua M.; Mosley, Sylvester L.; Dorgan, Kathleen M.; Zhou,
Zhaohui Sunny; Seley-Radtke, Katherine L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(15), 5520-5525

$RFMT $RIREG SCHEME342 STEP1
$RXN



  3  1
$MOL
(2E)-4-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-3-methyl-2-buten-1-ol
C21H28O2Si
929897-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 4.7712 0.0 0
M  V30 3 C 3.2311 5.3348 0.0 0
M  V30 4 C 6.6685 4.0012 0.0 0
M  V30 5 C 1.8973 4.5648 0.0 0
M  V30 6 C 2.4611 6.6687 0.0 0
M  V30 7 C 4.5648 6.1048 0.0 0
M  V30 8 C 8.0022 4.7712 0.0 0
M  V30 9 C 9.3360 4.0012 0.0 0
M  V30 10 C 8.0022 6.3112 0.0 0
M  V30 11 C 10.6697 4.7712 0.0 0
M  V30 12 O 12.0033 4.0012 0.0 0
M  V30 13 C 2.6673 3.2311 0.0 0
M  V30 14 C 2.6673 1.6911 0.0 0
M  V30 15 C 1.3337 4.0012 0.0 0
M  V30 16 C 1.3337 0.9211 0.0 0
M  V30 17 C 0.0000 3.2311 0.0 0
M  V30 18 C 0.0000 1.6911 0.0 0
M  V30 19 C 4.7712 2.6675 0.0 0
M  V30 20 C 6.3112 2.6675 0.0 0
M  V30 21 C 4.0012 1.3338 0.0 0
M  V30 22 C 7.0812 1.3338 0.0 0
M  V30 23 C 4.7712 0.0000 0.0 0
M  V30 24 C 6.3112 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 1 19
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Chlorosulfonyl isocyanate
CClNO3S
1189-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6675 0.5637 0.0 0
M  V30 2 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 0.0000 2.1037 0.0 0
M  V30 5 O 2.1038 2.6673 0.0 0
M  V30 6 O 0.5638 0.0000 0.0 0
M  V30 7 O 5.3350 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-4-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-3-methyl-2-buten-1-yl N-[(meth...
C23H32N2O5SSi
1009734-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 4.0012 0.0 0
M  V30 2 O 5.3348 4.7712 0.0 0
M  V30 3 C 3.2311 5.3348 0.0 0
M  V30 4 C 6.6685 4.0012 0.0 0
M  V30 5 C 4.5648 6.1048 0.0 0
M  V30 6 C 2.4611 6.6687 0.0 0
M  V30 7 C 1.8975 4.5648 0.0 0
M  V30 8 C 8.0023 4.7712 0.0 0
M  V30 9 C 9.3360 4.0012 0.0 0
M  V30 10 C 8.0023 6.3112 0.0 0
M  V30 11 C 10.6697 4.7712 0.0 0
M  V30 12 O 12.0035 4.0012 0.0 0
M  V30 13 C 13.3372 4.7712 0.0 0
M  V30 14 N 14.6708 4.0012 0.0 0
M  V30 15 O 13.3372 6.3112 0.0 0
M  V30 16 S 16.0045 4.7712 0.0 0 VAL=6
M  V30 17 N 17.3383 5.5412 0.0 0
M  V30 18 O 16.7745 3.4375 0.0 0
M  V30 19 O 15.2345 6.1048 0.0 0
M  V30 20 C 18.6720 4.7712 0.0 0
M  V30 21 C 2.6675 3.2311 0.0 0
M  V30 22 C 1.3337 4.0012 0.0 0
M  V30 23 C 2.6675 1.6911 0.0 0
M  V30 24 C 0.0000 3.2311 0.0 0
M  V30 25 C 1.3337 0.9211 0.0 0
M  V30 26 C 0.0000 1.6911 0.0 0
M  V30 27 C 4.7712 2.6675 0.0 0
M  V30 28 C 6.3112 2.6675 0.0 0
M  V30 29 C 4.0012 1.3338 0.0 0
M  V30 30 C 7.0812 1.3338 0.0 0
M  V30 31 C 4.7712 0.0000 0.0 0
M  V30 32 C 6.3112 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 21
M  V30 4 1 1 27
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 8
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 929897-51-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1189-71-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1009734-84-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-304-CAS-13309737
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Compounds 37-40. To a 0.75 M solution of 8 in dry toluene, cooled to 0
°C, was added dropwise chlorosulfonyl isocyanate (1 equiv). After
stirring for 30 min, the reaction was triturated to a concentration of
0.1 M by the addition of dry toluene. Pyridine (2.2 equiv) was added and
stirring was continued for 30 min at 0 °C. Subsequently, a solution of
the appropriate amine (6 equiv) in water or THF was added. The reaction
was stirred at 0 °C for 2 h and then at room temperature until completion
was noted. The reaction mixture was poured into a mixture of water and
EtOAc. The pH was lowered to 1 by adding concentrated sulfuric acid. The
aqueous layer was extracted with EtOAc and the combined organic layers
were washed with brine. After drying over MgSO4, filtering, and
concentrating the solution, a residue was obtained that was purified by
column chromatography to yield compounds 37-40.
(2E)-4-(tert-butyldiphenylsilyloxy)-3-methylbut-2-en-1-yl
[(methylamino)sulfonyl] carbamate 38, yield 94% white crystals Rf 0.21
(hexane/ethylacetate 75/25); mp 112-114°C; 1H-NMR (300.01 MHz, aceton-d6)
δ 9.79 (1H, br s), 7.72-7.67 (4H, m), 7.51-7.41 (6H, m), 6.46 (1H, q, J =
5.0 Hz), 5.79 (1H, tqt, app. t sext, J = 7.0, 1.5 Hz), 4.75 (2H, d, J =
7.0 Hz), 4.15 (2H, br s), 2.70 (3H, d, J = 5.0 Hz), 1.70 (3H, br s), 1.06
(9H, s); 13C-NMR (75.00 MHz, aceton-d6) δ 152.0 (C), 140.8 (C), 135.6
(CH), 133.5 (C), 130.1 (CH), 128.0 (CH), 117.5 (CH), 67.8 (CH2), 62.2
(CH2), 29.2 (CH3), 26.5 (CH3), 19.2 (C), 13.1 (CH3); Exact mass (ESI-MS):
calculated for C23H32N2O5SSi [M+Na+]499.1699; found 499.1694
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Analogues of (E)-1-Hydroxy-2-methylbut-2-enyl 4-Diphosphate,
an Isoprenoid Precursor and Human γδ T Cell Activator
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van Hoof, Steven; Lacey, Carl Jeffrey; Roehrich, Rene C.; Wiesner,
Jochen; Jomaa, Hassan; Van Calenbergh, Serge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(4), 1365-1370

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-amino-6-fluoro-4-benzothiazolecarboxylate
C9H7FN2O2S
1190320-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 O 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 F 2.3100 0.0000 0.0 0
M  V30 6 N 8.3912 5.2891 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 N 5.6506 5.1456 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 S 6.8964 2.9876 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 7.0574 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Amino-6-fluoro-N-methyl-4-benzothiazolecarboxamide
C9H8FN3OS
1620991-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 5.3347 0.0 0
M  V30 2 N 0.7700 5.3347 0.0 0
M  V30 3 O 3.0800 6.6685 0.0 0
M  V30 4 C 0.0000 6.6685 0.0 0
M  V30 5 F 2.3100 0.0000 0.0 0
M  V30 6 N 8.3912 5.2891 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 N 5.6506 5.1456 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 S 6.8964 2.9876 0.0 0
M  V30 14 C 4.6200 1.3338 0.0 0
M  V30 15 C 7.0574 4.5191 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 1 6 15
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190320-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1620991-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5433648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-catalyzed N-arylation of
2-aminobenzothiazole-4-carboxylates/carboxamides: facile synthesis of
PARP14 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Pingyuan; Li, Jian; Jiang, Xue; Liu, Zhiqing; Ye, Na; Xu, Youjun;
Yang, Guangfu; Xu, Yechun; Zhang, Ao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(35), 5666-5673

$RFMT $RIREG SCHEME344 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-O-(phenylmethyl)-L-seryl-(αS,3S)-1,4-dihydro...
C37H50N8O10
1191929-84-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 11.3569 0.0 0
M  V30 2 C 6.6685 12.8969 0.0 0 CFG=1
M  V30 3 O 8.0021 10.5869 0.0 0
M  V30 4 C 8.0021 13.6669 0.0 0
M  V30 5 N 5.3347 13.6669 0.0 0
M  V30 6 O 9.3358 12.8969 0.0 0
M  V30 7 C 5.3347 15.2069 0.0 0
M  V30 8 C 10.6694 13.6669 0.0 0
M  V30 9 O 4.0011 15.9769 0.0 0
M  V30 10 O 6.6685 15.9769 0.0 0
M  V30 11 C 4.0011 17.5169 0.0 0
M  V30 12 C 2.4611 17.5169 0.0 0
M  V30 13 C 4.0011 19.0569 0.0 0
M  V30 14 C 5.5411 17.5169 0.0 0
M  V30 15 O 4.3513 6.4849 0.0 0
M  V30 16 C 7.6285 5.7884 0.0 0 CFG=1
M  V30 17 C 9.1601 5.6273 0.0 0
M  V30 18 C 6.7233 4.5424 0.0 0
M  V30 19 N 9.7864 4.2205 0.0 0
M  V30 20 O 10.0653 6.8733 0.0 0
M  V30 21 C 11.3179 4.0596 0.0 0 CFG=2
M  V30 22 C 12.2231 5.3055 0.0 0
M  V30 23 C 11.9444 2.6527 0.0 0
M  V30 24 C 13.7547 5.1444 0.0 0
M  V30 25 O 11.0392 1.4068 0.0 0
M  V30 26 O 13.4759 2.4917 0.0 0
M  V30 27 C 14.6599 6.3904 0.0 0
M  V30 28 C 11.6655 0.0000 0.0 0
M  V30 29 N 16.1914 6.2293 0.0 0
M  V30 30 C 17.0966 7.4753 0.0 0
M  V30 31 N 18.6283 7.3142 0.0 0
M  V30 32 N 16.4703 8.8821 0.0 0
M  V30 33 N 19.5334 8.5601 0.0 0 VAL=5
M  V30 34 O 18.9070 9.9670 0.0 0
M  V30 35 O 21.0650 8.3992 0.0 0
M  V30 36 C 5.3347 9.0469 0.0 0 CFG=1
M  V30 37 N 5.3347 10.5869 0.0 0
M  V30 38 C 4.0011 8.2769 0.0 0
M  V30 39 C 5.4958 7.5154 0.0 0
M  V30 40 C 6.7417 9.6734 0.0 0
M  V30 41 C 4.0011 11.3569 0.0 0
M  V30 42 C 2.6674 9.0469 0.0 0
M  V30 43 N 7.0021 7.1952 0.0 0
M  V30 44 C 7.7721 8.5288 0.0 0
M  V30 45 C 2.6674 10.5869 0.0 0
M  V30 46 C 1.3338 8.2769 0.0 0
M  V30 47 C 1.3338 11.3569 0.0 0
M  V30 48 C 0.0000 9.0469 0.0 0
M  V30 49 C 0.0000 10.5869 0.0 0
M  V30 50 C 10.6694 15.2069 0.0 0
M  V30 51 C 12.0032 15.9769 0.0 0
M  V30 52 C 9.3358 15.9769 0.0 0
M  V30 53 C 12.0032 17.5169 0.0 0
M  V30 54 C 9.3358 17.5169 0.0 0
M  V30 55 C 10.6694 18.2869 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 37
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 50
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 39
M  V30 17 1 16 17
M  V30 18 1 16 18 CFG=3
M  V30 19 1 16 43
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 19 21
M  V30 23 1 21 22 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 1 29 30
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 2 33 34
M  V30 36 2 33 35
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 1 36 39
M  V30 40 1 36 40 CFG=3
M  V30 41 1 37 41
M  V30 42 1 38 42
M  V30 43 1 39 43
M  V30 44 1 40 44
M  V30 45 1 41 45
M  V30 46 1 42 45
M  V30 47 2 42 46
M  V30 48 1 43 44
M  V30 49 2 45 47
M  V30 50 1 46 48
M  V30 51 1 47 49
M  V30 52 2 48 49
M  V30 53 2 50 51
M  V30 54 1 50 52
M  V30 55 1 51 53
M  V30 56 2 52 54
M  V30 57 2 53 55
M  V30 58 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 16 21 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-O-(phenylmethyl)-L-seryl-(αS,3S)-1,4-dihydro...
C37H51N9O9
1191929-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  55 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 11.3569 0.0 0
M  V30 2 C 6.6685 12.8969 0.0 0 CFG=1
M  V30 3 O 8.0021 10.5869 0.0 0
M  V30 4 C 8.0021 13.6669 0.0 0
M  V30 5 N 5.3347 13.6669 0.0 0
M  V30 6 O 9.3358 12.8969 0.0 0
M  V30 7 C 5.3347 15.2069 0.0 0
M  V30 8 C 10.6694 13.6669 0.0 0
M  V30 9 O 4.0011 15.9769 0.0 0
M  V30 10 O 6.6685 15.9769 0.0 0
M  V30 11 C 4.0011 17.5169 0.0 0
M  V30 12 C 2.4611 17.5169 0.0 0
M  V30 13 C 4.0011 19.0569 0.0 0
M  V30 14 C 5.5411 17.5169 0.0 0
M  V30 15 O 4.3513 6.4849 0.0 0
M  V30 16 C 7.6285 5.7884 0.0 0 CFG=1
M  V30 17 C 9.1601 5.6273 0.0 0
M  V30 18 C 6.7233 4.5424 0.0 0
M  V30 19 N 9.7864 4.2205 0.0 0
M  V30 20 O 10.0653 6.8733 0.0 0
M  V30 21 C 11.3179 4.0596 0.0 0 CFG=2
M  V30 22 C 12.2231 5.3055 0.0 0
M  V30 23 C 11.9444 2.6527 0.0 0
M  V30 24 C 13.7547 5.1444 0.0 0
M  V30 25 N 11.0392 1.4068 0.0 0
M  V30 26 O 13.4759 2.4917 0.0 0
M  V30 27 C 14.6599 6.3904 0.0 0
M  V30 28 C 11.6655 0.0000 0.0 0
M  V30 29 N 16.1914 6.2293 0.0 0
M  V30 30 C 17.0966 7.4753 0.0 0
M  V30 31 N 18.6283 7.3142 0.0 0
M  V30 32 N 16.4703 8.8821 0.0 0
M  V30 33 N 19.5334 8.5601 0.0 0 VAL=5
M  V30 34 O 18.9070 9.9670 0.0 0
M  V30 35 O 21.0650 8.3992 0.0 0
M  V30 36 C 5.3347 9.0469 0.0 0 CFG=1
M  V30 37 N 5.3347 10.5869 0.0 0
M  V30 38 C 4.0011 8.2769 0.0 0
M  V30 39 C 5.4958 7.5154 0.0 0
M  V30 40 C 6.7417 9.6734 0.0 0
M  V30 41 C 4.0011 11.3569 0.0 0
M  V30 42 C 2.6674 9.0469 0.0 0
M  V30 43 N 7.0021 7.1952 0.0 0
M  V30 44 C 7.7721 8.5288 0.0 0
M  V30 45 C 2.6674 10.5869 0.0 0
M  V30 46 C 1.3338 8.2769 0.0 0
M  V30 47 C 1.3338 11.3569 0.0 0
M  V30 48 C 0.0000 9.0469 0.0 0
M  V30 49 C 0.0000 10.5869 0.0 0
M  V30 50 C 10.6694 15.2069 0.0 0
M  V30 51 C 9.3358 15.9769 0.0 0
M  V30 52 C 12.0032 15.9769 0.0 0
M  V30 53 C 9.3358 17.5169 0.0 0
M  V30 54 C 12.0032 17.5169 0.0 0
M  V30 55 C 10.6694 18.2869 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 37
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 50
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 39
M  V30 17 1 16 17
M  V30 18 1 16 18 CFG=3
M  V30 19 1 16 43
M  V30 20 1 17 19
M  V30 21 2 17 20
M  V30 22 1 19 21
M  V30 23 1 21 22 CFG=1
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 23 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 1 29 30
M  V30 32 1 30 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 2 33 34
M  V30 36 2 33 35
M  V30 37 1 36 37
M  V30 38 1 36 38
M  V30 39 1 36 39
M  V30 40 1 36 40 CFG=3
M  V30 41 1 37 41
M  V30 42 1 38 42
M  V30 43 1 39 43
M  V30 44 1 40 44
M  V30 45 1 41 45
M  V30 46 1 42 45
M  V30 47 2 42 46
M  V30 48 1 43 44
M  V30 49 2 45 47
M  V30 50 1 46 48
M  V30 51 1 47 49
M  V30 52 2 48 49
M  V30 53 2 50 51
M  V30 54 1 50 52
M  V30 55 1 51 53
M  V30 56 2 52 54
M  V30 57 2 53 55
M  V30 58 1 54 55
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 2 16 21 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191929-84-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1191929-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14476610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM tert-butyl
(S)-3-(benzyloxy)-1-((S)-1'-((S)-1-((S)-1-(methylamino)-5-((E)-2-nitroguanidino)-1-
oxopentan-2-ylamino)-1-oxopropan-2-yl)-2'-oxo-1H-spiro[isoquinoline-3,3'-pyrrolidine]-
2(4H)-yl)-1-oxopropan-2-ylcarbamate 4. Compound 12 (14 mg, 0.18 mmol) was
dissolved at room temperature in a solution of methyl amine in EtOH (1
mL, 8.03 M). The reaction mixture was stirred for 12 h and evaporated to
give 4 (13 mg, 94%) as a foam. Rf = 0.38 (EtOAc/MeOH 9 : 1). [α]D 25 =
-16.4 (c 0.4, CHCl3). 1H NMR (400 MHz, DMSO, 100 °C, 2:1 mixture of two
conformers, δ) 7.79-7.76 (m, 1H), 7.69-7.66 (m, 1H), 7.44-7.17 (m, 10H),
6.45 (m, 1H), 5.00-4.91 (m, 2H), 4.90-4.83 (m, 0.33H), 4.63-4.45 (m,
3.67H), 4.31-4.15 (m, 1H), 3.72-3.58 (m, 2H), 3.49-3.38 (m, 1H),
3.32-3.19 (m, 1H), 3.18-2.98 (m, 3H), 2.97-2.87 (m, 1H), 2.62 (d, J = 4.5
Hz, 2H), 2.57 (d, J =4.4 Hz, 1H), 2.12-2.03 (m, 0.33H), 2.03-1.94 (m,
0.66H), 1.87-1.75 (m, 1H), 1.74-1.63 (m, 2H), 1.61-1.47 (m, 2H),
1.46-1.23 (m, 2H), 1.43 (s, 3H), 1.37 (s, 6H), 1.28 (s, 3H). 13C NMR (100
MHz, CDC13, 2:1 mixture of two conformers, δ) 174.6, 172.2, 171.1, 170.6,
160.1 (minor) and 159.4 (major), 156.9, 155.5 (minor) and 154.9 (major),
137.6 (minor) and 137.3 (major), 133.7 (major) and 133.3 (minor),
128.5-127.3 (8C), 126.4, 80.4 (minor) and 80.3 (major), 73.5, 71.6, 69.9,
64.6(minor) and 64.4 (major), 51.9 (major) and 51.6 (minor), 50.5, 47.3,
40.3, 37.7 (minor) and 37.5 (major), 37.4 (minor) and 37.3 (major), 29.7
(minor) and 29.6 (major), 28.8, 28.4 (3C), 26.2, 25.4 (minor) and 25.2
(major), 13.9. HRMS (ESI) calcd. for C37H51N9NaO9 788.37074, found
788.37160 [MNa]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydroisoquinoline-based spirocyclic lactam as a type II' β-turn
inducing peptide mimetic
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lesma, Giordano; Landoni, Nicola; Pilati, Tullio; Sacchetti, Alessandro;
Silvani, Alessandra
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2009), 74(21), 8098-8105

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[(1-Chloroethenyl)sulfonyl]benzene
C8H7ClO2S
119197-76-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.3100 1.5400 0.0 0 VAL=6
M  V30 2 C 0.7700 1.5400 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 O 2.3100 3.0800 0.0 0
M  V30 5 C 0.0000 2.8737 0.0 0
M  V30 6 Cl 0.0000 0.2064 0.0 0
M  V30 7 C 3.8500 1.5400 0.0 0
M  V30 8 C 4.6201 2.8737 0.0 0
M  V30 9 C 4.6201 0.2064 0.0 0
M  V30 10 C 6.1601 2.8737 0.0 0
M  V30 11 C 6.1601 0.2064 0.0 0
M  V30 12 C 6.9301 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 2 6
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-methyl-2-(phenylsulfonyl)ethanamine
C9H12ClNO2S
1104196-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 2.3101 0.0 0 VAL=6
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 O 4.7712 3.6437 0.0 0
M  V30 4 O 3.2311 0.9764 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 Cl 5.3348 0.0000 0.0 0
M  V30 7 N 8.0023 1.5400 0.0 0
M  V30 8 C 9.3360 2.3101 0.0 0
M  V30 9 C 2.6675 3.0801 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 5.3901 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 9
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119197-76-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1104196-42-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9566883
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of substituted aziridines via intramolecular reactions of
β-N-chloroethylamino carbanions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Makosza, Mieczyslaw; Bobryk, Karolina; Krajewski, Dariusz
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2008), 76(2), 1511-1524

$RFMT $RIREG SCHEME346 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Vanillin
C8H8O3
121-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 C 1.5400 5.3349 0.0 0
M  V30 5 O 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methoxypropylidene)glycine ethyl ester
C8H15NO3
2781061-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 N 2.6675 3.0801 0.0 0
M  V30 3 C 0.0000 3.0801 0.0 0
M  V30 4 O 1.3337 0.7700 0.0 0
M  V30 5 C 4.0012 2.3101 0.0 0
M  V30 6 C 0.0000 4.6201 0.0 0
M  V30 7 C 0.0000 0.0000 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 O 6.6685 2.3101 0.0 0
M  V30 10 O 5.3348 4.6201 0.0 0
M  V30 11 C 8.0023 3.0801 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C14H16N2O3
3060089-74-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 O 7.3594 8.0453 0.0 0
M  V30 3 C 10.5458 3.6595 0.0 0
M  V30 4 C 11.9526 4.2860 0.0 0
M  V30 5 C 10.5458 7.0099 0.0 0
M  V30 6 O 0.7700 2.6674 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 O 2.3100 0.0000 0.0 0
M  V30 9 C 6.9300 5.3347 0.0 0
M  V30 10 N 7.8352 4.0889 0.0 0
M  V30 11 C 7.8352 6.5806 0.0 0
M  V30 12 C 9.2998 4.5647 0.0 0
M  V30 13 N 9.2998 6.1047 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 4.6200 1.3336 0.0 0
M  V30 19 C 3.0800 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 1 14
M  V30 3 2 2 11
M  V30 4 1 3 4
M  V30 5 1 3 12
M  V30 6 1 5 13
M  V30 7 1 6 7
M  V30 8 1 6 17
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-33-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2781061-89-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3060089-74-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42148783
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electronic and steric tuning of excited state proton transfer in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Cheng; Myasnyanko, Ivan N.; Baranov, Mikhail S.; Fang, Chong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2024), 1-21

$RFMT $RIREG SCHEME347 STEP1
$RXN



  2  1
$MOL
cis-4-[[(2′,4′-Difluoro[1,1′-biphenyl]-4-yl)sulfonyl]amino]cyclohexanecarboxy...
C19H19F2NO4S
1218794-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6675 4.6201 0.0 0
M  V30 2 F 0.0000 0.0000 0.0 0
M  V30 3 S 9.3360 5.3901 0.0 0 VAL=6
M  V30 4 N 10.6697 6.1601 0.0 0
M  V30 5 O 10.1060 4.0564 0.0 0
M  V30 6 O 8.5660 6.7238 0.0 0
M  V30 7 C 16.0045 3.0801 0.0 0
M  V30 8 O 17.3383 3.8501 0.0 0
M  V30 9 O 16.0045 1.5400 0.0 0
M  V30 10 C 4.0012 2.3101 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 0.7700 0.0 0
M  V30 13 C 1.3338 2.3101 0.0 0
M  V30 14 C 2.6675 0.0000 0.0 0
M  V30 15 C 1.3338 0.7700 0.0 0
M  V30 16 C 5.3348 3.0801 0.0 0
M  V30 17 C 5.3348 4.6201 0.0 0
M  V30 18 C 6.6687 2.3101 0.0 0
M  V30 19 C 6.6687 5.3901 0.0 0
M  V30 20 C 8.0023 3.0801 0.0 0
M  V30 21 C 8.0023 4.6201 0.0 0
M  V30 22 C 12.0035 5.3901 0.0 0 CFG=2
M  V30 23 C 13.3372 6.1601 0.0 0
M  V30 24 C 12.0035 3.8501 0.0 0
M  V30 25 C 14.6708 5.3901 0.0 0
M  V30 26 C 13.3372 3.0801 0.0 0
M  V30 27 C 14.6708 3.8501 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 21
M  V30 7 1 22 4 CFG=1
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 27 7 CFG=1
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 16
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
cis-4-[[(2′,4′-Difluoro[1,1′-biphenyl]-4-yl)sulfonyl]amino]-N-methylcyclohexa...
C20H22F2N2O3S
1218794-22-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 2.6675 4.6201 0.0 0
M  V30 2 F 0.0000 0.0000 0.0 0
M  V30 3 S 9.3360 5.3901 0.0 0 VAL=6
M  V30 4 N 10.6697 6.1601 0.0 0
M  V30 5 O 8.5660 6.7238 0.0 0
M  V30 6 O 10.1060 4.0564 0.0 0
M  V30 7 C 16.0045 3.0801 0.0 0
M  V30 8 N 17.3383 3.8501 0.0 0
M  V30 9 O 16.0045 1.5400 0.0 0
M  V30 10 C 18.6720 3.0801 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6675 3.0801 0.0 0
M  V30 13 C 4.0012 0.7700 0.0 0
M  V30 14 C 1.3337 2.3101 0.0 0
M  V30 15 C 2.6675 0.0000 0.0 0
M  V30 16 C 1.3337 0.7700 0.0 0
M  V30 17 C 5.3348 3.0801 0.0 0
M  V30 18 C 6.6685 2.3101 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 8.0023 3.0801 0.0 0
M  V30 21 C 6.6685 5.3901 0.0 0
M  V30 22 C 8.0023 4.6201 0.0 0
M  V30 23 C 12.0035 5.3901 0.0 0 CFG=2
M  V30 24 C 12.0035 3.8501 0.0 0
M  V30 25 C 13.3372 6.1601 0.0 0
M  V30 26 C 13.3372 3.0801 0.0 0
M  V30 27 C 14.6708 5.3901 0.0 0
M  V30 28 C 14.6708 3.8501 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 16
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 22
M  V30 7 1 23 4 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 28 7 CFG=3
M  V30 11 1 8 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1218794-21-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1218794-22-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3258209
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM cis-4-(2',4'-Difluorobiphenyl-4-ylsulfonamido)-N-methylcyclohexane
carboxamide (ABD824a) A suspension of ABD824b (920 mg, 2.33 mmol) in dry
DCM (15 mL) was cooled under argon to 0°C and (COCl)2 (245 μL, 325 mg,
2.56 mmol) was added, followed by DMF (30 μL, catalytic). The ice bath
was removed and the mixture was stirred at room temperature for 1.5
hours, giving a pale yellow solution. A solution of methylamine (2 M in
THF, 5.8 mL, 11.6 mmol) in dry DCM (15 mL) was cooled under argon to 0°C
and the solution of the acid chloride was added by cannula, resulting in
the formation of a precipitate. The mixture was stirred for 1 hour,
allowing it to warm to room temperature, and then diluted with further
DCM (30 mL) and washed with water (2 x 10 mL) and brine (10 mL). The
organic solvents were dried over MgSO4 and evaporated to give the title
compound as a pale yellow solid (890 mg, 94%), which required no further
purification. 1H NMR (300 MHz, CDCl3): δ 1.48 - 1.78 (8H, m), 2.05 - 2.15
(1H, m), 2.78 (3H, d, J = 5Hz), 3.48 - 3.57 (1H, m), 4.97 (1H, br s),
5.49 (1H, br s), 6.87 - 7.05 (2H, m), 7.40 (1H, q, J = 5 Hz), 7.64 (2H,
d, J = 9 Hz) and 7.94 (2H, d, J = 9 Hz). LCMS: (MH)+ = 409; (M-H)- = 407.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylphenylsulfonamidocycloalkyl derivatives useful in
treatment of diseases mediated by inappropriate activation of immune
system
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Greig, Iain Robert; Sheridan, Rose Mary; Fisher, Raymond; Tozer, Matthew
John; Clase, Juha Andrew; Smith, Andrew; Tuffnell, Andrew Robert; Van 'T
Hof, Robert Jurgen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010032009 A1 2010-03-25

$RFMT $RIREG SCHEME348 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 6-chloro-2-(2,2-difluoroethoxy)-5-nitro-3-pyridinecarboxylate
C9H7ClF2N2O5
1218944-63-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 O 5.3347 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 O 6.6684 3.8500 0.0 0
M  V30 6 C 8.0021 4.6200 0.0 0
M  V30 7 C 9.3358 3.8500 0.0 0
M  V30 8 F 9.3358 2.3100 0.0 0
M  V30 9 F 10.6694 4.6200 0.0 0
M  V30 10 N 1.3336 6.9300 0.0 0 VAL=5
M  V30 11 O 0.0000 6.1600 0.0 0
M  V30 12 O 1.3336 8.4700 0.0 0
M  V30 13 Cl 4.0011 8.4700 0.0 0
M  V30 14 C 4.0011 3.8500 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 2.6673 4.6200 0.0 0
M  V30 17 N 5.3347 6.1600 0.0 0
M  V30 18 C 2.6673 6.1600 0.0 0
M  V30 19 C 4.0011 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(2,2-difluoroethoxy)-6-(methylamino)-5-nitro-3-pyridinecarboxylate
C10H11F2N3O5
1218944-65-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 3.8500 0.0 0
M  V30 2 C 8.0021 4.6200 0.0 0
M  V30 3 C 9.3358 3.8500 0.0 0
M  V30 4 F 10.6694 4.6200 0.0 0
M  V30 5 F 9.3358 2.3100 0.0 0
M  V30 6 C 4.0011 2.3100 0.0 0
M  V30 7 O 2.6673 1.5400 0.0 0
M  V30 8 O 5.3347 1.5400 0.0 0
M  V30 9 C 2.6673 0.0000 0.0 0
M  V30 10 N 4.0011 8.4700 0.0 0
M  V30 11 C 5.3347 9.2400 0.0 0
M  V30 12 N 1.3336 6.9300 0.0 0 VAL=5
M  V30 13 O 1.3336 8.4700 0.0 0
M  V30 14 O 0.0000 6.1600 0.0 0
M  V30 15 C 5.3347 4.6200 0.0 0
M  V30 16 C 4.0011 3.8500 0.0 0
M  V30 17 N 5.3347 6.1600 0.0 0
M  V30 18 C 2.6673 4.6200 0.0 0
M  V30 19 C 4.0011 6.9300 0.0 0
M  V30 20 C 2.6673 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 16
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 19
M  V30 12 2 12 13
M  V30 13 2 12 14
M  V30 14 1 12 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1218944-63-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1218944-65-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3456256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (d) 2-(2,2-Difluoro-ethoxy)-6-methylamino-5-nitro-nicotinic acid methyl
ester Methylamine (2 M in THF; 32.0 mL, 64.0 mmol) is added at 10° C. to
6-chloro-2-(2,2-difluoro-ethoxy)-5-nitro-nicotinic acid methyl ester (9.1
g, 30.7 mmol) in THF (50 mL). After 1 h at rt the reaction mixture is
concentrated, treated with water and filtered. The filtercake is washed
with water and dried to give the sub-title compound. Yield: 8.4 g (94%).
Rf(TLC): 0.21 (silica gel, CH:EtOAc 8:2). MS m/z: 292 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylaminoimidazopyridinecarboxamide derivatives for use as
mPGES-1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Priepke, Henning; Doods, Henri; Kuelzer, Raimund; Pfau, Roland; Stenkamp,
Dirk; Pelcman, Benjamin; Roenn, Robert; Lubriks, Dimitrijs; Suna, Edgars
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012022792 A1 2012-02-23

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzoyl chloride
C7H4ClNO3
121-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzamide
C8H8N2O3
3400-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2890312
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Part I: Preparation of N-methyl-3-nitrobenzamide. 3-Nitrobenzoyl chloride
(7.00 g, 37.7 mmol) was dissolved in tetrahydrofuran (300 mL) and a 2.0 M
solution of methylamine in tetrahydrofuran (41.5 mL, 82.9 mmol) was
added. The reaction mixture was stirred for 2 hours. The reaction mixture
was diluted with ethyl acetate and washed three times with water. The
organic layer was dried over sodium sulfate and concentrated to provide a
solid (6.38 g, 94%) . N-methyl-3-nitrobenzamide, yield 6.38 g, 94% 1H NMR
(300 MHz, CDCl3), δ 8.84 (bs, 1H), 8.67 (m, 1H) , 8.37 (dd, J= 8, 2 Hz,
1H) , 8.28 (d, J= 7 Hz, 1H), 7.78 (dd, J= 8, 7 Hz, 1H), 2.83 (m, 3H) .
Mass spec (ES+) m+/z 181 (M+H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted spiro azabicyclics as modulators of chemokine
receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Batt, Douglas G.; Wacker, Dean A.; Delucca, George V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005080376 A1 2005-09-01

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzoyl chloride
C7H4ClNO3
121-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzamide
C8H8N2O3
3400-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-11775400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of Phenyl 3-(1-Methyl-1H-tetrazol-5-yl)-phenylcarbamate.
3-Nitrobenzoyl chloride (7.00 g, 37.7 mmol) was dissolved in
tetrahydrofuran (300 mL), and methylamine (41.5 mL of a 2.0 M solution in
tetrahydrofuran, 82.9 mmol) was added. The reaction mixture was stirred
for 2 h. The reaction mixture was diluted with ethyl acetate and washed
three times with water. The organic layer was dried over sodium sulfate
and concentrated to provide N-methyl-3-nitro-benzamide as a solid (6.38
g, 94%) which was used without further purification. 1H NMR (300 MHz,
CDCl3), δ TMS: 8.84 (bs, 1 H), 8.67 (m, 1 H), 8.37 (dd, J = 8, 2 Hz, 1
H), 8.28 (d, J = 7 Hz, 1 H), 7.78 (dd, J = 8, 7 Hz, 1 H), 2.83 (m, 3 H).
MS ESI (M + H)+ = 181.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of CC Chemokine Receptor-3 (CCR3) Antagonists with Picomolar
Potency
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Lucca, George V.; Kim, Ui Tae; Vargo, Brian J.; Duncia, John V.;
Santella, Joseph B. III; Gardner, Daniel S.; Zheng, Changsheng; Liauw,
Ann; Wang, Zhang; Emmett, George; Wacker, Dean A.; Welch, Patricia K.;
Covington, Maryanne; Stowell, Nicole C.; Wadman, Eric A.; Das, Anuk M.;
Davies, Paul; Yeleswaram, Swamy; Graden, Danielle M.; Solomon, Kimberly
A.; Newton, Robert C.; Trainor, George L.; Decicco, Carl P.; Ko, Soo. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2005), 48(6), 2194-2211

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzoyl chloride
C7H4ClNO3
121-90-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0800 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 4.6201 0.0 0
M  V30 4 N 6.6686 3.0800 0.0 0 VAL=5
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 0.0000 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-3-nitrobenzamide
C8H8N2O3
3400-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 9.3360 3.0801 0.0 0
M  V30 5 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 12 C 4.0012 0.0000 0.0 0
M  V30 13 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 121-90-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3400-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2427107
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperidine- and tetrazolyl-containing ureas and related
compounds as modulators of chemokine receptor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Batt, Douglas G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004028530 A1 2004-04-08

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-N-[(4-methoxyphenyl)methyl]-N-methylbenzenemethanamine
C17H21NO2
98340-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3360 0.0000 0.0 0
M  V30 2 N 8.0023 0.7700 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 2.3101 0.0 0
M  V30 5 O 14.6708 3.0801 0.0 0
M  V30 6 C 16.0046 2.3101 0.0 0
M  V30 7 O 1.3338 3.0801 0.0 0
M  V30 8 C 0.0000 2.3101 0.0 0
M  V30 9 C 10.6698 0.7700 0.0 0
M  V30 10 C 10.6698 2.3101 0.0 0
M  V30 11 C 12.0035 0.0000 0.0 0
M  V30 12 C 12.0035 3.0801 0.0 0
M  V30 13 C 13.3372 0.7700 0.0 0
M  V30 14 C 13.3372 2.3101 0.0 0
M  V30 15 C 5.3348 0.7700 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 4.0012 0.0000 0.0 0
M  V30 18 C 4.0012 3.0801 0.0 0
M  V30 19 C 2.6675 0.7700 0.0 0
M  V30 20 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 14
M  V30 8 1 7 8
M  V30 9 1 7 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 98340-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7588208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-06-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM nanowire
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel synthesis of N-alkyl amines from tandem coupling of either
methylamine or nitroalkane with aldehyde
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lu, Shuanglong; Peng, Jie; Wu, Junjie; Li, Chao; Cao, Xueqin; Gu, Hongwei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2016), 52(4),
760-763

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-(2,8-dichloro-3-quinolinyl)ethyl]carbamate
C16H18Cl2N2O2
1240186-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0801 0.0 0
M  V30 2 C 6.6685 5.3901 0.0 0 CFG=2
M  V30 3 N 8.0022 4.6201 0.0 0
M  V30 4 C 6.6685 6.9302 0.0 0
M  V30 5 C 9.3360 5.3901 0.0 0
M  V30 6 O 10.6697 4.6201 0.0 0
M  V30 7 O 9.3360 6.9302 0.0 0
M  V30 8 C 12.0033 5.3901 0.0 0
M  V30 9 C 11.2333 6.7238 0.0 0
M  V30 10 C 13.3370 6.1601 0.0 0
M  V30 11 C 12.7733 4.0564 0.0 0
M  V30 12 Cl 4.0010 6.9302 0.0 0
M  V30 13 C 4.0010 2.3101 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 16 C 4.0010 0.7700 0.0 0
M  V30 17 N 2.6673 4.6201 0.0 0
M  V30 18 C 1.3337 2.3101 0.0 0
M  V30 19 C 5.3348 4.6201 0.0 0
M  V30 20 C 2.6673 0.0000 0.0 0
M  V30 21 C 4.0010 5.3901 0.0 0
M  V30 22 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 3
M  V30 3 1 2 4 CFG=3
M  V30 4 1 2 19
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 21
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 2 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[8-chloro-2-(methylamino)-3-quinolinyl]ethyl]carb...
C17H22ClN3O2
1240186-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 3.0801 0.0 0
M  V30 2 N 4.0010 6.9302 0.0 0
M  V30 3 C 2.6673 7.7002 0.0 0
M  V30 4 C 6.6685 5.3901 0.0 0 CFG=2
M  V30 5 N 8.0022 4.6201 0.0 0
M  V30 6 C 6.6685 6.9302 0.0 0
M  V30 7 C 9.3360 5.3901 0.0 0
M  V30 8 O 10.6697 4.6201 0.0 0
M  V30 9 O 9.3360 6.9302 0.0 0
M  V30 10 C 12.0033 5.3901 0.0 0
M  V30 11 C 12.7733 4.0564 0.0 0
M  V30 12 C 13.3370 6.1601 0.0 0
M  V30 13 C 11.2333 6.7238 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 4.0010 2.3101 0.0 0
M  V30 16 N 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 5.3348 3.0801 0.0 0
M  V30 19 C 4.0010 0.7700 0.0 0
M  V30 20 C 4.0010 5.3901 0.0 0
M  V30 21 C 1.3337 0.7700 0.0 0
M  V30 22 C 5.3348 4.6201 0.0 0
M  V30 23 C 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 3
M  V30 3 1 2 20
M  V30 4 1 4 5
M  V30 5 1 4 6 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 15 18
M  V30 18 1 15 19
M  V30 19 2 16 20
M  V30 20 2 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1240186-30-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1240186-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7177772
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Alternative procedure: A mixture of Intermediate 23 (700 mg, 2.05 mmol)
and 2N MeNH2 in THF (4 mL) was heated at 70°C for 20 h. The reaction
mixture was concentrated in vacuo onto silica gel and purified by column
chromatography (SiO2, 10- 100% EtOAc in isohexane) to afford the title
compound (649 mg, 94%) as a clear gum. (S)-tert-Butyl
1-[8-chloro-2-(methylamino)quinolin-3-yl]ethyl carbamate, yield (649 mg,
94%). δH (CDCl3) 7.68 (1H, s), 7.62 (1H, dd, J 7.54, 1.43 Hz), 7.47 (1H,
dd, J 7.91, 1.42 Hz), 7.08 (1H, t, J 7.73 Hz), 4.92 (1H, br s), 4.53 (1H,
d, J 9.73 Hz), 3.19 (3H, d, J 4.63 Hz), 1.64 (3H, d, J 6.81 Hz), 1.45
(9H, s).
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation gave lower yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fused pyridines and related compounds as kinase inhibitors and their
preparation and use for the treatment of diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Daniel Rees; Brown, Julien Alistair; Buerli, Roland; Haughan, Alan
Findlay; MacDonald, Jonathan David; Matteucci, Mizio; Owens, Andrew Pate;
Raphy, Gilles; Saville-Stones, Elizabeth Anne; Sharpe, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010092340 A1 2010-08-19

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-(phenylmethyl)-2,4(1H,3H)-pyrimidinedione
C11H9ClN2O2
124218-96-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 Cl 4.0011 4.6200 0.0 0
M  V30 3 O 6.6684 0.0000 0.0 0
M  V30 4 O 9.3358 4.6200 0.0 0
M  V30 5 N 5.3347 2.3100 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 6.6684 1.5400 0.0 0
M  V30 8 C 6.6684 4.6200 0.0 0
M  V30 9 N 8.0021 2.3100 0.0 0
M  V30 10 C 8.0021 3.8500 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 1.3336 1.5400 0.0 0
M  V30 14 C 1.3336 4.6200 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 6
M  V30 4 2 3 7
M  V30 5 2 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Methylamino)-1-(phenylmethyl)-2,4(1H,3H)-pyrimidinedione
C12H13N3O2
823221-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.3100 0.0 0
M  V30 2 N 2.6674 0.7700 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 O 5.3347 5.3900 0.0 0
M  V30 5 O 0.0000 5.3900 0.0 0
M  V30 6 N 4.0011 3.0800 0.0 0
M  V30 7 C 2.6674 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 N 2.6674 5.3900 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 6.6684 3.0800 0.0 0
M  V30 13 C 8.0021 2.3100 0.0 0
M  V30 14 C 6.6684 4.6200 0.0 0
M  V30 15 C 9.3358 3.0800 0.0 0
M  V30 16 C 8.0021 5.3900 0.0 0
M  V30 17 C 9.3358 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 7
M  V30 5 2 4 8
M  V30 6 2 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 124218-96-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 823221-46-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8683690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 6-Aminouracils as precursors for the syntheses of fused di- and tricyclic
pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Youssif, Shaker
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Research (2004), (5), 341-343

$RFMT $RIREG SCHEME353 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3R)-4-[[(1,1-Dimethylethoxy)carbonyl]methylamino]-3-[[(1,1-dimethylethyl)...
C17H35NO5Si
1255212-71-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 4.0011 0.0 0 CFG=2
M  V30 2 O 4.6200 5.3347 0.0 0
M  V30 3 C 6.9300 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0 CFG=2
M  V30 5 Si 3.0800 5.3347 0.0 0
M  V30 6 N 7.7000 5.3347 0.0 0
M  V30 7 C 5.3900 1.3338 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 1.5400 5.3347 0.0 0
M  V30 10 C 3.0800 3.7947 0.0 0
M  V30 11 C 3.0800 6.8747 0.0 0
M  V30 12 C 9.2400 5.3347 0.0 0
M  V30 13 C 6.9300 6.6685 0.0 0
M  V30 14 O 4.6200 0.0000 0.0 0
M  V30 15 O 6.9300 1.3338 0.0 0
M  V30 16 C 1.5400 6.8747 0.0 0
M  V30 17 C 0.0000 5.3347 0.0 0
M  V30 18 C 1.5400 3.7947 0.0 0
M  V30 19 O 10.0100 6.6685 0.0 0
M  V30 20 O 10.0100 4.0011 0.0 0
M  V30 21 C 11.5500 6.6685 0.0 0
M  V30 22 C 11.5500 8.2085 0.0 0
M  V30 23 C 13.0900 6.6685 0.0 0
M  V30 24 C 11.5500 5.1285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=1
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 5 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 7 14
M  V30 14 2 7 15
M  V30 15 1 9 16
M  V30 16 1 9 17
M  V30 17 1 9 18
M  V30 18 1 12 19
M  V30 19 2 12 20
M  V30 20 1 19 21
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(2R,3S)-2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-meth...
C18H38N2O4Si
1326727-03-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 4.6200 6.6685 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 5 N 7.7000 6.6685 0.0 0
M  V30 6 Si 3.0800 6.6685 0.0 0
M  V30 7 C 5.3900 2.6674 0.0 0
M  V30 8 C 3.0800 4.0011 0.0 0
M  V30 9 C 9.2400 6.6685 0.0 0
M  V30 10 C 6.9300 8.0021 0.0 0
M  V30 11 C 1.5400 6.6685 0.0 0
M  V30 12 C 3.0800 8.2085 0.0 0
M  V30 13 C 3.0800 5.1285 0.0 0
M  V30 14 N 4.6200 1.3336 0.0 0
M  V30 15 O 6.9300 2.6674 0.0 0
M  V30 16 O 10.0100 8.0021 0.0 0
M  V30 17 O 10.0100 5.3347 0.0 0
M  V30 18 C 1.5400 5.1285 0.0 0
M  V30 19 C 0.0000 6.6685 0.0 0
M  V30 20 C 1.5400 8.2085 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 C 11.5500 8.0021 0.0 0
M  V30 23 C 11.5500 6.4621 0.0 0
M  V30 24 C 13.0900 8.0021 0.0 0
M  V30 25 C 11.5500 9.5421 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8 CFG=1
M  V30 8 1 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 6 13
M  V30 13 1 7 14
M  V30 14 2 7 15
M  V30 15 1 9 16
M  V30 16 2 9 17
M  V30 17 1 11 18
M  V30 18 1 11 19
M  V30 19 1 11 20
M  V30 20 1 14 21
M  V30 21 1 16 22
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1255212-71-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1326727-03-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13685362
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical asymmetric synthesis of β-hydroxy γ-amino acids via
complimentary aldol reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pandya, Bhaumik A.; Dandapani, Sivaraman; Duvall, Jeremy R.; Rowley, Ann;
Mulrooney, Carol A.; Ryba, Troy; Dombrowski, Michael; Harton, Marie;
Young, Damian W.; Marcaurelle, Lisa A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2011), 67(34), 6131-6137

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(methylthio)-2′,4-dioxospiro[2-cyclopentene-1,3′(2′H)-imidazo[1,2-a]p...
C15H14N2O4S
1256269-70-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.7953 0.9052 0.0 0
M  V30 2 C 6.0412 0.0000 0.0 0
M  V30 3 O 3.9554 0.7267 0.0 0
M  V30 4 C 7.6969 2.5805 0.0 0
M  V30 5 O 8.9428 3.4857 0.0 0
M  V30 6 O 7.8578 1.0489 0.0 0
M  V30 7 C 10.3496 2.8592 0.0 0
M  V30 8 C 11.5955 3.7644 0.0 0
M  V30 9 O 7.0002 5.8577 0.0 0
M  V30 10 C 3.8119 3.4674 0.0 0
M  V30 11 N 2.6673 4.4978 0.0 0
M  V30 12 C 4.9563 2.4368 0.0 0
M  V30 13 C 4.4382 4.8742 0.0 0
M  V30 14 C 3.1854 2.0604 0.0 0
M  V30 15 C 1.3337 3.7278 0.0 0
M  V30 16 C 2.6673 6.0378 0.0 0
M  V30 17 C 6.2899 3.2068 0.0 0
M  V30 18 C 5.9698 4.7133 0.0 0
M  V30 19 N 1.6538 2.2213 0.0 0
M  V30 20 C 0.0000 4.4978 0.0 0
M  V30 21 C 1.3337 6.8079 0.0 0
M  V30 22 C 0.0000 6.0378 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 2 15 19
M  V30 20 1 15 20
M  V30 21 2 16 21
M  V30 22 1 17 18
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(methylamino)-2′,4-dioxospiro[2-cyclopentene-1,3′(2′H)-imidazo[1,2-a]...
C15H15N3O4
1256269-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.7953 0.9052 0.0 0
M  V30 2 C 6.0412 0.0000 0.0 0
M  V30 3 O 3.9554 0.7267 0.0 0
M  V30 4 C 7.6969 2.5805 0.0 0
M  V30 5 O 8.9428 3.4857 0.0 0
M  V30 6 O 7.8578 1.0489 0.0 0
M  V30 7 C 10.3496 2.8592 0.0 0
M  V30 8 C 11.5955 3.7644 0.0 0
M  V30 9 O 7.0002 5.8577 0.0 0
M  V30 10 C 3.8119 3.4674 0.0 0
M  V30 11 N 2.6673 4.4978 0.0 0
M  V30 12 C 4.9563 2.4368 0.0 0
M  V30 13 C 4.4382 4.8742 0.0 0
M  V30 14 C 3.1854 2.0604 0.0 0
M  V30 15 C 1.3337 3.7278 0.0 0
M  V30 16 C 2.6673 6.0378 0.0 0
M  V30 17 C 6.2899 3.2068 0.0 0
M  V30 18 C 5.9698 4.7133 0.0 0
M  V30 19 N 1.6538 2.2213 0.0 0
M  V30 20 C 0.0000 4.4978 0.0 0
M  V30 21 C 1.3337 6.8079 0.0 0
M  V30 22 C 0.0000 6.0378 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 2 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 17
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 18
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 11 16
M  V30 16 2 12 17
M  V30 17 1 13 18
M  V30 18 1 14 19
M  V30 19 2 15 19
M  V30 20 1 15 20
M  V30 21 2 16 21
M  V30 22 1 17 18
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1256269-70-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1256269-73-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-5005995
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new nitrogen-bridged heterocycles. 70. Synthesis of
spiro[2-cyclopentene-1,3'-imidazo[1,2-a]-pyridine] derivatives and their
interesting behavior in 1H-NMR spectra in deuteriochloroform
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abe, Takashi; Kakehi, Akikazu; Suga, Hiroyuki; Okumura, Yukihisa; Itoh,
Kennosuke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2010), 81(9), 2075-2086

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridinium, 2-[[4-(methoxycarbonyl)benzoyl]oxy]-1-methyl-, 1,1,1-trifluoromet...
C15H14NO4.CF3O3S
1257841-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 8.6211 0.0 0
M  V30 2 O 4.6200 7.2874 0.0 0
M  V30 3 O 4.6200 9.9549 0.0 0
M  V30 4 C 11.5500 8.6211 0.0 0
M  V30 5 O 12.3200 9.9549 0.0 0
M  V30 6 O 12.3200 7.2874 0.0 0
M  V30 7 C 13.8600 9.9549 0.0 0
M  V30 8 C 3.0800 4.6200 0.0 0
M  V30 9 C 6.9300 8.6211 0.0 0
M  V30 10 C 7.7000 9.9549 0.0 0
M  V30 11 C 7.7000 7.2874 0.0 0
M  V30 12 C 9.2400 9.9549 0.0 0
M  V30 13 C 9.2400 7.2874 0.0 0
M  V30 14 C 10.0100 8.6211 0.0 0
M  V30 15 C 3.0800 7.2874 0.0 0
M  V30 16 N 2.3100 5.9538 0.0 0 CHG=1 VAL=4
M  V30 17 C 2.3100 8.6211 0.0 0
M  V30 18 C 0.7700 5.9538 0.0 0
M  V30 19 C 0.7700 8.6211 0.0 0
M  V30 20 C 0.0000 7.2874 0.0 0
M  V30 21 C 6.1600 1.5400 0.0 0
M  V30 22 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 23 F 5.3900 2.8736 0.0 0
M  V30 24 F 4.6200 1.5400 0.0 0
M  V30 25 F 5.3900 0.2064 0.0 0
M  V30 26 O 7.7000 3.0800 0.0 0
M  V30 27 O 7.7000 0.0000 0.0 0
M  V30 28 O 9.2400 1.5400 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 1 8 16
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 21 24
M  V30 25 1 21 25
M  V30 26 2 22 26
M  V30 27 2 22 27
M  V30 28 1 22 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(methylamino)carbonyl]benzoate
C10H11NO3
23754-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 N 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 C 8.4702 1.3337 0.0 0
M  V30 6 O 9.2402 0.0000 0.0 0
M  V30 7 O 9.2402 2.6673 0.0 0
M  V30 8 C 10.7802 0.0000 0.0 0
M  V30 9 C 3.8501 1.3337 0.0 0
M  V30 10 C 4.6201 0.0000 0.0 0
M  V30 11 C 4.6201 2.6673 0.0 0
M  V30 12 C 6.1601 0.0000 0.0 0
M  V30 13 C 6.1601 2.6673 0.0 0
M  V30 14 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 14
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1257841-78-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 23754-46-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8718655
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM gaseous methylamine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective deprotection and amidation of 2-pyridyl esters via
N-methylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yamada, Shinji; Abe, Misato
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(45), 8667-8671

$RFMT $RIREG SCHEME356 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-3,4-dihydro-8-methyl-1(2H)-naphthalenone
C11H11BrO
1260013-68-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.6687 2.3101 0.0 0
M  V30 2 C 1.3338 5.3901 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 5.3348 3.0801 0.0 0
M  V30 7 C 4.0012 0.7700 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 1.3338 2.3101 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Naphthalenamine, 5-bromo-1,2,3,4-tetrahydro-N,8-dimethyl-
C12H16BrN
3049676-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 5.3348 5.3901 0.0 0
M  V30 4 Br 0.0000 2.3101 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 5.3348 2.3101 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 1.3337 3.0801 0.0 0
M  V30 10 C 2.6675 0.7700 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 5.3901 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 8
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1260013-68-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3049676-59-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34553696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a selective c-MET inhibitor with a novel binding mode
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Collie, Gavin W.; Barlind, Louise; Bazzaz, Sana; Borjesson, Ulf; Dale,
Ian L.; Disch, Jeremy S.; Habeshian, Sevan; Jetson, Rachael; Khurana,
Puneet; Madin, Andrew; Michaelides, Iacovos N.; Peng, Ling; Snijder,
Arjan; Stubbs, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2022), 75128948

$RFMT $RIREG SCHEME357 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-2-(methylthio)-3-nitro-4H-1-benzopyran-4-one
C11H9NO4S
1264701-68-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 O 0.0000 3.8500 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 S 1.3336 1.5400 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 O 4.0011 1.5400 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methyl-2-(methylamino)-3-nitro-4H-1-benzopyran-4-one
C11H10N2O4
1264701-84-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.0011 6.1600 0.0 0
M  V30 2 N 1.3336 4.6200 0.0 0 VAL=5
M  V30 3 O 1.3336 6.1600 0.0 0
M  V30 4 O 0.0000 3.8500 0.0 0
M  V30 5 C 9.3358 4.6200 0.0 0
M  V30 6 N 1.3336 1.5400 0.0 0
M  V30 7 C 1.3336 0.0000 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 O 4.0011 1.5400 0.0 0
M  V30 13 C 6.6684 1.5400 0.0 0
M  V30 14 C 2.6674 3.8500 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 2.6674 2.3100 0.0 0
M  V30 17 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 14
M  V30 5 1 5 15
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1264701-68-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1264701-84-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6781025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise synthetic strategy to functionalized chromenones via [5+1]
heteroannulation and facile C-N/C-S/C-O bond formation with various
nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savant, Mahesh M.; Gowda, Neetha S.; Pansuriya, Akshay M.; Bhuva, Chirag
V.; Kapuriya, Naval; Anandalwar, Sridhar M.; Prasad, Shashidhara J.;
Shah, Anamik; Naliapara, Yogesh T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(2), 254-257

$RFMT $RIREG SCHEME358 STEP1
$RXN



  3  1
$MOL
Phosgene
CCl2O
75-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3101 0.0 0
M  V30 3 Cl 2.6673 2.3101 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine
C4H11ClN2O4S2
127792-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 4.0011 0.0 0
M  V30 2 N 3.0800 5.3349 0.0 0
M  V30 3 S 5.3900 4.0011 0.0 0 VAL=6
M  V30 4 C 3.0800 2.6674 0.0 0
M  V30 5 S 1.5400 5.3349 0.0 0 VAL=6
M  V30 6 C 6.9300 4.0011 0.0 0
M  V30 7 O 5.3900 2.4611 0.0 0
M  V30 8 O 5.3900 5.5411 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 0.0000 5.3349 0.0 0
M  V30 11 O 1.5400 6.8749 0.0 0
M  V30 12 O 1.5400 3.7949 0.0 0
M  V30 13 Cl 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 2 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 2 5 12
M  V30 12 1 9 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Laromustine
C6H14ClN3O5S2
173424-77-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 N 5.3347 3.8500 0.0 0
M  V30 3 S 4.0011 1.5400 0.0 0 VAL=6
M  V30 4 C 2.6674 3.8500 0.0 0
M  V30 5 S 5.3347 5.3900 0.0 0 VAL=6
M  V30 6 C 6.6684 3.0800 0.0 0
M  V30 7 C 4.0011 0.0000 0.0 0
M  V30 8 O 5.5411 1.5400 0.0 0
M  V30 9 O 2.4611 1.5400 0.0 0
M  V30 10 N 1.3336 3.0800 0.0 0
M  V30 11 O 2.6674 5.3900 0.0 0
M  V30 12 C 5.3347 6.9300 0.0 0
M  V30 13 O 3.7947 5.3900 0.0 0
M  V30 14 O 6.8747 5.3900 0.0 0
M  V30 15 C 8.0021 3.8500 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 Cl 9.3358 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 2 3 9
M  V30 9 1 4 10
M  V30 10 2 4 11
M  V30 11 1 5 12
M  V30 12 2 5 13
M  V30 13 2 5 14
M  V30 14 1 6 15
M  V30 15 1 10 16
M  V30 16 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-44-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 127792-84-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 173424-77-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9038508
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of Compound VNP40101M by Method A VNP4090CE (520 g) was
dissolved in acetonitrile (5,200 mL, 10±1 mL per g of VNP4090CE) and
placed on a cold bath (−8 to −15° C.). A commercially available 20%
phosgene toluene solution (1,170 mL, 2.255±0.020 mL per g of VNP4090CE)
and diisopropylethylamine (DIPEA, 387 mL, 0.745±0.015 mL per g of
VNP4090CE) were added into the stirred VNP4090CE solution. The reaction
mixture was kept stirring at below 0° C. for 30 min. A 2.0N methylamine
tetrahydrofuran (THF) solution (1,240 mL, 2.375±0.075 mL per g of
VNP4090CE) and another portion of DIPEA (387 mL, 0.745±0.015 mL per g of
VNP4090CE) were then added. The reaction mixture was stirred at below 0°
C. for 1 hr and at room temperature for another 60-90 min. The reaction
completion was monitored by thin layer chromatography (TLC) and
high-performance liquid chromatography with ultraviolet detector
(HPLC/UV). After evaporation to remove solvents, the residue was worked
up with brine and DCM twice. The organic phases were combined and dried
over anhydrous Na2SO4. After filtration and concentration, the crude
product was crystallized in ethanol. After filtration and drying under
vacuum, the product
1,2-bis(methylsulfonyl)-1-(2-chloroethyl)-2-[methylamino)carbonyl]-hydrazine
(VNP40101M) was obtained as white solids in a yield of 94%. Purity of
VNP40101M could be reached to 97% by using one more than one rounds of
ethanol solubilization and crystallization steps. The product VNP40101M
obtained by method A or method B above were consistent with the compound
described in the prior art procedure. 1H NMR spectrum (300 MHz) was
clean: DMSO-d6, δ 7.10 (bs, 1H), 3.95 (m, 2H), 3.83 (m, 2H), 3.53 (s,
3H), 3.30 (s, 3H), and 2.68 (d, J=4.2 Hz, 3H). CDCl3, δ 6.42 (bs, 1H),
4.04-3.75 (m, 4H), 3.49 (s, 3H), 3.22 (s, 3H), and 2.88 (d, J=4.8 Hz,
3H). Melting point (Capillary tube): 150-152° C. TLC: developed with 4%
ethyl acetate in dichloromethane and visualized by spraying a solution of
methanol/water/sulfuric acid (3:3:1, v/v/v) Rf=0.60-0.70. MS (m/z): 308
(M+H) and 330 (M+Na). IR (cm−1): 1706, 3047, 3008, and 2935.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the synthesis of anti-neoplasia agent VNP40101M
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Xu; King, Ivan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US8026395 B1 2011-09-27

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-[(4-Chlorophenoxy)methyl]oxirane
C9H9ClO2
129098-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.6673 0.0 0
M  V30 2 O 3.6437 1.3337 0.0 0
M  V30 3 Cl 9.8039 1.3337 0.0 0
M  V30 4 C 1.3337 2.6673 0.0 0 CFG=1
M  V30 5 C 0.0000 3.4374 0.0 0
M  V30 6 O 0.0000 1.8973 0.0 0
M  V30 7 C 5.1838 1.3337 0.0 0
M  V30 8 C 5.9538 0.0000 0.0 0
M  V30 9 C 5.9538 2.6673 0.0 0
M  V30 10 C 7.4938 0.0000 0.0 0
M  V30 11 C 7.4938 2.6673 0.0 0
M  V30 12 C 8.2638 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 4 1 CFG=1
M  V30 3 1 2 7
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-1-(4-Chlorophenoxy)-3-(methylamino)-2-propanol
C10H14ClNO2
511255-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0 CFG=1
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 8.0022 0.0000 0.0 0
M  V30 6 N 10.6697 1.5400 0.0 0
M  V30 7 C 12.0033 2.3101 0.0 0
M  V30 8 Cl 0.0000 4.6201 0.0 0
M  V30 9 C 4.0012 2.3101 0.0 0
M  V30 10 C 2.6673 1.5400 0.0 0
M  V30 11 C 4.0012 3.8501 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5 CFG=3
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 129098-57-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 511255-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-11223661
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Analogs of the dopamine D4 receptor ligand FAUC 113 with planar- and
central-chirality
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lober, Stefan; Ortner, Birgit; Bettinetti, Laura; Hubner, Harald;
Gmeiner, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron: Asymmetry (2002), 13(21), 2303-2310

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-leucine
C11H21NO4
13139-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 3.8501 0.0 0 CFG=2
M  V30 2 N 4.0012 4.6201 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 O 0.0000 3.8501 0.0 0
M  V30 8 O 1.3337 6.1601 0.0 0
M  V30 9 O 6.6685 4.6201 0.0 0
M  V30 10 O 5.3348 2.3101 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 8.0023 3.8501 0.0 0
M  V30 14 C 7.2323 2.5164 0.0 0
M  V30 15 C 9.3360 3.0801 0.0 0
M  V30 16 C 8.7723 5.1838 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 6 12
M  V30 12 1 9 13
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-3-methyl-1-[(methylamino)carbonyl]butyl]carbamate
C12H24N2O3
67308-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0 CFG=2
M  V30 2 C 2.3100 4.0011 0.0 0
M  V30 3 N 4.6200 5.3347 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 N 1.5400 5.3347 0.0 0
M  V30 6 O 1.5400 2.6674 0.0 0
M  V30 7 C 6.1600 5.3347 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 O 6.9300 6.6685 0.0 0
M  V30 11 O 6.9300 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0000 0.0 0
M  V30 14 C 8.4700 6.6685 0.0 0
M  V30 15 C 8.4700 5.1285 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 8.4700 8.2085 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 8 13
M  V30 13 1 10 14
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13139-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67308-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-5462931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Boc-Leu-NHMe (1.9) Boc-Leu-OH (6.0 g, 24.06 mmol) was dissolved in CH2Cl2
(275 mL). EDCI-HCl (5.6 g, 28.88 mmol) and DMAP (cat.) were added to the
solution. MeNH2 2M in THF (15 mL, 28.88 mmol), was then added and the
mixture was stirred for 30 h under N2. The reaction mixture was washed
with 1 N HCl (2 x 100 mL), NaHCO sat (2 x 100 mL) and brine (1 x 100 mL),
dried over Na2SO4 and concentrated under reduced pressure to leave 6 g of
a white solid (94 % yield). Boc-Leu-NHMe (1.9), yield 6 g,94 % 1H NMR
(300 MHz, CDCl3) δ 0.93 (d, J = 8.1 Hz, 3H), 0.95 (d, J = 8.4 Hz, 3H),
1.29- 1.39 (m, 1H), 1.50 (br s, 2H), 1.63-1.80 (m, 2H), 3.92 (dd, J = 9.0
and 6.6 Hz, 1H), 5.21 (d, J = 9.0 Hz, 1H), 6.46 (br s, 1H), 2.80 (d, J =
4.8 Hz, 1H), 3.37 (dd, J = 9.9 and 4.2 Hz, 1H), 7.54 (br s, 1H),13C NMR
(300 MHz, CDCl3) δ 21.6, 23.5, 25.0, 26.1, 43.8, 51.0, 175.8, ESI-MS
calc. [2MH]+ = [C14H22N4O2Na]+= 289.2603 obsd. [C14H22N4O2Na]+= 289.2598
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diacid Linkers That Promote Parallel β-Sheet Secondary Structure in Water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Freire, Felix; Fisk, John D.; Peoples, Aaron J.; Ivancic, Monika; Guzei,
Ilia A.; Gellman, Samuel H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2008), 130(25), 7839-7841

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,7aR)-7-(2-Bromoethyl)-3a,4,5,7a-tetrahydro-2,2-dimethyl-1,3-benzodioxole
C11H17BrO2
1315613-94-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9838 3.1737 0.0 0
M  V30 2 C 7.3176 3.9437 0.0 0
M  V30 3 Br 8.6512 3.1737 0.0 0
M  V30 4 C 0.0000 1.0304 0.0 0
M  V30 5 C 1.7849 0.0000 0.0 0
M  V30 6 C 3.3164 3.1737 0.0 0 CFG=2
M  V30 7 C 1.9828 3.9437 0.0 0 CFG=2
M  V30 8 C 4.6501 3.9437 0.0 0
M  V30 9 O 2.9963 1.6674 0.0 0
M  V30 10 O 0.8382 2.9133 0.0 0
M  V30 11 C 1.9828 5.4837 0.0 0
M  V30 12 C 4.6501 5.4837 0.0 0
M  V30 13 C 1.4647 1.5063 0.0 0
M  V30 14 C 3.3164 6.2537 0.0 0
M  V30 15 H 4.5623 2.2685 0.0 0
M  V30 16 H 0.5758 4.5700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 4 13
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15 CFG=3
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 16 CFG=3
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 13
M  V30 16 1 11 14
M  V30 17 1 12 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(3aR,7aS)-3a,6,7,7a-Tetrahydro-N,2,2-trimethyl-1,3-benzodioxole-4-ethanamine
C12H21NO2
1315613-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.2536 4.0011 0.0 0
M  V30 2 C 7.7937 4.0011 0.0 0
M  V30 3 N 8.5637 5.3349 0.0 0
M  V30 4 C 10.1037 5.3349 0.0 0
M  V30 5 C 0.0000 2.8653 0.0 0
M  V30 6 C 1.0304 4.6502 0.0 0
M  V30 7 C 3.9436 2.6674 0.0 0 CFG=2
M  V30 8 C 3.1736 1.3338 0.0 0 CFG=2
M  V30 9 C 5.4836 2.6674 0.0 0
M  V30 10 O 2.9132 3.8118 0.0 0
M  V30 11 O 1.6674 1.6540 0.0 0
M  V30 12 C 3.9436 0.0000 0.0 0
M  V30 13 C 6.2536 1.3338 0.0 0
M  V30 14 C 1.5063 3.1855 0.0 0
M  V30 15 C 5.4836 0.0000 0.0 0
M  V30 16 H 4.5700 4.0742 0.0 0
M  V30 17 H 2.2684 0.0879 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 14
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 16 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 17 CFG=1
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 14
M  V30 17 1 12 15
M  V30 18 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1315613-94-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1315613-95-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6295884
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoenzymatic total synthesis of ent-neopinone and formal total
synthesis of ent-codeinone from β-bromoethylbenzene
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duchek, Jan; Piercy, T. Graeme; Gilmet, Jacqueline; Hudlicky, Tomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canadian Journal of Chemistry (2011), 89(6), 709-728

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(4-fluorophenyl)-6-[(methylsulfonyl)amino]-3-benzofurancarboxylic acid
C16H11BrFNO5S
1333244-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 Br 1.5400 6.1600 0.0 0
M  V30 5 F 14.0710 4.6200 0.0 0
M  V30 6 N 1.5400 3.0800 0.0 0
M  V30 7 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 O 3.0800 1.5400 0.0 0
M  V30 11 C 7.9110 4.6200 0.0 0
M  V30 12 C 7.0058 5.8659 0.0 0
M  V30 13 O 7.0058 3.3741 0.0 0
M  V30 14 C 5.5411 5.3900 0.0 0
M  V30 15 C 5.5411 3.8500 0.0 0
M  V30 16 C 4.2074 6.1600 0.0 0
M  V30 17 C 4.2074 3.0800 0.0 0
M  V30 18 C 2.8738 5.3900 0.0 0
M  V30 19 C 2.8738 3.8500 0.0 0
M  V30 20 C 9.4510 4.6200 0.0 0
M  V30 21 C 10.2210 5.9536 0.0 0
M  V30 22 C 10.2210 3.2864 0.0 0
M  V30 23 C 11.7610 5.9536 0.0 0
M  V30 24 C 11.7610 3.2864 0.0 0
M  V30 25 C 12.5310 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 18
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(4-fluorophenyl)-N-methyl-6-[(methylsulfonyl)amino]-3-benzofurancar...
C17H14BrFN2O4S
1333244-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 Br 1.5400 3.7795 0.0 0
M  V30 6 F 14.0710 5.3195 0.0 0
M  V30 7 N 1.5400 6.8595 0.0 0
M  V30 8 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 9 C 1.5400 9.9395 0.0 0
M  V30 10 O 3.0800 8.3995 0.0 0
M  V30 11 O 0.0000 8.3995 0.0 0
M  V30 12 C 7.9110 5.3195 0.0 0
M  V30 13 C 7.0058 4.0736 0.0 0
M  V30 14 O 7.0058 6.5655 0.0 0
M  V30 15 C 5.5411 4.5495 0.0 0
M  V30 16 C 5.5411 6.0895 0.0 0
M  V30 17 C 4.2074 3.7795 0.0 0
M  V30 18 C 4.2074 6.8595 0.0 0
M  V30 19 C 2.8738 4.5495 0.0 0
M  V30 20 C 2.8738 6.0895 0.0 0
M  V30 21 C 9.4510 5.3195 0.0 0
M  V30 22 C 10.2210 6.6533 0.0 0
M  V30 23 C 10.2210 3.9858 0.0 0
M  V30 24 C 11.7610 6.6533 0.0 0
M  V30 25 C 11.7610 3.9858 0.0 0
M  V30 26 C 12.5310 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 1 6 26
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1333244-32-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333244-33-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18369918
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of a New Structural Class of Broadly Acting HCV
Non-Nucleoside Inhibitors Leading to the Discovery of MK-8876
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey C.; Palani, Anandan; Chang, Wei; Holloway, M. Katharine;
Lesburg, Charles A.; Li, Peng; Liverton, Nigel; Meinke, Peter T.; Olsen,
David B.; Peng, Xuanjia; Soll, Richard M.; Ummat, Ajay; Wu, Jie; Wu, Jin;
Zorn, Nicolas; Ludmerer, Steven W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2017), 12(17), 1436-1448

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
5-Bromo-2-(4-fluorophenyl)-6-[(methylsulfonyl)amino]-3-benzofurancarboxylic acid
C16H11BrFNO5S
1333244-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 7.3306 0.0 0
M  V30 2 O 6.4512 8.4749 0.0 0
M  V30 3 O 8.9879 7.6507 0.0 0
M  V30 4 Br 1.5400 6.1600 0.0 0
M  V30 5 F 14.0710 4.6200 0.0 0
M  V30 6 N 1.5400 3.0800 0.0 0
M  V30 7 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 8 C 1.5400 0.0000 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 O 3.0800 1.5400 0.0 0
M  V30 11 C 7.9110 4.6200 0.0 0
M  V30 12 C 7.0058 5.8659 0.0 0
M  V30 13 O 7.0058 3.3741 0.0 0
M  V30 14 C 5.5411 5.3900 0.0 0
M  V30 15 C 5.5411 3.8500 0.0 0
M  V30 16 C 4.2074 6.1600 0.0 0
M  V30 17 C 4.2074 3.0800 0.0 0
M  V30 18 C 2.8738 5.3900 0.0 0
M  V30 19 C 2.8738 3.8500 0.0 0
M  V30 20 C 9.4510 4.6200 0.0 0
M  V30 21 C 10.2210 5.9536 0.0 0
M  V30 22 C 10.2210 3.2864 0.0 0
M  V30 23 C 11.7610 5.9536 0.0 0
M  V30 24 C 11.7610 3.2864 0.0 0
M  V30 25 C 12.5310 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 4 18
M  V30 5 1 5 25
M  V30 6 1 6 7
M  V30 7 1 6 19
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 20
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(4-fluorophenyl)-N-methyl-6-[(methylsulfonyl)amino]-3-benzofurancar...
C17H14BrFN2O4S
1333244-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.4816 2.6091 0.0 0
M  V30 2 N 6.4512 1.4645 0.0 0
M  V30 3 O 8.9879 2.2889 0.0 0
M  V30 4 C 6.9271 0.0000 0.0 0
M  V30 5 Br 1.5400 3.7795 0.0 0
M  V30 6 F 14.0710 5.3195 0.0 0
M  V30 7 N 1.5400 6.8595 0.0 0
M  V30 8 S 1.5400 8.3995 0.0 0 VAL=6
M  V30 9 C 1.5400 9.9395 0.0 0
M  V30 10 O 3.0800 8.3995 0.0 0
M  V30 11 O 0.0000 8.3995 0.0 0
M  V30 12 C 7.9110 5.3195 0.0 0
M  V30 13 C 7.0058 4.0736 0.0 0
M  V30 14 O 7.0058 6.5655 0.0 0
M  V30 15 C 5.5411 4.5495 0.0 0
M  V30 16 C 5.5411 6.0895 0.0 0
M  V30 17 C 4.2074 3.7795 0.0 0
M  V30 18 C 4.2074 6.8595 0.0 0
M  V30 19 C 2.8738 4.5495 0.0 0
M  V30 20 C 2.8738 6.0895 0.0 0
M  V30 21 C 9.4510 5.3195 0.0 0
M  V30 22 C 10.2210 6.6533 0.0 0
M  V30 23 C 10.2210 3.9858 0.0 0
M  V30 24 C 11.7610 6.6533 0.0 0
M  V30 25 C 11.7610 3.9858 0.0 0
M  V30 26 C 12.5310 5.3195 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 1 6 26
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 21
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1333244-32-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1333244-33-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2244199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 7 - Synthesis of
5-Bromo-2-(4-fluoro-phenyl)-6-methanesulfonylamino-benzofuran-3-carboxylic
acid methylamide A solution of
5-bromo-2-(4-fluorophenyl)-6-(methylsulfonamido)benzofuran-3- carboxylic
acid (33 g, 77 mmol), HOBT (15.6 g, 115.5 mmol) and EDCI (22.2 g, 115.5
mmol) in DMF (250 mL) was stirred at room temperature. After 2 hours,
Et3N (50 mL) and CH3NH2 (HCl salt, 17.7 g, 231 mmol) was added to the
mixture, and the mixture was stirred overnight. After the solvent was
removed, H2O was added and the mixture was extracted with ethyl acetate.
The combined organic layer was washed with H2O, brine and concentrated in
vacuo. The resulting residue was washed with EtOAc to provide the product
of
5-bromo-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide.
Yield 32 g, 94%. 1H-NMR (DMSO-d6, 400 MHz) δ 9.55 (br s, 1H), 8.46~8.48
(m, 1H), 8.12~8.17 (m, 2H), 7.96 (s, 1H), 7.87 (s, 1H), 7.45~7.50 (m,
2H), 3.16 (s, 3H), 2.93 (d, J= 8.4 Hz, 3H). MS (M+H)+: 441 / 443.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridooxazinoindole derivatives and analogs for use as
antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McComas, Casey Cameron; Liverton, Nigel J.; Habermann, Joerg; Koch, Uwe;
Narjes, Frank; Li, Peng; Peng, Xuanjia; Soll, Richard; Wu, Hao; Palani,
Anandan; He, Shuwen; Dai, Xing; Liu, Hong; Lai, Zhong; London, Clare;
Xiao, Dong; Zorn, Nicolas; Nargund, Ravi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013033971 A1 2013-03-14

$RFMT $RIREG SCHEME363 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methylbenzenesulfonyl chloride
C7H7ClO2S
133-59-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 Cl 6.1600 2.6673 0.0 0
M  V30 3 O 4.6200 4.2073 0.0 0
M  V30 4 O 4.6200 1.1273 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6673 0.0 0
M  V30 7 C 2.3100 1.3336 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 0.7700 1.3336 0.0 0
M  V30 10 C 0.7700 4.0011 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,2-Dimethyl-N-[(2-methylphenyl)sulfonyl]-2-propenamide
C12H15NO3S
1456707-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.0011 3.0800 0.0 0 VAL=6
M  V30 2 N 5.3347 3.8500 0.0 0
M  V30 3 O 4.7711 1.7464 0.0 0
M  V30 4 O 3.2311 4.4136 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 5.3347 5.3900 0.0 0
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 O 6.6684 1.5400 0.0 0
M  V30 9 C 8.0021 5.3900 0.0 0
M  V30 10 C 9.3358 3.0800 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 2.6674 2.3100 0.0 0
M  V30 13 C 1.3336 3.0800 0.0 0
M  V30 14 C 2.6674 0.7700 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 16 C 1.3336 0.0000 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 13
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133-59-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690415
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[5-[[4-chloro-7-(phenylsulfonyl)-7H-pyrrolo[2,3-d]pyrimid...
C29H26ClFN6O5S
1344667-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.8987 8.9943 0.0 0 VAL=6
M  V30 2 O 2.9935 10.2401 0.0 0
M  V30 3 O 4.8037 7.7484 0.0 0
M  V30 4 C 9.0543 10.6695 0.0 0
M  V30 5 O 9.8243 12.0031 0.0 0
M  V30 6 Cl 8.3940 13.8975 0.0 0
M  V30 7 F 12.1343 10.6695 0.0 0
M  V30 8 N 12.1343 5.3347 0.0 0
M  V30 9 C 11.3643 4.0009 0.0 0
M  V30 10 O 12.1343 2.6673 0.0 0
M  V30 11 O 9.8243 4.0009 0.0 0
M  V30 12 C 11.3643 1.3336 0.0 0
M  V30 13 C 10.0307 2.1037 0.0 0
M  V30 14 C 10.5943 0.0000 0.0 0
M  V30 15 C 12.6980 0.5636 0.0 0
M  V30 16 C 18.2944 5.3347 0.0 0
M  V30 17 C 5.1446 11.4395 0.0 0
M  V30 18 C 6.6091 11.9153 0.0 0
M  V30 19 N 5.1446 9.8995 0.0 0
M  V30 20 N 4.0000 12.4699 0.0 0
M  V30 21 C 7.5143 10.6695 0.0 0
M  V30 22 C 6.9293 13.4216 0.0 0
M  V30 23 C 6.6091 9.4235 0.0 0
M  V30 24 C 4.3202 13.9762 0.0 0
M  V30 25 N 5.7849 14.4520 0.0 0
M  V30 26 C 2.6527 8.0890 0.0 0
M  V30 27 C 1.2459 8.7154 0.0 0
M  V30 28 C 2.8137 6.5575 0.0 0
M  V30 29 C 0.0000 7.8101 0.0 0
M  V30 30 C 1.5679 5.6523 0.0 0
M  V30 31 C 0.1609 6.2786 0.0 0
M  V30 32 C 9.8243 9.3357 0.0 0
M  V30 33 C 11.3643 9.3357 0.0 0
M  V30 34 C 9.0543 8.0020 0.0 0
M  V30 35 N 12.1343 8.0020 0.0 0
M  V30 36 C 9.8243 6.6684 0.0 0
M  V30 37 C 11.3643 6.6684 0.0 0
M  V30 38 C 13.6743 5.3347 0.0 0
M  V30 39 C 14.4443 4.0009 0.0 0
M  V30 40 C 14.4443 6.6684 0.0 0
M  V30 41 C 15.9844 4.0009 0.0 0
M  V30 42 N 15.9844 6.6684 0.0 0
M  V30 43 C 16.7544 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 26
M  V30 5 1 4 5
M  V30 6 1 4 21
M  V30 7 1 4 32
M  V30 8 1 6 22
M  V30 9 1 7 33
M  V30 10 1 8 9
M  V30 11 1 8 37
M  V30 12 1 8 38
M  V30 13 1 9 10
M  V30 14 2 9 11
M  V30 15 1 10 12
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 12 15
M  V30 19 1 16 43
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 2 17 20
M  V30 23 1 18 21
M  V30 24 2 18 22
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 2 21 23
M  V30 28 1 22 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 42 1 38 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 2 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[6-fluoro-5-[hydroxy[4-(methylamino)-7-(phenylsulfonyl)-7...
C30H30FN7O5S
1344667-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0543 10.6695 0.0 0
M  V30 2 O 9.8243 12.0033 0.0 0
M  V30 3 N 8.3940 13.8976 0.0 0
M  V30 4 C 8.7141 15.4041 0.0 0
M  V30 5 S 3.8987 8.9944 0.0 0 VAL=6
M  V30 6 O 4.8037 7.7484 0.0 0
M  V30 7 O 2.9935 10.2403 0.0 0
M  V30 8 F 12.1343 10.6695 0.0 0
M  V30 9 N 12.1343 5.3347 0.0 0
M  V30 10 C 11.3643 4.0011 0.0 0
M  V30 11 O 12.1343 2.6674 0.0 0
M  V30 12 O 9.8243 4.0011 0.0 0
M  V30 13 C 11.3643 1.3338 0.0 0
M  V30 14 C 10.0307 2.1038 0.0 0
M  V30 15 C 10.5943 0.0000 0.0 0
M  V30 16 C 12.6980 0.5638 0.0 0
M  V30 17 C 18.2944 5.3347 0.0 0
M  V30 18 C 6.6091 11.9155 0.0 0
M  V30 19 C 5.1446 11.4395 0.0 0
M  V30 20 C 7.5143 10.6695 0.0 0
M  V30 21 C 6.9293 13.4218 0.0 0
M  V30 22 N 5.1446 9.8995 0.0 0
M  V30 23 N 4.0000 12.4701 0.0 0
M  V30 24 C 6.6091 9.4236 0.0 0
M  V30 25 N 5.7849 14.4522 0.0 0
M  V30 26 C 4.3202 13.9763 0.0 0
M  V30 27 C 9.8243 9.3358 0.0 0
M  V30 28 C 11.3643 9.3358 0.0 0
M  V30 29 C 9.0543 8.0022 0.0 0
M  V30 30 N 12.1343 8.0022 0.0 0
M  V30 31 C 9.8243 6.6685 0.0 0
M  V30 32 C 11.3643 6.6685 0.0 0
M  V30 33 C 2.6527 8.0892 0.0 0
M  V30 34 C 2.8137 6.5575 0.0 0
M  V30 35 C 1.2459 8.7155 0.0 0
M  V30 36 C 1.5679 5.6524 0.0 0
M  V30 37 C 0.0000 7.8103 0.0 0
M  V30 38 C 0.1609 6.2788 0.0 0
M  V30 39 C 13.6743 5.3347 0.0 0
M  V30 40 C 14.4443 4.0011 0.0 0
M  V30 41 C 14.4443 6.6685 0.0 0
M  V30 42 C 15.9844 4.0011 0.0 0
M  V30 43 N 15.9844 6.6685 0.0 0
M  V30 44 C 16.7544 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 20
M  V30 3 1 1 27
M  V30 4 1 3 4
M  V30 5 1 3 21
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 22
M  V30 9 1 5 33
M  V30 10 1 8 28
M  V30 11 1 9 10
M  V30 12 1 9 32
M  V30 13 1 9 39
M  V30 14 1 10 11
M  V30 15 2 10 12
M  V30 16 1 11 13
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 1 13 16
M  V30 20 1 17 44
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 2 19 23
M  V30 26 2 20 24
M  V30 27 1 21 25
M  V30 28 1 22 24
M  V30 29 1 23 26
M  V30 30 2 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 2 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 2 35 37
M  V30 41 2 36 38
M  V30 42 1 37 38
M  V30 43 1 39 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1344667-02-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1344667-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-215116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2-Preparation of tert-butyl
N-[5-[[7-(benzenesulfonyl)-4-methylamino-pyrrolo[2,
3-d]pyrimidin-5-yl]-hydroxy-methyl]-6-fluoro-2-pyridyl]-N-(6-methyl-3-pyridyl)carbamate
86 [0714] To tert-butyl
N-[5-[[7-(benzenesulfonyl)-4-chloro-pyrrolo[2,3-d]pyrimidin-5-yl]-hydroxymethyl]-6-fluoro-2-pyridyl]-N-(6-methyl-3-pyridyl)carbamate
(85, 75 mg, 0.12 mmol) in Isopropyl alcohol (0.80 mL) was added 2M
methylamine in THF (0.6 ml). The resulting solution was stirred at 40 °C
for 6 hours. The reaction was concentrated to give product. (86, 70 mg,
94.2%). MS (ESI) [M+H+]+ = 620.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrrolopyrimidines and pyrrolopyridines as protein kinase modulators
useful in the treatment of protein kinase-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Jiazhong; Ibrahim, Prabha N.; Spevak, Wayne; Tsai, James; Ewing,
Todd; Zhang, Ying; Zhang, Chao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011133637 A2 2011-10-27

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-[(4aS,5S)-1-(4-Fluorophenyl)-1,4,4a,5,6,7-hexahydro-5-hydroxy-4a-methylc...
C26H25FN2O3
1352240-33-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.0694 6.9008 0.0 0
M  V30 2 C 12.2105 5.3348 0.0 0
M  V30 3 C 12.9805 4.0011 0.0 0
M  V30 4 O 10.8315 6.8663 0.0 0
M  V30 5 C 17.6005 1.3337 0.0 0
M  V30 6 O 19.1405 1.3337 0.0 0
M  V30 7 O 16.8305 0.0000 0.0 0
M  V30 8 F 0.0000 1.8533 0.0 0
M  V30 9 C 9.1642 5.6549 0.0 0 CFG=1
M  V30 10 C 8.3942 4.3213 0.0 0
M  V30 11 C 10.6705 5.3348 0.0 0 CFG=2
M  V30 12 C 8.3942 6.9886 0.0 0
M  V30 13 C 6.8541 4.3213 0.0 0
M  V30 14 C 9.4246 3.1769 0.0 0
M  V30 15 C 10.8315 3.8032 0.0 0
M  V30 16 C 6.8541 6.9886 0.0 0
M  V30 17 C 6.0841 5.6549 0.0 0
M  V30 18 C 5.8237 8.1331 0.0 0
M  V30 19 N 4.5777 5.9751 0.0 0
M  V30 20 N 4.4168 7.5068 0.0 0
M  V30 21 C 14.5205 4.0011 0.0 0
M  V30 22 C 15.2905 2.6675 0.0 0
M  V30 23 C 15.2905 5.3348 0.0 0
M  V30 24 C 16.8305 2.6675 0.0 0
M  V30 25 C 16.8305 5.3348 0.0 0
M  V30 26 C 17.6005 4.0011 0.0 0
M  V30 27 C 3.4333 4.9447 0.0 0
M  V30 28 C 1.9686 5.4205 0.0 0
M  V30 29 C 3.7535 3.4384 0.0 0
M  V30 30 C 0.8242 4.3901 0.0 0
M  V30 31 C 2.6091 2.4078 0.0 0
M  V30 32 C 1.1444 2.8837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 9 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 11 2 CFG=3
M  V30 4 1 3 21
M  V30 5 1 11 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 8 32
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 19 27
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
3-[2-[(4aS,5S)-1-(4-Fluorophenyl)-1,4,4a,5,6,7-hexahydro-5-hydroxy-4a-methylc...
C27H28FN3O2
1352240-38-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.0694 6.9008 0.0 0
M  V30 2 C 12.2105 5.3348 0.0 0
M  V30 3 C 12.9805 4.0011 0.0 0
M  V30 4 O 10.8316 6.8663 0.0 0
M  V30 5 C 17.6006 1.3337 0.0 0
M  V30 6 N 19.1406 1.3337 0.0 0
M  V30 7 O 16.8306 0.0000 0.0 0
M  V30 8 C 19.9106 0.0000 0.0 0
M  V30 9 F 0.0000 1.8533 0.0 0
M  V30 10 C 9.1642 5.6550 0.0 0 CFG=1
M  V30 11 C 8.3942 4.3213 0.0 0
M  V30 12 C 10.6705 5.3348 0.0 0 CFG=2
M  V30 13 C 8.3942 6.9886 0.0 0
M  V30 14 C 6.8542 4.3213 0.0 0
M  V30 15 C 9.4246 3.1769 0.0 0
M  V30 16 C 10.8316 3.8032 0.0 0
M  V30 17 C 6.8542 6.9886 0.0 0
M  V30 18 C 6.0842 5.6550 0.0 0
M  V30 19 C 5.8237 8.1332 0.0 0
M  V30 20 N 4.5777 5.9751 0.0 0
M  V30 21 N 4.4168 7.5068 0.0 0
M  V30 22 C 14.5206 4.0011 0.0 0
M  V30 23 C 15.2906 2.6675 0.0 0
M  V30 24 C 15.2906 5.3348 0.0 0
M  V30 25 C 16.8306 2.6675 0.0 0
M  V30 26 C 16.8306 5.3348 0.0 0
M  V30 27 C 17.6006 4.0011 0.0 0
M  V30 28 C 3.4333 4.9447 0.0 0
M  V30 29 C 3.7535 3.4384 0.0 0
M  V30 30 C 1.9686 5.4206 0.0 0
M  V30 31 C 2.6091 2.4078 0.0 0
M  V30 32 C 0.8242 4.3901 0.0 0
M  V30 33 C 1.1444 2.8837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 12 2 CFG=3
M  V30 4 1 3 22
M  V30 5 1 12 4 CFG=1
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 25
M  V30 9 1 6 8
M  V30 10 1 9 33
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 20 28
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1352240-33-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1352240-38-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13535593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of selective glucocorticoid receptor modulator MK-5932
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bungard, Christopher J.; Hartman, George D.; Manikowski, Jesse J.;
Perkins, James J.; Bai, Chang; Brandish, Philip E.; Euler, Danielle H.;
Hershey, James C.; Schmidt, Azriel; Fang, Yulin; Norcross, Ryan T.;
Rushmore, Tom H.; Thompson, Charles D.; Meissner, Robert S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2011), 19(24), 7374-7386

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,6-dimethoxybenzaldehyde
C9H9BrO3
1354050-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 6.1601 0.0 0
M  V30 2 O 2.6675 6.9302 0.0 0
M  V30 3 O 6.6687 4.6201 0.0 0
M  V30 4 C 8.0023 3.8501 0.0 0
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 Br 4.0012 0.0000 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,6-dimethoxy-N-methylbenzenemethanamine
C10H14BrNO2
2229205-74-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 N 6.9301 5.3348 0.0 0
M  V30 3 C 8.4701 5.3348 0.0 0
M  V30 4 O 4.6201 6.6686 0.0 0
M  V30 5 C 3.8500 8.0022 0.0 0
M  V30 6 O 4.6201 1.3337 0.0 0
M  V30 7 C 3.8500 0.0000 0.0 0
M  V30 8 Br 0.0000 4.0011 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 3.8500 5.3348 0.0 0
M  V30 11 C 3.8500 2.6675 0.0 0
M  V30 12 C 2.3100 5.3348 0.0 0
M  V30 13 C 2.3100 2.6675 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 6 7
M  V30 7 1 6 11
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1354050-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2229205-74-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21815646
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 16940-66-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of dioxopiperidinyl dioxoisoindoline derivatives as BRD9 or
MTH1 degraders for the treatment of BRD9- and MTH1-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nasveschuk, Christopher G.; Henderson, James A.; Vora, Harit U.; Veits,
Gesine Kerstin; Philips, Andrew J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020051235 A1 2020-03-12

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-(acetyloxy)-3-bromo-2-(bromomethyl)-4-methoxybenzoate
C12H12Br2O5
1360546-66-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 O 5.3348 1.5400 0.0 0
M  V30 3 O 2.6675 1.5400 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 Br 0.0000 4.6201 0.0 0
M  V30 7 Br 1.3337 6.9302 0.0 0
M  V30 8 O 6.6685 6.9302 0.0 0
M  V30 9 C 8.0023 6.1601 0.0 0
M  V30 10 C 9.3360 6.9302 0.0 0
M  V30 11 O 8.0023 4.6201 0.0 0
M  V30 12 O 4.0012 8.4702 0.0 0
M  V30 13 C 2.6675 9.2402 0.0 0
M  V30 14 C 4.0012 3.8501 0.0 0
M  V30 15 C 2.6675 4.6201 0.0 0
M  V30 16 C 5.3348 4.6201 0.0 0
M  V30 17 C 2.6675 6.1601 0.0 0
M  V30 18 C 5.3348 6.1601 0.0 0
M  V30 19 C 4.0012 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 15
M  V30 7 1 7 17
M  V30 8 1 8 9
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 12 13
M  V30 13 1 12 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2,3-dihydro-6-hydroxy-5-methoxy-2-methyl-1H-isoindol-1-one
C10H10BrNO3
1360546-57-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.0011 0.0000 0.0 0
M  V30 2 O 7.2753 5.7904 0.0 0
M  V30 3 O 1.3338 1.5400 0.0 0
M  V30 4 C 0.0000 2.3100 0.0 0
M  V30 5 C 9.2446 3.0800 0.0 0
M  V30 6 O 1.3338 4.6200 0.0 0
M  V30 7 C 5.3347 2.3100 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 6.7994 1.8340 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 6.7994 4.3259 0.0 0
M  V30 13 C 2.6674 2.3100 0.0 0
M  V30 14 N 7.7046 3.0800 0.0 0
M  V30 15 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 14
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 10
M  V30 10 2 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1360546-66-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360546-57-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9782504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and practical total synthesis of sauristolactam
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heo, Jung-Nyoung; Kim, Tae Jeong; Kim, Joa Kyum
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bulletin of the Korean Chemical Society (2011), 32(12), 4431-4434

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-2,6-Dimethyl-1,5-heptadiene-1-sulfonyl chloride
C9H15ClO2S
1365547-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 4.0012 0.0000 0.0 0
M  V30 5 S 1.3337 1.5400 0.0 0 VAL=6
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 Cl 0.0000 0.7700 0.0 0
M  V30 8 O 2.1037 0.2064 0.0 0
M  V30 9 O 0.5637 2.8737 0.0 0
M  V30 10 C 8.0023 2.3101 0.0 0
M  V30 11 C 9.3360 1.5400 0.0 0
M  V30 12 C 10.6697 2.3101 0.0 0
M  V30 13 C 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 2 10 11
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1E)-N,2,6-Trimethyl-1,5-heptadiene-1-sulfonamide
C10H19NO2S
1365547-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.6673 1.5400 0.0 0 VAL=6
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 N 1.3337 0.7700 0.0 0
M  V30 4 O 1.8973 2.8737 0.0 0
M  V30 5 O 3.4374 0.2064 0.0 0
M  V30 6 C 5.3348 1.5400 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 C 6.6685 2.3101 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 8.0022 1.5400 0.0 0
M  V30 11 C 9.3360 2.3101 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 13 C 12.0033 2.3101 0.0 0
M  V30 14 C 10.6697 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 2 11 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1365547-73-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1365547-10-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5923000
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-14-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: NQ 3060. Under argon atmosphere methylamine (8
M in EtOH, 1 mL, 1 mmol) was added to a solution of
(E)-2,6-dimethylhepta-1,5-diene-1-sulfonyl chloride (240 mg, 1.08 mmol)
and triethylamine (0.15 mL, 1.08 mmol) in CH2Cl2 at 0 °C. The resulting
mixture was stirred for 10 min at 0 °C, and then brine was added. The
organic layer was separated and the aqueous layer was extracted with
CH2Cl2 . The combined organic layers were dried (Na2SO4) and the solvent
was evaporated. The residue was purified by flash chromatography.
compound NQ 3060: (E)-N,2,6-trimethylhepta-1,5-diene-1-sulfonamide, (220
mg, 94%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ (ppm): 1.65 (s,
3H), 1.73 (s, 3H), 2.16 (d, J=l.l, 3H), 2.22-2.24 (m, 4H), 2.76 (d,
J=5.2, 3H), 4.46 (d, br, J=5.0, 1H), 5.08-5.10 (m, 1H), 6.01 (s, 1H); 13C
NMR (125 MHz, CDCl3): 17.29, 17.30, 25.21, 25.23, 28.44, 39.81, 121.47,
121.78, 132.67, 155.61, Chemical Formula: C10H19NO2S, Molecular Weight:
217.328. IC50: C (1-5 mM).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Terpenoid analogues and uses thereof for treating neurological conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reed, Mark A.; Weaver, Donald; Sun, Shengguo; McLellan, Alexander; Lu,
Erhu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012034232 A1 2012-03-22

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-[(1E)-2-(dimethylamino)ethenyl]-2,5-dihydro-5,5-dimethyl-2-oxo-3-fura...
C13H19NO4
1379803-83-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8501 2.6673 0.0 0
M  V30 2 C 2.3100 2.6673 0.0 0
M  V30 3 N 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 6 C 7.1821 3.0175 0.0 0
M  V30 7 O 8.6885 3.3378 0.0 0
M  V30 8 O 6.7062 1.5530 0.0 0
M  V30 9 C 9.7189 2.1933 0.0 0
M  V30 10 C 11.2252 2.5135 0.0 0
M  V30 11 C 2.6599 4.6379 0.0 0
M  V30 12 C 3.0884 6.6538 0.0 0
M  V30 13 O 7.8786 6.2948 0.0 0
M  V30 14 C 4.6201 4.0011 0.0 0
M  V30 15 C 6.1516 4.1621 0.0 0
M  V30 16 C 3.9936 5.4079 0.0 0
M  V30 17 C 6.4718 5.6684 0.0 0
M  V30 18 O 5.1381 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 15
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 11 16
M  V30 12 1 12 16
M  V30 13 2 13 17
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1,5-Trimethylfuro[3,4-c]pyridine-3,4(1H,5H)-dione
C10H11NO3
129748-28-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.1062 0.0000 0.0 0
M  V30 2 O 6.1264 1.3172 0.0 0
M  V30 3 C 1.3791 5.1960 0.0 0
M  V30 4 C 0.0000 3.6643 0.0 0
M  V30 5 C 7.6664 3.9844 0.0 0
M  V30 6 C 3.8164 2.6508 0.0 0
M  V30 7 C 3.0464 3.9844 0.0 0
M  V30 8 C 2.7859 1.5064 0.0 0
M  V30 9 C 5.3564 2.6508 0.0 0
M  V30 10 C 1.5400 3.6643 0.0 0
M  V30 11 C 3.8164 5.3182 0.0 0
M  V30 12 O 1.3791 2.1327 0.0 0
M  V30 13 N 6.1264 3.9844 0.0 0
M  V30 14 C 5.3564 5.3182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 1 4 10
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 12
M  V30 14 2 11 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1379803-83-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 129748-28-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14551958
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Two versatile routes towards Cerpegin and analogues: applications of a
one pot reaction to new analogues of Cerpegin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Villemin, Didier; Cheikh, Nawel; Liao, Liang; Bar, Nathalie; Lohier,
Jean-Francois; Sopkova, Jana; Choukchou-Braham, Noureddine; Mostefa-Kara,
Bachir
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(24), 4906-4918

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S)-1-(4-Bromophenyl)-3-chloropropyl]-1H-indole
C17H15BrClN
1380301-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 4.0011 0.0 0 CFG=1
M  V30 2 C 4.4608 2.6675 0.0 0
M  V30 3 C 5.2308 1.3337 0.0 0
M  V30 4 Cl 4.4608 0.0000 0.0 0
M  V30 5 Br 11.3909 4.0011 0.0 0
M  V30 6 N 4.4608 5.3348 0.0 0
M  V30 7 C 2.9293 5.4957 0.0 0
M  V30 8 C 5.0873 6.7417 0.0 0
M  V30 9 C 2.6091 7.0021 0.0 0
M  V30 10 C 1.7849 4.4653 0.0 0
M  V30 11 C 3.9428 7.7722 0.0 0
M  V30 12 C 1.1444 7.4780 0.0 0
M  V30 13 C 0.3202 4.9411 0.0 0
M  V30 14 C 0.0000 6.4476 0.0 0
M  V30 15 C 6.7708 4.0011 0.0 0
M  V30 16 C 7.5408 2.6675 0.0 0
M  V30 17 C 7.5408 5.3348 0.0 0
M  V30 18 C 9.0809 2.6675 0.0 0
M  V30 19 C 9.0809 5.3348 0.0 0
M  V30 20 C 9.8509 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 6
M  V30 3 1 1 15
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 5 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(γS)-γ-(4-Bromophenyl)-N-methyl-1H-indole-1-propanamine
C18H19BrN2
1380301-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 5.3348 0.0 0 CFG=1
M  V30 2 C 4.4608 4.0011 0.0 0
M  V30 3 C 5.2308 2.6673 0.0 0
M  V30 4 N 4.4608 1.3337 0.0 0
M  V30 5 C 5.2308 0.0000 0.0 0
M  V30 6 Br 11.3909 5.3348 0.0 0
M  V30 7 N 4.4608 6.6684 0.0 0
M  V30 8 C 2.9293 6.8295 0.0 0
M  V30 9 C 5.0873 8.0754 0.0 0
M  V30 10 C 2.6091 8.3358 0.0 0
M  V30 11 C 1.7849 5.7990 0.0 0
M  V30 12 C 3.9428 9.1058 0.0 0
M  V30 13 C 1.1444 8.8117 0.0 0
M  V30 14 C 0.3202 6.2748 0.0 0
M  V30 15 C 0.0000 7.7813 0.0 0
M  V30 16 C 6.7709 5.3348 0.0 0
M  V30 17 C 7.5409 4.0011 0.0 0
M  V30 18 C 7.5409 6.6684 0.0 0
M  V30 19 C 9.0809 4.0011 0.0 0
M  V30 20 C 9.0809 6.6684 0.0 0
M  V30 21 C 9.8509 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 7
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 2 9 12
M  V30 13 1 10 12
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1380301-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380301-69-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11264996
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric N-Allylation of Indoles Through the Iridium-Catalyzed Allylic
Alkylation/Oxidation of Indolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Wen-Bo; Zhang, Xiao; Dai, Li-Xin; You, Shu-Li
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(21), 5183-5187,
S5183/1-S5183/109

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-[(4-chloro-8-methyl-2-quinolinyl)oxy]acetate
C14H14ClNO3
1380598-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0010 0.0000 0.0 0
M  V30 2 C 1.3337 6.1601 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 C 8.0022 3.8501 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 O 10.6697 3.8501 0.0 0
M  V30 7 O 9.3360 6.1601 0.0 0
M  V30 8 C 12.0033 4.6201 0.0 0
M  V30 9 C 13.3370 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 1.3337 1.5400 0.0 0
M  V30 14 N 4.0010 4.6201 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 2 14 18
M  V30 18 2 15 19
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N,8-dimethyl-2-quinolinamine
C11H11ClN2
1380598-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 C 1.3336 6.1600 0.0 0
M  V30 3 N 6.6685 4.6200 0.0 0
M  V30 4 C 8.0021 3.8500 0.0 0
M  V30 5 C 2.6674 2.3100 0.0 0
M  V30 6 C 2.6674 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 C 1.3336 1.5400 0.0 0
M  V30 9 N 4.0011 4.6200 0.0 0
M  V30 10 C 1.3336 4.6200 0.0 0
M  V30 11 C 5.3347 2.3100 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 5.3347 3.8500 0.0 0
M  V30 14 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 10
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1380598-35-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380598-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1741554
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7646-69-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Smiles rearrangement (2nd stage), alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel one pot synthesis of 2-amino-4-chloroquinolines via Smiles
rearrangement
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Devadoss Karthik; Rajendran, Subramaniam Parameswaran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2012), 53(26), 3230-3232

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-(Acetylamino)phenyl]sulfonyl]-2-methylalanine methyl ester
C13H18N2O5S
1401065-80-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 0.0000 2.3100 0.0 0
M  V30 4 O 1.3336 0.0000 0.0 0
M  V30 5 S 5.3347 3.8500 0.0 0 VAL=6
M  V30 6 N 6.6685 3.0800 0.0 0
M  V30 7 O 6.1047 5.1836 0.0 0
M  V30 8 O 4.5647 2.5164 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 8.7721 2.5164 0.0 0
M  V30 11 C 7.2321 5.1836 0.0 0
M  V30 12 C 9.3358 4.6200 0.0 0
M  V30 13 O 10.3121 2.5164 0.0 0
M  V30 14 O 8.0021 1.1826 0.0 0
M  V30 15 C 11.0821 1.1826 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 4.0011 4.6200 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 4.0011 6.1600 0.0 0
M  V30 20 C 1.3336 6.1600 0.0 0
M  V30 21 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 17
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[[2-(Acetylamino)phenyl]sulfonyl]amino]-N,2-dimethylpropanamide
C13H19N3O4S
1401065-81-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.6674 2.3100 0.0 0
M  V30 2 C 1.3336 1.5400 0.0 0
M  V30 3 C 1.3336 0.0000 0.0 0
M  V30 4 O 0.0000 2.3100 0.0 0
M  V30 5 S 5.3347 3.8500 0.0 0 VAL=6
M  V30 6 N 6.6685 3.0800 0.0 0
M  V30 7 O 6.1047 5.1836 0.0 0
M  V30 8 O 4.5647 2.5164 0.0 0
M  V30 9 C 8.0021 3.8500 0.0 0
M  V30 10 C 8.7721 2.5164 0.0 0
M  V30 11 C 9.3358 4.6200 0.0 0
M  V30 12 C 7.2321 5.1836 0.0 0
M  V30 13 N 10.3121 2.5164 0.0 0
M  V30 14 O 8.0021 1.1826 0.0 0
M  V30 15 C 11.0821 1.1826 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 4.0011 4.6200 0.0 0
M  V30 18 C 1.3336 4.6200 0.0 0
M  V30 19 C 4.0011 6.1600 0.0 0
M  V30 20 C 1.3336 6.1600 0.0 0
M  V30 21 C 2.6674 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 17
M  V30 9 1 6 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 13 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 2 18 20
M  V30 20 2 19 21
M  V30 21 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401065-80-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401065-81-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11955062
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereo-retention
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An unusual conformational similarity of two peptide folds featuring
sulfonamide and carboxamide on the backbone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vijayadas, Kuruppanthara N.; Davis, Hilda C.; Kotmale, Amol S.; Gawade,
Rupesh L.; Puranik, Vedavadi G.; Rajamohanan, Pattuparambil R.; Sanjayan,
Gangadhar J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2012), 48(78),
9747-9749

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Iodo-1-[(4-methylphenyl)sulfonyl]-5-[5-(trichloromethyl)-1,2,4-oxadiazol-3-...
C18H11Cl3IN3O3S
1401349-88-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 11.5925 4.0287 0.0 0 VAL=6
M  V30 2 O 12.3625 2.6950 0.0 0
M  V30 3 O 10.8225 5.3623 0.0 0
M  V30 4 I 7.9651 0.0000 0.0 0
M  V30 5 C 16.9272 7.1087 0.0 0
M  V30 6 C 1.1444 7.2359 0.0 0
M  V30 7 Cl 0.0000 6.2055 0.0 0
M  V30 8 Cl 0.1140 8.3805 0.0 0
M  V30 9 Cl 2.2889 8.2665 0.0 0
M  V30 10 C 8.8520 3.8850 0.0 0
M  V30 11 N 10.2588 3.2587 0.0 0
M  V30 12 C 7.8214 2.7406 0.0 0
M  V30 13 C 8.3760 5.3497 0.0 0
M  V30 14 C 10.0979 1.7271 0.0 0
M  V30 15 C 6.3151 3.0608 0.0 0
M  V30 16 C 8.5914 1.4070 0.0 0
M  V30 17 C 6.8697 5.6699 0.0 0
M  V30 18 C 5.8393 4.5255 0.0 0
M  V30 19 C 12.9261 4.7987 0.0 0
M  V30 20 C 14.2599 4.0287 0.0 0
M  V30 21 C 12.9261 6.3387 0.0 0
M  V30 22 C 15.5936 4.7987 0.0 0
M  V30 23 C 14.2599 7.1087 0.0 0
M  V30 24 C 15.5936 6.3387 0.0 0
M  V30 25 C 4.3328 4.8457 0.0 0
M  V30 26 N 3.7065 6.2525 0.0 0
M  V30 27 N 3.1885 3.8151 0.0 0
M  V30 28 C 2.1750 6.0915 0.0 0
M  V30 29 O 1.8546 4.5851 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 19
M  V30 5 1 4 16
M  V30 6 1 5 24
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 2 17 18
M  V30 21 1 18 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[3-Iodo-1-[(4-methylphenyl)sulfonyl]-1H-indol-5-yl]-N-methyl-1,2,4-oxadiazo...
C18H15IN4O3S
1401349-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3347 4.0286 0.0 0 VAL=6
M  V30 2 O 6.1047 5.3623 0.0 0
M  V30 3 O 4.5647 2.6948 0.0 0
M  V30 4 I 8.9620 0.0000 0.0 0
M  V30 5 C 0.0000 7.1086 0.0 0
M  V30 6 N 15.7827 7.2358 0.0 0
M  V30 7 C 17.2890 6.9157 0.0 0
M  V30 8 C 8.0751 3.8850 0.0 0
M  V30 9 N 6.6684 3.2586 0.0 0
M  V30 10 C 9.1057 2.7406 0.0 0
M  V30 11 C 8.5512 5.3497 0.0 0
M  V30 12 C 6.8293 1.7270 0.0 0
M  V30 13 C 10.6120 3.0607 0.0 0
M  V30 14 C 8.3357 1.4068 0.0 0
M  V30 15 C 10.0574 5.6698 0.0 0
M  V30 16 C 11.0878 4.5253 0.0 0
M  V30 17 C 4.0011 4.7986 0.0 0
M  V30 18 C 4.0011 6.3386 0.0 0
M  V30 19 C 2.6673 4.0286 0.0 0
M  V30 20 C 2.6673 7.1086 0.0 0
M  V30 21 C 1.3336 4.7986 0.0 0
M  V30 22 C 1.3336 6.3386 0.0 0
M  V30 23 C 12.5943 4.8455 0.0 0
M  V30 24 N 13.2206 6.2524 0.0 0
M  V30 25 N 13.7386 3.8150 0.0 0
M  V30 26 C 14.7521 6.0915 0.0 0
M  V30 27 O 15.0724 4.5850 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 17
M  V30 5 1 4 14
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 26
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 16 23
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401349-88-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401349-94-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-185-CAS-21225208
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of compound 72a:
3-(3-iodo-1-tosyl-1H-indol-5-yl)-N-methyl-1,2,4-oxadiazol-5-amine.
N-Methylamine (1M in THF) (5 mL) was added to a sealed tube equipped with
magnetic stir bar followed by the addition of
3-(3-iodo-1-tosyl-1H-indol-5-yl)-5-(trichloromethyl)-1,2,4-oxadiazole
(250 mg, 0.43 mmol). The tube was sealed and heated at 90 °C in oil bath
for 12 h. After completion of the reaction, it was cooled to RT. The
mixture was treated with water and extracted with EtOAc (2 × 20mL). The
organic layer was dried over anhydrous Na2SO4, and concentrated in vacuo.
The residue was purified with basic alumina column chromatography
(eluent: 40% EtOAc in petroleum ether). Yield: (200 mg, 94.3%) as an off
white solid. MS (ESI, pos. ion) m/z 495.0 (M+1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Indoles and related compounds as PIM kinase inhibitors and their
preparation and use for the treatment of PIM kinase-related diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Hui-Ling; Cee, Victor C.; Herberich, Bradley J.; Jackson, Claire L.
M.; Lanman, Brian Alan; Nixey, Thomas; Pettus, Liping H.; Reed, Anthony
B.; Wu, Bin; Wurz, Ryan; Tasker, Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012129338 A1 2012-09-27

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2H-Thiopyran-2-carbothioic acid, 3,6-dihydro-2,4,5-trimethyl-, S-phenyl ester...
C15H18O2S2
1401823-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 2.8619 0.0 0
M  V30 2 S 4.0011 2.0919 0.0 0
M  V30 3 O 5.3347 4.4019 0.0 0
M  V30 4 C 5.6786 0.9123 0.0 0
M  V30 5 O 6.2053 4.7189 0.0 0
M  V30 6 C 10.1648 0.0000 0.0 0
M  V30 7 C 11.2183 2.8943 0.0 0
M  V30 8 C 6.6685 2.0919 0.0 0 CFG=1
M  V30 9 S 7.1952 3.5391 0.0 0 CFG=3 VAL=4
M  V30 10 C 7.6583 0.9123 0.0 0
M  V30 11 C 8.7118 3.8066 0.0 0
M  V30 12 C 9.1749 1.1796 0.0 0
M  V30 13 C 9.7017 2.6268 0.0 0
M  V30 14 C 2.6674 2.8619 0.0 0
M  V30 15 C 2.6674 4.4019 0.0 0
M  V30 16 C 1.3338 2.0919 0.0 0
M  V30 17 C 1.3338 5.1719 0.0 0
M  V30 18 C 0.0000 2.8619 0.0 0
M  V30 19 C 0.0000 4.4019 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 8 1 CFG=3
M  V30 4 1 2 14
M  V30 5 1 8 4 CFG=1
M  V30 6 2 5 9
M  V30 7 1 6 12
M  V30 8 1 7 13
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2H-Thiopyran-2-carboxamide, 3,6-dihydro-N,2,4,5-tetramethyl-, 1-oxide, (2R)-
C10H17NO2S
1401871-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7998 3.6573 0.0 0
M  V30 2 N 7.2468 3.1307 0.0 0
M  V30 3 O 5.5323 5.1739 0.0 0
M  V30 4 C 8.4266 4.1206 0.0 0
M  V30 5 C 5.7998 1.6775 0.0 0
M  V30 6 O 4.6200 5.3349 0.0 0
M  V30 7 C 1.5400 0.0000 0.0 0
M  V30 8 C 0.0000 2.6674 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0 CFG=1
M  V30 10 S 3.8500 4.0011 0.0 0 CFG=3 VAL=4
M  V30 11 C 3.8500 1.3338 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 2.3100 1.3338 0.0 0
M  V30 14 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 9 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 9 5 CFG=3
M  V30 6 2 6 10
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1401823-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1401871-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4783755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl-(2,4,5-trimethyl)-1-oxo-3,6-dihydro-2H-thiopyran-2-carboxamide
(6j): General procedure for synthesis of carboxamides. A solution of
amine (2.1 mmol) in dichloromethane (5 mL) was added to a solution of
thiolo ester 5 (2.0 mmol) in 5 mL of dichloromethane at room temperature.
The reaction was monitored by TLC (heptane: ethyl acetate = 1:1 or pure
ethyl acetate). After completion of the reaction the dichloromethane was
removed in vacuo and the crude product was chromatographed over silica
gel. To a solution of 5d (2.0 mmol) in 10 mL tetrahydrofuran was added a
40 % aqueous solution of methylamine in 0.25 mL portions with 10 min
intervals. The reaction was monitored by TLC (heptane: ethyl acetate =
1:1). Upon completion of the reaction the solvent was evaporated and the
product was chromatographed over a short path of silica gel
(heptane:ethyl acetate= 1:1) yielding 202 mg (94 %) 6j as colorless oil
that crystallised upon standing. Crystallization from di-i-propylether
gave small transparant platelets. mp 87-88 degC.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Sulfine-Based Synthesis of Four-, Five- and Six Membered Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lucassen, Andreas Christianus Bernadus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2003), (20121004), No pp.

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
6-(4-Fluorophenyl)-4-(methylthio)-2-oxo-2H-pyran-3-carboxylic acid
C13H9FO4S
1403495-70-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0012 0.0 0
M  V30 2 O 0.0000 2.6675 0.0 0
M  V30 3 O 0.0000 5.3348 0.0 0
M  V30 4 S 2.3101 1.3338 0.0 0
M  V30 5 C 3.0801 0.0000 0.0 0
M  V30 6 O 2.3101 6.6687 0.0 0
M  V30 7 F 11.5503 4.0012 0.0 0
M  V30 8 C 2.3101 4.0012 0.0 0
M  V30 9 C 3.0801 2.6675 0.0 0
M  V30 10 C 3.0801 5.3348 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 O 4.6201 5.3348 0.0 0
M  V30 13 C 5.3901 4.0012 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 7.7002 5.3348 0.0 0
M  V30 16 C 7.7002 2.6675 0.0 0
M  V30 17 C 9.2402 5.3348 0.0 0
M  V30 18 C 9.2402 2.6675 0.0 0
M  V30 19 C 10.0102 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 10
M  V30 7 1 7 19
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Fluorophenyl)-N-methyl-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
C14H12FNO3S
1512808-15-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 4.0012 0.0 0
M  V30 2 N 1.5400 5.3348 0.0 0
M  V30 3 O 1.5400 2.6675 0.0 0
M  V30 4 C 0.0000 5.3348 0.0 0
M  V30 5 S 3.8501 1.3338 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 O 3.8501 6.6687 0.0 0
M  V30 8 F 13.0903 4.0012 0.0 0
M  V30 9 C 3.8501 4.0012 0.0 0
M  V30 10 C 4.6201 2.6675 0.0 0
M  V30 11 C 4.6201 5.3348 0.0 0
M  V30 12 C 6.1601 2.6675 0.0 0
M  V30 13 O 6.1601 5.3348 0.0 0
M  V30 14 C 6.9302 4.0012 0.0 0
M  V30 15 C 8.4702 4.0012 0.0 0
M  V30 16 C 9.2402 5.3348 0.0 0
M  V30 17 C 9.2402 2.6675 0.0 0
M  V30 18 C 10.7802 5.3348 0.0 0
M  V30 19 C 10.7802 2.6675 0.0 0
M  V30 20 C 11.5503 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 2 7 11
M  V30 8 1 8 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1403495-70-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1512808-15-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9963246
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General method for the preparation of
substituted 4-(methylthio)-2-oxo-6-phenyl-2H-pyran-3-carboxamides (11) To
a stirring solution of appropriately substituted 10 (0.76 mmoles) in DMF
at rt, HATU (0.83 mmoles) and diisopropylethylamine (2.29 mmoles) was
added. Appropriately substituted amine (0.76 mmoles) was added after 15
min and stirring continued for another 1h at rt. The reaction was
monitored by TLC and then poured into ice water with stirring. The so
formed precipitate was filtered off and recrystallized from a mixture of
ethyl acetate and n-hexane to get pure compound.
6-(4-fluorophenyl)-4-(methylthio)-2-oxo-N-phenyl-2H-pyran-3-carboxamide
6-(4-fluorophenyl)-N-methyl-4-(methylthio)-2-oxo-2H-pyran-3-carboxamide
Yellow powder; Yield 94 %. mp 210-211°C; Mass [M++1] = 294.0; 1H NMR:
(400 MHz, DMSO-d6): δ 2.59 (s, 3H, Me), 2.75-2.76 (d, J = 4.4 Hz, 3H,
Me), 7.12 (s, 1H, Pyrone), 7.39-7.44 (t, J = 17.2 Hz, 2H, ArH), 8.06-8.09
(t, J = 13.6 Hz, 2H, ArH), 8.65-8.66 (q, J = 4.0 Hz, 1H, NH amide).
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Anti-HCV Activity of 4-Hydroxyamino α-Pyranone Carboxamide
Analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Konreddy, Ananda Kumar; Toyama, Massaki; Ito, Wataru; Bal, Chandralata;
Baba, Masanori; Sharon, Ashoke
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(3), 259-263

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (4-hydroxyphenyl)acetate
C9H10O3
14199-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-N-methylbenzeneacetamide
C9H11NO2
29121-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14199-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29121-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8091076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl 4-hydroxyphenylacetamide. Monomethylamine, (22.43 kg, 722.15
mol, 6 eq.) was added over a 7-hour period to a solution of
methyl-4-hydroxyphenylacetate (20.0 kg, 120.35 mol, 1.0 eq.) in methanol
(31.7 gal, 120 L) and stirred overnight at room temperature. Methanol was
then displaced under vacuum with ethyl acetate. The resulting slurry
(about 20 gal, 75.7 L) was stirred at +10°C. for 1 hour, then filtered
and dried under vacuum at 45°C. to yield the title compound. Yield 18.68
kg, 94% of theory. mp 124-125°C. NMR (300 MHz, d6-DMSO): δ =9.26 (s, 1H),
8.00-7.65 (br s, 1H), 7.21-6.90 (m, 2H), 6.86-6.55 (m, 2H), 3.26 (s, 2H),
2.75-2.45 (m, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combination of β3 agonists and growth hormone secretagogues for treatment
of diabetes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dow, Robert L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6657063 B1 2003-12-02

$RFMT $RIREG SCHEME376 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (4-hydroxyphenyl)acetate
C9H10O3
14199-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 O 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-N-methylbenzeneacetamide
C9H11NO2
29121-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6684 2.3100 0.0 0
M  V30 3 N 8.0022 3.0800 0.0 0
M  V30 4 O 6.6684 0.7700 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 O 0.0000 0.0000 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 3.0800 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 0.0000 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14199-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29121-34-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1911808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-Methyl 4-hydroxyphenylacetamide. Monomethylamine (22.43 kg, 722.15 mol,
6 eq.) was added over a 7-hour period to a solution of methyl-
4-hydroxyphenylacetate (20.0 kg, 120.35 mol, 1.0 eq.) in methanol (120 L)
and stirred overnight at room temperature. Methanol was then displaced
under vacuum with ethyl acetate. The resulting slurry (about 75.7 L) was
stirred at +10°C for 1 hour, then filtered and dried under vacuum at 45°C
to yield of the title compound (18.68 kg, 94% of theory), N-Methyl
4-hydroxyphenylacetamide, yield 18.68 kg, 94%. mp 124-125 °C. NMR (300
MHz, d6-DMSO): δ = 9.26 (s, 1H), 8.00-7.65 (br s, 1H), 7.21-6.90 (m, 2H),
6.86-6.55 (m, 2H), 3.26 (s, 2H), 2.75-2.45 (m, 3H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 2-aminopyridines as drug intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Devries, Keith Michael; Raggon, Jeffrey William; Shanker, Ravi Mysore;
Vanderplas, Brian Clement; Urban, Frank John
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP994105 A2 2000-04-19

$RFMT $RIREG SCHEME377 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Propanediol, 1-(2-nitrophenyl)-, 3-(4-methylbenzenesulfonate)
C16H17NO6S
1424832-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.0012 0.0 0
M  V30 2 C 6.1601 4.0012 0.0 0
M  V30 3 O 3.8501 5.3348 0.0 0
M  V30 4 C 6.9302 5.3348 0.0 0
M  V30 5 O 8.4702 5.3348 0.0 0
M  V30 6 S 9.2402 6.6687 0.0 0 VAL=6
M  V30 7 O 10.0102 8.0023 0.0 0
M  V30 8 O 7.9065 7.4387 0.0 0
M  V30 9 N 1.5400 4.0012 0.0 0 VAL=5
M  V30 10 O 0.0000 4.0012 0.0 0
M  V30 11 O 2.3101 5.3348 0.0 0
M  V30 12 C 14.5752 3.5886 0.0 0
M  V30 13 C 3.8501 2.6675 0.0 0
M  V30 14 C 2.3101 2.6675 0.0 0
M  V30 15 C 4.6201 1.3337 0.0 0
M  V30 16 C 1.5400 1.3337 0.0 0
M  V30 17 C 3.8501 0.0000 0.0 0
M  V30 18 C 2.3101 0.0000 0.0 0
M  V30 19 C 10.5740 5.8986 0.0 0
M  V30 20 C 11.9077 6.6687 0.0 0
M  V30 21 C 10.5740 4.3586 0.0 0
M  V30 22 C 13.2414 5.8986 0.0 0
M  V30 23 C 11.9077 3.5886 0.0 0
M  V30 24 C 13.2414 4.3586 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 19
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 14
M  V30 13 1 12 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trityl chloride
C19H15Cl
76-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 4.6201 0.0 0
M  V30 2 Cl 4.6201 6.1601 0.0 0
M  V30 3 C 3.0801 4.6201 0.0 0
M  V30 4 C 2.3101 5.9538 0.0 0
M  V30 5 C 2.3101 3.2864 0.0 0
M  V30 6 C 0.7700 5.9538 0.0 0
M  V30 7 C 0.7700 3.2864 0.0 0
M  V30 8 C 0.0000 4.6201 0.0 0
M  V30 9 C 4.6201 3.0801 0.0 0
M  V30 10 C 5.9538 2.3101 0.0 0
M  V30 11 C 3.2864 2.3101 0.0 0
M  V30 12 C 5.9538 0.7700 0.0 0
M  V30 13 C 3.2864 0.7700 0.0 0
M  V30 14 C 4.6201 0.0000 0.0 0
M  V30 15 C 6.1601 4.6201 0.0 0
M  V30 16 C 6.9302 5.9538 0.0 0
M  V30 17 C 6.9302 3.2864 0.0 0
M  V30 18 C 8.4702 5.9538 0.0 0
M  V30 19 C 8.4702 3.2864 0.0 0
M  V30 20 C 9.2402 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 2 3 4
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-[2-[Methyl(triphenylmethyl)amino]ethyl]-2-nitrobenzenemethanol
C29H28N2O3
1424832-40-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 N 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9538 0.0 0
M  V30 4 C 6.9300 3.2864 0.0 0
M  V30 5 C 8.4700 5.9538 0.0 0
M  V30 6 C 9.2400 7.2874 0.0 0
M  V30 7 O 8.4700 8.6211 0.0 0
M  V30 8 N 10.7800 9.9547 0.0 0 VAL=5
M  V30 9 O 9.2400 9.9547 0.0 0
M  V30 10 O 11.5500 11.2885 0.0 0
M  V30 11 C 4.6200 6.1600 0.0 0
M  V30 12 C 5.9536 6.9300 0.0 0
M  V30 13 C 3.2864 6.9300 0.0 0
M  V30 14 C 5.9536 8.4700 0.0 0
M  V30 15 C 3.2864 8.4700 0.0 0
M  V30 16 C 4.6200 9.2400 0.0 0
M  V30 17 C 3.0800 4.6200 0.0 0
M  V30 18 C 2.3100 3.2864 0.0 0
M  V30 19 C 2.3100 5.9538 0.0 0
M  V30 20 C 0.7700 3.2864 0.0 0
M  V30 21 C 0.7700 5.9538 0.0 0
M  V30 22 C 0.0000 4.6200 0.0 0
M  V30 23 C 4.6200 3.0800 0.0 0
M  V30 24 C 3.2864 2.3100 0.0 0
M  V30 25 C 5.9536 2.3100 0.0 0
M  V30 26 C 3.2864 0.7700 0.0 0
M  V30 27 C 5.9536 0.7700 0.0 0
M  V30 28 C 4.6200 0.0000 0.0 0
M  V30 29 C 10.7800 7.2874 0.0 0
M  V30 30 C 11.5500 8.6211 0.0 0
M  V30 31 C 11.5500 5.9538 0.0 0
M  V30 32 C 13.0900 8.6211 0.0 0
M  V30 33 C 13.0900 5.9538 0.0 0
M  V30 34 C 13.8600 7.2874 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 1 23
M  V30 5 1 2 3
M  V30 6 1 2 4
M  V30 7 1 3 5
M  V30 8 1 5 6
M  V30 9 1 6 7
M  V30 10 1 6 29
M  V30 11 2 8 9
M  V30 12 2 8 10
M  V30 13 1 8 30
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1424832-36-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-83-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1424832-40-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5982400
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 1-(2-nitrophenyl)-3-(N-methyl-N-tritylamino) propanol (6): A
solution of 3-(2-nitrophenyl)-3-hydroxy-propyl toluene-4-sulfonate (4)
(2.4 g, 6.83 mmol) and methylamine (40 ml of 2.0M solution in THF, 80
mmol) was stirred at room temperature for 3 days. The solvent was removed
in vacuo, co-evaporated twice with triethylamine. The crude amine 5 was
then dissolved in acetonitrile (50 ml). To the mixture was added
triethylamine (3.8 ml, 27.3 mmol), followed by tritylchloride (2 g, 7.17
mmol). The mixture was kept at room temperature for 30 min. The reaction
mixture was diluted with ethyl acetate (200 ml) and washed with sodium
bicarbonate solution and brine (100 ml each). After drying over anhydrous
sodium sulfate, the solvent was evaporated to give a residue which was
chromatographed to give product. Yellowish oil, yield 2.90 g, 94%. 1H NMR
(400 MHz, CDCl3), δ = 1.96-2.02 (2H, m), 2.11-2.16 (1H, m), 2.21 (3H, s),
3.20 (1H, m), 5.62 (1H, dd, J= 2.48, 8.98 Hz), 6.15 (1H, br-s), 7.21 (3H,
dd, J= 7.29, 7.30 Hz), 7.32 (6H, dd, J=7.33, 8.14 Hz), 7.44 (1H, ddd, J=
1.11, 8.36, 8.36 Hz), 7.52 (6H, d, J= 7.61 Hz), 7.70 (1H, ddd, J=1.20,
8.32, 8.32 Hz), 7.95 (1H, dd, J=1.30, 8.29 Hz), 8.05 (1H, dd, J= 0.78,
7.98 Hz).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photocleavable morpholino oligos with integral photolinkers for
modulating the activity of any selected gene transcript by exposure to
light
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yong-Fu; Summerton, James E.; Morcos, Paul A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20130053556 A1 2013-02-28

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Tetrahydro-2H-pyran-2-yl)-1H-benzimidazole-5-carboxaldehyde
C13H14N2O2
1425932-92-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8797 2.4780 0.0 0
M  V30 2 O 10.6497 3.8118 0.0 0
M  V30 3 C 5.2597 2.4780 0.0 0
M  V30 4 N 3.7534 2.1578 0.0 0
M  V30 5 C 6.0297 1.1444 0.0 0
M  V30 6 C 6.0297 3.8118 0.0 0
M  V30 7 C 3.5925 0.6263 0.0 0
M  V30 8 N 4.9993 0.0000 0.0 0
M  V30 9 C 7.5697 1.1444 0.0 0
M  V30 10 C 7.5697 3.8118 0.0 0
M  V30 11 C 8.3397 2.4780 0.0 0
M  V30 12 C 2.6091 3.1884 0.0 0
M  V30 13 C 1.1444 2.7124 0.0 0
M  V30 14 O 2.9292 4.6947 0.0 0
M  V30 15 C 0.0000 3.7430 0.0 0
M  V30 16 C 1.7847 5.7251 0.0 0
M  V30 17 C 0.3202 5.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 12
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[1-(Tetrahydro-2H-pyran-2-yl)-1H-benzimidazol-5-yl]methylene]methanamine
C14H17N3O
1425932-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.8797 2.4780 0.0 0
M  V30 2 N 10.6497 3.8118 0.0 0
M  V30 3 C 12.1897 3.8118 0.0 0
M  V30 4 C 5.2597 2.4780 0.0 0
M  V30 5 N 3.7534 2.1578 0.0 0
M  V30 6 C 6.0297 1.1444 0.0 0
M  V30 7 C 6.0297 3.8118 0.0 0
M  V30 8 C 3.5925 0.6263 0.0 0
M  V30 9 C 7.5697 1.1444 0.0 0
M  V30 10 N 4.9993 0.0000 0.0 0
M  V30 11 C 7.5697 3.8118 0.0 0
M  V30 12 C 8.3397 2.4780 0.0 0
M  V30 13 C 2.6091 3.1884 0.0 0
M  V30 14 C 1.1444 2.7124 0.0 0
M  V30 15 O 2.9292 4.6947 0.0 0
M  V30 16 C 0.0000 3.7430 0.0 0
M  V30 17 C 1.7847 5.7251 0.0 0
M  V30 18 C 0.3202 5.2492 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 2 8 10
M  V30 13 1 9 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1425932-92-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1425932-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12445662
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM step 2: To a solution of 64 (1.0 g, 4.34 mmol) in MeOH (10 mL) at 0 °C
was added a solution of MeNH2 in EtOH (33%, 2 mL). After stirring at RT
for 2 h, the mixture was concentrated under reduced pressure to afford
N-((1-(tetrahydro-2H-pyran-2-yl)-1H-benzo[d]imidazol-5-yl)methylene)-methanamine
(66). Yellow oil, yield 1.0 g (94%). MS (ESI) m/z= 244.2 [M+1]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzoimidazolylmethylpyrimidinediamine derivatives and
analogs for use as serine/threonine PAK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aliagas-Martin, Ignacio; Crawford, James; Lee, Wendy; Mathieu, Simon;
Rudolph, Joachim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013026914 A1 2013-02-28

$RFMT $RIREG SCHEME379 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-2-oxo-2H-1-benzopyran-7-yl 4-methoxybenzenesulfonate
C17H13ClO6S
1427203-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.3348 0.0 0
M  V30 2 Cl 0.0000 5.3348 0.0 0
M  V30 3 O 8.4702 4.0012 0.0 0
M  V30 4 S 9.2402 5.3348 0.0 0 VAL=6
M  V30 5 O 10.0102 6.6687 0.0 0
M  V30 6 O 7.9065 6.1048 0.0 0
M  V30 7 O 1.5400 0.0000 0.0 0
M  V30 8 O 14.5750 2.2548 0.0 0
M  V30 9 C 15.9089 3.0248 0.0 0
M  V30 10 C 3.8501 4.0012 0.0 0
M  V30 11 C 4.6201 2.6675 0.0 0
M  V30 12 C 2.3101 4.0012 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 6.1601 2.6675 0.0 0
M  V30 15 O 3.8501 1.3338 0.0 0
M  V30 16 C 1.5400 2.6675 0.0 0
M  V30 17 C 6.1601 5.3348 0.0 0
M  V30 18 C 6.9302 4.0012 0.0 0
M  V30 19 C 2.3101 1.3338 0.0 0
M  V30 20 C 10.5740 4.5648 0.0 0
M  V30 21 C 10.5740 3.0248 0.0 0
M  V30 22 C 11.9077 5.3348 0.0 0
M  V30 23 C 11.9077 2.2548 0.0 0
M  V30 24 C 13.2414 4.5648 0.0 0
M  V30 25 C 13.2414 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 20
M  V30 8 2 7 19
M  V30 9 1 8 9
M  V30 10 1 8 25
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 19
M  V30 21 2 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3E)-2,3-Dihydro-3-[2-(methylamino)-2-oxoethylidene]-6-benzofuranyl 4-methoxy...
C18H17NO6S
1427203-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.2890 2.5367 0.0 0
M  V30 2 C 2.6091 1.0304 0.0 0
M  V30 3 N 1.4647 0.0000 0.0 0
M  V30 4 O 4.0739 0.5546 0.0 0
M  V30 5 C 0.0000 0.4759 0.0 0
M  V30 6 O 9.5599 3.2472 0.0 0
M  V30 7 S 10.3299 1.9133 0.0 0 VAL=6
M  V30 8 O 11.0999 0.5797 0.0 0
M  V30 9 O 8.9963 1.1433 0.0 0
M  V30 10 O 15.6648 4.9934 0.0 0
M  V30 11 C 16.9986 4.2234 0.0 0
M  V30 12 C 4.9398 3.2472 0.0 0
M  V30 13 C 5.7098 4.5808 0.0 0
M  V30 14 C 3.4335 3.5673 0.0 0
M  V30 15 C 5.7098 1.9133 0.0 0
M  V30 16 C 7.2499 4.5808 0.0 0
M  V30 17 O 4.6794 5.7252 0.0 0
M  V30 18 C 3.2726 5.0989 0.0 0
M  V30 19 C 7.2499 1.9133 0.0 0
M  V30 20 C 8.0199 3.2472 0.0 0
M  V30 21 C 11.6638 2.6834 0.0 0
M  V30 22 C 12.9974 1.9133 0.0 0
M  V30 23 C 11.6638 4.2234 0.0 0
M  V30 24 C 14.3311 2.6834 0.0 0
M  V30 25 C 12.9974 4.9934 0.0 0
M  V30 26 C 14.3311 4.2234 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 14
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 20
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 21
M  V30 11 1 10 11
M  V30 12 1 10 26
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 2 13 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-5520760
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-3-[2-(Methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
4-Methoxybenzenesulfonate (29). 29 was purified by flash chromatography
(gradient eluent, ethyl acetate in n-hexane 20% → 90%). Yield: 94%. 1H
NMR (300 MHz, DMSO-d6) δ: 2.63 (d, J = 4.7 Hz, 3H), 3.85 (s, 3H), 5.22
(d, J = 2.5 Hz, 2H), 5.84 (t, J = 2.5 Hz, 1H), 6.50 (dd, J1 = 2.2 Hz, J2
= 8.8 Hz, 1H), 6.62 (d, J = 2.2 Hz, 1H), 7.15 (d, J = 9.1 Hz, 2H), 7.78
(d, J = 9.1 Hz, 2H), 8.02 (br q, J = 4.7 Hz, 1H, disappears with D2O),
8.82 (d, J = 8.8 Hz, 1H). IC50 ± SD (nM), MAO-A: 11 ± 2.2. Calculated: C
57.59, H 4.56, N 3.73; Found: C 57.84, H 4.59, N 3.78.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME380 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Chloromethyl)-8-methyl-7-[(phenylsulfonyl)oxy]-2H-1-benzopyran-2-one
C17H13ClO5S
1427203-71-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3111 1.3338 0.0 0
M  V30 2 C 11.7012 5.3348 0.0 0
M  V30 3 Cl 13.2412 5.3348 0.0 0
M  V30 4 O 4.7710 4.0012 0.0 0
M  V30 5 S 4.0010 5.3348 0.0 0 VAL=6
M  V30 6 O 3.2310 6.6687 0.0 0
M  V30 7 O 5.3348 6.1048 0.0 0
M  V30 8 O 11.7012 0.0000 0.0 0
M  V30 9 C 8.6211 2.6675 0.0 0
M  V30 10 C 9.3911 4.0012 0.0 0
M  V30 11 C 7.0811 2.6675 0.0 0
M  V30 12 O 9.3911 1.3338 0.0 0
M  V30 13 C 10.9312 4.0012 0.0 0
M  V30 14 C 8.6211 5.3348 0.0 0
M  V30 15 C 6.3111 4.0012 0.0 0
M  V30 16 C 10.9312 1.3338 0.0 0
M  V30 17 C 11.7012 2.6675 0.0 0
M  V30 18 C 7.0811 5.3348 0.0 0
M  V30 19 C 2.6673 4.5648 0.0 0
M  V30 20 C 1.3337 5.3348 0.0 0
M  V30 21 C 2.6673 3.0248 0.0 0
M  V30 22 C 0.0000 4.5648 0.0 0
M  V30 23 C 1.3337 2.2548 0.0 0
M  V30 24 C 0.0000 3.0248 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 4 15
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 2 8 16
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 18
M  V30 20 1 16 17
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-N-Methyl-2-[7-methyl-6-[(phenylsulfonyl)oxy]-3(2H)-benzofuranylidene]ace...
C18H17NO5S
1427203-88-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0420 3.3778 0.0 0
M  V30 2 C 11.7218 4.8841 0.0 0
M  V30 3 N 12.8664 5.9147 0.0 0
M  V30 4 O 10.2572 5.3601 0.0 0
M  V30 5 C 14.3309 5.4388 0.0 0
M  V30 6 C 6.3111 0.0000 0.0 0
M  V30 7 O 4.7710 2.6675 0.0 0
M  V30 8 S 4.0010 4.0012 0.0 0 VAL=6
M  V30 9 O 3.2310 5.3348 0.0 0
M  V30 10 O 5.3348 4.7712 0.0 0
M  V30 11 C 9.3911 2.6675 0.0 0
M  V30 12 C 8.6211 1.3338 0.0 0
M  V30 13 C 10.8976 2.3473 0.0 0
M  V30 14 C 8.6211 4.0012 0.0 0
M  V30 15 C 7.0811 1.3338 0.0 0
M  V30 16 O 9.6517 0.1893 0.0 0
M  V30 17 C 11.0585 0.8156 0.0 0
M  V30 18 C 7.0811 4.0012 0.0 0
M  V30 19 C 6.3111 2.6675 0.0 0
M  V30 20 C 2.6673 3.2311 0.0 0
M  V30 21 C 2.6673 1.6911 0.0 0
M  V30 22 C 1.3337 4.0012 0.0 0
M  V30 23 C 1.3337 0.9211 0.0 0
M  V30 24 C 0.0000 3.2311 0.0 0
M  V30 25 C 0.0000 1.6911 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 15
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 2 8 9
M  V30 10 2 8 10
M  V30 11 1 8 20
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1427203-71-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1427203-88-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9790321
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of Final
Compounds 20-38. A suitable sulfonate intermediate, 3-19 (2.0 mmol), was
suspended in dry THF (8.0 mL), and a commercially available 2.0 N
solution of methylamine (for compounds 20-36) or ethylamine (for compound
37) in THF (10 mL, 20 mmol) was added. For the synthesis of compound 38
isopropylamine (1.7 mL, 20 mmol) was previously dissolved in dry THF (2.0
mL) before addition to the reaction mixture. The resulting mixture was
stirred at room temperature until completion of the reaction as checked
by TLC control (3-24 h). The inorganic precipitate was filtered off, and
the solution was concentrated to dryness and purified by flash
chromatography (gradient eluent, different mixtures of ethyl acetate in
n-hexane). Product was purified by flash chromatography (gradient eluent,
ethyl acetate in n-hexane 20% → 80%).
(3E)-7-Methyl-3-[2-(methylamino)-2-oxoethylidene]-2,3-dihydro-1-benzofuran-6-yl
Benzenesulfonate (31). 31 was purified by flash chromatography (gradient
eluent, ethyl acetate in n-hexane 20% → 80%). Yield: 94%. 1H NMR (300
MHz, DMSO-d6) δ: 1.82 (s, 3H), 2.64 (d, J = 4.7 Hz, 3H), 5.24 (d, J = 2.2
Hz, 2H), 5.84 (t, J = 2.2 Hz, 1H), 6.43 (d, J = 8.8 Hz, 1H), 7.66-7.71
(m, 2H), 7.81-7.90 (m, 3H), 8.02 (br s, 1H, disappears with D2O), 8.68
(d, J = 8.8 Hz, 1H). IC50 ± SD (nM), MAO-A: 9.8 ± 1.4; MAO-B: 5 ± 0.5%.
Calculated: C 60.15, H 4.77, N 3.90; Found: C 60.46, H 4.88, N 3.96.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery, Biological Evaluation, and Structure-Activity and -Selectivity
Relationships of 6'-Substituted
(E)-2-(Benzofuran-3(2H)-ylidene)-N-methylacetamides, a Novel Class of
Potent and Selective Monoamine Oxidase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Barletta, Maria; Soto-Otero, Ramon; Nicolotti, Orazio;
Mendez-Alvarez, Estefania; Catto, Marco; Introcaso, Antonellina;
Stefanachi, Angela; Cellamare, Saverio; Altomare, Cosimo; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(6), 2651-2664

$RFMT $RIREG SCHEME381 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5-[2-fluoro-4-[(5S)-5-[[(methoxythioxomethyl)amino]methyl]-...
C21H30FN5O5S
1443005-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 15.3979 6.1961 0.0 0
M  V30 2 F 10.3485 0.8182 0.0 0
M  V30 3 C 18.5844 1.8103 0.0 0
M  V30 4 N 19.9911 2.4368 0.0 0
M  V30 5 C 21.2370 1.5315 0.0 0
M  V30 6 O 22.6440 2.1579 0.0 0
M  V30 7 S 21.0761 0.0000 0.0 0
M  V30 8 C 23.8898 1.2526 0.0 0
M  V30 9 C 4.0474 4.9237 0.0 0
M  V30 10 O 2.7751 4.0562 0.0 0
M  V30 11 O 3.9324 6.4594 0.0 0
M  V30 12 C 1.3875 4.7244 0.0 0
M  V30 13 C 2.0558 6.1120 0.0 0
M  V30 14 C 0.0000 5.3926 0.0 0
M  V30 15 C 0.7193 3.3369 0.0 0
M  V30 16 C 13.4286 3.4855 0.0 0
M  V30 17 C 12.6586 2.1519 0.0 0
M  V30 18 C 12.6586 4.8193 0.0 0
M  V30 19 C 11.1185 2.1519 0.0 0
M  V30 20 C 11.1185 4.8193 0.0 0
M  V30 21 C 10.3485 3.4855 0.0 0
M  V30 22 N 14.9686 3.4855 0.0 0
M  V30 23 C 15.8738 2.2396 0.0 0
M  V30 24 C 15.8738 4.7315 0.0 0
M  V30 25 C 17.3383 2.7155 0.0 0 CFG=2
M  V30 26 O 17.3383 4.2555 0.0 0
M  V30 27 N 8.8085 3.4855 0.0 0
M  V30 28 C 8.1403 4.8730 0.0 0
M  V30 29 C 8.1403 2.0981 0.0 0
M  V30 30 C 6.6390 5.2157 0.0 0
M  V30 31 C 6.6390 1.7553 0.0 0
M  V30 32 N 5.4350 4.2555 0.0 0
M  V30 33 N 5.4350 2.7155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 24
M  V30 2 1 2 19
M  V30 3 1 3 4
M  V30 4 1 25 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 32
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 22
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 21 27
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
O-Methyl N-[[(5S)-3-[3-fluoro-4-[hexahydro-1-[(methylamino)carbonyl]-5H-1,2,5...
C18H25FN6O4S
1489240-43-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.0104 6.1961 0.0 0
M  V30 2 C 17.1968 1.8103 0.0 0
M  V30 3 N 18.6036 2.4368 0.0 0
M  V30 4 C 19.8495 1.5315 0.0 0
M  V30 5 O 21.2564 2.1579 0.0 0
M  V30 6 S 19.6885 0.0000 0.0 0
M  V30 7 C 22.5023 1.2528 0.0 0
M  V30 8 F 8.9610 0.8182 0.0 0
M  V30 9 C 2.6599 4.9237 0.0 0
M  V30 10 N 1.3875 4.0562 0.0 0
M  V30 11 O 2.5449 6.4594 0.0 0
M  V30 12 C 0.0000 4.7244 0.0 0
M  V30 13 N 13.5810 3.4855 0.0 0
M  V30 14 C 14.4862 2.2396 0.0 0
M  V30 15 C 14.4862 4.7315 0.0 0
M  V30 16 C 15.9509 2.7155 0.0 0 CFG=2
M  V30 17 O 15.9509 4.2555 0.0 0
M  V30 18 C 12.0410 3.4855 0.0 0
M  V30 19 C 11.2710 2.1519 0.0 0
M  V30 20 C 11.2710 4.8193 0.0 0
M  V30 21 C 9.7310 2.1519 0.0 0
M  V30 22 C 9.7310 4.8193 0.0 0
M  V30 23 C 8.9610 3.4855 0.0 0
M  V30 24 N 7.4210 3.4855 0.0 0
M  V30 25 C 6.7528 4.8730 0.0 0
M  V30 26 C 6.7528 2.0981 0.0 0
M  V30 27 C 5.2514 5.2157 0.0 0
M  V30 28 C 5.2514 1.7553 0.0 0
M  V30 29 N 4.0474 4.2555 0.0 0
M  V30 30 N 4.0474 2.7155 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=1
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 29
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 18
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 25 1 23 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1443005-60-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1489240-43-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10763791
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM crude intermediate isolated (2nd stage)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones
having thiocarbamate at C-5 on the A-ring and an amide- or
urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Suzuki, Hideyuki; Utsunomiya, Iwao; Shudo, Koichi; Fukuhara, Norio;
Iwaki, Tsutomu; Yasukata, Tatsuro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 69262-277

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-4-[(1-methylethyl)amino]-3-pyridinecarboxylic acid
C9H11ClN2O2
1447226-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0
M  V30 2 O 6.9301 5.3348 0.0 0
M  V30 3 O 4.6201 6.6686 0.0 0
M  V30 4 N 2.3100 5.3348 0.0 0
M  V30 5 C 0.7700 5.3348 0.0 0
M  V30 6 C 0.0000 6.6686 0.0 0
M  V30 7 C 0.0000 4.0011 0.0 0
M  V30 8 Cl 2.3100 0.0000 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 5.3901 2.6675 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0
M  V30 13 N 4.6201 1.3338 0.0 0
M  V30 14 C 3.0800 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 8 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N-methyl-4-[(1-methylethyl)amino]-3-pyridinecarboxamide
C10H14ClN3O
2808391-84-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 3.8500 1.3338 0.0 0
M  V30 3 C 4.6200 0.0000 0.0 0
M  V30 4 C 2.3100 1.3338 0.0 0
M  V30 5 C 6.1600 5.3347 0.0 0
M  V30 6 N 6.9300 6.6685 0.0 0
M  V30 7 O 6.9300 4.0011 0.0 0
M  V30 8 C 8.4700 6.6685 0.0 0
M  V30 9 Cl 0.0000 5.3347 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 4.6200 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 3.8500 6.6685 0.0 0
M  V30 14 C 1.5400 5.3347 0.0 0
M  V30 15 N 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447226-47-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2808391-84-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33447248
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing
Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant
Non-Small-Cell Lung Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Eno, Meredith S.; Brubaker, Jason D.; Campbell, John E.; De Savi, Chris;
Guzi, Timothy J.; Williams, Brett D.; Wilson, Douglas; Wilson, Kevin;
Brooijmans, Natasja; Kim, Joseph; Ozen, Aysegul; Perola, Emanuele; Hsieh,
John; Brown, Victoria; Fetalvero, Kristina; Garner, Andrew; Zhang, Zhuo;
Stevison, Faith; Woessner, Rich; Singh, Jatinder; Timsit, Yoav; Kinkema,
Caitlin; Medendorp, Clare; Lee, Christopher; Albayya, Faris; Zalutskaya,
Alena; Schalm, Stefanie; Dineen, Thomas A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(14), 9662-9677

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (1R,3S)-2-(2-bromoethyl)-2,3,4,9-tetrahydro-1-phenyl-1H-pyrido[3,4-b]in...
C22H23BrN2O2
1447959-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 8.9401 0.0 0
M  V30 2 C 6.6685 9.7102 0.0 0
M  V30 3 Br 6.6685 11.2502 0.0 0
M  V30 4 C 8.0021 7.4001 0.0 0
M  V30 5 O 9.3359 6.6301 0.0 0
M  V30 6 O 8.0021 8.9401 0.0 0
M  V30 7 C 10.6696 7.4001 0.0 0
M  V30 8 C 12.0032 6.6301 0.0 0
M  V30 9 C 4.0011 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 5.0901 0.0 0
M  V30 11 N 5.3348 7.4001 0.0 0
M  V30 12 C 5.3348 4.3201 0.0 0
M  V30 13 N 2.8566 4.0597 0.0 0
M  V30 14 C 6.6685 6.6301 0.0 0 CFG=2
M  V30 15 C 5.0146 2.8138 0.0 0
M  V30 16 C 6.6685 5.0901 0.0 0
M  V30 17 C 3.4831 2.6527 0.0 0
M  V30 18 C 5.9198 1.5679 0.0 0
M  V30 19 C 2.8566 1.2459 0.0 0
M  V30 20 C 5.2934 0.1609 0.0 0
M  V30 21 C 3.7618 0.0000 0.0 0
M  V30 22 C 2.6673 7.4001 0.0 0
M  V30 23 C 1.3337 6.6301 0.0 0
M  V30 24 C 2.6673 8.9401 0.0 0
M  V30 25 C 0.0000 7.4001 0.0 0
M  V30 26 C 1.3337 9.7102 0.0 0
M  V30 27 C 0.0000 8.9401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 14 4 CFG=3
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6R,12aS)-3,4,6,7,12,12a-Hexahydro-2-methyl-6-phenylpyrazino[1′,2′:1,6]pyrido...
C21H21N3O
1447959-82-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 9.2400 0.0 0
M  V30 2 C 0.0000 7.7000 0.0 0
M  V30 3 C 5.3347 4.6200 0.0 0 CFG=1
M  V30 4 C 6.6684 5.3900 0.0 0
M  V30 5 N 4.0011 5.3900 0.0 0
M  V30 6 C 6.6684 6.9300 0.0 0
M  V30 7 N 8.1331 4.9142 0.0 0
M  V30 8 C 4.0011 6.9300 0.0 0 CFG=2
M  V30 9 C 2.6673 4.6200 0.0 0
M  V30 10 C 8.1331 7.4059 0.0 0
M  V30 11 C 5.3347 7.7000 0.0 0
M  V30 12 C 9.0383 6.1600 0.0 0
M  V30 13 C 2.6673 7.7000 0.0 0
M  V30 14 C 1.3336 5.3900 0.0 0
M  V30 15 C 8.7594 8.8128 0.0 0
M  V30 16 C 10.5698 6.3210 0.0 0
M  V30 17 N 1.3336 6.9300 0.0 0
M  V30 18 C 10.2909 8.9738 0.0 0
M  V30 19 C 11.1962 7.7279 0.0 0
M  V30 20 C 5.3347 3.0800 0.0 0
M  V30 21 C 6.6684 2.3100 0.0 0
M  V30 22 C 4.0011 2.3100 0.0 0
M  V30 23 C 6.6684 0.7700 0.0 0
M  V30 24 C 4.0011 0.7700 0.0 0
M  V30 25 C 5.3347 0.0000 0.0 0
M  V30 26 H 4.0011 8.4700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 1 2 17
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 20 CFG=1
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 1 8 11
M  V30 14 1 8 13
M  V30 15 1 8 26 CFG=1
M  V30 16 1 9 14
M  V30 17 1 10 12
M  V30 18 2 10 15
M  V30 19 2 12 16
M  V30 20 1 13 17
M  V30 21 1 14 17
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 2 18 19
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 3 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1447959-81-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1447959-82-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8756276
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5. General procedure for the synthesis of
compounds 13. A mixture of 12 (100 mg, 0.25 mmol) and the appropriate
amine (1.25 mmol) in dry EtOH (10 ml) was stirred for 24 h at room
temperature. Then, the solvent was evaporated and the residue extracted
with EtOAc. The combined organic phases were washed with saturated
NaHCO3, dried (MgSO4) and evaporated in vacuo. Purification by means of
column chromatography on silicagel (hexane/EtOAc) gave pure compound.
trans-2-Methyl-6-phenyl-3,4,6,7,12,12a-hexahydro-2H-pyrazino[1',2':1,6]pyrido[3,4-b]indol-1-one
13a. Yield 94%. White powder. mp: 253.4-255.8 °C. 1H NMR-300 MHz (CDCl3):
δ 2.48 (1H, ddd, J = 3.99, 9.20, 12.11 Hz, H-3a), 2.93 (3H, s, Me), 2.95
(1H, dd, J = 11.01, 15.93 Hz, H-12a), 3.05 (1H, dt, J = 12.11, 3.99 Hz,
H-3b), 3.20 (1H, dt, J = 11.55, 3.99 Hz, H-4a), 3.48 (1H, dd, J = 15.93,
4.68 Hz, H-12b), 3.58 (1H, ddd, J = 11.55, 3.99, 9.20 Hz, H-4b), 3.70
(1H, ddJ = 11.01, 4.68 Hz, H-13), 5.11 (1H, s, H-6), 7.08-7.20 (4H, m, 4×
═CH), 7.22-7.33 (4H, m, 4× ═CH), 7.58 (1H, db, J = 8.81, H-11), 7.78 (1H,
br. s, H-7). 13C NMR-68 MHz (CDCl3): δ 24.87 (C-12), 34.39 (Me), 46.70
(C-3), 48.41 (C-4), 54.66 (C-13), 63.13 (C-6), 109.21 (Cquat), 110.84
(C-8), 118.59 (C-11), 119.58 (C-10), 122.04 (C-9), 126.89 (Cquat), 128.37
(3× ═CH), 129.52 (2× ═CH), 131.93 (Cquat), 136.39 (Cquat), 137.21
(Cquat), 169.93 (C═O). IR (KBr) ν 3219 (NH), 2924, 2853, 1632 (C═O),
1493, 1454, 1333, 1164, 1074 cm-1. MS m/z (%). 332 (M+H+, 80), 328 (10),
221 (10), 220 (100).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of functionalized diketopiperazines as Cyclotryprostatin and
Tryprostatin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Van, Tuyen Nguyen; Claes, Pieter; De Kimpe, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2013), 24(8), 1006-1010

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(4-nitrobenzoyl)-N-(phenylmethyl)carbamate
C19H20N2O5
149327-06-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 5.3900 6.6684 0.0 0
M  V30 3 C 3.0800 5.3347 0.0 0
M  V30 4 C 5.3900 4.0011 0.0 0
M  V30 5 O 4.6200 8.0021 0.0 0
M  V30 6 O 4.6200 2.6674 0.0 0
M  V30 7 O 6.9300 4.0011 0.0 0
M  V30 8 C 5.3900 1.3336 0.0 0
M  V30 9 C 6.7236 2.1036 0.0 0
M  V30 10 C 6.1600 0.0000 0.0 0
M  V30 11 C 4.0564 0.5636 0.0 0
M  V30 12 N 11.5500 6.6684 0.0 0 VAL=5
M  V30 13 O 12.3200 5.3347 0.0 0
M  V30 14 O 12.3200 8.0021 0.0 0
M  V30 15 C 6.9300 6.6684 0.0 0
M  V30 16 C 7.7000 8.0021 0.0 0
M  V30 17 C 7.7000 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 10.0100 6.6684 0.0 0
M  V30 21 C 2.3100 6.6684 0.0 0
M  V30 22 C 0.7700 6.6684 0.0 0
M  V30 23 C 3.0800 8.0021 0.0 0
M  V30 24 C 0.0000 8.0021 0.0 0
M  V30 25 C 2.3100 9.3358 0.0 0
M  V30 26 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 15
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 2 12 13
M  V30 14 2 12 14
M  V30 15 1 12 20
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-nitrobenzamide
C8H8N2O3
2585-23-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 N 8.0023 3.8501 0.0 0
M  V30 3 O 6.6685 6.1601 0.0 0
M  V30 4 C 9.3360 4.6201 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 149327-06-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2585-23-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41165573
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-48-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM nitrogen-dopedcarbon supportted
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, reusable catalyst,
cobalt supported on nitrogen-doped carbon catalyst prepared and used, no
solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transamidation of secondary carboxamides and amidation of esters are
facilitated by magnetic Co@NC nanoparticles, as a highly efficient and
recyclable catalyst under neat conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Vishal; Rajput, Khushbu; Mahaur, Priya; Singh, Sundaram;
Srivastava, Vandana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2024), 48(30), 13350-13357

$RFMT $RIREG SCHEME385 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-tert-Butylbenzenesulfonyl chloride
C10H13ClO2S
15084-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 3.0800 0.0 0
M  V30 5 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 6 Cl 9.2400 1.5400 0.0 0
M  V30 7 O 7.7000 0.0000 0.0 0
M  V30 8 O 7.7000 3.0800 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[4-(1,1-Dimethylethyl)phenyl]sulfonyl]-N,2-dimethyl-2-propenamide
C15H21NO3S
1456707-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 10.7800 2.6673 0.0 0
M  V30 12 C 10.7800 1.1273 0.0 0
M  V30 13 C 12.3200 2.6673 0.0 0
M  V30 14 C 10.7800 4.2073 0.0 0
M  V30 15 C 6.1600 2.6673 0.0 0
M  V30 16 C 6.9300 1.3336 0.0 0
M  V30 17 C 6.9300 4.0011 0.0 0
M  V30 18 C 8.4700 1.3336 0.0 0
M  V30 19 C 8.4700 4.0011 0.0 0
M  V30 20 C 9.2400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 15
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 14
M  V30 14 1 11 20
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15084-51-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[7-[(3-Chlorophenyl)methoxy]-2-oxo-2H-1-benzopyran-4-yl]oxy]acetyl chloride
C18H12Cl2O5
1522346-16-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.3200 5.3347 0.0 0
M  V30 2 C 13.8600 5.3347 0.0 0
M  V30 3 C 14.6300 6.6685 0.0 0
M  V30 4 Cl 13.8600 8.0021 0.0 0
M  V30 5 O 16.1700 6.6685 0.0 0
M  V30 6 O 5.3900 4.0011 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 O 12.3200 0.0000 0.0 0
M  V30 9 Cl 0.0000 8.0021 0.0 0
M  V30 10 C 9.2400 2.6674 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 7.7000 2.6674 0.0 0
M  V30 13 O 10.0100 1.3336 0.0 0
M  V30 14 C 11.5500 4.0011 0.0 0
M  V30 15 C 9.2400 5.3347 0.0 0
M  V30 16 C 6.9300 4.0011 0.0 0
M  V30 17 C 11.5500 1.3336 0.0 0
M  V30 18 C 12.3200 2.6674 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 3.0800 5.3347 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 22 C 2.3100 4.0011 0.0 0
M  V30 23 C 0.7700 6.6685 0.0 0
M  V30 24 C 0.7700 4.0011 0.0 0
M  V30 25 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 16
M  V30 8 1 7 20
M  V30 9 2 8 17
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 2 16 19
M  V30 21 1 17 18
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[7-[(3-Chlorophenyl)methoxy]-2-oxo-2H-1-benzopyran-4-yl]oxy]-N-methylaceta...
C19H16ClNO5
1522346-04-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.3200 5.3347 0.0 0
M  V30 2 C 13.8600 5.3347 0.0 0
M  V30 3 C 14.6300 6.6685 0.0 0
M  V30 4 N 16.1700 6.6685 0.0 0
M  V30 5 O 13.8600 8.0021 0.0 0
M  V30 6 C 16.9400 8.0021 0.0 0
M  V30 7 O 5.3900 4.0011 0.0 0
M  V30 8 C 4.6200 5.3347 0.0 0
M  V30 9 O 12.3200 0.0000 0.0 0
M  V30 10 Cl 0.0000 8.0021 0.0 0
M  V30 11 C 10.0100 4.0011 0.0 0
M  V30 12 C 9.2400 2.6674 0.0 0
M  V30 13 C 11.5500 4.0011 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 7.7000 2.6674 0.0 0
M  V30 16 O 10.0100 1.3336 0.0 0
M  V30 17 C 12.3200 2.6674 0.0 0
M  V30 18 C 7.7000 5.3347 0.0 0
M  V30 19 C 6.9300 4.0011 0.0 0
M  V30 20 C 11.5500 1.3336 0.0 0
M  V30 21 C 3.0800 5.3347 0.0 0
M  V30 22 C 2.3100 6.6685 0.0 0
M  V30 23 C 2.3100 4.0011 0.0 0
M  V30 24 C 0.7700 6.6685 0.0 0
M  V30 25 C 0.7700 4.0011 0.0 0
M  V30 26 C 0.0000 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 8 21
M  V30 10 2 9 20
M  V30 11 1 10 24
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 2 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1522346-16-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1522346-04-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7575055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in
the search of potent and selective monoamine oxidase B inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pisani, Leonardo; Catto, Marco; Nicolotti, Orazio; Grossi, Giancarlo; Di
Braccio, Mario; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Stefanachi,
Angela; Gadaleta, Domenico; Carotti, Angelo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2013), 70723-739

$RFMT $RIREG SCHEME387 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-methoxy-γ-nitrobenzenebutanoate
C12H15NO5
1558681-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 6.9300 1.3338 0.0 0 VAL=5
M  V30 4 C 8.4700 4.0011 0.0 0
M  V30 5 O 6.1600 0.0000 0.0 0
M  V30 6 O 8.4700 1.3338 0.0 0
M  V30 7 C 9.2400 5.3347 0.0 0
M  V30 8 O 10.7800 5.3347 0.0 0
M  V30 9 O 8.4700 6.6685 0.0 0
M  V30 10 C 11.5500 6.6685 0.0 0
M  V30 11 O 1.5400 5.3347 0.0 0
M  V30 12 C 0.0000 5.3347 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 3.8500 1.3338 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 C 2.3100 1.3338 0.0 0
M  V30 18 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 11 12
M  V30 12 1 11 16
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(3-Methoxyphenyl)-1-methyl-5-nitro-2-piperidinone
C13H16N2O4
1558681-79-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.3414 0.9899 0.0 0 VAL=5
M  V30 2 O 3.1616 0.0000 0.0 0
M  V30 3 O 5.7886 0.4632 0.0 0
M  V30 4 C 0.0000 2.4431 0.0 0
M  V30 5 O 8.6939 5.1739 0.0 0
M  V30 6 C 10.2339 5.1739 0.0 0
M  V30 7 O 0.5348 5.4762 0.0 0
M  V30 8 C 4.0739 2.5065 0.0 0
M  V30 9 C 2.6268 1.9798 0.0 0
M  V30 10 C 4.3414 4.0231 0.0 0
M  V30 11 N 1.4471 2.9697 0.0 0
M  V30 12 C 3.1616 5.0130 0.0 0
M  V30 13 C 1.7145 4.4863 0.0 0
M  V30 14 C 5.6139 2.5065 0.0 0
M  V30 15 C 6.3839 3.8401 0.0 0
M  V30 16 C 6.3839 1.1729 0.0 0
M  V30 17 C 7.9239 3.8401 0.0 0
M  V30 18 C 7.9239 1.1729 0.0 0
M  V30 19 C 8.6939 2.5065 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 11
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 2 7 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1558681-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1558681-79-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7182075
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1:
rac-5-(3-Chloro-phenyl)-1-methy5-nitro-piperidin-2-one (52h) To a stirred
room temperature solution of 164 ul (1.940 mmol) methylamine (41 % in
water) in 1 mL dioxane was added 141 uL (1.940 mmol) formaldehyde (37 %
in water) dropwise (exothermic reaction). The mixture was stirred for 5
min and then a solution of 0.5 g (1.940 mmol)
rac-4-(3-chloro-phenyl)-4-nitro-butyric acid methyl ester 51h in 1.5 mL
dioxane was added at once. The mixture was stirred at 65 °C for 6 h. The
mixture was cooled to room temperature, ethyl acetate and a saturated
NaCl solution were added. Aqueous phase was extracted 2 times with ethyl
acetate. Combined organic phases were washed with a saturated NaCl
solution, dried over sodium sulfate and concentrated in vacuo. The crude
product was purified with flash column chromatography on silica gel
(Eluent: Heptane/ethyl acetate 0 to 100 %) to provide the desired
compound. Compound 52i, yield 94%.
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction, key step, exothermic in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and
Orally Active GlyT1 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pinard, Emmanuel; Alberati, Daniela; Alvarez-Sanchez, Ruben; Brom,
Virginie; Burner, Serge; Fischer, Holger; Hauser, Nicole; Kolczewski,
Sabine; Lengyel, Judith; Mory, Roland; Saladin, Christian; Schulz-Gasch,
Tanja; Stalder, Henri
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2014), 5(4), 428-433

$RFMT $RIREG SCHEME388 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-D-Glucofuranosiduronic acid, dodecyl, γ-lactone
C18H32O6
158603-98-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 3.7115 6.6354 0.0 0
M  V30 2 O 3.0608 0.0000 0.0 0
M  V30 3 O 6.7721 5.2726 0.0 0
M  V30 4 C 8.1060 4.5026 0.0 0
M  V30 5 C 9.4396 5.2726 0.0 0
M  V30 6 C 10.7733 4.5026 0.0 0
M  V30 7 C 12.1071 5.2726 0.0 0
M  V30 8 C 13.4408 4.5026 0.0 0
M  V30 9 C 14.7745 5.2726 0.0 0
M  V30 10 C 16.1081 4.5026 0.0 0
M  V30 11 C 17.4420 5.2726 0.0 0
M  V30 12 C 18.7756 4.5026 0.0 0
M  V30 13 C 20.1093 5.2726 0.0 0
M  V30 14 C 21.4430 4.5026 0.0 0
M  V30 15 C 22.7768 5.2726 0.0 0
M  V30 16 O 0.0000 1.3628 0.0 0
M  V30 17 C 3.0011 3.9845 0.0 0 CFG=2
M  V30 18 C 3.7711 2.6509 0.0 0 CFG=1
M  V30 19 C 4.0317 5.1291 0.0 0 CFG=1
M  V30 20 O 1.4948 3.6644 0.0 0
M  V30 21 O 5.2775 2.9710 0.0 0
M  V30 22 C 2.7406 1.5063 0.0 0 CFG=2
M  V30 23 C 5.4385 4.5026 0.0 0 CFG=1
M  V30 24 C 1.3338 2.1328 0.0 0
M  V30 25 H 2.2310 5.3182 0.0 0
M  V30 26 H 4.5411 1.3172 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 22 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 23 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 2 16 24
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 25 CFG=1
M  V30 21 1 18 21
M  V30 22 1 18 22
M  V30 23 1 18 26 CFG=1
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 17 18 19 22 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Dodecyl N-methyl-α-D-glucofuranosiduronamide
C19H37NO6
2170991-75-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0432 3.8850 0.0 0 CFG=2
M  V30 2 C 2.5369 3.5649 0.0 0
M  V30 3 O 4.5192 5.3498 0.0 0
M  V30 4 N 1.5065 4.7094 0.0 0
M  V30 5 O 2.0610 2.1003 0.0 0
M  V30 6 C 0.0000 4.3892 0.0 0
M  V30 7 O 5.2173 0.0000 0.0 0
M  V30 8 O 8.8449 4.0287 0.0 0
M  V30 9 C 10.1785 3.2587 0.0 0
M  V30 10 C 11.5122 4.0287 0.0 0
M  V30 11 C 12.8460 3.2587 0.0 0
M  V30 12 C 14.1797 4.0287 0.0 0
M  V30 13 C 15.5134 3.2587 0.0 0
M  V30 14 C 16.8470 4.0287 0.0 0
M  V30 15 C 18.1809 3.2587 0.0 0
M  V30 16 C 19.5145 4.0287 0.0 0
M  V30 17 C 20.8482 3.2587 0.0 0
M  V30 18 C 22.1819 4.0287 0.0 0
M  V30 19 C 23.5157 3.2587 0.0 0
M  V30 20 C 24.8494 4.0287 0.0 0
M  V30 21 O 8.4947 0.6966 0.0 0
M  V30 22 C 5.0738 2.7406 0.0 0 CFG=2
M  V30 23 O 6.1042 3.8850 0.0 0
M  V30 24 C 5.8438 1.4070 0.0 0 CFG=2
M  V30 25 C 7.5112 3.2587 0.0 0 CFG=2
M  V30 26 C 7.3501 1.7271 0.0 0 CFG=1
M  V30 27 H 3.8279 1.8354 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 22
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 24 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 25 8 CFG=3
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 19 20
M  V30 21 1 26 21 CFG=3
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 22 27 CFG=3
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 1 22 24 25 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 158603-98-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2170991-75-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-18624768
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Surfactant Properties of Nonionic Biosourced
Alkylglucuronamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lebeuf, Raphael; Liu, Chih-Yin; Pierlot, Christel; Nardello-Rataj,
Veronique
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Sustainable Chemistry & Engineering (2018), 6(2), 2758-2766

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
4-[4-(1-Methylethyl)phenoxy]benzoic acid
C16H16O3
158769-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6201 0.0 0
M  V30 2 C 1.3337 1.5400 0.0 0
M  V30 3 C 0.0000 2.3100 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 12.0032 1.5400 0.0 0
M  V30 6 O 13.3369 2.3100 0.0 0
M  V30 7 O 12.0032 0.0000 0.0 0
M  V30 8 C 5.3348 3.8500 0.0 0
M  V30 9 C 4.0010 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 2.6673 3.8500 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 2.6673 2.3100 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 9.3359 4.6201 0.0 0
M  V30 17 C 9.3359 1.5400 0.0 0
M  V30 18 C 10.6695 3.8500 0.0 0
M  V30 19 C 10.6695 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 13
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 19
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-4-[4-(1-methylethyl)phenoxy]benzamide
C17H19NO2
2243097-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.0033 1.5400 0.0 0
M  V30 2 N 13.3370 2.3101 0.0 0
M  V30 3 O 12.0033 0.0000 0.0 0
M  V30 4 C 14.6707 1.5400 0.0 0
M  V30 5 O 6.6685 4.6201 0.0 0
M  V30 6 C 1.3337 1.5400 0.0 0
M  V30 7 C 0.0000 2.3101 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0
M  V30 10 C 10.6697 3.8501 0.0 0
M  V30 11 C 9.3358 1.5400 0.0 0
M  V30 12 C 9.3358 4.6201 0.0 0
M  V30 13 C 8.0022 2.3101 0.0 0
M  V30 14 C 8.0022 3.8501 0.0 0
M  V30 15 C 5.3348 3.8501 0.0 0
M  V30 16 C 5.3348 2.3101 0.0 0
M  V30 17 C 4.0010 4.6201 0.0 0
M  V30 18 C 4.0010 1.5400 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 14
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 20
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 158769-82-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243097-38-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20465341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of di(hetero)aryl ether acid derivatives as Notch augmenting
compounds for treatment of cancer, immune disease, and other disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reinmueller, Viktoria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018154118 A2 2018-08-30

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylbenzyl chloride
C9H9Cl
1592-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 Cl 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethenyl-N-methylbenzenemethanamine
C10H13N
93207-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 93207-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1469680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of cyclopropenium polymers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lambert, Tristan Hayes; Campos, Luis M.; Bandar, Jeffrey; Dell, Emma Jane
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20150175727 A1 2015-06-25

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylbenzyl chloride
C9H9Cl
1592-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 Cl 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethenyl-N-methylbenzenemethanamine
C10H13N
93207-70-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 5.3348 0.7700 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 93207-70-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23506347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The evolution of cyclopropenium ions into functional polyelectrolytes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Yivan; Freyer, Jessica L.; Cotanda, Pepa; Brucks, Spencer D.;
Killops, Kato L.; Bandar, Jeffrey S.; Torsitano, Christopher; Balsara,
Nitash P.; Lambert, Tristan H.; Campos, Luis M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2015), 65950

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Ethenyl-9-(phenylmethyl)-9H-purine
C14H12N4
160516-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.6414 0.0 0
M  V30 2 C 10.3091 3.7537 0.0 0
M  V30 3 C 11.8154 3.4335 0.0 0
M  V30 4 C 6.7417 1.7849 0.0 0
M  V30 5 C 7.7722 2.9295 0.0 0
M  V30 6 N 5.3348 2.4114 0.0 0
M  V30 7 N 7.2177 0.3203 0.0 0
M  V30 8 C 9.2785 2.6091 0.0 0
M  V30 9 N 7.0022 4.2631 0.0 0
M  V30 10 C 5.4958 3.9429 0.0 0
M  V30 11 C 8.7240 0.0000 0.0 0
M  V30 12 N 9.7544 1.1446 0.0 0
M  V30 13 C 2.6673 2.4114 0.0 0
M  V30 14 C 1.3337 1.6414 0.0 0
M  V30 15 C 2.6673 3.9514 0.0 0
M  V30 16 C 0.0000 2.4114 0.0 0
M  V30 17 C 1.3337 4.7214 0.0 0
M  V30 18 C 0.0000 3.9514 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 13
M  V30 3 2 2 3
M  V30 4 1 2 8
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 10
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methyl-9-(phenylmethyl)-9H-purine-6-ethanamine
C15H17N5
920503-38-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5673 3.7537 0.0 0
M  V30 2 C 10.2192 3.6939 0.0 0
M  V30 3 C 11.5530 4.4639 0.0 0
M  V30 4 N 12.8867 3.6939 0.0 0
M  V30 5 C 14.2204 4.4639 0.0 0
M  V30 6 C 6.2182 4.4639 0.0 0
M  V30 7 C 7.5519 3.6939 0.0 0
M  V30 8 N 5.0736 3.4335 0.0 0
M  V30 9 N 6.2182 6.0040 0.0 0
M  V30 10 C 8.8855 4.4639 0.0 0
M  V30 11 N 7.2317 2.1875 0.0 0
M  V30 12 C 5.7001 2.0265 0.0 0
M  V30 13 C 7.5519 6.7740 0.0 0
M  V30 14 N 8.8855 6.0040 0.0 0
M  V30 15 C 2.5369 2.6091 0.0 0
M  V30 16 C 1.0304 2.9293 0.0 0
M  V30 17 C 3.0128 1.1446 0.0 0
M  V30 18 C 0.0000 1.7849 0.0 0
M  V30 19 C 1.9822 0.0000 0.0 0
M  V30 20 C 0.4759 0.3202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 10
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 11 12
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 160516-02-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 920503-38-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-3810723
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of purines bearing functionalized C-substituents by the
conjugate addition of nucleophiles to 6-vinylpurines and 6-ethynylpurines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuchar, Martin; Pohl, Radek; Votruba, Ivan; Hocek, Michal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2006), (22), 5083-5098

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[2-[[[3-[(4-Methoxyphenyl)thio]-6-[(4-methyl-4H-1,2,4-triazol-3-yl)thio]-2...
C21H18N6O4S4
1616378-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 11.4625 9.1059 0.0 0
M  V30 2 C 8.3824 9.1059 0.0 0
M  V30 3 N 6.8424 9.1059 0.0 0
M  V30 4 O 9.1524 10.4396 0.0 0
M  V30 5 S 8.3824 3.7711 0.0 0
M  V30 6 O 17.6226 9.1059 0.0 0
M  V30 7 C 18.3926 10.4396 0.0 0
M  V30 8 C 7.0198 0.7103 0.0 0
M  V30 9 S 2.8138 12.7333 0.0 0
M  V30 10 C 2.6527 14.2650 0.0 0
M  V30 11 C 1.2459 14.8914 0.0 0
M  V30 12 O 0.0000 13.9861 0.0 0
M  V30 13 O 1.0850 16.4229 0.0 0
M  V30 14 C 10.6925 7.7722 0.0 0
M  V30 15 C 9.1524 7.7722 0.0 0
M  V30 16 C 11.4625 6.4384 0.0 0
M  V30 17 N 8.3824 6.4384 0.0 0
M  V30 18 C 10.6925 5.1047 0.0 0
M  V30 19 C 9.1524 5.1047 0.0 0
M  V30 20 C 13.0025 9.1059 0.0 0
M  V30 21 C 13.7725 7.7722 0.0 0
M  V30 22 C 13.7725 10.4396 0.0 0
M  V30 23 C 15.3126 7.7722 0.0 0
M  V30 24 C 15.3126 10.4396 0.0 0
M  V30 25 C 16.0826 9.1059 0.0 0
M  V30 26 C 6.0724 10.4396 0.0 0
M  V30 27 S 4.5408 10.6005 0.0 0
M  V30 28 N 6.6988 11.8466 0.0 0
M  V30 29 C 4.2206 12.1070 0.0 0
M  V30 30 C 5.5543 12.8770 0.0 0
M  V30 31 C 9.1524 2.4374 0.0 0
M  V30 32 N 8.5261 1.0304 0.0 0
M  V30 33 N 10.6841 2.2763 0.0 0
M  V30 34 C 9.6705 0.0000 0.0 0
M  V30 35 N 11.0043 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 26
M  V30 7 1 5 19
M  V30 8 1 5 31
M  V30 9 1 6 7
M  V30 10 1 6 25
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 1 9 29
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 30
M  V30 34 1 31 32
M  V30 35 2 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Methoxyphenyl)thio]-N-[5-[[2-(methylamino)-2-oxoethyl]thio]-2-thiazolyl...
C22H21N7O3S4
1616378-02-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3348 9.4921 0.0 0
M  V30 2 C 8.0021 7.9521 0.0 0
M  V30 3 N 9.3359 7.1820 0.0 0
M  V30 4 O 8.0021 9.4921 0.0 0
M  V30 5 S 5.3348 3.3320 0.0 0
M  V30 6 O 0.0000 12.5721 0.0 0
M  V30 7 C 0.0000 14.1121 0.0 0
M  V30 8 C 4.9846 0.0000 0.0 0
M  V30 9 S 14.6385 8.3092 0.0 0
M  V30 10 C 15.5438 9.5551 0.0 0
M  V30 11 C 17.0753 9.3941 0.0 0
M  V30 12 N 17.9805 10.6400 0.0 0
M  V30 13 O 17.7016 7.9873 0.0 0
M  V30 14 C 19.5121 10.4791 0.0 0
M  V30 15 C 5.3348 7.9521 0.0 0
M  V30 16 C 6.6684 7.1820 0.0 0
M  V30 17 C 4.0011 7.1820 0.0 0
M  V30 18 N 6.6684 5.6420 0.0 0
M  V30 19 C 4.0011 5.6420 0.0 0
M  V30 20 C 5.3348 4.8720 0.0 0
M  V30 21 C 4.0011 10.2621 0.0 0
M  V30 22 C 4.0011 11.8021 0.0 0
M  V30 23 C 2.6673 9.4921 0.0 0
M  V30 24 C 2.6673 12.5721 0.0 0
M  V30 25 C 1.3337 10.2621 0.0 0
M  V30 26 C 1.3337 11.8021 0.0 0
M  V30 27 C 10.6696 7.9521 0.0 0
M  V30 28 S 12.0764 7.3257 0.0 0
M  V30 29 N 10.8305 9.4836 0.0 0
M  V30 30 C 13.1070 8.4701 0.0 0
M  V30 31 C 12.3370 9.8039 0.0 0
M  V30 32 C 4.0011 2.5620 0.0 0
M  V30 33 N 3.8400 1.0304 0.0 0
M  V30 34 N 2.5942 3.1885 0.0 0
M  V30 35 C 2.3337 0.7103 0.0 0
M  V30 36 N 1.5637 2.0439 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 3 27
M  V30 7 1 5 20
M  V30 8 1 5 32
M  V30 9 1 6 7
M  V30 10 1 6 26
M  V30 11 1 8 33
M  V30 12 1 9 10
M  V30 13 1 9 30
M  V30 14 1 10 11
M  V30 15 1 11 12
M  V30 16 2 11 13
M  V30 17 1 12 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 2 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 31
M  V30 35 1 32 33
M  V30 36 2 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1616378-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616378-02-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16176800
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel 2-pyridinecarboxamide derivatives as glucokinase
activators useful in treating diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Parmee, Emma R.; Xu, Jiayi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014099584 A1 2014-06-26

$RFMT $RIREG SCHEME393 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-sulfonyl chloride
C12H9ClO2S
1623-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 9.2400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 10.7800 1.5400 0.0 0
M  V30 3 O 9.2400 3.0800 0.0 0
M  V30 4 O 9.2400 0.0000 0.0 0
M  V30 5 C 4.6200 1.5400 0.0 0
M  V30 6 C 5.3900 0.2064 0.0 0
M  V30 7 C 5.3900 2.8736 0.0 0
M  V30 8 C 6.9300 0.2064 0.0 0
M  V30 9 C 6.9300 2.8736 0.0 0
M  V30 10 C 7.7000 1.5400 0.0 0
M  V30 11 C 3.0800 1.5400 0.0 0
M  V30 12 C 2.3100 0.2064 0.0 0
M  V30 13 C 2.3100 2.8736 0.0 0
M  V30 14 C 0.7700 0.2064 0.0 0
M  V30 15 C 0.7700 2.8736 0.0 0
M  V30 16 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methacryloyl chloride
C4H5ClO
920-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 Cl 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-([1,1′-Biphenyl]-4-ylsulfonyl)-N,2-dimethyl-2-propenamide
C17H17NO3S
1456707-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.6673 0.0 0 VAL=6
M  V30 2 N 3.0800 2.6673 0.0 0
M  V30 3 O 4.6200 1.1273 0.0 0
M  V30 4 O 4.6200 4.2073 0.0 0
M  V30 5 C 2.3100 1.3336 0.0 0
M  V30 6 C 2.3100 4.0011 0.0 0
M  V30 7 C 0.7700 1.3336 0.0 0
M  V30 8 O 3.0800 0.0000 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 11 C 9.2400 2.6673 0.0 0
M  V30 12 C 8.4700 4.0011 0.0 0
M  V30 13 C 8.4700 1.3336 0.0 0
M  V30 14 C 6.9300 4.0011 0.0 0
M  V30 15 C 6.9300 1.3336 0.0 0
M  V30 16 C 6.1600 2.6673 0.0 0
M  V30 17 C 10.7800 2.6673 0.0 0
M  V30 18 C 11.5500 1.3336 0.0 0
M  V30 19 C 11.5500 4.0011 0.0 0
M  V30 20 C 13.0900 1.3336 0.0 0
M  V30 21 C 13.0900 4.0011 0.0 0
M  V30 22 C 13.8600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 16
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 17
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1623-93-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 920-46-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1456707-41-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41690428
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu0-Promoted Truce-Smiles Rearrangement for Aryl-Difluoromethylenation of
the C=C Bonds via a Reductive Radical-Polar Crossover Process
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hongxiao; Hu, Kaiji; Zhang, Jianhua; Jiang, Haizhen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2024), 89(19), 13947-13952

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4′S,6′aR,10′aS,11′aR)-Octahydro-4′,10′,10′-trimethylspiro[1,3-dioxolane-2,9′...
C18H27NO4
1629911-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.6786 5.7998 0.0 0
M  V30 2 C 7.6584 5.7998 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 C 5.3348 3.8501 0.0 0 CFG=2
M  V30 6 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 7 O 4.0012 3.0801 0.0 0
M  V30 8 C 6.6685 4.6201 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 8.0022 3.8501 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0 CFG=1
M  V30 14 N 2.6673 2.3101 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 O 9.4091 3.2236 0.0 0
M  V30 17 O 8.1633 5.3816 0.0 0
M  V30 18 C 1.3337 4.6201 0.0 0
M  V30 19 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 20 C 10.4396 4.3682 0.0 0
M  V30 21 C 9.6696 5.7018 0.0 0
M  V30 22 C 0.0000 3.8501 0.0 0
M  V30 23 C 0.0000 2.3101 0.0 0
M  V30 24 H 2.6673 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 2 3 10
M  V30 4 1 19 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 7 CFG=1
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 12 17
M  V30 19 1 13 14
M  V30 20 1 13 18
M  V30 21 1 13 24 CFG=1
M  V30 22 1 14 19
M  V30 23 1 16 20
M  V30 24 1 17 21
M  V30 25 1 18 22
M  V30 26 1 19 23
M  V30 27 1 20 21
M  V30 28 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 5 6 13 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4S,6aS,10aS,11aR)-Decahydro-10a-hydroxy-4,10,10-trimethyl-6a-(methylamino)sp...
C19H32N2O4
1629911-32-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 0.7700 0.0 0
M  V30 2 C 6.6685 0.0000 0.0 0
M  V30 3 O 5.3348 5.3901 0.0 0
M  V30 4 O 4.0012 0.0000 0.0 0
M  V30 5 C 7.6584 5.7998 0.0 0
M  V30 6 C 5.6786 5.7998 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0 CFG=2
M  V30 9 C 5.3348 3.8501 0.0 0 CFG=1
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 6.6685 1.5400 0.0 0
M  V30 12 C 6.6685 4.6201 0.0 0
M  V30 13 C 4.0012 4.6201 0.0 0
M  V30 14 N 2.6673 2.3101 0.0 0
M  V30 15 C 8.0022 2.3101 0.0 0
M  V30 16 C 8.0022 3.8501 0.0 0
M  V30 17 C 2.6673 3.8501 0.0 0 CFG=1
M  V30 18 C 1.3337 1.5400 0.0 0 CFG=1
M  V30 19 O 9.4091 3.2236 0.0 0
M  V30 20 O 8.1633 5.3816 0.0 0
M  V30 21 C 1.3337 4.6201 0.0 0
M  V30 22 C 0.0000 2.3101 0.0 0
M  V30 23 C 10.4396 4.3682 0.0 0
M  V30 24 C 9.6696 5.7018 0.0 0
M  V30 25 C 0.0000 3.8501 0.0 0
M  V30 26 H 2.6673 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 8 1 CFG=3
M  V30 3 1 9 3 CFG=1
M  V30 4 2 4 10
M  V30 5 1 5 12
M  V30 6 1 6 12
M  V30 7 1 18 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 15 16
M  V30 20 1 16 19
M  V30 21 1 16 20
M  V30 22 1 17 21
M  V30 23 1 17 26 CFG=1
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 24
M  V30 27 1 21 25
M  V30 28 1 22 25
M  V30 29 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 8 9 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1629911-30-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629911-32-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-8358249
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4S,6aS,10aS,11aR)-10a-Hydroxy-4,10,10-trimethyl-6a-(methylamino)decahydrospiro[pyrido[1,2-b]isoquinoline-9,2'-[1,3]dioxolan]-6(6aH)-one
(63). A mixture of epoxyamide 62 (300 mg, 0.93 mmol) and aqueous
methylamine (4 mL, 40% w/w) was heated at 100 °C in a sealed tube for 48
h. The solution was allowed to cool to room temperature, and H2O (15 mL)
was added. The resulting mixture was extracted with CH2Cl2 (3 x 20 mL).
The combined organic layers were dried (Na2SO4) and concentrated under
reduced pressure. The residue was purified by flash chromatography,
eluting with EtOAc. 310 mg (94%) of aminoalcohol 63 as white solid. Mp
161-163 °C; 1H NMR (600 MHz) δ 4.68-4.64 (m, 1 H), 4.20 (d, J = 1.5 Hz, 1
H), 4.02-3.88 (comp, 4 H), 3.56-3.51 (m, 1 H), 2.25 (s, 3 H), 2.10 (dt, J
= 15.0, 3.6 Hz, 1 H), 1.93-1.85 (comp, 2 H), 1.81 (td, J = 15.0, 3.0 Hz,
1 H), 1.74-1.57 (comp, 6 H), 1.46 (dt, J = 13.2, 3.0 Hz, 1 H), 1.31 (s, 3
H), 1.21-1.14 (m, 1 H), 1.11 (d, J = 7.2 Hz, 3 H), 0.90 (s, 3 H); 13C NMR
(150 MHz) δ 172.5, 113.3, 76.4, 65.4, 64.18, 64.15, 47.3, 45.2, 44.2,
34.2, 31.3, 30.3, 30.2, 26.1, 21.9, 21.0, 19.2, 17.0, 14.4; IR (thin
film) 3503, 2935, 1633, 1426, 1322, 731 cm-1; HRMS-ESI m/z calculated for
[C19H33N2O4 (M+1)], 353.2435; found 353.2438.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Total Syntheses of Citrinadins A and B. Stereochemical
Revision of Their Assigned Structures
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bian, Zhiguo; Marvin, Christopher C.; Pettersson, Martin; Martin, Stephen
F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2014), 136(40), 14184-14192

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-9H-purin-2-amine
C16H18ClN5O7
16321-99-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.5542 9.0261 0.0 0
M  V30 2 C 4.3083 9.9314 0.0 0
M  V30 3 C 4.4693 11.4629 0.0 0
M  V30 4 O 2.9015 9.3049 0.0 0
M  V30 5 O 2.6527 7.3509 0.0 0
M  V30 6 C 1.4068 6.4457 0.0 0
M  V30 7 C 1.5679 4.9142 0.0 0
M  V30 8 O 0.0000 7.0720 0.0 0
M  V30 9 C 3.3494 4.0738 0.0 0
M  V30 10 O 3.8252 2.6091 0.0 0
M  V30 11 C 2.7948 1.4647 0.0 0
M  V30 12 C 3.2707 0.0000 0.0 0
M  V30 13 O 1.2884 1.7849 0.0 0
M  V30 14 Cl 13.1896 6.5238 0.0 0
M  V30 15 N 10.5223 1.9038 0.0 0
M  V30 16 C 6.5378 6.4640 0.0 0 CFG=2
M  V30 17 C 5.3933 7.4946 0.0 0 CFG=2
M  V30 18 O 5.9113 5.0572 0.0 0
M  V30 19 C 4.0596 6.7246 0.0 0 CFG=2
M  V30 20 C 4.3798 5.2182 0.0 0 CFG=2
M  V30 21 N 8.0441 6.7842 0.0 0
M  V30 22 C 9.1885 5.7538 0.0 0
M  V30 23 C 8.6704 8.1911 0.0 0
M  V30 24 C 10.5223 6.5238 0.0 0
M  V30 25 N 9.1885 4.2138 0.0 0
M  V30 26 N 10.2021 8.0302 0.0 0
M  V30 27 C 11.8559 5.7538 0.0 0
M  V30 28 C 10.5223 3.4438 0.0 0
M  V30 29 N 11.8559 4.2138 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 19 5 CFG=1
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 20 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 14 27
M  V30 15 1 15 28
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 21 CFG=3
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 22 25
M  V30 26 2 23 26
M  V30 27 1 24 26
M  V30 28 2 24 27
M  V30 29 1 25 28
M  V30 30 1 27 29
M  V30 31 2 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 16 17 19 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-Amino-N-methyladenosine
C11H16N6O4
5059-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 2.9016 7.1223 0.0 0
M  V30 2 N 10.5371 4.6201 0.0 0
M  V30 3 C 11.8709 3.8501 0.0 0
M  V30 4 N 7.8697 0.0000 0.0 0
M  V30 5 C 0.6967 2.1699 0.0 0
M  V30 6 O 1.1726 0.7053 0.0 0
M  V30 7 O 0.0000 5.4473 0.0 0
M  V30 8 N 5.3915 4.8805 0.0 0
M  V30 9 C 6.5361 3.8501 0.0 0
M  V30 10 C 6.0178 6.2873 0.0 0
M  V30 11 C 7.8697 4.6201 0.0 0
M  V30 12 N 6.5361 2.3101 0.0 0
M  V30 13 N 7.5496 6.1264 0.0 0
M  V30 14 C 9.2034 3.8501 0.0 0
M  V30 15 C 7.8697 1.5400 0.0 0
M  V30 16 N 9.2034 2.3101 0.0 0
M  V30 17 C 3.8852 4.5603 0.0 0 CFG=1
M  V30 18 O 3.2587 3.1534 0.0 0
M  V30 19 C 2.7406 5.5908 0.0 0 CFG=2
M  V30 20 C 1.7271 3.3145 0.0 0 CFG=2
M  V30 21 C 1.4070 4.8208 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 19 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 20 5 CFG=3
M  V30 7 1 21 7 CFG=1
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 17 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 13
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 1 14 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 17 19 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 16321-99-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5059-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5392903
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evidence for the Existence of a Specific G Protein-Coupled Receptor
Activated by Guanosine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Volpini, Rosaria; Marucci, Gabriella; Buccioni, Michela; Dal Ben, Diego;
Lambertucci, Catia; Lammi, Carmen; Mishra, Ram C.; Thomas, Ajiroghene;
Cristalli, Gloria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2011), 6(6), 1074-1080

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4,6-Dichloro-5-methyl-3-pyridinyl)methyl]-N-(2,6-difluoro-3,5-dimethoxyph...
C16H13Cl3F2N2O3
1632384-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 5.3901 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 6.6685 6.9302 0.0 0
M  V30 4 Cl 5.3348 7.7002 0.0 0
M  V30 5 O 8.0022 7.7002 0.0 0
M  V30 6 F 6.6685 2.3101 0.0 0
M  V30 7 F 9.3360 6.9302 0.0 0
M  V30 8 O 9.3360 0.7700 0.0 0
M  V30 9 C 10.6697 0.0000 0.0 0
M  V30 10 O 12.0033 5.3901 0.0 0
M  V30 11 C 13.3370 4.6201 0.0 0
M  V30 12 Cl 2.6673 3.0801 0.0 0
M  V30 13 C 0.0000 4.6201 0.0 0
M  V30 14 Cl 0.0000 7.7002 0.0 0
M  V30 15 C 8.0022 4.6201 0.0 0
M  V30 16 C 8.0022 3.0801 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 9.3360 2.3101 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 10.6697 3.0801 0.0 0
M  V30 21 C 4.0010 5.3901 0.0 0
M  V30 22 C 2.6673 4.6201 0.0 0
M  V30 23 C 4.0010 6.9302 0.0 0
M  V30 24 C 1.3337 5.3901 0.0 0
M  V30 25 N 2.6673 7.7002 0.0 0
M  V30 26 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 6 16
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 18
M  V30 11 1 10 11
M  V30 12 1 10 19
M  V30 13 1 12 22
M  V30 14 1 13 24
M  V30 15 1 14 26
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 22 1 21 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(4,6-Dichloro-5-methyl-3-pyridinyl)methyl]-N-(2,6-difluoro-3,5-dimethoxyph...
C17H17Cl2F2N3O3
1632384-93-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 5.3901 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 6.6685 6.9302 0.0 0
M  V30 4 N 8.0022 7.7002 0.0 0
M  V30 5 O 5.3348 7.7002 0.0 0
M  V30 6 C 8.0022 9.2402 0.0 0
M  V30 7 F 6.6685 2.3101 0.0 0
M  V30 8 F 9.3360 6.9302 0.0 0
M  V30 9 O 9.3360 0.7700 0.0 0
M  V30 10 C 10.6697 0.0000 0.0 0
M  V30 11 O 12.0033 5.3901 0.0 0
M  V30 12 C 13.3370 4.6201 0.0 0
M  V30 13 Cl 2.6673 3.0801 0.0 0
M  V30 14 C 0.0000 4.6201 0.0 0
M  V30 15 Cl 0.0000 7.7002 0.0 0
M  V30 16 C 8.0022 4.6201 0.0 0
M  V30 17 C 8.0022 3.0801 0.0 0
M  V30 18 C 9.3360 5.3901 0.0 0
M  V30 19 C 9.3360 2.3101 0.0 0
M  V30 20 C 10.6697 4.6201 0.0 0
M  V30 21 C 10.6697 3.0801 0.0 0
M  V30 22 C 4.0010 5.3901 0.0 0
M  V30 23 C 2.6673 4.6201 0.0 0
M  V30 24 C 4.0010 6.9302 0.0 0
M  V30 25 C 1.3337 5.3901 0.0 0
M  V30 26 N 2.6673 7.7002 0.0 0
M  V30 27 C 1.3337 6.9302 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 17
M  V30 9 1 8 18
M  V30 10 1 9 10
M  V30 11 1 9 19
M  V30 12 1 11 12
M  V30 13 1 11 20
M  V30 14 1 13 23
M  V30 15 1 14 25
M  V30 16 1 15 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 1 22 23
M  V30 24 2 22 24
M  V30 25 2 23 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 2 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1632384-92-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1632384-93-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-9983113
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heterocycles as FGFR inhibitors in the treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sun, Lin; Lu, Liang; Yao, Wenqing; Zhuo, Jincong; Wu, Liangxing; Xu,
Meizhong; Qian, Ding-Quan; Zhang, Fenglei; He, Chunhong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014172644 A2 2014-10-23

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-(dimethylamino)-3-isocyanato-2-propenoate
C8H12N2O3
1639290-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 4.0011 0.0 0
M  V30 2 C 5.3901 4.0011 0.0 0
M  V30 3 C 3.0800 2.6675 0.0 0
M  V30 4 N 3.0800 5.3348 0.0 0
M  V30 5 O 6.1601 2.6675 0.0 0
M  V30 6 O 6.1601 5.3348 0.0 0
M  V30 7 N 1.5400 2.6675 0.0 0
M  V30 8 C 3.8500 6.6686 0.0 0
M  V30 9 C 1.5400 5.3348 0.0 0
M  V30 10 C 7.7001 2.6675 0.0 0
M  V30 11 C 0.7700 1.3338 0.0 0
M  V30 12 C 8.4701 1.3338 0.0 0
M  V30 13 O 0.0000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 7 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Imidazole-4-carboxylic acid, 1-methyl-, ethyl ester
C7H10N2O2
41507-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 1.5400 0.0 0
M  V30 2 O 6.6363 2.3101 0.0 0
M  V30 3 O 5.3026 0.0000 0.0 0
M  V30 4 C 7.9700 1.5400 0.0 0
M  V30 5 C 9.3037 2.3101 0.0 0
M  V30 6 C 0.0000 2.6672 0.0 0
M  V30 7 C 3.9688 2.3101 0.0 0
M  V30 8 N 3.8079 3.8416 0.0 0
M  V30 9 C 2.5620 1.6836 0.0 0
M  V30 10 C 2.3016 4.1618 0.0 0
M  V30 11 N 1.5316 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 11
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1639290-39-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41507-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28395836
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):NOTES
$DATUM exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyrrolidinone derivatives as BET protein modulators
useful in treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blank, Jutta; Bold, Guido; Cotesta, Simona; Guagnano, Vito; Rueeger,
Heinrich; Vaupel, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014191894 A1 2014-12-04

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-ethyl-5,6-dihydrobenzofuro[3′,2′:2,3]oxepino[4,5-d]pyrimidine
C16H13ClN2O2
1639423-98-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.5400 0.5539 0.0 0
M  V30 2 C 1.5400 5.8887 0.0 0
M  V30 3 C 0.0000 5.8887 0.0 0
M  V30 4 C 6.1428 3.4507 0.0 0
M  V30 5 C 4.6200 3.2212 0.0 0
M  V30 6 C 7.2716 2.4033 0.0 0
M  V30 7 O 6.7900 4.8481 0.0 0
M  V30 8 C 3.8500 1.8876 0.0 0
M  V30 9 N 3.8500 4.5549 0.0 0
M  V30 10 C 8.6167 3.1533 0.0 0
M  V30 11 O 7.1566 0.8676 0.0 0
M  V30 12 C 8.3191 4.6642 0.0 0
M  V30 13 C 2.3100 1.8876 0.0 0
M  V30 14 C 4.4126 0.4540 0.0 0
M  V30 15 C 2.3100 4.5549 0.0 0
M  V30 16 C 10.0741 2.6556 0.0 0
M  V30 17 C 5.8842 0.0000 0.0 0
M  V30 18 C 9.4789 5.6774 0.0 0
M  V30 19 N 1.5400 3.2212 0.0 0
M  V30 20 C 11.2337 3.6688 0.0 0
M  V30 21 C 10.9362 5.1797 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 12
M  V30 16 2 10 16
M  V30 17 1 11 17
M  V30 18 2 12 18
M  V30 19 1 13 19
M  V30 20 1 14 17
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 1 18 21
M  V30 24 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl-5,6-dihydro-N-methylbenzofuro[3′,2′:2,3]oxepino[4,5-d]pyrimidin-4-amine
C17H17N3O2
1639454-52-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.4505 5.3901 0.0 0
M  V30 2 C 11.7843 4.6201 0.0 0
M  V30 3 C 7.7832 0.7700 0.0 0
M  V30 4 C 9.1168 0.0000 0.0 0
M  V30 5 C 5.0159 5.1827 0.0 0
M  V30 6 C 6.4495 4.6201 0.0 0
M  V30 7 C 4.5619 6.6543 0.0 0
M  V30 8 O 3.7566 4.2962 0.0 0
M  V30 9 C 7.7832 5.3901 0.0 0
M  V30 10 N 6.4495 3.0801 0.0 0
M  V30 11 C 3.0220 6.6773 0.0 0
M  V30 12 O 5.4294 7.9267 0.0 0
M  V30 13 C 2.5243 5.2199 0.0 0
M  V30 14 C 9.1168 4.6201 0.0 0
M  V30 15 C 8.0126 6.9129 0.0 0
M  V30 16 C 7.7832 2.3101 0.0 0
M  V30 17 C 2.0088 7.8371 0.0 0
M  V30 18 C 6.9653 8.0417 0.0 0
M  V30 19 C 1.0133 4.9223 0.0 0
M  V30 20 N 9.1168 3.0801 0.0 0
M  V30 21 C 0.4979 7.5394 0.0 0
M  V30 22 C 0.0000 6.0821 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 9 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 13
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 2 13 19
M  V30 20 1 14 20
M  V30 21 1 15 18
M  V30 22 2 16 20
M  V30 23 1 17 21
M  V30 24 1 19 22
M  V30 25 2 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1639423-98-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639454-52-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13756009
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polycyclic N-heterocyclic compounds. Part 76. Synthesis and antiplatelet
evaluation of 2,4-disubstituted
5,6-dihydro[1]benzofuro[3',2':2,3]oxepino[4,5-d]pyrimidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okuda, Kensuke; Takano, Jun-ichi; Hirota, Takashi; Sasaki, Kenji;
Nishina, Yuta; Ishida, Hiroyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2014), 51(3), 661-668

$RFMT $RIREG SCHEME399 STEP1
$RXN



  3  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diphenylacetylene
C14H10
501-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 C 8.4702 0.0000 0.0 0
M  V30 11 C 8.4702 2.6673 0.0 0
M  V30 12 C 10.0102 0.0000 0.0 0
M  V30 13 C 10.0102 2.6673 0.0 0
M  V30 14 C 10.7802 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 1 2 9
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetylbenzofuran
C10H8O2
1646-26-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0811 1.5400 0.0 0
M  V30 2 C 7.4149 2.3100 0.0 0
M  V30 3 O 6.0811 0.0000 0.0 0
M  V30 4 C 2.3100 2.8281 0.0 0
M  V30 5 C 3.0800 4.1618 0.0 0
M  V30 6 C 3.3406 1.6836 0.0 0
M  V30 7 C 0.7700 2.8281 0.0 0
M  V30 8 O 4.5865 3.8416 0.0 0
M  V30 9 C 2.3100 5.4954 0.0 0
M  V30 10 C 4.7474 2.3100 0.0 0
M  V30 11 C 0.0000 4.1618 0.0 0
M  V30 12 C 0.7700 5.4954 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 12
M  V30 13 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzofuro[2,3-c]pyridinium, 1,2-dimethyl-3,4-diphenyl-, tetrafluoroborate(1-)...
C25H20NO.BF4
1651171-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 4.6200 0.0 0
M  V30 2 C 2.6673 6.1600 0.0 0
M  V30 3 C 6.6684 8.4700 0.0 0
M  V30 4 C 5.3347 9.2400 0.0 0
M  V30 5 C 6.6684 6.9300 0.0 0
M  V30 6 C 8.1331 8.9459 0.0 0
M  V30 7 C 4.0011 8.4700 0.0 0
M  V30 8 O 8.1331 6.4541 0.0 0
M  V30 9 C 5.3347 6.1600 0.0 0
M  V30 10 C 9.0383 7.7000 0.0 0
M  V30 11 C 8.7594 10.3528 0.0 0
M  V30 12 N 4.0011 6.9300 0.0 0 CHG=1 VAL=4
M  V30 13 C 10.5698 7.8609 0.0 0
M  V30 14 C 10.2909 10.5138 0.0 0
M  V30 15 C 11.1962 9.2679 0.0 0
M  V30 16 C 5.3347 10.7800 0.0 0
M  V30 17 C 4.0011 11.5500 0.0 0
M  V30 18 C 6.6684 11.5500 0.0 0
M  V30 19 C 4.0011 13.0900 0.0 0
M  V30 20 C 6.6684 13.0900 0.0 0
M  V30 21 C 5.3347 13.8600 0.0 0
M  V30 22 C 2.6673 9.2400 0.0 0
M  V30 23 C 1.3336 8.4700 0.0 0
M  V30 24 C 2.6673 10.7800 0.0 0
M  V30 25 C 0.0000 9.2400 0.0 0
M  V30 26 C 1.3336 11.5500 0.0 0
M  V30 27 C 0.0000 10.7800 0.0 0
M  V30 28 B 5.5981 1.5400 0.0 0 CHG=3 VAL=4
M  V30 29 F 4.0581 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 30 F 7.1381 1.5400 0.0 0 CHG=-1 VAL=1
M  V30 31 F 5.5981 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 32 F 5.5981 3.0800 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 12
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 16
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 6 11
M  V30 12 2 7 12
M  V30 13 1 7 22
M  V30 14 1 8 10
M  V30 15 1 9 12
M  V30 16 2 10 13
M  V30 17 1 11 14
M  V30 18 1 13 15
M  V30 19 2 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 2 18 20
M  V30 24 2 19 21
M  V30 25 1 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 28 31
M  V30 35 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 501-65-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1646-26-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1651171-40-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6397240
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 13755-29-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12354-85-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Pyridinium Salts from Unsaturated Ketones, Amines and Alkynes A sealed
tube containing [Cp*RhCl2]2 (1.0 mol %), NaBF4 (0.31 mmol) and
Cu(OAc)2.H2O (0.56 mmol) was evacuated and purged with nitrogen gas three
times. Then, vinyl ketone 1 (0.34 mmol), amine 2 (0.28 mmol) and alkyne 3
(0.34 mmol) in MeOH (2.0 mL) were added to the system via syringe under a
nitrogen atmosphere and the reaction was allowed to stir at 80 °C for 24
h. When the reaction was completed, the mixture was diluted with CH2Cl2
(10 mL) and filtered through a Celite pad and the Celite pad was washed
several times with CH2Cl2 (50 mL). The combined filtrate was concentrated
in vacuo and the residue was purified by column chromatography on silica
gel using DCM/MeOH (95:5) as eluent. The desired pure product 4.
1,6-Dimethyl-2,3,4-triphenylpyridin-1-ium tetrafluoroborate (4a)
1,2-Dimethyl-3,4-diphenylbenzofuro[2,3-c]pyridin-2-ium tetrafluoroborate
(4ah) Yellow solid (115 mg, 94%). m.p. 307-309 °C; 1H NMR (400 MHz,
CDCl3): δ 7.73-7.66 (m, 2 H), 7.39-7.36 (m, 2 H), 7.32-7.27 (m, 6 H),
7.22-7.19 (m, 3 H), 6.90 (d, J = 8.0 Hz, 1 H), 4.04 (s, 3 H), 3.16 (s, 3
H); 13C NMR (100 MHz, CDCl3): δ 159.5 (C), 150.5 (C), 149.2 (C), 141.8
(C), 135.2 (C), 133.3 (C), 133.1 (CH), 132.9 (C), 131.6 (C), 130.0 (CH),
129.9 (2 CH), 129.3 (2 CH), 128.9 (CH), 128.8 (2 CH), 128.7 (2 CH), 124.9
(CH), 124.7 (CH), 121.1 (C), 112.9 (CH), 43.2 (CH3), 15.2 (CH3); HRMS
(FAB+) cal for C25H20ON+ 350.1539, found 350.1547; IR (KBr): 3054, 2923,
2854, 1735, 1643, 1442, 1396, 1319, 1180, 1056 (νB-F), 755 and 701 cm-1.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rhodium(III)-Catalyzed Vinylic C-H Activation: A Direct Route toward
Pyridinium Salts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luo, Ching-Zong; Jayakumar, Jayachandran; Gandeepan, Parthasarathy; Wu,
Yun-Ching; Cheng, Chien-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2015), 17(4), 924-927

$RFMT $RIREG SCHEME400 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[[2-[7-[(methylsulfonyl)oxy]heptyl]-1,3-dioxolan-2-yl]methyl]phosph...
C16H33O8PS
1647107-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5001 4.1294 0.0 0
M  V30 2 P 3.9685 3.9685 0.0 0 VAL=5
M  V30 3 O 2.4368 3.8074 0.0 0
M  V30 4 O 4.1294 2.4368 0.0 0
M  V30 5 O 3.8074 5.5001 0.0 0
M  V30 6 C 1.5317 5.0533 0.0 0
M  V30 7 C 2.8836 1.5317 0.0 0
M  V30 8 C 0.0000 4.8924 0.0 0
M  V30 9 C 3.0445 0.0000 0.0 0
M  V30 10 C 7.4601 4.7663 0.0 0
M  V30 11 C 8.7939 5.5363 0.0 0
M  V30 12 C 10.1276 4.7663 0.0 0
M  V30 13 C 11.4612 5.5363 0.0 0
M  V30 14 C 12.7949 4.7663 0.0 0
M  V30 15 C 14.1287 5.5363 0.0 0
M  V30 16 C 15.4624 4.7663 0.0 0
M  V30 17 O 16.7961 5.5363 0.0 0
M  V30 18 S 18.1297 4.7663 0.0 0 VAL=6
M  V30 19 C 18.8998 6.1001 0.0 0
M  V30 20 O 19.4636 3.9962 0.0 0
M  V30 21 O 17.3597 3.4326 0.0 0
M  V30 22 C 6.1264 5.5363 0.0 0
M  V30 23 O 7.0316 6.7823 0.0 0
M  V30 24 O 4.6618 6.0123 0.0 0
M  V30 25 C 6.1264 8.0282 0.0 0
M  V30 26 C 4.6618 7.5523 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 2 18 21
M  V30 22 1 22 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl P-[[2-[7-(methylamino)heptyl]-1,3-dioxolan-2-yl]methyl]phosphonate
C16H34NO5P
1647107-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 3.8500 0.0 0
M  V30 2 P 3.8500 3.8500 0.0 0 VAL=5
M  V30 3 O 2.3100 3.8500 0.0 0
M  V30 4 O 3.8500 2.3100 0.0 0
M  V30 5 O 3.8500 5.3900 0.0 0
M  V30 6 C 1.5400 5.1836 0.0 0
M  V30 7 C 2.5162 1.5400 0.0 0
M  V30 8 C 0.0000 5.1836 0.0 0
M  V30 9 C 2.5162 0.0000 0.0 0
M  V30 10 C 7.4059 4.2784 0.0 0
M  V30 11 C 8.8127 4.9049 0.0 0
M  V30 12 C 10.0585 3.9997 0.0 0
M  V30 13 C 11.4655 4.6260 0.0 0
M  V30 14 C 12.7113 3.7208 0.0 0
M  V30 15 C 14.1183 4.3473 0.0 0
M  V30 16 C 15.3641 3.4421 0.0 0
M  V30 17 N 16.7709 4.0684 0.0 0
M  V30 18 C 18.0168 3.1632 0.0 0
M  V30 19 C 6.1600 5.1836 0.0 0
M  V30 20 O 7.1904 6.3282 0.0 0
M  V30 21 O 4.7531 5.8101 0.0 0
M  V30 22 C 6.4204 7.6618 0.0 0
M  V30 23 C 4.9140 7.3416 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 19
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1647107-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1647107-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2870834
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Monomers for adhesive polymers. XV. Synthesis, photopolymerization, and
adhesive properties of polymerizable β-ketophosphonic acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Catel, Yohann; Bock, Thorsten; Moszner, Norbert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Polymer Science, Part A: Polymer Chemistry (2014), 52(24),
3550-3563

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (αE)-2-[(2,5-dimethylphenoxy)methyl]-α-(methoxyimino)benzeneacetate
C19H21NO4
167374-38-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 9.3360 2.3101 0.0 0
M  V30 4 O 6.6685 0.7700 0.0 0
M  V30 5 O 5.3348 3.0801 0.0 0
M  V30 6 O 10.6697 3.0801 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 O 4.0012 5.3901 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 8.0022 4.6201 0.0 0
M  V30 14 C 6.6685 5.3901 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 6.6685 6.9302 0.0 0
M  V30 17 C 9.3360 6.9302 0.0 0
M  V30 18 C 8.0022 7.7002 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 0.0000 4.6201 0.0 0
M  V30 23 C 1.3337 2.3101 0.0 0
M  V30 24 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 20
M  V30 13 1 12 23
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimoxystrobin
C19H22N2O3
149961-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 N 9.3360 2.3101 0.0 0
M  V30 4 N 6.6685 0.7700 0.0 0
M  V30 5 O 5.3348 3.0801 0.0 0
M  V30 6 O 10.6697 3.0801 0.0 0
M  V30 7 C 5.3348 0.0000 0.0 0
M  V30 8 C 12.0033 2.3101 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 O 4.0012 5.3901 0.0 0
M  V30 11 C 1.3337 6.9302 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 8.0022 4.6201 0.0 0
M  V30 14 C 6.6685 5.3901 0.0 0
M  V30 15 C 9.3360 5.3901 0.0 0
M  V30 16 C 6.6685 6.9302 0.0 0
M  V30 17 C 9.3360 6.9302 0.0 0
M  V30 18 C 8.0022 7.7002 0.0 0
M  V30 19 C 2.6673 4.6201 0.0 0
M  V30 20 C 1.3337 5.3901 0.0 0
M  V30 21 C 2.6673 3.0801 0.0 0
M  V30 22 C 0.0000 4.6201 0.0 0
M  V30 23 C 1.3337 2.3101 0.0 0
M  V30 24 C 0.0000 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 14
M  V30 11 1 10 19
M  V30 12 1 11 20
M  V30 13 1 12 23
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 167374-38-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 149961-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-16096170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Improved process for the synthesis of strobilurin fungicides viz
kresoxim-methyl, dimoxystrobin and orysastrobin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kamaraj, Pasumpon; Satam, Vijay Shrikant; Poonacha, Mohan; Vasania,
Kaizad; Durairaj, Sureshkumar; Naik, Parag; Lukka, Koteshwararao; Kadam,
Subhash; Hindupur, Rama Mohan; Prabhu, Venkatesh Moodbidri; Mane,
Avinash; Pati, Hari Narayan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM India, IN2014CH00264 A 2015-12-25

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]in...
C20H18N2O4
171596-41-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9149 2.3100 0.0 0
M  V30 2 O 3.5811 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5811 0.0000 0.0 0
M  V30 5 C 4.9149 6.9300 0.0 0
M  V30 6 C 3.5811 6.1600 0.0 0
M  V30 7 C 6.2486 6.1600 0.0 0 CFG=1
M  V30 8 N 4.5948 8.4363 0.0 0
M  V30 9 C 2.4368 7.1905 0.0 0
M  V30 10 C 3.5811 4.6200 0.0 0
M  V30 11 N 6.2486 4.6200 0.0 0
M  V30 12 C 3.0631 8.5972 0.0 0
M  V30 13 C 0.9052 7.0295 0.0 0
M  V30 14 C 4.9149 3.8500 0.0 0 CFG=2
M  V30 15 C 2.1579 9.8431 0.0 0
M  V30 16 C 0.0000 8.2754 0.0 0
M  V30 17 C 0.6263 9.6822 0.0 0
M  V30 18 C 7.5822 6.9300 0.0 0
M  V30 19 C 8.9159 6.1600 0.0 0
M  V30 20 C 7.5822 8.4700 0.0 0
M  V30 21 C 10.2497 6.9300 0.0 0
M  V30 22 C 8.9159 9.2400 0.0 0
M  V30 23 C 10.2497 8.4700 0.0 0
M  V30 24 O 11.7142 6.4540 0.0 0
M  V30 25 O 11.7142 8.9459 0.0 0
M  V30 26 C 12.6194 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 18 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 23
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1R,3R)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]...
C20H19N3O3
951661-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9149 2.3100 0.0 0
M  V30 2 N 3.5811 1.5400 0.0 0
M  V30 3 O 6.2486 1.5400 0.0 0
M  V30 4 C 3.5811 0.0000 0.0 0
M  V30 5 C 4.9149 6.9300 0.0 0
M  V30 6 C 3.5811 6.1600 0.0 0
M  V30 7 C 6.2486 6.1600 0.0 0 CFG=1
M  V30 8 N 4.5948 8.4363 0.0 0
M  V30 9 C 2.4368 7.1905 0.0 0
M  V30 10 C 3.5811 4.6200 0.0 0
M  V30 11 N 6.2486 4.6200 0.0 0
M  V30 12 C 3.0631 8.5972 0.0 0
M  V30 13 C 0.9052 7.0295 0.0 0
M  V30 14 C 4.9149 3.8500 0.0 0 CFG=2
M  V30 15 C 2.1579 9.8431 0.0 0
M  V30 16 C 0.0000 8.2754 0.0 0
M  V30 17 C 0.6263 9.6822 0.0 0
M  V30 18 C 7.5822 6.9300 0.0 0
M  V30 19 C 8.9159 6.1600 0.0 0
M  V30 20 C 7.5822 8.4700 0.0 0
M  V30 21 C 10.2497 6.9300 0.0 0
M  V30 22 C 8.9159 9.2400 0.0 0
M  V30 23 C 10.2497 8.4700 0.0 0
M  V30 24 O 11.7142 6.4540 0.0 0
M  V30 25 O 11.7142 8.9459 0.0 0
M  V30 26 C 12.6194 7.7000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 18 CFG=1
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 15 17
M  V30 20 2 16 17
M  V30 21 1 18 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 21 24
M  V30 27 2 22 23
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171596-41-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951661-82-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-38610461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective allosteric inhibitors of SARM1 for treatment of
neurodegenerative SARM1-modulated disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cravatt, Benjamin F.; Feldman, Hannah; Yokoyama, Minoru; Melillo, Bruno;
Schreiber, Stuart
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023235719 A2 2023-12-07

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrido[3,4-b]indole-3-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-2-(chloroa...
C22H19ClN2O5
171596-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7046 8.9402 0.0 0
M  V30 2 C 9.0383 9.7102 0.0 0
M  V30 3 O 6.3709 9.7102 0.0 0
M  V30 4 Cl 9.0383 11.2502 0.0 0
M  V30 5 C 10.3721 7.4001 0.0 0
M  V30 6 O 11.7058 6.6301 0.0 0
M  V30 7 O 10.3721 8.9402 0.0 0
M  V30 8 C 13.0394 7.4001 0.0 0
M  V30 9 C 6.3709 6.6301 0.0 0 CFG=1
M  V30 10 C 6.3709 5.0901 0.0 0
M  V30 11 N 7.7046 7.4001 0.0 0
M  V30 12 C 7.7046 4.3201 0.0 0
M  V30 13 N 5.2265 4.0597 0.0 0
M  V30 14 C 9.0383 6.6301 0.0 0 CFG=1
M  V30 15 C 7.3844 2.8138 0.0 0
M  V30 16 C 9.0383 5.0901 0.0 0
M  V30 17 C 5.8529 2.6527 0.0 0
M  V30 18 C 8.2897 1.5679 0.0 0
M  V30 19 C 5.2265 1.2459 0.0 0
M  V30 20 C 7.6633 0.1609 0.0 0
M  V30 21 C 6.1316 0.0000 0.0 0
M  V30 22 C 5.0373 7.4001 0.0 0
M  V30 23 C 3.7035 6.6301 0.0 0
M  V30 24 C 5.0373 8.9402 0.0 0
M  V30 25 C 2.3698 7.4001 0.0 0
M  V30 26 C 3.7035 9.7102 0.0 0
M  V30 27 C 2.3698 8.9402 0.0 0
M  V30 28 O 0.9052 6.9243 0.0 0
M  V30 29 O 0.9052 9.4160 0.0 0
M  V30 30 C 0.0000 8.1702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 14 5 CFG=1
M  V30 8 1 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 22 CFG=1
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 21
M  V30 25 1 22 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 25 28
M  V30 31 2 26 27
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyraz...
C22H19N3O4
171488-03-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 9.7101 0.0 0
M  V30 2 O 0.0000 6.6301 0.0 0
M  V30 3 C 0.0000 9.7101 0.0 0
M  V30 4 C 5.3348 6.6301 0.0 0 CFG=1
M  V30 5 C 5.3348 5.0901 0.0 0
M  V30 6 N 4.0011 7.4001 0.0 0
M  V30 7 C 4.0011 4.3201 0.0 0
M  V30 8 N 6.4792 4.0597 0.0 0
M  V30 9 C 2.6673 6.6301 0.0 0 CFG=1
M  V30 10 C 4.0011 8.9401 0.0 0
M  V30 11 C 4.3213 2.8138 0.0 0
M  V30 12 C 2.6673 5.0901 0.0 0
M  V30 13 C 5.8529 2.6527 0.0 0
M  V30 14 C 1.3337 7.4001 0.0 0
M  V30 15 C 2.6673 9.7101 0.0 0
M  V30 16 C 3.4161 1.5679 0.0 0
M  V30 17 C 6.4792 1.2459 0.0 0
M  V30 18 N 1.3337 8.9401 0.0 0
M  V30 19 C 4.0424 0.1609 0.0 0
M  V30 20 C 5.5741 0.0000 0.0 0
M  V30 21 C 6.6684 7.4001 0.0 0
M  V30 22 C 8.0021 6.6301 0.0 0
M  V30 23 C 6.6684 8.9401 0.0 0
M  V30 24 C 9.3359 7.4001 0.0 0
M  V30 25 C 8.0021 9.7101 0.0 0
M  V30 26 C 9.3359 8.9401 0.0 0
M  V30 27 O 10.8005 6.9242 0.0 0
M  V30 28 O 10.8005 9.4160 0.0 0
M  V30 29 C 11.7057 8.1701 0.0 0
M  V30 30 H 1.3337 5.8601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 14
M  V30 3 1 3 18
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 21 CFG=3
M  V30 7 2 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 8 13
M  V30 14 1 9 12
M  V30 15 1 9 14
M  V30 16 1 9 30 CFG=1
M  V30 17 1 10 15
M  V30 18 1 11 13
M  V30 19 2 11 16
M  V30 20 2 13 17
M  V30 21 1 14 18
M  V30 22 1 15 18
M  V30 23 1 16 19
M  V30 24 1 17 20
M  V30 25 2 19 20
M  V30 26 1 21 22
M  V30 27 2 21 23
M  V30 28 2 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 24 27
M  V30 32 2 25 26
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 171596-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 171488-03-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1773451
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
6-(1,3-Benzodioxol-5-yl)-2-butyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
(cis-11c). Representative example: A solution of cis-10c (0.6 g, 1.4
mmol, 1 equiv) and butylamine (0.28 mL, 2.8 mmol, 2 equiv) in methanol
(25 mL) was heated to reflux under a nitrogen atmosphere for 16 h. The
reaction mixture was cooled at room temperature and evaporated to dryness
under reduced pressure. The residue was dissolved in CH2Cl2, and the
organic layer was washed with water, dried over Na2SO4, filtered, and
concentrated to dryness. The crude product was then purified by flash
column chromatography eluting with toluene/AcOEt, 80/20.
6-(1,3-Benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
(cis-11i). The title compound was obtained from cis-10c and a 33%
solution of methylamine in ethanol as a white solid in 94% yield. mp
253-255 °C (MeOH); 1H NMR (CDCl3) δ 8.11 (s, 1H), 7.60 (m, 1H), 7.28-7.12
(m, 3H), 6.81 (d, 1H, J = 7.9 Hz), 6.71 (s, 1H), 6.66 (d, 1H, J = 8.1
Hz), 6.12 (s, 1H), 5.83 (d, 2H, J = 6.6 Hz), 4.28 (dd, 1H, J = 11.5, 4.3
Hz), 4.08 (d, 1H, J = 17.5 Hz), 3.90 (d, 1H, J = 17.5 Hz), 3.77 (dd, 1H,
J = 16.1, 4.3 Hz), 3.20 (dd, 1H, J = 16.1, 11.5 Hz), 3.02 (s, 3H); Anal.
(C22H19N3O4) C, H, N.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The discovery of tadalafil: a novel and highly selective PDE5 inhibitor.
2:
2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
analogue
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Daugan, Alain; Grondin, Pascal; Ruault, Cecile; Le Monnier de Gouville,
Anne-Charlotte; Coste, Herve; Linget, Jean Michel; Kirilovsky, Jorge;
Hyafil, Francois; Labaudiniere, Richard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2003), 46(21), 4533-4542

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-5-nitrobenzonitrile
C7H3FN2O2
17417-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 N 0.0000 0.7700 0.0 0
M  V30 3 F 1.3337 4.6201 0.0 0
M  V30 4 N 6.6686 1.5400 0.0 0 VAL=5
M  V30 5 O 6.6686 0.0000 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Methylamino)-5-nitrobenzonitrile
C8H7N3O2
85020-87-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3336 4.6200 0.0 0
M  V30 2 N 0.0000 5.3900 0.0 0
M  V30 3 N 1.3336 1.5400 0.0 0
M  V30 4 C 1.3336 0.0000 0.0 0
M  V30 5 N 6.6685 4.6200 0.0 0 VAL=5
M  V30 6 O 8.0021 3.8500 0.0 0
M  V30 7 O 6.6685 6.1600 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 4.6200 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17417-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 85020-87-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9087812
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Concomitant ring contraction cyclization strategy for the synthesis of
novel 4-oxo-4,5-dihydro-pyrroloquinolines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Manh, Gabriel Thia; Bakkali, Hicham; Maingot, Lucie; Pipelier, Muriel;
Joshi, Uday; Pradere, Jean Paul; Sabelle, Stephane; Tuloup, Remy;
Dubreuil, Didier
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(30), 5913-5916

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′,3′′,3′′′-(21H,23H-Porphine-5,10,15,20-tetrayl)tetrakis[2,4-dichlorobenze...
C44H18Cl12N4O8S4
177157-25-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  72 80 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0012 10.3650 0.0 0
M  V30 2 Cl 6.6685 14.9851 0.0 0
M  V30 3 S 1.3337 11.9051 0.0 0 VAL=6
M  V30 4 Cl 0.0000 11.1351 0.0 0
M  V30 5 O 2.1037 10.5714 0.0 0
M  V30 6 O 0.5637 13.2387 0.0 0
M  V30 7 Cl 10.3650 15.9755 0.0 0
M  V30 8 Cl 14.9851 13.3082 0.0 0
M  V30 9 Cl 9.6117 4.0012 0.0 0
M  V30 10 Cl 4.9916 6.6685 0.0 0
M  V30 11 S 11.9051 18.6430 0.0 0 VAL=6
M  V30 12 Cl 11.1351 19.9767 0.0 0
M  V30 13 O 10.5714 17.8730 0.0 0
M  V30 14 O 13.2387 19.4130 0.0 0
M  V30 15 S 8.0716 1.3337 0.0 0 VAL=6
M  V30 16 Cl 8.8416 0.0000 0.0 0
M  V30 17 O 9.4053 2.1037 0.0 0
M  V30 18 O 6.7380 0.5637 0.0 0
M  V30 19 Cl 15.9755 9.6117 0.0 0
M  V30 20 Cl 13.3082 4.9916 0.0 0
M  V30 21 S 18.6430 8.0716 0.0 0 VAL=6
M  V30 22 Cl 19.9767 8.8416 0.0 0
M  V30 23 O 17.8730 9.4053 0.0 0
M  V30 24 O 19.4130 6.7380 0.0 0
M  V30 25 C 6.6685 11.9051 0.0 0
M  V30 26 C 7.9601 12.7438 0.0 0
M  V30 27 C 6.5880 10.3670 0.0 0
M  V30 28 N 9.3979 12.1918 0.0 0
M  V30 29 C 8.0408 14.2817 0.0 0
M  V30 30 N 7.7849 9.3979 0.0 0
M  V30 31 C 5.2965 9.5283 0.0 0
M  V30 32 C 10.3670 13.3887 0.0 0
M  V30 33 C 9.5283 14.6802 0.0 0
M  V30 34 C 7.2329 7.9601 0.0 0
M  V30 35 C 5.6950 8.0408 0.0 0
M  V30 36 C 11.9051 13.3082 0.0 0
M  V30 37 C 8.0716 6.6685 0.0 0
M  V30 38 C 12.7438 12.0166 0.0 0
M  V30 39 C 9.6097 6.5880 0.0 0
M  V30 40 N 12.1918 10.5788 0.0 0
M  V30 41 C 14.2817 11.9359 0.0 0
M  V30 42 N 10.5788 7.7849 0.0 0
M  V30 43 C 10.4484 5.2965 0.0 0
M  V30 44 C 13.3887 9.6097 0.0 0
M  V30 45 C 14.6802 10.4484 0.0 0
M  V30 46 C 12.0166 7.2329 0.0 0
M  V30 47 C 11.9359 5.6950 0.0 0
M  V30 48 C 13.3082 8.0716 0.0 0
M  V30 49 C 5.3348 12.6751 0.0 0
M  V30 50 C 4.0012 11.9051 0.0 0
M  V30 51 C 5.3348 14.2151 0.0 0
M  V30 52 C 2.6673 12.6751 0.0 0
M  V30 53 C 4.0012 14.9851 0.0 0
M  V30 54 C 2.6675 14.2151 0.0 0
M  V30 55 C 12.6751 14.6419 0.0 0
M  V30 56 C 11.9051 15.9755 0.0 0
M  V30 57 C 14.2151 14.6419 0.0 0
M  V30 58 C 12.6751 17.3092 0.0 0
M  V30 59 C 14.9851 15.9755 0.0 0
M  V30 60 C 14.2151 17.3094 0.0 0
M  V30 61 C 7.3016 5.3348 0.0 0
M  V30 62 C 8.0716 4.0012 0.0 0
M  V30 63 C 5.7616 5.3348 0.0 0
M  V30 64 C 7.3016 2.6673 0.0 0
M  V30 65 C 4.9916 4.0012 0.0 0
M  V30 66 C 5.7616 2.6675 0.0 0
M  V30 67 C 14.6419 7.3016 0.0 0
M  V30 68 C 15.9755 8.0716 0.0 0
M  V30 69 C 14.6419 5.7616 0.0 0
M  V30 70 C 17.3094 7.3016 0.0 0
M  V30 71 C 15.9755 4.9916 0.0 0
M  V30 72 C 17.3092 5.7616 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 50
M  V30 2 1 2 51
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 52
M  V30 7 1 7 56
M  V30 8 1 8 57
M  V30 9 1 9 62
M  V30 10 1 10 63
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 11 14
M  V30 14 1 11 58
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 2 15 18
M  V30 18 1 15 64
M  V30 19 1 19 68
M  V30 20 1 20 69
M  V30 21 1 21 22
M  V30 22 2 21 23
M  V30 23 2 21 24
M  V30 24 1 21 70
M  V30 25 1 25 26
M  V30 26 2 25 27
M  V30 27 1 25 49
M  V30 28 1 26 28
M  V30 29 2 26 29
M  V30 30 1 27 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 33 1 29 33
M  V30 34 2 30 34
M  V30 35 2 31 35
M  V30 36 2 32 33
M  V30 37 1 32 36
M  V30 38 1 34 35
M  V30 39 1 34 37
M  V30 40 2 36 38
M  V30 41 1 36 55
M  V30 42 2 37 39
M  V30 43 1 37 61
M  V30 44 1 38 40
M  V30 45 1 38 41
M  V30 46 1 39 42
M  V30 47 1 39 43
M  V30 48 2 40 44
M  V30 49 2 41 45
M  V30 50 1 42 46
M  V30 51 2 43 47
M  V30 52 1 44 45
M  V30 53 1 44 48
M  V30 54 1 46 47
M  V30 55 2 46 48
M  V30 56 1 48 67
M  V30 57 2 49 50
M  V30 58 1 49 51
M  V30 59 1 50 52
M  V30 60 2 51 53
M  V30 61 2 52 54
M  V30 62 1 53 54
M  V30 63 2 55 56
M  V30 64 1 55 57
M  V30 65 1 56 58
M  V30 66 2 57 59
M  V30 67 2 58 60
M  V30 68 1 59 60
M  V30 69 2 61 62
M  V30 70 1 61 63
M  V30 71 1 62 64
M  V30 72 2 63 65
M  V30 73 2 64 66
M  V30 74 1 65 66
M  V30 75 2 67 68
M  V30 76 1 67 69
M  V30 77 1 68 70
M  V30 78 2 69 71
M  V30 79 2 70 72
M  V30 80 1 71 72
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,3′,3′′,3′′′-(21H,23H-Porphine-5,10,15,20-tetrayl)tetrakis[2,4-dichloro-N-me...
C48H34Cl8N8O8S4
1036956-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  76 84 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 11.6987 0.0 0
M  V30 2 Cl 8.0022 16.3188 0.0 0
M  V30 3 S 2.6673 13.2387 0.0 0 VAL=6
M  V30 4 N 1.3337 12.4687 0.0 0
M  V30 5 O 3.4374 11.9051 0.0 0
M  V30 6 O 1.8973 14.5724 0.0 0
M  V30 7 C 0.0000 13.2387 0.0 0
M  V30 8 Cl 11.6987 17.3092 0.0 0
M  V30 9 Cl 16.3188 14.6419 0.0 0
M  V30 10 Cl 10.9453 5.3348 0.0 0
M  V30 11 Cl 6.3252 8.0022 0.0 0
M  V30 12 S 13.2387 19.9767 0.0 0 VAL=6
M  V30 13 N 12.4687 21.3104 0.0 0
M  V30 14 O 14.5724 20.7467 0.0 0
M  V30 15 O 11.9051 19.2067 0.0 0
M  V30 16 C 13.2387 22.6440 0.0 0
M  V30 17 S 9.4053 2.6673 0.0 0 VAL=6
M  V30 18 N 10.1753 1.3337 0.0 0
M  V30 19 O 8.0716 1.8973 0.0 0
M  V30 20 O 10.7390 3.4374 0.0 0
M  V30 21 C 9.4053 0.0000 0.0 0
M  V30 22 Cl 17.3092 10.9453 0.0 0
M  V30 23 Cl 14.6419 6.3252 0.0 0
M  V30 24 S 19.9767 9.4053 0.0 0 VAL=6
M  V30 25 N 21.3104 10.1753 0.0 0
M  V30 26 O 19.2067 10.7390 0.0 0
M  V30 27 O 20.7467 8.0716 0.0 0
M  V30 28 C 22.6440 9.4053 0.0 0
M  V30 29 C 8.0022 13.2387 0.0 0
M  V30 30 C 9.2938 14.0774 0.0 0
M  V30 31 C 7.9216 11.7007 0.0 0
M  V30 32 N 10.7316 13.5255 0.0 0
M  V30 33 C 9.3745 15.6153 0.0 0
M  V30 34 N 9.1185 10.7316 0.0 0
M  V30 35 C 6.6302 10.8620 0.0 0
M  V30 36 C 11.7007 14.7224 0.0 0
M  V30 37 C 10.8620 16.0139 0.0 0
M  V30 38 C 8.5666 9.2938 0.0 0
M  V30 39 C 7.0287 9.3745 0.0 0
M  V30 40 C 13.2387 14.6419 0.0 0
M  V30 41 C 9.4053 8.0022 0.0 0
M  V30 42 C 14.0774 13.3502 0.0 0
M  V30 43 C 10.9433 7.9216 0.0 0
M  V30 44 N 13.5255 11.9125 0.0 0
M  V30 45 C 15.6153 13.2695 0.0 0
M  V30 46 N 11.9125 9.1185 0.0 0
M  V30 47 C 11.7820 6.6302 0.0 0
M  V30 48 C 14.7224 10.9433 0.0 0
M  V30 49 C 16.0139 11.7820 0.0 0
M  V30 50 C 13.3502 8.5666 0.0 0
M  V30 51 C 13.2695 7.0287 0.0 0
M  V30 52 C 14.6419 9.4053 0.0 0
M  V30 53 C 6.6685 14.0088 0.0 0
M  V30 54 C 5.3348 13.2387 0.0 0
M  V30 55 C 6.6685 15.5488 0.0 0
M  V30 56 C 4.0010 14.0088 0.0 0
M  V30 57 C 5.3348 16.3188 0.0 0
M  V30 58 C 4.0010 15.5488 0.0 0
M  V30 59 C 14.0088 15.9755 0.0 0
M  V30 60 C 13.2387 17.3092 0.0 0
M  V30 61 C 15.5488 15.9755 0.0 0
M  V30 62 C 14.0088 18.6429 0.0 0
M  V30 63 C 16.3188 17.3092 0.0 0
M  V30 64 C 15.5488 18.6429 0.0 0
M  V30 65 C 8.6353 6.6685 0.0 0
M  V30 66 C 9.4053 5.3348 0.0 0
M  V30 67 C 7.0952 6.6685 0.0 0
M  V30 68 C 8.6353 4.0010 0.0 0
M  V30 69 C 6.3252 5.3348 0.0 0
M  V30 70 C 7.0952 4.0010 0.0 0
M  V30 71 C 15.9755 8.6353 0.0 0
M  V30 72 C 17.3092 9.4053 0.0 0
M  V30 73 C 15.9755 7.0952 0.0 0
M  V30 74 C 18.6430 8.6353 0.0 0
M  V30 75 C 17.3092 6.3252 0.0 0
M  V30 76 C 18.6430 7.0952 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 54
M  V30 2 1 2 55
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 56
M  V30 7 1 4 7
M  V30 8 1 8 60
M  V30 9 1 9 61
M  V30 10 1 10 66
M  V30 11 1 11 67
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 2 12 15
M  V30 15 1 12 62
M  V30 16 1 13 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 2 17 20
M  V30 20 1 17 68
M  V30 21 1 18 21
M  V30 22 1 22 72
M  V30 23 1 23 73
M  V30 24 1 24 25
M  V30 25 2 24 26
M  V30 26 2 24 27
M  V30 27 1 24 74
M  V30 28 1 25 28
M  V30 29 1 29 30
M  V30 30 2 29 31
M  V30 31 1 29 53
M  V30 32 1 30 32
M  V30 33 2 30 33
M  V30 34 1 31 34
M  V30 35 1 31 35
M  V30 36 1 32 36
M  V30 37 1 33 37
M  V30 38 2 34 38
M  V30 39 2 35 39
M  V30 40 2 36 37
M  V30 41 1 36 40
M  V30 42 1 38 39
M  V30 43 1 38 41
M  V30 44 2 40 42
M  V30 45 1 40 59
M  V30 46 2 41 43
M  V30 47 1 41 65
M  V30 48 1 42 44
M  V30 49 1 42 45
M  V30 50 1 43 46
M  V30 51 1 43 47
M  V30 52 2 44 48
M  V30 53 2 45 49
M  V30 54 1 46 50
M  V30 55 2 47 51
M  V30 56 1 48 49
M  V30 57 1 48 52
M  V30 58 1 50 51
M  V30 59 2 50 52
M  V30 60 1 52 71
M  V30 61 2 53 54
M  V30 62 1 53 55
M  V30 63 1 54 56
M  V30 64 2 55 57
M  V30 65 2 56 58
M  V30 66 1 57 58
M  V30 67 2 59 60
M  V30 68 1 59 61
M  V30 69 1 60 62
M  V30 70 2 61 63
M  V30 71 2 62 64
M  V30 72 1 63 64
M  V30 73 2 65 66
M  V30 74 1 65 67
M  V30 75 1 66 68
M  V30 76 2 67 69
M  V30 77 2 68 70
M  V30 78 1 69 70
M  V30 79 2 71 72
M  V30 80 1 71 73
M  V30 81 1 72 74
M  V30 82 2 73 75
M  V30 83 2 74 76
M  V30 84 1 75 76
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 177157-25-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1036956-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-3957346
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of amphiphilic sulfonamide halogenated porphyrins: MALDI-TOFMS
characterization and evaluation of 1-octanol/water partition coefficients
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Monteiro, Carlos J. P.; Pereira, Mariette M.; Pinto, Sara M. A.; Simoes,
Ana V. C.; Sa, Goncalo F. F.; Arnaut, Luis G.; Formosinho, Sebastiao J.;
Simoes, Sergio; Wyatt, Mark F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2008), 64(22), 5132-5138

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Ethyl 4-(9-bicyclo[3.3.1]non-3-yl-9-azabicyclo[3.3.1]non-3-yl)-γ-[(carboxym...
C33H44N4O6
1781295-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 52 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.5334 9.3356 0.0 0
M  V30 2 C 13.0734 6.6684 0.0 0
M  V30 3 C 13.8434 8.0020 0.0 0
M  V30 4 N 13.8434 5.3347 0.0 0
M  V30 5 C 15.3834 8.0020 0.0 0
M  V30 6 O 13.0734 4.0009 0.0 0
M  V30 7 C 16.1534 9.3356 0.0 0
M  V30 8 C 13.8434 2.6673 0.0 0
M  V30 9 O 17.6934 9.3356 0.0 0
M  V30 10 O 15.3834 10.6694 0.0 0
M  V30 11 C 13.0734 1.3336 0.0 0
M  V30 12 C 18.4634 10.6694 0.0 0
M  V30 13 O 13.8434 0.0000 0.0 0
M  V30 14 O 11.5334 1.3336 0.0 0
M  V30 15 C 20.0034 10.6694 0.0 0
M  V30 16 N 9.2234 8.0020 0.0 0
M  V30 17 C 8.4534 6.6684 0.0 0
M  V30 18 C 10.7634 8.0020 0.0 0
M  V30 19 C 9.2234 5.3347 0.0 0
M  V30 20 C 6.9134 6.6684 0.0 0
M  V30 21 C 11.5334 6.6684 0.0 0
M  V30 22 N 10.7634 5.3347 0.0 0
M  V30 23 C 8.4534 4.0009 0.0 0
M  V30 24 C 6.1434 5.3347 0.0 0
M  V30 25 C 6.9134 4.0009 0.0 0
M  V30 26 C 8.4534 9.3356 0.0 0 CFG=2
M  V30 27 C 7.4317 10.1595 0.0 0
M  V30 28 C 8.2157 10.8573 0.0 0
M  V30 29 C 5.6718 10.1545 0.0 0 CFG=1
M  V30 30 C 6.3953 10.8827 0.0 0 CFG=2
M  V30 31 N 4.9323 11.2152 0.0 0
M  V30 32 C 5.5689 8.4643 0.0 0
M  V30 33 C 6.3061 9.1159 0.0 0
M  V30 34 C 7.0295 8.1398 0.0 0
M  V30 35 C 3.6549 12.0753 0.0 0 CFG=2
M  V30 36 C 2.3724 11.2184 0.0 0
M  V30 37 C 3.9666 13.5859 0.0 0
M  V30 38 C 0.8618 11.5301 0.0 0 CFG=2
M  V30 39 C 3.1097 14.8685 0.0 0 CFG=1
M  V30 40 C 1.3470 13.6295 0.0 0
M  V30 41 C 0.0134 12.8069 0.0 0
M  V30 42 C 1.6076 15.1744 0.0 0
M  V30 43 C 0.3166 14.3232 0.0 0
M  V30 44 H 4.1893 9.7377 0.0 0
M  V30 45 H 6.5776 12.4119 0.0 0
M  V30 46 H 0.0000 10.2539 0.0 0
M  V30 47 H 3.9683 16.1469 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 18
M  V30 2 1 2 3
M  V30 3 2 2 4 CFG=2
M  V30 4 1 2 21
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 26 16 CFG=1
M  V30 19 1 17 19
M  V30 20 2 17 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 2 19 23
M  V30 24 1 20 24
M  V30 25 2 21 22
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 29 32
M  V30 34 1 29 44 CFG=3
M  V30 35 1 30 31
M  V30 36 1 30 33
M  V30 37 1 30 45 CFG=1
M  V30 38 1 35 31 CFG=1
M  V30 39 1 32 34
M  V30 40 1 33 34
M  V30 41 1 35 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 1 38 40 CFG=1
M  V30 46 1 38 41
M  V30 47 1 38 46
M  V30 48 1 39 40 CFG=1
M  V30 49 1 39 42
M  V30 50 1 39 47
M  V30 51 1 41 43
M  V30 52 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(6 26 29 30 35 38 39)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Stereoisomer of 2-[[[1-[4-(9-bicyclo[3.3.1]non-3-yl-9-azabicyclo[3.3.1]non-3-...
C32H43N5O5
1781294-54-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.0192 6.6685 0.0 0
M  V30 2 C 13.0992 6.6685 0.0 0
M  V30 3 C 12.3292 5.3347 0.0 0
M  V30 4 N 14.6392 6.6685 0.0 0
M  V30 5 C 13.0992 4.0011 0.0 0
M  V30 6 O 15.4092 8.0021 0.0 0
M  V30 7 C 12.3292 2.6674 0.0 0
M  V30 8 C 16.9492 8.0021 0.0 0
M  V30 9 N 13.0992 1.3338 0.0 0
M  V30 10 O 10.7892 2.6674 0.0 0
M  V30 11 C 17.7192 9.3358 0.0 0
M  V30 12 C 12.3292 0.0000 0.0 0
M  V30 13 O 16.9492 10.6694 0.0 0
M  V30 14 O 19.2592 9.3358 0.0 0
M  V30 15 N 10.0192 9.3358 0.0 0
M  V30 16 C 10.7892 10.6694 0.0 0
M  V30 17 C 10.7892 8.0021 0.0 0
M  V30 18 C 12.3292 10.6694 0.0 0
M  V30 19 C 10.0192 12.0032 0.0 0
M  V30 20 C 12.3292 8.0021 0.0 0
M  V30 21 N 13.0992 9.3358 0.0 0
M  V30 22 C 13.0992 12.0032 0.0 0
M  V30 23 C 10.7892 13.3369 0.0 0
M  V30 24 C 12.3292 13.3369 0.0 0
M  V30 25 C 8.4792 9.3358 0.0 0 CFG=2
M  V30 26 C 7.2551 9.8087 0.0 0
M  V30 27 C 7.0427 8.7808 0.0 0
M  V30 28 C 6.3794 11.3353 0.0 0 CFG=1
M  V30 29 C 6.1104 10.3446 0.0 0 CFG=2
M  V30 30 N 5.0911 11.4454 0.0 0
M  V30 31 C 7.7918 12.2696 0.0 0
M  V30 32 C 7.5960 11.3053 0.0 0
M  V30 33 C 8.8029 11.1668 0.0 0
M  V30 34 C 3.7074 12.1216 0.0 0 CFG=2
M  V30 35 C 2.5550 11.0965 0.0 0
M  V30 36 C 3.8083 13.6609 0.0 0
M  V30 37 C 1.0159 11.1972 0.0 0 CFG=2
M  V30 38 C 2.7829 14.8131 0.0 0 CFG=1
M  V30 39 C 1.2077 13.3433 0.0 0
M  V30 40 C 0.0000 12.3451 0.0 0
M  V30 41 C 1.2531 14.9095 0.0 0
M  V30 42 C 0.0915 13.8888 0.0 0
M  V30 43 H 5.9991 12.8276 0.0 0
M  V30 44 H 4.8773 9.4222 0.0 0
M  V30 45 H 0.3380 9.8144 0.0 0
M  V30 46 H 3.4575 16.1977 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 17
M  V30 2 1 2 3
M  V30 3 2 2 4 CFG=2
M  V30 4 1 2 20
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 2 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 25 15 CFG=3
M  V30 18 1 16 18
M  V30 19 2 16 19
M  V30 20 1 17 20
M  V30 21 1 18 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 2 20 21
M  V30 25 1 22 24
M  V30 26 2 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 28 31
M  V30 33 1 28 43 CFG=1
M  V30 34 1 29 30
M  V30 35 1 29 32
M  V30 36 1 29 44 CFG=3
M  V30 37 1 34 30 CFG=1
M  V30 38 1 31 33
M  V30 39 1 32 33
M  V30 40 1 34 35
M  V30 41 1 34 36
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39 CFG=1
M  V30 45 1 37 40
M  V30 46 1 37 45
M  V30 47 1 38 39 CFG=1
M  V30 48 1 38 41
M  V30 49 1 38 46
M  V30 50 1 40 42
M  V30 51 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(6 25 28 29 34 37 38)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1781295-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1781294-54-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10273734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxime-substituted-quinoxaline-type piperidine compounds as
ORL-1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marra, Jeffrey Michael; Tsuno, Naoki; Ueno, Tatsuhiko; Zhou, Xiaoming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US9040533 B2 2015-05-26

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[(8R)-1-[(2S)-2-azidopropyl]-1,7,8,9-tetrahydropyrano[2,3-g]indazol...
C16H19N5O4
1818331-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1133 4.5978 0.0 0
M  V30 2 C 1.9688 3.5673 0.0 0 CFG=2
M  V30 3 N 2.2890 2.0609 0.0 0
M  V30 4 C 0.5042 4.0432 0.0 0
M  V30 5 N 1.1446 1.0304 0.0 0 CHG=1 VAL=4
M  V30 6 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 7 O 8.4437 4.5811 0.0 0
M  V30 8 C 9.9837 4.5811 0.0 0
M  V30 9 C 10.7537 3.2475 0.0 0
M  V30 10 O 12.2938 3.2475 0.0 0
M  V30 11 O 9.9837 1.9138 0.0 0
M  V30 12 C 13.0638 1.9138 0.0 0
M  V30 13 C 3.8236 7.2486 0.0 0
M  V30 14 C 5.3636 7.2486 0.0 0
M  V30 15 N 2.7930 6.1041 0.0 0
M  V30 16 C 3.0536 8.5823 0.0 0
M  V30 17 C 6.1336 8.5823 0.0 0
M  V30 18 C 6.1336 5.9150 0.0 0
M  V30 19 N 1.3862 6.7306 0.0 0
M  V30 20 C 1.5471 8.2621 0.0 0
M  V30 21 C 3.8236 9.9160 0.0 0
M  V30 22 C 5.3636 9.9160 0.0 0
M  V30 23 O 7.6737 8.5823 0.0 0
M  V30 24 C 7.6737 5.9150 0.0 0 CFG=1
M  V30 25 C 8.4437 7.2486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 24 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[[(8R)-1-[(2S)-2-Azidopropyl]-1,7,8,9-tetrahydropyrano[2,3-g]indazol-8-yl]o...
C16H20N6O3
1818331-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1133 4.5978 0.0 0
M  V30 2 C 1.9688 3.5673 0.0 0 CFG=2
M  V30 3 N 2.2890 2.0609 0.0 0
M  V30 4 C 0.5042 4.0432 0.0 0
M  V30 5 N 1.1446 1.0304 0.0 0 CHG=1 VAL=4
M  V30 6 N 0.0000 0.0000 0.0 0 CHG=-1
M  V30 7 O 8.4437 4.5811 0.0 0
M  V30 8 C 9.9837 4.5811 0.0 0
M  V30 9 C 10.7537 3.2475 0.0 0
M  V30 10 N 12.2938 3.2475 0.0 0
M  V30 11 O 9.9837 1.9138 0.0 0
M  V30 12 C 13.0638 1.9138 0.0 0
M  V30 13 C 3.8236 7.2486 0.0 0
M  V30 14 C 5.3636 7.2486 0.0 0
M  V30 15 N 2.7930 6.1041 0.0 0
M  V30 16 C 3.0536 8.5823 0.0 0
M  V30 17 C 6.1336 8.5823 0.0 0
M  V30 18 C 6.1336 5.9150 0.0 0
M  V30 19 N 1.3862 6.7306 0.0 0
M  V30 20 C 1.5471 8.2621 0.0 0
M  V30 21 C 3.8236 9.9160 0.0 0
M  V30 22 C 5.3636 9.9160 0.0 0
M  V30 23 O 7.6737 8.5823 0.0 0
M  V30 24 C 7.6737 5.9150 0.0 0 CFG=1
M  V30 25 C 8.4437 7.2486 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 2 3 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 24 7 CFG=3
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 2 13 16
M  V30 16 2 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 16 21
M  V30 21 1 17 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 2 19 20
M  V30 25 2 21 22
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1818331-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1818331-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6256668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ocular Hypotensive Response in Nonhuman Primates of
(8R)-1-[(2S)-2-Aminopropyl]-8,9-dihydro-7H-pyrano[2,3-g]indazol-8-ol a
Selective 5-HT2 Receptor Agonist
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM May, Jesse A.; Sharif, Najam A.; McLaughlin, Marsha A.; Chen,
Hwang-Hsing; Severns, Bryon S.; Kelly, Curtis R.; Holt, William F.;
Young, Richard; Glennon, Richard A.; Hellberg, Mark R.; Dean, Thomas R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2015), 58(22), 8818-8833

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2R)-4-[6-[[2-[4-[(3,3-Difluorocyclobutyl)oxy]-2-pyridinyl]acetyl]amino]-3...
C22H22F3N7O4
1853166-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7074 4.9318 0.0 0
M  V30 2 F 0.0000 3.4714 0.0 0
M  V30 3 F 1.0890 1.5853 0.0 0
M  V30 4 C 10.0423 4.9318 0.0 0
M  V30 5 C 11.3759 4.1618 0.0 0
M  V30 6 N 12.7096 4.9318 0.0 0
M  V30 7 O 11.3759 2.6218 0.0 0
M  V30 8 C 18.0444 1.8517 0.0 0
M  V30 9 C 19.3782 2.6218 0.0 0
M  V30 10 C 20.7119 1.8517 0.0 0 CFG=1
M  V30 11 C 22.0456 2.6218 0.0 0
M  V30 12 F 20.7119 0.3117 0.0 0
M  V30 13 C 27.3482 1.4946 0.0 0
M  V30 14 O 28.2535 0.2487 0.0 0
M  V30 15 O 27.9747 2.9016 0.0 0
M  V30 16 C 3.3738 4.1618 0.0 0
M  V30 17 C 2.9750 2.6743 0.0 0
M  V30 18 C 1.8861 4.5603 0.0 0
M  V30 19 C 1.4875 3.0728 0.0 0
M  V30 20 C 6.0411 4.1618 0.0 0
M  V30 21 C 7.3748 4.9318 0.0 0
M  V30 22 C 6.0411 2.6218 0.0 0
M  V30 23 C 8.7086 4.1618 0.0 0
M  V30 24 C 7.3748 1.8517 0.0 0
M  V30 25 N 8.7086 2.6218 0.0 0
M  V30 26 C 14.0434 4.1618 0.0 0
M  V30 27 C 14.0434 2.6218 0.0 0
M  V30 28 N 15.3771 4.9318 0.0 0
M  V30 29 C 15.3771 1.8517 0.0 0
M  V30 30 N 16.7108 4.1618 0.0 0
M  V30 31 C 16.7108 2.6218 0.0 0
M  V30 32 N 23.3793 1.8517 0.0 0
M  V30 33 C 24.7862 2.4782 0.0 0
M  V30 34 N 23.5403 0.3202 0.0 0
M  V30 35 C 25.8167 1.3337 0.0 0
M  V30 36 N 25.0466 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 20
M  V30 3 1 2 19
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 26
M  V30 10 1 8 9
M  V30 11 1 8 31
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 10 12 CFG=3
M  V30 15 1 11 32
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 35
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(3,3-Difluorocyclobutyl)oxy]-N-[6-[(3R)-3-fluoro-4-[4-[(methylamino)carbon...
C23H25F3N8O3
1853158-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7074 4.9318 0.0 0
M  V30 2 C 10.0423 4.9318 0.0 0
M  V30 3 C 11.3759 4.1618 0.0 0
M  V30 4 N 12.7097 4.9318 0.0 0
M  V30 5 O 11.3759 2.6218 0.0 0
M  V30 6 F 0.0000 3.4714 0.0 0
M  V30 7 F 1.0890 1.5853 0.0 0
M  V30 8 C 18.0446 1.8517 0.0 0
M  V30 9 C 19.3782 2.6218 0.0 0
M  V30 10 C 20.7119 1.8517 0.0 0 CFG=1
M  V30 11 C 22.0456 2.6218 0.0 0
M  V30 12 F 20.7119 0.3117 0.0 0
M  V30 13 C 27.3484 1.4946 0.0 0
M  V30 14 N 28.2536 0.2487 0.0 0
M  V30 15 O 27.9747 2.9016 0.0 0
M  V30 16 C 29.7852 0.4096 0.0 0
M  V30 17 C 6.0411 4.1618 0.0 0
M  V30 18 C 7.3749 4.9318 0.0 0
M  V30 19 C 6.0411 2.6218 0.0 0
M  V30 20 C 8.7086 4.1618 0.0 0
M  V30 21 C 7.3749 1.8517 0.0 0
M  V30 22 N 8.7086 2.6218 0.0 0
M  V30 23 C 3.3738 4.1618 0.0 0
M  V30 24 C 2.9752 2.6743 0.0 0
M  V30 25 C 1.8862 4.5603 0.0 0
M  V30 26 C 1.4875 3.0728 0.0 0
M  V30 27 C 14.0434 4.1618 0.0 0
M  V30 28 C 15.3771 4.9318 0.0 0
M  V30 29 N 14.0434 2.6218 0.0 0
M  V30 30 C 16.7108 4.1618 0.0 0
M  V30 31 N 15.3771 1.8517 0.0 0
M  V30 32 C 16.7108 2.6218 0.0 0
M  V30 33 N 23.3794 1.8517 0.0 0
M  V30 34 C 24.7862 2.4782 0.0 0
M  V30 35 N 23.5403 0.3202 0.0 0
M  V30 36 C 25.8168 1.3337 0.0 0
M  V30 37 N 25.0468 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 27
M  V30 8 1 6 26
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 10 12 CFG=3
M  V30 15 1 11 33
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 36
M  V30 19 1 14 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1853166-27-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1853158-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23722043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1)
Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Soth, Michael J.; Le, Kang; Di Francesco, Maria Emilia; Hamilton, Matthew
M.; Liu, Gang; Burke, Jason P.; Carroll, Chris L.; Kovacs, Jeffrey J.;
Bardenhagen, Jennifer P.; Bristow, Christopher A.; Cardozo, Mario; Czako,
Barbara; de Stanchina, Elisa; Feng, Ningping; Garvey, Jill R.; Gay, Jason
P.; Geck Do, Mary K.; Greer, Jennifer; Han, Michelle; Harris, Angela;
Herrera, Zachary; Huang, Sha; Giuliani, Virginia; Jiang, Yongying;
Johnson, Sarah B.; Johnson, Troy A.; Kang, Zhijun; Leonard, Paul G.; Liu,
Zhen; McAfoos, Timothy; Miller, Meredith; Morlacchi, Pietro; Mullinax,
Robert A.; Palmer, Wylie S.; Pang, Jihai; Rogers, Norma; Rudin, Charles
M.; Shepard, Hannah E.; Spencer, Nakia D.; Theroff, Jay; Wu, Qi; Xu,
Alan; Yau, Ju Anne; Draetta, Giulio; Toniatti, Carlo; Heffernan, Timothy
P.; Jones, Philip
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2020), 63(21), 12957-12977

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2R)-4-[6-[[2-[4-[(3,3-Difluorocyclobutyl)oxy]-2-pyridinyl]acetyl]amino]-3...
C22H22F3N7O4
1853166-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7074 4.9318 0.0 0
M  V30 2 F 0.0000 3.4714 0.0 0
M  V30 3 F 1.0890 1.5853 0.0 0
M  V30 4 C 10.0423 4.9318 0.0 0
M  V30 5 C 11.3759 4.1618 0.0 0
M  V30 6 N 12.7096 4.9318 0.0 0
M  V30 7 O 11.3759 2.6218 0.0 0
M  V30 8 C 18.0444 1.8517 0.0 0
M  V30 9 C 19.3782 2.6218 0.0 0
M  V30 10 C 20.7119 1.8517 0.0 0 CFG=1
M  V30 11 C 22.0456 2.6218 0.0 0
M  V30 12 F 20.7119 0.3117 0.0 0
M  V30 13 C 27.3482 1.4946 0.0 0
M  V30 14 O 28.2535 0.2487 0.0 0
M  V30 15 O 27.9747 2.9016 0.0 0
M  V30 16 C 3.3738 4.1618 0.0 0
M  V30 17 C 2.9750 2.6743 0.0 0
M  V30 18 C 1.8861 4.5603 0.0 0
M  V30 19 C 1.4875 3.0728 0.0 0
M  V30 20 C 6.0411 4.1618 0.0 0
M  V30 21 C 7.3748 4.9318 0.0 0
M  V30 22 C 6.0411 2.6218 0.0 0
M  V30 23 C 8.7086 4.1618 0.0 0
M  V30 24 C 7.3748 1.8517 0.0 0
M  V30 25 N 8.7086 2.6218 0.0 0
M  V30 26 C 14.0434 4.1618 0.0 0
M  V30 27 C 14.0434 2.6218 0.0 0
M  V30 28 N 15.3771 4.9318 0.0 0
M  V30 29 C 15.3771 1.8517 0.0 0
M  V30 30 N 16.7108 4.1618 0.0 0
M  V30 31 C 16.7108 2.6218 0.0 0
M  V30 32 N 23.3793 1.8517 0.0 0
M  V30 33 C 24.7862 2.4782 0.0 0
M  V30 34 N 23.5403 0.3202 0.0 0
M  V30 35 C 25.8167 1.3337 0.0 0
M  V30 36 N 25.0466 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 20
M  V30 3 1 2 19
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 26
M  V30 10 1 8 9
M  V30 11 1 8 31
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 10 12 CFG=3
M  V30 15 1 11 32
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 35
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(3,3-Difluorocyclobutyl)oxy]-N-[6-[(3R)-3-fluoro-4-[4-[(methylamino)carbon...
C23H25F3N8O3
1853158-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7074 4.9318 0.0 0
M  V30 2 C 10.0423 4.9318 0.0 0
M  V30 3 C 11.3759 4.1618 0.0 0
M  V30 4 N 12.7097 4.9318 0.0 0
M  V30 5 O 11.3759 2.6218 0.0 0
M  V30 6 F 0.0000 3.4714 0.0 0
M  V30 7 F 1.0890 1.5853 0.0 0
M  V30 8 C 18.0446 1.8517 0.0 0
M  V30 9 C 19.3782 2.6218 0.0 0
M  V30 10 C 20.7119 1.8517 0.0 0 CFG=1
M  V30 11 C 22.0456 2.6218 0.0 0
M  V30 12 F 20.7119 0.3117 0.0 0
M  V30 13 C 27.3484 1.4946 0.0 0
M  V30 14 N 28.2536 0.2487 0.0 0
M  V30 15 O 27.9747 2.9016 0.0 0
M  V30 16 C 29.7852 0.4096 0.0 0
M  V30 17 C 6.0411 4.1618 0.0 0
M  V30 18 C 7.3749 4.9318 0.0 0
M  V30 19 C 6.0411 2.6218 0.0 0
M  V30 20 C 8.7086 4.1618 0.0 0
M  V30 21 C 7.3749 1.8517 0.0 0
M  V30 22 N 8.7086 2.6218 0.0 0
M  V30 23 C 3.3738 4.1618 0.0 0
M  V30 24 C 2.9752 2.6743 0.0 0
M  V30 25 C 1.8862 4.5603 0.0 0
M  V30 26 C 1.4875 3.0728 0.0 0
M  V30 27 C 14.0434 4.1618 0.0 0
M  V30 28 C 15.3771 4.9318 0.0 0
M  V30 29 N 14.0434 2.6218 0.0 0
M  V30 30 C 16.7108 4.1618 0.0 0
M  V30 31 N 15.3771 1.8517 0.0 0
M  V30 32 C 16.7108 2.6218 0.0 0
M  V30 33 N 23.3794 1.8517 0.0 0
M  V30 34 C 24.7862 2.4782 0.0 0
M  V30 35 N 23.5403 0.3202 0.0 0
M  V30 36 C 25.8168 1.3337 0.0 0
M  V30 37 N 25.0468 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 27
M  V30 8 1 6 26
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 10 12 CFG=3
M  V30 15 1 11 33
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 36
M  V30 19 1 14 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1853166-27-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1853158-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15861651
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazole carboxamide derivatives as GLS1 inhibitors
disease useful for treatment of cancer and immunological and neurological
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Di Francesco, Maria Emilia; Jones, Philip; Heffernan, Timothy; Hamilton,
Matthew M.; Kang, Zhijun; Soth, Michael J.; Burke, Jason P.; Le, Kang;
Carroll, Christopher Lawrence; Palmer, Wylie S.; Lewis, Richard; McAfoos,
Timothy; Czako, Barbara; Liu, Gang; Theroff, Jay; Herrera, Zachary; Yau,
Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20160009704 A1 2016-01-14

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2R)-4-[6-[[2-[4-[(3,3-Difluorocyclobutyl)oxy]-2-pyridinyl]acetyl]amino]-3...
C22H22F3N7O4
1853166-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7074 4.9318 0.0 0
M  V30 2 F 0.0000 3.4714 0.0 0
M  V30 3 F 1.0890 1.5853 0.0 0
M  V30 4 C 10.0423 4.9318 0.0 0
M  V30 5 C 11.3759 4.1618 0.0 0
M  V30 6 N 12.7096 4.9318 0.0 0
M  V30 7 O 11.3759 2.6218 0.0 0
M  V30 8 C 18.0444 1.8517 0.0 0
M  V30 9 C 19.3782 2.6218 0.0 0
M  V30 10 C 20.7119 1.8517 0.0 0 CFG=1
M  V30 11 C 22.0456 2.6218 0.0 0
M  V30 12 F 20.7119 0.3117 0.0 0
M  V30 13 C 27.3482 1.4946 0.0 0
M  V30 14 O 28.2535 0.2487 0.0 0
M  V30 15 O 27.9747 2.9016 0.0 0
M  V30 16 C 3.3738 4.1618 0.0 0
M  V30 17 C 2.9750 2.6743 0.0 0
M  V30 18 C 1.8861 4.5603 0.0 0
M  V30 19 C 1.4875 3.0728 0.0 0
M  V30 20 C 6.0411 4.1618 0.0 0
M  V30 21 C 7.3748 4.9318 0.0 0
M  V30 22 C 6.0411 2.6218 0.0 0
M  V30 23 C 8.7086 4.1618 0.0 0
M  V30 24 C 7.3748 1.8517 0.0 0
M  V30 25 N 8.7086 2.6218 0.0 0
M  V30 26 C 14.0434 4.1618 0.0 0
M  V30 27 C 14.0434 2.6218 0.0 0
M  V30 28 N 15.3771 4.9318 0.0 0
M  V30 29 C 15.3771 1.8517 0.0 0
M  V30 30 N 16.7108 4.1618 0.0 0
M  V30 31 C 16.7108 2.6218 0.0 0
M  V30 32 N 23.3793 1.8517 0.0 0
M  V30 33 C 24.7862 2.4782 0.0 0
M  V30 34 N 23.5403 0.3202 0.0 0
M  V30 35 C 25.8167 1.3337 0.0 0
M  V30 36 N 25.0466 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 1 20
M  V30 3 1 2 19
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 26
M  V30 10 1 8 9
M  V30 11 1 8 31
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 10 12 CFG=3
M  V30 15 1 11 32
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 35
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[(3,3-Difluorocyclobutyl)oxy]-N-[6-[(3R)-3-fluoro-4-[4-[(methylamino)carbon...
C23H25F3N8O3
1853158-57-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.7074 4.9318 0.0 0
M  V30 2 C 10.0423 4.9318 0.0 0
M  V30 3 C 11.3759 4.1618 0.0 0
M  V30 4 N 12.7097 4.9318 0.0 0
M  V30 5 O 11.3759 2.6218 0.0 0
M  V30 6 F 0.0000 3.4714 0.0 0
M  V30 7 F 1.0890 1.5853 0.0 0
M  V30 8 C 18.0446 1.8517 0.0 0
M  V30 9 C 19.3782 2.6218 0.0 0
M  V30 10 C 20.7119 1.8517 0.0 0 CFG=1
M  V30 11 C 22.0456 2.6218 0.0 0
M  V30 12 F 20.7119 0.3117 0.0 0
M  V30 13 C 27.3484 1.4946 0.0 0
M  V30 14 N 28.2536 0.2487 0.0 0
M  V30 15 O 27.9747 2.9016 0.0 0
M  V30 16 C 29.7852 0.4096 0.0 0
M  V30 17 C 6.0411 4.1618 0.0 0
M  V30 18 C 7.3749 4.9318 0.0 0
M  V30 19 C 6.0411 2.6218 0.0 0
M  V30 20 C 8.7086 4.1618 0.0 0
M  V30 21 C 7.3749 1.8517 0.0 0
M  V30 22 N 8.7086 2.6218 0.0 0
M  V30 23 C 3.3738 4.1618 0.0 0
M  V30 24 C 2.9752 2.6743 0.0 0
M  V30 25 C 1.8862 4.5603 0.0 0
M  V30 26 C 1.4875 3.0728 0.0 0
M  V30 27 C 14.0434 4.1618 0.0 0
M  V30 28 C 15.3771 4.9318 0.0 0
M  V30 29 N 14.0434 2.6218 0.0 0
M  V30 30 C 16.7108 4.1618 0.0 0
M  V30 31 N 15.3771 1.8517 0.0 0
M  V30 32 C 16.7108 2.6218 0.0 0
M  V30 33 N 23.3794 1.8517 0.0 0
M  V30 34 C 24.7862 2.4782 0.0 0
M  V30 35 N 23.5403 0.3202 0.0 0
M  V30 36 C 25.8168 1.3337 0.0 0
M  V30 37 N 25.0468 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 2 20
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 27
M  V30 8 1 6 26
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 1 8 32
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 10 12 CFG=3
M  V30 15 1 11 33
M  V30 16 1 13 14
M  V30 17 2 13 15
M  V30 18 1 13 36
M  V30 19 1 14 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1853166-27-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1853158-57-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-15890783
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazole carboxamide derivatives as GLS1 inhibitors
disease useful for treatment of cancer and immunological and neurological
disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Di Francesco, Maria Emilia; Jones, Philip; Heffernan, Timothy; Hamilton,
Matthew; Kang, Zhijun; Soth, Michael P.; Burke, Jason P.; Le, Kang;
Carroll, Christopher Lawrence; Palmer, Wylie; Lewis, Richard; McAfoos,
Timothy; Czako, Barbara; Liu, Gang; Theroff, Jay; Herrera, Zachary; Yau,
Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016004404 A2 2016-01-07

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Methylamine
CH5N
74-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 N 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 5-(hydroxymethyl)-4-[(triphenylmethoxy)methyl]-1H-1,2,3-triazole-1-acetate
C27H27N3O4
1872201-37-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9537 0.0 0
M  V30 4 C 8.8994 8.6642 0.0 0
M  V30 5 O 9.9298 9.8086 0.0 0
M  V30 6 C 12.0858 7.6289 0.0 0
M  V30 7 C 13.4926 7.0026 0.0 0
M  V30 8 O 14.7385 7.9076 0.0 0
M  V30 9 O 13.6536 5.4709 0.0 0
M  V30 10 C 16.1454 7.2813 0.0 0
M  V30 11 C 17.3913 8.1865 0.0 0
M  V30 12 C 4.6200 6.1600 0.0 0
M  V30 13 C 5.9537 6.9300 0.0 0
M  V30 14 C 3.2864 6.9300 0.0 0
M  V30 15 C 5.9537 8.4700 0.0 0
M  V30 16 C 3.2864 8.4700 0.0 0
M  V30 17 C 4.6200 9.2400 0.0 0
M  V30 18 C 4.6200 3.0800 0.0 0
M  V30 19 C 5.9537 2.3100 0.0 0
M  V30 20 C 3.2864 2.3100 0.0 0
M  V30 21 C 5.9537 0.7700 0.0 0
M  V30 22 C 3.2864 0.7700 0.0 0
M  V30 23 C 4.6200 0.0000 0.0 0
M  V30 24 C 3.0800 4.6200 0.0 0
M  V30 25 C 2.3100 3.2864 0.0 0
M  V30 26 C 2.3100 5.9537 0.0 0
M  V30 27 C 0.7700 3.2864 0.0 0
M  V30 28 C 0.7700 5.9537 0.0 0
M  V30 29 C 0.0000 4.6200 0.0 0
M  V30 30 C 8.4700 5.9537 0.0 0
M  V30 31 C 9.3753 7.1995 0.0 0
M  V30 32 N 9.3753 4.7078 0.0 0
M  V30 33 N 10.8398 6.7237 0.0 0
M  V30 34 N 10.8398 5.1837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 1 24
M  V30 5 1 2 3
M  V30 6 1 3 30
M  V30 7 1 4 5
M  V30 8 1 4 31
M  V30 9 1 6 7
M  V30 10 1 6 33
M  V30 11 1 7 8
M  V30 12 2 7 9
M  V30 13 1 8 10
M  V30 14 1 10 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Hydroxymethyl)-N-methyl-4-[(triphenylmethoxy)methyl]-1H-1,2,3-triazole-1-a...
C26H26N4O3
1872201-50-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.6200 0.0 0
M  V30 2 O 6.1600 4.6200 0.0 0
M  V30 3 C 6.9300 5.9537 0.0 0
M  V30 4 C 8.8994 8.6642 0.0 0
M  V30 5 O 9.9298 9.8086 0.0 0
M  V30 6 C 12.0858 7.6289 0.0 0
M  V30 7 C 13.4926 7.0026 0.0 0
M  V30 8 N 14.7385 7.9076 0.0 0
M  V30 9 O 13.6536 5.4709 0.0 0
M  V30 10 C 16.1454 7.2813 0.0 0
M  V30 11 C 4.6200 3.0800 0.0 0
M  V30 12 C 3.2864 2.3100 0.0 0
M  V30 13 C 5.9537 2.3100 0.0 0
M  V30 14 C 3.2864 0.7700 0.0 0
M  V30 15 C 5.9537 0.7700 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 3.0800 4.6200 0.0 0
M  V30 18 C 2.3100 3.2864 0.0 0
M  V30 19 C 2.3100 5.9537 0.0 0
M  V30 20 C 0.7700 3.2864 0.0 0
M  V30 21 C 0.7700 5.9537 0.0 0
M  V30 22 C 0.0000 4.6200 0.0 0
M  V30 23 C 4.6200 6.1600 0.0 0
M  V30 24 C 3.2864 6.9300 0.0 0
M  V30 25 C 5.9537 6.9300 0.0 0
M  V30 26 C 3.2864 8.4700 0.0 0
M  V30 27 C 5.9537 8.4700 0.0 0
M  V30 28 C 4.6200 9.2400 0.0 0
M  V30 29 C 8.4700 5.9537 0.0 0
M  V30 30 C 9.3753 7.1995 0.0 0
M  V30 31 N 9.3753 4.7078 0.0 0
M  V30 32 N 10.8400 6.7237 0.0 0
M  V30 33 N 10.8400 5.1837 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 1 23
M  V30 5 1 2 3
M  V30 6 1 3 29
M  V30 7 1 4 5
M  V30 8 1 4 30
M  V30 9 1 6 7
M  V30 10 1 6 32
M  V30 11 1 7 8
M  V30 12 2 7 9
M  V30 13 1 8 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 2 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74-89-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1872201-37-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1872201-50-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-7892479
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 94
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(5-(Hydroxymethyl)-4-((trityloxy)methyl)-1H-1,2,3-triazol-1-yl)-N-methylacetamide
(8) To a solution of 4 (914 mg, 2.0mmol) in CH2Cl2 at 0°C (ice bath) was
added methylamine (2 mL) and stirred for 10 min. The residue was
concentrated in vacuo and purified on a silica gel column using petroleum
ether-EtOAc (3:7, v/v) as eluent, Compound 8 (831 mg, 94%) as a white
solid. M.p.109°C ∼ 110°C. 1H NMR (400 MHz, DMSO-d6) δ 8.28 (d, J = 4.5
Hz, 1 H), 7.52-7.26 (m, 15 H), 5.34 (t, J = 5.4 Hz, 1 H), 5.13 (s, 2 H),
4.48 (d, J = 5.4 Hz, 2 H), 4.07 (s, 2H), 2.66 (d, J = 4.6 Hz, 3 H). 13C
NMR (101 MHz, DMSO-d6) δ 166.43, 144.02, 141.43, 136.22, 128.79, 128.46,
127.62, 87.04, 57.29, 51.57, 50.80, 26.13. HRMS calculated for
[C26H27N4O3+H]+: 443.2083, Found: 443.2084.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Bioactivity of Novel Trisubstituted Triazole Nucleosides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wen, Yi-Ning; Zhang, Zhi-Feng; Liu, Ning-Ning; Xiang, Yu-Hong; Zhang,
Zhuo-Yong; Andrei, Graciela; Snoeck, Robert; Schols, Dominique; Zhang,
Qing-Shan; Wu, Qin-Pei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nucleosides, Nucleotides & Nucleic Acids (2016), 35(3), 147-160

